data_2ad9_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ad9 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.2 t . . . . . 0 N--CA 1.478 0.93 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 -51.87 -7.49 0.05 Allowed 'General case' 0 N--CA 1.474 0.775 1 C-N-CA 132.408 4.283 . . . . 0.0 120.412 -155.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.294 5.7 p -99.31 129.63 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-N 121.991 2.178 . . . . 0.0 112.099 170.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 16.1 mt -105.84 157.87 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 128.157 2.583 . . . . 0.0 108.149 170.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -128.17 142.87 51.05 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.206 1.802 . . . . 0.0 110.455 179.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.0 mt -123.76 140.01 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 126.953 2.101 . . . . 0.0 109.957 -174.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.69 174.3 6.03 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 125.958 1.703 . . . . 0.0 112.056 172.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.496 ' HE3' ' CE2' ' A' ' 127' ' ' TYR . 2.5 mmtp 71.39 -2.92 2.25 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 128.341 2.656 . . . . 0.0 116.571 172.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -35.34 145.72 0.2 Allowed Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 129.977 3.311 . . . . 0.0 115.933 -164.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.26 165.23 1.01 Allowed 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.36 2.707 . . . . 0.0 115.126 176.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 37.7 pt -56.66 -31.59 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 128.197 2.599 . . . . 0.0 113.984 -169.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -161.45 41.71 0.15 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.455 1.902 . . . . 0.0 110.365 -177.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -57.63 157.93 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 O-C-N 121.544 -0.722 . . . . 0.0 110.898 174.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 14.4 t -123.71 154.7 39.06 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 122.559 1.171 . . . . 0.0 113.216 -175.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -54.78 -42.6 71.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.74 175.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.62 -36.96 55.59 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.088 0.852 . . . . 0.0 113.463 178.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -71.44 -52.34 18.99 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.911 1.284 . . . . 0.0 112.16 173.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 57.6 t -59.71 -46.25 93.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -177.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.9 pp -69.75 -34.24 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 O-C-N 120.553 -1.342 . . . . 0.0 112.422 175.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 74.8 m -67.8 -19.31 65.07 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 119.895 1.225 . . . . 0.0 111.742 175.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 62.5 mt -89.62 -15.53 32.54 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 172.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -101.3 -13.23 33.79 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-N 119.168 0.894 . . . . 0.0 114.977 172.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.3 mt -63.34 -44.98 84.31 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 116.563 2.06 . . . . 0.0 116.563 -175.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.1 -5.22 1.28 Allowed 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 124.441 3.428 . . . . 0.0 117.972 176.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -103.96 -39.93 6.4 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -164.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -154.77 -82.77 0.04 OUTLIER Glycine 0 CA--C 1.518 0.257 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 172.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 22.5 tptp -152.05 -8.98 0.2 Allowed 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 116.972 2.212 . . . . 0.0 116.972 174.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.443 ' CG1' ' HE1' ' A' ' 101' ' ' MET . 0.4 OUTLIER 27.18 109.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.173 0 C-N-CA 127.635 2.374 . . . . 0.0 115.449 -147.208 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.2 m -59.3 -36.62 75.94 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 119.678 -1.889 . . . . 0.0 112.226 170.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -162.56 178.23 8.75 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 115.903 1.816 . . . . 0.0 115.903 175.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -136.88 172.76 12.53 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.31 1.844 . . . . 0.0 112.601 155.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.43 156.27 45.17 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.923 1.689 . . . . 0.0 109.538 169.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 3.5 mtt -128.98 107.76 9.87 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.92 0.888 . . . . 0.0 111.81 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -78.34 54.4 1.4 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.226 1.01 . . . . 0.0 109.488 164.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 66.4 tttt -64.78 -27.37 68.84 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -159.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -65.62 -14.39 60.25 Favored Glycine 0 CA--C 1.541 1.718 0 C-N-CA 125.152 1.358 . . . . 0.0 115.707 171.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.01 2.89 17.09 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.887 1.675 . . . . 0.0 113.054 169.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 7.9 m120 50.66 54.27 11.48 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.656 1.582 . . . . 0.0 112.164 -167.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -132.12 168.52 17.85 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.166 0.986 . . . . 0.0 110.76 173.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -154.6 166.47 33.24 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.918 1.287 . . . . 0.0 112.102 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -111.5 156.08 22.26 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.119 1.768 . . . . 0.0 108.359 161.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 15.2 tt -139.69 106.69 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.979 1.312 . . . . 0.0 109.045 166.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -96.97 137.6 35.81 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 129.291 3.036 . . . . 0.0 111.135 -174.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.443 ' HE1' ' CG1' ' A' ' 85' ' ' VAL 0.316 19.9 tpp -133.04 150.55 52.11 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 115.842 1.793 . . . . 0.0 115.842 -167.282 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -71.92 -15.28 62.09 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 114.166 1.172 . . . . 0.0 114.166 -166.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.53 143.83 31.03 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.41 1.084 . . . . 0.0 110.234 -177.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -64.2 -37.74 88.55 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.637 0.775 . . . . 0.0 111.424 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -73.26 -39.73 65.19 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.764 0.826 . . . . 0.0 113.007 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -54.62 -51.52 65.1 Favored 'General case' 0 C--O 1.217 -0.62 0 C-N-CA 123.494 0.718 . . . . 0.0 110.618 169.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.62 -37.6 76.9 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -55.54 -49.62 72.17 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.995 0.816 . . . . 0.0 110.552 169.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -66.63 -29.49 69.54 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-O 118.067 -0.968 . . . . 0.0 111.691 174.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 11.6 ttp -71.73 -45.25 62.36 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 120.329 1.422 . . . . 0.0 110.154 -177.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -68.74 -40.4 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 O-C-N 121.334 -0.854 . . . . 0.0 112.068 175.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -68.43 -43.1 77.85 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.737 -0.602 . . . . 0.0 110.402 178.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -48.57 -44.91 37.15 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 125.428 1.491 . . . . 0.0 111.833 165.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -80.24 -14.87 58.08 Favored 'General case' 0 C--N 1.332 -0.194 0 O-C-N 121.032 -1.043 . . . . 0.0 112.837 -177.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 97.8 m -85.22 -13.55 49.57 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.763 1.225 . . . . 0.0 110.635 171.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.89 -56.04 2.62 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 129.02 2.928 . . . . 0.0 112.892 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 9.9 p -70.86 -32.49 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 127.948 2.499 . . . . 0.0 113.436 -162.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.458 ' CG2' ' H ' ' A' ' 126' ' ' ILE . 1.3 m -6.26 113.86 0.03 OUTLIER Pre-proline 0 N--CA 1.483 1.178 0 C-N-CA 128.857 2.863 . . . . 0.0 115.864 -129.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -75.61 -0.72 10.49 Favored 'Trans proline' 0 CA--C 1.553 1.441 0 C-N-CA 124.154 3.236 . . . . 0.0 114.384 -159.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.2 t 59.89 108.96 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.787 1 C-N-CA 131.903 4.081 . . . . 0.0 115.645 176.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.9 tt -76.02 80.47 2.88 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.852 2.061 . . . . 0.0 109.271 174.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . 0.332 0.1 OUTLIER 45.3 -13.91 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 1 C-N-CA 133.707 4.803 . . . . 0.0 119.301 -173.146 . . . . . . . . 4 3 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 178.46 12.09 0.02 OUTLIER Glycine 0 CA--C 1.537 1.436 0 C-N-CA 126.431 1.967 . . . . 0.0 115.029 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -142.53 156.13 63.59 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 126.53 1.932 . . . . 0.0 109.325 177.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_exo -53.32 166.74 1.0 Allowed 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 123.35 2.7 . . . . 0.0 114.339 167.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.458 ' H ' ' CG2' ' A' ' 118' ' ' THR . 0.7 OUTLIER -119.21 142.86 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.528 1.531 . . . . 0.0 108.858 178.196 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . 0.496 ' CE2' ' HE3' ' A' ' 65' ' ' LYS . 3.0 m-85 -114.16 98.68 7.1 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.633 -156.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.18 147.56 25.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 124.014 0.926 . . . . 0.0 113.449 -174.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -150.96 160.51 43.87 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.495 1.918 . . . . 0.0 109.924 161.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -54.12 152.01 6.46 Favored 'General case' 0 CA--C 1.553 1.059 0 O-C-N 120.976 -1.077 . . . . 0.0 112.213 160.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 28.5 t -75.04 159.64 31.49 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.513 1.125 . . . . 0.0 113.594 -172.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -67.99 -12.3 60.51 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 126.41 1.884 . . . . 0.0 112.389 166.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 55.8 m-70 -118.24 -176.49 3.08 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.884 2.074 . . . . 0.0 113.057 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -129.73 147.08 51.47 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 126.855 2.062 . . . . 0.0 109.456 164.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 51.87 92.07 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 127.348 2.259 . . . . 0.0 115.554 176.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 42.4 tp -64.72 139.8 58.8 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.337 1.455 . . . . 0.0 112.546 174.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.478 0.961 0 C-N-CA 126.496 1.918 . . . . 0.0 111.361 167.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 65.1 m . . . . . 0 N--CA 1.481 1.082 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 72.5 mtm-85 -117.58 -17.48 9.96 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 -166.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.364 10.8 p -98.17 136.85 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 121.077 1.762 . . . . 0.0 113.575 170.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.8 mt -113.2 156.93 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 128.947 2.899 . . . . 0.0 107.937 170.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -124.99 132.38 53.27 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.672 1.589 . . . . 0.0 109.906 177.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.0 mt -111.97 131.16 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 127.747 2.419 . . . . 0.0 108.484 -175.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -87.55 178.67 6.72 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 119.898 1.226 . . . . 0.0 110.65 170.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 23.6 mtpp 33.49 53.95 0.46 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 129.03 2.932 . . . . 0.0 115.081 156.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.7 mt -68.88 152.11 96.93 Favored Pre-proline 0 C--N 1.309 -1.17 0 CA-C-N 113.628 -1.624 . . . . 0.0 109.206 167.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -51.12 160.98 1.76 Allowed 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 125.022 3.815 . . . . 0.0 115.339 174.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 29.7 pt -65.38 -24.13 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 128.533 2.733 . . . . 0.0 113.914 -176.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -139.97 19.63 2.47 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.624 1.969 . . . . 0.0 111.891 -171.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -57.87 166.48 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 123.956 0.902 . . . . 0.0 112.881 175.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.1 t -132.29 156.64 46.19 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-O 122.523 1.154 . . . . 0.0 112.42 171.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.5 -34.98 67.5 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.907 174.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -59.65 -31.32 70.85 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 125.303 1.43 . . . . 0.0 113.782 175.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -75.28 -44.88 43.31 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.718 1.207 . . . . 0.0 111.538 173.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 66.3 t -64.24 -45.43 96.26 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.4 pp -71.37 -29.49 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 O-C-N 120.216 -1.553 . . . . 0.0 113.317 174.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 35.1 t -63.24 -28.73 70.23 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 119.264 0.938 . . . . 0.0 110.649 171.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.9 mt -82.67 -17.11 45.72 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 173.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -94.44 -19.8 31.55 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-N 119.198 0.908 . . . . 0.0 115.188 172.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 13.9 mt -68.49 -33.13 4.28 Favored Pre-proline 0 CA--C 1.54 0.558 0 N-CA-C 117.547 2.425 . . . . 0.0 117.547 -169.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -59.0 -5.14 2.51 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.199 2.599 . . . . 0.0 117.16 169.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -109.47 -36.89 5.86 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -163.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -161.3 -98.83 0.14 Allowed Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 167.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 21.2 tptp -136.24 -10.83 1.95 Allowed 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 115.819 1.785 . . . . 0.0 115.819 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.429 ' HA ' ' HA ' ' A' ' 101' ' ' MET . 0.1 OUTLIER 28.87 89.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 129.423 3.089 . . . . 0.0 113.389 -174.511 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.24 -42.03 94.41 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.793 2.037 . . . . 0.0 111.916 -173.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -152.0 168.73 24.27 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -144.21 170.65 15.57 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.003 1.721 . . . . 0.0 112.165 159.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.7 156.96 44.7 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.867 1.667 . . . . 0.0 109.328 -177.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 8.3 mtt -130.21 107.22 9.13 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.581 0.753 . . . . 0.0 112.234 -177.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -77.15 68.29 3.26 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.552 1.141 . . . . 0.0 109.378 167.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -56.08 -39.22 71.77 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.414 1.085 . . . . 0.0 113.481 -166.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -64.57 -20.97 66.47 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 124.673 1.13 . . . . 0.0 115.779 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -109.31 1.32 20.03 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.611 1.565 . . . . 0.0 112.737 174.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.0 m120 56.97 46.2 19.89 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.252 1.821 . . . . 0.0 113.417 -169.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -126.01 173.12 9.4 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 120.937 -1.102 . . . . 0.0 112.131 -177.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -152.22 160.92 43.28 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.53 1.132 . . . . 0.0 112.234 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 5.6 m-30 -99.56 154.09 18.53 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 155.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 17.1 tt -134.4 106.41 7.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 124.781 1.232 . . . . 0.0 107.979 165.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -105.44 122.18 45.45 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.714 1.605 . . . . 0.0 110.863 -172.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.429 ' HA ' ' HA ' ' A' ' 85' ' ' VAL . 0.9 OUTLIER -124.79 148.77 47.97 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 115.74 1.755 . . . . 0.0 115.74 -166.572 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.77 -17.88 63.51 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 115.558 1.688 . . . . 0.0 115.558 -158.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.9 p -139.78 146.76 39.88 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.378 0.609 . . . . 0.0 110.468 -178.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -62.05 -34.56 76.48 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.019 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -77.24 -38.09 51.87 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 114.225 1.195 . . . . 0.0 114.225 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.66 -49.53 77.2 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-N 119.486 1.039 . . . . 0.0 110.431 170.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.54 -36.82 76.72 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 177.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -58.3 -46.47 86.06 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 119.727 1.149 . . . . 0.0 111.23 170.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -64.82 -33.91 77.12 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 121.032 -1.042 . . . . 0.0 111.127 173.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 9.8 ttp -65.43 -51.5 59.82 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.539 1.136 . . . . 0.0 110.414 -179.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -65.98 -36.7 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 C-N-CA 125.215 1.406 . . . . 0.0 112.593 177.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -72.19 -40.84 67.6 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.129 0.877 . . . . 0.0 111.165 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -52.76 -40.29 62.99 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.924 0.89 . . . . 0.0 111.693 162.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -88.5 12.86 13.29 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 119.667 -1.896 . . . . 0.0 112.291 177.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 52.0 m -112.52 -12.09 13.52 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.897 1.679 . . . . 0.0 110.175 169.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.52 -41.06 63.52 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.007 1.723 . . . . 0.0 111.544 153.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -142.38 160.8 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 124.897 1.279 . . . . 0.0 112.182 -150.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 18.7 m -125.01 135.63 27.04 Favored Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 125.657 1.583 . . . . 0.0 107.728 164.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -75.28 -17.09 19.23 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 121.895 1.73 . . . . 0.0 114.166 -171.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 4.0 t 39.85 73.88 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 128.39 2.676 . . . . 0.0 111.76 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.646 ' H ' HD13 ' A' ' 126' ' ' ILE . 5.5 tt -92.24 -32.8 14.92 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 112.397 -2.183 . . . . 0.0 110.609 -121.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -136.99 39.35 2.55 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.701 1.201 . . . . 0.0 111.539 151.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 126.66 2.68 6.72 Favored Glycine 0 CA--C 1.535 1.298 0 N-CA-C 119.328 2.491 . . . . 0.0 119.328 160.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.64 168.39 11.16 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 121.991 2.896 . . . . 0.0 113.604 173.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -60.33 147.12 94.98 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.912 2.408 . . . . 0.0 114.387 -172.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.646 HD13 ' H ' ' A' ' 121' ' ' LEU . 26.0 mm -120.3 -55.93 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 125.294 1.438 . . . . 0.0 113.245 -163.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 65.36 150.46 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.841 2.456 . . . . 0.0 115.743 -173.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.66 150.67 22.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 C-N-CA 126.958 2.103 . . . . 0.0 110.601 172.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -139.34 159.93 41.01 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.287 1.035 . . . . 0.0 108.623 149.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -51.81 150.73 3.86 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.348 -0.845 . . . . 0.0 110.931 159.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 44.0 t -72.14 154.06 41.29 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.59 -0.694 . . . . 0.0 111.623 174.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -77.46 -18.7 56.92 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.061 0.544 . . . . 0.0 112.398 165.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 38.0 m-70 -80.36 176.04 10.13 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.216 1.406 . . . . 0.0 110.144 160.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -119.2 -9.67 9.92 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -173.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -175.91 175.36 1.98 Allowed 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 129.129 2.971 . . . . 0.0 109.889 -172.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 23.8 tp -138.2 122.52 18.24 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.735 1.614 . . . . 0.0 113.033 -164.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 63.2 tttm . . . . . 0 N--CA 1.474 0.746 0 C-N-CA 126.549 1.94 . . . . 0.0 110.506 170.779 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 29.0 t . . . . . 0 N--CA 1.473 0.685 0 CA-C-O 120.771 0.32 . . . . 0.0 110.949 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.1 -3.89 2.01 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 116.246 1.943 . . . . 0.0 116.246 -172.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.322 8.7 p -81.34 128.61 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-N 121.17 1.804 . . . . 0.0 112.634 166.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 15.8 mt -113.67 153.73 15.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 128.867 2.867 . . . . 0.0 107.456 174.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -123.96 142.35 51.23 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.434 1.494 . . . . 0.0 110.772 178.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.8 mt -119.53 138.25 50.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 127.828 2.451 . . . . 0.0 109.837 -172.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 17.0 mtt85 -96.87 176.38 6.0 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 119.488 1.04 . . . . 0.0 110.521 171.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp 44.23 42.67 5.29 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 126.958 2.103 . . . . 0.0 116.291 158.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.2 mp -55.98 161.29 3.71 Favored Pre-proline 0 CA--C 1.558 1.279 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.473 160.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -60.06 -68.42 0.05 OUTLIER 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.734 2.956 . . . . 0.0 113.996 -173.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.1 pt -164.23 -39.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 130.848 3.659 . . . . 0.0 108.812 -171.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -151.69 -29.5 0.17 Allowed 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 -177.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.415 HG21 ' H ' ' A' ' 71' ' ' THR 0.29 2.0 p 40.02 -150.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 127.141 2.176 . . . . 0.0 112.192 -166.236 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.415 ' H ' HG21 ' A' ' 70' ' ' VAL . 2.9 t -141.75 141.91 33.25 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 120.482 -1.386 . . . . 0.0 109.681 156.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -57.1 -32.58 66.45 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 176.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.92 -41.08 58.6 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 125.088 1.328 . . . . 0.0 113.353 170.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -69.21 -48.94 60.66 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.451 -1.029 . . . . 0.0 111.107 172.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.5 t -58.81 -50.38 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 123.146 0.579 . . . . 0.0 112.497 -176.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -76.37 -27.98 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 O-C-N 120.103 -1.623 . . . . 0.0 113.877 177.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 33.0 t -62.77 -26.79 68.89 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 120.022 1.283 . . . . 0.0 110.826 169.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 33.8 mt -83.71 -18.26 38.54 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 114.306 1.225 . . . . 0.0 114.306 170.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -87.87 -18.64 55.86 Favored Glycine 0 CA--C 1.536 1.383 0 CA-C-N 119.376 0.989 . . . . 0.0 113.832 170.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 17.8 mt -73.96 -16.8 0.28 Allowed Pre-proline 0 CA--C 1.542 0.67 0 N-CA-C 119.035 2.976 . . . . 0.0 119.035 -174.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -59.55 -5.07 2.95 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.593 2.195 . . . . 0.0 116.773 168.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.411 ' CD2' ' HG3' ' A' ' 110' ' ' MET . 24.8 m-85 -120.66 -36.09 3.25 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -166.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -162.95 -101.59 0.16 Allowed Glycine 0 CA--C 1.523 0.548 0 C-N-CA 123.724 0.678 . . . . 0.0 111.782 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 32.2 tptt -147.73 -9.99 0.41 Allowed 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 117.348 2.351 . . . . 0.0 117.348 -174.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.416 ' CB ' ' HE1' ' A' ' 101' ' ' MET . 0.0 OUTLIER 32.21 89.03 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 C-N-CA 128.927 2.891 . . . . 0.0 113.651 -175.693 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 38.1 m -55.87 -40.65 73.26 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 127.142 2.177 . . . . 0.0 112.264 -175.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -153.18 168.81 24.72 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -141.89 173.53 11.42 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.685 1.594 . . . . 0.0 112.303 158.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.9 154.97 39.21 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.85 1.66 . . . . 0.0 109.678 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 14.8 mtt -129.66 110.57 11.9 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.934 0.894 . . . . 0.0 112.219 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -75.17 76.92 2.32 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 122.518 1.151 . . . . 0.0 109.761 169.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.17 -13.75 8.33 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.894 1.678 . . . . 0.0 115.309 -176.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -58.15 -40.9 94.35 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.685 1.612 . . . . 0.0 114.694 170.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -136.85 10.54 3.1 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 -162.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 52.65 49.37 20.5 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.022 1.329 . . . . 0.0 112.981 -167.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -113.52 167.09 10.89 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.516 0.726 . . . . 0.0 110.191 170.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -155.55 163.12 40.41 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 120.734 -1.229 . . . . 0.0 111.318 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 6.0 m-30 -108.32 155.88 20.02 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.444 1.497 . . . . 0.0 108.871 162.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.5 tt -141.68 106.69 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 125.872 1.669 . . . . 0.0 108.276 168.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -102.78 127.75 49.81 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 129.588 3.155 . . . . 0.0 110.776 -171.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.416 ' HE1' ' CB ' ' A' ' 85' ' ' VAL 0.362 1.9 tpp -124.58 158.7 32.4 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 118.201 2.667 . . . . 0.0 118.201 -171.144 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -71.27 -21.48 62.09 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.515 1.526 . . . . 0.0 114.07 -166.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.98 146.81 39.58 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.458 0.647 . . . . 0.0 110.988 -178.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -63.36 -37.9 89.07 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.726 0.81 . . . . 0.0 111.451 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -76.14 -38.03 57.27 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 178.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.35 -48.48 81.48 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-N 118.74 0.7 . . . . 0.0 110.565 171.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.18 -38.49 75.38 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 178.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -57.7 -46.99 83.61 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.996 0.816 . . . . 0.0 111.186 170.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -65.71 -29.6 70.16 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-O 117.799 -1.096 . . . . 0.0 111.525 171.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.411 ' HG3' ' CD2' ' A' ' 82' ' ' PHE . 18.8 ttp -69.24 -49.58 55.03 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 120.54 1.518 . . . . 0.0 109.839 -176.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -63.59 -40.01 87.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 124.116 0.966 . . . . 0.0 111.753 175.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -70.51 -43.65 69.24 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 121.663 -0.648 . . . . 0.0 111.076 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -48.93 -39.98 28.34 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 126.332 1.853 . . . . 0.0 111.667 166.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -85.28 -22.06 28.74 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 120.602 -1.311 . . . . 0.0 113.197 -178.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 99.0 m -76.51 -19.19 58.23 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.877 0.871 . . . . 0.0 110.174 172.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.9 -60.62 2.27 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 129.507 3.123 . . . . 0.0 111.252 170.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 2.3 p -79.42 -48.43 21.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 124.412 1.085 . . . . 0.0 112.478 -158.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 4.9 m 33.92 126.14 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 129.013 2.925 . . . . 0.0 114.248 -139.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -76.15 -10.59 19.42 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 121.366 1.377 . . . . 0.0 115.018 -170.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.4 t 30.02 89.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 130.04 3.336 . . . . 0.0 113.102 175.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.659 ' H ' HD13 ' A' ' 126' ' ' ILE . 1.5 tt -104.76 -68.48 0.85 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 112.301 -2.227 . . . . 0.0 108.159 -138.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -66.76 -44.67 80.83 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.118 0.967 . . . . 0.0 110.476 167.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 159.82 12.51 0.04 OUTLIER Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.315 1.436 . . . . 0.0 115.527 178.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -147.28 168.68 10.78 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 119.491 1.646 . . . . 0.0 112.007 -179.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -54.87 142.87 74.05 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.984 2.456 . . . . 0.0 114.235 -175.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.659 HD13 ' H ' ' A' ' 121' ' ' LEU . 20.2 mm -106.87 -43.05 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.729 1.211 . . . . 0.0 112.423 -167.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 61.11 141.38 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 128.192 2.597 . . . . 0.0 115.101 -173.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.46 155.56 31.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 126.264 1.825 . . . . 0.0 111.323 171.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -151.47 162.25 41.28 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.344 1.858 . . . . 0.0 109.252 158.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -52.29 143.37 14.93 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 121.201 -0.937 . . . . 0.0 111.147 160.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 30.2 t -66.93 153.39 43.68 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.24 1.016 . . . . 0.0 112.179 -179.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -64.76 -25.88 68.12 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.628 1.171 . . . . 0.0 112.349 168.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 57.5 m-70 -92.74 169.82 10.19 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.553 1.541 . . . . 0.0 111.259 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.66 111.75 14.66 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 125.096 1.358 . . . . 0.0 108.915 175.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 74.71 145.88 0.08 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 128.411 2.684 . . . . 0.0 113.592 -170.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 26.2 tp -113.32 111.62 22.32 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.802 2.041 . . . . 0.0 110.994 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.507 0 C-N-CA 128.002 2.521 . . . . 0.0 110.552 -177.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.5 t . . . . . 0 N--CA 1.477 0.887 0 CA-C-O 119.78 -0.152 . . . . 0.0 110.787 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.15 -7.33 40.81 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.306 7.5 p -79.91 126.4 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 120.173 1.351 . . . . 0.0 112.021 164.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 21.7 mt -107.2 154.53 8.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 128.08 2.552 . . . . 0.0 108.249 169.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -122.47 145.66 48.09 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.785 1.634 . . . . 0.0 110.87 176.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.5 mt -125.55 143.94 37.36 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 127.438 2.295 . . . . 0.0 110.097 -171.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.5 mtm-85 -108.12 170.18 8.16 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 125.847 1.659 . . . . 0.0 111.072 169.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp 56.22 32.32 20.07 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 155.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.5 171.74 2.58 Favored Pre-proline 0 C--N 1.321 -0.669 0 C-N-CA 124.728 1.211 . . . . 0.0 110.731 165.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -52.02 174.21 0.09 OUTLIER 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 124.185 3.257 . . . . 0.0 114.262 156.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 31.2 pt -64.6 -35.95 76.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 126.517 1.927 . . . . 0.0 113.027 -170.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -142.9 -10.99 0.77 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.848 1.659 . . . . 0.0 113.48 171.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.474 HG21 ' H ' ' A' ' 71' ' ' THR 0.287 4.3 p 42.34 -151.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 128.249 2.619 . . . . 0.0 112.065 -172.623 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.474 ' H ' HG21 ' A' ' 70' ' ' VAL . 1.1 p -129.36 145.19 51.43 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 120.601 -1.312 . . . . 0.0 109.88 153.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.98 -38.63 83.13 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 122.042 -0.411 . . . . 0.0 110.621 173.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -54.01 -41.29 68.15 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 125.658 1.599 . . . . 0.0 112.711 174.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -63.14 -53.61 50.65 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.106 0.962 . . . . 0.0 111.68 172.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.9 t -59.59 -48.0 88.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.344 0.657 . . . . 0.0 112.522 -178.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.0 pp -73.93 -33.0 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 O-C-N 120.488 -1.383 . . . . 0.0 112.801 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.5 t -63.55 -30.73 71.81 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.494 1.043 . . . . 0.0 110.771 171.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 14.0 mt -76.1 -20.43 57.68 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 173.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -96.66 -17.32 33.66 Favored Glycine 0 CA--C 1.536 1.37 0 N-CA-C 115.374 0.91 . . . . 0.0 115.374 172.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.6 mt -60.81 -52.8 69.84 Favored Pre-proline 0 CA--C 1.54 0.588 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 -170.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -76.21 42.44 1.0 Allowed 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 123.957 3.105 . . . . 0.0 113.5 -179.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -129.54 -41.89 1.34 Allowed 'General case' 0 C--O 1.233 0.218 0 C-N-CA 126.74 2.016 . . . . 0.0 111.196 178.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -158.11 -101.22 0.17 Allowed Glycine 0 C--N 1.34 0.784 0 CA-C-O 122.059 0.81 . . . . 0.0 112.053 163.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 13.8 tptm -143.48 139.04 29.66 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 130.084 3.354 . . . . 0.0 104.326 166.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.423 ' CG2' ' HE2' ' A' ' 101' ' ' MET . 3.6 t -123.35 99.41 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 120.203 1.365 . . . . 0.0 109.333 -169.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 16.0 m -65.21 -38.23 89.77 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 128.73 2.812 . . . . 0.0 112.283 -161.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.58 161.5 42.45 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 177.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -133.69 175.06 9.78 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.109 0.964 . . . . 0.0 111.033 156.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.32 154.21 37.46 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.932 1.693 . . . . 0.0 109.29 178.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 5.7 mtt -129.93 111.27 12.39 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.357 1.063 . . . . 0.0 111.273 -178.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -74.15 86.11 1.88 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.752 0.821 . . . . 0.0 110.156 174.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.6 tpmt? -63.65 89.01 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.943 1.697 . . . . 0.0 110.476 174.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 179.76 -61.97 0.08 OUTLIER Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.359 1.457 . . . . 0.0 112.748 -166.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.94 20.71 3.81 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 125.77 1.628 . . . . 0.0 114.161 -169.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 14.1 m-20 56.3 42.61 27.63 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.87 1.668 . . . . 0.0 113.496 -173.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -106.47 165.22 11.43 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.862 -0.524 . . . . 0.0 111.603 175.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -153.8 165.61 35.49 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.672 1.189 . . . . 0.0 111.371 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 6.0 m-30 -112.71 156.65 22.43 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.671 1.588 . . . . 0.0 108.689 163.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.8 tt -141.92 108.75 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 125.283 1.433 . . . . 0.0 109.606 166.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -100.46 122.01 42.49 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 129.09 2.956 . . . . 0.0 111.275 -175.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.423 ' HE2' ' CG2' ' A' ' 85' ' ' VAL 0.298 3.1 ttm -121.75 160.66 24.11 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 -173.766 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.95 -13.95 60.25 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.288 1.035 . . . . 0.0 113.616 -162.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.35 144.73 38.35 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.675 1.19 . . . . 0.0 111.194 177.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -63.38 -35.73 81.36 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.56 1.144 . . . . 0.0 111.846 176.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -75.99 -39.97 54.76 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -56.35 -50.66 70.87 Favored 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 122.809 0.444 . . . . 0.0 110.293 170.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.09 -37.19 72.43 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 121.026 -1.046 . . . . 0.0 113.334 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -56.18 -47.2 78.78 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.118 0.872 . . . . 0.0 111.408 169.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -65.21 -34.34 78.14 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 118.08 -0.962 . . . . 0.0 110.88 174.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 3.2 ttp -64.12 -52.18 60.4 Favored 'General case' 0 C--N 1.343 0.298 0 CA-C-N 119.664 1.12 . . . . 0.0 110.633 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.91 -37.84 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 C-N-CA 125.259 1.424 . . . . 0.0 112.133 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -72.01 -44.07 64.02 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.486 0.714 . . . . 0.0 111.702 177.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -49.4 -36.87 23.33 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.17 0.988 . . . . 0.0 112.071 165.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -87.23 -18.73 29.61 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 120.468 -1.395 . . . . 0.0 113.222 -177.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.22 -12.57 58.01 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.638 0.732 . . . . 0.0 110.912 170.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.91 -60.9 2.01 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 129.481 3.112 . . . . 0.0 111.874 168.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 4.2 p -78.08 -44.43 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.517 1.127 . . . . 0.0 113.622 -154.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.3 m 27.56 119.29 0.0 OUTLIER Pre-proline 0 N--CA 1.479 0.988 0 C-N-CA 129.855 3.262 . . . . 0.0 115.854 -139.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -76.53 -13.82 18.16 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 121.933 1.755 . . . . 0.0 116.073 -167.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.8 t 29.85 90.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 129.907 3.283 . . . . 0.0 114.067 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.532 ' H ' HD13 ' A' ' 126' ' ' ILE 0.265 1.1 tt -113.15 76.44 0.98 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 112.545 -2.116 . . . . 0.0 105.919 -134.592 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . 0.349 2.1 ppt_? 46.84 14.17 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 129.922 3.289 . . . . 0.0 116.73 -152.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -126.41 -113.52 1.87 Allowed Glycine 0 N--CA 1.472 1.065 0 C-N-CA 125.005 1.288 . . . . 0.0 116.254 -174.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.88 173.74 3.98 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 128.229 2.612 . . . . 0.0 108.062 -174.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -44.73 105.25 0.06 OUTLIER 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 123.691 2.927 . . . . 0.0 116.386 -163.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.532 HD13 ' H ' ' A' ' 121' ' ' LEU . 3.9 mm -68.18 162.09 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 125.24 1.416 . . . . 0.0 108.426 172.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -134.63 147.65 50.22 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 121.789 -0.57 . . . . 0.0 111.177 174.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.83 146.13 32.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.95 1.3 . . . . 0.0 110.896 173.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -147.3 158.79 44.09 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.478 1.911 . . . . 0.0 108.865 160.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -53.77 146.88 12.74 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.236 -0.915 . . . . 0.0 111.549 163.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 30.0 t -69.72 156.11 39.49 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.977 0.911 . . . . 0.0 112.706 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -66.95 -20.95 65.98 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.781 1.232 . . . . 0.0 112.888 167.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 40.4 m-70 -105.1 177.65 4.79 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.869 1.667 . . . . 0.0 112.188 -173.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 4.6 mptt -136.76 117.92 14.45 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 126.255 1.822 . . . . 0.0 109.679 -175.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 69.27 84.35 0.15 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.362 1.465 . . . . 0.0 113.328 176.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 31.4 tp -57.54 127.55 32.6 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.518 1.527 . . . . 0.0 112.586 177.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 99.1 mttt . . . . . 0 N--CA 1.473 0.697 0 C-N-CA 126.479 1.912 . . . . 0.0 110.581 173.615 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 57.4 m . . . . . 0 N--CA 1.475 0.799 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 31.0 mtp180 -50.84 -17.44 0.56 Allowed 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 128.902 2.881 . . . . 0.0 118.063 -177.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.265 3.4 p -96.98 137.17 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-N 120.261 1.391 . . . . 0.0 112.966 172.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.2 mt -118.88 130.78 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 127.93 2.492 . . . . 0.0 108.787 175.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -96.69 141.23 30.18 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.33 1.052 . . . . 0.0 110.719 176.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.3 mt -116.51 135.5 56.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 126.79 2.036 . . . . 0.0 108.291 -178.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.0 ptt-85 -119.53 171.48 8.32 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 127.387 2.275 . . . . 0.0 111.376 165.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.6 mmmt 61.29 23.34 13.58 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.579 1.552 . . . . 0.0 113.27 178.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.7 mt -69.31 173.97 3.35 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 126.313 1.845 . . . . 0.0 111.502 166.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -48.79 176.43 0.02 OUTLIER 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 123.042 2.495 . . . . 0.0 114.295 152.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 26.5 pt -64.81 -41.24 91.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.863 1.665 . . . . 0.0 112.961 -171.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -141.89 -11.85 0.87 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.016 1.726 . . . . 0.0 114.539 174.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.469 HG21 ' H ' ' A' ' 71' ' ' THR 0.309 2.9 p 43.0 -154.48 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 128.124 2.57 . . . . 0.0 113.412 -175.719 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.469 ' H ' HG21 ' A' ' 70' ' ' VAL . 10.8 t -142.32 148.53 38.14 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 120.065 -1.647 . . . . 0.0 111.665 171.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -55.6 -46.25 77.33 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.328 1.051 . . . . 0.0 111.961 -177.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -51.37 -43.18 51.51 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.526 1.06 . . . . 0.0 113.116 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -64.85 -56.03 15.91 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.778 0.831 . . . . 0.0 112.264 172.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 80.1 t -56.06 -53.81 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-O 121.657 0.741 . . . . 0.0 111.811 -176.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.9 pp -67.29 -39.54 83.08 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 CA-C-O 117.89 -1.052 . . . . 0.0 112.437 -178.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.8 t -68.52 -19.97 64.55 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 119.945 1.248 . . . . 0.0 111.384 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 26.6 mt -87.45 -21.78 25.35 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 172.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -99.36 -21.98 13.83 Favored Glycine 0 C--O 1.215 -1.077 0 CA-C-N 119.376 0.989 . . . . 0.0 113.705 177.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.8 mt -60.1 -35.51 28.69 Favored Pre-proline 0 CA--C 1.549 0.936 0 N-CA-C 118.785 2.883 . . . . 0.0 118.785 -173.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -55.36 7.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.949 1 C-N-CA 125.739 4.293 . . . . 0.0 120.728 -171.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -125.33 -19.42 5.08 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 -171.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -163.96 -100.06 0.14 Allowed Glycine 0 CA--C 1.524 0.62 0 CA-C-N 118.622 0.647 . . . . 0.0 112.444 -177.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 31.5 tptt -153.06 156.46 38.79 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 125.03 1.332 . . . . 0.0 107.891 165.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -131.22 106.04 11.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 119.812 1.187 . . . . 0.0 109.177 -174.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 33.9 p -104.66 -25.77 12.58 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.399 -1.273 . . . . 0.0 112.393 -162.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -138.03 152.49 48.91 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.101 0.864 . . . . 0.0 113.095 170.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -137.61 169.86 17.05 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.419 1.088 . . . . 0.0 111.267 159.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.63 153.22 39.1 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.091 1.356 . . . . 0.0 109.589 178.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 5.2 mtp -135.59 98.98 4.07 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.91 0.884 . . . . 0.0 110.326 -169.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -74.56 89.12 2.18 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.961 0.904 . . . . 0.0 110.693 177.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.9 pttt -122.01 60.24 0.98 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.227 1.811 . . . . 0.0 113.829 -178.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 84.1 -118.41 4.69 Favored Glycine 0 N--CA 1.47 0.96 0 C-N-CA 130.286 3.803 . . . . 0.0 113.769 4.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.5 mtmm -135.05 -95.39 0.27 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.69 1.596 . . . . 0.0 110.464 -167.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -155.88 32.32 0.35 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 129.737 3.215 . . . . 0.0 110.15 -176.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -122.8 163.52 20.07 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -173.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -154.51 166.16 34.17 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 126.364 1.866 . . . . 0.0 110.348 177.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 5.7 m-30 -112.5 149.44 32.64 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.867 1.667 . . . . 0.0 107.329 162.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.8 tt -128.83 121.03 53.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 C-N-CA 124.186 0.994 . . . . 0.0 108.883 159.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.497 ' HG3' ' H ' ' A' ' 136' ' ' LEU . 2.0 tm-20 -110.95 108.89 18.8 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 126.018 1.727 . . . . 0.0 110.159 -174.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -102.18 149.66 24.07 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 112.921 -1.945 . . . . 0.0 111.403 -176.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.43 -13.34 60.7 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.577 1.551 . . . . 0.0 114.065 -161.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.03 144.02 48.44 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.502 0.721 . . . . 0.0 110.789 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -63.46 -41.06 98.63 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.021 0.928 . . . . 0.0 111.575 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -74.78 -36.75 62.52 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 178.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.95 -46.34 89.74 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 118.708 0.685 . . . . 0.0 110.305 171.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.57 -37.79 80.18 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 175.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -56.38 -50.78 70.59 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 120.946 -1.096 . . . . 0.0 111.372 169.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -64.63 -26.08 68.24 Favored 'General case' 0 C--O 1.219 -0.548 0 O-C-N 120.597 -1.315 . . . . 0.0 111.374 173.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 18.8 ttp -69.35 -48.51 61.12 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-N 120.168 1.349 . . . . 0.0 110.38 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -64.27 -38.2 81.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 O-C-N 121.046 -1.034 . . . . 0.0 111.66 176.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -67.57 -47.33 70.09 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.358 1.063 . . . . 0.0 111.137 173.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -49.91 -34.19 19.68 Favored 'General case' 0 C--O 1.223 -0.329 0 C-N-CA 126.151 1.781 . . . . 0.0 112.236 169.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -90.76 -18.91 24.15 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 120.437 -1.415 . . . . 0.0 113.312 -177.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -81.59 -10.62 59.39 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 121.581 0.705 . . . . 0.0 111.196 168.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.36 -63.96 1.24 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 130.226 3.41 . . . . 0.0 111.743 168.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 2.2 p -78.76 -46.5 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 124.626 1.17 . . . . 0.0 112.213 -156.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.4 m 37.33 123.85 0.0 OUTLIER Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 130.17 3.388 . . . . 0.0 115.023 -145.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -75.01 -20.96 16.32 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 121.88 1.72 . . . . 0.0 115.723 -168.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 5.6 t 42.4 99.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 129.595 3.158 . . . . 0.0 114.579 176.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.618 ' H ' HD13 ' A' ' 126' ' ' ILE . 4.5 tt -135.3 -59.5 0.78 Allowed 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 113.591 -1.641 . . . . 0.0 109.844 -137.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.07 -3.04 14.67 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 156.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 98.76 17.06 29.3 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 125.392 1.472 . . . . 0.0 115.945 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -153.61 170.59 8.07 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 127.634 2.373 . . . . 0.0 109.794 171.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -47.02 142.13 11.49 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 124.009 3.139 . . . . 0.0 115.644 -179.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.618 HD13 ' H ' ' A' ' 121' ' ' LEU . 4.9 mm -117.08 143.81 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 127.347 2.259 . . . . 0.0 107.823 -177.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 9.1 m-30 -116.82 125.34 51.43 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 121.249 -0.907 . . . . 0.0 110.523 -166.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.1 149.95 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -178.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -149.26 160.1 43.69 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 127.525 2.33 . . . . 0.0 109.326 163.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -53.2 149.77 6.75 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 120.803 -1.186 . . . . 0.0 112.09 160.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 27.5 t -72.0 154.78 40.95 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.36 0.664 . . . . 0.0 112.207 177.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -66.61 -12.09 56.45 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.664 1.586 . . . . 0.0 113.261 168.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 65.2 m-70 -114.94 171.49 7.63 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.631 1.572 . . . . 0.0 112.837 -169.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -123.9 103.13 8.16 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 126.412 1.885 . . . . 0.0 110.961 -176.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 62.02 115.67 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 126.773 2.029 . . . . 0.0 113.364 -170.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.497 ' H ' ' HG3' ' A' ' 100' ' ' GLU . 24.0 tp -64.03 101.04 0.35 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.063 1.745 . . . . 0.0 111.86 168.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 67.4 mttm . . . . . 0 N--CA 1.469 0.513 0 C-N-CA 125.42 1.488 . . . . 0.0 109.139 170.902 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 45.3 m . . . . . 0 CA--C 1.549 0.938 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 46.5 mtp180 -55.13 -16.85 3.4 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 119.521 3.156 . . . . 0.0 119.521 -161.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.31 6.9 p -98.2 128.91 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 CA-C-N 121.366 1.894 . . . . 0.0 112.879 169.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 39.7 mt -100.4 155.01 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.84 1.656 . . . . 0.0 108.378 165.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -119.08 148.76 42.69 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.58 1.552 . . . . 0.0 110.957 173.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.4 mt -127.98 141.4 46.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 126.501 1.92 . . . . 0.0 109.639 -172.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.45 165.83 17.73 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 127.95 2.5 . . . . 0.0 109.885 167.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 67.31 23.59 9.26 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 125.148 1.379 . . . . 0.0 113.887 177.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.99 165.62 0.76 Allowed Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 127.7 2.4 . . . . 0.0 111.292 165.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -58.68 175.61 0.55 Allowed 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 123.007 2.471 . . . . 0.0 113.993 154.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 28.1 pt -73.81 -32.36 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 126.645 1.978 . . . . 0.0 113.47 -175.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -154.91 32.34 0.4 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.871 1.668 . . . . 0.0 111.357 -168.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -51.49 147.61 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.574 0.75 . . . . 0.0 112.267 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.4 t -88.91 140.97 28.89 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 122.584 1.183 . . . . 0.0 112.092 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -57.84 -36.03 71.72 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.429 175.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -57.4 -36.0 74.63 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 123.643 0.639 . . . . 0.0 112.865 177.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -70.34 -51.33 30.83 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.955 1.302 . . . . 0.0 112.045 172.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 88.6 t -63.13 -41.49 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -176.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.0 pp -72.73 -34.8 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 O-C-N 120.285 -1.509 . . . . 0.0 112.413 174.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 73.1 m -66.54 -22.49 66.16 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 119.809 1.186 . . . . 0.0 111.886 174.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.6 mt -76.39 -30.86 57.68 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.016 0.927 . . . . 0.0 113.046 170.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -94.27 -11.89 56.81 Favored Glycine 0 CA--C 1.534 1.272 0 CA-C-N 119.818 1.19 . . . . 0.0 115.693 178.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.7 mt -64.71 -36.07 15.94 Favored Pre-proline 0 CA--C 1.545 0.764 0 N-CA-C 117.379 2.363 . . . . 0.0 117.379 -172.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.74 -5.18 1.69 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.575 2.85 . . . . 0.0 117.583 173.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -107.48 -33.76 7.25 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -163.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -164.92 -98.26 0.12 Allowed Glycine 0 CA--C 1.522 0.527 0 C-N-CA 124.201 0.905 . . . . 0.0 111.344 172.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 33.6 tptt -149.15 145.04 26.99 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 105.423 -2.065 . . . . 0.0 105.423 161.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.455 ' CG2' ' HE2' ' A' ' 101' ' ' MET . 3.5 t -128.48 89.13 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-N 120.331 1.423 . . . . 0.0 108.76 -171.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 31.3 p -77.58 -19.04 56.28 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 126.817 2.047 . . . . 0.0 113.016 -161.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -148.27 160.97 42.43 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 172.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.8 pp -140.32 172.23 13.03 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.775 1.23 . . . . 0.0 111.493 155.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.2 152.77 43.45 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 125.93 1.692 . . . . 0.0 108.747 175.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 5.4 mtt -132.19 102.64 5.87 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.159 0.984 . . . . 0.0 111.84 -174.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -72.43 100.17 2.63 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.587 1.155 . . . . 0.0 110.215 177.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -57.8 -23.0 50.33 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.82 1.648 . . . . 0.0 114.933 -176.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -63.97 -44.87 95.34 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.659 1.599 . . . . 0.0 115.956 -174.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -136.92 8.97 3.03 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 115.394 1.628 . . . . 0.0 115.394 -151.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 55.15 60.69 3.29 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.7 1.2 . . . . 0.0 110.745 -165.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -130.66 163.92 26.13 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.647 0.779 . . . . 0.0 112.255 177.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -155.36 167.19 31.2 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.917 1.287 . . . . 0.0 111.941 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 4.8 m-30 -110.19 152.17 26.4 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.594 1.958 . . . . 0.0 107.24 160.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 19.8 tt -134.09 105.4 6.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 125.252 1.421 . . . . 0.0 108.717 167.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 21.4 tp10 -96.95 124.1 40.84 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 127.377 2.271 . . . . 0.0 110.753 -175.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.455 ' HE2' ' CG2' ' A' ' 85' ' ' VAL 0.305 1.6 ttm -125.23 157.27 36.95 Favored 'General case' 0 C--O 1.223 -0.301 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 -177.213 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -69.97 -18.99 63.37 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.731 2.012 . . . . 0.0 113.318 -165.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.09 140.72 42.16 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 122.62 1.2 . . . . 0.0 111.875 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -61.84 -40.9 96.93 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.577 1.151 . . . . 0.0 111.137 177.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -74.54 -35.24 63.11 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -56.43 -55.4 34.05 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-N 118.755 0.707 . . . . 0.0 109.861 168.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.5 -34.36 76.99 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.444 1.02 . . . . 0.0 113.585 -178.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -56.56 -51.48 68.44 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.149 -0.969 . . . . 0.0 111.633 169.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -63.26 -31.21 72.31 Favored 'General case' 0 C--O 1.224 -0.257 0 O-C-N 121.289 -0.882 . . . . 0.0 110.972 174.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 6.2 ttp -71.0 -46.45 62.24 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.872 1.269 . . . . 0.0 111.886 -178.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -67.81 -37.88 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 O-C-N 120.843 -1.16 . . . . 0.0 111.366 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -71.78 -41.93 67.74 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.441 1.096 . . . . 0.0 111.285 176.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -48.78 -52.29 24.69 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.51 1.124 . . . . 0.0 110.819 165.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -77.9 12.41 1.77 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 118.74 -2.475 . . . . 0.0 113.344 178.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . 0.289 0.5 OUTLIER -116.35 -10.63 11.33 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.814 0.846 . . . . 0.0 113.067 167.494 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.46 -42.51 15.53 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 126.029 1.732 . . . . 0.0 111.45 159.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 85.5 t -116.22 -63.33 1.99 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.228 0 C-N-CA 124.937 1.295 . . . . 0.0 111.09 -144.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.0 m 68.96 136.47 0.05 OUTLIER Pre-proline 0 N--CA 1.484 1.255 0 C-N-CA 127.93 2.492 . . . . 0.0 112.588 -175.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -81.41 -9.76 12.4 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 122.605 2.203 . . . . 0.0 115.616 -174.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.5 t 26.57 90.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 130.867 3.667 . . . . 0.0 114.606 173.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.658 ' H ' HD13 ' A' ' 126' ' ' ILE . 1.7 tt -118.98 -59.27 1.87 Allowed 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.716 -126.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.72 -1.56 39.06 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 153.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 106.27 32.55 3.69 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 124.999 1.285 . . . . 0.0 115.047 -177.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -139.49 150.51 63.96 Favored Pre-proline 0 CA--C 1.536 0.404 0 C-N-CA 125.342 1.457 . . . . 0.0 110.762 175.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -55.59 109.1 0.37 Allowed 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.354 2.703 . . . . 0.0 112.713 174.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.658 HD13 ' H ' ' A' ' 121' ' ' LEU . 5.1 mm -78.19 145.77 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 124.892 1.277 . . . . 0.0 109.109 178.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 9.8 m-30 -111.02 128.71 55.94 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.82 0.848 . . . . 0.0 109.811 -173.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.3 tt -131.48 146.0 34.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 124.505 1.122 . . . . 0.0 111.667 -178.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -155.21 160.25 40.72 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.179 1.792 . . . . 0.0 108.958 160.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -50.71 148.57 3.89 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.271 -0.893 . . . . 0.0 112.767 167.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 37.5 t -68.24 158.02 34.23 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.509 0.724 . . . . 0.0 112.057 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -67.34 -13.36 61.93 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.563 1.145 . . . . 0.0 112.72 164.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 36.5 m-70 -111.81 178.82 4.2 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 127.778 2.431 . . . . 0.0 110.473 -178.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -125.6 -0.55 7.46 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 115.737 1.754 . . . . 0.0 115.737 -171.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -164.48 166.85 20.11 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 130.087 3.355 . . . . 0.0 108.302 -173.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 21.3 tp -134.67 105.51 6.52 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.431 1.492 . . . . 0.0 110.979 175.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 8.1 mmpt? . . . . . 0 CA--C 1.536 0.438 0 C-N-CA 126.216 1.806 . . . . 0.0 109.829 176.358 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.7 m . . . . . 0 N--CA 1.473 0.714 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 35.6 mtp180 61.72 -12.68 0.06 Allowed 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 128.789 2.836 . . . . 0.0 118.029 167.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.417 HG23 ' CD2' ' A' ' 98' ' ' PHE 0.298 2.4 p -107.52 139.86 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 124.306 1.042 . . . . 0.0 112.207 164.443 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.2 mt -113.54 152.35 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 128.927 2.891 . . . . 0.0 107.581 170.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 5.0 t-80 -120.25 150.46 40.64 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.353 1.461 . . . . 0.0 110.741 175.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.5 mt -129.9 141.73 45.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 126.114 1.766 . . . . 0.0 109.479 -175.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.86 173.38 6.91 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 127.348 2.259 . . . . 0.0 111.067 171.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 17.2 mmmt 62.67 28.88 16.78 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 126.064 1.745 . . . . 0.0 113.503 175.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.89 164.41 21.7 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 124.7 1.2 . . . . 0.0 110.802 173.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -59.19 -175.82 0.09 OUTLIER 'Trans proline' 0 CA--C 1.537 0.64 1 C-N-CA 125.505 4.137 . . . . 0.0 113.965 157.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 30.3 pt -82.56 -30.18 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 126.665 1.986 . . . . 0.0 112.893 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -155.23 35.15 0.38 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.737 1.615 . . . . 0.0 111.331 -168.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -51.54 150.4 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.644 0.778 . . . . 0.0 111.398 174.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.9 t -89.89 136.42 33.05 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 123.129 1.442 . . . . 0.0 112.413 -177.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.49 -37.59 65.46 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 114.487 -1.233 . . . . 0.0 111.395 173.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -56.21 -38.55 78.01 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.292 0.949 . . . . 0.0 113.605 175.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -65.85 -52.41 50.67 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.222 1.009 . . . . 0.0 111.214 171.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.4 t -60.75 -49.05 86.13 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 122.828 0.451 . . . . 0.0 112.203 -177.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.3 pp -70.51 -30.01 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 O-C-N 120.176 -1.577 . . . . 0.0 113.44 178.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 52.1 m -72.19 -17.84 61.9 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 119.175 0.898 . . . . 0.0 112.017 172.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 35.0 mt -85.52 -17.27 36.85 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 165.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.409 ' HA2' ' SD ' ' A' ' 110' ' ' MET . . . -74.12 -40.74 41.57 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 124.3 0.952 . . . . 0.0 112.901 167.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.9 mt -70.17 -34.12 3.91 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 119.097 2.999 . . . . 0.0 119.097 -155.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -59.36 4.16 0.15 Allowed 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 124.029 3.153 . . . . 0.0 117.551 175.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.41 ' CD2' ' HG3' ' A' ' 110' ' ' MET . 56.7 m-85 -120.34 -41.37 2.62 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -167.024 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -147.61 -113.62 0.75 Allowed Glycine 0 C--N 1.341 0.809 0 CA-C-O 122.374 0.986 . . . . 0.0 111.983 176.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 33.5 tptt -149.48 117.42 6.3 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 129.821 3.248 . . . . 0.0 104.78 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . 0.29 16.3 t -127.29 82.68 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 CA-C-O 122.9 1.334 . . . . 0.0 109.145 -158.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.3 t -74.3 -26.82 60.41 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 127.054 2.142 . . . . 0.0 112.148 -162.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -141.02 166.22 25.4 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 123.268 1.508 . . . . 0.0 114.364 177.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -147.38 174.83 11.3 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 128.047 2.539 . . . . 0.0 109.874 160.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.63 155.77 43.23 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.96 1.304 . . . . 0.0 110.137 177.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 3.7 mtt -127.55 107.05 9.6 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.096 0.958 . . . . 0.0 111.705 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -76.08 64.66 1.98 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.958 0.903 . . . . 0.0 109.133 165.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 31.8 tttp -53.48 -45.19 69.51 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.706 1.602 . . . . 0.0 113.471 -159.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -70.73 -11.62 69.39 Favored Glycine 0 CA--C 1.539 1.592 0 C-N-CA 124.979 1.276 . . . . 0.0 115.797 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.6 -1.04 25.15 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 118.919 1.36 . . . . 0.0 113.191 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.4 m120 60.24 38.26 20.08 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.441 1.496 . . . . 0.0 112.64 -167.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -128.35 163.25 25.24 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.146 0.979 . . . . 0.0 112.062 -172.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -155.0 166.41 33.68 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.79 1.636 . . . . 0.0 112.035 -178.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.417 ' CD2' HG23 ' A' ' 60' ' ' VAL . 5.1 m-30 -113.66 155.8 24.87 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.769 2.028 . . . . 0.0 108.512 160.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.6 tt -137.02 130.61 45.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 119.632 1.106 . . . . 0.0 109.711 162.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -127.16 120.04 27.88 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.995 2.118 . . . . 0.0 112.241 -160.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -134.72 154.34 51.61 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 112.994 -1.912 . . . . 0.0 113.232 -164.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.26 -20.31 61.55 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 115.29 1.589 . . . . 0.0 115.29 -158.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 9.4 p -136.66 138.07 40.71 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.702 1.201 . . . . 0.0 111.209 -175.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -58.42 -32.29 68.54 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.96 174.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -73.54 -42.67 61.41 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -54.34 -53.11 58.3 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 119.669 1.122 . . . . 0.0 109.518 169.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.62 -34.33 71.98 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -174.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -58.44 -50.47 73.61 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.109 0.868 . . . . 0.0 110.56 169.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -62.11 -33.1 73.83 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 121.583 -0.698 . . . . 0.0 110.99 175.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.41 ' HG3' ' CD2' ' A' ' 82' ' ' PHE . 11.1 ttp -73.46 -48.94 29.58 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 124.085 0.954 . . . . 0.0 112.263 -176.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 1.1 p -63.78 -38.72 83.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 124.341 1.056 . . . . 0.0 110.995 179.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -71.96 -42.59 66.4 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.881 1.272 . . . . 0.0 111.549 177.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -47.68 -55.56 9.19 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.909 1.284 . . . . 0.0 109.984 165.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -78.29 11.58 2.32 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 118.855 -2.403 . . . . 0.0 113.826 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 53.3 m -111.82 -15.48 13.37 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.633 1.173 . . . . 0.0 110.988 171.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.41 -44.59 10.07 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.733 2.013 . . . . 0.0 111.841 163.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 96.4 t -112.35 -49.73 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 125.02 1.328 . . . . 0.0 111.951 -143.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.406 ' CG2' ' H ' ' A' ' 126' ' ' ILE . 31.5 m 69.81 141.45 0.08 OUTLIER Pre-proline 0 N--CA 1.485 1.29 0 C-N-CA 128.21 2.604 . . . . 0.0 112.308 -173.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -82.05 -12.88 10.52 Favored 'Trans proline' 0 CA--C 1.549 1.251 0 C-N-CA 123.385 2.723 . . . . 0.0 114.105 -176.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 22.0 t 50.6 101.17 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 131.144 3.778 . . . . 0.0 115.541 175.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.2 tt -92.08 101.62 14.16 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 123.763 0.825 . . . . 0.0 109.819 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 45.6 62.47 2.18 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.735 2.014 . . . . 0.0 112.086 178.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 81.2 6.93 89.01 Favored Glycine 0 CA--C 1.537 1.426 0 N-CA-C 116.015 1.166 . . . . 0.0 116.015 173.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 35.1 tp60 -131.72 142.49 45.45 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 125.83 1.652 . . . . 0.0 110.109 -173.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -61.1 166.31 10.94 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 123.119 2.546 . . . . 0.0 114.529 179.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.406 ' H ' ' CG2' ' A' ' 118' ' ' THR . 0.6 OUTLIER -136.79 154.41 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.797 1.639 . . . . 0.0 109.989 178.088 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -120.45 91.05 3.45 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 124.33 1.052 . . . . 0.0 109.056 -155.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -95.95 152.76 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 124.913 1.285 . . . . 0.0 111.994 -179.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -147.92 161.48 41.22 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.75 1.62 . . . . 0.0 108.339 152.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.91 153.31 4.86 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.006 -1.059 . . . . 0.0 112.041 158.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 54.7 p -65.11 170.17 4.76 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 177.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -87.64 6.75 33.13 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.405 1.482 . . . . 0.0 112.874 164.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -132.84 -176.01 3.97 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.445 1.498 . . . . 0.0 113.243 -161.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 42.0 tttp -140.26 101.35 4.11 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.536 1.935 . . . . 0.0 111.162 -177.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 64.74 108.11 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 127.448 2.299 . . . . 0.0 114.611 -174.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 18.8 tp -63.88 124.7 22.2 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.245 1.818 . . . . 0.0 111.956 169.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt . . . . . 0 N--CA 1.473 0.715 0 C-N-CA 127.163 2.185 . . . . 0.0 110.634 167.288 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 30.0 p . . . . . 0 CA--C 1.547 0.836 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 32.2 mtp180 -61.02 -6.09 1.72 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 130.541 3.537 . . . . 0.0 118.339 -165.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.43 HG23 ' CD2' ' A' ' 98' ' ' PHE 0.254 2.5 p -101.17 131.35 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 120.809 1.64 . . . . 0.0 112.092 166.973 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 16.9 mt -103.24 153.92 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 127.379 2.272 . . . . 0.0 109.478 165.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -120.39 143.95 48.16 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.772 1.629 . . . . 0.0 110.528 175.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.9 mt -122.58 133.46 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 127.071 2.148 . . . . 0.0 109.776 -173.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 28.9 mtt180 -88.39 166.63 14.12 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.672 1.589 . . . . 0.0 110.543 173.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.9 mtpp 50.51 35.42 11.23 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 155.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.79 162.82 0.71 Allowed Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 126.446 1.898 . . . . 0.0 111.521 162.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -56.14 179.24 0.1 OUTLIER 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 124.326 3.351 . . . . 0.0 114.912 156.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 31.1 pt -77.36 -30.41 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 126.599 1.96 . . . . 0.0 113.168 -176.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -157.75 36.86 0.26 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.993 1.717 . . . . 0.0 110.971 -170.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -50.27 151.05 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.966 0.906 . . . . 0.0 111.627 175.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.7 t -85.19 128.05 34.52 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 123.583 1.659 . . . . 0.0 111.11 174.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -60.9 -22.68 64.57 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 114.823 -1.081 . . . . 0.0 111.773 174.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -62.38 -35.91 92.35 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 125.224 1.392 . . . . 0.0 114.024 167.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -67.88 -46.46 71.61 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.576 -0.955 . . . . 0.0 109.812 171.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 62.0 t -64.85 -44.55 96.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -176.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -75.81 -25.7 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-N 121.973 2.17 . . . . 0.0 114.051 173.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.7 t -62.61 -28.05 69.63 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 119.705 1.139 . . . . 0.0 111.126 166.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 14.8 mt -81.84 -16.02 52.18 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 170.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.422 ' HA2' ' SD ' ' A' ' 110' ' ' MET . . . -91.71 -25.69 22.17 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 115.091 0.796 . . . . 0.0 115.091 171.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 13.4 mt -74.36 -26.72 0.7 Allowed Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 117.974 2.583 . . . . 0.0 117.974 -165.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -59.87 -0.62 0.89 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.174 2.583 . . . . 0.0 116.615 167.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -114.6 -43.92 3.12 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 -168.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -148.42 -112.85 0.68 Allowed Glycine 0 C--N 1.338 0.658 0 CA-C-O 122.587 1.104 . . . . 0.0 112.652 173.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 32.7 tptt -146.1 123.02 11.34 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 130.545 3.538 . . . . 0.0 103.894 176.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . 0.276 17.8 t -130.48 85.79 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 CA-C-O 122.604 1.192 . . . . 0.0 109.432 -159.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 22.2 p -72.49 -36.04 68.32 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 112.74 -2.027 . . . . 0.0 111.741 -162.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -135.01 160.3 38.76 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 122.822 1.296 . . . . 0.0 114.047 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -149.88 171.95 15.95 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 126.454 1.902 . . . . 0.0 110.487 161.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.7 155.03 42.11 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.49 1.116 . . . . 0.0 110.101 -175.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 3.0 mtt -132.94 102.99 5.84 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.357 1.063 . . . . 0.0 111.476 -174.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.0 69.43 3.29 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 122.341 1.067 . . . . 0.0 109.748 168.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -60.53 -20.6 60.78 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.296 1.438 . . . . 0.0 113.25 -177.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.63 -30.34 62.25 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 125.358 1.456 . . . . 0.0 114.968 169.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.6 mtmt -132.39 -5.67 3.35 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 115.548 1.684 . . . . 0.0 115.548 -170.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.7 m120 72.61 38.71 0.76 Allowed 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 127.614 2.366 . . . . 0.0 113.611 -173.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -112.13 167.17 10.61 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.546 0.738 . . . . 0.0 111.271 171.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -147.39 164.48 33.18 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.499 1.519 . . . . 0.0 111.232 172.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.43 ' CD2' HG23 ' A' ' 60' ' ' VAL . 6.7 m-30 -109.27 157.33 18.94 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.44 1.496 . . . . 0.0 107.99 160.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 19.2 tt -137.31 124.33 29.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 124.599 1.16 . . . . 0.0 109.216 162.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -120.91 123.6 42.9 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 127.514 2.326 . . . . 0.0 111.445 -167.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -133.99 157.45 46.04 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 112.724 -2.035 . . . . 0.0 113.222 -164.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -70.78 -23.06 62.32 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.376 1.251 . . . . 0.0 114.376 -161.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 9.8 p -135.58 140.64 44.79 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 122.622 1.201 . . . . 0.0 111.772 -175.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -59.83 -33.01 71.21 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.084 174.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -74.49 -41.61 60.41 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -54.54 -51.67 64.48 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 119.4 1.0 . . . . 0.0 109.803 168.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.28 -36.09 74.15 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -176.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -58.91 -46.98 86.6 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.226 -0.921 . . . . 0.0 111.034 170.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -64.32 -32.7 74.41 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.024 -1.048 . . . . 0.0 111.278 173.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.422 ' SD ' ' HA2' ' A' ' 79' ' ' GLY . 12.9 ttp -71.75 -48.76 44.65 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 119.729 1.15 . . . . 0.0 111.238 -176.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.16 -40.44 89.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 124.498 1.119 . . . . 0.0 111.071 177.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -68.67 -44.77 73.35 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.512 0.725 . . . . 0.0 110.445 177.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -50.15 -38.05 37.5 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.114 1.366 . . . . 0.0 112.25 168.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -92.92 -11.16 34.09 Favored 'General case' 0 C--O 1.231 0.127 0 O-C-N 120.064 -1.648 . . . . 0.0 113.131 -177.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 84.2 m -80.89 -18.22 47.97 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.37 1.068 . . . . 0.0 110.069 166.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.04 -62.2 1.63 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 129.621 3.168 . . . . 0.0 112.3 170.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 1.4 p -83.02 -44.51 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 124.418 1.087 . . . . 0.0 113.018 -151.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.0 m 38.0 121.54 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.068 0 C-N-CA 130.674 3.589 . . . . 0.0 114.636 -147.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -69.84 -33.2 16.74 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 121.204 1.269 . . . . 0.0 114.118 -171.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.2 t 50.89 99.17 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 128.757 2.823 . . . . 0.0 112.313 -176.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.617 ' H ' HD13 ' A' ' 126' ' ' ILE . 1.2 tt -116.33 -73.37 0.65 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 112.201 -2.272 . . . . 0.0 107.472 -146.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.53 -35.01 79.59 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.56 1.144 . . . . 0.0 111.643 172.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 147.41 4.38 0.39 Allowed Glycine 0 CA--C 1.533 1.2 0 C-N-CA 125.083 1.325 . . . . 0.0 116.229 175.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -152.6 167.59 13.02 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 119.15 1.475 . . . . 0.0 111.272 178.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -45.3 110.06 0.22 Allowed 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 124.347 3.364 . . . . 0.0 116.447 -171.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.617 HD13 ' H ' ' A' ' 121' ' ' LEU . 2.5 mm -74.14 166.19 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 125.175 1.39 . . . . 0.0 107.707 166.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -140.66 156.34 46.26 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.218 -0.926 . . . . 0.0 110.483 168.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.21 153.27 38.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 125.517 1.527 . . . . 0.0 111.098 176.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -150.2 167.99 25.3 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.357 1.463 . . . . 0.0 108.772 154.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -55.12 149.47 12.19 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 120.878 -1.139 . . . . 0.0 111.74 159.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 30.8 t -69.28 153.16 44.08 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.897 0.879 . . . . 0.0 112.669 176.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -61.86 -29.13 69.98 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.047 1.339 . . . . 0.0 112.15 167.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 51.1 m-70 -95.11 175.96 6.42 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.592 1.957 . . . . 0.0 111.548 -174.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -134.64 120.53 19.67 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.272 1.429 . . . . 0.0 111.072 -177.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 58.55 90.39 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 128.201 2.601 . . . . 0.0 114.131 -178.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 35.9 tp -59.04 128.73 38.66 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.2 1.4 . . . . 0.0 112.111 176.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt . . . . . 0 N--CA 1.469 0.483 0 C-N-CA 126.348 1.859 . . . . 0.0 110.523 170.075 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 49.1 m . . . . . 0 N--CA 1.479 1.015 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 34.4 mtp180 -55.82 -7.43 0.3 Allowed 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 129.909 3.284 . . . . 0.0 119.324 -170.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.6 p -105.66 134.71 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-N 119.759 1.163 . . . . 0.0 111.878 169.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 10.4 mt -106.0 150.25 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 126.433 1.893 . . . . 0.0 108.561 167.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -114.03 143.97 43.87 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.082 1.353 . . . . 0.0 110.569 173.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 7.2 mt -118.46 144.8 25.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 126.488 1.915 . . . . 0.0 108.395 -175.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.23 167.87 17.75 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 127.739 2.415 . . . . 0.0 109.639 168.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.72 27.91 17.27 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.816 1.246 . . . . 0.0 113.229 178.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 28.2 mt -66.96 177.25 0.9 Allowed Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 125.05 1.34 . . . . 0.0 109.792 163.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -51.88 -171.97 0.01 OUTLIER 'Trans proline' 0 CA--C 1.545 1.062 0 C-N-CA 123.181 2.587 . . . . 0.0 114.507 147.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.7 mm -60.31 -47.26 93.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 127.427 2.291 . . . . 0.0 111.189 -176.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -155.51 -7.44 0.12 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 129.334 3.054 . . . . 0.0 111.666 -162.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.307 7.9 p 26.05 -127.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 128.903 2.881 . . . . 0.0 113.457 -167.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.8 t -154.51 143.8 21.27 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 120.004 1.275 . . . . 0.0 110.421 163.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -58.31 -42.12 86.0 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 123.562 0.745 . . . . 0.0 112.276 -175.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -55.79 -37.94 71.33 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 123.861 0.743 . . . . 0.0 112.516 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -69.12 -53.37 20.53 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.454 1.102 . . . . 0.0 112.125 173.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 97.7 t -58.97 -46.69 91.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 122.941 0.496 . . . . 0.0 112.14 -176.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.0 pp -73.05 -33.74 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 O-C-N 120.674 -1.266 . . . . 0.0 112.531 177.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 64.0 m -69.55 -21.44 63.64 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 120.047 1.294 . . . . 0.0 111.599 175.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.9 mt -77.63 -27.67 51.17 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 170.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -89.98 -21.25 39.84 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-N 119.239 0.927 . . . . 0.0 114.526 176.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.0 mt -64.05 -37.65 28.68 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 117.858 2.54 . . . . 0.0 117.858 -169.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.48 -4.01 1.09 Allowed 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.787 2.991 . . . . 0.0 116.845 171.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -106.97 -35.34 6.93 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 113.496 0.925 . . . . 0.0 113.496 -167.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -154.58 -108.37 0.31 Allowed Glycine 0 C--N 1.338 0.647 0 CA-C-O 122.622 1.123 . . . . 0.0 111.964 172.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 32.0 tptt -149.61 122.14 8.54 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 130.415 3.486 . . . . 0.0 104.135 175.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . 0.308 20.8 t -128.74 83.98 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 CA-C-N 120.034 1.288 . . . . 0.0 109.955 -160.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.5 t -79.72 -21.22 44.84 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 126.894 2.077 . . . . 0.0 112.765 -163.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -141.51 161.74 37.17 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 175.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -149.37 171.82 15.92 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.577 2.351 . . . . 0.0 110.551 162.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.99 154.47 44.05 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.266 1.426 . . . . 0.0 108.772 172.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 3.7 mtt -128.28 105.62 8.47 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.748 1.219 . . . . 0.0 110.434 -175.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -74.11 71.52 1.64 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.186 0.994 . . . . 0.0 110.525 173.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -49.85 118.87 3.11 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.835 1.654 . . . . 0.0 111.574 -176.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.04 -6.37 82.72 Favored Glycine 0 CA--C 1.539 1.556 0 CA-C-O 118.279 -1.289 . . . . 0.0 116.178 177.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.51 -2.98 50.72 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-N 119.837 1.818 . . . . 0.0 113.154 165.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.9 m120 63.24 27.37 15.5 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.313 1.845 . . . . 0.0 113.283 -167.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -124.58 164.51 19.66 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.513 0.725 . . . . 0.0 112.302 -168.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -164.12 170.71 16.07 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.091 1.756 . . . . 0.0 111.177 -178.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 4.3 m-30 -116.74 156.02 27.9 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.448 1.899 . . . . 0.0 108.088 164.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 17.4 tt -138.14 124.41 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 124.722 1.209 . . . . 0.0 109.138 164.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -122.79 122.17 38.04 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 127.034 2.134 . . . . 0.0 111.474 -164.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -132.63 157.33 45.07 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 113.389 -1.732 . . . . 0.0 112.97 -166.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.79 -19.34 62.02 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 114.065 -1.425 . . . . 0.0 114.308 -159.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 16.8 p -137.83 142.64 40.77 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 122.956 1.36 . . . . 0.0 111.766 -176.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -59.43 -37.42 78.04 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 114.125 -1.398 . . . . 0.0 110.706 176.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -71.64 -40.35 69.79 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 179.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.0 -52.53 62.85 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 119.403 1.001 . . . . 0.0 110.073 169.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.99 -38.16 82.35 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -56.15 -48.24 76.65 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.818 -0.551 . . . . 0.0 111.048 171.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -64.84 -35.01 79.74 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 118.407 -0.806 . . . . 0.0 111.233 173.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 8.2 ttp -67.76 -48.55 66.07 Favored 'General case' 0 C--N 1.343 0.303 0 C-N-CA 124.554 1.142 . . . . 0.0 110.554 -175.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.84 -40.64 88.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 C-N-CA 124.752 1.221 . . . . 0.0 111.761 178.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -67.71 -45.3 75.48 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.377 0.671 . . . . 0.0 110.693 177.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -50.97 -38.31 49.98 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.604 1.562 . . . . 0.0 112.482 167.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -88.73 -16.47 32.15 Favored 'General case' 0 CA--C 1.517 -0.289 0 O-C-N 119.966 -1.709 . . . . 0.0 112.88 -178.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 70.0 m -79.06 -18.61 53.13 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.434 1.093 . . . . 0.0 109.865 169.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.42 -60.58 2.22 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 129.384 3.074 . . . . 0.0 111.697 169.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -88.47 -48.07 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.048 0.939 . . . . 0.0 112.955 -153.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.2 m 43.08 125.28 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.88 0 C-N-CA 129.866 3.266 . . . . 0.0 114.267 -148.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -70.14 -35.35 11.67 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 121.416 1.411 . . . . 0.0 114.012 -171.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.6 t 53.86 102.33 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 128.597 2.759 . . . . 0.0 113.031 -178.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.599 ' H ' HD13 ' A' ' 126' ' ' ILE . 0.8 OUTLIER -123.59 -71.46 0.72 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 112.479 -2.146 . . . . 0.0 108.28 -147.293 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.78 -42.51 99.09 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.521 0.728 . . . . 0.0 111.086 171.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 158.18 -2.47 0.12 Allowed Glycine 0 CA--C 1.533 1.198 0 N-CA-C 116.208 1.243 . . . . 0.0 116.208 173.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -148.13 169.56 9.07 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 119.54 1.67 . . . . 0.0 111.192 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -50.98 116.07 2.41 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.734 2.956 . . . . 0.0 116.535 -166.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.599 HD13 ' H ' ' A' ' 121' ' ' LEU . 4.3 mm -76.27 150.06 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 126.364 1.866 . . . . 0.0 109.166 174.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 10.2 m-30 -114.7 136.7 52.77 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.042 -1.036 . . . . 0.0 110.787 -176.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.5 149.3 32.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 125.1 1.36 . . . . 0.0 112.319 176.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -153.46 164.9 37.39 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.763 2.025 . . . . 0.0 109.627 153.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -53.19 152.23 4.53 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 120.873 -1.142 . . . . 0.0 112.593 167.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 27.9 t -76.18 157.87 32.27 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.726 0.81 . . . . 0.0 113.086 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -68.51 -12.03 60.68 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.854 1.662 . . . . 0.0 113.636 168.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 42.6 m-70 -119.6 -178.69 3.68 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.484 1.513 . . . . 0.0 112.895 -170.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -136.88 124.95 22.9 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.981 2.112 . . . . 0.0 110.639 178.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 58.28 93.05 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 127.185 2.194 . . . . 0.0 113.946 -178.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 28.9 tp -64.01 110.96 2.31 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.666 1.587 . . . . 0.0 111.814 178.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt . . . . . 0 N--CA 1.473 0.678 0 C-N-CA 126.204 1.802 . . . . 0.0 110.425 174.989 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.1 t . . . . . 0 N--CA 1.473 0.714 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 25.8 mtp180 61.5 -8.54 0.09 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 128.836 2.854 . . . . 0.0 117.839 171.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.3 3.9 p -104.81 130.3 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 120.906 1.685 . . . . 0.0 113.409 175.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.8 mp -103.21 155.21 5.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 127.617 2.367 . . . . 0.0 108.103 169.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -126.93 140.96 51.94 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.801 2.04 . . . . 0.0 111.024 177.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.6 mt -120.75 136.63 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 128.309 2.644 . . . . 0.0 109.857 -170.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.6 mtt180 -97.19 176.65 5.85 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 120.517 1.508 . . . . 0.0 111.02 172.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp 45.34 35.79 2.01 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 127.739 2.415 . . . . 0.0 117.068 159.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.8 mp -52.03 157.42 2.16 Favored Pre-proline 0 CA--C 1.559 1.303 0 C-N-CA 124.771 1.228 . . . . 0.0 110.912 165.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -42.0 -65.72 0.18 Allowed 'Trans proline' 0 CA--C 1.537 0.648 1 C-N-CA 126.033 4.488 . . . . 0.0 115.385 177.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 pt -160.54 -55.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 130.262 3.425 . . . . 0.0 107.898 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -145.99 -9.47 0.52 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.31 1.444 . . . . 0.0 114.508 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.456 HG21 ' H ' ' A' ' 71' ' ' THR 0.28 1.7 p 45.14 -154.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 127.611 2.364 . . . . 0.0 112.997 -178.616 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.456 ' H ' HG21 ' A' ' 70' ' ' VAL . 4.0 t -137.43 143.0 41.63 Favored 'General case' 0 C--O 1.238 0.499 0 O-C-N 120.396 -1.44 . . . . 0.0 110.466 160.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -58.46 -33.41 69.71 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.763 177.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -56.59 -41.3 89.16 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 123.953 0.787 . . . . 0.0 112.96 175.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -64.53 -55.83 18.0 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.815 0.846 . . . . 0.0 111.11 171.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.7 t -61.05 -44.22 97.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -173.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.9 pp -69.44 -32.65 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 O-C-N 120.301 -1.499 . . . . 0.0 112.652 175.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.6 p -64.28 -21.23 66.52 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 119.738 1.153 . . . . 0.0 112.214 173.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 86.8 mt -91.6 -16.14 27.55 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 173.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -90.02 -22.78 34.52 Favored Glycine 0 CA--C 1.538 1.509 0 CA-C-N 119.144 0.884 . . . . 0.0 113.214 168.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.0 mt -73.37 -14.98 0.25 Allowed Pre-proline 0 CA--C 1.543 0.677 0 N-CA-C 119.314 3.079 . . . . 0.0 119.314 -175.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -60.5 -1.53 1.49 Allowed 'Trans proline' 0 C--N 1.348 0.525 0 CA-C-N 123.152 2.162 . . . . 0.0 116.62 168.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -122.05 -53.62 1.94 Allowed 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 114.698 1.369 . . . . 0.0 114.698 -168.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -144.06 -106.57 0.54 Allowed Glycine 0 C--N 1.337 0.598 0 C-N-CA 124.149 0.88 . . . . 0.0 111.985 -178.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 13.7 tptm -143.41 -7.52 0.78 Allowed 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 116.805 2.15 . . . . 0.0 116.805 -174.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 101' ' ' MET . 0.1 OUTLIER 30.26 87.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 129.029 2.932 . . . . 0.0 113.37 -176.782 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 24.1 m -55.42 -42.3 73.94 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 127.378 2.271 . . . . 0.0 111.695 -175.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -149.72 169.53 20.83 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.4 pp -139.49 171.95 13.51 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.97 1.708 . . . . 0.0 112.189 155.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -144.18 151.95 40.22 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.176 1.79 . . . . 0.0 108.476 173.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 5.1 mtt -128.77 103.52 7.11 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.326 1.05 . . . . 0.0 111.924 -175.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -74.43 96.02 2.82 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.927 1.291 . . . . 0.0 110.878 172.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 49.4 mttp -61.17 -19.18 61.26 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 171.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -53.33 -61.07 7.33 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 126.379 1.942 . . . . 0.0 114.968 -177.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.34 27.06 4.79 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.632 1.973 . . . . 0.0 112.239 -175.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 59.45 48.5 9.78 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.723 2.009 . . . . 0.0 113.709 -177.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . 0.28 0.0 OUTLIER -117.59 176.14 5.31 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.042 0.937 . . . . 0.0 111.935 176.838 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -166.48 165.81 16.73 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 120.276 -1.515 . . . . 0.0 111.018 -174.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 4.2 m-30 -112.46 157.37 21.17 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.908 1.683 . . . . 0.0 108.484 166.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 8.6 tt -143.62 108.32 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 126.111 1.764 . . . . 0.0 107.618 170.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -115.34 131.91 56.78 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.846 2.058 . . . . 0.0 112.014 -166.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.443 ' HA ' ' HA ' ' A' ' 85' ' ' VAL 0.292 1.2 tpp -130.46 153.5 48.72 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 116.835 2.161 . . . . 0.0 116.835 -161.498 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.0 -9.2 51.23 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.182 1.793 . . . . 0.0 114.675 -165.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -148.76 143.89 26.68 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.459 1.504 . . . . 0.0 110.111 -177.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -66.54 -32.76 74.31 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.221 1.008 . . . . 0.0 111.726 176.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -71.83 -47.44 53.16 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.346 0.658 . . . . 0.0 112.09 177.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.79 -46.47 87.48 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 122.83 0.452 . . . . 0.0 110.619 175.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.22 -40.65 82.0 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -60.77 -46.43 90.48 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.851 -0.531 . . . . 0.0 111.102 171.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -63.3 -29.09 70.48 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 120.421 -1.425 . . . . 0.0 111.198 171.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 10.4 ttp -67.06 -52.11 46.27 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 120.13 1.332 . . . . 0.0 110.048 -177.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.74 -40.51 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 124.547 1.139 . . . . 0.0 111.85 176.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -71.29 -44.07 65.91 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.751 0.82 . . . . 0.0 111.824 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -48.42 -38.66 20.22 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.454 1.501 . . . . 0.0 111.629 166.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -85.98 -22.26 27.42 Favored 'General case' 0 N--CA 1.445 -0.715 0 O-C-N 120.649 -1.282 . . . . 0.0 113.248 -175.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.08 -15.89 57.54 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.984 0.897 . . . . 0.0 111.107 171.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.7 -59.43 2.79 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 128.932 2.893 . . . . 0.0 111.045 169.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.2 p -78.01 -48.92 22.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 124.474 1.11 . . . . 0.0 112.43 -158.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.5 m 28.78 121.91 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.038 0 C-N-CA 129.044 2.938 . . . . 0.0 114.789 -138.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -80.86 -7.65 13.34 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 121.789 1.659 . . . . 0.0 115.002 -167.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 4.1 t 28.88 85.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 C-N-CA 130.239 3.416 . . . . 0.0 114.041 173.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.645 ' H ' HD13 ' A' ' 126' ' ' ILE 0.268 9.7 tt -106.95 -23.6 12.29 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 118.01 -1.476 . . . . 0.0 112.507 -121.126 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.35 -6.68 11.25 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.633 1.173 . . . . 0.0 113.997 148.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 139.74 11.51 0.72 Allowed Glycine 0 CA--C 1.536 1.364 0 N-CA-C 118.059 1.984 . . . . 0.0 118.059 -169.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.8 155.75 69.06 Favored Pre-proline 0 C--N 1.346 0.417 0 CA-C-N 120.771 2.286 . . . . 0.0 112.999 172.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.04 152.72 49.68 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.985 2.456 . . . . 0.0 113.674 -177.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.645 HD13 ' H ' ' A' ' 121' ' ' LEU . 29.8 mm -117.74 -53.88 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 123.646 0.778 . . . . 0.0 112.917 -163.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 62.13 151.14 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.975 2.11 . . . . 0.0 115.255 -170.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.45 157.06 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 125.914 1.686 . . . . 0.0 110.799 174.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -147.75 166.06 28.65 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.384 1.474 . . . . 0.0 109.453 155.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -55.64 146.89 19.58 Favored 'General case' 0 CA--C 1.547 0.858 0 O-C-N 121.353 -0.842 . . . . 0.0 111.303 158.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 29.4 t -73.39 161.48 30.4 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.669 1.187 . . . . 0.0 113.673 -175.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -73.03 -10.88 60.27 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.139 1.376 . . . . 0.0 113.573 167.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 57.7 m-70 -115.46 172.35 7.16 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.441 1.497 . . . . 0.0 112.403 -172.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -122.02 110.04 15.31 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 126.576 1.95 . . . . 0.0 109.728 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 61.88 167.94 0.11 Allowed 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 126.592 1.957 . . . . 0.0 113.924 -166.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 22.7 tp -132.19 97.87 4.25 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 128.617 2.767 . . . . 0.0 112.521 -172.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? . . . . . 0 N--CA 1.474 0.754 0 C-N-CA 127.601 2.361 . . . . 0.0 111.156 179.796 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 CA--C 1.543 0.71 0 CA-C-O 120.995 0.426 . . . . 0.0 111.65 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 44.4 mtp180 -55.11 -9.21 0.37 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 130.121 3.368 . . . . 0.0 119.474 -158.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.409 7.2 p -101.26 132.27 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 CA-C-N 122.404 2.366 . . . . 0.0 113.495 170.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 26.0 mt -111.22 153.71 12.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 128.287 2.635 . . . . 0.0 107.696 172.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -124.14 146.99 48.29 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.874 1.27 . . . . 0.0 111.446 178.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.1 mt -126.27 142.76 41.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 127.367 2.267 . . . . 0.0 109.977 -173.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.09 172.55 8.16 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 126.904 2.082 . . . . 0.0 112.41 170.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 67.13 19.51 10.4 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 126.456 1.902 . . . . 0.0 114.529 175.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.2 mp -54.02 154.95 6.92 Favored Pre-proline 0 CA--C 1.556 1.174 0 C-N-CA 122.791 0.437 . . . . 0.0 111.897 171.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -48.75 -58.4 1.78 Allowed 'Trans proline' 0 CA--C 1.536 0.596 1 C-N-CA 125.454 4.102 . . . . 0.0 114.651 175.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 pt -171.6 -53.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 131.372 3.869 . . . . 0.0 108.428 -178.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -147.27 -10.13 0.43 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 126.096 1.758 . . . . 0.0 113.701 -171.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.293 5.0 p 40.47 -136.64 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 127.262 2.225 . . . . 0.0 112.251 -177.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 t -143.32 133.99 25.12 Favored 'General case' 0 C--O 1.241 0.618 0 O-C-N 120.846 -1.159 . . . . 0.0 109.175 156.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.59 -30.21 68.5 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.335 -178.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -60.31 -36.59 91.32 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.938 1.256 . . . . 0.0 113.405 174.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -66.23 -52.25 49.63 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 118.153 0.976 . . . . 0.0 110.814 170.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.0 t -63.58 -42.29 95.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -174.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.3 pp -72.92 -32.43 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 O-C-N 120.168 -1.583 . . . . 0.0 113.131 175.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 36.2 t -62.38 -27.31 68.99 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 119.038 0.836 . . . . 0.0 110.852 171.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 31.3 mt -86.53 -15.67 39.27 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 173.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -92.43 -19.59 37.85 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.887 1.232 . . . . 0.0 113.599 172.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.5 mt -65.11 -46.08 73.02 Favored Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 116.808 2.151 . . . . 0.0 116.808 -171.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.61 -4.03 0.74 Allowed 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 124.657 3.571 . . . . 0.0 118.496 178.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -104.92 -33.8 8.25 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -165.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -160.99 -78.34 0.03 OUTLIER Glycine 0 C--N 1.331 0.262 0 C-N-CA 125.785 1.659 . . . . 0.0 109.032 176.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -150.96 -13.79 0.22 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 116.678 2.103 . . . . 0.0 116.678 170.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.2 m 29.49 171.73 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.246 0 CA-C-O 123.262 1.506 . . . . 0.0 114.829 -127.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.3 t -124.27 -26.81 3.89 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 119.16 -2.212 . . . . 0.0 112.435 163.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -162.22 166.28 25.7 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 172.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -140.43 166.85 23.58 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.656 1.582 . . . . 0.0 113.411 159.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.13 151.44 40.7 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 128.073 2.549 . . . . 0.0 108.662 -177.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 6.4 mtt -127.45 111.9 14.36 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.258 1.023 . . . . 0.0 111.132 -179.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -73.31 72.4 1.28 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.689 1.196 . . . . 0.0 111.102 175.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -57.79 125.36 22.69 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.467 1.107 . . . . 0.0 110.75 175.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 96.58 -8.72 66.41 Favored Glycine 0 CA--C 1.537 1.458 0 C-N-CA 125.242 1.401 . . . . 0.0 115.56 -173.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.94 -9.14 10.13 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 119.343 1.571 . . . . 0.0 113.693 169.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.2 m120 59.76 39.67 20.54 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.305 1.842 . . . . 0.0 112.806 -174.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -121.82 172.64 8.02 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.232 1.013 . . . . 0.0 111.325 -179.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -159.75 165.38 32.6 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.654 1.582 . . . . 0.0 111.336 178.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -115.44 150.39 36.52 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 126.498 1.919 . . . . 0.0 107.638 166.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 16.2 tt -134.92 98.93 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 125.046 1.339 . . . . 0.0 108.659 167.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -85.49 131.67 34.33 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 127.495 2.318 . . . . 0.0 110.974 176.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . 0.283 11.6 tpp -120.27 155.81 32.5 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 -170.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.72 -22.0 64.36 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -170.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.91 147.64 37.4 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.168 0.987 . . . . 0.0 110.96 -175.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -66.04 -38.53 88.63 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.047 0.539 . . . . 0.0 111.843 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -71.9 -40.71 68.67 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 178.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -54.67 -50.52 68.0 Favored 'General case' 0 C--O 1.219 -0.545 0 C-N-CA 122.997 0.519 . . . . 0.0 110.607 170.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.59 -37.88 73.95 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -178.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -55.92 -47.87 76.72 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.45 1.023 . . . . 0.0 110.875 169.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -66.39 -32.04 73.18 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-O 118.345 -0.836 . . . . 0.0 111.649 173.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 13.3 ttp -70.41 -45.79 65.22 Favored 'General case' 0 C--N 1.345 0.388 0 C-N-CA 125.069 1.348 . . . . 0.0 110.588 -176.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -67.79 -41.11 84.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 124.183 0.993 . . . . 0.0 111.745 177.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -68.52 -44.92 73.59 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.299 0.64 . . . . 0.0 110.564 178.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -47.14 -45.23 22.4 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.375 1.47 . . . . 0.0 111.98 166.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -82.23 -16.66 48.81 Favored 'General case' 0 N--CA 1.456 -0.128 0 O-C-N 121.054 -1.029 . . . . 0.0 112.64 -176.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 92.8 m -80.57 -14.63 58.04 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.364 1.065 . . . . 0.0 110.653 170.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.33 -54.53 3.02 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 128.809 2.843 . . . . 0.0 113.229 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 10.9 p -71.46 -35.82 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 127.171 2.189 . . . . 0.0 114.274 -156.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.415 ' CG2' ' H ' ' A' ' 126' ' ' ILE . 0.2 OUTLIER -2.51 115.91 0.01 OUTLIER Pre-proline 0 N--CA 1.486 1.347 0 C-N-CA 127.754 2.422 . . . . 0.0 116.875 -125.876 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -76.16 -18.88 15.98 Favored 'Trans proline' 0 CA--C 1.547 1.166 0 C-N-CA 123.506 2.804 . . . . 0.0 113.095 -167.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 6.4 t 60.9 104.03 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 130.072 3.349 . . . . 0.0 113.057 -178.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.6 tt -65.5 -66.93 0.48 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.583 1.153 . . . . 0.0 111.714 -158.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.07 66.56 1.24 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.248 1.419 . . . . 0.0 110.054 168.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 86.04 12.37 71.2 Favored Glycine 0 CA--C 1.54 1.654 0 C-N-CA 124.628 1.109 . . . . 0.0 114.985 -178.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -136.18 141.47 36.31 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 126.564 1.945 . . . . 0.0 109.399 177.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -56.68 166.44 3.72 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 123.579 2.853 . . . . 0.0 112.65 171.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.415 ' H ' ' CG2' ' A' ' 118' ' ' THR . 0.8 OUTLIER -125.23 146.38 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.388 1.075 . . . . 0.0 110.124 -174.957 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -128.94 95.17 4.01 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.28 -1.327 . . . . 0.0 109.039 -153.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.12 151.49 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 124.682 1.193 . . . . 0.0 112.953 -173.225 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -156.66 170.02 23.37 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.38 1.072 . . . . 0.0 109.976 147.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -52.34 149.28 5.71 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 120.853 -1.154 . . . . 0.0 112.525 170.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 30.3 t -70.64 158.53 36.03 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.182 0.993 . . . . 0.0 112.381 179.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -63.34 -15.27 56.89 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.826 1.25 . . . . 0.0 112.859 163.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 28.2 m-70 -117.61 -179.83 3.85 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 127.354 2.262 . . . . 0.0 111.206 -175.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -130.81 11.87 5.22 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.73 1.612 . . . . 0.0 113.398 -173.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -167.76 150.95 5.98 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.895 2.078 . . . . 0.0 110.571 -166.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 55.9 tp -140.07 -62.47 0.51 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.019 1.328 . . . . 0.0 113.207 177.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.4 ptmm? . . . . . 0 N--CA 1.481 1.099 0 C-N-CA 128.969 2.907 . . . . 0.0 116.455 178.519 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.2 m . . . . . 0 N--CA 1.478 0.969 0 N-CA-C 117.887 2.551 . . . . 0.0 117.887 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 40.6 mtm-85 81.5 -6.53 1.52 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 128.361 2.665 . . . . 0.0 117.484 152.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.421 HG23 ' CD2' ' A' ' 98' ' ' PHE . 2.5 p -118.22 136.57 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 CA-C-N 120.297 1.408 . . . . 0.0 113.125 163.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 10.9 mt -110.86 147.61 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 126.987 2.115 . . . . 0.0 108.795 168.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -110.7 116.59 31.57 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.295 1.438 . . . . 0.0 110.601 175.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 8.9 mt -89.53 134.3 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 126.505 1.922 . . . . 0.0 108.416 175.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -123.38 168.85 11.98 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 126.425 1.89 . . . . 0.0 112.248 171.019 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.5 mmtt 46.38 39.05 5.92 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 127.664 2.386 . . . . 0.0 114.418 -172.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.2 mt -60.55 174.22 0.54 Allowed Pre-proline 0 CA--C 1.556 1.207 0 C-N-CA 125.466 1.506 . . . . 0.0 111.043 158.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.56 -169.88 0.01 OUTLIER 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 124.55 3.5 . . . . 0.0 114.743 151.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 22.4 pt -58.81 -52.5 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.3 1.44 . . . . 0.0 112.644 -175.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -149.07 8.69 0.74 Allowed 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 127.103 2.161 . . . . 0.0 112.889 172.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.309 10.4 p 30.88 -125.46 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 C-N-CA 128.38 2.672 . . . . 0.0 113.294 -169.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.8 t -153.8 143.1 21.49 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 120.248 1.385 . . . . 0.0 110.237 167.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -55.86 -43.21 76.88 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.03 0.932 . . . . 0.0 112.329 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.03 -42.79 61.46 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 124.074 0.845 . . . . 0.0 112.907 178.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -64.94 -53.42 46.62 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.726 0.81 . . . . 0.0 111.894 172.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 83.5 t -59.5 -48.81 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 123.506 0.722 . . . . 0.0 112.442 -175.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.7 pp -70.01 -35.34 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 O-C-N 120.654 -1.279 . . . . 0.0 112.403 178.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.0 m -69.52 -20.85 63.69 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 119.714 1.143 . . . . 0.0 111.82 175.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.2 mt -79.48 -24.5 42.29 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 170.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -94.37 -21.6 26.68 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-N 119.061 0.846 . . . . 0.0 115.161 174.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.5 mt -59.95 -43.02 93.56 Favored Pre-proline 0 CA--C 1.538 0.514 0 N-CA-C 117.113 2.264 . . . . 0.0 117.113 -169.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.54 -6.18 1.44 Allowed 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.88 3.053 . . . . 0.0 116.981 174.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -104.03 -36.08 7.86 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 -167.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -153.03 -108.19 0.35 Allowed Glycine 0 C--N 1.336 0.54 0 CA-C-O 122.763 1.202 . . . . 0.0 111.846 172.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 7.0 tppt? -149.53 122.22 8.63 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 130.42 3.488 . . . . 0.0 104.533 175.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . 0.288 21.6 t -129.06 84.71 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 CA-C-O 122.954 1.359 . . . . 0.0 109.213 -160.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 41.0 p -82.66 -17.21 45.36 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 127.524 2.33 . . . . 0.0 113.008 -162.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -141.51 160.16 40.73 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 174.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -146.21 175.73 10.28 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.575 1.95 . . . . 0.0 110.773 158.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.48 153.43 34.61 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 125.728 1.611 . . . . 0.0 109.645 177.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 4.9 mtp -134.73 95.67 3.39 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.535 0.734 . . . . 0.0 111.628 -167.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.0 91.3 2.5 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.111 1.364 . . . . 0.0 110.947 173.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -63.85 -17.31 63.02 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -65.18 -51.5 49.53 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 125.394 1.473 . . . . 0.0 115.155 -174.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 29.0 mtmt -126.11 22.92 7.19 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 125.73 1.612 . . . . 0.0 112.852 -172.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 20.9 m120 62.45 49.54 4.04 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.661 1.984 . . . . 0.0 113.621 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . 0.281 0.0 OUTLIER -128.78 172.51 11.21 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 177.157 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -157.54 163.24 38.59 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 127.095 2.158 . . . . 0.0 109.614 -175.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.421 ' CD2' HG23 ' A' ' 60' ' ' VAL . 5.2 m-30 -107.84 154.59 21.33 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.98 1.312 . . . . 0.0 107.887 162.089 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.0 tt -134.51 123.82 43.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 124.404 1.082 . . . . 0.0 108.636 164.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -121.19 122.36 39.81 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.539 1.936 . . . . 0.0 111.769 -165.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -137.98 150.29 46.87 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 113.041 -1.891 . . . . 0.0 113.249 -164.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.98 -18.87 64.12 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 113.038 -1.892 . . . . 0.0 114.385 -155.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 30.2 p -138.54 141.47 39.3 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 123.32 1.533 . . . . 0.0 112.08 -175.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -57.54 -37.31 72.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 113.769 -1.559 . . . . 0.0 110.75 176.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -72.59 -41.39 65.69 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.05 -52.56 62.79 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 119.231 0.923 . . . . 0.0 110.02 170.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.63 -36.87 79.21 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -178.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -55.77 -50.83 69.36 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 118.83 0.741 . . . . 0.0 110.506 170.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -63.66 -35.33 80.19 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-O 118.19 -0.909 . . . . 0.0 111.178 174.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 8.5 ttp -66.93 -51.14 58.88 Favored 'General case' 0 C--N 1.343 0.291 0 CA-C-N 119.747 1.158 . . . . 0.0 110.802 -176.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.41 -39.58 85.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 124.673 1.189 . . . . 0.0 111.761 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -70.22 -45.15 67.16 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.472 0.709 . . . . 0.0 110.942 177.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -50.62 -33.88 23.94 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.678 1.191 . . . . 0.0 112.556 167.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -92.12 -11.74 34.85 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 119.929 -1.732 . . . . 0.0 113.619 -177.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.2 t -86.13 -14.39 44.32 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.964 0.887 . . . . 0.0 111.629 165.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.29 -58.76 3.1 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 128.448 2.699 . . . . 0.0 111.449 167.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -92.27 -49.33 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 123.709 0.804 . . . . 0.0 112.736 -155.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.6 m 45.68 125.9 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.04 0 C-N-CA 130.493 3.517 . . . . 0.0 113.701 -152.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -77.02 -13.88 17.16 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 121.775 1.65 . . . . 0.0 115.76 -171.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.1 t 30.11 92.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 130.032 3.333 . . . . 0.0 114.36 175.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.623 ' H ' HD13 ' A' ' 126' ' ' ILE . 1.4 tt -102.92 -57.31 2.07 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 113.489 -1.687 . . . . 0.0 109.419 -131.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.91 6.71 43.48 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.992 1.717 . . . . 0.0 113.61 165.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 103.23 20.54 11.02 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 126.061 1.791 . . . . 0.0 115.127 -178.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 10.8 tp60 -146.71 142.06 16.83 Favored Pre-proline 0 CA--C 1.538 0.489 0 CA-C-O 116.706 -1.616 . . . . 0.0 110.245 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -52.18 147.35 27.94 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 124.636 3.557 . . . . 0.0 116.115 -167.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.623 HD13 ' H ' ' A' ' 121' ' ' LEU . 3.2 mm -117.93 153.01 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 126.653 1.981 . . . . 0.0 108.629 -177.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 20.0 m-30 -122.54 142.37 50.67 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.979 0.912 . . . . 0.0 110.209 -175.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -131.88 147.88 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.019 1.327 . . . . 0.0 111.628 172.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -147.52 162.54 38.87 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.836 0.854 . . . . 0.0 109.977 145.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -53.35 147.68 10.06 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.47 0.708 . . . . 0.0 112.171 168.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 29.2 t -74.68 133.89 42.04 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 121.486 -0.758 . . . . 0.0 112.215 178.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -67.95 -19.87 65.0 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 176.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -69.59 -52.28 27.53 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -177.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 16.4 mtmm 79.15 152.65 0.13 Allowed 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 128.739 2.816 . . . . 0.0 111.461 -149.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 36.29 95.59 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 129.389 3.076 . . . . 0.0 117.258 164.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 27.6 tp -64.58 110.32 2.29 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.03 1.732 . . . . 0.0 111.596 172.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt . . . . . 0 N--CA 1.473 0.697 0 C-N-CA 125.239 1.416 . . . . 0.0 110.537 172.297 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 25.1 m . . . . . 0 N--CA 1.478 0.928 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 25.1 mtp180 -125.86 -16.4 5.66 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 118.05 2.611 . . . . 0.0 118.05 -159.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.328 7.1 p -105.59 136.58 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 CA-C-N 121.138 1.79 . . . . 0.0 112.002 166.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.4 mt -113.41 155.33 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 128.773 2.829 . . . . 0.0 108.06 171.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -122.33 135.44 54.72 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.358 1.463 . . . . 0.0 110.377 177.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.4 mt -120.85 117.15 52.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 126.736 2.014 . . . . 0.0 109.291 -174.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.0 ptt180 -98.26 177.25 5.44 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 126.083 1.753 . . . . 0.0 112.917 177.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 59.63 25.9 14.87 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 127.192 2.197 . . . . 0.0 114.623 175.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 26.2 mt -64.45 150.94 92.53 Favored Pre-proline 0 CA--C 1.56 1.329 0 C-N-CA 122.927 0.491 . . . . 0.0 111.244 176.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -45.91 -66.52 0.15 Allowed 'Trans proline' 0 C--N 1.352 0.751 1 C-N-CA 125.313 4.009 . . . . 0.0 115.124 -178.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 12.4 pt -159.73 -41.87 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 130.177 3.391 . . . . 0.0 109.968 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -154.21 -11.48 0.14 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.949 1.3 . . . . 0.0 113.072 -169.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.295 14.4 p 31.29 -121.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 127.099 2.16 . . . . 0.0 111.296 -161.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.1 t -151.29 133.94 15.6 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 126.395 1.878 . . . . 0.0 106.439 155.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -69.28 -20.99 63.91 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.059 -1.026 . . . . 0.0 113.041 -173.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -58.6 -33.6 72.82 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 125.182 1.372 . . . . 0.0 113.665 164.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -75.58 -40.87 55.98 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 121.232 -1.158 . . . . 0.0 111.798 170.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.1 t -57.11 -46.15 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -84.73 -24.56 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 O-C-N 120.534 -1.354 . . . . 0.0 114.52 175.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.0 t -60.79 -31.97 71.33 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 120.187 1.358 . . . . 0.0 110.764 166.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 15.6 mt -74.22 -31.02 62.45 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 171.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -85.72 -19.25 58.45 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-N 119.438 1.017 . . . . 0.0 115.141 178.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.0 mt -70.27 -33.14 3.12 Favored Pre-proline 0 CA--C 1.541 0.605 0 N-CA-C 118.016 2.599 . . . . 0.0 118.016 -165.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -60.25 1.15 0.52 Allowed 'Trans proline' 0 C--N 1.35 0.605 0 C-N-CA 123.646 2.898 . . . . 0.0 116.809 170.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.403 ' CG ' ' HG3' ' A' ' 110' ' ' MET . 33.8 m-85 -116.02 -44.17 2.93 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -167.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -148.14 -108.7 0.51 Allowed Glycine 0 C--N 1.338 0.683 0 C-N-CA 123.873 0.749 . . . . 0.0 111.855 174.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 37.0 tptt -144.49 -12.98 0.59 Allowed 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 178.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' A' ' 101' ' ' MET 0.355 1.4 t 45.63 79.71 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 128.577 2.751 . . . . 0.0 114.553 164.914 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.1 m -66.01 -43.34 87.99 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 129.798 3.239 . . . . 0.0 111.811 -168.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -138.32 170.57 15.8 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 122.993 1.378 . . . . 0.0 113.362 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -146.63 173.27 12.49 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.153 2.181 . . . . 0.0 110.827 159.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.59 156.51 41.52 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.45 1.9 . . . . 0.0 109.495 176.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 8.1 mtt -129.32 110.56 12.03 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.605 1.162 . . . . 0.0 113.2 -178.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -77.29 97.87 4.99 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.407 1.883 . . . . 0.0 112.396 178.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -75.36 64.37 1.53 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.736 1.614 . . . . 0.0 111.738 167.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.52 -70.14 0.02 OUTLIER Glycine 0 N--CA 1.473 1.125 0 C-N-CA 124.863 1.22 . . . . 0.0 113.313 -177.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -114.5 26.6 10.09 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 127.06 2.144 . . . . 0.0 110.659 176.043 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 51.6 67.5 0.95 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.795 2.038 . . . . 0.0 113.043 -173.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.64 -178.47 4.38 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 177.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -155.17 164.22 39.13 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.72 2.408 . . . . 0.0 110.118 178.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -107.78 150.23 27.24 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.423 1.489 . . . . 0.0 108.146 161.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 19.2 tt -132.87 119.75 38.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.938 1.295 . . . . 0.0 108.356 165.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -121.47 133.55 55.05 Favored 'General case' 0 CA--C 1.513 -0.454 0 C-N-CA 125.947 1.699 . . . . 0.0 110.84 -165.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.444 ' HA ' ' HA ' ' A' ' 85' ' ' VAL 0.287 1.3 ptm -137.66 159.41 42.06 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 117.188 2.292 . . . . 0.0 117.188 -169.935 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.4 -18.07 64.37 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 127.035 2.134 . . . . 0.0 112.726 -165.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.11 143.59 34.4 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-O 123.504 1.621 . . . . 0.0 111.86 178.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -66.71 -32.93 74.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 113.492 -1.685 . . . . 0.0 110.762 177.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -72.56 -37.82 68.13 Favored 'General case' 0 N--CA 1.462 0.13 0 C-N-CA 123.763 0.825 . . . . 0.0 113.024 177.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -57.12 -59.25 5.37 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 119.033 0.833 . . . . 0.0 109.62 169.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.45 -39.41 87.47 Favored 'General case' 0 C--O 1.224 -0.26 0 N-CA-C 114.752 1.389 . . . . 0.0 114.752 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -56.01 -51.05 69.14 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.475 -0.766 . . . . 0.0 111.047 172.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -63.65 -32.3 73.73 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.536 -0.727 . . . . 0.0 111.231 175.032 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.403 ' HG3' ' CG ' ' A' ' 82' ' ' PHE . 5.1 ttp -71.01 -49.05 49.39 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.083 1.353 . . . . 0.0 111.13 -176.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -64.97 -40.17 88.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 124.43 1.092 . . . . 0.0 111.23 178.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -67.58 -46.3 73.06 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.798 0.839 . . . . 0.0 110.196 177.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -49.37 -41.72 39.94 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.18 1.392 . . . . 0.0 112.279 168.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -88.85 -11.46 44.67 Favored 'General case' 0 C--O 1.232 0.166 0 O-C-N 120.405 -1.435 . . . . 0.0 112.996 -176.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 70.6 m -81.04 -17.82 48.88 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.095 0.958 . . . . 0.0 110.195 167.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.62 -57.89 2.71 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 129.189 2.995 . . . . 0.0 113.294 176.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 5.9 p -79.44 -37.65 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -149.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 12.09 112.71 0.0 OUTLIER Pre-proline 0 N--CA 1.484 1.268 0 C-N-CA 130.095 3.358 . . . . 0.0 116.396 -137.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.424 ' HD2' ' CD1' ' A' ' 126' ' ' ILE . 5.0 Cg_exo -79.38 -20.37 9.7 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.979 3.119 . . . . 0.0 113.684 -168.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 6.9 t 64.29 99.98 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 128.742 2.817 . . . . 0.0 112.659 176.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 6.2 tt -70.61 -75.3 0.12 Allowed 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -155.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -92.08 -44.36 8.88 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.908 1.283 . . . . 0.0 109.512 175.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -177.35 18.61 0.04 OUTLIER Glycine 0 CA--C 1.538 1.472 0 C-N-CA 126.192 1.853 . . . . 0.0 112.948 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -144.39 156.8 57.06 Favored Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 126.67 1.988 . . . . 0.0 110.766 -170.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -59.58 164.16 11.78 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 122.502 2.135 . . . . 0.0 113.815 -179.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.424 ' CD1' ' HD2' ' A' ' 119' ' ' PRO . 0.4 OUTLIER -127.47 149.24 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.125 1.37 . . . . 0.0 110.018 -178.805 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -130.1 95.73 4.0 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.007 -153.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -108.28 144.64 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 124.134 0.974 . . . . 0.0 112.844 -177.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -145.17 159.01 43.66 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.632 1.973 . . . . 0.0 109.085 154.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -54.6 155.32 4.18 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 121.262 -0.899 . . . . 0.0 111.733 165.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 27.1 t -79.25 148.96 32.0 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 177.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -61.08 -31.07 70.74 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.404 1.481 . . . . 0.0 112.945 167.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 57.3 m-70 -89.33 -18.83 26.14 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.767 1.227 . . . . 0.0 113.407 -176.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . 0.28 62.6 pttt 48.94 9.07 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 130.181 3.392 . . . . 0.0 118.205 177.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 59.9 tt0 -164.98 124.94 1.89 Allowed 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 128.973 2.909 . . . . 0.0 110.463 172.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 22.7 tp -106.86 106.27 16.71 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.682 1.993 . . . . 0.0 110.857 -178.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt . . . . . 0 N--CA 1.472 0.653 0 C-N-CA 125.791 1.636 . . . . 0.0 109.269 173.754 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 58.2 m . . . . . 0 N--CA 1.48 1.026 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 25.2 mtp180 -124.19 -11.48 7.49 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 116.432 2.012 . . . . 0.0 116.432 -160.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.293 3.6 p -110.89 137.57 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 119.815 1.188 . . . . 0.0 112.162 172.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.0 mt -119.55 142.03 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 127.923 2.489 . . . . 0.0 108.369 175.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -112.51 148.39 34.56 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.937 1.695 . . . . 0.0 111.222 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 mp -133.12 138.98 50.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 126.227 1.811 . . . . 0.0 109.854 -176.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.67 176.61 5.11 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 125.6 1.56 . . . . 0.0 111.87 169.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.431 ' HG3' ' CD1' ' A' ' 127' ' ' TYR . 21.9 mmmt 73.98 8.64 4.76 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 127.015 2.126 . . . . 0.0 115.003 165.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.74 159.82 41.16 Favored Pre-proline 0 CA--C 1.546 0.804 0 CA-C-N 119.181 0.9 . . . . 0.0 112.937 -176.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -51.72 173.75 0.09 OUTLIER 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 124.385 3.39 . . . . 0.0 115.087 163.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 36.4 pt -60.95 -34.55 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 127.065 2.146 . . . . 0.0 113.221 -167.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -140.01 -10.59 1.14 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.822 1.649 . . . . 0.0 113.485 166.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.298 3.8 p 38.98 -139.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 127.599 2.359 . . . . 0.0 111.87 -169.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.7 t -147.97 139.54 23.74 Favored 'General case' 0 C--O 1.239 0.519 0 O-C-N 120.803 -1.185 . . . . 0.0 109.931 154.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -55.93 -32.63 63.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.621 173.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -61.28 -32.53 81.1 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 125.05 1.31 . . . . 0.0 112.871 175.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -67.19 -55.41 14.21 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 118.725 1.263 . . . . 0.0 110.648 167.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.2 t -57.66 -44.83 86.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -175.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.3 pp -81.33 -29.16 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 O-C-N 120.313 -1.492 . . . . 0.0 113.871 -179.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 18.1 t -63.75 -29.36 70.58 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 119.61 1.096 . . . . 0.0 110.55 168.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.0 mt -78.72 -20.69 49.45 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 172.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -101.45 -16.55 24.41 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-N 119.859 1.209 . . . . 0.0 116.116 176.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.9 mt -61.55 -52.57 68.76 Favored Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 117.171 2.286 . . . . 0.0 117.171 -172.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -75.2 39.52 0.61 Allowed 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 124.125 3.217 . . . . 0.0 113.974 -178.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -127.84 -36.65 1.99 Allowed 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 126.87 2.068 . . . . 0.0 111.902 177.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -152.76 -108.84 0.38 Allowed Glycine 0 CA--C 1.525 0.717 0 CA-C-O 122.774 1.208 . . . . 0.0 111.989 168.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 15.6 tptm -149.23 132.01 16.01 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 131.625 3.97 . . . . 0.0 103.726 173.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.416 ' CG2' ' HE2' ' A' ' 101' ' ' MET 0.313 14.3 t -128.1 92.56 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-N 120.666 1.576 . . . . 0.0 110.773 -163.666 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.5 t -80.82 -32.75 35.09 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 126.727 2.011 . . . . 0.0 112.825 -161.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -130.74 160.53 34.06 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 174.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -147.19 167.83 23.21 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 126.963 2.105 . . . . 0.0 110.102 166.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.76 152.09 34.67 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 125.288 1.435 . . . . 0.0 108.969 173.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 5.8 mtt -126.93 110.4 12.97 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.406 1.483 . . . . 0.0 110.267 177.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -72.1 79.65 0.95 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.62 1.168 . . . . 0.0 110.178 178.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -44.69 -47.97 10.63 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 127.549 2.339 . . . . 0.0 114.445 -168.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -79.79 -12.16 83.84 Favored Glycine 0 CA--C 1.535 1.317 0 N-CA-C 116.31 1.284 . . . . 0.0 116.31 -174.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -126.66 3.04 6.79 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 -173.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.0 m120 58.94 36.1 24.39 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.187 1.395 . . . . 0.0 113.918 -178.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -111.2 176.13 5.15 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.519 0.727 . . . . 0.0 111.095 175.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -158.03 167.36 30.11 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.708 1.603 . . . . 0.0 111.928 176.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 4.8 m-30 -118.72 152.62 35.81 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.966 2.106 . . . . 0.0 108.118 163.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 14.4 tt -135.41 127.19 46.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 124.778 1.231 . . . . 0.0 108.669 163.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -130.98 121.1 24.49 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.252 1.421 . . . . 0.0 112.929 -163.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.416 ' HE2' ' CG2' ' A' ' 85' ' ' VAL . 1.0 OUTLIER -129.22 162.62 27.43 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.12 -1.4 . . . . 0.0 113.696 -159.479 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.35 -12.57 60.09 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -158.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -143.18 142.47 31.45 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.177 1.391 . . . . 0.0 110.879 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -61.46 -33.41 73.7 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.742 175.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -75.74 -36.04 60.03 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 123.641 0.776 . . . . 0.0 112.987 178.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -56.82 -52.08 66.45 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-N 118.973 0.806 . . . . 0.0 110.642 168.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.94 -39.16 79.73 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -54.93 -48.41 73.16 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 118.754 0.706 . . . . 0.0 111.255 170.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -64.77 -32.5 74.22 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 121.242 -0.911 . . . . 0.0 111.46 175.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 7.5 ttp -65.86 -57.63 7.47 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.467 1.107 . . . . 0.0 109.686 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -57.97 -41.65 80.72 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.372 0 C-N-CA 124.95 1.3 . . . . 0.0 111.607 177.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -65.43 -42.9 91.94 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 118.897 0.771 . . . . 0.0 111.924 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -53.92 -37.43 63.83 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 118.61 0.641 . . . . 0.0 112.037 167.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -85.73 -13.88 47.0 Favored 'General case' 0 C--N 1.332 -0.182 0 O-C-N 120.263 -1.523 . . . . 0.0 113.192 -178.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 54.8 m -84.79 -15.62 44.3 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.144 1.377 . . . . 0.0 110.307 169.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.28 -49.04 11.22 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 128.464 2.706 . . . . 0.0 111.26 172.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -94.97 178.82 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 127.556 2.342 . . . . 0.0 111.754 -165.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.1 m -137.91 130.06 16.31 Favored Pre-proline 0 N--CA 1.477 0.876 0 O-C-N 120.985 -1.072 . . . . 0.0 109.212 129.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -83.44 -16.85 6.7 Favored 'Trans proline' 0 CA--C 1.547 1.157 0 C-N-CA 122.667 2.245 . . . . 0.0 112.753 -167.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 14.3 t 58.36 99.37 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 129.759 3.224 . . . . 0.0 113.498 177.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.6 tt -67.1 -62.6 1.35 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.285 1.034 . . . . 0.0 112.4 -156.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -125.56 4.41 7.57 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 126.722 2.009 . . . . 0.0 114.566 -179.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 124.5 9.26 5.51 Favored Glycine 0 CA--C 1.539 1.565 0 C-N-CA 125.119 1.342 . . . . 0.0 114.725 -160.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -139.66 144.33 38.74 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 126.854 2.061 . . . . 0.0 109.658 -176.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.99 166.23 7.29 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 123.576 2.851 . . . . 0.0 112.966 175.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -127.67 145.01 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.165 0.986 . . . . 0.0 111.056 -173.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . 0.431 ' CD1' ' HG3' ' A' ' 65' ' ' LYS . 3.6 m-85 -126.26 79.66 1.86 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.105 -1.407 . . . . 0.0 109.441 -153.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -91.1 149.81 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 124.514 1.125 . . . . 0.0 112.688 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -145.37 159.42 43.09 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 128.235 2.614 . . . . 0.0 108.159 161.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -55.98 155.49 6.25 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 120.437 -1.415 . . . . 0.0 111.368 154.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 31.0 t -71.03 158.33 36.69 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.473 -0.767 . . . . 0.0 112.167 172.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -65.29 -11.76 44.83 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.857 1.263 . . . . 0.0 112.861 163.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 40.5 m-70 -116.05 -179.15 3.58 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 127.675 2.39 . . . . 0.0 110.726 -175.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -125.4 4.26 7.69 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 125.525 1.53 . . . . 0.0 114.4 -172.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -176.36 164.79 2.68 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 128.3 2.64 . . . . 0.0 109.111 -170.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 23.9 tp -137.15 91.87 2.66 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.035 1.734 . . . . 0.0 111.482 -174.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.472 0.644 0 C-N-CA 124.436 1.095 . . . . 0.0 110.493 172.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 44.3 t . . . . . 0 N--CA 1.476 0.865 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.44 -2.14 18.37 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.585 1.154 . . . . 0.0 113.596 167.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.312 7.4 p -85.11 131.11 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 119.396 0.998 . . . . 0.0 111.628 163.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.0 mt -110.72 144.99 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 127.785 2.434 . . . . 0.0 107.769 169.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -108.21 150.49 27.19 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.993 1.317 . . . . 0.0 110.529 172.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 7.5 mt -127.56 142.27 44.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 125.888 1.675 . . . . 0.0 109.093 -173.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.26 170.06 11.14 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 128.579 2.752 . . . . 0.0 109.223 164.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.57 20.29 12.1 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.617 1.167 . . . . 0.0 113.989 176.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 37.5 mt -64.01 167.7 7.36 Favored Pre-proline 0 CA--C 1.542 0.673 0 C-N-CA 123.474 0.71 . . . . 0.0 110.908 162.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -54.41 172.29 0.33 Allowed 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.934 2.423 . . . . 0.0 113.981 156.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 21.7 pt -80.98 -18.6 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 127.614 2.366 . . . . 0.0 113.332 -179.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -144.97 12.17 1.41 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 127.347 2.259 . . . . 0.0 113.281 -164.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -55.22 151.37 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.8 t -101.27 148.54 25.0 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 122.398 1.094 . . . . 0.0 113.281 -173.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -50.45 -44.24 55.5 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.217 1.407 . . . . 0.0 111.432 174.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -58.36 -35.1 77.39 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 123.852 0.739 . . . . 0.0 113.349 -179.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -74.7 -44.04 52.07 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.456 1.103 . . . . 0.0 112.167 175.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 95.1 t -60.68 -51.61 71.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 123.168 0.587 . . . . 0.0 111.084 177.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.1 pp -69.12 -30.45 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 O-C-N 120.73 -1.231 . . . . 0.0 113.099 178.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 49.2 m -73.73 -16.66 61.18 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 119.288 0.949 . . . . 0.0 112.306 174.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 22.7 mt -86.44 -15.25 40.83 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.121 0.968 . . . . 0.0 113.291 165.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.427 ' HA2' ' SD ' ' A' ' 110' ' ' MET . . . -75.88 -33.09 51.81 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 124.311 0.958 . . . . 0.0 113.241 168.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 16.5 mt -80.22 -16.83 0.24 Allowed Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 119.923 3.305 . . . . 0.0 119.923 -159.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -61.07 -4.61 3.96 Favored 'Trans proline' 0 C--N 1.347 0.493 0 CA-C-N 122.919 2.078 . . . . 0.0 116.474 169.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.484 ' CD2' ' HG3' ' A' ' 110' ' ' MET . 34.2 m-85 -120.6 -43.66 2.48 Favored 'General case' 0 C--N 1.34 0.195 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 -166.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -142.38 -118.36 1.37 Allowed Glycine 0 CA--C 1.525 0.706 0 CA-C-O 122.648 1.138 . . . . 0.0 112.555 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 15.2 tptm -148.03 122.24 9.57 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 130.45 3.5 . . . . 0.0 104.363 179.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.403 ' CG2' ' HE2' ' A' ' 101' ' ' MET 0.28 19.6 t -130.36 82.49 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 CA-C-O 122.778 1.275 . . . . 0.0 109.213 -159.515 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 41.5 p -79.86 -16.4 55.47 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 127.433 2.293 . . . . 0.0 112.725 -163.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -142.17 158.3 43.9 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 173.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.24 170.23 16.69 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.693 2.397 . . . . 0.0 110.34 167.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.49 155.12 40.75 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.184 0.994 . . . . 0.0 109.805 174.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 4.0 mtp -132.55 94.15 3.36 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.353 0.661 . . . . 0.0 111.355 -168.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.07 66.74 1.66 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.57 1.148 . . . . 0.0 110.505 170.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 53.9 tttm -55.79 -34.38 65.24 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.538 1.535 . . . . 0.0 113.579 -169.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -64.18 -16.86 60.67 Favored Glycine 0 CA--C 1.54 1.603 0 C-N-CA 125.538 1.542 . . . . 0.0 116.075 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 18.9 mtmt -124.53 7.26 8.27 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.123 1.369 . . . . 0.0 114.216 -176.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.5 m120 58.92 34.03 23.39 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.786 1.235 . . . . 0.0 112.095 -168.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -117.87 164.47 15.0 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.723 0.809 . . . . 0.0 111.985 -175.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -158.06 168.98 25.6 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.684 1.593 . . . . 0.0 111.662 -179.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -114.8 157.76 22.8 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.105 1.762 . . . . 0.0 108.42 160.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 19.8 tt -140.45 122.06 14.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 125.084 1.354 . . . . 0.0 109.129 163.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -119.3 125.73 49.79 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 127.242 2.217 . . . . 0.0 111.253 -169.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.403 ' HE2' ' CG2' ' A' ' 85' ' ' VAL . 0.3 OUTLIER -128.87 160.06 33.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 113.276 -1.784 . . . . 0.0 114.129 -167.519 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.81 -20.44 61.84 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 -163.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 8.3 p -138.45 137.73 37.47 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.128 1.371 . . . . 0.0 110.988 -174.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -59.25 -34.67 72.5 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.199 175.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -73.27 -40.05 64.91 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.99 -52.52 63.9 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-N 119.491 1.041 . . . . 0.0 109.552 168.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.71 -37.1 79.25 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 -175.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -56.12 -52.23 65.06 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.779 0.718 . . . . 0.0 110.684 169.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -61.33 -32.18 72.06 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 118.931 -0.557 . . . . 0.0 111.324 174.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.484 ' HG3' ' CD2' ' A' ' 82' ' ' PHE . 13.4 ttp -73.48 -50.16 22.98 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-N 119.486 1.039 . . . . 0.0 111.918 -175.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -63.14 -35.34 71.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.168 0.987 . . . . 0.0 111.107 178.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -75.65 -41.58 53.73 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.381 1.072 . . . . 0.0 112.091 176.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -48.28 -52.95 19.0 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.509 1.124 . . . . 0.0 109.989 165.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -79.88 16.12 1.25 Allowed 'General case' 0 C--N 1.326 -0.423 0 O-C-N 118.932 -2.355 . . . . 0.0 113.044 178.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . 0.289 0.5 OUTLIER -118.63 -10.32 10.06 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 164.584 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.01 -43.05 14.31 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.273 1.829 . . . . 0.0 111.413 161.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 89.6 t -115.12 -57.9 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.386 1.074 . . . . 0.0 111.856 -144.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.0 m 70.89 135.04 0.04 OUTLIER Pre-proline 0 N--CA 1.485 1.315 0 C-N-CA 128.027 2.531 . . . . 0.0 112.234 -173.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -76.26 -22.49 12.64 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.256 1.971 . . . . 0.0 114.966 -176.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.9 t 36.37 89.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 129.802 3.241 . . . . 0.0 113.305 175.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.621 ' H ' HD13 ' A' ' 126' ' ' ILE . 2.4 tt -100.05 -66.09 0.93 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 113.783 -1.553 . . . . 0.0 109.597 -134.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -84.53 -9.6 58.19 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 159.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 110.34 55.42 0.53 Allowed Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.347 1.451 . . . . 0.0 113.22 -166.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -145.06 162.49 37.54 Favored Pre-proline 0 CA--C 1.541 0.631 0 CA-C-N 119.075 1.438 . . . . 0.0 112.931 156.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.34 100.22 0.15 Allowed 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 123.293 2.662 . . . . 0.0 111.973 168.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.621 HD13 ' H ' ' A' ' 121' ' ' LEU . 3.0 mm -77.75 138.24 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.303 1.041 . . . . 0.0 108.69 177.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 11.7 m-30 -109.3 128.6 55.22 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 120.674 -1.266 . . . . 0.0 110.667 -173.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.25 151.07 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.902 1.281 . . . . 0.0 111.888 178.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -158.27 160.8 37.47 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.158 1.783 . . . . 0.0 110.172 157.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -54.65 144.2 22.58 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.261 -0.899 . . . . 0.0 112.398 170.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 21.4 t -73.78 147.13 43.74 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.986 -0.447 . . . . 0.0 111.371 173.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 12.7 p30 -80.62 -9.24 59.8 Favored 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 113.977 1.102 . . . . 0.0 113.977 175.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -83.63 179.82 7.51 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.381 1.072 . . . . 0.0 112.608 174.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -113.06 97.25 6.4 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.794 2.038 . . . . 0.0 109.837 173.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 61.28 -174.97 0.13 Allowed 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.696 1.998 . . . . 0.0 112.558 -176.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 34.7 tp -135.14 99.36 4.24 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 126.413 1.885 . . . . 0.0 110.962 -170.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 50.8 tttp . . . . . 0 N--CA 1.468 0.439 0 C-N-CA 125.719 1.608 . . . . 0.0 110.062 176.172 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.7 t . . . . . 0 N--CA 1.477 0.906 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.2 mtp180 -54.44 -13.51 0.95 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 131.536 3.935 . . . . 0.0 118.804 -173.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.408 HG23 ' CD2' ' A' ' 98' ' ' PHE 0.269 0.1 OUTLIER -81.94 122.45 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-N 120.885 1.675 . . . . 0.0 110.106 162.534 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.0 mp -87.18 135.38 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 156.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -102.61 144.37 31.1 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.888 1.275 . . . . 0.0 110.566 174.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.2 mt -129.94 140.71 48.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 126.158 1.783 . . . . 0.0 109.862 -176.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 5.4 ptt-85 -123.74 179.15 4.91 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 126.835 2.054 . . . . 0.0 112.281 173.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 58.64 17.94 5.46 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 127.083 2.153 . . . . 0.0 114.607 178.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.6 mp -50.29 156.83 1.32 Allowed Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 125.273 1.429 . . . . 0.0 113.15 178.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -45.3 -62.55 0.43 Allowed 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 125.075 3.85 . . . . 0.0 114.776 -179.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.5 pt -163.64 -52.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 131.324 3.85 . . . . 0.0 107.723 176.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -146.3 -11.31 0.48 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.567 1.547 . . . . 0.0 114.143 -176.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.301 2.9 p 42.4 -145.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 127.268 2.227 . . . . 0.0 112.148 -174.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.0 t -141.97 137.44 31.21 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 120.553 -1.342 . . . . 0.0 110.772 164.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -55.54 -39.35 70.45 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.367 1.067 . . . . 0.0 111.883 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.25 -38.28 56.51 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 125.111 1.339 . . . . 0.0 113.937 172.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -72.51 -48.12 43.09 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 121.449 -1.03 . . . . 0.0 112.405 174.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.3 t -58.63 -49.37 82.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-N 117.979 0.354 . . . . 0.0 111.701 -176.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.95 -31.43 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 O-C-N 120.86 -1.15 . . . . 0.0 114.001 177.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 48.7 m -71.42 -18.12 62.35 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 120.664 1.575 . . . . 0.0 111.433 176.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 29.6 mt -84.37 -24.17 29.8 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 167.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -86.36 -18.92 58.11 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-N 118.72 0.691 . . . . 0.0 114.168 175.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 13.0 mt -73.29 -18.1 0.34 Allowed Pre-proline 0 CA--C 1.548 0.872 0 N-CA-C 119.416 3.117 . . . . 0.0 119.416 -171.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -59.16 -2.42 1.24 Allowed 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.411 2.74 . . . . 0.0 118.083 174.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -120.83 -35.91 3.26 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 -169.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -151.73 -109.69 0.44 Allowed Glycine 0 C--N 1.337 0.638 0 CA-C-O 122.253 0.918 . . . . 0.0 112.51 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -152.89 129.08 10.46 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 129.408 3.083 . . . . 0.0 104.893 -176.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.455 ' CG2' ' HE2' ' A' ' 101' ' ' MET 0.304 11.9 t -135.24 81.92 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 120.161 1.346 . . . . 0.0 109.678 -165.562 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 58.9 p -79.64 -22.31 43.72 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 126.829 2.051 . . . . 0.0 112.436 -164.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 65.5 m-80 -136.03 156.0 49.38 Favored 'General case' 0 C--N 1.343 0.323 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 177.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -146.91 170.33 17.29 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.824 2.05 . . . . 0.0 110.044 162.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.01 153.93 45.77 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.837 1.655 . . . . 0.0 109.748 175.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 40.0 mtt -131.22 117.29 18.8 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.062 0.945 . . . . 0.0 110.908 178.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -76.2 69.67 2.76 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.754 1.222 . . . . 0.0 110.325 175.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -56.21 105.98 0.24 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.626 1.97 . . . . 0.0 111.327 -177.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 124.03 -15.97 7.77 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 126.077 1.798 . . . . 0.0 115.052 -176.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 10.6 mtmt -118.22 -2.21 11.21 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 119.142 1.471 . . . . 0.0 114.644 178.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.3 m120 60.05 46.9 10.26 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.0 1.72 . . . . 0.0 112.398 -173.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -131.8 165.76 23.08 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.44 0.696 . . . . 0.0 112.418 -179.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -157.82 163.26 38.19 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.131 1.372 . . . . 0.0 113.001 -178.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.408 ' CD2' HG23 ' A' ' 60' ' ' VAL . 4.5 m-30 -115.91 148.2 40.27 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 128.61 2.764 . . . . 0.0 106.287 166.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 6.4 tp -134.5 106.79 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 125.854 1.662 . . . . 0.0 108.874 170.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -102.93 109.38 20.91 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 128.602 2.761 . . . . 0.0 111.552 -167.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.455 ' HE2' ' CG2' ' A' ' 85' ' ' VAL . 16.1 ttm -107.02 158.5 17.0 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 114.095 -1.411 . . . . 0.0 112.695 -174.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.96 -21.23 60.1 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -163.098 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.9 p -138.15 147.43 43.89 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.805 0.842 . . . . 0.0 111.74 -175.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -64.92 -36.65 85.07 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.432 0.693 . . . . 0.0 112.15 179.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -72.35 -42.56 65.17 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 118.763 0.71 . . . . 0.0 112.817 179.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -57.73 -48.25 80.13 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 118.567 0.622 . . . . 0.0 110.071 172.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.16 -37.4 78.21 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -55.62 -51.89 65.64 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 121.339 -0.85 . . . . 0.0 110.876 169.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -64.81 -24.76 67.65 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-O 117.77 -1.109 . . . . 0.0 111.665 173.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 10.3 ttp -73.13 -48.51 34.92 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 120.514 1.506 . . . . 0.0 110.227 -178.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -65.56 -37.78 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 O-C-N 121.532 -0.73 . . . . 0.0 111.441 177.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -68.05 -46.48 71.0 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.869 0.868 . . . . 0.0 110.958 174.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -48.43 -42.27 31.82 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.026 1.73 . . . . 0.0 112.01 167.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -84.01 -17.7 39.58 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 120.843 -1.16 . . . . 0.0 112.563 -176.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 84.1 m -80.97 -14.63 57.78 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.514 1.126 . . . . 0.0 110.469 170.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.55 -58.18 2.36 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 129.766 3.226 . . . . 0.0 112.879 176.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 6.0 p -74.19 -35.66 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 126.683 1.993 . . . . 0.0 113.056 -158.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.464 ' CG2' ' H ' ' A' ' 126' ' ' ILE . 0.8 OUTLIER 4.09 114.57 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.047 0 C-N-CA 130.351 3.46 . . . . 0.0 115.953 -134.711 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -77.76 -3.84 13.94 Favored 'Trans proline' 0 CA--C 1.55 1.303 0 C-N-CA 123.711 2.941 . . . . 0.0 113.99 -159.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.4 t 62.07 112.47 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 131.62 3.968 . . . . 0.0 115.799 174.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.8 tt -72.82 75.69 1.14 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 127.909 2.483 . . . . 0.0 109.583 173.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . 0.262 0.0 OUTLIER 48.39 -15.68 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.507 1 C-N-CA 132.713 4.405 . . . . 0.0 119.004 -170.56 . . . . . . . . 4 3 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -179.51 2.95 0.02 OUTLIER Glycine 0 CA--C 1.54 1.624 0 C-N-CA 125.869 1.699 . . . . 0.0 115.265 -172.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -139.62 148.0 54.19 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 126.995 2.118 . . . . 0.0 109.46 -177.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -57.6 167.0 4.24 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.35 2.7 . . . . 0.0 114.35 175.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.464 ' H ' ' CG2' ' A' ' 118' ' ' THR . 0.5 OUTLIER -120.86 148.79 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.911 1.684 . . . . 0.0 109.299 179.697 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -122.35 101.05 7.27 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.494 1.118 . . . . 0.0 110.951 -154.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.45 152.74 28.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -167.117 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -150.87 171.44 17.22 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 129.46 3.104 . . . . 0.0 109.418 165.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -65.38 166.01 10.87 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 120.311 -1.493 . . . . 0.0 111.394 153.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 83.3 p -60.26 154.11 20.76 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 120.933 -1.104 . . . . 0.0 112.546 163.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 14.3 p30 -85.69 -19.42 30.91 Favored 'General case' 0 CA--C 1.548 0.897 0 O-C-N 121.363 -0.836 . . . . 0.0 112.28 158.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 67.5 m-70 -75.21 -171.1 1.31 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.772 1.629 . . . . 0.0 111.985 164.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -141.7 121.21 13.27 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 127.123 2.169 . . . . 0.0 110.181 174.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 66.04 99.4 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 126.026 1.73 . . . . 0.0 114.939 171.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 61.8 tp -61.78 125.71 24.79 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.273 1.429 . . . . 0.0 112.171 172.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 86.8 tttt . . . . . 0 N--CA 1.476 0.845 0 C-N-CA 125.023 1.329 . . . . 0.0 113.763 179.505 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 73.8 m . . . . . 0 N--CA 1.474 0.773 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 41.0 mtp180 59.92 -28.78 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 131.342 3.857 . . . . 0.0 118.017 172.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.487 HG23 ' CD2' ' A' ' 98' ' ' PHE . 1.7 p -98.09 134.72 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 120.254 1.388 . . . . 0.0 112.122 167.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.8 mt -110.07 124.32 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 C-N-CA 127.585 2.354 . . . . 0.0 108.263 168.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -83.44 149.02 26.92 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.898 0.856 . . . . 0.0 111.208 169.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 8.7 mt -124.47 140.83 46.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 126.539 1.936 . . . . 0.0 108.99 179.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.51 167.91 13.27 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 127.432 2.293 . . . . 0.0 110.464 165.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 19.8 mmtt 53.64 41.57 32.05 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.768 1.627 . . . . 0.0 113.04 -176.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.62 176.99 0.63 Allowed Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 126.493 1.917 . . . . 0.0 109.737 159.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -59.52 -175.37 0.09 OUTLIER 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 124.53 3.487 . . . . 0.0 114.543 147.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 28.7 pt -81.24 -31.99 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 126.038 1.735 . . . . 0.0 113.479 -177.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -156.37 37.44 0.33 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.557 1.943 . . . . 0.0 110.725 -168.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -51.75 156.49 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.869 0.867 . . . . 0.0 112.669 177.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.82 144.28 26.68 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 122.448 1.118 . . . . 0.0 112.188 -176.235 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -58.04 -42.67 85.91 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.127 171.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.62 -39.8 61.55 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.927 1.251 . . . . 0.0 112.938 178.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -68.37 -49.41 60.36 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.688 1.195 . . . . 0.0 112.098 173.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 95.6 t -61.61 -44.89 99.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 122.965 0.506 . . . . 0.0 112.005 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.8 pp -74.68 -30.04 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 O-C-N 120.597 -1.314 . . . . 0.0 112.488 176.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.7 t -61.92 -31.74 72.08 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 119.839 1.2 . . . . 0.0 110.482 170.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 10.3 mt -78.23 -21.83 49.34 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 175.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -98.66 -16.14 32.28 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-N 119.116 0.871 . . . . 0.0 115.186 175.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.4 mt -57.69 -54.59 53.65 Favored Pre-proline 0 CA--C 1.543 0.675 0 N-CA-C 116.823 2.157 . . . . 0.0 116.823 -168.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -77.72 41.88 1.07 Allowed 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 124.0 3.133 . . . . 0.0 114.081 -175.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -129.3 -42.48 1.34 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.901 1.68 . . . . 0.0 112.589 179.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -155.79 -99.44 0.16 Allowed Glycine 0 C--N 1.336 0.564 0 C-N-CA 124.484 1.04 . . . . 0.0 110.653 167.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 38.9 tptt -136.08 -12.84 1.9 Allowed 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 116.132 1.901 . . . . 0.0 116.132 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' A' ' 101' ' ' MET 0.25 0.1 OUTLIER 30.44 82.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 128.643 2.777 . . . . 0.0 113.247 -174.184 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.6 t -68.5 -31.03 70.0 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.092 0.957 . . . . 0.0 112.554 -170.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -147.85 174.07 12.21 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 123.296 1.522 . . . . 0.0 114.586 175.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -143.24 174.64 10.53 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 127.324 2.249 . . . . 0.0 111.371 157.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.15 154.08 43.53 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.964 2.105 . . . . 0.0 108.148 169.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 5.0 mtp -129.71 106.51 8.76 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.641 1.176 . . . . 0.0 110.597 -176.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -74.18 76.15 1.79 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.025 0.93 . . . . 0.0 110.519 173.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt -64.54 98.62 0.26 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.986 1.314 . . . . 0.0 110.269 173.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 168.76 -52.94 0.21 Allowed Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.909 1.719 . . . . 0.0 112.689 -166.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt -133.1 12.61 4.26 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.12 1.368 . . . . 0.0 114.559 -166.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 59.83 53.38 4.84 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.014 1.726 . . . . 0.0 112.161 -172.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -130.28 166.0 21.27 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.396 1.078 . . . . 0.0 111.855 -179.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -166.05 169.97 14.01 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.513 1.925 . . . . 0.0 110.628 -177.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.487 ' CD2' HG23 ' A' ' 60' ' ' VAL . 4.5 m-30 -118.22 141.07 48.88 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.783 2.433 . . . . 0.0 105.46 166.253 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 15.6 tt -122.2 113.26 37.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 125.336 1.454 . . . . 0.0 107.446 166.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -109.71 117.01 32.77 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 127.27 2.228 . . . . 0.0 110.333 -166.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.472 ' HA ' ' HA ' ' A' ' 85' ' ' VAL 0.296 0.9 OUTLIER -121.46 146.5 46.85 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -169.067 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.13 -18.08 63.04 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 113.673 -1.603 . . . . 0.0 114.653 -160.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.1 p -139.68 146.57 39.81 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.934 0.873 . . . . 0.0 111.125 -176.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -59.34 -41.25 88.75 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.096 178.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -77.37 -35.64 54.33 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -177.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.02 -51.38 69.93 Favored 'General case' 0 C--O 1.222 -0.387 0 CA-C-N 119.992 1.269 . . . . 0.0 110.253 169.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.83 -36.53 78.3 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 178.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -57.9 -47.16 83.61 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.693 1.133 . . . . 0.0 111.262 170.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -64.77 -33.96 77.21 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-O 117.915 -1.041 . . . . 0.0 110.9 173.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 11.1 ttp -66.66 -47.89 71.11 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 120.019 1.281 . . . . 0.0 111.225 -178.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -68.34 -38.55 79.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 124.604 1.161 . . . . 0.0 112.055 178.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -70.18 -43.39 70.88 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.442 0.697 . . . . 0.0 110.597 176.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -49.62 -37.7 29.03 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.803 1.241 . . . . 0.0 112.075 166.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -90.77 -12.95 34.97 Favored 'General case' 0 CA--C 1.518 -0.252 0 O-C-N 120.162 -1.586 . . . . 0.0 113.657 -177.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -83.93 -15.78 46.68 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.75 0.786 . . . . 0.0 110.932 167.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.89 -59.79 2.64 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 128.567 2.747 . . . . 0.0 111.742 166.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -93.84 -49.57 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -153.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.5 m 54.88 129.36 0.01 OUTLIER Pre-proline 0 N--CA 1.481 1.101 0 C-N-CA 129.535 3.134 . . . . 0.0 113.069 -157.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -75.76 -22.25 13.7 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 121.991 1.794 . . . . 0.0 114.752 -173.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.5 t 38.87 89.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 129.223 3.009 . . . . 0.0 113.179 174.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.615 ' H ' HD13 ' A' ' 126' ' ' ILE . 2.8 tt -101.45 -50.56 3.71 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 113.444 -1.707 . . . . 0.0 110.376 -132.469 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.96 1.94 29.24 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 126.266 1.827 . . . . 0.0 113.64 165.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 125.46 12.37 3.81 Favored Glycine 0 CA--C 1.537 1.411 0 N-CA-C 117.108 1.603 . . . . 0.0 117.108 175.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -147.13 163.97 25.64 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 120.251 2.025 . . . . 0.0 112.837 174.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -56.74 143.57 89.73 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.522 2.815 . . . . 0.0 115.621 -168.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.615 HD13 ' H ' ' A' ' 121' ' ' LEU . 3.9 mm -118.81 147.28 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 127.292 2.237 . . . . 0.0 108.122 -178.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 19.5 m-30 -117.82 127.9 54.33 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.193 -0.942 . . . . 0.0 111.099 -169.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -124.65 147.13 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.764 1.225 . . . . 0.0 113.326 -178.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -158.37 159.43 35.8 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.308 1.843 . . . . 0.0 110.001 159.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -56.43 162.48 2.12 Favored 'General case' 0 CA--C 1.556 1.177 0 O-C-N 120.473 -1.392 . . . . 0.0 113.057 166.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 5.3 p -72.25 174.72 6.86 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 116.135 1.902 . . . . 0.0 116.135 -174.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -95.37 2.58 54.67 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 127.246 2.218 . . . . 0.0 114.068 166.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -121.99 -26.72 4.72 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 117.19 2.293 . . . . 0.0 117.19 -162.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp 58.82 109.51 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 126.108 1.763 . . . . 0.0 112.963 -164.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 60.28 110.26 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 128.06 2.544 . . . . 0.0 115.406 176.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 32.1 tp -71.32 140.87 50.43 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.054 1.341 . . . . 0.0 111.479 174.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.014 0 C-N-CA 126.157 1.783 . . . . 0.0 110.82 168.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 66.5 p . . . . . 0 N--CA 1.476 0.825 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 -124.73 -10.46 7.28 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 -161.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.337 3.8 p -112.03 135.95 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-N 119.842 1.201 . . . . 0.0 112.154 168.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.6 mt -114.93 150.56 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 127.629 2.372 . . . . 0.0 107.859 173.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -118.08 130.2 56.0 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.758 1.223 . . . . 0.0 110.73 178.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.5 mt -117.01 125.77 74.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 127.494 2.318 . . . . 0.0 108.414 -173.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -112.43 175.91 5.24 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 125.931 1.692 . . . . 0.0 113.024 -178.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 11.6 mmmt 59.34 27.81 16.99 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 127.392 2.277 . . . . 0.0 114.671 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.3 mp -55.01 155.63 8.17 Favored Pre-proline 0 CA--C 1.554 1.126 0 C-N-CA 124.858 1.263 . . . . 0.0 112.321 176.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -45.8 -67.25 0.12 Allowed 'Trans proline' 0 C--N 1.351 0.706 1 C-N-CA 125.87 4.38 . . . . 0.0 115.151 -177.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.7 pt -153.05 -50.36 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 130.933 3.693 . . . . 0.0 107.615 175.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -151.52 -5.99 0.25 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.309 1.444 . . . . 0.0 114.174 178.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.291 2.8 p 43.8 -146.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 C-N-CA 127.237 2.215 . . . . 0.0 112.084 -174.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.2 t -140.02 136.02 33.27 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 120.723 -1.236 . . . . 0.0 110.522 161.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -56.76 -34.91 68.04 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.598 0.759 . . . . 0.0 113.03 179.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -55.28 -40.17 74.72 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.892 1.234 . . . . 0.0 113.434 172.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -67.12 -50.9 59.87 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.776 -0.837 . . . . 0.0 111.292 171.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 87.7 t -55.89 -49.89 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.578 0.751 . . . . 0.0 112.725 -176.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -82.01 -26.07 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 O-C-N 120.264 -1.522 . . . . 0.0 114.409 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.3 t -61.56 -32.4 72.48 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 119.76 1.164 . . . . 0.0 110.377 168.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.9 mt -76.3 -26.18 55.6 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 171.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -85.51 -19.86 57.63 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-N 119.549 1.068 . . . . 0.0 114.836 175.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 11.5 mt -69.95 -31.17 2.28 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 117.982 2.586 . . . . 0.0 117.982 -168.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -58.62 -4.63 1.96 Allowed 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 123.517 2.811 . . . . 0.0 116.821 169.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -108.41 -40.61 5.09 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -166.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -150.88 -109.78 0.47 Allowed Glycine 0 CA--C 1.525 0.665 0 CA-C-O 122.348 0.971 . . . . 0.0 111.974 176.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 17.1 tptm -147.7 138.16 23.12 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 128.895 2.878 . . . . 0.0 103.997 164.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.45 ' CG2' ' HE2' ' A' ' 101' ' ' MET 0.307 12.4 t -130.15 82.97 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 CA-C-N 120.717 1.599 . . . . 0.0 109.567 -163.047 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.5 t -77.08 -21.83 53.77 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 126.669 1.988 . . . . 0.0 113.149 -159.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -141.51 165.65 26.91 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-O 122.615 1.197 . . . . 0.0 113.619 165.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -137.55 179.07 6.63 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.253 1.421 . . . . 0.0 109.924 157.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.47 159.12 44.71 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.395 1.478 . . . . 0.0 109.69 172.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 6.9 mtt -133.65 100.58 4.83 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.074 0.95 . . . . 0.0 112.529 -174.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -73.92 92.34 2.08 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.087 1.355 . . . . 0.0 111.15 171.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 48.8 mttp -62.41 -20.94 64.99 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 175.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.89 -53.98 41.06 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 125.768 1.651 . . . . 0.0 115.138 -174.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.5 mtmt -123.33 20.05 9.71 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 126.04 1.736 . . . . 0.0 112.01 179.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 23.2 m120 53.67 66.64 1.17 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 126.841 2.056 . . . . 0.0 112.575 -173.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . 0.257 0.0 OUTLIER -125.53 179.43 5.14 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.51 0.671 . . . . 0.0 112.471 170.087 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -154.07 162.77 40.96 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 126.542 1.937 . . . . 0.0 109.904 -176.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 5.6 m-30 -108.11 150.91 26.58 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.546 1.539 . . . . 0.0 107.333 159.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.2 tt -132.9 124.04 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 124.624 1.169 . . . . 0.0 108.405 163.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -130.74 126.6 36.86 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 122.588 1.185 . . . . 0.0 112.946 -162.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.45 ' HE2' ' CG2' ' A' ' 85' ' ' VAL . 0.5 OUTLIER -134.04 161.37 35.02 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.111 -1.404 . . . . 0.0 113.933 -159.903 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -79.32 -12.64 59.93 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.391 1.877 . . . . 0.0 113.26 -161.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.34 138.38 33.05 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.845 1.258 . . . . 0.0 111.32 -178.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -62.44 -34.79 77.5 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.312 176.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -75.69 -36.53 60.01 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.763 0.825 . . . . 0.0 112.963 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -56.22 -53.68 54.23 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 118.823 0.738 . . . . 0.0 109.693 168.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.31 -36.22 79.0 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -177.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -55.19 -50.28 69.75 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.109 0.868 . . . . 0.0 110.955 168.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -65.27 -30.75 71.65 Favored 'General case' 0 C--O 1.225 -0.222 0 O-C-N 121.441 -0.787 . . . . 0.0 111.603 174.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 5.6 ttp -73.39 -46.33 49.48 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 119.908 1.231 . . . . 0.0 111.591 -177.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -65.21 -40.12 87.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 124.145 0.978 . . . . 0.0 110.958 177.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -68.5 -46.1 70.55 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.597 0.759 . . . . 0.0 110.647 176.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -48.34 -42.88 32.67 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.111 1.364 . . . . 0.0 111.937 168.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -84.96 -14.21 48.28 Favored 'General case' 0 C--N 1.334 -0.105 0 O-C-N 120.764 -1.21 . . . . 0.0 112.485 -176.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 92.9 m -83.18 -14.06 54.2 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.422 1.089 . . . . 0.0 110.618 169.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.21 -56.83 2.5 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 129.228 3.011 . . . . 0.0 113.257 178.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 9.8 p -72.65 -33.55 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 127.187 2.195 . . . . 0.0 113.777 -157.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.41 ' CG2' ' H ' ' A' ' 126' ' ' ILE . 0.3 OUTLIER -2.25 114.36 0.01 OUTLIER Pre-proline 0 N--CA 1.484 1.256 0 C-N-CA 129.206 3.002 . . . . 0.0 116.449 -131.544 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -77.26 -7.76 17.19 Favored 'Trans proline' 0 CA--C 1.546 1.117 0 C-N-CA 123.675 2.916 . . . . 0.0 114.336 -161.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.5 t 61.05 107.95 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 130.71 3.604 . . . . 0.0 114.509 176.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 14.2 tp -73.17 -55.86 5.89 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.766 0.826 . . . . 0.0 112.335 -168.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -125.52 -4.95 7.14 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 127.584 2.354 . . . . 0.0 113.492 -161.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 99.63 13.87 36.56 Favored Glycine 0 CA--C 1.539 1.556 0 C-N-CA 124.282 0.944 . . . . 0.0 112.432 -148.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -138.9 144.7 42.49 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 128.402 2.681 . . . . 0.0 109.259 -178.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -57.35 168.96 2.46 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 124.0 3.133 . . . . 0.0 114.077 176.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.41 ' H ' ' CG2' ' A' ' 118' ' ' THR . 0.3 OUTLIER -125.27 149.45 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.092 1.357 . . . . 0.0 109.896 -177.661 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -120.88 101.35 7.64 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.419 -153.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.85 150.51 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.53 1.132 . . . . 0.0 112.739 -177.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -152.37 163.6 39.16 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 126.832 2.053 . . . . 0.0 109.074 154.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -53.02 151.81 4.49 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.362 -0.836 . . . . 0.0 112.076 164.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 31.6 t -71.6 156.22 39.65 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.665 0.745 . . . . 0.0 112.051 176.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -68.99 -7.71 37.88 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.137 1.375 . . . . 0.0 113.196 164.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 36.8 m-70 -119.47 177.89 4.75 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 127.361 2.264 . . . . 0.0 110.916 -176.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -119.55 5.9 11.07 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 -167.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 162.41 167.45 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 131.077 3.751 . . . . 0.0 111.22 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -74.54 147.55 41.69 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.669 0.788 . . . . 0.0 109.475 158.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 16.4 tttp . . . . . 0 N--CA 1.469 0.521 0 CA-C-O 122.558 1.171 . . . . 0.0 110.506 173.173 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 31.5 t . . . . . 0 CA--C 1.546 0.795 0 N-CA-C 115.354 1.613 . . . . 0.0 115.354 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 21.9 mtp180 -139.54 -9.19 1.25 Allowed 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 117.01 2.226 . . . . 0.0 117.01 -154.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.272 3.9 p -106.82 131.15 57.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 CA-C-N 120.615 1.552 . . . . 0.0 112.13 169.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.2 mt -109.97 155.8 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 127.672 2.389 . . . . 0.0 108.231 170.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -124.02 138.72 54.41 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.349 1.46 . . . . 0.0 110.689 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.2 mt -122.38 132.18 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 126.95 2.1 . . . . 0.0 109.807 -171.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.96 173.89 6.12 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 125.803 1.641 . . . . 0.0 113.246 178.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 13.8 mmmt 64.9 15.98 10.24 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 128.903 2.881 . . . . 0.0 116.416 173.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 30.8 mt -61.99 141.89 95.45 Favored Pre-proline 0 CA--C 1.555 1.158 0 CA-C-O 118.444 -0.788 . . . . 0.0 110.517 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -37.54 -62.92 0.26 Allowed 'Trans proline' 0 CA--C 1.539 0.766 1 C-N-CA 125.589 4.193 . . . . 0.0 116.043 -177.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.1 pt -153.74 -42.44 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 129.964 3.306 . . . . 0.0 109.323 174.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -153.3 -7.49 0.17 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.412 1.485 . . . . 0.0 113.187 -170.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.298 12.0 p 34.27 -122.21 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 127.09 2.156 . . . . 0.0 111.496 -165.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -148.75 135.55 19.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 122.368 1.08 . . . . 0.0 109.045 152.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -55.17 -31.13 61.12 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.057 0.943 . . . . 0.0 112.768 178.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -60.42 -37.94 93.98 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 124.832 1.206 . . . . 0.0 114.121 172.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -69.86 -44.86 68.98 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.422 -1.046 . . . . 0.0 110.579 172.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 85.5 t -57.76 -51.76 66.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 123.808 0.843 . . . . 0.0 112.182 -176.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -78.92 -26.06 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 O-C-N 120.341 -1.474 . . . . 0.0 114.381 177.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 38.7 t -62.15 -28.53 69.72 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 119.846 1.203 . . . . 0.0 110.553 169.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 22.8 mt -82.55 -23.48 34.48 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.923 1.082 . . . . 0.0 113.923 170.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -89.06 -11.02 65.6 Favored Glycine 0 CA--C 1.534 1.229 0 CA-C-N 119.406 1.003 . . . . 0.0 114.67 176.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.2 mt -77.55 -17.12 0.26 Allowed Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 118.859 2.911 . . . . 0.0 118.859 -174.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -59.6 -2.51 1.51 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.868 2.379 . . . . 0.0 117.363 169.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -119.56 -44.77 2.54 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -166.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -150.88 -108.52 0.42 Allowed Glycine 0 C--N 1.337 0.591 0 C-N-CA 123.796 0.712 . . . . 0.0 111.581 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 21.7 tptp -142.84 -15.73 0.71 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 115.524 1.675 . . . . 0.0 115.524 -171.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.473 ' HA ' ' HA ' ' A' ' 101' ' ' MET 0.256 0.2 OUTLIER 34.6 81.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 128.159 2.584 . . . . 0.0 113.493 175.088 . . . . . . . . 4 4 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 54.3 p -68.06 -36.18 79.43 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.352 1.061 . . . . 0.0 112.205 -169.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -145.0 165.71 27.39 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 123.611 1.672 . . . . 0.0 114.838 -177.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -150.31 169.14 22.1 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 126.489 1.916 . . . . 0.0 112.377 162.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.67 150.97 37.28 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 127.305 2.242 . . . . 0.0 108.536 -174.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 5.5 mtp -133.45 94.97 3.4 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.786 0.834 . . . . 0.0 111.811 -169.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.34 84.35 1.07 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.102 1.361 . . . . 0.0 111.443 175.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.01 -11.28 12.82 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 115.265 1.579 . . . . 0.0 115.265 170.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -60.62 -56.45 24.26 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 126.403 1.954 . . . . 0.0 114.494 177.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 31.6 mtmt -125.49 22.51 7.66 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 126.16 1.784 . . . . 0.0 112.144 -176.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 57.51 56.18 5.16 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.559 2.344 . . . . 0.0 113.92 -178.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . 0.264 0.0 OUTLIER -129.63 -179.39 5.15 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 173.964 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -158.25 164.78 36.14 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.72 2.008 . . . . 0.0 110.44 -177.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 4.8 m-30 -111.14 151.77 27.78 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.488 1.915 . . . . 0.0 107.896 163.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.9 tt -133.79 104.21 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 C-N-CA 125.544 1.538 . . . . 0.0 108.018 167.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -97.77 127.69 43.9 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 128.387 2.675 . . . . 0.0 110.762 -174.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.473 ' HA ' ' HA ' ' A' ' 85' ' ' VAL 0.305 20.8 ttm -126.86 157.52 39.12 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 -173.921 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -54.54 -37.07 64.98 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 127.037 2.135 . . . . 0.0 114.299 -172.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 69.2 p -141.39 137.78 32.53 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.976 0.91 . . . . 0.0 110.589 -162.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -59.81 -38.62 82.48 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.658 0.783 . . . . 0.0 112.041 -177.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -74.18 -37.94 63.79 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -178.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -57.64 -48.85 78.31 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 119.185 0.902 . . . . 0.0 110.408 169.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.74 -37.29 70.58 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.338 0.972 . . . . 0.0 113.585 -178.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -55.21 -50.86 68.3 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 120.96 -1.088 . . . . 0.0 111.085 169.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -64.33 -27.84 69.3 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-O 117.961 -1.019 . . . . 0.0 111.466 173.048 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 16.7 ttp -71.64 -47.78 52.18 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-N 120.444 1.474 . . . . 0.0 110.335 -177.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.51 -40.61 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 123.636 0.775 . . . . 0.0 111.207 176.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -67.43 -47.28 70.67 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.586 0.754 . . . . 0.0 110.829 177.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -48.26 -41.84 28.89 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.93 1.692 . . . . 0.0 112.561 167.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -85.36 -17.62 36.21 Favored 'General case' 0 C--O 1.232 0.166 0 O-C-N 120.551 -1.343 . . . . 0.0 112.613 -177.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 67.5 m -78.18 -16.58 57.76 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.071 0.948 . . . . 0.0 110.193 169.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.47 -57.43 2.77 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 129.126 2.97 . . . . 0.0 112.808 177.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 8.8 p -76.68 -40.82 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.504 1.521 . . . . 0.0 113.66 -154.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 11.52 113.67 0.0 OUTLIER Pre-proline 0 N--CA 1.482 1.14 0 C-N-CA 129.011 2.924 . . . . 0.0 116.175 -133.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -75.77 -19.33 16.39 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.463 2.775 . . . . 0.0 112.969 -165.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 6.4 t 61.08 110.19 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 130.514 3.526 . . . . 0.0 113.065 -178.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.0 tt -75.0 80.01 2.19 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.732 1.613 . . . . 0.0 109.6 -176.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . 0.29 2.9 ppt_? 46.61 -13.19 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.249 1 C-N-CA 132.733 4.413 . . . . 0.0 118.906 -168.944 . . . . . . . . 3 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -174.04 3.37 0.03 OUTLIER Glycine 0 CA--C 1.538 1.512 0 N-CA-C 116.493 1.357 . . . . 0.0 116.493 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 5.3 tp60 -139.37 140.72 26.63 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 126.019 1.728 . . . . 0.0 109.489 -177.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.94 164.68 7.73 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 123.628 2.885 . . . . 0.0 113.329 174.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -127.76 147.6 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.462 1.105 . . . . 0.0 110.762 -174.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -127.19 102.07 6.78 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.637 1.175 . . . . 0.0 109.923 -153.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.8 150.19 23.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -173.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -153.04 161.98 41.87 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 126.485 1.914 . . . . 0.0 109.264 154.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -53.33 151.39 5.43 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-O 121.756 0.788 . . . . 0.0 112.24 164.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 32.6 t -68.09 154.21 42.14 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.901 0.88 . . . . 0.0 112.283 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -64.22 -16.72 62.59 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.35 1.06 . . . . 0.0 112.85 165.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 54.9 m-70 -110.57 -176.95 3.11 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 127.523 2.329 . . . . 0.0 112.075 -176.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -134.47 153.58 51.86 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.607 1.563 . . . . 0.0 110.975 159.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 45.93 93.71 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 128.313 2.645 . . . . 0.0 115.262 -178.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 25.2 tp -56.09 100.34 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 127.463 2.305 . . . . 0.0 112.38 173.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.47 0.537 0 C-N-CA 126.832 2.053 . . . . 0.0 109.478 172.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.0 t . . . . . 0 N--CA 1.474 0.74 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.4 mtp180 -46.61 -20.44 0.13 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 130.436 3.494 . . . . 0.0 119.167 -166.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.311 7.4 p -93.9 130.8 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 CA-C-N 121.585 1.993 . . . . 0.0 112.946 173.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 21.6 mt -105.21 156.97 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 127.19 2.196 . . . . 0.0 108.338 167.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -121.62 140.64 51.99 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.706 1.602 . . . . 0.0 110.374 177.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.0 mt -120.37 141.11 42.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 127.667 2.387 . . . . 0.0 108.777 -176.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.12 -171.79 2.05 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 125.667 1.587 . . . . 0.0 111.244 176.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 52.71 11.62 0.21 Allowed 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 127.664 2.386 . . . . 0.0 117.363 169.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 22.4 mt -62.75 155.94 67.73 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 124.785 1.234 . . . . 0.0 113.241 -176.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -51.95 173.06 0.12 Allowed 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 123.58 2.853 . . . . 0.0 114.669 161.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 32.5 pt -69.54 -30.78 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 126.568 1.947 . . . . 0.0 112.951 -172.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -156.36 34.86 0.32 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.78 2.032 . . . . 0.0 110.702 -170.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -53.09 147.75 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 O-C-N 121.095 -1.003 . . . . 0.0 111.051 174.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.5 t -88.91 136.83 32.8 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 123.05 1.405 . . . . 0.0 112.187 -173.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -55.49 -34.45 64.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.588 -1.187 . . . . 0.0 112.984 171.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -54.83 -40.3 71.48 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.856 1.217 . . . . 0.0 113.277 171.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -66.94 -51.2 58.15 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.052 0.941 . . . . 0.0 110.868 172.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 86.2 t -58.61 -48.7 84.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 123.652 0.781 . . . . 0.0 112.788 -175.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -80.7 -24.64 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 O-C-N 120.191 -1.568 . . . . 0.0 114.432 177.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 75.5 m -64.16 -27.1 68.84 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 120.407 1.458 . . . . 0.0 110.856 168.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.7 mt -77.68 -28.38 51.06 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 118.16 -0.924 . . . . 0.0 113.237 170.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -89.44 -13.78 61.02 Favored Glycine 0 CA--C 1.536 1.404 0 CA-C-N 119.979 1.263 . . . . 0.0 115.425 175.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.3 mt -68.13 -38.06 12.74 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 117.429 2.381 . . . . 0.0 117.429 -169.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -57.51 -3.52 0.94 Allowed 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.89 3.06 . . . . 0.0 117.277 173.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -106.34 -27.12 11.18 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -164.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -172.14 -95.45 0.1 OUTLIER Glycine 0 C--N 1.336 0.542 0 C-N-CA 124.631 1.11 . . . . 0.0 110.634 169.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.7 tppt? -149.24 155.65 40.91 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 127.021 2.129 . . . . 0.0 105.503 160.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.42 ' CG2' ' HE2' ' A' ' 101' ' ' MET . 3.1 t -131.4 102.0 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 120.341 1.428 . . . . 0.0 110.05 -171.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 30.5 m -67.23 -46.88 72.47 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 128.872 2.869 . . . . 0.0 112.22 -162.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 53.3 m-20 -144.92 162.06 37.8 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 122.236 1.017 . . . . 0.0 112.491 177.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -135.61 171.78 13.95 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.378 1.071 . . . . 0.0 110.936 157.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.56 152.36 39.59 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.563 1.545 . . . . 0.0 109.11 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 8.2 mtt -131.61 104.13 6.77 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.139 0.976 . . . . 0.0 112.408 -175.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -78.03 74.03 4.58 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.019 1.328 . . . . 0.0 109.878 170.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -58.27 -28.78 65.26 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -172.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -79.15 -6.49 88.84 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 125.279 1.419 . . . . 0.0 115.491 175.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.4 mtmt -120.8 4.47 10.53 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.252 1.821 . . . . 0.0 114.139 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 15.5 m120 54.42 38.5 29.7 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.317 1.447 . . . . 0.0 112.507 -170.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -137.09 160.0 40.24 Favored 'General case' 0 CA--C 1.554 1.129 0 O-C-N 121.258 -0.901 . . . . 0.0 111.032 -159.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -154.78 167.82 28.93 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 120.127 -1.608 . . . . 0.0 112.644 -177.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -116.05 155.52 27.98 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.63 1.972 . . . . 0.0 108.818 165.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 16.6 tt -139.68 99.41 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 125.373 1.469 . . . . 0.0 109.249 168.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.0 tp10 -88.97 122.67 32.57 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 128.617 2.767 . . . . 0.0 110.628 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.42 ' HE2' ' CG2' ' A' ' 85' ' ' VAL 0.332 0.9 OUTLIER -119.17 161.18 20.78 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 -176.942 . . . . . . . . 4 4 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.0 -15.81 63.08 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.376 1.47 . . . . 0.0 113.336 -164.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.28 144.77 33.44 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 122.153 0.978 . . . . 0.0 111.069 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -60.98 -43.42 98.84 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.78 177.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -73.55 -35.42 65.5 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -178.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -57.13 -54.61 44.81 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 168.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.58 -39.17 91.33 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 120.986 -1.071 . . . . 0.0 113.458 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -49.3 -55.07 13.98 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 120.226 1.375 . . . . 0.0 113.211 168.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -62.49 -34.62 77.21 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 118.708 -0.663 . . . . 0.0 111.012 175.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 4.6 ttp -63.34 -56.05 19.52 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.009 1.324 . . . . 0.0 110.189 179.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -61.4 -37.57 78.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 125.877 1.671 . . . . 0.0 112.006 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -69.96 -46.42 65.3 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.706 0.802 . . . . 0.0 111.301 177.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -49.35 -38.48 28.33 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.434 0.694 . . . . 0.0 111.821 166.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -83.98 -20.69 32.41 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 120.723 -1.236 . . . . 0.0 113.075 -174.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -82.56 -13.69 56.15 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.993 0.901 . . . . 0.0 111.222 171.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.77 -53.17 5.3 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 127.721 2.408 . . . . 0.0 112.37 174.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 10.0 p -75.8 -42.66 40.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 125.695 1.598 . . . . 0.0 114.868 -157.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 1.53 113.35 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.462 0 C-N-CA 127.349 2.26 . . . . 0.0 116.437 -124.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.414 ' HD2' ' CD1' ' A' ' 126' ' ' ILE . 5.4 Cg_exo -76.66 -18.85 14.99 Favored 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 123.604 2.869 . . . . 0.0 113.216 -164.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.6 t 62.46 105.05 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 129.938 3.295 . . . . 0.0 112.947 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.8 tt -70.87 -64.35 0.92 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.233 0.613 . . . . 0.0 111.563 -162.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -142.02 71.69 1.36 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.492 1.517 . . . . 0.0 109.879 172.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 77.85 8.82 87.24 Favored Glycine 0 CA--C 1.538 1.476 0 N-CA-C 115.641 1.016 . . . . 0.0 115.641 -179.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -138.29 139.34 25.0 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 126.142 1.777 . . . . 0.0 110.417 177.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -58.79 162.07 13.87 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 123.35 2.7 . . . . 0.0 111.872 171.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.414 ' CD1' ' HD2' ' A' ' 119' ' ' PRO . 3.0 mt -106.39 -45.07 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -156.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 77.25 110.07 0.07 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.992 2.117 . . . . 0.0 112.103 170.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.47 153.84 35.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 125.723 1.609 . . . . 0.0 111.206 178.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -151.33 164.2 37.21 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.919 1.688 . . . . 0.0 109.005 151.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -51.89 146.16 8.75 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.278 -0.889 . . . . 0.0 111.673 164.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 29.0 t -68.73 154.37 42.07 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.919 -0.488 . . . . 0.0 111.576 178.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -63.54 -20.42 65.62 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.177 0.991 . . . . 0.0 112.525 165.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 37.4 m-70 -101.08 177.43 4.95 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.955 2.102 . . . . 0.0 110.665 178.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -128.7 7.66 5.72 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.94 1.296 . . . . 0.0 113.87 -168.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -173.16 155.58 3.0 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 127.821 2.449 . . . . 0.0 109.643 -167.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 47.6 tp -134.61 74.46 1.53 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.528 1.931 . . . . 0.0 110.034 170.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 23.7 tptm . . . . . 0 N--CA 1.47 0.561 0 C-N-CA 124.709 1.204 . . . . 0.0 109.651 176.605 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.642 0 N-CA-C 112.229 -0.349 . . . . 0.0 112.229 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -94.2 -1.7 53.69 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.145 1.778 . . . . 0.0 114.951 -175.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.5 m -61.62 -5.47 1.89 Allowed 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 127.29 2.236 . . . . 0.0 116.896 -169.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 23.1 mmt180 -56.65 -48.98 76.38 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.937 1.295 . . . . 0.0 111.904 173.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.8 m -75.94 136.05 40.07 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.741 1.216 . . . . 0.0 111.831 177.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.62 166.96 11.83 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.103 0.961 . . . . 0.0 113.551 172.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -153.47 -36.96 0.03 OUTLIER Glycine 0 CA--C 1.536 1.391 0 C-N-CA 125.723 1.63 . . . . 0.0 113.096 170.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.3 p -143.97 71.72 16.74 Favored Pre-proline 0 N--CA 1.479 1.01 0 C-N-CA 126.577 1.951 . . . . 0.0 109.734 164.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -93.2 -173.25 0.37 Allowed 'Trans proline' 0 CA--C 1.548 1.208 1 C-N-CA 125.436 4.091 . . . . 0.0 112.276 -163.636 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.2 t -138.34 -178.59 5.35 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.265 1.026 . . . . 0.0 113.448 176.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 -51.87 -7.49 0.05 Allowed 'General case' 0 N--CA 1.474 0.775 1 C-N-CA 132.408 4.283 . . . . 0.0 120.412 -155.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.294 5.7 p -99.31 129.63 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-N 121.991 2.178 . . . . 0.0 112.099 170.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 16.1 mt -105.84 157.87 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 128.157 2.583 . . . . 0.0 108.149 170.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -128.17 142.87 51.05 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.206 1.802 . . . . 0.0 110.455 179.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.0 mt -123.76 140.01 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 126.953 2.101 . . . . 0.0 109.957 -174.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.69 174.3 6.03 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 125.958 1.703 . . . . 0.0 112.056 172.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.496 ' HE3' ' CE2' ' A' ' 127' ' ' TYR . 2.5 mmtp 71.39 -2.92 2.25 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 128.341 2.656 . . . . 0.0 116.571 172.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -35.34 145.72 0.2 Allowed Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 129.977 3.311 . . . . 0.0 115.933 -164.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.26 165.23 1.01 Allowed 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.36 2.707 . . . . 0.0 115.126 176.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 37.7 pt -56.66 -31.59 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 128.197 2.599 . . . . 0.0 113.984 -169.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -161.45 41.71 0.15 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.455 1.902 . . . . 0.0 110.365 -177.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -57.63 157.93 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 O-C-N 121.544 -0.722 . . . . 0.0 110.898 174.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 14.4 t -123.71 154.7 39.06 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 122.559 1.171 . . . . 0.0 113.216 -175.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -54.78 -42.6 71.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.74 175.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.62 -36.96 55.59 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.088 0.852 . . . . 0.0 113.463 178.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -71.44 -52.34 18.99 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.911 1.284 . . . . 0.0 112.16 173.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 57.6 t -59.71 -46.25 93.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -177.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.9 pp -69.75 -34.24 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 O-C-N 120.553 -1.342 . . . . 0.0 112.422 175.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 74.8 m -67.8 -19.31 65.07 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 119.895 1.225 . . . . 0.0 111.742 175.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 62.5 mt -89.62 -15.53 32.54 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 172.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -101.3 -13.23 33.79 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-N 119.168 0.894 . . . . 0.0 114.977 172.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.3 mt -63.34 -44.98 84.31 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 116.563 2.06 . . . . 0.0 116.563 -175.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.1 -5.22 1.28 Allowed 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 124.441 3.428 . . . . 0.0 117.972 176.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -103.96 -39.93 6.4 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -164.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -154.77 -82.77 0.04 OUTLIER Glycine 0 CA--C 1.518 0.257 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 172.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 22.5 tptp -152.05 -8.98 0.2 Allowed 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 116.972 2.212 . . . . 0.0 116.972 174.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.443 ' CG1' ' HE1' ' A' ' 101' ' ' MET . 0.4 OUTLIER 27.18 109.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.173 0 C-N-CA 127.635 2.374 . . . . 0.0 115.449 -147.208 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.2 m -59.3 -36.62 75.94 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 119.678 -1.889 . . . . 0.0 112.226 170.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -162.56 178.23 8.75 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 115.903 1.816 . . . . 0.0 115.903 175.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -136.88 172.76 12.53 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.31 1.844 . . . . 0.0 112.601 155.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.43 156.27 45.17 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.923 1.689 . . . . 0.0 109.538 169.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 3.5 mtt -128.98 107.76 9.87 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.92 0.888 . . . . 0.0 111.81 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -78.34 54.4 1.4 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.226 1.01 . . . . 0.0 109.488 164.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 66.4 tttt -64.78 -27.37 68.84 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -159.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -65.62 -14.39 60.25 Favored Glycine 0 CA--C 1.541 1.718 0 C-N-CA 125.152 1.358 . . . . 0.0 115.707 171.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.01 2.89 17.09 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.887 1.675 . . . . 0.0 113.054 169.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 7.9 m120 50.66 54.27 11.48 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.656 1.582 . . . . 0.0 112.164 -167.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -132.12 168.52 17.85 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.166 0.986 . . . . 0.0 110.76 173.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -154.6 166.47 33.24 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.918 1.287 . . . . 0.0 112.102 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -111.5 156.08 22.26 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.119 1.768 . . . . 0.0 108.359 161.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 15.2 tt -139.69 106.69 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.979 1.312 . . . . 0.0 109.045 166.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -96.97 137.6 35.81 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 129.291 3.036 . . . . 0.0 111.135 -174.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.443 ' HE1' ' CG1' ' A' ' 85' ' ' VAL 0.316 19.9 tpp -133.04 150.55 52.11 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 115.842 1.793 . . . . 0.0 115.842 -167.282 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -71.92 -15.28 62.09 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 114.166 1.172 . . . . 0.0 114.166 -166.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.53 143.83 31.03 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.41 1.084 . . . . 0.0 110.234 -177.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -64.2 -37.74 88.55 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.637 0.775 . . . . 0.0 111.424 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -73.26 -39.73 65.19 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.764 0.826 . . . . 0.0 113.007 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -54.62 -51.52 65.1 Favored 'General case' 0 C--O 1.217 -0.62 0 C-N-CA 123.494 0.718 . . . . 0.0 110.618 169.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.62 -37.6 76.9 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -55.54 -49.62 72.17 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.995 0.816 . . . . 0.0 110.552 169.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -66.63 -29.49 69.54 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-O 118.067 -0.968 . . . . 0.0 111.691 174.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 11.6 ttp -71.73 -45.25 62.36 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 120.329 1.422 . . . . 0.0 110.154 -177.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -68.74 -40.4 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 O-C-N 121.334 -0.854 . . . . 0.0 112.068 175.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -68.43 -43.1 77.85 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.737 -0.602 . . . . 0.0 110.402 178.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -48.57 -44.91 37.15 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 125.428 1.491 . . . . 0.0 111.833 165.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -80.24 -14.87 58.08 Favored 'General case' 0 C--N 1.332 -0.194 0 O-C-N 121.032 -1.043 . . . . 0.0 112.837 -177.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 97.8 m -85.22 -13.55 49.57 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.763 1.225 . . . . 0.0 110.635 171.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.89 -56.04 2.62 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 129.02 2.928 . . . . 0.0 112.892 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 9.9 p -70.86 -32.49 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 127.948 2.499 . . . . 0.0 113.436 -162.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.458 ' CG2' ' H ' ' A' ' 126' ' ' ILE . 1.3 m -6.26 113.86 0.03 OUTLIER Pre-proline 0 N--CA 1.483 1.178 0 C-N-CA 128.857 2.863 . . . . 0.0 115.864 -129.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -75.61 -0.72 10.49 Favored 'Trans proline' 0 CA--C 1.553 1.441 0 C-N-CA 124.154 3.236 . . . . 0.0 114.384 -159.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.2 t 59.89 108.96 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.787 1 C-N-CA 131.903 4.081 . . . . 0.0 115.645 176.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.9 tt -76.02 80.47 2.88 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.852 2.061 . . . . 0.0 109.271 174.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . 0.332 0.1 OUTLIER 45.3 -13.91 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 1 C-N-CA 133.707 4.803 . . . . 0.0 119.301 -173.146 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 178.46 12.09 0.02 OUTLIER Glycine 0 CA--C 1.537 1.436 0 C-N-CA 126.431 1.967 . . . . 0.0 115.029 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -142.53 156.13 63.59 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 126.53 1.932 . . . . 0.0 109.325 177.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_exo -53.32 166.74 1.0 Allowed 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 123.35 2.7 . . . . 0.0 114.339 167.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.458 ' H ' ' CG2' ' A' ' 118' ' ' THR . 0.7 OUTLIER -119.21 142.86 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.528 1.531 . . . . 0.0 108.858 178.196 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.496 ' CE2' ' HE3' ' A' ' 65' ' ' LYS . 3.0 m-85 -114.16 98.68 7.1 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.633 -156.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.18 147.56 25.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 124.014 0.926 . . . . 0.0 113.449 -174.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -150.96 160.51 43.87 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.495 1.918 . . . . 0.0 109.924 161.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -54.12 152.01 6.46 Favored 'General case' 0 CA--C 1.553 1.059 0 O-C-N 120.976 -1.077 . . . . 0.0 112.213 160.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 28.5 t -75.04 159.64 31.49 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.513 1.125 . . . . 0.0 113.594 -172.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -67.99 -12.3 60.51 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 126.41 1.884 . . . . 0.0 112.389 166.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 55.8 m-70 -118.24 -176.49 3.08 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.884 2.074 . . . . 0.0 113.057 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -129.73 147.08 51.47 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 126.855 2.062 . . . . 0.0 109.456 164.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 51.87 92.07 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 127.348 2.259 . . . . 0.0 115.554 176.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 42.4 tp -64.72 139.8 58.8 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.337 1.455 . . . . 0.0 112.546 174.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.0 146.51 52.12 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.496 1.918 . . . . 0.0 111.361 167.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 48.2 p -132.65 15.47 4.4 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.678 1.191 . . . . 0.0 113.902 -164.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -61.14 156.08 19.09 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.044 1.338 . . . . 0.0 113.876 -178.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 65.7 m -69.99 166.31 19.93 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.448 1.899 . . . . 0.0 114.344 -176.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 99.3 p -71.0 160.87 81.1 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 125.099 1.36 . . . . 0.0 113.646 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_exo -57.88 -25.24 68.53 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 123.934 3.089 . . . . 0.0 115.263 173.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -60.67 -43.69 97.37 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.91 0.884 . . . . 0.0 112.385 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -55.44 -36.8 66.91 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.637 1.175 . . . . 0.0 113.108 -178.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.4 -13.41 62.35 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.337 1.455 . . . . 0.0 114.582 177.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 . . . . . 0 N--CA 1.473 0.719 0 C-N-CA 126.312 1.845 . . . . 0.0 114.655 -165.008 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 147' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.506 0 N19-C1'-C2' 116.97 2.231 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 148' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.453 0 O4'-C1'-N19 111.83 3.63 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 149' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.622 2.897 1 O5'-C5'-C4' 117.594 5.281 OUTLIER-EPSILON 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 150' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.687 3 P-O3'-C3' 127.133 6.194 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 151' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.545 2.713 0 O4'-C1'-N19 110.646 2.446 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 152' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.444 0 O4'-C1'-N19 111.184 2.984 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.555 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -72.38 94.21 1.6 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.929 1.291 . . . . 0.0 111.557 176.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.5 m -57.72 -16.95 12.61 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 116.16 1.911 . . . . 0.0 116.16 -169.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -63.93 -26.6 68.66 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.228 1.411 . . . . 0.0 113.144 169.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.5 m -68.15 158.36 33.33 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.725 1.21 . . . . 0.0 113.65 -175.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.79 176.6 6.17 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 124.549 1.14 . . . . 0.0 112.086 165.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -86.4 -62.02 1.59 Allowed Glycine 0 N--CA 1.471 1.017 0 O-C-N 121.045 -1.035 . . . . 0.0 112.349 -168.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 17.1 t -134.88 75.3 61.89 Favored Pre-proline 0 N--CA 1.476 0.828 0 C-N-CA 124.738 1.215 . . . . 0.0 110.387 169.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -99.68 163.29 0.54 Allowed 'Trans proline' 0 CA--C 1.546 1.116 0 C-N-CA 125.124 3.882 . . . . 0.0 112.645 -169.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 65.1 m -141.29 -86.64 0.17 Allowed 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -177.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 72.5 mtm-85 -117.58 -17.48 9.96 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 -166.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.364 10.8 p -98.17 136.85 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 121.077 1.762 . . . . 0.0 113.575 170.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.8 mt -113.2 156.93 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 128.947 2.899 . . . . 0.0 107.937 170.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -124.99 132.38 53.27 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.672 1.589 . . . . 0.0 109.906 177.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.0 mt -111.97 131.16 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 127.747 2.419 . . . . 0.0 108.484 -175.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -87.55 178.67 6.72 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 119.898 1.226 . . . . 0.0 110.65 170.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 23.6 mtpp 33.49 53.95 0.46 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 129.03 2.932 . . . . 0.0 115.081 156.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.7 mt -68.88 152.11 96.93 Favored Pre-proline 0 C--N 1.309 -1.17 0 CA-C-N 113.628 -1.624 . . . . 0.0 109.206 167.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -51.12 160.98 1.76 Allowed 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 125.022 3.815 . . . . 0.0 115.339 174.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 29.7 pt -65.38 -24.13 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 128.533 2.733 . . . . 0.0 113.914 -176.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -139.97 19.63 2.47 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.624 1.969 . . . . 0.0 111.891 -171.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -57.87 166.48 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 123.956 0.902 . . . . 0.0 112.881 175.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.1 t -132.29 156.64 46.19 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-O 122.523 1.154 . . . . 0.0 112.42 171.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.5 -34.98 67.5 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.907 174.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -59.65 -31.32 70.85 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 125.303 1.43 . . . . 0.0 113.782 175.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -75.28 -44.88 43.31 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.718 1.207 . . . . 0.0 111.538 173.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 66.3 t -64.24 -45.43 96.26 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.4 pp -71.37 -29.49 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 O-C-N 120.216 -1.553 . . . . 0.0 113.317 174.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 35.1 t -63.24 -28.73 70.23 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 119.264 0.938 . . . . 0.0 110.649 171.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.9 mt -82.67 -17.11 45.72 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 173.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -94.44 -19.8 31.55 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-N 119.198 0.908 . . . . 0.0 115.188 172.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 13.9 mt -68.49 -33.13 4.28 Favored Pre-proline 0 CA--C 1.54 0.558 0 N-CA-C 117.547 2.425 . . . . 0.0 117.547 -169.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -59.0 -5.14 2.51 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.199 2.599 . . . . 0.0 117.16 169.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -109.47 -36.89 5.86 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -163.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -161.3 -98.83 0.14 Allowed Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 167.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 21.2 tptp -136.24 -10.83 1.95 Allowed 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 115.819 1.785 . . . . 0.0 115.819 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.429 ' HA ' ' HA ' ' A' ' 101' ' ' MET . 0.1 OUTLIER 28.87 89.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 129.423 3.089 . . . . 0.0 113.389 -174.511 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.24 -42.03 94.41 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.793 2.037 . . . . 0.0 111.916 -173.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -152.0 168.73 24.27 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -144.21 170.65 15.57 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.003 1.721 . . . . 0.0 112.165 159.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.7 156.96 44.7 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.867 1.667 . . . . 0.0 109.328 -177.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 8.3 mtt -130.21 107.22 9.13 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.581 0.753 . . . . 0.0 112.234 -177.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -77.15 68.29 3.26 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.552 1.141 . . . . 0.0 109.378 167.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -56.08 -39.22 71.77 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.414 1.085 . . . . 0.0 113.481 -166.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -64.57 -20.97 66.47 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 124.673 1.13 . . . . 0.0 115.779 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -109.31 1.32 20.03 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.611 1.565 . . . . 0.0 112.737 174.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.0 m120 56.97 46.2 19.89 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.252 1.821 . . . . 0.0 113.417 -169.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -126.01 173.12 9.4 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 120.937 -1.102 . . . . 0.0 112.131 -177.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -152.22 160.92 43.28 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.53 1.132 . . . . 0.0 112.234 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 5.6 m-30 -99.56 154.09 18.53 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 155.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 17.1 tt -134.4 106.41 7.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 124.781 1.232 . . . . 0.0 107.979 165.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -105.44 122.18 45.45 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.714 1.605 . . . . 0.0 110.863 -172.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.429 ' HA ' ' HA ' ' A' ' 85' ' ' VAL . 0.9 OUTLIER -124.79 148.77 47.97 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 115.74 1.755 . . . . 0.0 115.74 -166.572 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.77 -17.88 63.51 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 115.558 1.688 . . . . 0.0 115.558 -158.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.9 p -139.78 146.76 39.88 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.378 0.609 . . . . 0.0 110.468 -178.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -62.05 -34.56 76.48 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.019 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -77.24 -38.09 51.87 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 114.225 1.195 . . . . 0.0 114.225 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.66 -49.53 77.2 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-N 119.486 1.039 . . . . 0.0 110.431 170.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.54 -36.82 76.72 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 177.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -58.3 -46.47 86.06 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 119.727 1.149 . . . . 0.0 111.23 170.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -64.82 -33.91 77.12 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 121.032 -1.042 . . . . 0.0 111.127 173.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 9.8 ttp -65.43 -51.5 59.82 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.539 1.136 . . . . 0.0 110.414 -179.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -65.98 -36.7 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 C-N-CA 125.215 1.406 . . . . 0.0 112.593 177.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -72.19 -40.84 67.6 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.129 0.877 . . . . 0.0 111.165 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -52.76 -40.29 62.99 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.924 0.89 . . . . 0.0 111.693 162.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -88.5 12.86 13.29 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 119.667 -1.896 . . . . 0.0 112.291 177.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 52.0 m -112.52 -12.09 13.52 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.897 1.679 . . . . 0.0 110.175 169.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.52 -41.06 63.52 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.007 1.723 . . . . 0.0 111.544 153.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -142.38 160.8 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 124.897 1.279 . . . . 0.0 112.182 -150.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 18.7 m -125.01 135.63 27.04 Favored Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 125.657 1.583 . . . . 0.0 107.728 164.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -75.28 -17.09 19.23 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 121.895 1.73 . . . . 0.0 114.166 -171.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 4.0 t 39.85 73.88 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 128.39 2.676 . . . . 0.0 111.76 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.646 ' H ' HD13 ' A' ' 126' ' ' ILE . 5.5 tt -92.24 -32.8 14.92 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 112.397 -2.183 . . . . 0.0 110.609 -121.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -136.99 39.35 2.55 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.701 1.201 . . . . 0.0 111.539 151.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 126.66 2.68 6.72 Favored Glycine 0 CA--C 1.535 1.298 0 N-CA-C 119.328 2.491 . . . . 0.0 119.328 160.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.64 168.39 11.16 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 121.991 2.896 . . . . 0.0 113.604 173.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -60.33 147.12 94.98 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.912 2.408 . . . . 0.0 114.387 -172.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.646 HD13 ' H ' ' A' ' 121' ' ' LEU . 26.0 mm -120.3 -55.93 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 125.294 1.438 . . . . 0.0 113.245 -163.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 65.36 150.46 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.841 2.456 . . . . 0.0 115.743 -173.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.66 150.67 22.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 C-N-CA 126.958 2.103 . . . . 0.0 110.601 172.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -139.34 159.93 41.01 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.287 1.035 . . . . 0.0 108.623 149.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -51.81 150.73 3.86 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.348 -0.845 . . . . 0.0 110.931 159.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 44.0 t -72.14 154.06 41.29 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.59 -0.694 . . . . 0.0 111.623 174.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -77.46 -18.7 56.92 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.061 0.544 . . . . 0.0 112.398 165.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 38.0 m-70 -80.36 176.04 10.13 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.216 1.406 . . . . 0.0 110.144 160.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -119.2 -9.67 9.92 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -173.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -175.91 175.36 1.98 Allowed 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 129.129 2.971 . . . . 0.0 109.889 -172.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 23.8 tp -138.2 122.52 18.24 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.735 1.614 . . . . 0.0 113.033 -164.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -113.07 96.04 5.72 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.549 1.94 . . . . 0.0 110.506 170.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 10.7 p -75.71 -9.8 58.9 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.463 1.505 . . . . 0.0 114.194 174.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -70.39 88.62 0.66 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.882 1.673 . . . . 0.0 112.131 175.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 61.2 p -149.26 80.26 1.41 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.795 2.038 . . . . 0.0 112.266 176.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 47.6 m -62.37 152.35 79.9 Favored Pre-proline 0 N--CA 1.475 0.801 0 C-N-CA 125.122 1.369 . . . . 0.0 112.969 179.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -68.89 -23.53 34.86 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 122.844 2.363 . . . . 0.0 114.03 -177.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -66.47 -32.38 73.72 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.272 1.029 . . . . 0.0 113.249 175.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -122.16 82.8 2.01 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.489 1.516 . . . . 0.0 110.303 177.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.35 -25.11 66.93 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.497 1.919 . . . . 0.0 115.338 -174.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 63.3 ttp85 . . . . . 0 N--CA 1.476 0.848 0 C-N-CA 125.944 1.698 . . . . 99.989999999999995 111.209 -177.581 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 147' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.32 0 O4'-C1'-N19 111.328 3.128 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 148' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.729 0 O4'-C4'-C3' 110.036 3.24 . 0.01 4p . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 149' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.43 0 N19-C1'-C2' 107.903 -3.436 . 0.074 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 150' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.946 1 O4'-C1'-N19 112.721 4.521 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 151' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.537 2.068 1 O4'-C1'-N19 112.868 4.668 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 152' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.541 2.42 0 O4'-C1'-N19 111.643 3.443 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.707 0 N-CA-C 111.886 -0.485 . . . . 0.0 111.886 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -59.85 -16.86 32.04 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 -172.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 58.6 m -60.28 -30.25 69.34 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 121.164 -0.96 . . . . 0.0 112.978 170.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 39.8 mmt180 -68.22 -28.37 67.18 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.318 1.047 . . . . 0.0 112.771 175.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 17.4 m -74.31 -5.83 44.49 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.677 1.591 . . . . 0.0 114.197 176.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -132.26 -10.55 3.29 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 125.732 1.613 . . . . 0.0 113.926 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.12 41.89 7.32 Favored Glycine 0 CA--C 1.534 1.266 0 O-C-N 120.892 -1.13 . . . . 0.0 114.11 178.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.7 t 49.84 74.01 0.89 Allowed Pre-proline 0 N--CA 1.479 0.98 0 C-N-CA 127.715 2.406 . . . . 0.0 109.907 -171.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -90.92 -179.32 1.49 Allowed 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.867 3.044 . . . . 0.0 113.757 -149.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 29.0 t -131.99 -177.97 4.68 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.37 1.868 . . . . 0.0 110.949 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.1 -3.89 2.01 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 116.246 1.943 . . . . 0.0 116.246 -172.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.322 8.7 p -81.34 128.61 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-N 121.17 1.804 . . . . 0.0 112.634 166.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 15.8 mt -113.67 153.73 15.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 128.867 2.867 . . . . 0.0 107.456 174.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.444 ' CD2' ' C6 ' ' B' ' 149' ' ' ' C' . 1.8 t-80 -123.96 142.35 51.23 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.434 1.494 . . . . 0.0 110.772 178.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.8 mt -119.53 138.25 50.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 127.828 2.451 . . . . 0.0 109.837 -172.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 17.0 mtt85 -96.87 176.38 6.0 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 119.488 1.04 . . . . 0.0 110.521 171.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp 44.23 42.67 5.29 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 126.958 2.103 . . . . 0.0 116.291 158.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.2 mp -55.98 161.29 3.71 Favored Pre-proline 0 CA--C 1.558 1.279 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.473 160.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -60.06 -68.42 0.05 OUTLIER 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.734 2.956 . . . . 0.0 113.996 -173.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.1 pt -164.23 -39.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 130.848 3.659 . . . . 0.0 108.812 -171.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -151.69 -29.5 0.17 Allowed 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 -177.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.415 HG21 ' H ' ' A' ' 71' ' ' THR 0.29 2.0 p 40.02 -150.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 127.141 2.176 . . . . 0.0 112.192 -166.236 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.415 ' H ' HG21 ' A' ' 70' ' ' VAL . 2.9 t -141.75 141.91 33.25 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 120.482 -1.386 . . . . 0.0 109.681 156.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -57.1 -32.58 66.45 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 176.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.92 -41.08 58.6 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 125.088 1.328 . . . . 0.0 113.353 170.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -69.21 -48.94 60.66 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.451 -1.029 . . . . 0.0 111.107 172.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.5 t -58.81 -50.38 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 123.146 0.579 . . . . 0.0 112.497 -176.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -76.37 -27.98 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 O-C-N 120.103 -1.623 . . . . 0.0 113.877 177.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 33.0 t -62.77 -26.79 68.89 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 120.022 1.283 . . . . 0.0 110.826 169.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 33.8 mt -83.71 -18.26 38.54 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 114.306 1.225 . . . . 0.0 114.306 170.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -87.87 -18.64 55.86 Favored Glycine 0 CA--C 1.536 1.383 0 CA-C-N 119.376 0.989 . . . . 0.0 113.832 170.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 17.8 mt -73.96 -16.8 0.28 Allowed Pre-proline 0 CA--C 1.542 0.67 0 N-CA-C 119.035 2.976 . . . . 0.0 119.035 -174.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -59.55 -5.07 2.95 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.593 2.195 . . . . 0.0 116.773 168.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.411 ' CD2' ' HG3' ' A' ' 110' ' ' MET . 24.8 m-85 -120.66 -36.09 3.25 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -166.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -162.95 -101.59 0.16 Allowed Glycine 0 CA--C 1.523 0.548 0 C-N-CA 123.724 0.678 . . . . 0.0 111.782 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 32.2 tptt -147.73 -9.99 0.41 Allowed 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 117.348 2.351 . . . . 0.0 117.348 -174.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.416 ' CB ' ' HE1' ' A' ' 101' ' ' MET . 0.0 OUTLIER 32.21 89.03 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 C-N-CA 128.927 2.891 . . . . 0.0 113.651 -175.693 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 38.1 m -55.87 -40.65 73.26 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 127.142 2.177 . . . . 0.0 112.264 -175.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -153.18 168.81 24.72 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -141.89 173.53 11.42 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.685 1.594 . . . . 0.0 112.303 158.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.9 154.97 39.21 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.85 1.66 . . . . 0.0 109.678 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 14.8 mtt -129.66 110.57 11.9 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.934 0.894 . . . . 0.0 112.219 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -75.17 76.92 2.32 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 122.518 1.151 . . . . 0.0 109.761 169.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.17 -13.75 8.33 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.894 1.678 . . . . 0.0 115.309 -176.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -58.15 -40.9 94.35 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.685 1.612 . . . . 0.0 114.694 170.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -136.85 10.54 3.1 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 -162.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 52.65 49.37 20.5 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.022 1.329 . . . . 0.0 112.981 -167.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -113.52 167.09 10.89 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.516 0.726 . . . . 0.0 110.191 170.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -155.55 163.12 40.41 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 120.734 -1.229 . . . . 0.0 111.318 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 6.0 m-30 -108.32 155.88 20.02 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.444 1.497 . . . . 0.0 108.871 162.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.5 tt -141.68 106.69 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 125.872 1.669 . . . . 0.0 108.276 168.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -102.78 127.75 49.81 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 129.588 3.155 . . . . 0.0 110.776 -171.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.416 ' HE1' ' CB ' ' A' ' 85' ' ' VAL 0.362 1.9 tpp -124.58 158.7 32.4 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 118.201 2.667 . . . . 0.0 118.201 -171.144 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -71.27 -21.48 62.09 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.515 1.526 . . . . 0.0 114.07 -166.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.98 146.81 39.58 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.458 0.647 . . . . 0.0 110.988 -178.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -63.36 -37.9 89.07 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.726 0.81 . . . . 0.0 111.451 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -76.14 -38.03 57.27 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 178.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.35 -48.48 81.48 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-N 118.74 0.7 . . . . 0.0 110.565 171.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.18 -38.49 75.38 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 178.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -57.7 -46.99 83.61 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.996 0.816 . . . . 0.0 111.186 170.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -65.71 -29.6 70.16 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-O 117.799 -1.096 . . . . 0.0 111.525 171.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.411 ' HG3' ' CD2' ' A' ' 82' ' ' PHE . 18.8 ttp -69.24 -49.58 55.03 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 120.54 1.518 . . . . 0.0 109.839 -176.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -63.59 -40.01 87.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 124.116 0.966 . . . . 0.0 111.753 175.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -70.51 -43.65 69.24 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 121.663 -0.648 . . . . 0.0 111.076 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -48.93 -39.98 28.34 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 126.332 1.853 . . . . 0.0 111.667 166.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -85.28 -22.06 28.74 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 120.602 -1.311 . . . . 0.0 113.197 -178.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 99.0 m -76.51 -19.19 58.23 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.877 0.871 . . . . 0.0 110.174 172.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.9 -60.62 2.27 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 129.507 3.123 . . . . 0.0 111.252 170.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 2.3 p -79.42 -48.43 21.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 124.412 1.085 . . . . 0.0 112.478 -158.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 4.9 m 33.92 126.14 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 129.013 2.925 . . . . 0.0 114.248 -139.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -76.15 -10.59 19.42 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 121.366 1.377 . . . . 0.0 115.018 -170.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.4 t 30.02 89.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 130.04 3.336 . . . . 0.0 113.102 175.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.659 ' H ' HD13 ' A' ' 126' ' ' ILE . 1.5 tt -104.76 -68.48 0.85 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 112.301 -2.227 . . . . 0.0 108.159 -138.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -66.76 -44.67 80.83 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.118 0.967 . . . . 0.0 110.476 167.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 159.82 12.51 0.04 OUTLIER Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.315 1.436 . . . . 0.0 115.527 178.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -147.28 168.68 10.78 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 119.491 1.646 . . . . 0.0 112.007 -179.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -54.87 142.87 74.05 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.984 2.456 . . . . 0.0 114.235 -175.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.659 HD13 ' H ' ' A' ' 121' ' ' LEU . 20.2 mm -106.87 -43.05 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.729 1.211 . . . . 0.0 112.423 -167.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 61.11 141.38 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 128.192 2.597 . . . . 0.0 115.101 -173.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.46 155.56 31.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 126.264 1.825 . . . . 0.0 111.323 171.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -151.47 162.25 41.28 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.344 1.858 . . . . 0.0 109.252 158.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -52.29 143.37 14.93 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 121.201 -0.937 . . . . 0.0 111.147 160.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 30.2 t -66.93 153.39 43.68 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.24 1.016 . . . . 0.0 112.179 -179.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -64.76 -25.88 68.12 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.628 1.171 . . . . 0.0 112.349 168.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 57.5 m-70 -92.74 169.82 10.19 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.553 1.541 . . . . 0.0 111.259 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.66 111.75 14.66 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 125.096 1.358 . . . . 0.0 108.915 175.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 74.71 145.88 0.08 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 128.411 2.684 . . . . 0.0 113.592 -170.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 26.2 tp -113.32 111.62 22.32 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.802 2.041 . . . . 0.0 110.994 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.98 83.39 1.93 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 128.002 2.521 . . . . 0.0 110.552 -177.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 16.4 p -69.97 -14.02 62.51 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.67 1.588 . . . . 0.0 114.068 178.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -69.16 -10.24 56.72 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.539 1.535 . . . . 0.0 114.335 175.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 26.4 m 55.62 40.18 30.98 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.179 1.792 . . . . 0.0 114.53 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 55.4 p -62.3 148.17 90.07 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 124.179 0.991 . . . . 0.0 112.373 173.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -78.68 -25.61 6.37 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 123.07 2.513 . . . . 0.0 114.088 -173.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -154.33 -54.9 0.1 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.411 1.484 . . . . 0.0 111.867 -177.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -145.75 175.0 10.73 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.617 1.567 . . . . 0.0 112.074 -176.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.67 -25.36 67.34 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.395 1.478 . . . . 0.0 114.985 -174.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 . . . . . 0 N--CA 1.475 0.785 0 C-N-CA 126.133 1.773 . . . . 99.989999999999995 110.311 172.282 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 147' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.19 0 C5'-C4'-C3' 111.402 -2.732 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 148' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.883 1 C5'-C4'-C3' 108.171 -4.886 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 149' ' ' ' C' . . . . . 0.444 ' C6 ' ' CD2' ' A' ' 62' ' ' HIS . . . . . . . . 0 O4'--C4' 1.418 -2.93 0 N19-C1'-C2' 107.972 -3.392 . 0.01 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 150' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.657 1 O4'-C1'-N19 112.833 4.633 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 151' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.543 2.549 0 O5'-C5'-C4' 113.257 2.183 . 0.07 1[ . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 152' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.536 2.023 1 O4'-C1'-N19 112.962 4.762 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.711 0 N-CA-C 110.644 -0.983 . . . . 0.0 110.644 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -77.16 49.17 0.66 Allowed 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 125.036 1.335 . . . . 0.0 111.757 170.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.3 m -75.37 8.05 3.07 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 128.304 2.642 . . . . 0.0 115.464 -164.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.4 -8.64 1.24 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 128.256 2.623 . . . . 0.0 116.625 179.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 69.5 m -131.37 96.53 4.02 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.702 2.001 . . . . 0.0 109.889 -177.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -143.98 179.29 7.28 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 129.712 3.205 . . . . 0.0 112.056 -0.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -85.36 -61.47 1.72 Allowed Glycine 0 N--CA 1.473 1.106 0 C-N-CA 124.657 1.122 . . . . 0.0 112.357 -167.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.2 t -134.9 74.19 64.47 Favored Pre-proline 0 N--CA 1.479 1.019 0 C-N-CA 124.659 1.183 . . . . 0.0 110.347 168.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 0.8 OUTLIER -97.66 178.48 0.43 Allowed 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 125.12 3.88 . . . . 0.0 113.607 -168.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.5 t -151.74 -175.12 5.08 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.737 2.015 . . . . 0.0 110.787 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.15 -7.33 40.81 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.306 7.5 p -79.91 126.4 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 120.173 1.351 . . . . 0.0 112.021 164.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 21.7 mt -107.2 154.53 8.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 128.08 2.552 . . . . 0.0 108.249 169.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.42 ' CD2' ' C6 ' ' B' ' 149' ' ' ' C' . 2.2 t-80 -122.47 145.66 48.09 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.785 1.634 . . . . 0.0 110.87 176.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.5 mt -125.55 143.94 37.36 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 127.438 2.295 . . . . 0.0 110.097 -171.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.5 mtm-85 -108.12 170.18 8.16 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 125.847 1.659 . . . . 0.0 111.072 169.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp 56.22 32.32 20.07 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 155.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.5 171.74 2.58 Favored Pre-proline 0 C--N 1.321 -0.669 0 C-N-CA 124.728 1.211 . . . . 0.0 110.731 165.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -52.02 174.21 0.09 OUTLIER 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 124.185 3.257 . . . . 0.0 114.262 156.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 31.2 pt -64.6 -35.95 76.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 126.517 1.927 . . . . 0.0 113.027 -170.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -142.9 -10.99 0.77 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.848 1.659 . . . . 0.0 113.48 171.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.474 HG21 ' H ' ' A' ' 71' ' ' THR 0.287 4.3 p 42.34 -151.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 128.249 2.619 . . . . 0.0 112.065 -172.623 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.474 ' H ' HG21 ' A' ' 70' ' ' VAL . 1.1 p -129.36 145.19 51.43 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 120.601 -1.312 . . . . 0.0 109.88 153.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.98 -38.63 83.13 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 122.042 -0.411 . . . . 0.0 110.621 173.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -54.01 -41.29 68.15 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 125.658 1.599 . . . . 0.0 112.711 174.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -63.14 -53.61 50.65 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.106 0.962 . . . . 0.0 111.68 172.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.9 t -59.59 -48.0 88.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.344 0.657 . . . . 0.0 112.522 -178.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.0 pp -73.93 -33.0 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 O-C-N 120.488 -1.383 . . . . 0.0 112.801 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.5 t -63.55 -30.73 71.81 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.494 1.043 . . . . 0.0 110.771 171.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 14.0 mt -76.1 -20.43 57.68 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 173.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -96.66 -17.32 33.66 Favored Glycine 0 CA--C 1.536 1.37 0 N-CA-C 115.374 0.91 . . . . 0.0 115.374 172.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.6 mt -60.81 -52.8 69.84 Favored Pre-proline 0 CA--C 1.54 0.588 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 -170.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -76.21 42.44 1.0 Allowed 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 123.957 3.105 . . . . 0.0 113.5 -179.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -129.54 -41.89 1.34 Allowed 'General case' 0 C--O 1.233 0.218 0 C-N-CA 126.74 2.016 . . . . 0.0 111.196 178.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -158.11 -101.22 0.17 Allowed Glycine 0 C--N 1.34 0.784 0 CA-C-O 122.059 0.81 . . . . 0.0 112.053 163.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 13.8 tptm -143.48 139.04 29.66 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 130.084 3.354 . . . . 0.0 104.326 166.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.423 ' CG2' ' HE2' ' A' ' 101' ' ' MET . 3.6 t -123.35 99.41 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 120.203 1.365 . . . . 0.0 109.333 -169.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 16.0 m -65.21 -38.23 89.77 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 128.73 2.812 . . . . 0.0 112.283 -161.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.58 161.5 42.45 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 177.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -133.69 175.06 9.78 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.109 0.964 . . . . 0.0 111.033 156.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.32 154.21 37.46 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.932 1.693 . . . . 0.0 109.29 178.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 5.7 mtt -129.93 111.27 12.39 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.357 1.063 . . . . 0.0 111.273 -178.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -74.15 86.11 1.88 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.752 0.821 . . . . 0.0 110.156 174.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.6 tpmt? -63.65 89.01 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.943 1.697 . . . . 0.0 110.476 174.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 179.76 -61.97 0.08 OUTLIER Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.359 1.457 . . . . 0.0 112.748 -166.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.94 20.71 3.81 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 125.77 1.628 . . . . 0.0 114.161 -169.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 14.1 m-20 56.3 42.61 27.63 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.87 1.668 . . . . 0.0 113.496 -173.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -106.47 165.22 11.43 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.862 -0.524 . . . . 0.0 111.603 175.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -153.8 165.61 35.49 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.672 1.189 . . . . 0.0 111.371 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 6.0 m-30 -112.71 156.65 22.43 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.671 1.588 . . . . 0.0 108.689 163.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.8 tt -141.92 108.75 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 125.283 1.433 . . . . 0.0 109.606 166.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -100.46 122.01 42.49 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 129.09 2.956 . . . . 0.0 111.275 -175.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.423 ' HE2' ' CG2' ' A' ' 85' ' ' VAL 0.298 3.1 ttm -121.75 160.66 24.11 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 -173.766 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.95 -13.95 60.25 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.288 1.035 . . . . 0.0 113.616 -162.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.35 144.73 38.35 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.675 1.19 . . . . 0.0 111.194 177.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -63.38 -35.73 81.36 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.56 1.144 . . . . 0.0 111.846 176.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -75.99 -39.97 54.76 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -56.35 -50.66 70.87 Favored 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 122.809 0.444 . . . . 0.0 110.293 170.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.09 -37.19 72.43 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 121.026 -1.046 . . . . 0.0 113.334 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -56.18 -47.2 78.78 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.118 0.872 . . . . 0.0 111.408 169.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -65.21 -34.34 78.14 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 118.08 -0.962 . . . . 0.0 110.88 174.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 3.2 ttp -64.12 -52.18 60.4 Favored 'General case' 0 C--N 1.343 0.298 0 CA-C-N 119.664 1.12 . . . . 0.0 110.633 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.91 -37.84 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 C-N-CA 125.259 1.424 . . . . 0.0 112.133 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -72.01 -44.07 64.02 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.486 0.714 . . . . 0.0 111.702 177.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -49.4 -36.87 23.33 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.17 0.988 . . . . 0.0 112.071 165.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -87.23 -18.73 29.61 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 120.468 -1.395 . . . . 0.0 113.222 -177.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.22 -12.57 58.01 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.638 0.732 . . . . 0.0 110.912 170.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.91 -60.9 2.01 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 129.481 3.112 . . . . 0.0 111.874 168.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 4.2 p -78.08 -44.43 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.517 1.127 . . . . 0.0 113.622 -154.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.3 m 27.56 119.29 0.0 OUTLIER Pre-proline 0 N--CA 1.479 0.988 0 C-N-CA 129.855 3.262 . . . . 0.0 115.854 -139.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -76.53 -13.82 18.16 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 121.933 1.755 . . . . 0.0 116.073 -167.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.8 t 29.85 90.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 129.907 3.283 . . . . 0.0 114.067 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.532 ' H ' HD13 ' A' ' 126' ' ' ILE 0.265 1.1 tt -113.15 76.44 0.98 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 112.545 -2.116 . . . . 0.0 105.919 -134.592 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . 0.349 2.1 ppt_? 46.84 14.17 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 129.922 3.289 . . . . 0.0 116.73 -152.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -126.41 -113.52 1.87 Allowed Glycine 0 N--CA 1.472 1.065 0 C-N-CA 125.005 1.288 . . . . 0.0 116.254 -174.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.88 173.74 3.98 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 128.229 2.612 . . . . 0.0 108.062 -174.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -44.73 105.25 0.06 OUTLIER 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 123.691 2.927 . . . . 0.0 116.386 -163.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.532 HD13 ' H ' ' A' ' 121' ' ' LEU . 3.9 mm -68.18 162.09 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 125.24 1.416 . . . . 0.0 108.426 172.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -134.63 147.65 50.22 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 121.789 -0.57 . . . . 0.0 111.177 174.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.83 146.13 32.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.95 1.3 . . . . 0.0 110.896 173.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -147.3 158.79 44.09 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.478 1.911 . . . . 0.0 108.865 160.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -53.77 146.88 12.74 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.236 -0.915 . . . . 0.0 111.549 163.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 30.0 t -69.72 156.11 39.49 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.977 0.911 . . . . 0.0 112.706 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -66.95 -20.95 65.98 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.781 1.232 . . . . 0.0 112.888 167.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 40.4 m-70 -105.1 177.65 4.79 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.869 1.667 . . . . 0.0 112.188 -173.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 4.6 mptt -136.76 117.92 14.45 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 126.255 1.822 . . . . 0.0 109.679 -175.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 69.27 84.35 0.15 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.362 1.465 . . . . 0.0 113.328 176.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 31.4 tp -57.54 127.55 32.6 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.518 1.527 . . . . 0.0 112.586 177.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -128.04 109.34 11.45 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 126.479 1.912 . . . . 0.0 110.581 173.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 56.6 p -103.09 -4.12 24.95 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.286 1.434 . . . . 0.0 113.469 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -60.86 -38.5 85.76 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.652 1.981 . . . . 0.0 114.654 -167.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.3 t -79.08 96.92 5.94 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.018 1.327 . . . . 0.0 111.693 -178.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 42.1 m -62.13 138.8 96.03 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 124.526 1.13 . . . . 0.0 112.825 -176.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -54.62 -25.01 39.39 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 124.364 3.376 . . . . 0.0 116.735 -178.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -70.53 -1.5 11.17 Favored 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 115.362 1.615 . . . . 0.0 115.362 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -67.54 86.34 0.19 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.381 1.073 . . . . 0.0 112.197 176.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -57.96 -34.86 70.37 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.389 1.875 . . . . 0.0 114.289 -176.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 . . . . . 0 N--CA 1.479 0.999 0 C-N-CA 126.327 1.851 . . . . 99.989999999999995 115.373 -177.811 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 147' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.145 0 C5'-C4'-C3' 110.698 -3.201 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 148' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.284 0 C1'-O4'-C4' 107.129 -2.745 . 0.419 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 149' ' ' ' C' . . . . . 0.42 ' C6 ' ' CD2' ' A' ' 62' ' ' HIS . . . . . . . . 0 O4'--C4' 1.426 -2.226 1 O4'-C1'-N19 112.341 4.141 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 150' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.063 2 O4'-C1'-N19 113.695 5.495 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 151' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.151 0 N19-C1'-C2' 117.514 2.571 OUTLIER-DELTA 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 152' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.618 2.499 1 O4'-C1'-N19 113.97 5.77 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.385 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -139.81 -60.02 0.55 Allowed 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.001 1.32 . . . . 0.0 112.539 -173.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.6 m 57.48 14.18 2.16 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 116.445 2.017 . . . . 0.0 116.445 178.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.4 ttm180 -68.04 -28.92 67.81 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.589 1.955 . . . . 0.0 113.924 -175.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 68.3 m -133.8 130.48 38.02 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.843 1.657 . . . . 0.0 111.356 -173.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -130.68 -12.72 3.8 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.328 1.451 . . . . 0.0 114.718 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 135.88 -77.4 0.36 Allowed Glycine 0 C--N 1.338 0.656 0 C-N-CA 126.056 1.789 . . . . 0.0 108.737 -179.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 19.9 t -147.74 74.08 11.35 Favored Pre-proline 0 N--CA 1.48 1.065 0 C-N-CA 125.218 1.407 . . . . 0.0 108.352 165.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -90.81 159.17 4.12 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.227 2.618 . . . . 0.0 113.759 -162.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 57.4 m -142.75 -173.66 3.94 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.298 1.439 . . . . 0.0 112.753 -163.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 31.0 mtp180 -50.84 -17.44 0.56 Allowed 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 128.902 2.881 . . . . 0.0 118.063 -177.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.265 3.4 p -96.98 137.17 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-N 120.261 1.391 . . . . 0.0 112.966 172.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.2 mt -118.88 130.78 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 127.93 2.492 . . . . 0.0 108.787 175.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.444 ' CD2' ' C6 ' ' B' ' 149' ' ' ' C' . 1.8 t-80 -96.69 141.23 30.18 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.33 1.052 . . . . 0.0 110.719 176.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.3 mt -116.51 135.5 56.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 126.79 2.036 . . . . 0.0 108.291 -178.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.0 ptt-85 -119.53 171.48 8.32 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 127.387 2.275 . . . . 0.0 111.376 165.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.6 mmmt 61.29 23.34 13.58 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.579 1.552 . . . . 0.0 113.27 178.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.7 mt -69.31 173.97 3.35 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 126.313 1.845 . . . . 0.0 111.502 166.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -48.79 176.43 0.02 OUTLIER 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 123.042 2.495 . . . . 0.0 114.295 152.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 26.5 pt -64.81 -41.24 91.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.863 1.665 . . . . 0.0 112.961 -171.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -141.89 -11.85 0.87 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.016 1.726 . . . . 0.0 114.539 174.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.469 HG21 ' H ' ' A' ' 71' ' ' THR 0.309 2.9 p 43.0 -154.48 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 128.124 2.57 . . . . 0.0 113.412 -175.719 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.469 ' H ' HG21 ' A' ' 70' ' ' VAL . 10.8 t -142.32 148.53 38.14 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 120.065 -1.647 . . . . 0.0 111.665 171.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -55.6 -46.25 77.33 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.328 1.051 . . . . 0.0 111.961 -177.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -51.37 -43.18 51.51 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.526 1.06 . . . . 0.0 113.116 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -64.85 -56.03 15.91 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.778 0.831 . . . . 0.0 112.264 172.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 80.1 t -56.06 -53.81 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-O 121.657 0.741 . . . . 0.0 111.811 -176.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.9 pp -67.29 -39.54 83.08 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 CA-C-O 117.89 -1.052 . . . . 0.0 112.437 -178.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.8 t -68.52 -19.97 64.55 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 119.945 1.248 . . . . 0.0 111.384 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 26.6 mt -87.45 -21.78 25.35 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 172.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -99.36 -21.98 13.83 Favored Glycine 0 C--O 1.215 -1.077 0 CA-C-N 119.376 0.989 . . . . 0.0 113.705 177.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.8 mt -60.1 -35.51 28.69 Favored Pre-proline 0 CA--C 1.549 0.936 0 N-CA-C 118.785 2.883 . . . . 0.0 118.785 -173.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -55.36 7.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.949 1 C-N-CA 125.739 4.293 . . . . 0.0 120.728 -171.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -125.33 -19.42 5.08 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 -171.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -163.96 -100.06 0.14 Allowed Glycine 0 CA--C 1.524 0.62 0 CA-C-N 118.622 0.647 . . . . 0.0 112.444 -177.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 31.5 tptt -153.06 156.46 38.79 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 125.03 1.332 . . . . 0.0 107.891 165.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -131.22 106.04 11.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 119.812 1.187 . . . . 0.0 109.177 -174.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 33.9 p -104.66 -25.77 12.58 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.399 -1.273 . . . . 0.0 112.393 -162.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -138.03 152.49 48.91 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.101 0.864 . . . . 0.0 113.095 170.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -137.61 169.86 17.05 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.419 1.088 . . . . 0.0 111.267 159.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.63 153.22 39.1 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.091 1.356 . . . . 0.0 109.589 178.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 5.2 mtp -135.59 98.98 4.07 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.91 0.884 . . . . 0.0 110.326 -169.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -74.56 89.12 2.18 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.961 0.904 . . . . 0.0 110.693 177.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.9 pttt -122.01 60.24 0.98 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.227 1.811 . . . . 0.0 113.829 -178.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 84.1 -118.41 4.69 Favored Glycine 0 N--CA 1.47 0.96 0 C-N-CA 130.286 3.803 . . . . 0.0 113.769 4.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.5 mtmm -135.05 -95.39 0.27 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.69 1.596 . . . . 0.0 110.464 -167.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -155.88 32.32 0.35 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 129.737 3.215 . . . . 0.0 110.15 -176.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -122.8 163.52 20.07 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -173.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -154.51 166.16 34.17 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 126.364 1.866 . . . . 0.0 110.348 177.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 5.7 m-30 -112.5 149.44 32.64 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.867 1.667 . . . . 0.0 107.329 162.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.8 tt -128.83 121.03 53.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 C-N-CA 124.186 0.994 . . . . 0.0 108.883 159.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.497 ' HG3' ' H ' ' A' ' 136' ' ' LEU . 2.0 tm-20 -110.95 108.89 18.8 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 126.018 1.727 . . . . 0.0 110.159 -174.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -102.18 149.66 24.07 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 112.921 -1.945 . . . . 0.0 111.403 -176.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.43 -13.34 60.7 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.577 1.551 . . . . 0.0 114.065 -161.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.03 144.02 48.44 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.502 0.721 . . . . 0.0 110.789 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -63.46 -41.06 98.63 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.021 0.928 . . . . 0.0 111.575 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -74.78 -36.75 62.52 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 178.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.95 -46.34 89.74 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 118.708 0.685 . . . . 0.0 110.305 171.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.57 -37.79 80.18 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 175.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -56.38 -50.78 70.59 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 120.946 -1.096 . . . . 0.0 111.372 169.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -64.63 -26.08 68.24 Favored 'General case' 0 C--O 1.219 -0.548 0 O-C-N 120.597 -1.315 . . . . 0.0 111.374 173.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 18.8 ttp -69.35 -48.51 61.12 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-N 120.168 1.349 . . . . 0.0 110.38 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -64.27 -38.2 81.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 O-C-N 121.046 -1.034 . . . . 0.0 111.66 176.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -67.57 -47.33 70.09 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.358 1.063 . . . . 0.0 111.137 173.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -49.91 -34.19 19.68 Favored 'General case' 0 C--O 1.223 -0.329 0 C-N-CA 126.151 1.781 . . . . 0.0 112.236 169.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -90.76 -18.91 24.15 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 120.437 -1.415 . . . . 0.0 113.312 -177.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -81.59 -10.62 59.39 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 121.581 0.705 . . . . 0.0 111.196 168.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.36 -63.96 1.24 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 130.226 3.41 . . . . 0.0 111.743 168.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 2.2 p -78.76 -46.5 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 124.626 1.17 . . . . 0.0 112.213 -156.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.4 m 37.33 123.85 0.0 OUTLIER Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 130.17 3.388 . . . . 0.0 115.023 -145.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -75.01 -20.96 16.32 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 121.88 1.72 . . . . 0.0 115.723 -168.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 5.6 t 42.4 99.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 129.595 3.158 . . . . 0.0 114.579 176.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.618 ' H ' HD13 ' A' ' 126' ' ' ILE . 4.5 tt -135.3 -59.5 0.78 Allowed 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 113.591 -1.641 . . . . 0.0 109.844 -137.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.07 -3.04 14.67 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 156.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 98.76 17.06 29.3 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 125.392 1.472 . . . . 0.0 115.945 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -153.61 170.59 8.07 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 127.634 2.373 . . . . 0.0 109.794 171.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -47.02 142.13 11.49 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 124.009 3.139 . . . . 0.0 115.644 -179.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.618 HD13 ' H ' ' A' ' 121' ' ' LEU . 4.9 mm -117.08 143.81 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 127.347 2.259 . . . . 0.0 107.823 -177.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 9.1 m-30 -116.82 125.34 51.43 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 121.249 -0.907 . . . . 0.0 110.523 -166.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.1 149.95 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -178.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -149.26 160.1 43.69 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 127.525 2.33 . . . . 0.0 109.326 163.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -53.2 149.77 6.75 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 120.803 -1.186 . . . . 0.0 112.09 160.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 27.5 t -72.0 154.78 40.95 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.36 0.664 . . . . 0.0 112.207 177.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -66.61 -12.09 56.45 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.664 1.586 . . . . 0.0 113.261 168.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 65.2 m-70 -114.94 171.49 7.63 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.631 1.572 . . . . 0.0 112.837 -169.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -123.9 103.13 8.16 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 126.412 1.885 . . . . 0.0 110.961 -176.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 62.02 115.67 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 126.773 2.029 . . . . 0.0 113.364 -170.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.497 ' H ' ' HG3' ' A' ' 100' ' ' GLU . 24.0 tp -64.03 101.04 0.35 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.063 1.745 . . . . 0.0 111.86 168.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -92.63 106.65 18.6 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.42 1.488 . . . . 0.0 109.139 170.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 11.0 t -145.51 159.61 42.85 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.147 1.379 . . . . 0.0 112.278 -175.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -77.19 -14.9 59.7 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.132 1.373 . . . . 0.0 112.729 167.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.8 t -75.14 79.42 2.28 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.184 1.793 . . . . 0.0 113.35 -177.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 93.3 p -143.16 161.13 49.61 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 125.307 1.443 . . . . 0.0 112.503 172.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -60.42 161.54 20.11 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.755 2.97 . . . . 0.0 115.197 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -132.35 -29.6 1.57 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.191 1.796 . . . . 0.0 113.965 177.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -58.33 -22.9 54.93 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -172.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -73.15 -19.89 61.03 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 176.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 . . . . . 0 N--CA 1.481 1.097 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -167.131 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 147' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.207 0 O5'-C5'-C4' 113.81 2.579 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 148' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.26 0 O4'-C1'-N19 111.742 3.542 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 149' ' ' ' C' . . . . . 0.444 ' C6 ' ' CD2' ' A' ' 62' ' ' HIS . . . . . . . . 0 O4'--C4' 1.421 -2.68 0 N19-C1'-C2' 107.995 -3.378 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 150' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 1 O4'--C4' 1.404 -4.08 0 O4'-C1'-N19 111.895 3.695 . 0.01 0a . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 151' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.543 2.568 1 O4'-C1'-N19 112.386 4.186 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 152' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.226 0 N19-C1'-C2' 118.046 2.904 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.566 0 N-CA-C 111.061 -0.815 . . . . 0.0 111.061 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -68.56 -39.63 80.98 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.733 0.813 . . . . 0.0 112.363 175.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 79.0 p -78.06 179.72 6.64 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.911 2.084 . . . . 0.0 113.31 171.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 84.6 mmt-85 -129.3 175.55 8.65 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.514 1.926 . . . . 0.0 110.622 173.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 57.6 p -54.14 156.2 3.21 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.253 1.021 . . . . 0.0 112.38 171.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 54.78 6.65 0.13 Allowed 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 126.074 1.75 . . . . 0.0 115.571 -169.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.85 30.89 55.28 Favored Glycine 0 CA--C 1.535 1.297 0 O-C-N 120.75 -1.219 . . . . 0.0 113.623 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 51.0 t 58.82 80.45 0.28 Allowed Pre-proline 0 N--CA 1.476 0.843 0 C-N-CA 127.967 2.507 . . . . 0.0 109.95 -171.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -95.27 169.57 1.44 Allowed 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.03 2.487 . . . . 0.0 114.474 -148.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 45.3 m -147.49 -166.15 2.44 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.022 1.329 . . . . 0.0 112.908 -165.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 46.5 mtp180 -55.13 -16.85 3.4 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 119.521 3.156 . . . . 0.0 119.521 -161.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.31 6.9 p -98.2 128.91 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 CA-C-N 121.366 1.894 . . . . 0.0 112.879 169.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 39.7 mt -100.4 155.01 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.84 1.656 . . . . 0.0 108.378 165.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -119.08 148.76 42.69 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.58 1.552 . . . . 0.0 110.957 173.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.4 mt -127.98 141.4 46.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 126.501 1.92 . . . . 0.0 109.639 -172.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.45 165.83 17.73 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 127.95 2.5 . . . . 0.0 109.885 167.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 67.31 23.59 9.26 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 125.148 1.379 . . . . 0.0 113.887 177.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.99 165.62 0.76 Allowed Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 127.7 2.4 . . . . 0.0 111.292 165.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -58.68 175.61 0.55 Allowed 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 123.007 2.471 . . . . 0.0 113.993 154.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 28.1 pt -73.81 -32.36 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 126.645 1.978 . . . . 0.0 113.47 -175.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -154.91 32.34 0.4 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.871 1.668 . . . . 0.0 111.357 -168.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -51.49 147.61 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.574 0.75 . . . . 0.0 112.267 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.4 t -88.91 140.97 28.89 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 122.584 1.183 . . . . 0.0 112.092 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -57.84 -36.03 71.72 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.429 175.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -57.4 -36.0 74.63 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 123.643 0.639 . . . . 0.0 112.865 177.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -70.34 -51.33 30.83 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.955 1.302 . . . . 0.0 112.045 172.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 88.6 t -63.13 -41.49 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -176.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.0 pp -72.73 -34.8 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 O-C-N 120.285 -1.509 . . . . 0.0 112.413 174.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 73.1 m -66.54 -22.49 66.16 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 119.809 1.186 . . . . 0.0 111.886 174.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.6 mt -76.39 -30.86 57.68 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.016 0.927 . . . . 0.0 113.046 170.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -94.27 -11.89 56.81 Favored Glycine 0 CA--C 1.534 1.272 0 CA-C-N 119.818 1.19 . . . . 0.0 115.693 178.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.7 mt -64.71 -36.07 15.94 Favored Pre-proline 0 CA--C 1.545 0.764 0 N-CA-C 117.379 2.363 . . . . 0.0 117.379 -172.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.74 -5.18 1.69 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.575 2.85 . . . . 0.0 117.583 173.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -107.48 -33.76 7.25 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -163.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -164.92 -98.26 0.12 Allowed Glycine 0 CA--C 1.522 0.527 0 C-N-CA 124.201 0.905 . . . . 0.0 111.344 172.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 33.6 tptt -149.15 145.04 26.99 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 105.423 -2.065 . . . . 0.0 105.423 161.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.455 ' CG2' ' HE2' ' A' ' 101' ' ' MET . 3.5 t -128.48 89.13 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-N 120.331 1.423 . . . . 0.0 108.76 -171.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 31.3 p -77.58 -19.04 56.28 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 126.817 2.047 . . . . 0.0 113.016 -161.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -148.27 160.97 42.43 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 172.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.8 pp -140.32 172.23 13.03 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.775 1.23 . . . . 0.0 111.493 155.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.2 152.77 43.45 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 125.93 1.692 . . . . 0.0 108.747 175.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 5.4 mtt -132.19 102.64 5.87 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.159 0.984 . . . . 0.0 111.84 -174.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -72.43 100.17 2.63 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.587 1.155 . . . . 0.0 110.215 177.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -57.8 -23.0 50.33 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.82 1.648 . . . . 0.0 114.933 -176.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -63.97 -44.87 95.34 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.659 1.599 . . . . 0.0 115.956 -174.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -136.92 8.97 3.03 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 115.394 1.628 . . . . 0.0 115.394 -151.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 55.15 60.69 3.29 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.7 1.2 . . . . 0.0 110.745 -165.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -130.66 163.92 26.13 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.647 0.779 . . . . 0.0 112.255 177.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -155.36 167.19 31.2 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.917 1.287 . . . . 0.0 111.941 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 4.8 m-30 -110.19 152.17 26.4 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.594 1.958 . . . . 0.0 107.24 160.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 19.8 tt -134.09 105.4 6.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 125.252 1.421 . . . . 0.0 108.717 167.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 21.4 tp10 -96.95 124.1 40.84 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 127.377 2.271 . . . . 0.0 110.753 -175.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.455 ' HE2' ' CG2' ' A' ' 85' ' ' VAL 0.305 1.6 ttm -125.23 157.27 36.95 Favored 'General case' 0 C--O 1.223 -0.301 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 -177.213 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -69.97 -18.99 63.37 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.731 2.012 . . . . 0.0 113.318 -165.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.09 140.72 42.16 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 122.62 1.2 . . . . 0.0 111.875 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -61.84 -40.9 96.93 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.577 1.151 . . . . 0.0 111.137 177.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -74.54 -35.24 63.11 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -56.43 -55.4 34.05 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-N 118.755 0.707 . . . . 0.0 109.861 168.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.5 -34.36 76.99 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.444 1.02 . . . . 0.0 113.585 -178.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -56.56 -51.48 68.44 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.149 -0.969 . . . . 0.0 111.633 169.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -63.26 -31.21 72.31 Favored 'General case' 0 C--O 1.224 -0.257 0 O-C-N 121.289 -0.882 . . . . 0.0 110.972 174.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 6.2 ttp -71.0 -46.45 62.24 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.872 1.269 . . . . 0.0 111.886 -178.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -67.81 -37.88 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 O-C-N 120.843 -1.16 . . . . 0.0 111.366 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -71.78 -41.93 67.74 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.441 1.096 . . . . 0.0 111.285 176.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -48.78 -52.29 24.69 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.51 1.124 . . . . 0.0 110.819 165.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -77.9 12.41 1.77 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 118.74 -2.475 . . . . 0.0 113.344 178.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . 0.289 0.5 OUTLIER -116.35 -10.63 11.33 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.814 0.846 . . . . 0.0 113.067 167.494 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.46 -42.51 15.53 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 126.029 1.732 . . . . 0.0 111.45 159.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 85.5 t -116.22 -63.33 1.99 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.228 0 C-N-CA 124.937 1.295 . . . . 0.0 111.09 -144.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.0 m 68.96 136.47 0.05 OUTLIER Pre-proline 0 N--CA 1.484 1.255 0 C-N-CA 127.93 2.492 . . . . 0.0 112.588 -175.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -81.41 -9.76 12.4 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 122.605 2.203 . . . . 0.0 115.616 -174.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.5 t 26.57 90.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 130.867 3.667 . . . . 0.0 114.606 173.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.658 ' H ' HD13 ' A' ' 126' ' ' ILE . 1.7 tt -118.98 -59.27 1.87 Allowed 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.716 -126.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.72 -1.56 39.06 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 153.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 106.27 32.55 3.69 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 124.999 1.285 . . . . 0.0 115.047 -177.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -139.49 150.51 63.96 Favored Pre-proline 0 CA--C 1.536 0.404 0 C-N-CA 125.342 1.457 . . . . 0.0 110.762 175.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -55.59 109.1 0.37 Allowed 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.354 2.703 . . . . 0.0 112.713 174.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.658 HD13 ' H ' ' A' ' 121' ' ' LEU . 5.1 mm -78.19 145.77 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 124.892 1.277 . . . . 0.0 109.109 178.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 9.8 m-30 -111.02 128.71 55.94 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.82 0.848 . . . . 0.0 109.811 -173.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.3 tt -131.48 146.0 34.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 124.505 1.122 . . . . 0.0 111.667 -178.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -155.21 160.25 40.72 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.179 1.792 . . . . 0.0 108.958 160.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -50.71 148.57 3.89 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.271 -0.893 . . . . 0.0 112.767 167.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 37.5 t -68.24 158.02 34.23 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.509 0.724 . . . . 0.0 112.057 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -67.34 -13.36 61.93 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.563 1.145 . . . . 0.0 112.72 164.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 36.5 m-70 -111.81 178.82 4.2 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 127.778 2.431 . . . . 0.0 110.473 -178.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -125.6 -0.55 7.46 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 115.737 1.754 . . . . 0.0 115.737 -171.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -164.48 166.85 20.11 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 130.087 3.355 . . . . 0.0 108.302 -173.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 21.3 tp -134.67 105.51 6.52 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.431 1.492 . . . . 0.0 110.979 175.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 8.1 mmpt? -94.72 99.27 11.4 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.216 1.806 . . . . 0.0 109.829 176.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.6 p -82.28 1.85 34.83 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.864 1.666 . . . . 0.0 113.75 174.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -63.35 -4.21 2.49 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 127.297 2.239 . . . . 0.0 115.178 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 42.8 m 62.35 31.99 17.12 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.947 2.099 . . . . 0.0 115.086 173.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 46.8 m -148.24 149.35 31.9 Favored Pre-proline 0 N--CA 1.474 0.769 0 C-N-CA 126.849 2.06 . . . . 0.0 110.242 162.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -74.44 -22.74 15.8 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 123.184 2.59 . . . . 0.0 113.539 -177.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -145.41 167.66 22.4 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 127.778 2.431 . . . . 0.0 108.858 172.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -69.16 93.57 0.61 Allowed 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.1 -1.0 . . . . 0.0 112.066 178.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -68.55 172.08 6.67 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.894 1.678 . . . . 0.0 112.773 172.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 25.1 tpp180 . . . . . 0 N--CA 1.471 0.602 0 C-N-CA 125.35 1.46 . . . . 0.0 110.864 170.784 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 147' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.2 0 C5'-C4'-C3' 111.736 -2.51 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 148' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.734 0 O5'-C5'-C4' 115.358 3.684 . 0.0 OUTLIER '7D dist 4p' 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 149' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.521 1 N19-C1'-C2' 106.885 -4.072 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 150' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.407 -3.853 0 O4'-C1'-N19 111.537 3.337 . 0.01 4a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 151' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.123 1 O4'-C1'-N19 112.539 4.339 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 152' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.147 1 O4'-C1'-N19 113.69 5.49 . 0.43 2u . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.634 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -53.55 -48.57 68.97 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 126.076 1.75 . . . . 0.0 113.825 -169.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.8 m -66.12 -19.83 65.96 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.738 1.215 . . . . 0.0 114.212 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.2 ttt180 -72.07 -2.32 17.98 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.437 1.495 . . . . 0.0 113.666 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.0 p -60.23 -14.46 17.87 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.088 1.755 . . . . 0.0 114.41 166.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -135.81 176.05 9.04 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 126.242 1.817 . . . . 0.0 111.179 162.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -83.9 -55.82 2.73 Favored Glycine 0 N--CA 1.473 1.123 0 O-C-N 120.979 -1.076 . . . . 0.0 112.963 -163.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.1 p -140.8 70.73 30.12 Favored Pre-proline 0 N--CA 1.475 0.81 0 C-N-CA 124.643 1.177 . . . . 0.0 110.877 167.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -96.67 148.13 1.05 Allowed 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 124.62 3.546 . . . . 0.0 113.089 -165.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.7 m -161.97 117.75 2.01 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.495 1.118 . . . . 0.0 113.137 176.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 35.6 mtp180 61.72 -12.68 0.06 Allowed 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 128.789 2.836 . . . . 0.0 118.029 167.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.417 HG23 ' CD2' ' A' ' 98' ' ' PHE 0.298 2.4 p -107.52 139.86 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 124.306 1.042 . . . . 0.0 112.207 164.443 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.2 mt -113.54 152.35 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 128.927 2.891 . . . . 0.0 107.581 170.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.467 ' CD2' ' C6 ' ' B' ' 149' ' ' ' C' . 5.0 t-80 -120.25 150.46 40.64 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.353 1.461 . . . . 0.0 110.741 175.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.5 mt -129.9 141.73 45.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 126.114 1.766 . . . . 0.0 109.479 -175.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.86 173.38 6.91 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 127.348 2.259 . . . . 0.0 111.067 171.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 17.2 mmmt 62.67 28.88 16.78 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 126.064 1.745 . . . . 0.0 113.503 175.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.89 164.41 21.7 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 124.7 1.2 . . . . 0.0 110.802 173.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -59.19 -175.82 0.09 OUTLIER 'Trans proline' 0 CA--C 1.537 0.64 1 C-N-CA 125.505 4.137 . . . . 0.0 113.965 157.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 30.3 pt -82.56 -30.18 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 126.665 1.986 . . . . 0.0 112.893 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -155.23 35.15 0.38 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.737 1.615 . . . . 0.0 111.331 -168.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -51.54 150.4 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.644 0.778 . . . . 0.0 111.398 174.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.9 t -89.89 136.42 33.05 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 123.129 1.442 . . . . 0.0 112.413 -177.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.49 -37.59 65.46 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 114.487 -1.233 . . . . 0.0 111.395 173.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -56.21 -38.55 78.01 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.292 0.949 . . . . 0.0 113.605 175.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -65.85 -52.41 50.67 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.222 1.009 . . . . 0.0 111.214 171.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.4 t -60.75 -49.05 86.13 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 122.828 0.451 . . . . 0.0 112.203 -177.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.3 pp -70.51 -30.01 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 O-C-N 120.176 -1.577 . . . . 0.0 113.44 178.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 52.1 m -72.19 -17.84 61.9 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 119.175 0.898 . . . . 0.0 112.017 172.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 35.0 mt -85.52 -17.27 36.85 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 165.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.409 ' HA2' ' SD ' ' A' ' 110' ' ' MET . . . -74.12 -40.74 41.57 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 124.3 0.952 . . . . 0.0 112.901 167.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.9 mt -70.17 -34.12 3.91 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 119.097 2.999 . . . . 0.0 119.097 -155.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -59.36 4.16 0.15 Allowed 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 124.029 3.153 . . . . 0.0 117.551 175.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.41 ' CD2' ' HG3' ' A' ' 110' ' ' MET . 56.7 m-85 -120.34 -41.37 2.62 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -167.024 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -147.61 -113.62 0.75 Allowed Glycine 0 C--N 1.341 0.809 0 CA-C-O 122.374 0.986 . . . . 0.0 111.983 176.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 33.5 tptt -149.48 117.42 6.3 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 129.821 3.248 . . . . 0.0 104.78 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . 0.29 16.3 t -127.29 82.68 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 CA-C-O 122.9 1.334 . . . . 0.0 109.145 -158.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.3 t -74.3 -26.82 60.41 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 127.054 2.142 . . . . 0.0 112.148 -162.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -141.02 166.22 25.4 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 123.268 1.508 . . . . 0.0 114.364 177.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -147.38 174.83 11.3 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 128.047 2.539 . . . . 0.0 109.874 160.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.63 155.77 43.23 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.96 1.304 . . . . 0.0 110.137 177.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 3.7 mtt -127.55 107.05 9.6 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.096 0.958 . . . . 0.0 111.705 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -76.08 64.66 1.98 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.958 0.903 . . . . 0.0 109.133 165.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 31.8 tttp -53.48 -45.19 69.51 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.706 1.602 . . . . 0.0 113.471 -159.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -70.73 -11.62 69.39 Favored Glycine 0 CA--C 1.539 1.592 0 C-N-CA 124.979 1.276 . . . . 0.0 115.797 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.6 -1.04 25.15 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 118.919 1.36 . . . . 0.0 113.191 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.4 m120 60.24 38.26 20.08 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.441 1.496 . . . . 0.0 112.64 -167.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -128.35 163.25 25.24 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.146 0.979 . . . . 0.0 112.062 -172.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -155.0 166.41 33.68 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.79 1.636 . . . . 0.0 112.035 -178.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.417 ' CD2' HG23 ' A' ' 60' ' ' VAL . 5.1 m-30 -113.66 155.8 24.87 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.769 2.028 . . . . 0.0 108.512 160.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.6 tt -137.02 130.61 45.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 119.632 1.106 . . . . 0.0 109.711 162.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -127.16 120.04 27.88 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.995 2.118 . . . . 0.0 112.241 -160.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -134.72 154.34 51.61 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 112.994 -1.912 . . . . 0.0 113.232 -164.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.26 -20.31 61.55 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 115.29 1.589 . . . . 0.0 115.29 -158.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 9.4 p -136.66 138.07 40.71 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.702 1.201 . . . . 0.0 111.209 -175.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -58.42 -32.29 68.54 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.96 174.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -73.54 -42.67 61.41 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -54.34 -53.11 58.3 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 119.669 1.122 . . . . 0.0 109.518 169.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.62 -34.33 71.98 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -174.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -58.44 -50.47 73.61 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.109 0.868 . . . . 0.0 110.56 169.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -62.11 -33.1 73.83 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 121.583 -0.698 . . . . 0.0 110.99 175.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.41 ' HG3' ' CD2' ' A' ' 82' ' ' PHE . 11.1 ttp -73.46 -48.94 29.58 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 124.085 0.954 . . . . 0.0 112.263 -176.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 1.1 p -63.78 -38.72 83.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 124.341 1.056 . . . . 0.0 110.995 179.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -71.96 -42.59 66.4 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.881 1.272 . . . . 0.0 111.549 177.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -47.68 -55.56 9.19 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.909 1.284 . . . . 0.0 109.984 165.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -78.29 11.58 2.32 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 118.855 -2.403 . . . . 0.0 113.826 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 53.3 m -111.82 -15.48 13.37 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.633 1.173 . . . . 0.0 110.988 171.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.41 -44.59 10.07 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.733 2.013 . . . . 0.0 111.841 163.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 96.4 t -112.35 -49.73 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 125.02 1.328 . . . . 0.0 111.951 -143.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.406 ' CG2' ' H ' ' A' ' 126' ' ' ILE . 31.5 m 69.81 141.45 0.08 OUTLIER Pre-proline 0 N--CA 1.485 1.29 0 C-N-CA 128.21 2.604 . . . . 0.0 112.308 -173.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -82.05 -12.88 10.52 Favored 'Trans proline' 0 CA--C 1.549 1.251 0 C-N-CA 123.385 2.723 . . . . 0.0 114.105 -176.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 22.0 t 50.6 101.17 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 131.144 3.778 . . . . 0.0 115.541 175.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.2 tt -92.08 101.62 14.16 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 123.763 0.825 . . . . 0.0 109.819 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 45.6 62.47 2.18 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.735 2.014 . . . . 0.0 112.086 178.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 81.2 6.93 89.01 Favored Glycine 0 CA--C 1.537 1.426 0 N-CA-C 116.015 1.166 . . . . 0.0 116.015 173.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 35.1 tp60 -131.72 142.49 45.45 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 125.83 1.652 . . . . 0.0 110.109 -173.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -61.1 166.31 10.94 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 123.119 2.546 . . . . 0.0 114.529 179.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.406 ' H ' ' CG2' ' A' ' 118' ' ' THR . 0.6 OUTLIER -136.79 154.41 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.797 1.639 . . . . 0.0 109.989 178.088 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -120.45 91.05 3.45 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 124.33 1.052 . . . . 0.0 109.056 -155.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -95.95 152.76 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 124.913 1.285 . . . . 0.0 111.994 -179.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -147.92 161.48 41.22 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.75 1.62 . . . . 0.0 108.339 152.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.91 153.31 4.86 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.006 -1.059 . . . . 0.0 112.041 158.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 54.7 p -65.11 170.17 4.76 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 177.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -87.64 6.75 33.13 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.405 1.482 . . . . 0.0 112.874 164.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -132.84 -176.01 3.97 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.445 1.498 . . . . 0.0 113.243 -161.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 42.0 tttp -140.26 101.35 4.11 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.536 1.935 . . . . 0.0 111.162 -177.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 64.74 108.11 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 127.448 2.299 . . . . 0.0 114.611 -174.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 18.8 tp -63.88 124.7 22.2 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.245 1.818 . . . . 0.0 111.956 169.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -101.89 102.58 13.17 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 127.163 2.185 . . . . 0.0 110.634 167.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 12.9 p -77.24 60.61 1.98 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 126.094 1.758 . . . . 0.0 111.788 174.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -60.55 -44.99 95.53 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.474 1.51 . . . . 0.0 114.877 -168.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 74.6 m -88.74 87.3 7.2 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.109 1.363 . . . . 0.0 113.195 -174.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 49.8 m -65.73 136.12 95.78 Favored Pre-proline 0 N--CA 1.475 0.819 0 C-N-CA 124.368 1.067 . . . . 0.0 112.268 173.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -51.63 138.96 48.78 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 124.025 3.15 . . . . 0.0 114.645 176.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -72.49 84.86 1.13 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.178 1.391 . . . . 0.0 110.877 175.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -123.68 -81.14 0.63 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.41 1.084 . . . . 0.0 113.476 -163.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -74.81 -70.84 0.38 Allowed 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -165.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 56.4 ttm-85 . . . . . 0 N--CA 1.482 1.149 0 C-N-CA 125.947 1.699 . . . . 0.0 113.599 -172.988 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 147' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.665 0 O4'-C4'-C3' 108.79 2.35 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 148' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.749 1 C5'-C4'-C3' 109.277 -4.149 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 149' ' ' ' C' . . . . . 0.467 ' C6 ' ' CD2' ' A' ' 62' ' ' HIS . . . . . . . . 0 O4'--C4' 1.423 -2.539 0 N19-C1'-C2' 107.657 -3.589 . 0.01 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 150' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.676 1 O4'-C1'-N19 113.087 4.887 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 151' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.541 2.378 0 O4'-C1'-N19 110.642 2.442 . 0.01 7p . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 152' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.537 2.077 0 O4'-C1'-N19 111.682 3.482 . 0.341 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.564 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -65.26 155.79 34.01 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.167 0.987 . . . . 0.0 113.509 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 82.8 p -135.1 -5.27 2.37 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.688 1.995 . . . . 0.0 114.077 169.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 72.7 mtp85 -75.93 -28.24 57.9 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.639 1.176 . . . . 0.0 113.664 -174.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.5 t -58.51 161.9 4.2 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.965 0.906 . . . . 0.0 112.543 173.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 53.52 6.29 0.07 Allowed 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 127.235 2.214 . . . . 0.0 115.957 -176.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.56 38.95 26.91 Favored Glycine 0 CA--C 1.536 1.4 0 O-C-N 120.721 -1.237 . . . . 0.0 113.317 -174.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . 0.321 14.1 p 50.31 78.0 0.43 Allowed Pre-proline 0 N--CA 1.485 1.283 0 C-N-CA 127.558 2.343 . . . . 0.0 111.374 -174.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -97.34 -179.73 0.38 Allowed 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 123.344 2.696 . . . . 0.0 113.431 -144.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 30.0 p -144.96 -156.79 0.73 Allowed 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -175.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 32.2 mtp180 -61.02 -6.09 1.72 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 130.541 3.537 . . . . 0.0 118.339 -165.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.43 HG23 ' CD2' ' A' ' 98' ' ' PHE 0.254 2.5 p -101.17 131.35 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 120.809 1.64 . . . . 0.0 112.092 166.973 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 16.9 mt -103.24 153.92 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 127.379 2.272 . . . . 0.0 109.478 165.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.427 ' CD2' ' C6 ' ' B' ' 149' ' ' ' C' . 2.1 t-80 -120.39 143.95 48.16 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.772 1.629 . . . . 0.0 110.528 175.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.9 mt -122.58 133.46 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 127.071 2.148 . . . . 0.0 109.776 -173.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 28.9 mtt180 -88.39 166.63 14.12 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.672 1.589 . . . . 0.0 110.543 173.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.9 mtpp 50.51 35.42 11.23 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 155.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.79 162.82 0.71 Allowed Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 126.446 1.898 . . . . 0.0 111.521 162.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -56.14 179.24 0.1 OUTLIER 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 124.326 3.351 . . . . 0.0 114.912 156.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 31.1 pt -77.36 -30.41 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 126.599 1.96 . . . . 0.0 113.168 -176.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -157.75 36.86 0.26 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.993 1.717 . . . . 0.0 110.971 -170.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -50.27 151.05 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.966 0.906 . . . . 0.0 111.627 175.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.7 t -85.19 128.05 34.52 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 123.583 1.659 . . . . 0.0 111.11 174.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -60.9 -22.68 64.57 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 114.823 -1.081 . . . . 0.0 111.773 174.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -62.38 -35.91 92.35 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 125.224 1.392 . . . . 0.0 114.024 167.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -67.88 -46.46 71.61 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.576 -0.955 . . . . 0.0 109.812 171.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 62.0 t -64.85 -44.55 96.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -176.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -75.81 -25.7 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-N 121.973 2.17 . . . . 0.0 114.051 173.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.7 t -62.61 -28.05 69.63 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 119.705 1.139 . . . . 0.0 111.126 166.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 14.8 mt -81.84 -16.02 52.18 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 170.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.422 ' HA2' ' SD ' ' A' ' 110' ' ' MET . . . -91.71 -25.69 22.17 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 115.091 0.796 . . . . 0.0 115.091 171.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 13.4 mt -74.36 -26.72 0.7 Allowed Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 117.974 2.583 . . . . 0.0 117.974 -165.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -59.87 -0.62 0.89 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.174 2.583 . . . . 0.0 116.615 167.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -114.6 -43.92 3.12 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 -168.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -148.42 -112.85 0.68 Allowed Glycine 0 C--N 1.338 0.658 0 CA-C-O 122.587 1.104 . . . . 0.0 112.652 173.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 32.7 tptt -146.1 123.02 11.34 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 130.545 3.538 . . . . 0.0 103.894 176.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . 0.276 17.8 t -130.48 85.79 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 CA-C-O 122.604 1.192 . . . . 0.0 109.432 -159.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 22.2 p -72.49 -36.04 68.32 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 112.74 -2.027 . . . . 0.0 111.741 -162.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -135.01 160.3 38.76 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 122.822 1.296 . . . . 0.0 114.047 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -149.88 171.95 15.95 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 126.454 1.902 . . . . 0.0 110.487 161.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.7 155.03 42.11 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.49 1.116 . . . . 0.0 110.101 -175.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 3.0 mtt -132.94 102.99 5.84 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.357 1.063 . . . . 0.0 111.476 -174.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.0 69.43 3.29 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 122.341 1.067 . . . . 0.0 109.748 168.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -60.53 -20.6 60.78 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.296 1.438 . . . . 0.0 113.25 -177.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.63 -30.34 62.25 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 125.358 1.456 . . . . 0.0 114.968 169.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.6 mtmt -132.39 -5.67 3.35 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 115.548 1.684 . . . . 0.0 115.548 -170.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.7 m120 72.61 38.71 0.76 Allowed 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 127.614 2.366 . . . . 0.0 113.611 -173.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -112.13 167.17 10.61 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.546 0.738 . . . . 0.0 111.271 171.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -147.39 164.48 33.18 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.499 1.519 . . . . 0.0 111.232 172.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.43 ' CD2' HG23 ' A' ' 60' ' ' VAL . 6.7 m-30 -109.27 157.33 18.94 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.44 1.496 . . . . 0.0 107.99 160.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 19.2 tt -137.31 124.33 29.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 124.599 1.16 . . . . 0.0 109.216 162.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -120.91 123.6 42.9 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 127.514 2.326 . . . . 0.0 111.445 -167.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -133.99 157.45 46.04 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 112.724 -2.035 . . . . 0.0 113.222 -164.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -70.78 -23.06 62.32 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.376 1.251 . . . . 0.0 114.376 -161.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 9.8 p -135.58 140.64 44.79 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 122.622 1.201 . . . . 0.0 111.772 -175.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -59.83 -33.01 71.21 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.084 174.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -74.49 -41.61 60.41 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -54.54 -51.67 64.48 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 119.4 1.0 . . . . 0.0 109.803 168.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.28 -36.09 74.15 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -176.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -58.91 -46.98 86.6 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.226 -0.921 . . . . 0.0 111.034 170.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -64.32 -32.7 74.41 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.024 -1.048 . . . . 0.0 111.278 173.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.422 ' SD ' ' HA2' ' A' ' 79' ' ' GLY . 12.9 ttp -71.75 -48.76 44.65 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 119.729 1.15 . . . . 0.0 111.238 -176.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.16 -40.44 89.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 124.498 1.119 . . . . 0.0 111.071 177.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -68.67 -44.77 73.35 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.512 0.725 . . . . 0.0 110.445 177.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -50.15 -38.05 37.5 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.114 1.366 . . . . 0.0 112.25 168.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -92.92 -11.16 34.09 Favored 'General case' 0 C--O 1.231 0.127 0 O-C-N 120.064 -1.648 . . . . 0.0 113.131 -177.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 84.2 m -80.89 -18.22 47.97 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.37 1.068 . . . . 0.0 110.069 166.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.04 -62.2 1.63 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 129.621 3.168 . . . . 0.0 112.3 170.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 1.4 p -83.02 -44.51 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 124.418 1.087 . . . . 0.0 113.018 -151.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.0 m 38.0 121.54 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.068 0 C-N-CA 130.674 3.589 . . . . 0.0 114.636 -147.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -69.84 -33.2 16.74 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 121.204 1.269 . . . . 0.0 114.118 -171.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.2 t 50.89 99.17 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 128.757 2.823 . . . . 0.0 112.313 -176.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.617 ' H ' HD13 ' A' ' 126' ' ' ILE . 1.2 tt -116.33 -73.37 0.65 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 112.201 -2.272 . . . . 0.0 107.472 -146.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.53 -35.01 79.59 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.56 1.144 . . . . 0.0 111.643 172.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 147.41 4.38 0.39 Allowed Glycine 0 CA--C 1.533 1.2 0 C-N-CA 125.083 1.325 . . . . 0.0 116.229 175.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -152.6 167.59 13.02 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 119.15 1.475 . . . . 0.0 111.272 178.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -45.3 110.06 0.22 Allowed 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 124.347 3.364 . . . . 0.0 116.447 -171.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.617 HD13 ' H ' ' A' ' 121' ' ' LEU . 2.5 mm -74.14 166.19 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 125.175 1.39 . . . . 0.0 107.707 166.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -140.66 156.34 46.26 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.218 -0.926 . . . . 0.0 110.483 168.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.21 153.27 38.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 125.517 1.527 . . . . 0.0 111.098 176.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -150.2 167.99 25.3 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.357 1.463 . . . . 0.0 108.772 154.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -55.12 149.47 12.19 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 120.878 -1.139 . . . . 0.0 111.74 159.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 30.8 t -69.28 153.16 44.08 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.897 0.879 . . . . 0.0 112.669 176.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -61.86 -29.13 69.98 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.047 1.339 . . . . 0.0 112.15 167.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 51.1 m-70 -95.11 175.96 6.42 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.592 1.957 . . . . 0.0 111.548 -174.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -134.64 120.53 19.67 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.272 1.429 . . . . 0.0 111.072 -177.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 58.55 90.39 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 128.201 2.601 . . . . 0.0 114.131 -178.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 35.9 tp -59.04 128.73 38.66 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.2 1.4 . . . . 0.0 112.111 176.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -113.76 112.09 22.85 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 126.348 1.859 . . . . 0.0 110.523 170.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 21.2 p -118.67 164.28 15.58 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.351 1.861 . . . . 0.0 110.895 171.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -64.02 158.99 21.1 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.472 0.709 . . . . 0.0 111.704 172.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 41.2 m 49.71 41.44 21.97 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.716 1.606 . . . . 0.0 114.469 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 38.0 m -61.66 140.07 95.21 Favored Pre-proline 0 N--CA 1.474 0.732 0 C-N-CA 123.878 0.871 . . . . 0.0 111.563 174.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -76.26 0.6 9.23 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 123.671 2.914 . . . . 0.0 114.801 -176.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -66.41 -1.27 3.31 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 126.275 1.83 . . . . 0.0 114.981 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 54.63 78.24 0.18 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.821 2.449 . . . . 0.0 113.969 177.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -151.33 168.12 25.77 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.341 1.456 . . . . 0.0 111.275 166.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 . . . . . 0 N--CA 1.476 0.831 0 C-N-CA 126.14 1.776 . . . . 0.0 111.609 178.278 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 147' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.265 0 C5'-C4'-C3' 111.312 -2.792 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 148' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.598 0 O4'-C1'-N19 110.599 2.399 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 149' ' ' ' C' . . . . . 0.427 ' C6 ' ' CD2' ' A' ' 62' ' ' HIS . . . . . . . . 0 O4'--C4' 1.421 -2.695 0 C3'-C2'-C1' 104.027 2.807 . 0.112 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 150' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.817 1 O4'-C1'-N19 113.752 5.552 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 151' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.277 0 O4'-C1'-N19 110.844 2.644 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 152' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.259 0 O4'-C1'-N19 112.084 3.884 . 0.189 5q . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.645 0 N-CA-C 112.104 -0.398 . . . . 0.0 112.104 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -141.89 -50.1 0.39 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 127.948 2.499 . . . . 0.0 112.32 -0.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.6 m -62.28 -18.93 62.62 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.768 1.227 . . . . 0.0 114.255 179.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 49.9 tpt85 -58.07 -26.71 62.87 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 126.279 1.832 . . . . 0.0 114.273 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 48.7 m -60.17 -25.58 65.66 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 114.684 1.364 . . . . 0.0 114.684 -178.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -77.76 -2.13 34.78 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.889 1.676 . . . . 0.0 114.052 172.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 90.38 38.31 6.32 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 125.123 1.344 . . . . 0.0 113.839 -177.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . 0.314 7.7 p 47.78 76.66 0.52 Allowed Pre-proline 0 N--CA 1.485 1.302 0 C-N-CA 127.648 2.379 . . . . 0.0 111.619 -169.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -95.39 178.24 0.73 Allowed 'Trans proline' 0 CA--C 1.546 1.101 0 C-N-CA 123.927 3.085 . . . . 0.0 114.262 -147.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 49.1 m -135.97 177.88 7.49 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.944 1.298 . . . . 0.0 114.396 -167.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 34.4 mtp180 -55.82 -7.43 0.3 Allowed 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 129.909 3.284 . . . . 0.0 119.324 -170.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.6 p -105.66 134.71 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-N 119.759 1.163 . . . . 0.0 111.878 169.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 10.4 mt -106.0 150.25 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 126.433 1.893 . . . . 0.0 108.561 167.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.406 ' CD2' ' C6 ' ' B' ' 149' ' ' ' C' . 2.6 t-80 -114.03 143.97 43.87 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.082 1.353 . . . . 0.0 110.569 173.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 7.2 mt -118.46 144.8 25.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 126.488 1.915 . . . . 0.0 108.395 -175.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.23 167.87 17.75 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 127.739 2.415 . . . . 0.0 109.639 168.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.72 27.91 17.27 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.816 1.246 . . . . 0.0 113.229 178.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 28.2 mt -66.96 177.25 0.9 Allowed Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 125.05 1.34 . . . . 0.0 109.792 163.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -51.88 -171.97 0.01 OUTLIER 'Trans proline' 0 CA--C 1.545 1.062 0 C-N-CA 123.181 2.587 . . . . 0.0 114.507 147.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.7 mm -60.31 -47.26 93.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 127.427 2.291 . . . . 0.0 111.189 -176.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -155.51 -7.44 0.12 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 129.334 3.054 . . . . 0.0 111.666 -162.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.307 7.9 p 26.05 -127.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 128.903 2.881 . . . . 0.0 113.457 -167.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.8 t -154.51 143.8 21.27 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 120.004 1.275 . . . . 0.0 110.421 163.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -58.31 -42.12 86.0 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 123.562 0.745 . . . . 0.0 112.276 -175.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -55.79 -37.94 71.33 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 123.861 0.743 . . . . 0.0 112.516 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -69.12 -53.37 20.53 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.454 1.102 . . . . 0.0 112.125 173.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 97.7 t -58.97 -46.69 91.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 122.941 0.496 . . . . 0.0 112.14 -176.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.0 pp -73.05 -33.74 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 O-C-N 120.674 -1.266 . . . . 0.0 112.531 177.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 64.0 m -69.55 -21.44 63.64 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 120.047 1.294 . . . . 0.0 111.599 175.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.9 mt -77.63 -27.67 51.17 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 170.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -89.98 -21.25 39.84 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-N 119.239 0.927 . . . . 0.0 114.526 176.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.0 mt -64.05 -37.65 28.68 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 117.858 2.54 . . . . 0.0 117.858 -169.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.48 -4.01 1.09 Allowed 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.787 2.991 . . . . 0.0 116.845 171.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -106.97 -35.34 6.93 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 113.496 0.925 . . . . 0.0 113.496 -167.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -154.58 -108.37 0.31 Allowed Glycine 0 C--N 1.338 0.647 0 CA-C-O 122.622 1.123 . . . . 0.0 111.964 172.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 32.0 tptt -149.61 122.14 8.54 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 130.415 3.486 . . . . 0.0 104.135 175.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . 0.308 20.8 t -128.74 83.98 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 CA-C-N 120.034 1.288 . . . . 0.0 109.955 -160.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.5 t -79.72 -21.22 44.84 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 126.894 2.077 . . . . 0.0 112.765 -163.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -141.51 161.74 37.17 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 175.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -149.37 171.82 15.92 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.577 2.351 . . . . 0.0 110.551 162.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.99 154.47 44.05 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.266 1.426 . . . . 0.0 108.772 172.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 3.7 mtt -128.28 105.62 8.47 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.748 1.219 . . . . 0.0 110.434 -175.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -74.11 71.52 1.64 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.186 0.994 . . . . 0.0 110.525 173.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -49.85 118.87 3.11 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.835 1.654 . . . . 0.0 111.574 -176.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.04 -6.37 82.72 Favored Glycine 0 CA--C 1.539 1.556 0 CA-C-O 118.279 -1.289 . . . . 0.0 116.178 177.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.51 -2.98 50.72 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-N 119.837 1.818 . . . . 0.0 113.154 165.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.9 m120 63.24 27.37 15.5 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.313 1.845 . . . . 0.0 113.283 -167.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -124.58 164.51 19.66 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.513 0.725 . . . . 0.0 112.302 -168.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -164.12 170.71 16.07 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.091 1.756 . . . . 0.0 111.177 -178.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 4.3 m-30 -116.74 156.02 27.9 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.448 1.899 . . . . 0.0 108.088 164.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 17.4 tt -138.14 124.41 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 124.722 1.209 . . . . 0.0 109.138 164.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -122.79 122.17 38.04 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 127.034 2.134 . . . . 0.0 111.474 -164.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -132.63 157.33 45.07 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 113.389 -1.732 . . . . 0.0 112.97 -166.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.79 -19.34 62.02 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 114.065 -1.425 . . . . 0.0 114.308 -159.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 16.8 p -137.83 142.64 40.77 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 122.956 1.36 . . . . 0.0 111.766 -176.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -59.43 -37.42 78.04 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 114.125 -1.398 . . . . 0.0 110.706 176.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -71.64 -40.35 69.79 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 179.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.0 -52.53 62.85 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 119.403 1.001 . . . . 0.0 110.073 169.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.99 -38.16 82.35 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -56.15 -48.24 76.65 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.818 -0.551 . . . . 0.0 111.048 171.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -64.84 -35.01 79.74 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 118.407 -0.806 . . . . 0.0 111.233 173.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 8.2 ttp -67.76 -48.55 66.07 Favored 'General case' 0 C--N 1.343 0.303 0 C-N-CA 124.554 1.142 . . . . 0.0 110.554 -175.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.84 -40.64 88.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 C-N-CA 124.752 1.221 . . . . 0.0 111.761 178.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -67.71 -45.3 75.48 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.377 0.671 . . . . 0.0 110.693 177.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -50.97 -38.31 49.98 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.604 1.562 . . . . 0.0 112.482 167.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -88.73 -16.47 32.15 Favored 'General case' 0 CA--C 1.517 -0.289 0 O-C-N 119.966 -1.709 . . . . 0.0 112.88 -178.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 70.0 m -79.06 -18.61 53.13 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.434 1.093 . . . . 0.0 109.865 169.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.42 -60.58 2.22 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 129.384 3.074 . . . . 0.0 111.697 169.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -88.47 -48.07 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.048 0.939 . . . . 0.0 112.955 -153.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.2 m 43.08 125.28 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.88 0 C-N-CA 129.866 3.266 . . . . 0.0 114.267 -148.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -70.14 -35.35 11.67 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 121.416 1.411 . . . . 0.0 114.012 -171.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.6 t 53.86 102.33 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 128.597 2.759 . . . . 0.0 113.031 -178.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.599 ' H ' HD13 ' A' ' 126' ' ' ILE . 0.8 OUTLIER -123.59 -71.46 0.72 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 112.479 -2.146 . . . . 0.0 108.28 -147.293 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.78 -42.51 99.09 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.521 0.728 . . . . 0.0 111.086 171.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 158.18 -2.47 0.12 Allowed Glycine 0 CA--C 1.533 1.198 0 N-CA-C 116.208 1.243 . . . . 0.0 116.208 173.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -148.13 169.56 9.07 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 119.54 1.67 . . . . 0.0 111.192 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -50.98 116.07 2.41 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.734 2.956 . . . . 0.0 116.535 -166.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.599 HD13 ' H ' ' A' ' 121' ' ' LEU . 4.3 mm -76.27 150.06 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 126.364 1.866 . . . . 0.0 109.166 174.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 10.2 m-30 -114.7 136.7 52.77 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.042 -1.036 . . . . 0.0 110.787 -176.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.5 149.3 32.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 125.1 1.36 . . . . 0.0 112.319 176.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -153.46 164.9 37.39 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.763 2.025 . . . . 0.0 109.627 153.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -53.19 152.23 4.53 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 120.873 -1.142 . . . . 0.0 112.593 167.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 27.9 t -76.18 157.87 32.27 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.726 0.81 . . . . 0.0 113.086 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -68.51 -12.03 60.68 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.854 1.662 . . . . 0.0 113.636 168.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 42.6 m-70 -119.6 -178.69 3.68 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.484 1.513 . . . . 0.0 112.895 -170.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -136.88 124.95 22.9 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.981 2.112 . . . . 0.0 110.639 178.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 58.28 93.05 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 127.185 2.194 . . . . 0.0 113.946 -178.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 28.9 tp -64.01 110.96 2.31 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.666 1.587 . . . . 0.0 111.814 178.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -107.48 100.41 9.84 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.204 1.802 . . . . 0.0 110.425 174.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 22.1 p -91.62 -7.09 51.06 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 126.165 1.786 . . . . 0.0 114.044 178.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 20.2 t70 64.61 -6.79 0.28 Allowed 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 128.244 2.618 . . . . 0.0 116.642 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 54.8 m 31.91 73.13 0.06 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 129.051 2.94 . . . . 0.0 115.347 171.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 82.6 p -114.62 158.28 40.65 Favored Pre-proline 0 N--CA 1.476 0.832 0 C-N-CA 124.591 1.156 . . . . 0.0 113.907 -173.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -57.64 -22.64 53.15 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.778 2.985 . . . . 0.0 115.456 175.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -70.72 -23.42 62.45 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.95 1.3 . . . . 0.0 113.832 178.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -76.3 167.97 20.9 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -174.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -120.88 1.1 10.43 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -157.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.998 0 C-N-CA 125.926 1.691 . . . . 0.0 111.022 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 147' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.306 0 C5'-C4'-C3' 111.335 -2.776 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 148' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.377 1 O4'-C1'-N19 113.273 5.073 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 149' ' ' ' C' . . . . . 0.406 ' C6 ' ' CD2' ' A' ' 62' ' ' HIS . . . . . . . . 0 O4'--C4' 1.422 -2.586 0 O4'-C1'-N19 111.908 3.708 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 150' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.28 2 O4'-C1'-N19 114.881 6.681 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 151' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.544 2.618 0 C4'-C3'-C2' 99.8 -2.9 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 152' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.166 0 O4'-C1'-N19 111.177 2.977 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.642 0 N-CA-C 111.823 -0.511 . . . . 0.0 111.823 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -144.77 151.51 38.95 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.534 1.533 . . . . 0.0 111.511 178.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 11.0 m -71.69 29.44 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 127.188 2.195 . . . . 0.0 114.531 178.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 31.9 mtp85 42.03 54.34 4.07 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 127.592 2.357 . . . . 0.0 112.06 -169.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.5 m 57.31 -82.22 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 128.319 2.648 . . . . 0.0 113.952 -169.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 55.55 -67.91 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 128.78 2.832 . . . . 0.0 114.917 -170.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 160.77 -78.21 0.17 Allowed Glycine 0 CA--C 1.53 0.98 0 C-N-CA 126.731 2.11 . . . . 0.0 110.178 174.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.1 t -147.84 76.97 10.43 Favored Pre-proline 0 N--CA 1.479 0.989 0 C-N-CA 126.786 2.034 . . . . 0.0 107.614 169.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -104.97 19.05 0.14 Allowed 'Trans proline' 0 CA--C 1.543 0.974 0 C-N-CA 123.734 2.956 . . . . 0.0 114.222 -152.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.1 t -43.08 118.18 1.23 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.882 1.673 . . . . 0.0 114.785 -159.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 25.8 mtp180 61.5 -8.54 0.09 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 128.836 2.854 . . . . 0.0 117.839 171.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.3 3.9 p -104.81 130.3 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 120.906 1.685 . . . . 0.0 113.409 175.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.8 mp -103.21 155.21 5.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 127.617 2.367 . . . . 0.0 108.103 169.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.427 ' CD2' ' C6 ' ' B' ' 149' ' ' ' C' . 3.1 t-80 -126.93 140.96 51.94 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.801 2.04 . . . . 0.0 111.024 177.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.6 mt -120.75 136.63 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 128.309 2.644 . . . . 0.0 109.857 -170.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.6 mtt180 -97.19 176.65 5.85 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 120.517 1.508 . . . . 0.0 111.02 172.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp 45.34 35.79 2.01 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 127.739 2.415 . . . . 0.0 117.068 159.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.8 mp -52.03 157.42 2.16 Favored Pre-proline 0 CA--C 1.559 1.303 0 C-N-CA 124.771 1.228 . . . . 0.0 110.912 165.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -42.0 -65.72 0.18 Allowed 'Trans proline' 0 CA--C 1.537 0.648 1 C-N-CA 126.033 4.488 . . . . 0.0 115.385 177.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 pt -160.54 -55.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 130.262 3.425 . . . . 0.0 107.898 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -145.99 -9.47 0.52 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.31 1.444 . . . . 0.0 114.508 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.456 HG21 ' H ' ' A' ' 71' ' ' THR 0.28 1.7 p 45.14 -154.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 127.611 2.364 . . . . 0.0 112.997 -178.616 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.456 ' H ' HG21 ' A' ' 70' ' ' VAL . 4.0 t -137.43 143.0 41.63 Favored 'General case' 0 C--O 1.238 0.499 0 O-C-N 120.396 -1.44 . . . . 0.0 110.466 160.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -58.46 -33.41 69.71 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.763 177.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -56.59 -41.3 89.16 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 123.953 0.787 . . . . 0.0 112.96 175.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -64.53 -55.83 18.0 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.815 0.846 . . . . 0.0 111.11 171.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.7 t -61.05 -44.22 97.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -173.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.9 pp -69.44 -32.65 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 O-C-N 120.301 -1.499 . . . . 0.0 112.652 175.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.6 p -64.28 -21.23 66.52 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 119.738 1.153 . . . . 0.0 112.214 173.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 86.8 mt -91.6 -16.14 27.55 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 173.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -90.02 -22.78 34.52 Favored Glycine 0 CA--C 1.538 1.509 0 CA-C-N 119.144 0.884 . . . . 0.0 113.214 168.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.0 mt -73.37 -14.98 0.25 Allowed Pre-proline 0 CA--C 1.543 0.677 0 N-CA-C 119.314 3.079 . . . . 0.0 119.314 -175.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -60.5 -1.53 1.49 Allowed 'Trans proline' 0 C--N 1.348 0.525 0 CA-C-N 123.152 2.162 . . . . 0.0 116.62 168.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -122.05 -53.62 1.94 Allowed 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 114.698 1.369 . . . . 0.0 114.698 -168.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -144.06 -106.57 0.54 Allowed Glycine 0 C--N 1.337 0.598 0 C-N-CA 124.149 0.88 . . . . 0.0 111.985 -178.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 13.7 tptm -143.41 -7.52 0.78 Allowed 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 116.805 2.15 . . . . 0.0 116.805 -174.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 101' ' ' MET . 0.1 OUTLIER 30.26 87.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 129.029 2.932 . . . . 0.0 113.37 -176.782 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 24.1 m -55.42 -42.3 73.94 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 127.378 2.271 . . . . 0.0 111.695 -175.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -149.72 169.53 20.83 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.4 pp -139.49 171.95 13.51 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.97 1.708 . . . . 0.0 112.189 155.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -144.18 151.95 40.22 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.176 1.79 . . . . 0.0 108.476 173.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 5.1 mtt -128.77 103.52 7.11 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.326 1.05 . . . . 0.0 111.924 -175.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -74.43 96.02 2.82 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.927 1.291 . . . . 0.0 110.878 172.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 49.4 mttp -61.17 -19.18 61.26 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 171.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -53.33 -61.07 7.33 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 126.379 1.942 . . . . 0.0 114.968 -177.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.34 27.06 4.79 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.632 1.973 . . . . 0.0 112.239 -175.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 59.45 48.5 9.78 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.723 2.009 . . . . 0.0 113.709 -177.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . 0.28 0.0 OUTLIER -117.59 176.14 5.31 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.042 0.937 . . . . 0.0 111.935 176.838 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -166.48 165.81 16.73 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 120.276 -1.515 . . . . 0.0 111.018 -174.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 4.2 m-30 -112.46 157.37 21.17 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.908 1.683 . . . . 0.0 108.484 166.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 8.6 tt -143.62 108.32 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 126.111 1.764 . . . . 0.0 107.618 170.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -115.34 131.91 56.78 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.846 2.058 . . . . 0.0 112.014 -166.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.443 ' HA ' ' HA ' ' A' ' 85' ' ' VAL 0.292 1.2 tpp -130.46 153.5 48.72 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 116.835 2.161 . . . . 0.0 116.835 -161.498 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.0 -9.2 51.23 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.182 1.793 . . . . 0.0 114.675 -165.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -148.76 143.89 26.68 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.459 1.504 . . . . 0.0 110.111 -177.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -66.54 -32.76 74.31 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.221 1.008 . . . . 0.0 111.726 176.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -71.83 -47.44 53.16 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.346 0.658 . . . . 0.0 112.09 177.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.79 -46.47 87.48 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 122.83 0.452 . . . . 0.0 110.619 175.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.22 -40.65 82.0 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -60.77 -46.43 90.48 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.851 -0.531 . . . . 0.0 111.102 171.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -63.3 -29.09 70.48 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 120.421 -1.425 . . . . 0.0 111.198 171.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 10.4 ttp -67.06 -52.11 46.27 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 120.13 1.332 . . . . 0.0 110.048 -177.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.74 -40.51 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 124.547 1.139 . . . . 0.0 111.85 176.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -71.29 -44.07 65.91 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.751 0.82 . . . . 0.0 111.824 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -48.42 -38.66 20.22 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.454 1.501 . . . . 0.0 111.629 166.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -85.98 -22.26 27.42 Favored 'General case' 0 N--CA 1.445 -0.715 0 O-C-N 120.649 -1.282 . . . . 0.0 113.248 -175.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.08 -15.89 57.54 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.984 0.897 . . . . 0.0 111.107 171.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.7 -59.43 2.79 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 128.932 2.893 . . . . 0.0 111.045 169.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.2 p -78.01 -48.92 22.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 124.474 1.11 . . . . 0.0 112.43 -158.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.5 m 28.78 121.91 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.038 0 C-N-CA 129.044 2.938 . . . . 0.0 114.789 -138.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -80.86 -7.65 13.34 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 121.789 1.659 . . . . 0.0 115.002 -167.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 4.1 t 28.88 85.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 C-N-CA 130.239 3.416 . . . . 0.0 114.041 173.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.645 ' H ' HD13 ' A' ' 126' ' ' ILE 0.268 9.7 tt -106.95 -23.6 12.29 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 118.01 -1.476 . . . . 0.0 112.507 -121.126 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.35 -6.68 11.25 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.633 1.173 . . . . 0.0 113.997 148.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 139.74 11.51 0.72 Allowed Glycine 0 CA--C 1.536 1.364 0 N-CA-C 118.059 1.984 . . . . 0.0 118.059 -169.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.8 155.75 69.06 Favored Pre-proline 0 C--N 1.346 0.417 0 CA-C-N 120.771 2.286 . . . . 0.0 112.999 172.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.04 152.72 49.68 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.985 2.456 . . . . 0.0 113.674 -177.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.645 HD13 ' H ' ' A' ' 121' ' ' LEU . 29.8 mm -117.74 -53.88 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 123.646 0.778 . . . . 0.0 112.917 -163.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 62.13 151.14 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.975 2.11 . . . . 0.0 115.255 -170.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.45 157.06 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 125.914 1.686 . . . . 0.0 110.799 174.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -147.75 166.06 28.65 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.384 1.474 . . . . 0.0 109.453 155.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -55.64 146.89 19.58 Favored 'General case' 0 CA--C 1.547 0.858 0 O-C-N 121.353 -0.842 . . . . 0.0 111.303 158.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 29.4 t -73.39 161.48 30.4 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.669 1.187 . . . . 0.0 113.673 -175.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -73.03 -10.88 60.27 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.139 1.376 . . . . 0.0 113.573 167.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 57.7 m-70 -115.46 172.35 7.16 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.441 1.497 . . . . 0.0 112.403 -172.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -122.02 110.04 15.31 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 126.576 1.95 . . . . 0.0 109.728 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 61.88 167.94 0.11 Allowed 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 126.592 1.957 . . . . 0.0 113.924 -166.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 22.7 tp -132.19 97.87 4.25 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 128.617 2.767 . . . . 0.0 112.521 -172.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -99.33 93.27 5.83 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 127.601 2.361 . . . . 0.0 111.156 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 16.7 p -94.57 -18.72 21.14 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 115.908 1.818 . . . . 0.0 115.908 -171.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -126.64 -59.49 1.28 Allowed 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -163.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 49.3 m 49.26 36.3 9.1 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.309 1.443 . . . . 0.0 114.064 -170.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 25.5 p -67.45 155.63 90.51 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 125.584 1.554 . . . . 0.0 112.733 178.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -58.08 161.59 13.11 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.394 2.73 . . . . 0.0 114.123 173.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -135.75 -38.91 0.72 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.904 1.682 . . . . 0.0 111.573 170.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -68.41 167.08 15.4 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.141 1.776 . . . . 0.0 112.453 165.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -73.05 179.15 3.92 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.875 1.27 . . . . 0.0 112.638 169.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 75.2 ttt-85 . . . . . 0 N--CA 1.48 1.042 0 C-N-CA 125.722 1.609 . . . . 0.0 114.013 177.673 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 147' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.196 0 O4'-C1'-N19 110.849 2.649 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 148' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.422 0 O4'-C1'-N19 111.036 2.836 . 0.324 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 149' ' ' ' C' . . . . . 0.427 ' C6 ' ' CD2' ' A' ' 62' ' ' HIS . . . . . . . . 0 O4'--C4' 1.422 -2.59 0 O4'-C1'-N19 111.659 3.459 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 150' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.291 2 O4'-C1'-N19 113.262 5.062 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 151' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.386 0 C4'-C3'-C2' 98.991 -3.709 . 0.01 1g . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 152' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.122 1 O4'-C1'-N19 112.588 4.388 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.559 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -125.52 4.57 7.59 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.658 1.583 . . . . 0.0 114.319 -171.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 56.0 p -61.75 -29.99 70.49 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.686 1.594 . . . . 0.0 114.688 -175.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -77.93 73.73 4.49 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.668 1.587 . . . . 0.0 110.877 175.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 68.1 m -74.76 -7.3 52.94 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -114.23 -72.32 0.7 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.765 1.226 . . . . 0.0 112.307 -175.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.07 68.08 1.13 Allowed Glycine 0 CA--C 1.531 1.042 0 C-N-CA 124.644 1.116 . . . . 0.0 111.932 175.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 36.8 t 45.49 72.15 1.32 Allowed Pre-proline 0 N--CA 1.481 1.101 0 C-N-CA 127.656 2.382 . . . . 0.0 110.933 -170.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -93.59 -179.79 0.89 Allowed 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 124.624 3.549 . . . . 0.0 114.185 -156.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.3 t -145.77 -157.09 0.76 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.19 1.396 . . . . 0.0 111.65 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 44.4 mtp180 -55.11 -9.21 0.37 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 130.121 3.368 . . . . 0.0 119.474 -158.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.409 7.2 p -101.26 132.27 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 CA-C-N 122.404 2.366 . . . . 0.0 113.495 170.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 26.0 mt -111.22 153.71 12.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 128.287 2.635 . . . . 0.0 107.696 172.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -124.14 146.99 48.29 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.874 1.27 . . . . 0.0 111.446 178.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.1 mt -126.27 142.76 41.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 127.367 2.267 . . . . 0.0 109.977 -173.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.09 172.55 8.16 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 126.904 2.082 . . . . 0.0 112.41 170.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 67.13 19.51 10.4 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 126.456 1.902 . . . . 0.0 114.529 175.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.2 mp -54.02 154.95 6.92 Favored Pre-proline 0 CA--C 1.556 1.174 0 C-N-CA 122.791 0.437 . . . . 0.0 111.897 171.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -48.75 -58.4 1.78 Allowed 'Trans proline' 0 CA--C 1.536 0.596 1 C-N-CA 125.454 4.102 . . . . 0.0 114.651 175.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 pt -171.6 -53.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 131.372 3.869 . . . . 0.0 108.428 -178.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -147.27 -10.13 0.43 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 126.096 1.758 . . . . 0.0 113.701 -171.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.293 5.0 p 40.47 -136.64 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 127.262 2.225 . . . . 0.0 112.251 -177.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 t -143.32 133.99 25.12 Favored 'General case' 0 C--O 1.241 0.618 0 O-C-N 120.846 -1.159 . . . . 0.0 109.175 156.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.59 -30.21 68.5 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.335 -178.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -60.31 -36.59 91.32 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.938 1.256 . . . . 0.0 113.405 174.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -66.23 -52.25 49.63 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 118.153 0.976 . . . . 0.0 110.814 170.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.0 t -63.58 -42.29 95.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -174.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.3 pp -72.92 -32.43 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 O-C-N 120.168 -1.583 . . . . 0.0 113.131 175.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 36.2 t -62.38 -27.31 68.99 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 119.038 0.836 . . . . 0.0 110.852 171.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 31.3 mt -86.53 -15.67 39.27 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 173.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -92.43 -19.59 37.85 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.887 1.232 . . . . 0.0 113.599 172.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.5 mt -65.11 -46.08 73.02 Favored Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 116.808 2.151 . . . . 0.0 116.808 -171.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.61 -4.03 0.74 Allowed 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 124.657 3.571 . . . . 0.0 118.496 178.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -104.92 -33.8 8.25 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -165.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -160.99 -78.34 0.03 OUTLIER Glycine 0 C--N 1.331 0.262 0 C-N-CA 125.785 1.659 . . . . 0.0 109.032 176.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -150.96 -13.79 0.22 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 116.678 2.103 . . . . 0.0 116.678 170.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.2 m 29.49 171.73 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.246 0 CA-C-O 123.262 1.506 . . . . 0.0 114.829 -127.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.3 t -124.27 -26.81 3.89 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 119.16 -2.212 . . . . 0.0 112.435 163.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -162.22 166.28 25.7 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 172.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -140.43 166.85 23.58 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.656 1.582 . . . . 0.0 113.411 159.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.13 151.44 40.7 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 128.073 2.549 . . . . 0.0 108.662 -177.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 6.4 mtt -127.45 111.9 14.36 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.258 1.023 . . . . 0.0 111.132 -179.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -73.31 72.4 1.28 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.689 1.196 . . . . 0.0 111.102 175.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -57.79 125.36 22.69 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.467 1.107 . . . . 0.0 110.75 175.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 96.58 -8.72 66.41 Favored Glycine 0 CA--C 1.537 1.458 0 C-N-CA 125.242 1.401 . . . . 0.0 115.56 -173.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.94 -9.14 10.13 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 119.343 1.571 . . . . 0.0 113.693 169.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.2 m120 59.76 39.67 20.54 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.305 1.842 . . . . 0.0 112.806 -174.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -121.82 172.64 8.02 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.232 1.013 . . . . 0.0 111.325 -179.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -159.75 165.38 32.6 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.654 1.582 . . . . 0.0 111.336 178.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -115.44 150.39 36.52 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 126.498 1.919 . . . . 0.0 107.638 166.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 16.2 tt -134.92 98.93 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 125.046 1.339 . . . . 0.0 108.659 167.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -85.49 131.67 34.33 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 127.495 2.318 . . . . 0.0 110.974 176.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . 0.283 11.6 tpp -120.27 155.81 32.5 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 -170.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.72 -22.0 64.36 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -170.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.91 147.64 37.4 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.168 0.987 . . . . 0.0 110.96 -175.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -66.04 -38.53 88.63 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.047 0.539 . . . . 0.0 111.843 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -71.9 -40.71 68.67 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 178.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -54.67 -50.52 68.0 Favored 'General case' 0 C--O 1.219 -0.545 0 C-N-CA 122.997 0.519 . . . . 0.0 110.607 170.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.59 -37.88 73.95 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -178.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -55.92 -47.87 76.72 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.45 1.023 . . . . 0.0 110.875 169.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -66.39 -32.04 73.18 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-O 118.345 -0.836 . . . . 0.0 111.649 173.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 13.3 ttp -70.41 -45.79 65.22 Favored 'General case' 0 C--N 1.345 0.388 0 C-N-CA 125.069 1.348 . . . . 0.0 110.588 -176.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -67.79 -41.11 84.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 124.183 0.993 . . . . 0.0 111.745 177.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -68.52 -44.92 73.59 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.299 0.64 . . . . 0.0 110.564 178.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -47.14 -45.23 22.4 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.375 1.47 . . . . 0.0 111.98 166.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -82.23 -16.66 48.81 Favored 'General case' 0 N--CA 1.456 -0.128 0 O-C-N 121.054 -1.029 . . . . 0.0 112.64 -176.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 92.8 m -80.57 -14.63 58.04 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.364 1.065 . . . . 0.0 110.653 170.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.33 -54.53 3.02 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 128.809 2.843 . . . . 0.0 113.229 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 10.9 p -71.46 -35.82 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 127.171 2.189 . . . . 0.0 114.274 -156.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.415 ' CG2' ' H ' ' A' ' 126' ' ' ILE . 0.2 OUTLIER -2.51 115.91 0.01 OUTLIER Pre-proline 0 N--CA 1.486 1.347 0 C-N-CA 127.754 2.422 . . . . 0.0 116.875 -125.876 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -76.16 -18.88 15.98 Favored 'Trans proline' 0 CA--C 1.547 1.166 0 C-N-CA 123.506 2.804 . . . . 0.0 113.095 -167.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 6.4 t 60.9 104.03 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 130.072 3.349 . . . . 0.0 113.057 -178.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.6 tt -65.5 -66.93 0.48 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.583 1.153 . . . . 0.0 111.714 -158.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.07 66.56 1.24 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.248 1.419 . . . . 0.0 110.054 168.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 86.04 12.37 71.2 Favored Glycine 0 CA--C 1.54 1.654 0 C-N-CA 124.628 1.109 . . . . 0.0 114.985 -178.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -136.18 141.47 36.31 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 126.564 1.945 . . . . 0.0 109.399 177.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -56.68 166.44 3.72 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 123.579 2.853 . . . . 0.0 112.65 171.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.415 ' H ' ' CG2' ' A' ' 118' ' ' THR . 0.8 OUTLIER -125.23 146.38 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.388 1.075 . . . . 0.0 110.124 -174.957 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -128.94 95.17 4.01 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.28 -1.327 . . . . 0.0 109.039 -153.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.12 151.49 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 124.682 1.193 . . . . 0.0 112.953 -173.225 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -156.66 170.02 23.37 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.38 1.072 . . . . 0.0 109.976 147.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -52.34 149.28 5.71 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 120.853 -1.154 . . . . 0.0 112.525 170.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 30.3 t -70.64 158.53 36.03 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.182 0.993 . . . . 0.0 112.381 179.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -63.34 -15.27 56.89 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.826 1.25 . . . . 0.0 112.859 163.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 28.2 m-70 -117.61 -179.83 3.85 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 127.354 2.262 . . . . 0.0 111.206 -175.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -130.81 11.87 5.22 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.73 1.612 . . . . 0.0 113.398 -173.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -167.76 150.95 5.98 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.895 2.078 . . . . 0.0 110.571 -166.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 55.9 tp -140.07 -62.47 0.51 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.019 1.328 . . . . 0.0 113.207 177.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.4 ptmm? 28.37 69.73 0.07 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 128.969 2.907 . . . . 0.0 116.455 178.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 41.7 p -72.38 -5.58 37.44 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -63.15 -16.97 61.8 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.375 1.87 . . . . 0.0 115.795 -172.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 19.7 m -73.72 35.94 0.09 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 127.071 2.148 . . . . 0.0 115.53 -175.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 77.8 p -74.21 162.99 71.43 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 125.936 1.695 . . . . 0.0 113.52 176.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.89 164.15 10.33 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 124.09 3.193 . . . . 0.0 114.968 174.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -95.92 153.29 17.84 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.931 1.292 . . . . 0.0 111.988 173.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -74.26 -55.57 5.89 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.438 1.095 . . . . 0.0 112.654 177.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -77.51 -52.68 8.66 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.034 1.334 . . . . 0.0 112.908 -173.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 22.8 tpp85 . . . . . 0 N--CA 1.472 0.643 0 C-N-CA 125.017 1.327 . . . . 0.0 110.925 179.469 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 147' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.244 0 C5'-C4'-C3' 112.154 -2.231 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 148' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.782 0 O4'-C4'-C3' 109.671 2.979 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 149' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.526 0 N19-C1'-C2' 107.683 -3.573 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 150' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.213 2 O4'-C1'-N19 113.799 5.599 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 151' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.537 2.073 1 O4'-C1'-N19 112.655 4.455 . 0.132 &a . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 152' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.201 1 O4'-C1'-N19 113.715 5.515 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.535 0 N-CA-C 111.955 -0.458 . . . . 0.0 111.955 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -133.42 54.81 1.93 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.432 1.493 . . . . 0.0 110.955 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.7 m -61.18 -7.65 2.91 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 127.015 2.126 . . . . 0.0 116.431 -168.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -58.66 -17.62 23.97 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 126.473 1.909 . . . . 0.0 114.661 173.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.0 t -138.81 152.7 48.1 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.93 1.692 . . . . 0.0 111.33 168.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -80.9 -11.13 59.63 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.752 1.221 . . . . 0.0 113.518 171.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.61 43.42 8.44 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.324 0.964 . . . . 0.0 113.55 176.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.4 t 51.75 84.8 0.2 Allowed Pre-proline 0 N--CA 1.478 0.927 0 C-N-CA 127.949 2.5 . . . . 0.0 110.825 -171.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -106.96 9.28 0.16 Allowed 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 123.481 2.787 . . . . 0.0 116.108 -149.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.2 m -4.66 107.49 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 130.443 3.497 . . . . 0.0 117.887 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 40.6 mtm-85 81.5 -6.53 1.52 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 128.361 2.665 . . . . 0.0 117.484 152.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.421 HG23 ' CD2' ' A' ' 98' ' ' PHE . 2.5 p -118.22 136.57 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 CA-C-N 120.297 1.408 . . . . 0.0 113.125 163.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 10.9 mt -110.86 147.61 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 126.987 2.115 . . . . 0.0 108.795 168.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -110.7 116.59 31.57 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.295 1.438 . . . . 0.0 110.601 175.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 8.9 mt -89.53 134.3 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 126.505 1.922 . . . . 0.0 108.416 175.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -123.38 168.85 11.98 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 126.425 1.89 . . . . 0.0 112.248 171.019 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.5 mmtt 46.38 39.05 5.92 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 127.664 2.386 . . . . 0.0 114.418 -172.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.2 mt -60.55 174.22 0.54 Allowed Pre-proline 0 CA--C 1.556 1.207 0 C-N-CA 125.466 1.506 . . . . 0.0 111.043 158.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.56 -169.88 0.01 OUTLIER 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 124.55 3.5 . . . . 0.0 114.743 151.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 22.4 pt -58.81 -52.5 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.3 1.44 . . . . 0.0 112.644 -175.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -149.07 8.69 0.74 Allowed 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 127.103 2.161 . . . . 0.0 112.889 172.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.309 10.4 p 30.88 -125.46 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 C-N-CA 128.38 2.672 . . . . 0.0 113.294 -169.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.8 t -153.8 143.1 21.49 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 120.248 1.385 . . . . 0.0 110.237 167.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -55.86 -43.21 76.88 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.03 0.932 . . . . 0.0 112.329 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.03 -42.79 61.46 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 124.074 0.845 . . . . 0.0 112.907 178.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -64.94 -53.42 46.62 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.726 0.81 . . . . 0.0 111.894 172.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 83.5 t -59.5 -48.81 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 123.506 0.722 . . . . 0.0 112.442 -175.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.7 pp -70.01 -35.34 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 O-C-N 120.654 -1.279 . . . . 0.0 112.403 178.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.0 m -69.52 -20.85 63.69 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 119.714 1.143 . . . . 0.0 111.82 175.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.2 mt -79.48 -24.5 42.29 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 170.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -94.37 -21.6 26.68 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-N 119.061 0.846 . . . . 0.0 115.161 174.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.5 mt -59.95 -43.02 93.56 Favored Pre-proline 0 CA--C 1.538 0.514 0 N-CA-C 117.113 2.264 . . . . 0.0 117.113 -169.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.54 -6.18 1.44 Allowed 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.88 3.053 . . . . 0.0 116.981 174.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -104.03 -36.08 7.86 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 -167.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -153.03 -108.19 0.35 Allowed Glycine 0 C--N 1.336 0.54 0 CA-C-O 122.763 1.202 . . . . 0.0 111.846 172.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 7.0 tppt? -149.53 122.22 8.63 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 130.42 3.488 . . . . 0.0 104.533 175.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . 0.288 21.6 t -129.06 84.71 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 CA-C-O 122.954 1.359 . . . . 0.0 109.213 -160.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 41.0 p -82.66 -17.21 45.36 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 127.524 2.33 . . . . 0.0 113.008 -162.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -141.51 160.16 40.73 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 174.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -146.21 175.73 10.28 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.575 1.95 . . . . 0.0 110.773 158.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.48 153.43 34.61 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 125.728 1.611 . . . . 0.0 109.645 177.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 4.9 mtp -134.73 95.67 3.39 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.535 0.734 . . . . 0.0 111.628 -167.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.0 91.3 2.5 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.111 1.364 . . . . 0.0 110.947 173.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -63.85 -17.31 63.02 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -65.18 -51.5 49.53 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 125.394 1.473 . . . . 0.0 115.155 -174.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 29.0 mtmt -126.11 22.92 7.19 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 125.73 1.612 . . . . 0.0 112.852 -172.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 20.9 m120 62.45 49.54 4.04 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.661 1.984 . . . . 0.0 113.621 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . 0.281 0.0 OUTLIER -128.78 172.51 11.21 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 177.157 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -157.54 163.24 38.59 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 127.095 2.158 . . . . 0.0 109.614 -175.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.421 ' CD2' HG23 ' A' ' 60' ' ' VAL . 5.2 m-30 -107.84 154.59 21.33 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.98 1.312 . . . . 0.0 107.887 162.089 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.0 tt -134.51 123.82 43.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 124.404 1.082 . . . . 0.0 108.636 164.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -121.19 122.36 39.81 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.539 1.936 . . . . 0.0 111.769 -165.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -137.98 150.29 46.87 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 113.041 -1.891 . . . . 0.0 113.249 -164.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.98 -18.87 64.12 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 113.038 -1.892 . . . . 0.0 114.385 -155.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 30.2 p -138.54 141.47 39.3 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 123.32 1.533 . . . . 0.0 112.08 -175.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -57.54 -37.31 72.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 113.769 -1.559 . . . . 0.0 110.75 176.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -72.59 -41.39 65.69 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.05 -52.56 62.79 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 119.231 0.923 . . . . 0.0 110.02 170.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.63 -36.87 79.21 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -178.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -55.77 -50.83 69.36 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 118.83 0.741 . . . . 0.0 110.506 170.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -63.66 -35.33 80.19 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-O 118.19 -0.909 . . . . 0.0 111.178 174.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 8.5 ttp -66.93 -51.14 58.88 Favored 'General case' 0 C--N 1.343 0.291 0 CA-C-N 119.747 1.158 . . . . 0.0 110.802 -176.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.41 -39.58 85.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 124.673 1.189 . . . . 0.0 111.761 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -70.22 -45.15 67.16 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.472 0.709 . . . . 0.0 110.942 177.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -50.62 -33.88 23.94 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.678 1.191 . . . . 0.0 112.556 167.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -92.12 -11.74 34.85 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 119.929 -1.732 . . . . 0.0 113.619 -177.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.2 t -86.13 -14.39 44.32 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.964 0.887 . . . . 0.0 111.629 165.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.29 -58.76 3.1 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 128.448 2.699 . . . . 0.0 111.449 167.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -92.27 -49.33 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 123.709 0.804 . . . . 0.0 112.736 -155.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.6 m 45.68 125.9 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.04 0 C-N-CA 130.493 3.517 . . . . 0.0 113.701 -152.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -77.02 -13.88 17.16 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 121.775 1.65 . . . . 0.0 115.76 -171.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.1 t 30.11 92.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 130.032 3.333 . . . . 0.0 114.36 175.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.623 ' H ' HD13 ' A' ' 126' ' ' ILE . 1.4 tt -102.92 -57.31 2.07 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 113.489 -1.687 . . . . 0.0 109.419 -131.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.91 6.71 43.48 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.992 1.717 . . . . 0.0 113.61 165.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 103.23 20.54 11.02 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 126.061 1.791 . . . . 0.0 115.127 -178.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 10.8 tp60 -146.71 142.06 16.83 Favored Pre-proline 0 CA--C 1.538 0.489 0 CA-C-O 116.706 -1.616 . . . . 0.0 110.245 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -52.18 147.35 27.94 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 124.636 3.557 . . . . 0.0 116.115 -167.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.623 HD13 ' H ' ' A' ' 121' ' ' LEU . 3.2 mm -117.93 153.01 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 126.653 1.981 . . . . 0.0 108.629 -177.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 20.0 m-30 -122.54 142.37 50.67 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.979 0.912 . . . . 0.0 110.209 -175.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -131.88 147.88 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.019 1.327 . . . . 0.0 111.628 172.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -147.52 162.54 38.87 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.836 0.854 . . . . 0.0 109.977 145.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -53.35 147.68 10.06 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.47 0.708 . . . . 0.0 112.171 168.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 29.2 t -74.68 133.89 42.04 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 121.486 -0.758 . . . . 0.0 112.215 178.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -67.95 -19.87 65.0 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 176.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -69.59 -52.28 27.53 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -177.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 16.4 mtmm 79.15 152.65 0.13 Allowed 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 128.739 2.816 . . . . 0.0 111.461 -149.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 36.29 95.59 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 129.389 3.076 . . . . 0.0 117.258 164.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 27.6 tp -64.58 110.32 2.29 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.03 1.732 . . . . 0.0 111.596 172.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -97.74 141.7 30.42 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.239 1.416 . . . . 0.0 110.537 172.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 46.2 p -137.11 154.47 50.28 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.457 1.503 . . . . 0.0 111.641 -173.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -75.91 -65.26 0.93 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.171 0.988 . . . . 0.0 113.278 -170.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 37.3 p -74.99 159.92 31.19 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.6 1.56 . . . . 0.0 113.705 -177.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 67.9 p -78.67 161.07 70.67 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 124.805 1.242 . . . . 0.0 112.104 169.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -57.1 -47.02 24.74 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 123.472 2.782 . . . . 0.0 113.689 174.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -158.68 145.96 17.67 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.797 1.639 . . . . 0.0 111.197 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -81.0 94.55 6.58 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.27 1.028 . . . . 0.0 110.038 166.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -64.78 165.15 10.97 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -178.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 . . . . . 0 N--CA 1.475 0.788 0 C-N-CA 125.921 1.688 . . . . 0.0 111.974 174.143 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 147' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.338 0 O4'-C1'-N19 110.973 2.773 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 148' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.462 0 O4'-C1'-N19 111.324 3.124 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 149' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.142 0 N19-C1'-C2' 107.688 -3.57 . 0.165 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 150' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.203 1 O4'-C1'-N19 112.941 4.741 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 151' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.536 2.032 0 C5'-C4'-C3' 109.553 -3.964 . 0.204 1t . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 152' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.534 1.883 1 O4'-C1'-N19 113.361 5.161 . 0.742 2u . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.549 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -69.95 166.92 18.57 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.656 1.182 . . . . 0.0 113.735 175.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.8 m -142.19 155.54 45.29 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.124 1.77 . . . . 0.0 111.17 174.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -138.07 -62.94 0.57 Allowed 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.81 1.244 . . . . 0.0 113.795 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.8 m -65.36 -14.75 61.55 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 116.772 2.138 . . . . 0.0 116.772 -164.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -134.77 -63.64 0.69 Allowed 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 119.592 1.087 . . . . 0.0 112.791 -171.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 93.01 63.16 1.1 Allowed Glycine 0 N--CA 1.472 1.066 0 C-N-CA 124.476 1.036 . . . . 0.0 112.777 174.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 42.7 t 46.19 72.19 1.33 Allowed Pre-proline 0 N--CA 1.479 0.996 0 C-N-CA 127.598 2.359 . . . . 0.0 110.632 -170.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -91.41 170.7 3.08 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 124.763 3.642 . . . . 0.0 113.979 -155.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 25.1 m -140.35 -84.83 0.22 Allowed 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -164.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 25.1 mtp180 -125.86 -16.4 5.66 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 118.05 2.611 . . . . 0.0 118.05 -159.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.328 7.1 p -105.59 136.58 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 CA-C-N 121.138 1.79 . . . . 0.0 112.002 166.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.4 mt -113.41 155.33 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 128.773 2.829 . . . . 0.0 108.06 171.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -122.33 135.44 54.72 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.358 1.463 . . . . 0.0 110.377 177.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.4 mt -120.85 117.15 52.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 126.736 2.014 . . . . 0.0 109.291 -174.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.0 ptt180 -98.26 177.25 5.44 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 126.083 1.753 . . . . 0.0 112.917 177.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 59.63 25.9 14.87 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 127.192 2.197 . . . . 0.0 114.623 175.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 26.2 mt -64.45 150.94 92.53 Favored Pre-proline 0 CA--C 1.56 1.329 0 C-N-CA 122.927 0.491 . . . . 0.0 111.244 176.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -45.91 -66.52 0.15 Allowed 'Trans proline' 0 C--N 1.352 0.751 1 C-N-CA 125.313 4.009 . . . . 0.0 115.124 -178.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 12.4 pt -159.73 -41.87 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 130.177 3.391 . . . . 0.0 109.968 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -154.21 -11.48 0.14 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.949 1.3 . . . . 0.0 113.072 -169.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.295 14.4 p 31.29 -121.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 127.099 2.16 . . . . 0.0 111.296 -161.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.1 t -151.29 133.94 15.6 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 126.395 1.878 . . . . 0.0 106.439 155.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -69.28 -20.99 63.91 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.059 -1.026 . . . . 0.0 113.041 -173.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -58.6 -33.6 72.82 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 125.182 1.372 . . . . 0.0 113.665 164.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -75.58 -40.87 55.98 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 121.232 -1.158 . . . . 0.0 111.798 170.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.1 t -57.11 -46.15 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -84.73 -24.56 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 O-C-N 120.534 -1.354 . . . . 0.0 114.52 175.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.0 t -60.79 -31.97 71.33 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 120.187 1.358 . . . . 0.0 110.764 166.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 15.6 mt -74.22 -31.02 62.45 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 171.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -85.72 -19.25 58.45 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-N 119.438 1.017 . . . . 0.0 115.141 178.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.0 mt -70.27 -33.14 3.12 Favored Pre-proline 0 CA--C 1.541 0.605 0 N-CA-C 118.016 2.599 . . . . 0.0 118.016 -165.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -60.25 1.15 0.52 Allowed 'Trans proline' 0 C--N 1.35 0.605 0 C-N-CA 123.646 2.898 . . . . 0.0 116.809 170.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.403 ' CG ' ' HG3' ' A' ' 110' ' ' MET . 33.8 m-85 -116.02 -44.17 2.93 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -167.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -148.14 -108.7 0.51 Allowed Glycine 0 C--N 1.338 0.683 0 C-N-CA 123.873 0.749 . . . . 0.0 111.855 174.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 37.0 tptt -144.49 -12.98 0.59 Allowed 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 178.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' A' ' 101' ' ' MET 0.355 1.4 t 45.63 79.71 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 128.577 2.751 . . . . 0.0 114.553 164.914 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.1 m -66.01 -43.34 87.99 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 129.798 3.239 . . . . 0.0 111.811 -168.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -138.32 170.57 15.8 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 122.993 1.378 . . . . 0.0 113.362 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -146.63 173.27 12.49 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.153 2.181 . . . . 0.0 110.827 159.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.59 156.51 41.52 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.45 1.9 . . . . 0.0 109.495 176.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 8.1 mtt -129.32 110.56 12.03 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.605 1.162 . . . . 0.0 113.2 -178.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -77.29 97.87 4.99 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.407 1.883 . . . . 0.0 112.396 178.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -75.36 64.37 1.53 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.736 1.614 . . . . 0.0 111.738 167.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.52 -70.14 0.02 OUTLIER Glycine 0 N--CA 1.473 1.125 0 C-N-CA 124.863 1.22 . . . . 0.0 113.313 -177.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -114.5 26.6 10.09 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 127.06 2.144 . . . . 0.0 110.659 176.043 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 51.6 67.5 0.95 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.795 2.038 . . . . 0.0 113.043 -173.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.64 -178.47 4.38 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 177.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -155.17 164.22 39.13 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.72 2.408 . . . . 0.0 110.118 178.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -107.78 150.23 27.24 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.423 1.489 . . . . 0.0 108.146 161.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 19.2 tt -132.87 119.75 38.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.938 1.295 . . . . 0.0 108.356 165.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -121.47 133.55 55.05 Favored 'General case' 0 CA--C 1.513 -0.454 0 C-N-CA 125.947 1.699 . . . . 0.0 110.84 -165.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.444 ' HA ' ' HA ' ' A' ' 85' ' ' VAL 0.287 1.3 ptm -137.66 159.41 42.06 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 117.188 2.292 . . . . 0.0 117.188 -169.935 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.4 -18.07 64.37 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 127.035 2.134 . . . . 0.0 112.726 -165.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.11 143.59 34.4 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-O 123.504 1.621 . . . . 0.0 111.86 178.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -66.71 -32.93 74.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 113.492 -1.685 . . . . 0.0 110.762 177.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -72.56 -37.82 68.13 Favored 'General case' 0 N--CA 1.462 0.13 0 C-N-CA 123.763 0.825 . . . . 0.0 113.024 177.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -57.12 -59.25 5.37 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 119.033 0.833 . . . . 0.0 109.62 169.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.45 -39.41 87.47 Favored 'General case' 0 C--O 1.224 -0.26 0 N-CA-C 114.752 1.389 . . . . 0.0 114.752 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -56.01 -51.05 69.14 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.475 -0.766 . . . . 0.0 111.047 172.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -63.65 -32.3 73.73 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.536 -0.727 . . . . 0.0 111.231 175.032 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.403 ' HG3' ' CG ' ' A' ' 82' ' ' PHE . 5.1 ttp -71.01 -49.05 49.39 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.083 1.353 . . . . 0.0 111.13 -176.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -64.97 -40.17 88.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 124.43 1.092 . . . . 0.0 111.23 178.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -67.58 -46.3 73.06 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.798 0.839 . . . . 0.0 110.196 177.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -49.37 -41.72 39.94 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.18 1.392 . . . . 0.0 112.279 168.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -88.85 -11.46 44.67 Favored 'General case' 0 C--O 1.232 0.166 0 O-C-N 120.405 -1.435 . . . . 0.0 112.996 -176.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 70.6 m -81.04 -17.82 48.88 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.095 0.958 . . . . 0.0 110.195 167.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.62 -57.89 2.71 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 129.189 2.995 . . . . 0.0 113.294 176.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 5.9 p -79.44 -37.65 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -149.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 12.09 112.71 0.0 OUTLIER Pre-proline 0 N--CA 1.484 1.268 0 C-N-CA 130.095 3.358 . . . . 0.0 116.396 -137.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.424 ' HD2' ' CD1' ' A' ' 126' ' ' ILE . 5.0 Cg_exo -79.38 -20.37 9.7 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.979 3.119 . . . . 0.0 113.684 -168.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 6.9 t 64.29 99.98 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 128.742 2.817 . . . . 0.0 112.659 176.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 6.2 tt -70.61 -75.3 0.12 Allowed 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -155.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -92.08 -44.36 8.88 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.908 1.283 . . . . 0.0 109.512 175.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -177.35 18.61 0.04 OUTLIER Glycine 0 CA--C 1.538 1.472 0 C-N-CA 126.192 1.853 . . . . 0.0 112.948 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -144.39 156.8 57.06 Favored Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 126.67 1.988 . . . . 0.0 110.766 -170.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -59.58 164.16 11.78 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 122.502 2.135 . . . . 0.0 113.815 -179.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.424 ' CD1' ' HD2' ' A' ' 119' ' ' PRO . 0.4 OUTLIER -127.47 149.24 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.125 1.37 . . . . 0.0 110.018 -178.805 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -130.1 95.73 4.0 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.007 -153.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -108.28 144.64 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 124.134 0.974 . . . . 0.0 112.844 -177.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -145.17 159.01 43.66 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.632 1.973 . . . . 0.0 109.085 154.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -54.6 155.32 4.18 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 121.262 -0.899 . . . . 0.0 111.733 165.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 27.1 t -79.25 148.96 32.0 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 177.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -61.08 -31.07 70.74 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.404 1.481 . . . . 0.0 112.945 167.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 57.3 m-70 -89.33 -18.83 26.14 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.767 1.227 . . . . 0.0 113.407 -176.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . 0.28 62.6 pttt 48.94 9.07 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 130.181 3.392 . . . . 0.0 118.205 177.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 59.9 tt0 -164.98 124.94 1.89 Allowed 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 128.973 2.909 . . . . 0.0 110.463 172.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 22.7 tp -106.86 106.27 16.71 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.682 1.993 . . . . 0.0 110.857 -178.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt -131.17 84.26 2.17 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.791 1.636 . . . . 0.0 109.269 173.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 23.9 p -54.28 -36.84 64.08 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 126.664 1.986 . . . . 0.0 115.987 -159.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -128.94 5.74 5.43 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.537 1.535 . . . . 0.0 114.215 -173.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.3 t -69.12 154.87 41.34 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -168.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 68.6 m -69.13 168.57 15.06 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 127.726 2.41 . . . . 0.0 113.557 177.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -65.48 -177.2 0.64 Allowed 'Trans proline' 0 CA--C 1.547 1.154 0 C-N-CA 123.094 2.529 . . . . 0.0 111.801 158.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -65.59 74.1 0.06 Allowed 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 126.524 1.929 . . . . 0.0 113.841 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -65.87 166.88 10.43 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.09 1.756 . . . . 0.0 112.79 174.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -141.82 -39.63 0.37 Allowed 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 -173.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? . . . . . 0 N--CA 1.484 1.253 0 C-N-CA 126.217 1.807 . . . . 0.0 113.441 -177.685 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 147' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.263 0 O5'-C5'-C4' 113.62 2.443 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 148' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.492 1 O4'-C1'-N19 112.364 4.164 . 0.014 4p . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 149' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.541 2.404 0 N19-C1'-C2' 107.756 -3.527 . 0.087 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 150' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.85 1 O4'-C1'-N19 113.876 5.676 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 151' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.148 1 O4'-C1'-N19 113.362 5.162 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 152' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.543 2.515 1 O4'-C1'-N19 113.89 5.69 . 0.532 4s . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.447 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -62.1 139.61 58.44 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.431 1.092 . . . . 0.0 112.581 176.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 79.2 p -142.41 -8.76 0.86 Allowed 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 -173.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.1 ptp85 -66.72 161.48 23.42 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.599 1.16 . . . . 0.0 113.813 -177.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 98.4 p -160.63 154.66 22.89 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.198 1.799 . . . . 0.0 110.85 159.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -158.09 -170.51 3.17 Favored 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 128.481 2.713 . . . . 0.0 107.629 167.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -137.1 67.08 0.54 Allowed Glycine 0 N--CA 1.471 1.015 0 O-C-N 120.322 -1.486 . . . . 0.0 111.639 -176.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . 0.276 13.6 p 35.15 69.48 1.08 Allowed Pre-proline 0 N--CA 1.484 1.234 0 C-N-CA 127.343 2.257 . . . . 0.0 111.294 -163.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -91.52 164.1 3.53 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 123.318 2.679 . . . . 0.0 113.887 -138.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 58.2 m -134.88 -82.33 0.43 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 -165.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 25.2 mtp180 -124.19 -11.48 7.49 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 116.432 2.012 . . . . 0.0 116.432 -160.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.293 3.6 p -110.89 137.57 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 119.815 1.188 . . . . 0.0 112.162 172.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.0 mt -119.55 142.03 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 127.923 2.489 . . . . 0.0 108.369 175.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -112.51 148.39 34.56 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.937 1.695 . . . . 0.0 111.222 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 mp -133.12 138.98 50.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 126.227 1.811 . . . . 0.0 109.854 -176.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.67 176.61 5.11 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 125.6 1.56 . . . . 0.0 111.87 169.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.431 ' HG3' ' CD1' ' A' ' 127' ' ' TYR . 21.9 mmmt 73.98 8.64 4.76 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 127.015 2.126 . . . . 0.0 115.003 165.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.74 159.82 41.16 Favored Pre-proline 0 CA--C 1.546 0.804 0 CA-C-N 119.181 0.9 . . . . 0.0 112.937 -176.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -51.72 173.75 0.09 OUTLIER 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 124.385 3.39 . . . . 0.0 115.087 163.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 36.4 pt -60.95 -34.55 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 127.065 2.146 . . . . 0.0 113.221 -167.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -140.01 -10.59 1.14 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.822 1.649 . . . . 0.0 113.485 166.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.298 3.8 p 38.98 -139.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 127.599 2.359 . . . . 0.0 111.87 -169.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.7 t -147.97 139.54 23.74 Favored 'General case' 0 C--O 1.239 0.519 0 O-C-N 120.803 -1.185 . . . . 0.0 109.931 154.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -55.93 -32.63 63.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.621 173.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -61.28 -32.53 81.1 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 125.05 1.31 . . . . 0.0 112.871 175.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -67.19 -55.41 14.21 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 118.725 1.263 . . . . 0.0 110.648 167.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.2 t -57.66 -44.83 86.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -175.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.3 pp -81.33 -29.16 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 O-C-N 120.313 -1.492 . . . . 0.0 113.871 -179.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 18.1 t -63.75 -29.36 70.58 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 119.61 1.096 . . . . 0.0 110.55 168.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.0 mt -78.72 -20.69 49.45 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 172.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -101.45 -16.55 24.41 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-N 119.859 1.209 . . . . 0.0 116.116 176.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.9 mt -61.55 -52.57 68.76 Favored Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 117.171 2.286 . . . . 0.0 117.171 -172.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -75.2 39.52 0.61 Allowed 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 124.125 3.217 . . . . 0.0 113.974 -178.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -127.84 -36.65 1.99 Allowed 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 126.87 2.068 . . . . 0.0 111.902 177.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -152.76 -108.84 0.38 Allowed Glycine 0 CA--C 1.525 0.717 0 CA-C-O 122.774 1.208 . . . . 0.0 111.989 168.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 15.6 tptm -149.23 132.01 16.01 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 131.625 3.97 . . . . 0.0 103.726 173.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.416 ' CG2' ' HE2' ' A' ' 101' ' ' MET 0.313 14.3 t -128.1 92.56 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-N 120.666 1.576 . . . . 0.0 110.773 -163.666 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.5 t -80.82 -32.75 35.09 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 126.727 2.011 . . . . 0.0 112.825 -161.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -130.74 160.53 34.06 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 174.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -147.19 167.83 23.21 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 126.963 2.105 . . . . 0.0 110.102 166.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.76 152.09 34.67 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 125.288 1.435 . . . . 0.0 108.969 173.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 5.8 mtt -126.93 110.4 12.97 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.406 1.483 . . . . 0.0 110.267 177.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -72.1 79.65 0.95 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.62 1.168 . . . . 0.0 110.178 178.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -44.69 -47.97 10.63 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 127.549 2.339 . . . . 0.0 114.445 -168.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -79.79 -12.16 83.84 Favored Glycine 0 CA--C 1.535 1.317 0 N-CA-C 116.31 1.284 . . . . 0.0 116.31 -174.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -126.66 3.04 6.79 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 -173.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.0 m120 58.94 36.1 24.39 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.187 1.395 . . . . 0.0 113.918 -178.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -111.2 176.13 5.15 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.519 0.727 . . . . 0.0 111.095 175.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -158.03 167.36 30.11 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.708 1.603 . . . . 0.0 111.928 176.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 4.8 m-30 -118.72 152.62 35.81 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.966 2.106 . . . . 0.0 108.118 163.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 14.4 tt -135.41 127.19 46.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 124.778 1.231 . . . . 0.0 108.669 163.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -130.98 121.1 24.49 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.252 1.421 . . . . 0.0 112.929 -163.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.416 ' HE2' ' CG2' ' A' ' 85' ' ' VAL . 1.0 OUTLIER -129.22 162.62 27.43 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.12 -1.4 . . . . 0.0 113.696 -159.479 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.35 -12.57 60.09 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -158.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -143.18 142.47 31.45 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.177 1.391 . . . . 0.0 110.879 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -61.46 -33.41 73.7 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.742 175.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -75.74 -36.04 60.03 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 123.641 0.776 . . . . 0.0 112.987 178.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -56.82 -52.08 66.45 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-N 118.973 0.806 . . . . 0.0 110.642 168.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.94 -39.16 79.73 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -54.93 -48.41 73.16 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 118.754 0.706 . . . . 0.0 111.255 170.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -64.77 -32.5 74.22 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 121.242 -0.911 . . . . 0.0 111.46 175.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 7.5 ttp -65.86 -57.63 7.47 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.467 1.107 . . . . 0.0 109.686 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -57.97 -41.65 80.72 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.372 0 C-N-CA 124.95 1.3 . . . . 0.0 111.607 177.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -65.43 -42.9 91.94 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 118.897 0.771 . . . . 0.0 111.924 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -53.92 -37.43 63.83 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 118.61 0.641 . . . . 0.0 112.037 167.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -85.73 -13.88 47.0 Favored 'General case' 0 C--N 1.332 -0.182 0 O-C-N 120.263 -1.523 . . . . 0.0 113.192 -178.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 54.8 m -84.79 -15.62 44.3 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.144 1.377 . . . . 0.0 110.307 169.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.28 -49.04 11.22 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 128.464 2.706 . . . . 0.0 111.26 172.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -94.97 178.82 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 127.556 2.342 . . . . 0.0 111.754 -165.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.1 m -137.91 130.06 16.31 Favored Pre-proline 0 N--CA 1.477 0.876 0 O-C-N 120.985 -1.072 . . . . 0.0 109.212 129.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -83.44 -16.85 6.7 Favored 'Trans proline' 0 CA--C 1.547 1.157 0 C-N-CA 122.667 2.245 . . . . 0.0 112.753 -167.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 14.3 t 58.36 99.37 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 129.759 3.224 . . . . 0.0 113.498 177.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.6 tt -67.1 -62.6 1.35 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.285 1.034 . . . . 0.0 112.4 -156.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -125.56 4.41 7.57 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 126.722 2.009 . . . . 0.0 114.566 -179.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 124.5 9.26 5.51 Favored Glycine 0 CA--C 1.539 1.565 0 C-N-CA 125.119 1.342 . . . . 0.0 114.725 -160.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -139.66 144.33 38.74 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 126.854 2.061 . . . . 0.0 109.658 -176.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.99 166.23 7.29 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 123.576 2.851 . . . . 0.0 112.966 175.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -127.67 145.01 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.165 0.986 . . . . 0.0 111.056 -173.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.431 ' CD1' ' HG3' ' A' ' 65' ' ' LYS . 3.6 m-85 -126.26 79.66 1.86 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.105 -1.407 . . . . 0.0 109.441 -153.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -91.1 149.81 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 124.514 1.125 . . . . 0.0 112.688 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -145.37 159.42 43.09 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 128.235 2.614 . . . . 0.0 108.159 161.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -55.98 155.49 6.25 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 120.437 -1.415 . . . . 0.0 111.368 154.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 31.0 t -71.03 158.33 36.69 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.473 -0.767 . . . . 0.0 112.167 172.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -65.29 -11.76 44.83 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.857 1.263 . . . . 0.0 112.861 163.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 40.5 m-70 -116.05 -179.15 3.58 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 127.675 2.39 . . . . 0.0 110.726 -175.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -125.4 4.26 7.69 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 125.525 1.53 . . . . 0.0 114.4 -172.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -176.36 164.79 2.68 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 128.3 2.64 . . . . 0.0 109.111 -170.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 23.9 tp -137.15 91.87 2.66 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.035 1.734 . . . . 0.0 111.482 -174.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.7 91.48 6.54 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.436 1.095 . . . . 0.0 110.493 172.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 10.0 p -75.28 94.05 2.96 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.847 1.259 . . . . 0.0 109.933 173.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -55.12 -37.1 66.47 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 115.208 1.559 . . . . 0.0 115.208 -167.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 98.5 p -157.31 177.16 11.77 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.898 1.679 . . . . 0.0 111.936 176.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 66.9 m -110.93 143.18 27.76 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 124.947 1.299 . . . . 0.0 111.26 175.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -68.02 125.13 12.64 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.356 2.704 . . . . 0.0 112.024 -178.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -137.6 166.77 23.11 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.29 1.836 . . . . 0.0 111.113 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -135.39 166.03 24.11 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 126.019 1.727 . . . . 0.0 112.516 178.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -64.91 -25.64 67.97 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.729 1.612 . . . . 0.0 114.474 -179.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 11.8 ptm85 . . . . . 0 N--CA 1.476 0.835 0 C-N-CA 126.756 2.022 . . . . 0.0 112.127 176.137 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 147' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.406 0 C5'-C4'-C3' 110.635 -3.244 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 148' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.376 1 O4'-C1'-N19 112.277 4.077 . 0.024 2[ . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 149' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.508 0 N19-C1'-C2' 107.875 -3.453 . 0.056 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 150' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.167 2 O4'-C1'-N19 114.123 5.923 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 151' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.535 1.924 0 O4'-C1'-N19 111.735 3.535 . 0.092 1b . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 152' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.547 2.859 0 O5'-C5'-C4' 114.4 3.0 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.595 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -125.45 -3.43 7.34 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.663 1.585 . . . . 0.0 114.909 -174.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 79.7 p -87.33 177.98 6.98 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.446 1.898 . . . . 0.0 113.531 178.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -137.04 136.37 38.35 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 126.8 2.04 . . . . 0.0 110.725 177.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.7 m -63.13 -65.09 0.73 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.302 1.441 . . . . 0.0 114.68 -167.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -102.94 86.96 2.82 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.823 1.249 . . . . 0.0 111.621 178.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -82.94 -25.13 50.57 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 123.325 0.488 . . . . 0.0 113.917 170.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.9 p -161.21 72.43 2.62 Favored Pre-proline 0 N--CA 1.479 1.01 0 C-N-CA 126.875 2.07 . . . . 0.0 110.637 178.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER -93.5 -144.56 0.02 OUTLIER 'Trans proline' 0 CA--C 1.547 1.148 0 C-N-CA 124.702 3.602 . . . . 0.0 113.331 -159.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 44.3 t -144.45 177.69 8.47 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.564 1.545 . . . . 0.0 112.947 -169.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.44 -2.14 18.37 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.585 1.154 . . . . 0.0 113.596 167.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.312 7.4 p -85.11 131.11 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 119.396 0.998 . . . . 0.0 111.628 163.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.0 mt -110.72 144.99 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 127.785 2.434 . . . . 0.0 107.769 169.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.438 ' CD2' ' C6 ' ' B' ' 149' ' ' ' C' . 2.1 t-80 -108.21 150.49 27.19 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.993 1.317 . . . . 0.0 110.529 172.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 7.5 mt -127.56 142.27 44.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 125.888 1.675 . . . . 0.0 109.093 -173.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.26 170.06 11.14 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 128.579 2.752 . . . . 0.0 109.223 164.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.57 20.29 12.1 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.617 1.167 . . . . 0.0 113.989 176.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 37.5 mt -64.01 167.7 7.36 Favored Pre-proline 0 CA--C 1.542 0.673 0 C-N-CA 123.474 0.71 . . . . 0.0 110.908 162.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -54.41 172.29 0.33 Allowed 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.934 2.423 . . . . 0.0 113.981 156.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 21.7 pt -80.98 -18.6 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 127.614 2.366 . . . . 0.0 113.332 -179.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -144.97 12.17 1.41 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 127.347 2.259 . . . . 0.0 113.281 -164.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -55.22 151.37 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.8 t -101.27 148.54 25.0 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 122.398 1.094 . . . . 0.0 113.281 -173.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -50.45 -44.24 55.5 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.217 1.407 . . . . 0.0 111.432 174.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -58.36 -35.1 77.39 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 123.852 0.739 . . . . 0.0 113.349 -179.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -74.7 -44.04 52.07 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.456 1.103 . . . . 0.0 112.167 175.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 95.1 t -60.68 -51.61 71.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 123.168 0.587 . . . . 0.0 111.084 177.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.1 pp -69.12 -30.45 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 O-C-N 120.73 -1.231 . . . . 0.0 113.099 178.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 49.2 m -73.73 -16.66 61.18 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 119.288 0.949 . . . . 0.0 112.306 174.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 22.7 mt -86.44 -15.25 40.83 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.121 0.968 . . . . 0.0 113.291 165.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.427 ' HA2' ' SD ' ' A' ' 110' ' ' MET . . . -75.88 -33.09 51.81 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 124.311 0.958 . . . . 0.0 113.241 168.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 16.5 mt -80.22 -16.83 0.24 Allowed Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 119.923 3.305 . . . . 0.0 119.923 -159.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -61.07 -4.61 3.96 Favored 'Trans proline' 0 C--N 1.347 0.493 0 CA-C-N 122.919 2.078 . . . . 0.0 116.474 169.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.484 ' CD2' ' HG3' ' A' ' 110' ' ' MET . 34.2 m-85 -120.6 -43.66 2.48 Favored 'General case' 0 C--N 1.34 0.195 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 -166.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -142.38 -118.36 1.37 Allowed Glycine 0 CA--C 1.525 0.706 0 CA-C-O 122.648 1.138 . . . . 0.0 112.555 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 15.2 tptm -148.03 122.24 9.57 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 130.45 3.5 . . . . 0.0 104.363 179.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.403 ' CG2' ' HE2' ' A' ' 101' ' ' MET 0.28 19.6 t -130.36 82.49 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 CA-C-O 122.778 1.275 . . . . 0.0 109.213 -159.515 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 41.5 p -79.86 -16.4 55.47 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 127.433 2.293 . . . . 0.0 112.725 -163.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -142.17 158.3 43.9 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 173.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.24 170.23 16.69 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.693 2.397 . . . . 0.0 110.34 167.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.49 155.12 40.75 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.184 0.994 . . . . 0.0 109.805 174.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 4.0 mtp -132.55 94.15 3.36 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.353 0.661 . . . . 0.0 111.355 -168.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.07 66.74 1.66 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.57 1.148 . . . . 0.0 110.505 170.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 53.9 tttm -55.79 -34.38 65.24 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.538 1.535 . . . . 0.0 113.579 -169.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -64.18 -16.86 60.67 Favored Glycine 0 CA--C 1.54 1.603 0 C-N-CA 125.538 1.542 . . . . 0.0 116.075 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 18.9 mtmt -124.53 7.26 8.27 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.123 1.369 . . . . 0.0 114.216 -176.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.5 m120 58.92 34.03 23.39 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.786 1.235 . . . . 0.0 112.095 -168.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -117.87 164.47 15.0 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.723 0.809 . . . . 0.0 111.985 -175.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -158.06 168.98 25.6 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.684 1.593 . . . . 0.0 111.662 -179.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -114.8 157.76 22.8 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.105 1.762 . . . . 0.0 108.42 160.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 19.8 tt -140.45 122.06 14.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 125.084 1.354 . . . . 0.0 109.129 163.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -119.3 125.73 49.79 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 127.242 2.217 . . . . 0.0 111.253 -169.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.403 ' HE2' ' CG2' ' A' ' 85' ' ' VAL . 0.3 OUTLIER -128.87 160.06 33.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 113.276 -1.784 . . . . 0.0 114.129 -167.519 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.81 -20.44 61.84 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 -163.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 8.3 p -138.45 137.73 37.47 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.128 1.371 . . . . 0.0 110.988 -174.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -59.25 -34.67 72.5 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.199 175.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -73.27 -40.05 64.91 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.99 -52.52 63.9 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-N 119.491 1.041 . . . . 0.0 109.552 168.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.71 -37.1 79.25 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 -175.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -56.12 -52.23 65.06 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.779 0.718 . . . . 0.0 110.684 169.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -61.33 -32.18 72.06 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 118.931 -0.557 . . . . 0.0 111.324 174.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.484 ' HG3' ' CD2' ' A' ' 82' ' ' PHE . 13.4 ttp -73.48 -50.16 22.98 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-N 119.486 1.039 . . . . 0.0 111.918 -175.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -63.14 -35.34 71.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.168 0.987 . . . . 0.0 111.107 178.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -75.65 -41.58 53.73 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.381 1.072 . . . . 0.0 112.091 176.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -48.28 -52.95 19.0 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.509 1.124 . . . . 0.0 109.989 165.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -79.88 16.12 1.25 Allowed 'General case' 0 C--N 1.326 -0.423 0 O-C-N 118.932 -2.355 . . . . 0.0 113.044 178.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . 0.289 0.5 OUTLIER -118.63 -10.32 10.06 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 164.584 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.01 -43.05 14.31 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.273 1.829 . . . . 0.0 111.413 161.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 89.6 t -115.12 -57.9 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.386 1.074 . . . . 0.0 111.856 -144.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.0 m 70.89 135.04 0.04 OUTLIER Pre-proline 0 N--CA 1.485 1.315 0 C-N-CA 128.027 2.531 . . . . 0.0 112.234 -173.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -76.26 -22.49 12.64 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.256 1.971 . . . . 0.0 114.966 -176.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.9 t 36.37 89.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 129.802 3.241 . . . . 0.0 113.305 175.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.621 ' H ' HD13 ' A' ' 126' ' ' ILE . 2.4 tt -100.05 -66.09 0.93 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 113.783 -1.553 . . . . 0.0 109.597 -134.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -84.53 -9.6 58.19 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 159.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 110.34 55.42 0.53 Allowed Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.347 1.451 . . . . 0.0 113.22 -166.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -145.06 162.49 37.54 Favored Pre-proline 0 CA--C 1.541 0.631 0 CA-C-N 119.075 1.438 . . . . 0.0 112.931 156.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.34 100.22 0.15 Allowed 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 123.293 2.662 . . . . 0.0 111.973 168.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.621 HD13 ' H ' ' A' ' 121' ' ' LEU . 3.0 mm -77.75 138.24 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.303 1.041 . . . . 0.0 108.69 177.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 11.7 m-30 -109.3 128.6 55.22 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 120.674 -1.266 . . . . 0.0 110.667 -173.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.25 151.07 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.902 1.281 . . . . 0.0 111.888 178.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -158.27 160.8 37.47 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.158 1.783 . . . . 0.0 110.172 157.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -54.65 144.2 22.58 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.261 -0.899 . . . . 0.0 112.398 170.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 21.4 t -73.78 147.13 43.74 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.986 -0.447 . . . . 0.0 111.371 173.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 12.7 p30 -80.62 -9.24 59.8 Favored 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 113.977 1.102 . . . . 0.0 113.977 175.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -83.63 179.82 7.51 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.381 1.072 . . . . 0.0 112.608 174.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -113.06 97.25 6.4 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.794 2.038 . . . . 0.0 109.837 173.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 61.28 -174.97 0.13 Allowed 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.696 1.998 . . . . 0.0 112.558 -176.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 34.7 tp -135.14 99.36 4.24 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 126.413 1.885 . . . . 0.0 110.962 -170.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 50.8 tttp -98.55 111.51 23.85 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.719 1.608 . . . . 0.0 110.062 176.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 40.8 p -110.64 -1.58 16.72 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 126.021 1.729 . . . . 0.0 112.823 176.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -54.73 126.72 25.16 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.281 1.832 . . . . 0.0 112.692 177.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 61.0 m -136.93 170.74 15.6 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.758 2.023 . . . . 0.0 112.475 -175.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 32.0 m -59.73 154.32 47.41 Favored Pre-proline 0 N--CA 1.475 0.792 0 C-N-CA 125.097 1.359 . . . . 0.0 112.965 177.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -70.59 174.5 10.14 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 123.389 2.726 . . . . 0.0 112.728 176.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 63.99 8.99 4.27 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 126.96 2.104 . . . . 0.0 115.051 -177.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -139.27 164.34 30.08 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.854 2.062 . . . . 0.0 110.525 176.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -127.74 -172.31 2.65 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.719 1.608 . . . . 0.0 112.893 -178.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 23.4 ptt-85 . . . . . 0 N--CA 1.473 0.715 0 C-N-CA 127.374 2.27 . . . . 0.0 114.688 -178.796 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 147' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.168 0 C5'-C4'-C3' 111.247 -2.835 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 148' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.422 0 O4'-C1'-N19 111.895 3.695 . 0.0 OUTLIER alpha 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 149' ' ' ' C' . . . . . 0.438 ' C6 ' ' CD2' ' A' ' 62' ' ' HIS . . . . . . . . 0 O4'--C4' 1.425 -2.341 0 N19-C1'-C2' 107.972 -3.393 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 150' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.412 -3.38 1 O4'-C1'-N19 112.583 4.383 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 151' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.613 2.017 0 O4'-C1'-N19 110.873 2.673 . 0.0 OUTLIER '7D dist 1f' 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 152' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.278 0 O4'-C1'-N19 110.639 2.439 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.537 0 N-CA-C 111.714 -0.555 . . . . 0.0 111.714 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -122.95 65.32 0.97 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.697 1.599 . . . . 0.0 111.049 -177.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 45.5 m -70.45 150.39 46.26 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.059 1.344 . . . . 0.0 112.898 -179.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -130.2 158.97 38.25 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 126.294 1.838 . . . . 0.0 110.879 171.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.7 m -68.86 154.74 41.47 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.887 1.275 . . . . 0.0 113.002 178.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.02 -26.57 61.36 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 114.784 1.402 . . . . 0.0 114.784 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 132.66 -68.35 0.55 Allowed Glycine 0 CA--C 1.528 0.888 0 C-N-CA 125.5 1.524 . . . . 0.0 111.11 172.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.1 p -150.66 69.79 8.69 Favored Pre-proline 0 N--CA 1.477 0.895 0 C-N-CA 125.49 1.516 . . . . 0.0 110.591 169.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -97.02 172.03 0.8 Allowed 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 124.368 3.379 . . . . 0.0 113.863 -158.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.7 t -154.64 -159.45 0.95 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.313 1.045 . . . . 0.0 113.249 179.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.2 mtp180 -54.44 -13.51 0.95 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 131.536 3.935 . . . . 0.0 118.804 -173.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.408 HG23 ' CD2' ' A' ' 98' ' ' PHE 0.269 0.1 OUTLIER -81.94 122.45 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-N 120.885 1.675 . . . . 0.0 110.106 162.534 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.0 mp -87.18 135.38 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 156.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -102.61 144.37 31.1 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.888 1.275 . . . . 0.0 110.566 174.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.2 mt -129.94 140.71 48.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 126.158 1.783 . . . . 0.0 109.862 -176.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 5.4 ptt-85 -123.74 179.15 4.91 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 126.835 2.054 . . . . 0.0 112.281 173.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 58.64 17.94 5.46 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 127.083 2.153 . . . . 0.0 114.607 178.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.6 mp -50.29 156.83 1.32 Allowed Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 125.273 1.429 . . . . 0.0 113.15 178.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -45.3 -62.55 0.43 Allowed 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 125.075 3.85 . . . . 0.0 114.776 -179.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.5 pt -163.64 -52.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 131.324 3.85 . . . . 0.0 107.723 176.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -146.3 -11.31 0.48 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.567 1.547 . . . . 0.0 114.143 -176.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.301 2.9 p 42.4 -145.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 127.268 2.227 . . . . 0.0 112.148 -174.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.0 t -141.97 137.44 31.21 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 120.553 -1.342 . . . . 0.0 110.772 164.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -55.54 -39.35 70.45 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.367 1.067 . . . . 0.0 111.883 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.25 -38.28 56.51 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 125.111 1.339 . . . . 0.0 113.937 172.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -72.51 -48.12 43.09 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 121.449 -1.03 . . . . 0.0 112.405 174.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.3 t -58.63 -49.37 82.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-N 117.979 0.354 . . . . 0.0 111.701 -176.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.95 -31.43 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 O-C-N 120.86 -1.15 . . . . 0.0 114.001 177.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 48.7 m -71.42 -18.12 62.35 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 120.664 1.575 . . . . 0.0 111.433 176.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 29.6 mt -84.37 -24.17 29.8 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 167.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -86.36 -18.92 58.11 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-N 118.72 0.691 . . . . 0.0 114.168 175.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 13.0 mt -73.29 -18.1 0.34 Allowed Pre-proline 0 CA--C 1.548 0.872 0 N-CA-C 119.416 3.117 . . . . 0.0 119.416 -171.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -59.16 -2.42 1.24 Allowed 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.411 2.74 . . . . 0.0 118.083 174.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -120.83 -35.91 3.26 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 -169.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -151.73 -109.69 0.44 Allowed Glycine 0 C--N 1.337 0.638 0 CA-C-O 122.253 0.918 . . . . 0.0 112.51 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -152.89 129.08 10.46 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 129.408 3.083 . . . . 0.0 104.893 -176.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.455 ' CG2' ' HE2' ' A' ' 101' ' ' MET 0.304 11.9 t -135.24 81.92 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 120.161 1.346 . . . . 0.0 109.678 -165.562 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 58.9 p -79.64 -22.31 43.72 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 126.829 2.051 . . . . 0.0 112.436 -164.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 65.5 m-80 -136.03 156.0 49.38 Favored 'General case' 0 C--N 1.343 0.323 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 177.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -146.91 170.33 17.29 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.824 2.05 . . . . 0.0 110.044 162.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.01 153.93 45.77 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.837 1.655 . . . . 0.0 109.748 175.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 40.0 mtt -131.22 117.29 18.8 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.062 0.945 . . . . 0.0 110.908 178.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -76.2 69.67 2.76 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.754 1.222 . . . . 0.0 110.325 175.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -56.21 105.98 0.24 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.626 1.97 . . . . 0.0 111.327 -177.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 124.03 -15.97 7.77 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 126.077 1.798 . . . . 0.0 115.052 -176.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 10.6 mtmt -118.22 -2.21 11.21 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 119.142 1.471 . . . . 0.0 114.644 178.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.3 m120 60.05 46.9 10.26 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.0 1.72 . . . . 0.0 112.398 -173.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -131.8 165.76 23.08 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.44 0.696 . . . . 0.0 112.418 -179.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -157.82 163.26 38.19 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.131 1.372 . . . . 0.0 113.001 -178.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.408 ' CD2' HG23 ' A' ' 60' ' ' VAL . 4.5 m-30 -115.91 148.2 40.27 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 128.61 2.764 . . . . 0.0 106.287 166.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 6.4 tp -134.5 106.79 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 125.854 1.662 . . . . 0.0 108.874 170.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -102.93 109.38 20.91 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 128.602 2.761 . . . . 0.0 111.552 -167.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.455 ' HE2' ' CG2' ' A' ' 85' ' ' VAL . 16.1 ttm -107.02 158.5 17.0 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 114.095 -1.411 . . . . 0.0 112.695 -174.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.96 -21.23 60.1 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -163.098 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.9 p -138.15 147.43 43.89 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.805 0.842 . . . . 0.0 111.74 -175.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -64.92 -36.65 85.07 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.432 0.693 . . . . 0.0 112.15 179.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -72.35 -42.56 65.17 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 118.763 0.71 . . . . 0.0 112.817 179.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -57.73 -48.25 80.13 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 118.567 0.622 . . . . 0.0 110.071 172.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.16 -37.4 78.21 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -55.62 -51.89 65.64 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 121.339 -0.85 . . . . 0.0 110.876 169.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -64.81 -24.76 67.65 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-O 117.77 -1.109 . . . . 0.0 111.665 173.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 10.3 ttp -73.13 -48.51 34.92 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 120.514 1.506 . . . . 0.0 110.227 -178.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -65.56 -37.78 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 O-C-N 121.532 -0.73 . . . . 0.0 111.441 177.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -68.05 -46.48 71.0 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.869 0.868 . . . . 0.0 110.958 174.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -48.43 -42.27 31.82 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.026 1.73 . . . . 0.0 112.01 167.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -84.01 -17.7 39.58 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 120.843 -1.16 . . . . 0.0 112.563 -176.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 84.1 m -80.97 -14.63 57.78 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.514 1.126 . . . . 0.0 110.469 170.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.55 -58.18 2.36 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 129.766 3.226 . . . . 0.0 112.879 176.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 6.0 p -74.19 -35.66 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 126.683 1.993 . . . . 0.0 113.056 -158.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.464 ' CG2' ' H ' ' A' ' 126' ' ' ILE . 0.8 OUTLIER 4.09 114.57 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.047 0 C-N-CA 130.351 3.46 . . . . 0.0 115.953 -134.711 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -77.76 -3.84 13.94 Favored 'Trans proline' 0 CA--C 1.55 1.303 0 C-N-CA 123.711 2.941 . . . . 0.0 113.99 -159.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.4 t 62.07 112.47 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 131.62 3.968 . . . . 0.0 115.799 174.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.8 tt -72.82 75.69 1.14 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 127.909 2.483 . . . . 0.0 109.583 173.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . 0.262 0.0 OUTLIER 48.39 -15.68 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.507 1 C-N-CA 132.713 4.405 . . . . 0.0 119.004 -170.56 . . . . . . . . 4 3 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -179.51 2.95 0.02 OUTLIER Glycine 0 CA--C 1.54 1.624 0 C-N-CA 125.869 1.699 . . . . 0.0 115.265 -172.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -139.62 148.0 54.19 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 126.995 2.118 . . . . 0.0 109.46 -177.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -57.6 167.0 4.24 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.35 2.7 . . . . 0.0 114.35 175.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.464 ' H ' ' CG2' ' A' ' 118' ' ' THR . 0.5 OUTLIER -120.86 148.79 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.911 1.684 . . . . 0.0 109.299 179.697 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -122.35 101.05 7.27 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.494 1.118 . . . . 0.0 110.951 -154.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.45 152.74 28.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -167.117 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -150.87 171.44 17.22 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 129.46 3.104 . . . . 0.0 109.418 165.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -65.38 166.01 10.87 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 120.311 -1.493 . . . . 0.0 111.394 153.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 83.3 p -60.26 154.11 20.76 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 120.933 -1.104 . . . . 0.0 112.546 163.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 14.3 p30 -85.69 -19.42 30.91 Favored 'General case' 0 CA--C 1.548 0.897 0 O-C-N 121.363 -0.836 . . . . 0.0 112.28 158.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 67.5 m-70 -75.21 -171.1 1.31 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.772 1.629 . . . . 0.0 111.985 164.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -141.7 121.21 13.27 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 127.123 2.169 . . . . 0.0 110.181 174.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 66.04 99.4 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 126.026 1.73 . . . . 0.0 114.939 171.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 61.8 tp -61.78 125.71 24.79 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.273 1.429 . . . . 0.0 112.171 172.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -74.64 -58.14 3.48 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.023 1.329 . . . . 0.0 113.763 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.4 p 34.17 81.82 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 128.029 2.532 . . . . 0.0 114.988 -174.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -59.28 -26.12 64.68 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.781 0.832 . . . . 0.0 113.129 166.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 12.9 t -145.81 109.87 4.91 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.903 2.081 . . . . 0.0 110.513 168.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 97.5 p -74.9 163.18 69.94 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 125.133 1.373 . . . . 0.0 112.549 177.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -75.29 7.06 3.15 Favored 'Trans proline' 0 CA--C 1.548 1.192 0 C-N-CA 123.814 3.009 . . . . 0.0 114.65 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -50.08 116.54 1.88 Allowed 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 126.318 1.847 . . . . 0.0 112.393 174.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -52.29 -42.64 63.9 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.515 1.526 . . . . 0.0 114.063 -170.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -67.67 -14.71 63.17 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -179.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 8.5 ttm180 . . . . . 0 N--CA 1.476 0.835 0 C-N-CA 125.515 1.526 . . . . 0.0 114.612 -168.297 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 147' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.319 0 O5'-C5'-C4' 113.635 2.453 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 148' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.43 1 O5'-C5'-C4' 117.359 5.114 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 149' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.446 0 O4'-C1'-N19 111.728 3.528 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 150' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.414 -3.257 1 O4'-C1'-N19 112.857 4.657 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 151' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.277 1 O4'-C1'-N19 112.519 4.319 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 152' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.429 -2.041 0 N19-C1'-C2' 117.462 2.539 . 0.121 8d . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.608 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -63.21 -21.66 66.36 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -176.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 19.1 m -69.01 -2.51 10.12 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 126.743 2.017 . . . . 0.0 115.237 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.1 ttt85 -57.64 158.51 5.99 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 126.805 2.042 . . . . 0.0 113.149 177.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.4 p 64.0 177.47 0.17 Allowed 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 128.244 2.617 . . . . 0.0 114.893 -174.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -138.67 -21.59 1.0 Allowed 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 116.694 2.109 . . . . 0.0 116.694 -165.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 146.22 -85.0 0.18 Allowed Glycine 0 N--CA 1.468 0.82 0 N-CA-C 109.979 -1.249 . . . . 0.0 109.979 -172.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 13.7 t -143.69 74.13 16.82 Favored Pre-proline 0 N--CA 1.487 1.425 0 C-N-CA 124.788 1.235 . . . . 0.0 108.501 163.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -91.26 86.74 0.29 Allowed 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.42 2.08 . . . . 0.0 115.272 -153.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 73.8 m -140.96 122.64 15.21 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.208 1.403 . . . . 0.0 112.745 177.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 41.0 mtp180 59.92 -28.78 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 131.342 3.857 . . . . 0.0 118.017 172.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.487 HG23 ' CD2' ' A' ' 98' ' ' PHE . 1.7 p -98.09 134.72 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 120.254 1.388 . . . . 0.0 112.122 167.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.8 mt -110.07 124.32 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 C-N-CA 127.585 2.354 . . . . 0.0 108.263 168.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -83.44 149.02 26.92 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.898 0.856 . . . . 0.0 111.208 169.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 8.7 mt -124.47 140.83 46.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 126.539 1.936 . . . . 0.0 108.99 179.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.51 167.91 13.27 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 127.432 2.293 . . . . 0.0 110.464 165.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 19.8 mmtt 53.64 41.57 32.05 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.768 1.627 . . . . 0.0 113.04 -176.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.62 176.99 0.63 Allowed Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 126.493 1.917 . . . . 0.0 109.737 159.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -59.52 -175.37 0.09 OUTLIER 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 124.53 3.487 . . . . 0.0 114.543 147.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 28.7 pt -81.24 -31.99 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 126.038 1.735 . . . . 0.0 113.479 -177.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -156.37 37.44 0.33 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.557 1.943 . . . . 0.0 110.725 -168.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -51.75 156.49 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.869 0.867 . . . . 0.0 112.669 177.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.82 144.28 26.68 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 122.448 1.118 . . . . 0.0 112.188 -176.235 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -58.04 -42.67 85.91 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.127 171.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.62 -39.8 61.55 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.927 1.251 . . . . 0.0 112.938 178.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -68.37 -49.41 60.36 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.688 1.195 . . . . 0.0 112.098 173.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 95.6 t -61.61 -44.89 99.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 122.965 0.506 . . . . 0.0 112.005 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.8 pp -74.68 -30.04 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 O-C-N 120.597 -1.314 . . . . 0.0 112.488 176.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.7 t -61.92 -31.74 72.08 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 119.839 1.2 . . . . 0.0 110.482 170.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 10.3 mt -78.23 -21.83 49.34 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 175.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -98.66 -16.14 32.28 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-N 119.116 0.871 . . . . 0.0 115.186 175.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.4 mt -57.69 -54.59 53.65 Favored Pre-proline 0 CA--C 1.543 0.675 0 N-CA-C 116.823 2.157 . . . . 0.0 116.823 -168.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -77.72 41.88 1.07 Allowed 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 124.0 3.133 . . . . 0.0 114.081 -175.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -129.3 -42.48 1.34 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.901 1.68 . . . . 0.0 112.589 179.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -155.79 -99.44 0.16 Allowed Glycine 0 C--N 1.336 0.564 0 C-N-CA 124.484 1.04 . . . . 0.0 110.653 167.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 38.9 tptt -136.08 -12.84 1.9 Allowed 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 116.132 1.901 . . . . 0.0 116.132 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' A' ' 101' ' ' MET 0.25 0.1 OUTLIER 30.44 82.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 128.643 2.777 . . . . 0.0 113.247 -174.184 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.6 t -68.5 -31.03 70.0 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.092 0.957 . . . . 0.0 112.554 -170.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -147.85 174.07 12.21 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 123.296 1.522 . . . . 0.0 114.586 175.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -143.24 174.64 10.53 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 127.324 2.249 . . . . 0.0 111.371 157.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.15 154.08 43.53 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.964 2.105 . . . . 0.0 108.148 169.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 5.0 mtp -129.71 106.51 8.76 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.641 1.176 . . . . 0.0 110.597 -176.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -74.18 76.15 1.79 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.025 0.93 . . . . 0.0 110.519 173.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt -64.54 98.62 0.26 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.986 1.314 . . . . 0.0 110.269 173.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 168.76 -52.94 0.21 Allowed Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.909 1.719 . . . . 0.0 112.689 -166.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt -133.1 12.61 4.26 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.12 1.368 . . . . 0.0 114.559 -166.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 59.83 53.38 4.84 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.014 1.726 . . . . 0.0 112.161 -172.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -130.28 166.0 21.27 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.396 1.078 . . . . 0.0 111.855 -179.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -166.05 169.97 14.01 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.513 1.925 . . . . 0.0 110.628 -177.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.487 ' CD2' HG23 ' A' ' 60' ' ' VAL . 4.5 m-30 -118.22 141.07 48.88 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.783 2.433 . . . . 0.0 105.46 166.253 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 15.6 tt -122.2 113.26 37.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 125.336 1.454 . . . . 0.0 107.446 166.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -109.71 117.01 32.77 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 127.27 2.228 . . . . 0.0 110.333 -166.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.472 ' HA ' ' HA ' ' A' ' 85' ' ' VAL 0.296 0.9 OUTLIER -121.46 146.5 46.85 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -169.067 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.13 -18.08 63.04 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 113.673 -1.603 . . . . 0.0 114.653 -160.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.1 p -139.68 146.57 39.81 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.934 0.873 . . . . 0.0 111.125 -176.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -59.34 -41.25 88.75 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.096 178.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -77.37 -35.64 54.33 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -177.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.02 -51.38 69.93 Favored 'General case' 0 C--O 1.222 -0.387 0 CA-C-N 119.992 1.269 . . . . 0.0 110.253 169.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.83 -36.53 78.3 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 178.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -57.9 -47.16 83.61 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.693 1.133 . . . . 0.0 111.262 170.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -64.77 -33.96 77.21 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-O 117.915 -1.041 . . . . 0.0 110.9 173.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 11.1 ttp -66.66 -47.89 71.11 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 120.019 1.281 . . . . 0.0 111.225 -178.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -68.34 -38.55 79.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 124.604 1.161 . . . . 0.0 112.055 178.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -70.18 -43.39 70.88 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.442 0.697 . . . . 0.0 110.597 176.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -49.62 -37.7 29.03 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.803 1.241 . . . . 0.0 112.075 166.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -90.77 -12.95 34.97 Favored 'General case' 0 CA--C 1.518 -0.252 0 O-C-N 120.162 -1.586 . . . . 0.0 113.657 -177.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -83.93 -15.78 46.68 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.75 0.786 . . . . 0.0 110.932 167.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.89 -59.79 2.64 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 128.567 2.747 . . . . 0.0 111.742 166.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -93.84 -49.57 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -153.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.5 m 54.88 129.36 0.01 OUTLIER Pre-proline 0 N--CA 1.481 1.101 0 C-N-CA 129.535 3.134 . . . . 0.0 113.069 -157.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -75.76 -22.25 13.7 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 121.991 1.794 . . . . 0.0 114.752 -173.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.5 t 38.87 89.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 129.223 3.009 . . . . 0.0 113.179 174.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.615 ' H ' HD13 ' A' ' 126' ' ' ILE . 2.8 tt -101.45 -50.56 3.71 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 113.444 -1.707 . . . . 0.0 110.376 -132.469 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.96 1.94 29.24 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 126.266 1.827 . . . . 0.0 113.64 165.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 125.46 12.37 3.81 Favored Glycine 0 CA--C 1.537 1.411 0 N-CA-C 117.108 1.603 . . . . 0.0 117.108 175.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -147.13 163.97 25.64 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 120.251 2.025 . . . . 0.0 112.837 174.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -56.74 143.57 89.73 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.522 2.815 . . . . 0.0 115.621 -168.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.615 HD13 ' H ' ' A' ' 121' ' ' LEU . 3.9 mm -118.81 147.28 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 127.292 2.237 . . . . 0.0 108.122 -178.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 19.5 m-30 -117.82 127.9 54.33 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.193 -0.942 . . . . 0.0 111.099 -169.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -124.65 147.13 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.764 1.225 . . . . 0.0 113.326 -178.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -158.37 159.43 35.8 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.308 1.843 . . . . 0.0 110.001 159.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -56.43 162.48 2.12 Favored 'General case' 0 CA--C 1.556 1.177 0 O-C-N 120.473 -1.392 . . . . 0.0 113.057 166.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 5.3 p -72.25 174.72 6.86 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 116.135 1.902 . . . . 0.0 116.135 -174.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -95.37 2.58 54.67 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 127.246 2.218 . . . . 0.0 114.068 166.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -121.99 -26.72 4.72 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 117.19 2.293 . . . . 0.0 117.19 -162.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp 58.82 109.51 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 126.108 1.763 . . . . 0.0 112.963 -164.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 60.28 110.26 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 128.06 2.544 . . . . 0.0 115.406 176.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 32.1 tp -71.32 140.87 50.43 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.054 1.341 . . . . 0.0 111.479 174.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.72 111.24 8.06 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 126.157 1.783 . . . . 0.0 110.82 168.098 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 21.7 p -98.37 -75.95 0.54 Allowed 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 125.378 1.471 . . . . 0.0 112.222 -175.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -69.67 -23.14 63.42 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.675 1.59 . . . . 0.0 114.033 -174.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 19.3 m -74.88 54.97 0.67 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 127.162 2.185 . . . . 0.0 113.636 -177.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 46.7 m -60.1 143.97 87.63 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 124.877 1.271 . . . . 0.0 112.355 178.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -79.1 66.07 8.8 Favored 'Trans proline' 0 CA--C 1.546 1.093 0 C-N-CA 124.275 3.317 . . . . 0.0 112.218 -178.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -69.46 -20.72 63.75 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -178.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -152.23 -176.85 5.85 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.998 1.719 . . . . 0.0 112.395 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -121.19 -176.29 3.25 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 126.373 1.869 . . . . 0.0 111.189 165.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 77.3 ttt-85 . . . . . 0 N--CA 1.48 1.072 0 C-N-CA 125.868 1.667 . . . . 0.0 113.499 177.714 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 147' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.323 0 O4'-C1'-N19 111.2 3.0 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 148' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.98 1 C5'-C4'-C3' 108.105 -4.93 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 149' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.639 0 N19-C1'-C2' 108.736 -2.915 . 0.01 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 150' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.282 2 O4'-C1'-N19 114.568 6.368 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 151' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.541 2.348 0 O4'-C1'-N19 110.987 2.787 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 152' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.325 0 C5'-C4'-C3' 110.903 -3.065 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.7 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -68.64 -45.35 72.06 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.361 1.065 . . . . 0.0 112.656 178.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 45.7 m -68.51 99.14 0.93 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.834 1.654 . . . . 0.0 112.52 -177.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 24.5 mtm180 -130.82 -49.36 1.04 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.943 1.697 . . . . 0.0 113.184 178.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 87.5 p -148.66 171.47 16.12 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.324 1.45 . . . . 0.0 112.451 177.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -140.43 -87.69 0.19 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.118 1.367 . . . . 0.0 110.885 177.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -148.95 43.83 0.77 Allowed Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.959 1.742 . . . . 0.0 112.09 175.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 62.1 t 53.94 72.07 1.21 Allowed Pre-proline 0 N--CA 1.48 1.042 0 C-N-CA 127.75 2.42 . . . . 0.0 109.568 -162.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -96.68 164.96 1.09 Allowed 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 124.68 3.587 . . . . 0.0 112.639 -156.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 66.5 p -156.27 -75.52 0.1 Allowed 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -175.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 -124.73 -10.46 7.28 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 -161.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.337 3.8 p -112.03 135.95 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-N 119.842 1.201 . . . . 0.0 112.154 168.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.6 mt -114.93 150.56 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 127.629 2.372 . . . . 0.0 107.859 173.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -118.08 130.2 56.0 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.758 1.223 . . . . 0.0 110.73 178.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.5 mt -117.01 125.77 74.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 127.494 2.318 . . . . 0.0 108.414 -173.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -112.43 175.91 5.24 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 125.931 1.692 . . . . 0.0 113.024 -178.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 11.6 mmmt 59.34 27.81 16.99 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 127.392 2.277 . . . . 0.0 114.671 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.3 mp -55.01 155.63 8.17 Favored Pre-proline 0 CA--C 1.554 1.126 0 C-N-CA 124.858 1.263 . . . . 0.0 112.321 176.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -45.8 -67.25 0.12 Allowed 'Trans proline' 0 C--N 1.351 0.706 1 C-N-CA 125.87 4.38 . . . . 0.0 115.151 -177.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.7 pt -153.05 -50.36 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 130.933 3.693 . . . . 0.0 107.615 175.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -151.52 -5.99 0.25 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.309 1.444 . . . . 0.0 114.174 178.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.291 2.8 p 43.8 -146.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 C-N-CA 127.237 2.215 . . . . 0.0 112.084 -174.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.2 t -140.02 136.02 33.27 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 120.723 -1.236 . . . . 0.0 110.522 161.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -56.76 -34.91 68.04 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.598 0.759 . . . . 0.0 113.03 179.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -55.28 -40.17 74.72 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.892 1.234 . . . . 0.0 113.434 172.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -67.12 -50.9 59.87 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.776 -0.837 . . . . 0.0 111.292 171.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 87.7 t -55.89 -49.89 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.578 0.751 . . . . 0.0 112.725 -176.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -82.01 -26.07 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 O-C-N 120.264 -1.522 . . . . 0.0 114.409 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.3 t -61.56 -32.4 72.48 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 119.76 1.164 . . . . 0.0 110.377 168.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.9 mt -76.3 -26.18 55.6 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 171.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -85.51 -19.86 57.63 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-N 119.549 1.068 . . . . 0.0 114.836 175.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 11.5 mt -69.95 -31.17 2.28 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 117.982 2.586 . . . . 0.0 117.982 -168.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -58.62 -4.63 1.96 Allowed 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 123.517 2.811 . . . . 0.0 116.821 169.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -108.41 -40.61 5.09 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -166.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -150.88 -109.78 0.47 Allowed Glycine 0 CA--C 1.525 0.665 0 CA-C-O 122.348 0.971 . . . . 0.0 111.974 176.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 17.1 tptm -147.7 138.16 23.12 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 128.895 2.878 . . . . 0.0 103.997 164.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.45 ' CG2' ' HE2' ' A' ' 101' ' ' MET 0.307 12.4 t -130.15 82.97 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 CA-C-N 120.717 1.599 . . . . 0.0 109.567 -163.047 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.5 t -77.08 -21.83 53.77 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 126.669 1.988 . . . . 0.0 113.149 -159.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -141.51 165.65 26.91 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-O 122.615 1.197 . . . . 0.0 113.619 165.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -137.55 179.07 6.63 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.253 1.421 . . . . 0.0 109.924 157.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.47 159.12 44.71 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.395 1.478 . . . . 0.0 109.69 172.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 6.9 mtt -133.65 100.58 4.83 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.074 0.95 . . . . 0.0 112.529 -174.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -73.92 92.34 2.08 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.087 1.355 . . . . 0.0 111.15 171.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 48.8 mttp -62.41 -20.94 64.99 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 175.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.89 -53.98 41.06 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 125.768 1.651 . . . . 0.0 115.138 -174.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.5 mtmt -123.33 20.05 9.71 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 126.04 1.736 . . . . 0.0 112.01 179.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 23.2 m120 53.67 66.64 1.17 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 126.841 2.056 . . . . 0.0 112.575 -173.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . 0.257 0.0 OUTLIER -125.53 179.43 5.14 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.51 0.671 . . . . 0.0 112.471 170.087 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -154.07 162.77 40.96 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 126.542 1.937 . . . . 0.0 109.904 -176.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 5.6 m-30 -108.11 150.91 26.58 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.546 1.539 . . . . 0.0 107.333 159.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.2 tt -132.9 124.04 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 124.624 1.169 . . . . 0.0 108.405 163.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -130.74 126.6 36.86 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 122.588 1.185 . . . . 0.0 112.946 -162.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.45 ' HE2' ' CG2' ' A' ' 85' ' ' VAL . 0.5 OUTLIER -134.04 161.37 35.02 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.111 -1.404 . . . . 0.0 113.933 -159.903 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -79.32 -12.64 59.93 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.391 1.877 . . . . 0.0 113.26 -161.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.34 138.38 33.05 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.845 1.258 . . . . 0.0 111.32 -178.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -62.44 -34.79 77.5 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.312 176.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -75.69 -36.53 60.01 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.763 0.825 . . . . 0.0 112.963 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -56.22 -53.68 54.23 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 118.823 0.738 . . . . 0.0 109.693 168.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.31 -36.22 79.0 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -177.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -55.19 -50.28 69.75 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.109 0.868 . . . . 0.0 110.955 168.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -65.27 -30.75 71.65 Favored 'General case' 0 C--O 1.225 -0.222 0 O-C-N 121.441 -0.787 . . . . 0.0 111.603 174.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 5.6 ttp -73.39 -46.33 49.48 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 119.908 1.231 . . . . 0.0 111.591 -177.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -65.21 -40.12 87.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 124.145 0.978 . . . . 0.0 110.958 177.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -68.5 -46.1 70.55 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.597 0.759 . . . . 0.0 110.647 176.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -48.34 -42.88 32.67 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.111 1.364 . . . . 0.0 111.937 168.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -84.96 -14.21 48.28 Favored 'General case' 0 C--N 1.334 -0.105 0 O-C-N 120.764 -1.21 . . . . 0.0 112.485 -176.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 92.9 m -83.18 -14.06 54.2 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.422 1.089 . . . . 0.0 110.618 169.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.21 -56.83 2.5 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 129.228 3.011 . . . . 0.0 113.257 178.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 9.8 p -72.65 -33.55 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 127.187 2.195 . . . . 0.0 113.777 -157.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.41 ' CG2' ' H ' ' A' ' 126' ' ' ILE . 0.3 OUTLIER -2.25 114.36 0.01 OUTLIER Pre-proline 0 N--CA 1.484 1.256 0 C-N-CA 129.206 3.002 . . . . 0.0 116.449 -131.544 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -77.26 -7.76 17.19 Favored 'Trans proline' 0 CA--C 1.546 1.117 0 C-N-CA 123.675 2.916 . . . . 0.0 114.336 -161.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.5 t 61.05 107.95 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 130.71 3.604 . . . . 0.0 114.509 176.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 14.2 tp -73.17 -55.86 5.89 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.766 0.826 . . . . 0.0 112.335 -168.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -125.52 -4.95 7.14 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 127.584 2.354 . . . . 0.0 113.492 -161.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 99.63 13.87 36.56 Favored Glycine 0 CA--C 1.539 1.556 0 C-N-CA 124.282 0.944 . . . . 0.0 112.432 -148.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -138.9 144.7 42.49 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 128.402 2.681 . . . . 0.0 109.259 -178.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -57.35 168.96 2.46 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 124.0 3.133 . . . . 0.0 114.077 176.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.41 ' H ' ' CG2' ' A' ' 118' ' ' THR . 0.3 OUTLIER -125.27 149.45 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.092 1.357 . . . . 0.0 109.896 -177.661 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -120.88 101.35 7.64 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.419 -153.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.85 150.51 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.53 1.132 . . . . 0.0 112.739 -177.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -152.37 163.6 39.16 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 126.832 2.053 . . . . 0.0 109.074 154.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -53.02 151.81 4.49 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.362 -0.836 . . . . 0.0 112.076 164.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 31.6 t -71.6 156.22 39.65 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.665 0.745 . . . . 0.0 112.051 176.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -68.99 -7.71 37.88 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.137 1.375 . . . . 0.0 113.196 164.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 36.8 m-70 -119.47 177.89 4.75 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 127.361 2.264 . . . . 0.0 110.916 -176.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -119.55 5.9 11.07 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 -167.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 162.41 167.45 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 131.077 3.751 . . . . 0.0 111.22 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -74.54 147.55 41.69 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.669 0.788 . . . . 0.0 109.475 158.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 16.4 tttp -140.39 71.13 1.36 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.558 1.171 . . . . 0.0 110.506 173.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 29.9 p -69.64 -17.43 63.51 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.339 1.856 . . . . 0.0 113.606 178.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -58.15 128.21 36.0 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.175 1.39 . . . . 0.0 111.76 166.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 87.9 p -133.31 23.4 4.09 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.327 1.851 . . . . 0.0 114.013 175.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.8 m -65.03 137.84 97.25 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 125.48 1.512 . . . . 0.0 112.744 -174.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -75.27 -9.06 20.25 Favored 'Trans proline' 0 CA--C 1.545 1.049 0 C-N-CA 123.251 2.634 . . . . 0.0 114.018 177.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.03 -22.16 65.89 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.494 1.517 . . . . 0.0 114.342 -172.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -139.55 -19.08 0.95 Allowed 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 -174.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -157.75 -159.42 0.83 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.979 1.712 . . . . 0.0 110.432 -177.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.344 0 C-N-CA 126.168 1.787 . . . . 0.0 113.736 178.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 147' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.536 2.012 0 O4'-C1'-N19 111.034 2.834 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 148' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.173 0 O4'-C1'-N19 112.039 3.839 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 149' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.424 0 O4'-C1'-N19 112.047 3.847 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 150' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -3.034 2 O4'-C1'-N19 113.204 5.004 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 151' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.192 0 C5'-C4'-C3' 111.282 -2.812 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 152' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.365 1 O4'-C1'-N19 113.467 5.267 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.597 0 N-CA-C 111.559 -0.617 . . . . 0.0 111.559 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -72.42 172.19 10.89 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.23 1.012 . . . . 0.0 113.54 176.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 16.5 m -76.51 -12.56 60.05 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 116.283 1.957 . . . . 0.0 116.283 -170.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 61.9 mtp180 -101.69 151.64 21.79 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 119.96 1.255 . . . . 0.0 113.235 -167.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.2 m -87.79 -10.2 51.64 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.338 1.455 . . . . 0.0 113.711 171.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -143.64 159.77 41.87 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.777 1.631 . . . . 0.0 112.325 175.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -140.02 -42.74 0.07 OUTLIER Glycine 0 CA--C 1.537 1.415 0 C-N-CA 126.135 1.826 . . . . 0.0 113.181 171.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 20.1 t -140.5 75.12 27.42 Favored Pre-proline 0 N--CA 1.485 1.306 0 C-N-CA 126.293 1.837 . . . . 0.0 108.862 168.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -98.6 -0.74 1.11 Allowed 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 125.095 3.863 . . . . 0.0 114.344 -163.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 31.5 t 55.98 -87.74 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 128.037 2.535 . . . . 0.0 115.354 175.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 21.9 mtp180 -139.54 -9.19 1.25 Allowed 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 117.01 2.226 . . . . 0.0 117.01 -154.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.272 3.9 p -106.82 131.15 57.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 CA-C-N 120.615 1.552 . . . . 0.0 112.13 169.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.2 mt -109.97 155.8 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 127.672 2.389 . . . . 0.0 108.231 170.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -124.02 138.72 54.41 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.349 1.46 . . . . 0.0 110.689 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.2 mt -122.38 132.18 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 126.95 2.1 . . . . 0.0 109.807 -171.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.96 173.89 6.12 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 125.803 1.641 . . . . 0.0 113.246 178.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 13.8 mmmt 64.9 15.98 10.24 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 128.903 2.881 . . . . 0.0 116.416 173.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 30.8 mt -61.99 141.89 95.45 Favored Pre-proline 0 CA--C 1.555 1.158 0 CA-C-O 118.444 -0.788 . . . . 0.0 110.517 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -37.54 -62.92 0.26 Allowed 'Trans proline' 0 CA--C 1.539 0.766 1 C-N-CA 125.589 4.193 . . . . 0.0 116.043 -177.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.1 pt -153.74 -42.44 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 129.964 3.306 . . . . 0.0 109.323 174.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -153.3 -7.49 0.17 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.412 1.485 . . . . 0.0 113.187 -170.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.298 12.0 p 34.27 -122.21 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 127.09 2.156 . . . . 0.0 111.496 -165.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -148.75 135.55 19.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 122.368 1.08 . . . . 0.0 109.045 152.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -55.17 -31.13 61.12 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.057 0.943 . . . . 0.0 112.768 178.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -60.42 -37.94 93.98 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 124.832 1.206 . . . . 0.0 114.121 172.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -69.86 -44.86 68.98 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.422 -1.046 . . . . 0.0 110.579 172.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 85.5 t -57.76 -51.76 66.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 123.808 0.843 . . . . 0.0 112.182 -176.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -78.92 -26.06 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 O-C-N 120.341 -1.474 . . . . 0.0 114.381 177.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 38.7 t -62.15 -28.53 69.72 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 119.846 1.203 . . . . 0.0 110.553 169.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 22.8 mt -82.55 -23.48 34.48 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.923 1.082 . . . . 0.0 113.923 170.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -89.06 -11.02 65.6 Favored Glycine 0 CA--C 1.534 1.229 0 CA-C-N 119.406 1.003 . . . . 0.0 114.67 176.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.2 mt -77.55 -17.12 0.26 Allowed Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 118.859 2.911 . . . . 0.0 118.859 -174.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -59.6 -2.51 1.51 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.868 2.379 . . . . 0.0 117.363 169.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -119.56 -44.77 2.54 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -166.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -150.88 -108.52 0.42 Allowed Glycine 0 C--N 1.337 0.591 0 C-N-CA 123.796 0.712 . . . . 0.0 111.581 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 21.7 tptp -142.84 -15.73 0.71 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 115.524 1.675 . . . . 0.0 115.524 -171.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.473 ' HA ' ' HA ' ' A' ' 101' ' ' MET 0.256 0.2 OUTLIER 34.6 81.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 128.159 2.584 . . . . 0.0 113.493 175.088 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 54.3 p -68.06 -36.18 79.43 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.352 1.061 . . . . 0.0 112.205 -169.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -145.0 165.71 27.39 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 123.611 1.672 . . . . 0.0 114.838 -177.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -150.31 169.14 22.1 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 126.489 1.916 . . . . 0.0 112.377 162.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.67 150.97 37.28 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 127.305 2.242 . . . . 0.0 108.536 -174.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 5.5 mtp -133.45 94.97 3.4 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.786 0.834 . . . . 0.0 111.811 -169.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.34 84.35 1.07 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.102 1.361 . . . . 0.0 111.443 175.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.01 -11.28 12.82 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 115.265 1.579 . . . . 0.0 115.265 170.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -60.62 -56.45 24.26 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 126.403 1.954 . . . . 0.0 114.494 177.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 31.6 mtmt -125.49 22.51 7.66 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 126.16 1.784 . . . . 0.0 112.144 -176.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 57.51 56.18 5.16 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.559 2.344 . . . . 0.0 113.92 -178.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . 0.264 0.0 OUTLIER -129.63 -179.39 5.15 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 173.964 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -158.25 164.78 36.14 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.72 2.008 . . . . 0.0 110.44 -177.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 4.8 m-30 -111.14 151.77 27.78 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.488 1.915 . . . . 0.0 107.896 163.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.9 tt -133.79 104.21 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 C-N-CA 125.544 1.538 . . . . 0.0 108.018 167.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -97.77 127.69 43.9 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 128.387 2.675 . . . . 0.0 110.762 -174.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.473 ' HA ' ' HA ' ' A' ' 85' ' ' VAL 0.305 20.8 ttm -126.86 157.52 39.12 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 -173.921 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -54.54 -37.07 64.98 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 127.037 2.135 . . . . 0.0 114.299 -172.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 69.2 p -141.39 137.78 32.53 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.976 0.91 . . . . 0.0 110.589 -162.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -59.81 -38.62 82.48 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.658 0.783 . . . . 0.0 112.041 -177.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -74.18 -37.94 63.79 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -178.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -57.64 -48.85 78.31 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 119.185 0.902 . . . . 0.0 110.408 169.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.74 -37.29 70.58 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.338 0.972 . . . . 0.0 113.585 -178.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -55.21 -50.86 68.3 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 120.96 -1.088 . . . . 0.0 111.085 169.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -64.33 -27.84 69.3 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-O 117.961 -1.019 . . . . 0.0 111.466 173.048 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 16.7 ttp -71.64 -47.78 52.18 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-N 120.444 1.474 . . . . 0.0 110.335 -177.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.51 -40.61 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 123.636 0.775 . . . . 0.0 111.207 176.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -67.43 -47.28 70.67 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.586 0.754 . . . . 0.0 110.829 177.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -48.26 -41.84 28.89 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.93 1.692 . . . . 0.0 112.561 167.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -85.36 -17.62 36.21 Favored 'General case' 0 C--O 1.232 0.166 0 O-C-N 120.551 -1.343 . . . . 0.0 112.613 -177.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 67.5 m -78.18 -16.58 57.76 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.071 0.948 . . . . 0.0 110.193 169.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.47 -57.43 2.77 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 129.126 2.97 . . . . 0.0 112.808 177.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 8.8 p -76.68 -40.82 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.504 1.521 . . . . 0.0 113.66 -154.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 11.52 113.67 0.0 OUTLIER Pre-proline 0 N--CA 1.482 1.14 0 C-N-CA 129.011 2.924 . . . . 0.0 116.175 -133.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -75.77 -19.33 16.39 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.463 2.775 . . . . 0.0 112.969 -165.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 6.4 t 61.08 110.19 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 130.514 3.526 . . . . 0.0 113.065 -178.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.0 tt -75.0 80.01 2.19 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.732 1.613 . . . . 0.0 109.6 -176.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . 0.29 2.9 ppt_? 46.61 -13.19 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.249 1 C-N-CA 132.733 4.413 . . . . 0.0 118.906 -168.944 . . . . . . . . 3 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -174.04 3.37 0.03 OUTLIER Glycine 0 CA--C 1.538 1.512 0 N-CA-C 116.493 1.357 . . . . 0.0 116.493 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 5.3 tp60 -139.37 140.72 26.63 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 126.019 1.728 . . . . 0.0 109.489 -177.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.94 164.68 7.73 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 123.628 2.885 . . . . 0.0 113.329 174.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -127.76 147.6 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.462 1.105 . . . . 0.0 110.762 -174.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -127.19 102.07 6.78 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.637 1.175 . . . . 0.0 109.923 -153.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.8 150.19 23.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -173.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -153.04 161.98 41.87 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 126.485 1.914 . . . . 0.0 109.264 154.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -53.33 151.39 5.43 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-O 121.756 0.788 . . . . 0.0 112.24 164.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 32.6 t -68.09 154.21 42.14 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.901 0.88 . . . . 0.0 112.283 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -64.22 -16.72 62.59 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.35 1.06 . . . . 0.0 112.85 165.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 54.9 m-70 -110.57 -176.95 3.11 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 127.523 2.329 . . . . 0.0 112.075 -176.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -134.47 153.58 51.86 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.607 1.563 . . . . 0.0 110.975 159.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 45.93 93.71 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 128.313 2.645 . . . . 0.0 115.262 -178.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 25.2 tp -56.09 100.34 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 127.463 2.305 . . . . 0.0 112.38 173.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -81.64 94.85 7.02 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.832 2.053 . . . . 0.0 109.478 172.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 6.7 t -131.25 7.57 4.61 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.277 1.431 . . . . 0.0 113.615 -176.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -77.54 -3.01 38.5 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.942 1.697 . . . . 0.0 115.156 -173.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 63.6 m -58.0 151.6 18.18 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.91 1.284 . . . . 0.0 113.216 179.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 19.5 m -55.63 118.25 18.73 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 125.615 1.566 . . . . 0.0 113.5 -172.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.59 -37.94 94.67 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 124.195 3.263 . . . . 0.0 115.142 178.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 23.5 t30 -143.4 110.6 5.73 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.555 1.542 . . . . 0.0 110.928 -174.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -151.58 164.86 35.93 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 128.98 2.912 . . . . 0.0 111.087 -2.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -77.54 169.12 18.85 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.187 0.995 . . . . 0.0 112.545 168.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.484 1.257 0 C-N-CA 127.697 2.399 . . . . 0.0 114.723 171.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 147' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.18 0 O4'-C1'-N19 110.811 2.611 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 148' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.33 1 C5'-C4'-C3' 108.391 -4.739 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 149' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.385 1 N19-C1'-C2' 106.793 -4.129 . 0.139 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 150' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.413 -3.311 0 C3'-C2'-C1' 104.893 3.77 . 0.0 OUTLIER '7D dist 4a' 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 151' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.429 -1.998 0 O4'-C1'-N19 111.807 3.607 . 0.01 5q . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 152' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.536 2.022 0 O4'-C1'-N19 111.561 3.361 . 0.0 OUTLIER '7D dist 2o' 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.498 0 N-CA-C 112.257 -0.337 . . . . 0.0 112.257 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -65.51 -27.24 68.33 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.92 1.288 . . . . 0.0 114.104 -178.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 45.2 m -64.97 100.19 0.4 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.173 1.789 . . . . 0.0 112.62 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 82.9 mtt85 -67.08 168.85 9.38 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.138 1.375 . . . . 0.0 112.195 170.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.4 m -123.99 -80.01 0.62 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.146 1.378 . . . . 0.0 110.588 174.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -98.62 -25.38 14.74 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.212 1.005 . . . . 0.0 113.221 175.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.47 51.03 4.5 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.585 1.088 . . . . 0.0 113.113 175.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 40.5 t 48.63 74.51 0.8 Allowed Pre-proline 0 N--CA 1.478 0.965 0 C-N-CA 127.727 2.411 . . . . 0.0 110.985 -172.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -93.92 176.65 1.25 Allowed 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 124.498 3.465 . . . . 0.0 113.595 -155.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.0 t -152.48 -157.79 0.83 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.948 1.299 . . . . 0.0 111.887 177.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.4 mtp180 -46.61 -20.44 0.13 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 130.436 3.494 . . . . 0.0 119.167 -166.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.311 7.4 p -93.9 130.8 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 CA-C-N 121.585 1.993 . . . . 0.0 112.946 173.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 21.6 mt -105.21 156.97 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 127.19 2.196 . . . . 0.0 108.338 167.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.403 ' CD2' ' C6 ' ' B' ' 149' ' ' ' C' . 1.0 OUTLIER -121.62 140.64 51.99 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.706 1.602 . . . . 0.0 110.374 177.314 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.0 mt -120.37 141.11 42.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 127.667 2.387 . . . . 0.0 108.777 -176.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.12 -171.79 2.05 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 125.667 1.587 . . . . 0.0 111.244 176.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 52.71 11.62 0.21 Allowed 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 127.664 2.386 . . . . 0.0 117.363 169.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 22.4 mt -62.75 155.94 67.73 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 124.785 1.234 . . . . 0.0 113.241 -176.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -51.95 173.06 0.12 Allowed 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 123.58 2.853 . . . . 0.0 114.669 161.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 32.5 pt -69.54 -30.78 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 126.568 1.947 . . . . 0.0 112.951 -172.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -156.36 34.86 0.32 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.78 2.032 . . . . 0.0 110.702 -170.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -53.09 147.75 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 O-C-N 121.095 -1.003 . . . . 0.0 111.051 174.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.5 t -88.91 136.83 32.8 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 123.05 1.405 . . . . 0.0 112.187 -173.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -55.49 -34.45 64.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.588 -1.187 . . . . 0.0 112.984 171.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -54.83 -40.3 71.48 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.856 1.217 . . . . 0.0 113.277 171.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -66.94 -51.2 58.15 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.052 0.941 . . . . 0.0 110.868 172.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 86.2 t -58.61 -48.7 84.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 123.652 0.781 . . . . 0.0 112.788 -175.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -80.7 -24.64 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 O-C-N 120.191 -1.568 . . . . 0.0 114.432 177.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 75.5 m -64.16 -27.1 68.84 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 120.407 1.458 . . . . 0.0 110.856 168.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.7 mt -77.68 -28.38 51.06 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 118.16 -0.924 . . . . 0.0 113.237 170.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -89.44 -13.78 61.02 Favored Glycine 0 CA--C 1.536 1.404 0 CA-C-N 119.979 1.263 . . . . 0.0 115.425 175.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.3 mt -68.13 -38.06 12.74 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 117.429 2.381 . . . . 0.0 117.429 -169.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -57.51 -3.52 0.94 Allowed 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.89 3.06 . . . . 0.0 117.277 173.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -106.34 -27.12 11.18 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -164.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -172.14 -95.45 0.1 OUTLIER Glycine 0 C--N 1.336 0.542 0 C-N-CA 124.631 1.11 . . . . 0.0 110.634 169.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.7 tppt? -149.24 155.65 40.91 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 127.021 2.129 . . . . 0.0 105.503 160.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.42 ' CG2' ' HE2' ' A' ' 101' ' ' MET . 3.1 t -131.4 102.0 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 120.341 1.428 . . . . 0.0 110.05 -171.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 30.5 m -67.23 -46.88 72.47 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 128.872 2.869 . . . . 0.0 112.22 -162.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 53.3 m-20 -144.92 162.06 37.8 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 122.236 1.017 . . . . 0.0 112.491 177.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -135.61 171.78 13.95 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.378 1.071 . . . . 0.0 110.936 157.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.56 152.36 39.59 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.563 1.545 . . . . 0.0 109.11 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 8.2 mtt -131.61 104.13 6.77 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.139 0.976 . . . . 0.0 112.408 -175.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -78.03 74.03 4.58 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.019 1.328 . . . . 0.0 109.878 170.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -58.27 -28.78 65.26 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -172.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -79.15 -6.49 88.84 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 125.279 1.419 . . . . 0.0 115.491 175.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.4 mtmt -120.8 4.47 10.53 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.252 1.821 . . . . 0.0 114.139 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 15.5 m120 54.42 38.5 29.7 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.317 1.447 . . . . 0.0 112.507 -170.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -137.09 160.0 40.24 Favored 'General case' 0 CA--C 1.554 1.129 0 O-C-N 121.258 -0.901 . . . . 0.0 111.032 -159.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -154.78 167.82 28.93 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 120.127 -1.608 . . . . 0.0 112.644 -177.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -116.05 155.52 27.98 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.63 1.972 . . . . 0.0 108.818 165.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 16.6 tt -139.68 99.41 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 125.373 1.469 . . . . 0.0 109.249 168.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.0 tp10 -88.97 122.67 32.57 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 128.617 2.767 . . . . 0.0 110.628 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.42 ' HE2' ' CG2' ' A' ' 85' ' ' VAL 0.332 0.9 OUTLIER -119.17 161.18 20.78 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 -176.942 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.0 -15.81 63.08 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.376 1.47 . . . . 0.0 113.336 -164.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.28 144.77 33.44 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 122.153 0.978 . . . . 0.0 111.069 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -60.98 -43.42 98.84 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.78 177.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -73.55 -35.42 65.5 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -178.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -57.13 -54.61 44.81 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 168.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.58 -39.17 91.33 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 120.986 -1.071 . . . . 0.0 113.458 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -49.3 -55.07 13.98 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 120.226 1.375 . . . . 0.0 113.211 168.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -62.49 -34.62 77.21 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 118.708 -0.663 . . . . 0.0 111.012 175.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 4.6 ttp -63.34 -56.05 19.52 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.009 1.324 . . . . 0.0 110.189 179.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -61.4 -37.57 78.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 125.877 1.671 . . . . 0.0 112.006 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -69.96 -46.42 65.3 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.706 0.802 . . . . 0.0 111.301 177.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -49.35 -38.48 28.33 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.434 0.694 . . . . 0.0 111.821 166.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -83.98 -20.69 32.41 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 120.723 -1.236 . . . . 0.0 113.075 -174.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -82.56 -13.69 56.15 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.993 0.901 . . . . 0.0 111.222 171.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.77 -53.17 5.3 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 127.721 2.408 . . . . 0.0 112.37 174.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 10.0 p -75.8 -42.66 40.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 125.695 1.598 . . . . 0.0 114.868 -157.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 1.53 113.35 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.462 0 C-N-CA 127.349 2.26 . . . . 0.0 116.437 -124.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.414 ' HD2' ' CD1' ' A' ' 126' ' ' ILE . 5.4 Cg_exo -76.66 -18.85 14.99 Favored 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 123.604 2.869 . . . . 0.0 113.216 -164.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.6 t 62.46 105.05 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 129.938 3.295 . . . . 0.0 112.947 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.8 tt -70.87 -64.35 0.92 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.233 0.613 . . . . 0.0 111.563 -162.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -142.02 71.69 1.36 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.492 1.517 . . . . 0.0 109.879 172.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 77.85 8.82 87.24 Favored Glycine 0 CA--C 1.538 1.476 0 N-CA-C 115.641 1.016 . . . . 0.0 115.641 -179.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -138.29 139.34 25.0 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 126.142 1.777 . . . . 0.0 110.417 177.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -58.79 162.07 13.87 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 123.35 2.7 . . . . 0.0 111.872 171.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.414 ' CD1' ' HD2' ' A' ' 119' ' ' PRO . 3.0 mt -106.39 -45.07 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -156.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 77.25 110.07 0.07 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.992 2.117 . . . . 0.0 112.103 170.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.47 153.84 35.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 125.723 1.609 . . . . 0.0 111.206 178.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -151.33 164.2 37.21 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.919 1.688 . . . . 0.0 109.005 151.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -51.89 146.16 8.75 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.278 -0.889 . . . . 0.0 111.673 164.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 29.0 t -68.73 154.37 42.07 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.919 -0.488 . . . . 0.0 111.576 178.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -63.54 -20.42 65.62 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.177 0.991 . . . . 0.0 112.525 165.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 37.4 m-70 -101.08 177.43 4.95 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.955 2.102 . . . . 0.0 110.665 178.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -128.7 7.66 5.72 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.94 1.296 . . . . 0.0 113.87 -168.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -173.16 155.58 3.0 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 127.821 2.449 . . . . 0.0 109.643 -167.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 47.6 tp -134.61 74.46 1.53 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.528 1.931 . . . . 0.0 110.034 170.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -80.76 91.36 5.9 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.709 1.204 . . . . 0.0 109.651 176.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 22.8 p -68.58 -15.83 63.66 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.977 1.711 . . . . 0.0 114.366 -177.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 27.7 t70 46.15 58.29 4.59 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 127.282 2.233 . . . . 0.0 114.287 172.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 22.1 m -61.46 161.31 9.64 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.495 1.518 . . . . 0.0 113.868 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 37.3 m -62.64 157.79 55.39 Favored Pre-proline 0 N--CA 1.476 0.849 0 C-N-CA 125.04 1.336 . . . . 0.0 113.293 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -54.92 153.76 24.12 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.799 2.999 . . . . 0.0 114.219 173.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -106.54 -21.17 13.15 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.633 1.173 . . . . 0.0 114.051 -178.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -69.81 147.07 50.87 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.164 0.985 . . . . 0.0 111.461 178.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -58.48 -43.96 89.19 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.554 1.541 . . . . 0.0 114.239 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 56.9 mmm-85 . . . . . 0 N--CA 1.483 1.187 0 C-N-CA 126.247 1.819 . . . . 0.0 114.804 -176.894 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 147' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.13 0 O4'-C1'-N19 110.492 2.292 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 148' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.43 0 O4'-C4'-C3' 108.78 2.343 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 149' ' ' ' C' . . . . . 0.403 ' C6 ' ' CD2' ' A' ' 62' ' ' HIS . . . . . . . . 0 O4'--C4' 1.422 -2.588 0 N19-C1'-C2' 107.263 -3.836 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 150' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.822 2 O4'-C1'-N19 113.41 5.21 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 151' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.293 1 C5'-C4'-C3' 108.878 -4.415 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 152' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.544 2.598 0 C5'-C4'-C3' 110.034 -3.644 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.2 t . . . . . 0 N--CA 1.478 0.93 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 -51.87 -7.49 0.05 Allowed 'General case' 0 N--CA 1.474 0.775 1 C-N-CA 132.408 4.283 . . . . 0.0 120.412 -155.438 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.678 HG13 ' HB3' ' A' ' 131' ' ' SER 0.294 5.7 p -99.31 129.63 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-N 121.991 2.178 . . . . 0.0 112.099 170.241 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 16.1 mt -105.84 157.87 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 128.157 2.583 . . . . 0.0 108.149 170.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -128.17 142.87 51.05 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.206 1.802 . . . . 0.0 110.455 179.116 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.0 mt -123.76 140.01 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 126.953 2.101 . . . . 0.0 109.957 -174.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.69 174.3 6.03 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 125.958 1.703 . . . . 0.0 112.056 172.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.494 ' HE3' ' CE2' ' A' ' 127' ' ' TYR . 2.5 mmtp 71.39 -2.92 2.25 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 128.341 2.656 . . . . 0.0 116.571 172.029 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -35.34 145.72 0.2 Allowed Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 129.977 3.311 . . . . 0.0 115.933 -164.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.26 165.23 1.01 Allowed 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.36 2.707 . . . . 0.0 115.126 176.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 37.7 pt -56.66 -31.59 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 128.197 2.599 . . . . 0.0 113.984 -169.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -161.45 41.71 0.15 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.455 1.902 . . . . 0.0 110.365 -177.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -57.63 157.93 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 O-C-N 121.544 -0.722 . . . . 0.0 110.898 174.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 14.4 t -123.71 154.7 39.06 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 122.559 1.171 . . . . 0.0 113.216 -175.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -54.78 -42.6 71.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.74 175.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.62 -36.96 55.59 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.088 0.852 . . . . 0.0 113.463 178.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -71.44 -52.34 18.99 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.911 1.284 . . . . 0.0 112.16 173.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 57.6 t -59.71 -46.25 93.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -177.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.9 pp -69.75 -34.24 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 O-C-N 120.553 -1.342 . . . . 0.0 112.422 175.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 74.8 m -67.8 -19.31 65.07 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 119.895 1.225 . . . . 0.0 111.742 175.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 62.5 mt -89.62 -15.53 32.54 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 172.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -101.3 -13.23 33.79 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-N 119.168 0.894 . . . . 0.0 114.977 172.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.3 mt -63.34 -44.98 84.31 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 116.563 2.06 . . . . 0.0 116.563 -175.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.1 -5.22 1.28 Allowed 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 124.441 3.428 . . . . 0.0 117.972 176.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -103.96 -39.93 6.4 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -164.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -154.77 -82.77 0.04 OUTLIER Glycine 0 CA--C 1.518 0.257 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 172.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 22.5 tptp -152.05 -8.98 0.2 Allowed 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 116.972 2.212 . . . . 0.0 116.972 174.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.413 ' H ' ' HE1' ' A' ' 101' ' ' MET . 0.4 OUTLIER 27.18 109.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.173 0 C-N-CA 127.635 2.374 . . . . 0.0 115.449 -147.208 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.2 m -59.3 -36.62 75.94 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 119.678 -1.889 . . . . 0.0 112.226 170.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -162.56 178.23 8.75 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 115.903 1.816 . . . . 0.0 115.903 175.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -136.88 172.76 12.53 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.31 1.844 . . . . 0.0 112.601 155.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.51 HD23 ' C ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -142.43 156.27 45.17 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.923 1.689 . . . . 0.0 109.538 169.984 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 3.5 mtt -128.98 107.76 9.87 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.92 0.888 . . . . 0.0 111.81 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -78.34 54.4 1.4 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.226 1.01 . . . . 0.0 109.488 164.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 66.4 tttt -64.78 -27.37 68.84 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -159.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -65.62 -14.39 60.25 Favored Glycine 0 CA--C 1.541 1.718 0 C-N-CA 125.152 1.358 . . . . 0.0 115.707 171.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.01 2.89 17.09 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.887 1.675 . . . . 0.0 113.054 169.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 7.9 m120 50.66 54.27 11.48 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.656 1.582 . . . . 0.0 112.164 -167.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -132.12 168.52 17.85 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.166 0.986 . . . . 0.0 110.76 173.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -154.6 166.47 33.24 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.918 1.287 . . . . 0.0 112.102 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.473 ' CD2' HG21 ' A' ' 60' ' ' VAL . 5.2 m-30 -111.5 156.08 22.26 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.119 1.768 . . . . 0.0 108.359 161.086 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 15.2 tt -139.69 106.69 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.979 1.312 . . . . 0.0 109.045 166.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -96.97 137.6 35.81 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 129.291 3.036 . . . . 0.0 111.135 -174.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.481 ' HE2' ' HB2' ' A' ' 101' ' ' MET 0.316 19.9 tpp -133.04 150.55 52.11 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 115.842 1.793 . . . . 0.0 115.842 -167.282 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.92 -15.28 62.09 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 114.166 1.172 . . . . 0.0 114.166 -166.508 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.53 143.83 31.03 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.41 1.084 . . . . 0.0 110.234 -177.001 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -64.2 -37.74 88.55 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.637 0.775 . . . . 0.0 111.424 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -73.26 -39.73 65.19 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.764 0.826 . . . . 0.0 113.007 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -54.62 -51.52 65.1 Favored 'General case' 0 C--O 1.217 -0.62 0 C-N-CA 123.494 0.718 . . . . 0.0 110.618 169.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.62 -37.6 76.9 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -55.54 -49.62 72.17 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.995 0.816 . . . . 0.0 110.552 169.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -66.63 -29.49 69.54 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-O 118.067 -0.968 . . . . 0.0 111.691 174.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 11.6 ttp -71.73 -45.25 62.36 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 120.329 1.422 . . . . 0.0 110.154 -177.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -68.74 -40.4 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 O-C-N 121.334 -0.854 . . . . 0.0 112.068 175.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -68.43 -43.1 77.85 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.737 -0.602 . . . . 0.0 110.402 178.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -48.57 -44.91 37.15 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 125.428 1.491 . . . . 0.0 111.833 165.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.579 ' HA ' HG12 ' A' ' 117' ' ' VAL . 14.2 m-85 -80.24 -14.87 58.08 Favored 'General case' 0 C--N 1.332 -0.194 0 O-C-N 121.032 -1.043 . . . . 0.0 112.837 -177.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 97.8 m -85.22 -13.55 49.57 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.763 1.225 . . . . 0.0 110.635 171.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.89 -56.04 2.62 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 129.02 2.928 . . . . 0.0 112.892 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.579 HG12 ' HA ' ' A' ' 114' ' ' TYR . 9.9 p -70.86 -32.49 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 127.948 2.499 . . . . 0.0 113.436 -162.233 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.491 ' CG2' ' H ' ' A' ' 126' ' ' ILE . 1.3 m -6.26 113.86 0.03 OUTLIER Pre-proline 0 N--CA 1.483 1.178 0 C-N-CA 128.857 2.863 . . . . 0.0 115.864 -129.133 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 118' ' ' THR . 5.5 Cg_exo -75.61 -0.72 10.49 Favored 'Trans proline' 0 CA--C 1.553 1.441 0 C-N-CA 124.154 3.236 . . . . 0.0 114.384 -159.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.2 t 59.89 108.96 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.787 1 C-N-CA 131.903 4.081 . . . . 0.0 115.645 176.038 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.9 tt -76.02 80.47 2.88 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.852 2.061 . . . . 0.0 109.271 174.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . 0.332 0.1 OUTLIER 45.3 -13.91 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 1 C-N-CA 133.707 4.803 . . . . 0.0 119.301 -173.146 . . . . . . . . 4 3 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 178.46 12.09 0.02 OUTLIER Glycine 0 CA--C 1.537 1.436 0 C-N-CA 126.431 1.967 . . . . 0.0 115.029 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -142.53 156.13 63.59 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 126.53 1.932 . . . . 0.0 109.325 177.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_exo -53.32 166.74 1.0 Allowed 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 123.35 2.7 . . . . 0.0 114.339 167.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.491 ' H ' ' CG2' ' A' ' 118' ' ' THR . 0.7 OUTLIER -119.21 142.86 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.528 1.531 . . . . 0.0 108.858 178.196 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.494 ' CE2' ' HE3' ' A' ' 65' ' ' LYS . 3.0 m-85 -114.16 98.68 7.1 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.633 -156.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.18 147.56 25.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 124.014 0.926 . . . . 0.0 113.449 -174.22 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -150.96 160.51 43.87 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.495 1.918 . . . . 0.0 109.924 161.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -54.12 152.01 6.46 Favored 'General case' 0 CA--C 1.553 1.059 0 O-C-N 120.976 -1.077 . . . . 0.0 112.213 160.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.678 ' HB3' HG13 ' A' ' 60' ' ' VAL . 28.5 t -75.04 159.64 31.49 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.513 1.125 . . . . 0.0 113.594 -172.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -67.99 -12.3 60.51 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 126.41 1.884 . . . . 0.0 112.389 166.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 55.8 m-70 -118.24 -176.49 3.08 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.884 2.074 . . . . 0.0 113.057 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -129.73 147.08 51.47 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 126.855 2.062 . . . . 0.0 109.456 164.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 51.87 92.07 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 127.348 2.259 . . . . 0.0 115.554 176.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 42.4 tp -64.72 139.8 58.8 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.337 1.455 . . . . 0.0 112.546 174.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.478 0.961 0 C-N-CA 126.496 1.918 . . . . 0.0 111.361 167.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 65.1 m . . . . . 0 N--CA 1.481 1.082 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 72.5 mtm-85 -117.58 -17.48 9.96 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 -166.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.668 HG13 ' HB3' ' A' ' 131' ' ' SER 0.364 10.8 p -98.17 136.85 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 121.077 1.762 . . . . 0.0 113.575 170.117 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.8 mt -113.2 156.93 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 128.947 2.899 . . . . 0.0 107.937 170.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -124.99 132.38 53.27 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.672 1.589 . . . . 0.0 109.906 177.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.0 mt -111.97 131.16 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 127.747 2.419 . . . . 0.0 108.484 -175.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -87.55 178.67 6.72 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 119.898 1.226 . . . . 0.0 110.65 170.312 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 23.6 mtpp 33.49 53.95 0.46 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 129.03 2.932 . . . . 0.0 115.081 156.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.7 mt -68.88 152.11 96.93 Favored Pre-proline 0 C--N 1.309 -1.17 0 CA-C-N 113.628 -1.624 . . . . 0.0 109.206 167.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -51.12 160.98 1.76 Allowed 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 125.022 3.815 . . . . 0.0 115.339 174.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 29.7 pt -65.38 -24.13 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 128.533 2.733 . . . . 0.0 113.914 -176.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -139.97 19.63 2.47 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.624 1.969 . . . . 0.0 111.891 -171.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -57.87 166.48 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 123.956 0.902 . . . . 0.0 112.881 175.002 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.1 t -132.29 156.64 46.19 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-O 122.523 1.154 . . . . 0.0 112.42 171.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.5 -34.98 67.5 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.907 174.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -59.65 -31.32 70.85 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 125.303 1.43 . . . . 0.0 113.782 175.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -75.28 -44.88 43.31 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.718 1.207 . . . . 0.0 111.538 173.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 66.3 t -64.24 -45.43 96.26 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.427 HG23 HD13 ' A' ' 88' ' ' LEU . 2.4 pp -71.37 -29.49 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 O-C-N 120.216 -1.553 . . . . 0.0 113.317 174.539 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 35.1 t -63.24 -28.73 70.23 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 119.264 0.938 . . . . 0.0 110.649 171.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.9 mt -82.67 -17.11 45.72 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 173.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -94.44 -19.8 31.55 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-N 119.198 0.908 . . . . 0.0 115.188 172.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 13.9 mt -68.49 -33.13 4.28 Favored Pre-proline 0 CA--C 1.54 0.558 0 N-CA-C 117.547 2.425 . . . . 0.0 117.547 -169.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -59.0 -5.14 2.51 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.199 2.599 . . . . 0.0 117.16 169.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -109.47 -36.89 5.86 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -163.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -161.3 -98.83 0.14 Allowed Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 167.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.422 ' HB3' ' CG ' ' A' ' 102' ' ' ASN . 21.2 tptp -136.24 -10.83 1.95 Allowed 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 115.819 1.785 . . . . 0.0 115.819 -178.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.523 HG13 ' HB2' ' A' ' 101' ' ' MET . 0.1 OUTLIER 28.87 89.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 129.423 3.089 . . . . 0.0 113.389 -174.511 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.24 -42.03 94.41 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.793 2.037 . . . . 0.0 111.916 -173.389 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -152.0 168.73 24.27 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.427 HD13 HG23 ' A' ' 76' ' ' ILE . 1.9 pt? -144.21 170.65 15.57 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.003 1.721 . . . . 0.0 112.165 159.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.482 HD23 ' C ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -143.7 156.96 44.7 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.867 1.667 . . . . 0.0 109.328 -177.925 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 8.3 mtt -130.21 107.22 9.13 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.581 0.753 . . . . 0.0 112.234 -177.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -77.15 68.29 3.26 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.552 1.141 . . . . 0.0 109.378 167.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -56.08 -39.22 71.77 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.414 1.085 . . . . 0.0 113.481 -166.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -64.57 -20.97 66.47 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 124.673 1.13 . . . . 0.0 115.779 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -109.31 1.32 20.03 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.611 1.565 . . . . 0.0 112.737 174.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.0 m120 56.97 46.2 19.89 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.252 1.821 . . . . 0.0 113.417 -169.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -126.01 173.12 9.4 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 120.937 -1.102 . . . . 0.0 112.131 -177.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -152.22 160.92 43.28 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.53 1.132 . . . . 0.0 112.234 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.42 ' CD2' HG21 ' A' ' 60' ' ' VAL . 5.6 m-30 -99.56 154.09 18.53 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 155.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 17.1 tt -134.4 106.41 7.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 124.781 1.232 . . . . 0.0 107.979 165.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -105.44 122.18 45.45 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.714 1.605 . . . . 0.0 110.863 -172.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.523 ' HB2' HG13 ' A' ' 85' ' ' VAL . 0.9 OUTLIER -124.79 148.77 47.97 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 115.74 1.755 . . . . 0.0 115.74 -166.572 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.422 ' CG ' ' HB3' ' A' ' 84' ' ' LYS . 3.6 p-10 -63.77 -17.88 63.51 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 115.558 1.688 . . . . 0.0 115.558 -158.246 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.9 p -139.78 146.76 39.88 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.378 0.609 . . . . 0.0 110.468 -178.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -62.05 -34.56 76.48 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.019 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -77.24 -38.09 51.87 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 114.225 1.195 . . . . 0.0 114.225 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.66 -49.53 77.2 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-N 119.486 1.039 . . . . 0.0 110.431 170.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.54 -36.82 76.72 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 177.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -58.3 -46.47 86.06 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 119.727 1.149 . . . . 0.0 111.23 170.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -64.82 -33.91 77.12 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 121.032 -1.042 . . . . 0.0 111.127 173.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 9.8 ttp -65.43 -51.5 59.82 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.539 1.136 . . . . 0.0 110.414 -179.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -65.98 -36.7 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 C-N-CA 125.215 1.406 . . . . 0.0 112.593 177.013 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -72.19 -40.84 67.6 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.129 0.877 . . . . 0.0 111.165 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -52.76 -40.29 62.99 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.924 0.89 . . . . 0.0 111.693 162.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -88.5 12.86 13.29 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 119.667 -1.896 . . . . 0.0 112.291 177.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 52.0 m -112.52 -12.09 13.52 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.897 1.679 . . . . 0.0 110.175 169.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.52 -41.06 63.52 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.007 1.723 . . . . 0.0 111.544 153.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -142.38 160.8 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 124.897 1.279 . . . . 0.0 112.182 -150.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 18.7 m -125.01 135.63 27.04 Favored Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 125.657 1.583 . . . . 0.0 107.728 164.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -75.28 -17.09 19.23 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 121.895 1.73 . . . . 0.0 114.166 -171.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 4.0 t 39.85 73.88 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 128.39 2.676 . . . . 0.0 111.76 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.636 ' H ' HD11 ' A' ' 126' ' ' ILE . 5.5 tt -92.24 -32.8 14.92 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 112.397 -2.183 . . . . 0.0 110.609 -121.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -136.99 39.35 2.55 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.701 1.201 . . . . 0.0 111.539 151.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 126.66 2.68 6.72 Favored Glycine 0 CA--C 1.535 1.298 0 N-CA-C 119.328 2.491 . . . . 0.0 119.328 160.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.64 168.39 11.16 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 121.991 2.896 . . . . 0.0 113.604 173.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -60.33 147.12 94.98 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.912 2.408 . . . . 0.0 114.387 -172.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.636 HD11 ' H ' ' A' ' 121' ' ' LEU . 26.0 mm -120.3 -55.93 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 125.294 1.438 . . . . 0.0 113.245 -163.505 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 65.36 150.46 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.841 2.456 . . . . 0.0 115.743 -173.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.66 150.67 22.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 C-N-CA 126.958 2.103 . . . . 0.0 110.601 172.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -139.34 159.93 41.01 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.287 1.035 . . . . 0.0 108.623 149.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -51.81 150.73 3.86 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.348 -0.845 . . . . 0.0 110.931 159.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.668 ' HB3' HG13 ' A' ' 60' ' ' VAL . 44.0 t -72.14 154.06 41.29 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.59 -0.694 . . . . 0.0 111.623 174.412 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -77.46 -18.7 56.92 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.061 0.544 . . . . 0.0 112.398 165.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 38.0 m-70 -80.36 176.04 10.13 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.216 1.406 . . . . 0.0 110.144 160.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -119.2 -9.67 9.92 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -173.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -175.91 175.36 1.98 Allowed 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 129.129 2.971 . . . . 0.0 109.889 -172.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 23.8 tp -138.2 122.52 18.24 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.735 1.614 . . . . 0.0 113.033 -164.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 63.2 tttm . . . . . 0 N--CA 1.474 0.746 0 C-N-CA 126.549 1.94 . . . . 0.0 110.506 170.779 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 29.0 t . . . . . 0 N--CA 1.473 0.685 0 CA-C-O 120.771 0.32 . . . . 0.0 110.949 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.445 ' H ' ' HD3' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -63.1 -3.89 2.01 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 116.246 1.943 . . . . 0.0 116.246 -172.44 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.688 HG13 ' HB3' ' A' ' 131' ' ' SER 0.322 8.7 p -81.34 128.61 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-N 121.17 1.804 . . . . 0.0 112.634 166.918 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 15.8 mt -113.67 153.73 15.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 128.867 2.867 . . . . 0.0 107.456 174.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -123.96 142.35 51.23 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.434 1.494 . . . . 0.0 110.772 178.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.8 mt -119.53 138.25 50.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 127.828 2.451 . . . . 0.0 109.837 -172.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 17.0 mtt85 -96.87 176.38 6.0 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 119.488 1.04 . . . . 0.0 110.521 171.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp 44.23 42.67 5.29 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 126.958 2.103 . . . . 0.0 116.291 158.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.2 mp -55.98 161.29 3.71 Favored Pre-proline 0 CA--C 1.558 1.279 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.473 160.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.45 ' HD3' HD22 ' A' ' 121' ' ' LEU . 9.9 Cg_endo -60.06 -68.42 0.05 OUTLIER 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.734 2.956 . . . . 0.0 113.996 -173.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.1 pt -164.23 -39.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 130.848 3.659 . . . . 0.0 108.812 -171.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -151.69 -29.5 0.17 Allowed 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 -177.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.48 HG22 ' H ' ' A' ' 71' ' ' THR 0.29 2.0 p 40.02 -150.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 127.141 2.176 . . . . 0.0 112.192 -166.236 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.48 ' H ' HG22 ' A' ' 70' ' ' VAL . 2.9 t -141.75 141.91 33.25 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 120.482 -1.386 . . . . 0.0 109.681 156.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -57.1 -32.58 66.45 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 176.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.92 -41.08 58.6 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 125.088 1.328 . . . . 0.0 113.353 170.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -69.21 -48.94 60.66 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.451 -1.029 . . . . 0.0 111.107 172.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.5 t -58.81 -50.38 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 123.146 0.579 . . . . 0.0 112.497 -176.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -76.37 -27.98 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 O-C-N 120.103 -1.623 . . . . 0.0 113.877 177.247 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 33.0 t -62.77 -26.79 68.89 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 120.022 1.283 . . . . 0.0 110.826 169.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 33.8 mt -83.71 -18.26 38.54 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 114.306 1.225 . . . . 0.0 114.306 170.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -87.87 -18.64 55.86 Favored Glycine 0 CA--C 1.536 1.383 0 CA-C-N 119.376 0.989 . . . . 0.0 113.832 170.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 80' ' ' LEU . 17.8 mt -73.96 -16.8 0.28 Allowed Pre-proline 0 CA--C 1.542 0.67 0 N-CA-C 119.035 2.976 . . . . 0.0 119.035 -174.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -59.55 -5.07 2.95 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.593 2.195 . . . . 0.0 116.773 168.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.419 ' CD2' ' HG3' ' A' ' 110' ' ' MET . 24.8 m-85 -120.66 -36.09 3.25 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -166.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -162.95 -101.59 0.16 Allowed Glycine 0 CA--C 1.523 0.548 0 C-N-CA 123.724 0.678 . . . . 0.0 111.782 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 32.2 tptt -147.73 -9.99 0.41 Allowed 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 117.348 2.351 . . . . 0.0 117.348 -174.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.434 HG13 ' HB2' ' A' ' 101' ' ' MET . 0.0 OUTLIER 32.21 89.03 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 C-N-CA 128.927 2.891 . . . . 0.0 113.651 -175.693 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 38.1 m -55.87 -40.65 73.26 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 127.142 2.177 . . . . 0.0 112.264 -175.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -153.18 168.81 24.72 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -141.89 173.53 11.42 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.685 1.594 . . . . 0.0 112.303 158.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.468 HD23 ' C ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -149.9 154.97 39.21 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.85 1.66 . . . . 0.0 109.678 -179.835 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 14.8 mtt -129.66 110.57 11.9 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.934 0.894 . . . . 0.0 112.219 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -75.17 76.92 2.32 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 122.518 1.151 . . . . 0.0 109.761 169.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.17 -13.75 8.33 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.894 1.678 . . . . 0.0 115.309 -176.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -58.15 -40.9 94.35 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.685 1.612 . . . . 0.0 114.694 170.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -136.85 10.54 3.1 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 -162.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 52.65 49.37 20.5 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.022 1.329 . . . . 0.0 112.981 -167.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -113.52 167.09 10.89 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.516 0.726 . . . . 0.0 110.191 170.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -155.55 163.12 40.41 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 120.734 -1.229 . . . . 0.0 111.318 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.453 ' CD2' HG21 ' A' ' 60' ' ' VAL . 6.0 m-30 -108.32 155.88 20.02 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.444 1.497 . . . . 0.0 108.871 162.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.5 tt -141.68 106.69 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 125.872 1.669 . . . . 0.0 108.276 168.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -102.78 127.75 49.81 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 129.588 3.155 . . . . 0.0 110.776 -171.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.434 ' HB2' HG13 ' A' ' 85' ' ' VAL 0.362 1.9 tpp -124.58 158.7 32.4 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 118.201 2.667 . . . . 0.0 118.201 -171.144 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -71.27 -21.48 62.09 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.515 1.526 . . . . 0.0 114.07 -166.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.98 146.81 39.58 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.458 0.647 . . . . 0.0 110.988 -178.063 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -63.36 -37.9 89.07 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.726 0.81 . . . . 0.0 111.451 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -76.14 -38.03 57.27 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 178.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.35 -48.48 81.48 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-N 118.74 0.7 . . . . 0.0 110.565 171.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.18 -38.49 75.38 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 178.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -57.7 -46.99 83.61 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.996 0.816 . . . . 0.0 111.186 170.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -65.71 -29.6 70.16 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-O 117.799 -1.096 . . . . 0.0 111.525 171.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.419 ' HG3' ' CD2' ' A' ' 82' ' ' PHE . 18.8 ttp -69.24 -49.58 55.03 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 120.54 1.518 . . . . 0.0 109.839 -176.424 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -63.59 -40.01 87.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 124.116 0.966 . . . . 0.0 111.753 175.055 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -70.51 -43.65 69.24 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 121.663 -0.648 . . . . 0.0 111.076 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -48.93 -39.98 28.34 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 126.332 1.853 . . . . 0.0 111.667 166.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.61 ' HA ' HG12 ' A' ' 117' ' ' VAL . 11.3 m-85 -85.28 -22.06 28.74 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 120.602 -1.311 . . . . 0.0 113.197 -178.271 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 99.0 m -76.51 -19.19 58.23 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.877 0.871 . . . . 0.0 110.174 172.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.9 -60.62 2.27 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 129.507 3.123 . . . . 0.0 111.252 170.601 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.61 HG12 ' HA ' ' A' ' 114' ' ' TYR . 2.3 p -79.42 -48.43 21.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 124.412 1.085 . . . . 0.0 112.478 -158.051 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 4.9 m 33.92 126.14 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 129.013 2.925 . . . . 0.0 114.248 -139.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -76.15 -10.59 19.42 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 121.366 1.377 . . . . 0.0 115.018 -170.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.4 t 30.02 89.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 130.04 3.336 . . . . 0.0 113.102 175.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.569 ' H ' HD11 ' A' ' 126' ' ' ILE . 1.5 tt -104.76 -68.48 0.85 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 112.301 -2.227 . . . . 0.0 108.159 -138.37 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -66.76 -44.67 80.83 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.118 0.967 . . . . 0.0 110.476 167.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 159.82 12.51 0.04 OUTLIER Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.315 1.436 . . . . 0.0 115.527 178.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -147.28 168.68 10.78 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 119.491 1.646 . . . . 0.0 112.007 -179.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -54.87 142.87 74.05 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.984 2.456 . . . . 0.0 114.235 -175.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.569 HD11 ' H ' ' A' ' 121' ' ' LEU . 20.2 mm -106.87 -43.05 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.729 1.211 . . . . 0.0 112.423 -167.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 61.11 141.38 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 128.192 2.597 . . . . 0.0 115.101 -173.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.46 155.56 31.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 126.264 1.825 . . . . 0.0 111.323 171.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -151.47 162.25 41.28 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.344 1.858 . . . . 0.0 109.252 158.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -52.29 143.37 14.93 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 121.201 -0.937 . . . . 0.0 111.147 160.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.688 ' HB3' HG13 ' A' ' 60' ' ' VAL . 30.2 t -66.93 153.39 43.68 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.24 1.016 . . . . 0.0 112.179 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -64.76 -25.88 68.12 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.628 1.171 . . . . 0.0 112.349 168.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 27.2 m80 -92.74 169.82 10.19 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.553 1.541 . . . . 0.0 111.259 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.66 111.75 14.66 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 125.096 1.358 . . . . 0.0 108.915 175.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 74.71 145.88 0.08 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 128.411 2.684 . . . . 0.0 113.592 -170.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 26.2 tp -113.32 111.62 22.32 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.802 2.041 . . . . 0.0 110.994 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.507 0 C-N-CA 128.002 2.521 . . . . 0.0 110.552 -177.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.5 t . . . . . 0 N--CA 1.477 0.887 0 CA-C-O 119.78 -0.152 . . . . 0.0 110.787 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.15 -7.33 40.81 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.689 HG13 ' HB3' ' A' ' 131' ' ' SER 0.306 7.5 p -79.91 126.4 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 120.173 1.351 . . . . 0.0 112.021 164.065 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 21.7 mt -107.2 154.53 8.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 128.08 2.552 . . . . 0.0 108.249 169.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -122.47 145.66 48.09 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.785 1.634 . . . . 0.0 110.87 176.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.5 mt -125.55 143.94 37.36 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 127.438 2.295 . . . . 0.0 110.097 -171.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.5 mtm-85 -108.12 170.18 8.16 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 125.847 1.659 . . . . 0.0 111.072 169.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp 56.22 32.32 20.07 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 155.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.5 171.74 2.58 Favored Pre-proline 0 C--N 1.321 -0.669 0 C-N-CA 124.728 1.211 . . . . 0.0 110.731 165.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -52.02 174.21 0.09 OUTLIER 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 124.185 3.257 . . . . 0.0 114.262 156.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 31.2 pt -64.6 -35.95 76.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 126.517 1.927 . . . . 0.0 113.027 -170.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -142.9 -10.99 0.77 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.848 1.659 . . . . 0.0 113.48 171.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.538 HG22 ' H ' ' A' ' 71' ' ' THR 0.287 4.3 p 42.34 -151.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 128.249 2.619 . . . . 0.0 112.065 -172.623 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.538 ' H ' HG22 ' A' ' 70' ' ' VAL . 1.1 p -129.36 145.19 51.43 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 120.601 -1.312 . . . . 0.0 109.88 153.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.98 -38.63 83.13 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 122.042 -0.411 . . . . 0.0 110.621 173.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -54.01 -41.29 68.15 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 125.658 1.599 . . . . 0.0 112.711 174.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -63.14 -53.61 50.65 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.106 0.962 . . . . 0.0 111.68 172.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.9 t -59.59 -48.0 88.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.344 0.657 . . . . 0.0 112.522 -178.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.0 pp -73.93 -33.0 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 O-C-N 120.488 -1.383 . . . . 0.0 112.801 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.5 t -63.55 -30.73 71.81 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.494 1.043 . . . . 0.0 110.771 171.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 14.0 mt -76.1 -20.43 57.68 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 173.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -96.66 -17.32 33.66 Favored Glycine 0 CA--C 1.536 1.37 0 N-CA-C 115.374 0.91 . . . . 0.0 115.374 172.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.6 mt -60.81 -52.8 69.84 Favored Pre-proline 0 CA--C 1.54 0.588 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 -170.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -76.21 42.44 1.0 Allowed 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 123.957 3.105 . . . . 0.0 113.5 -179.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -129.54 -41.89 1.34 Allowed 'General case' 0 C--O 1.233 0.218 0 C-N-CA 126.74 2.016 . . . . 0.0 111.196 178.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -158.11 -101.22 0.17 Allowed Glycine 0 C--N 1.34 0.784 0 CA-C-O 122.059 0.81 . . . . 0.0 112.053 163.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 13.8 tptm -143.48 139.04 29.66 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 130.084 3.354 . . . . 0.0 104.326 166.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.699 HG22 ' HE2' ' A' ' 101' ' ' MET . 3.6 t -123.35 99.41 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 120.203 1.365 . . . . 0.0 109.333 -169.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 16.0 m -65.21 -38.23 89.77 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 128.73 2.812 . . . . 0.0 112.283 -161.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.58 161.5 42.45 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 177.336 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -133.69 175.06 9.78 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.109 0.964 . . . . 0.0 111.033 156.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.468 HD23 ' C ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -150.32 154.21 37.46 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.932 1.693 . . . . 0.0 109.29 178.739 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 5.7 mtt -129.93 111.27 12.39 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.357 1.063 . . . . 0.0 111.273 -178.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -74.15 86.11 1.88 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.752 0.821 . . . . 0.0 110.156 174.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.6 tpmt? -63.65 89.01 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.943 1.697 . . . . 0.0 110.476 174.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 179.76 -61.97 0.08 OUTLIER Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.359 1.457 . . . . 0.0 112.748 -166.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.94 20.71 3.81 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 125.77 1.628 . . . . 0.0 114.161 -169.183 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 14.1 m-20 56.3 42.61 27.63 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.87 1.668 . . . . 0.0 113.496 -173.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -106.47 165.22 11.43 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.862 -0.524 . . . . 0.0 111.603 175.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -153.8 165.61 35.49 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.672 1.189 . . . . 0.0 111.371 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.466 ' CD2' HG21 ' A' ' 60' ' ' VAL . 6.0 m-30 -112.71 156.65 22.43 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.671 1.588 . . . . 0.0 108.689 163.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.8 tt -141.92 108.75 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 125.283 1.433 . . . . 0.0 109.606 166.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -100.46 122.01 42.49 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 129.09 2.956 . . . . 0.0 111.275 -175.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.699 ' HE2' HG22 ' A' ' 85' ' ' VAL 0.298 3.1 ttm -121.75 160.66 24.11 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 -173.766 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -75.95 -13.95 60.25 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.288 1.035 . . . . 0.0 113.616 -162.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.35 144.73 38.35 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.675 1.19 . . . . 0.0 111.194 177.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -63.38 -35.73 81.36 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.56 1.144 . . . . 0.0 111.846 176.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -75.99 -39.97 54.76 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -56.35 -50.66 70.87 Favored 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 122.809 0.444 . . . . 0.0 110.293 170.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.09 -37.19 72.43 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 121.026 -1.046 . . . . 0.0 113.334 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -56.18 -47.2 78.78 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.118 0.872 . . . . 0.0 111.408 169.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -65.21 -34.34 78.14 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 118.08 -0.962 . . . . 0.0 110.88 174.013 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 3.2 ttp -64.12 -52.18 60.4 Favored 'General case' 0 C--N 1.343 0.298 0 CA-C-N 119.664 1.12 . . . . 0.0 110.633 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.91 -37.84 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 C-N-CA 125.259 1.424 . . . . 0.0 112.133 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -72.01 -44.07 64.02 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.486 0.714 . . . . 0.0 111.702 177.019 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -49.4 -36.87 23.33 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.17 0.988 . . . . 0.0 112.071 165.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.583 ' HA ' HG12 ' A' ' 117' ' ' VAL . 13.2 m-85 -87.23 -18.73 29.61 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 120.468 -1.395 . . . . 0.0 113.222 -177.277 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.22 -12.57 58.01 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.638 0.732 . . . . 0.0 110.912 170.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.91 -60.9 2.01 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 129.481 3.112 . . . . 0.0 111.874 168.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.583 HG12 ' HA ' ' A' ' 114' ' ' TYR . 4.2 p -78.08 -44.43 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.517 1.127 . . . . 0.0 113.622 -154.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.3 m 27.56 119.29 0.0 OUTLIER Pre-proline 0 N--CA 1.479 0.988 0 C-N-CA 129.855 3.262 . . . . 0.0 115.854 -139.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -76.53 -13.82 18.16 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 121.933 1.755 . . . . 0.0 116.073 -167.13 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.8 t 29.85 90.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 129.907 3.283 . . . . 0.0 114.067 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.48 ' H ' HD11 ' A' ' 126' ' ' ILE 0.265 1.1 tt -113.15 76.44 0.98 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 112.545 -2.116 . . . . 0.0 105.919 -134.592 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . 0.349 2.1 ppt_? 46.84 14.17 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 129.922 3.289 . . . . 0.0 116.73 -152.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -126.41 -113.52 1.87 Allowed Glycine 0 N--CA 1.472 1.065 0 C-N-CA 125.005 1.288 . . . . 0.0 116.254 -174.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.413 ' O ' HD13 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -148.88 173.74 3.98 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 128.229 2.612 . . . . 0.0 108.062 -174.242 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -44.73 105.25 0.06 OUTLIER 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 123.691 2.927 . . . . 0.0 116.386 -163.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.48 HD11 ' H ' ' A' ' 121' ' ' LEU . 3.9 mm -68.18 162.09 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 125.24 1.416 . . . . 0.0 108.426 172.268 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -134.63 147.65 50.22 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 121.789 -0.57 . . . . 0.0 111.177 174.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.83 146.13 32.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.95 1.3 . . . . 0.0 110.896 173.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -147.3 158.79 44.09 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.478 1.911 . . . . 0.0 108.865 160.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -53.77 146.88 12.74 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.236 -0.915 . . . . 0.0 111.549 163.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.689 ' HB3' HG13 ' A' ' 60' ' ' VAL . 30.0 t -69.72 156.11 39.49 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.977 0.911 . . . . 0.0 112.706 -179.041 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -66.95 -20.95 65.98 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.781 1.232 . . . . 0.0 112.888 167.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 40.4 m-70 -105.1 177.65 4.79 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.869 1.667 . . . . 0.0 112.188 -173.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 4.6 mptt -136.76 117.92 14.45 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 126.255 1.822 . . . . 0.0 109.679 -175.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 69.27 84.35 0.15 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.362 1.465 . . . . 0.0 113.328 176.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 31.4 tp -57.54 127.55 32.6 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.518 1.527 . . . . 0.0 112.586 177.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 99.1 mttt . . . . . 0 N--CA 1.473 0.697 0 C-N-CA 126.479 1.912 . . . . 0.0 110.581 173.615 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 57.4 m . . . . . 0 N--CA 1.475 0.799 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 31.0 mtp180 -50.84 -17.44 0.56 Allowed 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 128.902 2.881 . . . . 0.0 118.063 -177.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.645 HG13 ' HB3' ' A' ' 131' ' ' SER 0.265 3.4 p -96.98 137.17 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-N 120.261 1.391 . . . . 0.0 112.966 172.488 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.2 mt -118.88 130.78 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 127.93 2.492 . . . . 0.0 108.787 175.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -96.69 141.23 30.18 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.33 1.052 . . . . 0.0 110.719 176.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.3 mt -116.51 135.5 56.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 126.79 2.036 . . . . 0.0 108.291 -178.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.0 ptt-85 -119.53 171.48 8.32 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 127.387 2.275 . . . . 0.0 111.376 165.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.6 mmmt 61.29 23.34 13.58 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.579 1.552 . . . . 0.0 113.27 178.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.551 ' CD2' HD13 ' A' ' 121' ' ' LEU . 14.7 mt -69.31 173.97 3.35 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 126.313 1.845 . . . . 0.0 111.502 166.257 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -48.79 176.43 0.02 OUTLIER 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 123.042 2.495 . . . . 0.0 114.295 152.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 26.5 pt -64.81 -41.24 91.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.863 1.665 . . . . 0.0 112.961 -171.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -141.89 -11.85 0.87 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.016 1.726 . . . . 0.0 114.539 174.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.584 HG22 ' H ' ' A' ' 71' ' ' THR 0.309 2.9 p 43.0 -154.48 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 128.124 2.57 . . . . 0.0 113.412 -175.719 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.584 ' H ' HG22 ' A' ' 70' ' ' VAL . 10.8 t -142.32 148.53 38.14 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 120.065 -1.647 . . . . 0.0 111.665 171.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -55.6 -46.25 77.33 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.328 1.051 . . . . 0.0 111.961 -177.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -51.37 -43.18 51.51 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.526 1.06 . . . . 0.0 113.116 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -64.85 -56.03 15.91 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.778 0.831 . . . . 0.0 112.264 172.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 80.1 t -56.06 -53.81 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-O 121.657 0.741 . . . . 0.0 111.811 -176.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.9 pp -67.29 -39.54 83.08 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 CA-C-O 117.89 -1.052 . . . . 0.0 112.437 -178.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.8 t -68.52 -19.97 64.55 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 119.945 1.248 . . . . 0.0 111.384 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 26.6 mt -87.45 -21.78 25.35 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 172.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -99.36 -21.98 13.83 Favored Glycine 0 C--O 1.215 -1.077 0 CA-C-N 119.376 0.989 . . . . 0.0 113.705 177.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.8 mt -60.1 -35.51 28.69 Favored Pre-proline 0 CA--C 1.549 0.936 0 N-CA-C 118.785 2.883 . . . . 0.0 118.785 -173.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -55.36 7.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.949 1 C-N-CA 125.739 4.293 . . . . 0.0 120.728 -171.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -125.33 -19.42 5.08 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 -171.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -163.96 -100.06 0.14 Allowed Glycine 0 CA--C 1.524 0.62 0 CA-C-N 118.622 0.647 . . . . 0.0 112.444 -177.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 31.5 tptt -153.06 156.46 38.79 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 125.03 1.332 . . . . 0.0 107.891 165.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -131.22 106.04 11.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 119.812 1.187 . . . . 0.0 109.177 -174.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 33.9 p -104.66 -25.77 12.58 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.399 -1.273 . . . . 0.0 112.393 -162.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -138.03 152.49 48.91 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.101 0.864 . . . . 0.0 113.095 170.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -137.61 169.86 17.05 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.419 1.088 . . . . 0.0 111.267 159.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.513 HD23 ' C ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -147.63 153.22 39.1 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.091 1.356 . . . . 0.0 109.589 178.191 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 5.2 mtp -135.59 98.98 4.07 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.91 0.884 . . . . 0.0 110.326 -169.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -74.56 89.12 2.18 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.961 0.904 . . . . 0.0 110.693 177.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.9 pttt -122.01 60.24 0.98 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.227 1.811 . . . . 0.0 113.829 -178.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 84.1 -118.41 4.69 Favored Glycine 0 N--CA 1.47 0.96 0 C-N-CA 130.286 3.803 . . . . 0.0 113.769 4.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.5 mtmm -135.05 -95.39 0.27 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.69 1.596 . . . . 0.0 110.464 -167.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -155.88 32.32 0.35 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 129.737 3.215 . . . . 0.0 110.15 -176.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -122.8 163.52 20.07 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -173.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -154.51 166.16 34.17 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 126.364 1.866 . . . . 0.0 110.348 177.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.532 ' CD2' HG21 ' A' ' 60' ' ' VAL . 5.7 m-30 -112.5 149.44 32.64 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.867 1.667 . . . . 0.0 107.329 162.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.8 tt -128.83 121.03 53.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 C-N-CA 124.186 0.994 . . . . 0.0 108.883 159.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.499 ' HG3' ' H ' ' A' ' 136' ' ' LEU . 2.0 tm-20 -110.95 108.89 18.8 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 126.018 1.727 . . . . 0.0 110.159 -174.453 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -102.18 149.66 24.07 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 112.921 -1.945 . . . . 0.0 111.403 -176.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.43 -13.34 60.7 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.577 1.551 . . . . 0.0 114.065 -161.019 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.03 144.02 48.44 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.502 0.721 . . . . 0.0 110.789 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -63.46 -41.06 98.63 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.021 0.928 . . . . 0.0 111.575 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -74.78 -36.75 62.52 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 178.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.95 -46.34 89.74 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 118.708 0.685 . . . . 0.0 110.305 171.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.57 -37.79 80.18 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 175.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -56.38 -50.78 70.59 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 120.946 -1.096 . . . . 0.0 111.372 169.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -64.63 -26.08 68.24 Favored 'General case' 0 C--O 1.219 -0.548 0 O-C-N 120.597 -1.315 . . . . 0.0 111.374 173.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 18.8 ttp -69.35 -48.51 61.12 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-N 120.168 1.349 . . . . 0.0 110.38 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -64.27 -38.2 81.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 O-C-N 121.046 -1.034 . . . . 0.0 111.66 176.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -67.57 -47.33 70.09 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.358 1.063 . . . . 0.0 111.137 173.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -49.91 -34.19 19.68 Favored 'General case' 0 C--O 1.223 -0.329 0 C-N-CA 126.151 1.781 . . . . 0.0 112.236 169.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.528 ' HA ' HG12 ' A' ' 117' ' ' VAL . 17.0 m-85 -90.76 -18.91 24.15 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 120.437 -1.415 . . . . 0.0 113.312 -177.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -81.59 -10.62 59.39 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 121.581 0.705 . . . . 0.0 111.196 168.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.36 -63.96 1.24 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 130.226 3.41 . . . . 0.0 111.743 168.322 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.528 HG12 ' HA ' ' A' ' 114' ' ' TYR . 2.2 p -78.76 -46.5 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 124.626 1.17 . . . . 0.0 112.213 -156.625 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.4 m 37.33 123.85 0.0 OUTLIER Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 130.17 3.388 . . . . 0.0 115.023 -145.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -75.01 -20.96 16.32 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 121.88 1.72 . . . . 0.0 115.723 -168.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 5.6 t 42.4 99.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 129.595 3.158 . . . . 0.0 114.579 176.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.551 HD13 ' CD2' ' A' ' 66' ' ' LEU . 4.5 tt -135.3 -59.5 0.78 Allowed 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 113.591 -1.641 . . . . 0.0 109.844 -137.375 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.07 -3.04 14.67 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 156.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 98.76 17.06 29.3 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 125.392 1.472 . . . . 0.0 115.945 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -153.61 170.59 8.07 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 127.634 2.373 . . . . 0.0 109.794 171.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -47.02 142.13 11.49 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 124.009 3.139 . . . . 0.0 115.644 -179.003 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.428 HD11 ' H ' ' A' ' 121' ' ' LEU . 4.9 mm -117.08 143.81 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 127.347 2.259 . . . . 0.0 107.823 -177.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 9.1 m-30 -116.82 125.34 51.43 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 121.249 -0.907 . . . . 0.0 110.523 -166.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.1 149.95 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -178.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -149.26 160.1 43.69 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 127.525 2.33 . . . . 0.0 109.326 163.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -53.2 149.77 6.75 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 120.803 -1.186 . . . . 0.0 112.09 160.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.645 ' HB3' HG13 ' A' ' 60' ' ' VAL . 27.5 t -72.0 154.78 40.95 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.36 0.664 . . . . 0.0 112.207 177.191 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -66.61 -12.09 56.45 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.664 1.586 . . . . 0.0 113.261 168.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 65.2 m-70 -114.94 171.49 7.63 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.631 1.572 . . . . 0.0 112.837 -169.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -123.9 103.13 8.16 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 126.412 1.885 . . . . 0.0 110.961 -176.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 62.02 115.67 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 126.773 2.029 . . . . 0.0 113.364 -170.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.499 ' H ' ' HG3' ' A' ' 100' ' ' GLU . 24.0 tp -64.03 101.04 0.35 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.063 1.745 . . . . 0.0 111.86 168.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 67.4 mttm . . . . . 0 N--CA 1.469 0.513 0 C-N-CA 125.42 1.488 . . . . 0.0 109.139 170.902 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 45.3 m . . . . . 0 CA--C 1.549 0.938 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 46.5 mtp180 -55.13 -16.85 3.4 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 119.521 3.156 . . . . 0.0 119.521 -161.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.607 HG13 ' HB3' ' A' ' 131' ' ' SER 0.31 6.9 p -98.2 128.91 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 CA-C-N 121.366 1.894 . . . . 0.0 112.879 169.605 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 39.7 mt -100.4 155.01 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.84 1.656 . . . . 0.0 108.378 165.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -119.08 148.76 42.69 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.58 1.552 . . . . 0.0 110.957 173.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.4 mt -127.98 141.4 46.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 126.501 1.92 . . . . 0.0 109.639 -172.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.45 165.83 17.73 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 127.95 2.5 . . . . 0.0 109.885 167.245 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 67.31 23.59 9.26 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 125.148 1.379 . . . . 0.0 113.887 177.249 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.99 165.62 0.76 Allowed Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 127.7 2.4 . . . . 0.0 111.292 165.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -58.68 175.61 0.55 Allowed 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 123.007 2.471 . . . . 0.0 113.993 154.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 28.1 pt -73.81 -32.36 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 126.645 1.978 . . . . 0.0 113.47 -175.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -154.91 32.34 0.4 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.871 1.668 . . . . 0.0 111.357 -168.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -51.49 147.61 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.574 0.75 . . . . 0.0 112.267 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.401 HG23 ' H ' ' A' ' 74' ' ' GLU . 8.4 t -88.91 140.97 28.89 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 122.584 1.183 . . . . 0.0 112.092 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -57.84 -36.03 71.72 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.429 175.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -57.4 -36.0 74.63 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 123.643 0.639 . . . . 0.0 112.865 177.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.401 ' H ' HG23 ' A' ' 71' ' ' THR . 6.0 mm-40 -70.34 -51.33 30.83 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.955 1.302 . . . . 0.0 112.045 172.325 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 88.6 t -63.13 -41.49 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -176.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.0 pp -72.73 -34.8 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 O-C-N 120.285 -1.509 . . . . 0.0 112.413 174.04 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 73.1 m -66.54 -22.49 66.16 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 119.809 1.186 . . . . 0.0 111.886 174.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.6 mt -76.39 -30.86 57.68 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.016 0.927 . . . . 0.0 113.046 170.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -94.27 -11.89 56.81 Favored Glycine 0 CA--C 1.534 1.272 0 CA-C-N 119.818 1.19 . . . . 0.0 115.693 178.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.7 mt -64.71 -36.07 15.94 Favored Pre-proline 0 CA--C 1.545 0.764 0 N-CA-C 117.379 2.363 . . . . 0.0 117.379 -172.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.74 -5.18 1.69 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.575 2.85 . . . . 0.0 117.583 173.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -107.48 -33.76 7.25 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -163.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -164.92 -98.26 0.12 Allowed Glycine 0 CA--C 1.522 0.527 0 C-N-CA 124.201 0.905 . . . . 0.0 111.344 172.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 33.6 tptt -149.15 145.04 26.99 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 105.423 -2.065 . . . . 0.0 105.423 161.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.709 HG22 ' HE2' ' A' ' 101' ' ' MET . 3.5 t -128.48 89.13 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-N 120.331 1.423 . . . . 0.0 108.76 -171.13 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 31.3 p -77.58 -19.04 56.28 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 126.817 2.047 . . . . 0.0 113.016 -161.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -148.27 160.97 42.43 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 172.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.8 pp -140.32 172.23 13.03 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.775 1.23 . . . . 0.0 111.493 155.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.52 HD23 ' C ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -142.2 152.77 43.45 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 125.93 1.692 . . . . 0.0 108.747 175.709 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 5.4 mtt -132.19 102.64 5.87 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.159 0.984 . . . . 0.0 111.84 -174.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -72.43 100.17 2.63 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.587 1.155 . . . . 0.0 110.215 177.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -57.8 -23.0 50.33 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.82 1.648 . . . . 0.0 114.933 -176.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -63.97 -44.87 95.34 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.659 1.599 . . . . 0.0 115.956 -174.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -136.92 8.97 3.03 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 115.394 1.628 . . . . 0.0 115.394 -151.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 55.15 60.69 3.29 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.7 1.2 . . . . 0.0 110.745 -165.172 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -130.66 163.92 26.13 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.647 0.779 . . . . 0.0 112.255 177.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -155.36 167.19 31.2 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.917 1.287 . . . . 0.0 111.941 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.452 ' CD2' HG21 ' A' ' 60' ' ' VAL . 4.8 m-30 -110.19 152.17 26.4 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.594 1.958 . . . . 0.0 107.24 160.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 19.8 tt -134.09 105.4 6.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 125.252 1.421 . . . . 0.0 108.717 167.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 21.4 tp10 -96.95 124.1 40.84 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 127.377 2.271 . . . . 0.0 110.753 -175.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.709 ' HE2' HG22 ' A' ' 85' ' ' VAL 0.305 1.6 ttm -125.23 157.27 36.95 Favored 'General case' 0 C--O 1.223 -0.301 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 -177.213 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -69.97 -18.99 63.37 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.731 2.012 . . . . 0.0 113.318 -165.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.09 140.72 42.16 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 122.62 1.2 . . . . 0.0 111.875 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -61.84 -40.9 96.93 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.577 1.151 . . . . 0.0 111.137 177.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -74.54 -35.24 63.11 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -56.43 -55.4 34.05 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-N 118.755 0.707 . . . . 0.0 109.861 168.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.5 -34.36 76.99 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.444 1.02 . . . . 0.0 113.585 -178.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -56.56 -51.48 68.44 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.149 -0.969 . . . . 0.0 111.633 169.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -63.26 -31.21 72.31 Favored 'General case' 0 C--O 1.224 -0.257 0 O-C-N 121.289 -0.882 . . . . 0.0 110.972 174.583 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 6.2 ttp -71.0 -46.45 62.24 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.872 1.269 . . . . 0.0 111.886 -178.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -67.81 -37.88 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 O-C-N 120.843 -1.16 . . . . 0.0 111.366 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -71.78 -41.93 67.74 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.441 1.096 . . . . 0.0 111.285 176.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -48.78 -52.29 24.69 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.51 1.124 . . . . 0.0 110.819 165.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -77.9 12.41 1.77 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 118.74 -2.475 . . . . 0.0 113.344 178.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . 0.289 0.5 OUTLIER -116.35 -10.63 11.33 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.814 0.846 . . . . 0.0 113.067 167.494 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.482 ' CB ' HG23 ' A' ' 117' ' ' VAL . 0.4 OUTLIER -84.46 -42.51 15.53 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 126.029 1.732 . . . . 0.0 111.45 159.926 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.482 HG23 ' CB ' ' A' ' 116' ' ' SER . 85.5 t -116.22 -63.33 1.99 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.228 0 C-N-CA 124.937 1.295 . . . . 0.0 111.09 -144.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.0 m 68.96 136.47 0.05 OUTLIER Pre-proline 0 N--CA 1.484 1.255 0 C-N-CA 127.93 2.492 . . . . 0.0 112.588 -175.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -81.41 -9.76 12.4 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 122.605 2.203 . . . . 0.0 115.616 -174.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.5 t 26.57 90.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 130.867 3.667 . . . . 0.0 114.606 173.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.7 tt -118.98 -59.27 1.87 Allowed 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.716 -126.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.72 -1.56 39.06 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 153.369 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 106.27 32.55 3.69 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 124.999 1.285 . . . . 0.0 115.047 -177.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -139.49 150.51 63.96 Favored Pre-proline 0 CA--C 1.536 0.404 0 C-N-CA 125.342 1.457 . . . . 0.0 110.762 175.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -55.59 109.1 0.37 Allowed 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.354 2.703 . . . . 0.0 112.713 174.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.1 mm -78.19 145.77 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 124.892 1.277 . . . . 0.0 109.109 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 9.8 m-30 -111.02 128.71 55.94 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.82 0.848 . . . . 0.0 109.811 -173.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.3 tt -131.48 146.0 34.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 124.505 1.122 . . . . 0.0 111.667 -178.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -155.21 160.25 40.72 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.179 1.792 . . . . 0.0 108.958 160.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -50.71 148.57 3.89 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.271 -0.893 . . . . 0.0 112.767 167.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.607 ' HB3' HG13 ' A' ' 60' ' ' VAL . 37.5 t -68.24 158.02 34.23 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.509 0.724 . . . . 0.0 112.057 178.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -67.34 -13.36 61.93 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.563 1.145 . . . . 0.0 112.72 164.052 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 36.5 m-70 -111.81 178.82 4.2 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 127.778 2.431 . . . . 0.0 110.473 -178.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -125.6 -0.55 7.46 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 115.737 1.754 . . . . 0.0 115.737 -171.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -164.48 166.85 20.11 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 130.087 3.355 . . . . 0.0 108.302 -173.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 21.3 tp -134.67 105.51 6.52 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.431 1.492 . . . . 0.0 110.979 175.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 8.1 mmpt? . . . . . 0 CA--C 1.536 0.438 0 C-N-CA 126.216 1.806 . . . . 0.0 109.829 176.358 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.7 m . . . . . 0 N--CA 1.473 0.714 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 35.6 mtp180 61.72 -12.68 0.06 Allowed 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 128.789 2.836 . . . . 0.0 118.029 167.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.52 HG21 ' CD2' ' A' ' 98' ' ' PHE 0.298 2.4 p -107.52 139.86 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 124.306 1.042 . . . . 0.0 112.207 164.443 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.2 mt -113.54 152.35 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 128.927 2.891 . . . . 0.0 107.581 170.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 5.0 t-80 -120.25 150.46 40.64 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.353 1.461 . . . . 0.0 110.741 175.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.5 mt -129.9 141.73 45.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 126.114 1.766 . . . . 0.0 109.479 -175.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.86 173.38 6.91 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 127.348 2.259 . . . . 0.0 111.067 171.051 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 17.2 mmmt 62.67 28.88 16.78 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 126.064 1.745 . . . . 0.0 113.503 175.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.89 164.41 21.7 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 124.7 1.2 . . . . 0.0 110.802 173.648 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.477 ' HD3' HD13 ' A' ' 121' ' ' LEU . 52.2 Cg_exo -59.19 -175.82 0.09 OUTLIER 'Trans proline' 0 CA--C 1.537 0.64 1 C-N-CA 125.505 4.137 . . . . 0.0 113.965 157.287 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 30.3 pt -82.56 -30.18 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 126.665 1.986 . . . . 0.0 112.893 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -155.23 35.15 0.38 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.737 1.615 . . . . 0.0 111.331 -168.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -51.54 150.4 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.644 0.778 . . . . 0.0 111.398 174.041 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.425 HG23 ' H ' ' A' ' 74' ' ' GLU . 8.9 t -89.89 136.42 33.05 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 123.129 1.442 . . . . 0.0 112.413 -177.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.49 -37.59 65.46 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 114.487 -1.233 . . . . 0.0 111.395 173.43 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -56.21 -38.55 78.01 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.292 0.949 . . . . 0.0 113.605 175.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.425 ' H ' HG23 ' A' ' 71' ' ' THR . 11.2 mt-10 -65.85 -52.41 50.67 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.222 1.009 . . . . 0.0 111.214 171.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.4 t -60.75 -49.05 86.13 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 122.828 0.451 . . . . 0.0 112.203 -177.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.3 pp -70.51 -30.01 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 O-C-N 120.176 -1.577 . . . . 0.0 113.44 178.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 52.1 m -72.19 -17.84 61.9 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 119.175 0.898 . . . . 0.0 112.017 172.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 35.0 mt -85.52 -17.27 36.85 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 165.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.427 ' HA2' ' SD ' ' A' ' 110' ' ' MET . . . -74.12 -40.74 41.57 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 124.3 0.952 . . . . 0.0 112.901 167.175 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.9 mt -70.17 -34.12 3.91 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 119.097 2.999 . . . . 0.0 119.097 -155.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -59.36 4.16 0.15 Allowed 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 124.029 3.153 . . . . 0.0 117.551 175.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.434 ' CD2' ' HG3' ' A' ' 110' ' ' MET . 56.7 m-85 -120.34 -41.37 2.62 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -167.024 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -147.61 -113.62 0.75 Allowed Glycine 0 C--N 1.341 0.809 0 CA-C-O 122.374 0.986 . . . . 0.0 111.983 176.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.429 ' HB3' ' CG ' ' A' ' 102' ' ' ASN . 33.5 tptt -149.48 117.42 6.3 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 129.821 3.248 . . . . 0.0 104.78 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.437 HG22 ' HE2' ' A' ' 101' ' ' MET 0.29 16.3 t -127.29 82.68 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 CA-C-O 122.9 1.334 . . . . 0.0 109.145 -158.229 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.3 t -74.3 -26.82 60.41 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 127.054 2.142 . . . . 0.0 112.148 -162.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -141.02 166.22 25.4 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 123.268 1.508 . . . . 0.0 114.364 177.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -147.38 174.83 11.3 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 128.047 2.539 . . . . 0.0 109.874 160.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.516 HD23 ' C ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -145.63 155.77 43.23 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.96 1.304 . . . . 0.0 110.137 177.179 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 3.7 mtt -127.55 107.05 9.6 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.096 0.958 . . . . 0.0 111.705 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -76.08 64.66 1.98 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.958 0.903 . . . . 0.0 109.133 165.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 31.8 tttp -53.48 -45.19 69.51 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.706 1.602 . . . . 0.0 113.471 -159.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -70.73 -11.62 69.39 Favored Glycine 0 CA--C 1.539 1.592 0 C-N-CA 124.979 1.276 . . . . 0.0 115.797 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.6 -1.04 25.15 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 118.919 1.36 . . . . 0.0 113.191 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.4 m120 60.24 38.26 20.08 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.441 1.496 . . . . 0.0 112.64 -167.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -128.35 163.25 25.24 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.146 0.979 . . . . 0.0 112.062 -172.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -155.0 166.41 33.68 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.79 1.636 . . . . 0.0 112.035 -178.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.52 ' CD2' HG21 ' A' ' 60' ' ' VAL . 5.1 m-30 -113.66 155.8 24.87 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.769 2.028 . . . . 0.0 108.512 160.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.6 tt -137.02 130.61 45.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 119.632 1.106 . . . . 0.0 109.711 162.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -127.16 120.04 27.88 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.995 2.118 . . . . 0.0 112.241 -160.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.437 ' HE2' HG22 ' A' ' 85' ' ' VAL . 0.2 OUTLIER -134.72 154.34 51.61 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 112.994 -1.912 . . . . 0.0 113.232 -164.479 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.449 ' CG ' HG23 ' A' ' 103' ' ' THR . 4.2 p-10 -72.26 -20.31 61.55 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 115.29 1.589 . . . . 0.0 115.29 -158.253 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.449 HG23 ' CG ' ' A' ' 102' ' ' ASN . 9.4 p -136.66 138.07 40.71 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.702 1.201 . . . . 0.0 111.209 -175.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -58.42 -32.29 68.54 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.96 174.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -73.54 -42.67 61.41 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -54.34 -53.11 58.3 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 119.669 1.122 . . . . 0.0 109.518 169.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.62 -34.33 71.98 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -174.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -58.44 -50.47 73.61 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.109 0.868 . . . . 0.0 110.56 169.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -62.11 -33.1 73.83 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 121.583 -0.698 . . . . 0.0 110.99 175.154 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.434 ' HG3' ' CD2' ' A' ' 82' ' ' PHE . 11.1 ttp -73.46 -48.94 29.58 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 124.085 0.954 . . . . 0.0 112.263 -176.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 1.1 p -63.78 -38.72 83.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 124.341 1.056 . . . . 0.0 110.995 179.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -71.96 -42.59 66.4 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.881 1.272 . . . . 0.0 111.549 177.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -47.68 -55.56 9.19 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.909 1.284 . . . . 0.0 109.984 165.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -78.29 11.58 2.32 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 118.855 -2.403 . . . . 0.0 113.826 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 53.3 m -111.82 -15.48 13.37 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.633 1.173 . . . . 0.0 110.988 171.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.417 ' CB ' HG23 ' A' ' 117' ' ' VAL . 0.4 OUTLIER -89.41 -44.59 10.07 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.733 2.013 . . . . 0.0 111.841 163.763 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.417 HG23 ' CB ' ' A' ' 116' ' ' SER . 96.4 t -112.35 -49.73 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 125.02 1.328 . . . . 0.0 111.951 -143.395 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.445 ' CG2' ' H ' ' A' ' 126' ' ' ILE . 31.5 m 69.81 141.45 0.08 OUTLIER Pre-proline 0 N--CA 1.485 1.29 0 C-N-CA 128.21 2.604 . . . . 0.0 112.308 -173.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -82.05 -12.88 10.52 Favored 'Trans proline' 0 CA--C 1.549 1.251 0 C-N-CA 123.385 2.723 . . . . 0.0 114.105 -176.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 22.0 t 50.6 101.17 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 131.144 3.778 . . . . 0.0 115.541 175.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.477 HD13 ' HD3' ' A' ' 67' ' ' PRO . 1.2 tt -92.08 101.62 14.16 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 123.763 0.825 . . . . 0.0 109.819 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 45.6 62.47 2.18 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.735 2.014 . . . . 0.0 112.086 178.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 81.2 6.93 89.01 Favored Glycine 0 CA--C 1.537 1.426 0 N-CA-C 116.015 1.166 . . . . 0.0 116.015 173.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 35.1 tp60 -131.72 142.49 45.45 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 125.83 1.652 . . . . 0.0 110.109 -173.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -61.1 166.31 10.94 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 123.119 2.546 . . . . 0.0 114.529 179.026 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.445 ' H ' ' CG2' ' A' ' 118' ' ' THR . 0.6 OUTLIER -136.79 154.41 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.797 1.639 . . . . 0.0 109.989 178.088 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -120.45 91.05 3.45 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 124.33 1.052 . . . . 0.0 109.056 -155.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -95.95 152.76 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 124.913 1.285 . . . . 0.0 111.994 -179.1 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -147.92 161.48 41.22 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.75 1.62 . . . . 0.0 108.339 152.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.91 153.31 4.86 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.006 -1.059 . . . . 0.0 112.041 158.064 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.498 ' OG ' HG13 ' A' ' 60' ' ' VAL . 54.7 p -65.11 170.17 4.76 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 177.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -87.64 6.75 33.13 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.405 1.482 . . . . 0.0 112.874 164.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -132.84 -176.01 3.97 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.445 1.498 . . . . 0.0 113.243 -161.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 42.0 tttp -140.26 101.35 4.11 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.536 1.935 . . . . 0.0 111.162 -177.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 64.74 108.11 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 127.448 2.299 . . . . 0.0 114.611 -174.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 18.8 tp -63.88 124.7 22.2 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.245 1.818 . . . . 0.0 111.956 169.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt . . . . . 0 N--CA 1.473 0.715 0 C-N-CA 127.163 2.185 . . . . 0.0 110.634 167.288 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 30.0 p . . . . . 0 CA--C 1.547 0.836 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 32.2 mtp180 -61.02 -6.09 1.72 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 130.541 3.537 . . . . 0.0 118.339 -165.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.617 HG13 ' HB3' ' A' ' 131' ' ' SER 0.254 2.5 p -101.17 131.35 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 120.809 1.64 . . . . 0.0 112.092 166.973 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 16.9 mt -103.24 153.92 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 127.379 2.272 . . . . 0.0 109.478 165.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -120.39 143.95 48.16 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.772 1.629 . . . . 0.0 110.528 175.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.9 mt -122.58 133.46 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 127.071 2.148 . . . . 0.0 109.776 -173.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 28.9 mtt180 -88.39 166.63 14.12 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.672 1.589 . . . . 0.0 110.543 173.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.9 mtpp 50.51 35.42 11.23 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 155.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.79 162.82 0.71 Allowed Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 126.446 1.898 . . . . 0.0 111.521 162.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -56.14 179.24 0.1 OUTLIER 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 124.326 3.351 . . . . 0.0 114.912 156.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 31.1 pt -77.36 -30.41 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 126.599 1.96 . . . . 0.0 113.168 -176.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -157.75 36.86 0.26 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.993 1.717 . . . . 0.0 110.971 -170.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -50.27 151.05 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.966 0.906 . . . . 0.0 111.627 175.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.7 t -85.19 128.05 34.52 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 123.583 1.659 . . . . 0.0 111.11 174.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -60.9 -22.68 64.57 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 114.823 -1.081 . . . . 0.0 111.773 174.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -62.38 -35.91 92.35 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 125.224 1.392 . . . . 0.0 114.024 167.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -67.88 -46.46 71.61 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.576 -0.955 . . . . 0.0 109.812 171.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 62.0 t -64.85 -44.55 96.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -176.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -75.81 -25.7 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-N 121.973 2.17 . . . . 0.0 114.051 173.292 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.7 t -62.61 -28.05 69.63 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 119.705 1.139 . . . . 0.0 111.126 166.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 14.8 mt -81.84 -16.02 52.18 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 170.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.43 ' HA2' ' SD ' ' A' ' 110' ' ' MET . . . -91.71 -25.69 22.17 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 115.091 0.796 . . . . 0.0 115.091 171.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 13.4 mt -74.36 -26.72 0.7 Allowed Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 117.974 2.583 . . . . 0.0 117.974 -165.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -59.87 -0.62 0.89 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.174 2.583 . . . . 0.0 116.615 167.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -114.6 -43.92 3.12 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 -168.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -148.42 -112.85 0.68 Allowed Glycine 0 C--N 1.338 0.658 0 CA-C-O 122.587 1.104 . . . . 0.0 112.652 173.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.42 ' HB3' ' CG ' ' A' ' 102' ' ' ASN . 32.7 tptt -146.1 123.02 11.34 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 130.545 3.538 . . . . 0.0 103.894 176.394 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.466 HG22 ' HE2' ' A' ' 101' ' ' MET 0.276 17.8 t -130.48 85.79 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 CA-C-O 122.604 1.192 . . . . 0.0 109.432 -159.564 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 22.2 p -72.49 -36.04 68.32 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 112.74 -2.027 . . . . 0.0 111.741 -162.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -135.01 160.3 38.76 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 122.822 1.296 . . . . 0.0 114.047 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -149.88 171.95 15.95 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 126.454 1.902 . . . . 0.0 110.487 161.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.506 HD23 ' C ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -146.7 155.03 42.11 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.49 1.116 . . . . 0.0 110.101 -175.187 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 3.0 mtt -132.94 102.99 5.84 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.357 1.063 . . . . 0.0 111.476 -174.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.0 69.43 3.29 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 122.341 1.067 . . . . 0.0 109.748 168.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -60.53 -20.6 60.78 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.296 1.438 . . . . 0.0 113.25 -177.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.63 -30.34 62.25 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 125.358 1.456 . . . . 0.0 114.968 169.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.6 mtmt -132.39 -5.67 3.35 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 115.548 1.684 . . . . 0.0 115.548 -170.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.7 m120 72.61 38.71 0.76 Allowed 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 127.614 2.366 . . . . 0.0 113.611 -173.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -112.13 167.17 10.61 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.546 0.738 . . . . 0.0 111.271 171.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -147.39 164.48 33.18 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.499 1.519 . . . . 0.0 111.232 172.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.476 ' CD2' HG21 ' A' ' 60' ' ' VAL . 6.7 m-30 -109.27 157.33 18.94 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.44 1.496 . . . . 0.0 107.99 160.251 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 19.2 tt -137.31 124.33 29.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 124.599 1.16 . . . . 0.0 109.216 162.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -120.91 123.6 42.9 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 127.514 2.326 . . . . 0.0 111.445 -167.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.466 ' HE2' HG22 ' A' ' 85' ' ' VAL . 0.1 OUTLIER -133.99 157.45 46.04 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 112.724 -2.035 . . . . 0.0 113.222 -164.287 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.455 ' CG ' HG23 ' A' ' 103' ' ' THR . 2.5 p-10 -70.78 -23.06 62.32 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.376 1.251 . . . . 0.0 114.376 -161.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.455 HG23 ' CG ' ' A' ' 102' ' ' ASN . 9.8 p -135.58 140.64 44.79 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 122.622 1.201 . . . . 0.0 111.772 -175.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -59.83 -33.01 71.21 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.084 174.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -74.49 -41.61 60.41 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -54.54 -51.67 64.48 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 119.4 1.0 . . . . 0.0 109.803 168.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.28 -36.09 74.15 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -176.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -58.91 -46.98 86.6 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.226 -0.921 . . . . 0.0 111.034 170.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -64.32 -32.7 74.41 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.024 -1.048 . . . . 0.0 111.278 173.012 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.43 ' SD ' ' HA2' ' A' ' 79' ' ' GLY . 12.9 ttp -71.75 -48.76 44.65 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 119.729 1.15 . . . . 0.0 111.238 -176.354 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.16 -40.44 89.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 124.498 1.119 . . . . 0.0 111.071 177.336 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -68.67 -44.77 73.35 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.512 0.725 . . . . 0.0 110.445 177.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -50.15 -38.05 37.5 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.114 1.366 . . . . 0.0 112.25 168.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.442 ' HA ' HG12 ' A' ' 117' ' ' VAL . 25.8 m-85 -92.92 -11.16 34.09 Favored 'General case' 0 C--O 1.231 0.127 0 O-C-N 120.064 -1.648 . . . . 0.0 113.131 -177.187 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 84.2 m -80.89 -18.22 47.97 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.37 1.068 . . . . 0.0 110.069 166.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.04 -62.2 1.63 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 129.621 3.168 . . . . 0.0 112.3 170.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.442 HG12 ' HA ' ' A' ' 114' ' ' TYR . 1.4 p -83.02 -44.51 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 124.418 1.087 . . . . 0.0 113.018 -151.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.0 m 38.0 121.54 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.068 0 C-N-CA 130.674 3.589 . . . . 0.0 114.636 -147.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -69.84 -33.2 16.74 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 121.204 1.269 . . . . 0.0 114.118 -171.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.2 t 50.89 99.17 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 128.757 2.823 . . . . 0.0 112.313 -176.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.589 ' H ' HD11 ' A' ' 126' ' ' ILE . 1.2 tt -116.33 -73.37 0.65 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 112.201 -2.272 . . . . 0.0 107.472 -146.147 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.53 -35.01 79.59 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.56 1.144 . . . . 0.0 111.643 172.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 147.41 4.38 0.39 Allowed Glycine 0 CA--C 1.533 1.2 0 C-N-CA 125.083 1.325 . . . . 0.0 116.229 175.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -152.6 167.59 13.02 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 119.15 1.475 . . . . 0.0 111.272 178.594 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -45.3 110.06 0.22 Allowed 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 124.347 3.364 . . . . 0.0 116.447 -171.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.589 HD11 ' H ' ' A' ' 121' ' ' LEU . 2.5 mm -74.14 166.19 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 125.175 1.39 . . . . 0.0 107.707 166.05 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -140.66 156.34 46.26 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.218 -0.926 . . . . 0.0 110.483 168.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.21 153.27 38.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 125.517 1.527 . . . . 0.0 111.098 176.337 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -150.2 167.99 25.3 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.357 1.463 . . . . 0.0 108.772 154.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -55.12 149.47 12.19 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 120.878 -1.139 . . . . 0.0 111.74 159.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.617 ' HB3' HG13 ' A' ' 60' ' ' VAL . 30.8 t -69.28 153.16 44.08 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.897 0.879 . . . . 0.0 112.669 176.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -61.86 -29.13 69.98 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.047 1.339 . . . . 0.0 112.15 167.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 24.6 m80 -95.11 175.96 6.42 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.592 1.957 . . . . 0.0 111.548 -174.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -134.64 120.53 19.67 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.272 1.429 . . . . 0.0 111.072 -177.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 58.55 90.39 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 128.201 2.601 . . . . 0.0 114.131 -178.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 35.9 tp -59.04 128.73 38.66 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.2 1.4 . . . . 0.0 112.111 176.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt . . . . . 0 N--CA 1.469 0.483 0 C-N-CA 126.348 1.859 . . . . 0.0 110.523 170.075 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 49.1 m . . . . . 0 N--CA 1.479 1.015 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 34.4 mtp180 -55.82 -7.43 0.3 Allowed 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 129.909 3.284 . . . . 0.0 119.324 -170.086 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.658 HG13 ' HB3' ' A' ' 131' ' ' SER . 2.6 p -105.66 134.71 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-N 119.759 1.163 . . . . 0.0 111.878 169.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 10.4 mt -106.0 150.25 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 126.433 1.893 . . . . 0.0 108.561 167.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -114.03 143.97 43.87 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.082 1.353 . . . . 0.0 110.569 173.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 7.2 mt -118.46 144.8 25.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 126.488 1.915 . . . . 0.0 108.395 -175.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.23 167.87 17.75 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 127.739 2.415 . . . . 0.0 109.639 168.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.72 27.91 17.27 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.816 1.246 . . . . 0.0 113.229 178.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 28.2 mt -66.96 177.25 0.9 Allowed Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 125.05 1.34 . . . . 0.0 109.792 163.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -51.88 -171.97 0.01 OUTLIER 'Trans proline' 0 CA--C 1.545 1.062 0 C-N-CA 123.181 2.587 . . . . 0.0 114.507 147.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.418 HG12 ' H ' ' A' ' 68' ' ' ILE . 3.7 mm -60.31 -47.26 93.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 127.427 2.291 . . . . 0.0 111.189 -176.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -155.51 -7.44 0.12 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 129.334 3.054 . . . . 0.0 111.666 -162.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.429 HG22 ' H ' ' A' ' 71' ' ' THR 0.307 7.9 p 26.05 -127.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 128.903 2.881 . . . . 0.0 113.457 -167.956 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.429 ' H ' HG22 ' A' ' 70' ' ' VAL . 9.8 t -154.51 143.8 21.27 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 120.004 1.275 . . . . 0.0 110.421 163.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -58.31 -42.12 86.0 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 123.562 0.745 . . . . 0.0 112.276 -175.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -55.79 -37.94 71.33 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 123.861 0.743 . . . . 0.0 112.516 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -69.12 -53.37 20.53 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.454 1.102 . . . . 0.0 112.125 173.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 97.7 t -58.97 -46.69 91.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 122.941 0.496 . . . . 0.0 112.14 -176.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.0 pp -73.05 -33.74 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 O-C-N 120.674 -1.266 . . . . 0.0 112.531 177.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 64.0 m -69.55 -21.44 63.64 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 120.047 1.294 . . . . 0.0 111.599 175.136 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.9 mt -77.63 -27.67 51.17 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 170.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -89.98 -21.25 39.84 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-N 119.239 0.927 . . . . 0.0 114.526 176.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.0 mt -64.05 -37.65 28.68 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 117.858 2.54 . . . . 0.0 117.858 -169.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.48 -4.01 1.09 Allowed 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.787 2.991 . . . . 0.0 116.845 171.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -106.97 -35.34 6.93 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 113.496 0.925 . . . . 0.0 113.496 -167.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -154.58 -108.37 0.31 Allowed Glycine 0 C--N 1.338 0.647 0 CA-C-O 122.622 1.123 . . . . 0.0 111.964 172.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.416 ' HB3' ' CG ' ' A' ' 102' ' ' ASN . 32.0 tptt -149.61 122.14 8.54 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 130.415 3.486 . . . . 0.0 104.135 175.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.431 HG22 ' HE2' ' A' ' 101' ' ' MET 0.308 20.8 t -128.74 83.98 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 CA-C-N 120.034 1.288 . . . . 0.0 109.955 -160.409 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.5 t -79.72 -21.22 44.84 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 126.894 2.077 . . . . 0.0 112.765 -163.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -141.51 161.74 37.17 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 175.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -149.37 171.82 15.92 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.577 2.351 . . . . 0.0 110.551 162.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.529 HD13 ' C ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -142.99 154.47 44.05 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.266 1.426 . . . . 0.0 108.772 172.692 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 3.7 mtt -128.28 105.62 8.47 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.748 1.219 . . . . 0.0 110.434 -175.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.415 HD13 HD11 ' A' ' 89' ' ' LEU . 1.6 mm? -74.11 71.52 1.64 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.186 0.994 . . . . 0.0 110.525 173.127 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -49.85 118.87 3.11 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.835 1.654 . . . . 0.0 111.574 -176.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.04 -6.37 82.72 Favored Glycine 0 CA--C 1.539 1.556 0 CA-C-O 118.279 -1.289 . . . . 0.0 116.178 177.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.51 -2.98 50.72 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-N 119.837 1.818 . . . . 0.0 113.154 165.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.9 m120 63.24 27.37 15.5 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.313 1.845 . . . . 0.0 113.283 -167.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -124.58 164.51 19.66 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.513 0.725 . . . . 0.0 112.302 -168.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -164.12 170.71 16.07 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.091 1.756 . . . . 0.0 111.177 -178.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.478 ' CD2' HG21 ' A' ' 60' ' ' VAL . 4.3 m-30 -116.74 156.02 27.9 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.448 1.899 . . . . 0.0 108.088 164.405 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 17.4 tt -138.14 124.41 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 124.722 1.209 . . . . 0.0 109.138 164.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -122.79 122.17 38.04 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 127.034 2.134 . . . . 0.0 111.474 -164.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.431 ' HE2' HG22 ' A' ' 85' ' ' VAL . 0.9 OUTLIER -132.63 157.33 45.07 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 113.389 -1.732 . . . . 0.0 112.97 -166.028 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.416 ' CG ' ' HB3' ' A' ' 84' ' ' LYS . 2.2 p-10 -71.79 -19.34 62.02 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 114.065 -1.425 . . . . 0.0 114.308 -159.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.415 HG23 ' CG ' ' A' ' 102' ' ' ASN . 16.8 p -137.83 142.64 40.77 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 122.956 1.36 . . . . 0.0 111.766 -176.375 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -59.43 -37.42 78.04 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 114.125 -1.398 . . . . 0.0 110.706 176.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -71.64 -40.35 69.79 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 179.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.0 -52.53 62.85 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 119.403 1.001 . . . . 0.0 110.073 169.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.99 -38.16 82.35 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -56.15 -48.24 76.65 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.818 -0.551 . . . . 0.0 111.048 171.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -64.84 -35.01 79.74 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 118.407 -0.806 . . . . 0.0 111.233 173.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 8.2 ttp -67.76 -48.55 66.07 Favored 'General case' 0 C--N 1.343 0.303 0 C-N-CA 124.554 1.142 . . . . 0.0 110.554 -175.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.84 -40.64 88.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 C-N-CA 124.752 1.221 . . . . 0.0 111.761 178.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -67.71 -45.3 75.48 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.377 0.671 . . . . 0.0 110.693 177.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -50.97 -38.31 49.98 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.604 1.562 . . . . 0.0 112.482 167.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.442 ' HA ' HG12 ' A' ' 117' ' ' VAL . 17.8 m-85 -88.73 -16.47 32.15 Favored 'General case' 0 CA--C 1.517 -0.289 0 O-C-N 119.966 -1.709 . . . . 0.0 112.88 -178.167 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 70.0 m -79.06 -18.61 53.13 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.434 1.093 . . . . 0.0 109.865 169.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.42 -60.58 2.22 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 129.384 3.074 . . . . 0.0 111.697 169.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.442 HG12 ' HA ' ' A' ' 114' ' ' TYR . 0.8 OUTLIER -88.47 -48.07 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.048 0.939 . . . . 0.0 112.955 -153.302 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.2 m 43.08 125.28 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.88 0 C-N-CA 129.866 3.266 . . . . 0.0 114.267 -148.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -70.14 -35.35 11.67 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 121.416 1.411 . . . . 0.0 114.012 -171.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.6 t 53.86 102.33 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 128.597 2.759 . . . . 0.0 113.031 -178.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.532 ' H ' HD11 ' A' ' 126' ' ' ILE . 0.8 OUTLIER -123.59 -71.46 0.72 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 112.479 -2.146 . . . . 0.0 108.28 -147.293 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.78 -42.51 99.09 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.521 0.728 . . . . 0.0 111.086 171.456 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 158.18 -2.47 0.12 Allowed Glycine 0 CA--C 1.533 1.198 0 N-CA-C 116.208 1.243 . . . . 0.0 116.208 173.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -148.13 169.56 9.07 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 119.54 1.67 . . . . 0.0 111.192 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -50.98 116.07 2.41 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.734 2.956 . . . . 0.0 116.535 -166.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.532 HD11 ' H ' ' A' ' 121' ' ' LEU . 4.3 mm -76.27 150.06 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 126.364 1.866 . . . . 0.0 109.166 174.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 10.2 m-30 -114.7 136.7 52.77 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.042 -1.036 . . . . 0.0 110.787 -176.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.5 149.3 32.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 125.1 1.36 . . . . 0.0 112.319 176.335 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -153.46 164.9 37.39 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.763 2.025 . . . . 0.0 109.627 153.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -53.19 152.23 4.53 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 120.873 -1.142 . . . . 0.0 112.593 167.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.658 ' HB3' HG13 ' A' ' 60' ' ' VAL . 27.9 t -76.18 157.87 32.27 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.726 0.81 . . . . 0.0 113.086 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -68.51 -12.03 60.68 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.854 1.662 . . . . 0.0 113.636 168.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 42.6 m-70 -119.6 -178.69 3.68 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.484 1.513 . . . . 0.0 112.895 -170.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -136.88 124.95 22.9 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.981 2.112 . . . . 0.0 110.639 178.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 58.28 93.05 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 127.185 2.194 . . . . 0.0 113.946 -178.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 28.9 tp -64.01 110.96 2.31 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.666 1.587 . . . . 0.0 111.814 178.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt . . . . . 0 N--CA 1.473 0.678 0 C-N-CA 126.204 1.802 . . . . 0.0 110.425 174.989 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.1 t . . . . . 0 N--CA 1.473 0.714 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 25.8 mtp180 61.5 -8.54 0.09 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 128.836 2.854 . . . . 0.0 117.839 171.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.681 HG13 ' HB3' ' A' ' 131' ' ' SER 0.3 3.9 p -104.81 130.3 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 120.906 1.685 . . . . 0.0 113.409 175.347 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.8 mp -103.21 155.21 5.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 127.617 2.367 . . . . 0.0 108.103 169.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -126.93 140.96 51.94 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.801 2.04 . . . . 0.0 111.024 177.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.6 mt -120.75 136.63 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 128.309 2.644 . . . . 0.0 109.857 -170.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.6 mtt180 -97.19 176.65 5.85 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 120.517 1.508 . . . . 0.0 111.02 172.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp 45.34 35.79 2.01 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 127.739 2.415 . . . . 0.0 117.068 159.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.8 mp -52.03 157.42 2.16 Favored Pre-proline 0 CA--C 1.559 1.303 0 C-N-CA 124.771 1.228 . . . . 0.0 110.912 165.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -42.0 -65.72 0.18 Allowed 'Trans proline' 0 CA--C 1.537 0.648 1 C-N-CA 126.033 4.488 . . . . 0.0 115.385 177.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 pt -160.54 -55.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 130.262 3.425 . . . . 0.0 107.898 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -145.99 -9.47 0.52 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.31 1.444 . . . . 0.0 114.508 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.518 HG22 ' H ' ' A' ' 71' ' ' THR 0.28 1.7 p 45.14 -154.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 127.611 2.364 . . . . 0.0 112.997 -178.616 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.518 ' H ' HG22 ' A' ' 70' ' ' VAL . 4.0 t -137.43 143.0 41.63 Favored 'General case' 0 C--O 1.238 0.499 0 O-C-N 120.396 -1.44 . . . . 0.0 110.466 160.441 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -58.46 -33.41 69.71 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.763 177.05 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -56.59 -41.3 89.16 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 123.953 0.787 . . . . 0.0 112.96 175.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -64.53 -55.83 18.0 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.815 0.846 . . . . 0.0 111.11 171.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.7 t -61.05 -44.22 97.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -173.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.9 pp -69.44 -32.65 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 O-C-N 120.301 -1.499 . . . . 0.0 112.652 175.104 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.6 p -64.28 -21.23 66.52 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 119.738 1.153 . . . . 0.0 112.214 173.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 86.8 mt -91.6 -16.14 27.55 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 173.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -90.02 -22.78 34.52 Favored Glycine 0 CA--C 1.538 1.509 0 CA-C-N 119.144 0.884 . . . . 0.0 113.214 168.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 80' ' ' LEU . 21.0 mt -73.37 -14.98 0.25 Allowed Pre-proline 0 CA--C 1.543 0.677 0 N-CA-C 119.314 3.079 . . . . 0.0 119.314 -175.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -60.5 -1.53 1.49 Allowed 'Trans proline' 0 C--N 1.348 0.525 0 CA-C-N 123.152 2.162 . . . . 0.0 116.62 168.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -122.05 -53.62 1.94 Allowed 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 114.698 1.369 . . . . 0.0 114.698 -168.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -144.06 -106.57 0.54 Allowed Glycine 0 C--N 1.337 0.598 0 C-N-CA 124.149 0.88 . . . . 0.0 111.985 -178.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 13.7 tptm -143.41 -7.52 0.78 Allowed 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 116.805 2.15 . . . . 0.0 116.805 -174.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 101' ' ' MET . 0.1 OUTLIER 30.26 87.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 129.029 2.932 . . . . 0.0 113.37 -176.782 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 24.1 m -55.42 -42.3 73.94 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 127.378 2.271 . . . . 0.0 111.695 -175.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -149.72 169.53 20.83 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.4 pp -139.49 171.95 13.51 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.97 1.708 . . . . 0.0 112.189 155.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.529 HD13 ' C ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -144.18 151.95 40.22 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.176 1.79 . . . . 0.0 108.476 173.867 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 5.1 mtt -128.77 103.52 7.11 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.326 1.05 . . . . 0.0 111.924 -175.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.444 ' CD1' HD11 ' A' ' 89' ' ' LEU . 1.2 mm? -74.43 96.02 2.82 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.927 1.291 . . . . 0.0 110.878 172.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 49.4 mttp -61.17 -19.18 61.26 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 171.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -53.33 -61.07 7.33 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 126.379 1.942 . . . . 0.0 114.968 -177.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.34 27.06 4.79 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.632 1.973 . . . . 0.0 112.239 -175.116 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 59.45 48.5 9.78 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.723 2.009 . . . . 0.0 113.709 -177.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . 0.28 0.0 OUTLIER -117.59 176.14 5.31 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.042 0.937 . . . . 0.0 111.935 176.838 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -166.48 165.81 16.73 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 120.276 -1.515 . . . . 0.0 111.018 -174.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.439 ' CD2' HG21 ' A' ' 60' ' ' VAL . 4.2 m-30 -112.46 157.37 21.17 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.908 1.683 . . . . 0.0 108.484 166.198 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 8.6 tt -143.62 108.32 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 126.111 1.764 . . . . 0.0 107.618 170.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -115.34 131.91 56.78 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.846 2.058 . . . . 0.0 112.014 -166.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.452 ' HA ' ' HA ' ' A' ' 85' ' ' VAL 0.292 1.2 tpp -130.46 153.5 48.72 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 116.835 2.161 . . . . 0.0 116.835 -161.498 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -69.0 -9.2 51.23 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.182 1.793 . . . . 0.0 114.675 -165.191 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -148.76 143.89 26.68 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.459 1.504 . . . . 0.0 110.111 -177.279 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -66.54 -32.76 74.31 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.221 1.008 . . . . 0.0 111.726 176.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -71.83 -47.44 53.16 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.346 0.658 . . . . 0.0 112.09 177.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.79 -46.47 87.48 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 122.83 0.452 . . . . 0.0 110.619 175.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.22 -40.65 82.0 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -60.77 -46.43 90.48 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.851 -0.531 . . . . 0.0 111.102 171.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -63.3 -29.09 70.48 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 120.421 -1.425 . . . . 0.0 111.198 171.29 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 10.4 ttp -67.06 -52.11 46.27 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 120.13 1.332 . . . . 0.0 110.048 -177.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.74 -40.51 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 124.547 1.139 . . . . 0.0 111.85 176.2 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -71.29 -44.07 65.91 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.751 0.82 . . . . 0.0 111.824 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -48.42 -38.66 20.22 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.454 1.501 . . . . 0.0 111.629 166.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.64 ' HA ' HG12 ' A' ' 117' ' ' VAL . 11.6 m-85 -85.98 -22.26 27.42 Favored 'General case' 0 N--CA 1.445 -0.715 0 O-C-N 120.649 -1.282 . . . . 0.0 113.248 -175.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.08 -15.89 57.54 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.984 0.897 . . . . 0.0 111.107 171.5 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.7 -59.43 2.79 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 128.932 2.893 . . . . 0.0 111.045 169.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.64 HG12 ' HA ' ' A' ' 114' ' ' TYR . 3.2 p -78.01 -48.92 22.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 124.474 1.11 . . . . 0.0 112.43 -158.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.5 m 28.78 121.91 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.038 0 C-N-CA 129.044 2.938 . . . . 0.0 114.789 -138.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -80.86 -7.65 13.34 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 121.789 1.659 . . . . 0.0 115.002 -167.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 4.1 t 28.88 85.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 C-N-CA 130.239 3.416 . . . . 0.0 114.041 173.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . 0.268 9.7 tt -106.95 -23.6 12.29 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 118.01 -1.476 . . . . 0.0 112.507 -121.126 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.35 -6.68 11.25 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.633 1.173 . . . . 0.0 113.997 148.053 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 139.74 11.51 0.72 Allowed Glycine 0 CA--C 1.536 1.364 0 N-CA-C 118.059 1.984 . . . . 0.0 118.059 -169.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.8 155.75 69.06 Favored Pre-proline 0 C--N 1.346 0.417 0 CA-C-N 120.771 2.286 . . . . 0.0 112.999 172.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.04 152.72 49.68 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.985 2.456 . . . . 0.0 113.674 -177.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 29.8 mm -117.74 -53.88 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 123.646 0.778 . . . . 0.0 112.917 -163.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 62.13 151.14 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.975 2.11 . . . . 0.0 115.255 -170.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.45 157.06 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 125.914 1.686 . . . . 0.0 110.799 174.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -147.75 166.06 28.65 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.384 1.474 . . . . 0.0 109.453 155.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -55.64 146.89 19.58 Favored 'General case' 0 CA--C 1.547 0.858 0 O-C-N 121.353 -0.842 . . . . 0.0 111.303 158.195 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.681 ' HB3' HG13 ' A' ' 60' ' ' VAL . 29.4 t -73.39 161.48 30.4 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.669 1.187 . . . . 0.0 113.673 -175.149 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -73.03 -10.88 60.27 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.139 1.376 . . . . 0.0 113.573 167.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 29.5 m80 -115.46 172.35 7.16 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.441 1.497 . . . . 0.0 112.403 -172.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -122.02 110.04 15.31 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 126.576 1.95 . . . . 0.0 109.728 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 61.88 167.94 0.11 Allowed 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 126.592 1.957 . . . . 0.0 113.924 -166.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 22.7 tp -132.19 97.87 4.25 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 128.617 2.767 . . . . 0.0 112.521 -172.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? . . . . . 0 N--CA 1.474 0.754 0 C-N-CA 127.601 2.361 . . . . 0.0 111.156 179.796 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 CA--C 1.543 0.71 0 CA-C-O 120.995 0.426 . . . . 0.0 111.65 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 44.4 mtp180 -55.11 -9.21 0.37 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 130.121 3.368 . . . . 0.0 119.474 -158.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.479 HG13 ' HB3' ' A' ' 131' ' ' SER 0.409 7.2 p -101.26 132.27 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 CA-C-N 122.404 2.366 . . . . 0.0 113.495 170.702 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 26.0 mt -111.22 153.71 12.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 128.287 2.635 . . . . 0.0 107.696 172.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -124.14 146.99 48.29 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.874 1.27 . . . . 0.0 111.446 178.42 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.1 mt -126.27 142.76 41.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 127.367 2.267 . . . . 0.0 109.977 -173.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.09 172.55 8.16 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 126.904 2.082 . . . . 0.0 112.41 170.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 67.13 19.51 10.4 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 126.456 1.902 . . . . 0.0 114.529 175.524 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.2 mp -54.02 154.95 6.92 Favored Pre-proline 0 CA--C 1.556 1.174 0 C-N-CA 122.791 0.437 . . . . 0.0 111.897 171.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -48.75 -58.4 1.78 Allowed 'Trans proline' 0 CA--C 1.536 0.596 1 C-N-CA 125.454 4.102 . . . . 0.0 114.651 175.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 pt -171.6 -53.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 131.372 3.869 . . . . 0.0 108.428 -178.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -147.27 -10.13 0.43 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 126.096 1.758 . . . . 0.0 113.701 -171.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.412 HG22 ' H ' ' A' ' 71' ' ' THR 0.293 5.0 p 40.47 -136.64 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 127.262 2.225 . . . . 0.0 112.251 -177.833 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.412 ' H ' HG22 ' A' ' 70' ' ' VAL . 1.8 t -143.32 133.99 25.12 Favored 'General case' 0 C--O 1.241 0.618 0 O-C-N 120.846 -1.159 . . . . 0.0 109.175 156.123 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.59 -30.21 68.5 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.335 -178.64 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -60.31 -36.59 91.32 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.938 1.256 . . . . 0.0 113.405 174.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -66.23 -52.25 49.63 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 118.153 0.976 . . . . 0.0 110.814 170.022 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.0 t -63.58 -42.29 95.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -174.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.423 ' CG2' HD22 ' A' ' 88' ' ' LEU . 2.3 pp -72.92 -32.43 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 O-C-N 120.168 -1.583 . . . . 0.0 113.131 175.69 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 36.2 t -62.38 -27.31 68.99 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 119.038 0.836 . . . . 0.0 110.852 171.253 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 31.3 mt -86.53 -15.67 39.27 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 173.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -92.43 -19.59 37.85 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.887 1.232 . . . . 0.0 113.599 172.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.5 mt -65.11 -46.08 73.02 Favored Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 116.808 2.151 . . . . 0.0 116.808 -171.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.61 -4.03 0.74 Allowed 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 124.657 3.571 . . . . 0.0 118.496 178.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -104.92 -33.8 8.25 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -165.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -160.99 -78.34 0.03 OUTLIER Glycine 0 C--N 1.331 0.262 0 C-N-CA 125.785 1.659 . . . . 0.0 109.032 176.006 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -150.96 -13.79 0.22 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 116.678 2.103 . . . . 0.0 116.678 170.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.485 ' H ' ' HE1' ' A' ' 101' ' ' MET . 2.2 m 29.49 171.73 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.246 0 CA-C-O 123.262 1.506 . . . . 0.0 114.829 -127.579 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.3 t -124.27 -26.81 3.89 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 119.16 -2.212 . . . . 0.0 112.435 163.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -162.22 166.28 25.7 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 172.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.423 HD22 ' CG2' ' A' ' 76' ' ' ILE . 1.4 pt? -140.43 166.85 23.58 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.656 1.582 . . . . 0.0 113.411 159.346 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.516 HD13 ' C ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -143.13 151.44 40.7 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 128.073 2.549 . . . . 0.0 108.662 -177.562 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 6.4 mtt -127.45 111.9 14.36 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.258 1.023 . . . . 0.0 111.132 -179.253 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.469 HD13 HD11 ' A' ' 89' ' ' LEU . 1.9 mm? -73.31 72.4 1.28 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.689 1.196 . . . . 0.0 111.102 175.247 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -57.79 125.36 22.69 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.467 1.107 . . . . 0.0 110.75 175.317 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 96.58 -8.72 66.41 Favored Glycine 0 CA--C 1.537 1.458 0 C-N-CA 125.242 1.401 . . . . 0.0 115.56 -173.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.94 -9.14 10.13 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 119.343 1.571 . . . . 0.0 113.693 169.125 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.2 m120 59.76 39.67 20.54 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.305 1.842 . . . . 0.0 112.806 -174.292 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -121.82 172.64 8.02 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.232 1.013 . . . . 0.0 111.325 -179.006 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -159.75 165.38 32.6 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.654 1.582 . . . . 0.0 111.336 178.237 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.432 ' CD2' HG21 ' A' ' 60' ' ' VAL . 4.0 m-30 -115.44 150.39 36.52 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 126.498 1.919 . . . . 0.0 107.638 166.273 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 16.2 tt -134.92 98.93 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 125.046 1.339 . . . . 0.0 108.659 167.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -85.49 131.67 34.33 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 127.495 2.318 . . . . 0.0 110.974 176.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.485 ' HE1' ' H ' ' A' ' 85' ' ' VAL 0.283 11.6 tpp -120.27 155.81 32.5 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 -170.989 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.72 -22.0 64.36 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -170.423 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.91 147.64 37.4 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.168 0.987 . . . . 0.0 110.96 -175.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -66.04 -38.53 88.63 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.047 0.539 . . . . 0.0 111.843 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -71.9 -40.71 68.67 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 178.124 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -54.67 -50.52 68.0 Favored 'General case' 0 C--O 1.219 -0.545 0 C-N-CA 122.997 0.519 . . . . 0.0 110.607 170.147 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.59 -37.88 73.95 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -178.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -55.92 -47.87 76.72 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.45 1.023 . . . . 0.0 110.875 169.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -66.39 -32.04 73.18 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-O 118.345 -0.836 . . . . 0.0 111.649 173.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 13.3 ttp -70.41 -45.79 65.22 Favored 'General case' 0 C--N 1.345 0.388 0 C-N-CA 125.069 1.348 . . . . 0.0 110.588 -176.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -67.79 -41.11 84.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 124.183 0.993 . . . . 0.0 111.745 177.47 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -68.52 -44.92 73.59 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.299 0.64 . . . . 0.0 110.564 178.382 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -47.14 -45.23 22.4 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.375 1.47 . . . . 0.0 111.98 166.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.597 ' HA ' HG12 ' A' ' 117' ' ' VAL . 12.6 m-85 -82.23 -16.66 48.81 Favored 'General case' 0 N--CA 1.456 -0.128 0 O-C-N 121.054 -1.029 . . . . 0.0 112.64 -176.529 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 92.8 m -80.57 -14.63 58.04 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.364 1.065 . . . . 0.0 110.653 170.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.33 -54.53 3.02 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 128.809 2.843 . . . . 0.0 113.229 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.597 HG12 ' HA ' ' A' ' 114' ' ' TYR . 10.9 p -71.46 -35.82 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 127.171 2.189 . . . . 0.0 114.274 -156.381 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.455 ' HA ' ' HD3' ' A' ' 119' ' ' PRO . 0.2 OUTLIER -2.51 115.91 0.01 OUTLIER Pre-proline 0 N--CA 1.486 1.347 0 C-N-CA 127.754 2.422 . . . . 0.0 116.875 -125.876 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 118' ' ' THR . 6.1 Cg_exo -76.16 -18.88 15.98 Favored 'Trans proline' 0 CA--C 1.547 1.166 0 C-N-CA 123.506 2.804 . . . . 0.0 113.095 -167.406 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 6.4 t 60.9 104.03 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 130.072 3.349 . . . . 0.0 113.057 -178.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.6 tt -65.5 -66.93 0.48 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.583 1.153 . . . . 0.0 111.714 -158.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.07 66.56 1.24 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.248 1.419 . . . . 0.0 110.054 168.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 86.04 12.37 71.2 Favored Glycine 0 CA--C 1.54 1.654 0 C-N-CA 124.628 1.109 . . . . 0.0 114.985 -178.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -136.18 141.47 36.31 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 126.564 1.945 . . . . 0.0 109.399 177.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -56.68 166.44 3.72 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 123.579 2.853 . . . . 0.0 112.65 171.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.45 ' H ' ' CG2' ' A' ' 118' ' ' THR . 0.8 OUTLIER -125.23 146.38 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.388 1.075 . . . . 0.0 110.124 -174.957 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -128.94 95.17 4.01 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.28 -1.327 . . . . 0.0 109.039 -153.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.12 151.49 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 124.682 1.193 . . . . 0.0 112.953 -173.225 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -156.66 170.02 23.37 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.38 1.072 . . . . 0.0 109.976 147.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -52.34 149.28 5.71 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 120.853 -1.154 . . . . 0.0 112.525 170.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.479 ' HB3' HG13 ' A' ' 60' ' ' VAL . 30.3 t -70.64 158.53 36.03 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.182 0.993 . . . . 0.0 112.381 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -63.34 -15.27 56.89 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.826 1.25 . . . . 0.0 112.859 163.417 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 28.2 m-70 -117.61 -179.83 3.85 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 127.354 2.262 . . . . 0.0 111.206 -175.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -130.81 11.87 5.22 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.73 1.612 . . . . 0.0 113.398 -173.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -167.76 150.95 5.98 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.895 2.078 . . . . 0.0 110.571 -166.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 55.9 tp -140.07 -62.47 0.51 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.019 1.328 . . . . 0.0 113.207 177.029 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.4 ptmm? . . . . . 0 N--CA 1.481 1.099 0 C-N-CA 128.969 2.907 . . . . 0.0 116.455 178.519 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.2 m . . . . . 0 N--CA 1.478 0.969 0 N-CA-C 117.887 2.551 . . . . 0.0 117.887 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 40.6 mtm-85 81.5 -6.53 1.52 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 128.361 2.665 . . . . 0.0 117.484 152.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.662 HG13 ' HB3' ' A' ' 131' ' ' SER . 2.5 p -118.22 136.57 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 CA-C-N 120.297 1.408 . . . . 0.0 113.125 163.065 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 10.9 mt -110.86 147.61 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 126.987 2.115 . . . . 0.0 108.795 168.268 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -110.7 116.59 31.57 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.295 1.438 . . . . 0.0 110.601 175.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 8.9 mt -89.53 134.3 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 126.505 1.922 . . . . 0.0 108.416 175.058 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -123.38 168.85 11.98 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 126.425 1.89 . . . . 0.0 112.248 171.019 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.5 mmtt 46.38 39.05 5.92 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 127.664 2.386 . . . . 0.0 114.418 -172.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.2 mt -60.55 174.22 0.54 Allowed Pre-proline 0 CA--C 1.556 1.207 0 C-N-CA 125.466 1.506 . . . . 0.0 111.043 158.208 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.56 -169.88 0.01 OUTLIER 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 124.55 3.5 . . . . 0.0 114.743 151.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 22.4 pt -58.81 -52.5 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.3 1.44 . . . . 0.0 112.644 -175.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -149.07 8.69 0.74 Allowed 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 127.103 2.161 . . . . 0.0 112.889 172.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.309 10.4 p 30.88 -125.46 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 C-N-CA 128.38 2.672 . . . . 0.0 113.294 -169.436 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.8 t -153.8 143.1 21.49 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 120.248 1.385 . . . . 0.0 110.237 167.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -55.86 -43.21 76.88 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.03 0.932 . . . . 0.0 112.329 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.03 -42.79 61.46 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 124.074 0.845 . . . . 0.0 112.907 178.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -64.94 -53.42 46.62 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.726 0.81 . . . . 0.0 111.894 172.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 83.5 t -59.5 -48.81 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 123.506 0.722 . . . . 0.0 112.442 -175.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.7 pp -70.01 -35.34 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 O-C-N 120.654 -1.279 . . . . 0.0 112.403 178.284 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.0 m -69.52 -20.85 63.69 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 119.714 1.143 . . . . 0.0 111.82 175.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.2 mt -79.48 -24.5 42.29 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 170.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -94.37 -21.6 26.68 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-N 119.061 0.846 . . . . 0.0 115.161 174.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.5 mt -59.95 -43.02 93.56 Favored Pre-proline 0 CA--C 1.538 0.514 0 N-CA-C 117.113 2.264 . . . . 0.0 117.113 -169.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.54 -6.18 1.44 Allowed 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.88 3.053 . . . . 0.0 116.981 174.325 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -104.03 -36.08 7.86 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 -167.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -153.03 -108.19 0.35 Allowed Glycine 0 C--N 1.336 0.54 0 CA-C-O 122.763 1.202 . . . . 0.0 111.846 172.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.424 ' HB3' ' CG ' ' A' ' 102' ' ' ASN . 7.0 tppt? -149.53 122.22 8.63 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 130.42 3.488 . . . . 0.0 104.533 175.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.42 HG22 ' HE2' ' A' ' 101' ' ' MET 0.288 21.6 t -129.06 84.71 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 CA-C-O 122.954 1.359 . . . . 0.0 109.213 -160.705 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 41.0 p -82.66 -17.21 45.36 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 127.524 2.33 . . . . 0.0 113.008 -162.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -141.51 160.16 40.73 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 174.211 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -146.21 175.73 10.28 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.575 1.95 . . . . 0.0 110.773 158.032 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.463 HD23 ' C ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -151.48 153.43 34.61 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 125.728 1.611 . . . . 0.0 109.645 177.654 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 4.9 mtp -134.73 95.67 3.39 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.535 0.734 . . . . 0.0 111.628 -167.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.0 91.3 2.5 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.111 1.364 . . . . 0.0 110.947 173.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -63.85 -17.31 63.02 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -65.18 -51.5 49.53 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 125.394 1.473 . . . . 0.0 115.155 -174.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 29.0 mtmt -126.11 22.92 7.19 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 125.73 1.612 . . . . 0.0 112.852 -172.124 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 20.9 m120 62.45 49.54 4.04 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.661 1.984 . . . . 0.0 113.621 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . 0.281 0.0 OUTLIER -128.78 172.51 11.21 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 177.157 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -157.54 163.24 38.59 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 127.095 2.158 . . . . 0.0 109.614 -175.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.528 ' CD2' HG21 ' A' ' 60' ' ' VAL . 5.2 m-30 -107.84 154.59 21.33 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.98 1.312 . . . . 0.0 107.887 162.089 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.0 tt -134.51 123.82 43.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 124.404 1.082 . . . . 0.0 108.636 164.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -121.19 122.36 39.81 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.539 1.936 . . . . 0.0 111.769 -165.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.42 ' HE2' HG22 ' A' ' 85' ' ' VAL . 0.6 OUTLIER -137.98 150.29 46.87 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 113.041 -1.891 . . . . 0.0 113.249 -164.721 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.424 ' CG ' ' HB3' ' A' ' 84' ' ' LYS . 2.7 p-10 -68.98 -18.87 64.12 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 113.038 -1.892 . . . . 0.0 114.385 -155.587 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.405 HG23 ' CG ' ' A' ' 102' ' ' ASN . 30.2 p -138.54 141.47 39.3 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 123.32 1.533 . . . . 0.0 112.08 -175.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -57.54 -37.31 72.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 113.769 -1.559 . . . . 0.0 110.75 176.073 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -72.59 -41.39 65.69 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.05 -52.56 62.79 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 119.231 0.923 . . . . 0.0 110.02 170.183 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.63 -36.87 79.21 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -178.312 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -55.77 -50.83 69.36 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 118.83 0.741 . . . . 0.0 110.506 170.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -63.66 -35.33 80.19 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-O 118.19 -0.909 . . . . 0.0 111.178 174.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 8.5 ttp -66.93 -51.14 58.88 Favored 'General case' 0 C--N 1.343 0.291 0 CA-C-N 119.747 1.158 . . . . 0.0 110.802 -176.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.41 -39.58 85.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 124.673 1.189 . . . . 0.0 111.761 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -70.22 -45.15 67.16 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.472 0.709 . . . . 0.0 110.942 177.053 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -50.62 -33.88 23.94 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.678 1.191 . . . . 0.0 112.556 167.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -92.12 -11.74 34.85 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 119.929 -1.732 . . . . 0.0 113.619 -177.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.2 t -86.13 -14.39 44.32 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.964 0.887 . . . . 0.0 111.629 165.083 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.29 -58.76 3.1 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 128.448 2.699 . . . . 0.0 111.449 167.549 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -92.27 -49.33 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 123.709 0.804 . . . . 0.0 112.736 -155.307 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.6 m 45.68 125.9 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.04 0 C-N-CA 130.493 3.517 . . . . 0.0 113.701 -152.391 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -77.02 -13.88 17.16 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 121.775 1.65 . . . . 0.0 115.76 -171.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.1 t 30.11 92.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 130.032 3.333 . . . . 0.0 114.36 175.189 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.471 HD23 ' C ' ' A' ' 121' ' ' LEU . 1.4 tt -102.92 -57.31 2.07 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 113.489 -1.687 . . . . 0.0 109.419 -131.501 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.91 6.71 43.48 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.992 1.717 . . . . 0.0 113.61 165.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 103.23 20.54 11.02 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 126.061 1.791 . . . . 0.0 115.127 -178.102 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.419 ' HA ' ' HD3' ' A' ' 125' ' ' PRO . 10.8 tp60 -146.71 142.06 16.83 Favored Pre-proline 0 CA--C 1.538 0.489 0 CA-C-O 116.706 -1.616 . . . . 0.0 110.245 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 124' ' ' GLN . 78.5 Cg_exo -52.18 147.35 27.94 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 124.636 3.557 . . . . 0.0 116.115 -167.698 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.423 HD11 ' H ' ' A' ' 121' ' ' LEU . 3.2 mm -117.93 153.01 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 126.653 1.981 . . . . 0.0 108.629 -177.306 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 20.0 m-30 -122.54 142.37 50.67 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.979 0.912 . . . . 0.0 110.209 -175.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -131.88 147.88 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.019 1.327 . . . . 0.0 111.628 172.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -147.52 162.54 38.87 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.836 0.854 . . . . 0.0 109.977 145.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -53.35 147.68 10.06 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.47 0.708 . . . . 0.0 112.171 168.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.662 ' HB3' HG13 ' A' ' 60' ' ' VAL . 29.2 t -74.68 133.89 42.04 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 121.486 -0.758 . . . . 0.0 112.215 178.088 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -67.95 -19.87 65.0 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 176.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -69.59 -52.28 27.53 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -177.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 16.4 mtmm 79.15 152.65 0.13 Allowed 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 128.739 2.816 . . . . 0.0 111.461 -149.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 36.29 95.59 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 129.389 3.076 . . . . 0.0 117.258 164.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 27.6 tp -64.58 110.32 2.29 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.03 1.732 . . . . 0.0 111.596 172.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt . . . . . 0 N--CA 1.473 0.697 0 C-N-CA 125.239 1.416 . . . . 0.0 110.537 172.297 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 25.1 m . . . . . 0 N--CA 1.478 0.928 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 25.1 mtp180 -125.86 -16.4 5.66 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 118.05 2.611 . . . . 0.0 118.05 -159.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.748 HG13 ' HB3' ' A' ' 131' ' ' SER 0.328 7.1 p -105.59 136.58 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 CA-C-N 121.138 1.79 . . . . 0.0 112.002 166.13 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.4 mt -113.41 155.33 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 128.773 2.829 . . . . 0.0 108.06 171.054 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -122.33 135.44 54.72 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.358 1.463 . . . . 0.0 110.377 177.095 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.4 mt -120.85 117.15 52.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 126.736 2.014 . . . . 0.0 109.291 -174.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.0 ptt180 -98.26 177.25 5.44 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 126.083 1.753 . . . . 0.0 112.917 177.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 59.63 25.9 14.87 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 127.192 2.197 . . . . 0.0 114.623 175.272 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 26.2 mt -64.45 150.94 92.53 Favored Pre-proline 0 CA--C 1.56 1.329 0 C-N-CA 122.927 0.491 . . . . 0.0 111.244 176.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -45.91 -66.52 0.15 Allowed 'Trans proline' 0 C--N 1.352 0.751 1 C-N-CA 125.313 4.009 . . . . 0.0 115.124 -178.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 12.4 pt -159.73 -41.87 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 130.177 3.391 . . . . 0.0 109.968 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -154.21 -11.48 0.14 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.949 1.3 . . . . 0.0 113.072 -169.116 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.512 HG22 ' H ' ' A' ' 71' ' ' THR 0.295 14.4 p 31.29 -121.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 127.099 2.16 . . . . 0.0 111.296 -161.225 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.512 ' H ' HG22 ' A' ' 70' ' ' VAL . 1.1 t -151.29 133.94 15.6 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 126.395 1.878 . . . . 0.0 106.439 155.007 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -69.28 -20.99 63.91 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.059 -1.026 . . . . 0.0 113.041 -173.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -58.6 -33.6 72.82 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 125.182 1.372 . . . . 0.0 113.665 164.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -75.58 -40.87 55.98 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 121.232 -1.158 . . . . 0.0 111.798 170.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.1 t -57.11 -46.15 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -84.73 -24.56 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 O-C-N 120.534 -1.354 . . . . 0.0 114.52 175.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.0 t -60.79 -31.97 71.33 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 120.187 1.358 . . . . 0.0 110.764 166.044 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 15.6 mt -74.22 -31.02 62.45 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 171.128 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -85.72 -19.25 58.45 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-N 119.438 1.017 . . . . 0.0 115.141 178.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.0 mt -70.27 -33.14 3.12 Favored Pre-proline 0 CA--C 1.541 0.605 0 N-CA-C 118.016 2.599 . . . . 0.0 118.016 -165.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -60.25 1.15 0.52 Allowed 'Trans proline' 0 C--N 1.35 0.605 0 C-N-CA 123.646 2.898 . . . . 0.0 116.809 170.148 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.42 ' CG ' ' HG3' ' A' ' 110' ' ' MET . 33.8 m-85 -116.02 -44.17 2.93 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -167.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -148.14 -108.7 0.51 Allowed Glycine 0 C--N 1.338 0.683 0 C-N-CA 123.873 0.749 . . . . 0.0 111.855 174.252 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 37.0 tptt -144.49 -12.98 0.59 Allowed 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 178.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.443 HG22 ' CE ' ' A' ' 101' ' ' MET 0.355 1.4 t 45.63 79.71 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 128.577 2.751 . . . . 0.0 114.553 164.914 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.1 m -66.01 -43.34 87.99 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 129.798 3.239 . . . . 0.0 111.811 -168.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -138.32 170.57 15.8 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 122.993 1.378 . . . . 0.0 113.362 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -146.63 173.27 12.49 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.153 2.181 . . . . 0.0 110.827 159.618 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.464 HD23 ' C ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -150.59 156.51 41.52 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.45 1.9 . . . . 0.0 109.495 176.003 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 8.1 mtt -129.32 110.56 12.03 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.605 1.162 . . . . 0.0 113.2 -178.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -77.29 97.87 4.99 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.407 1.883 . . . . 0.0 112.396 178.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -75.36 64.37 1.53 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.736 1.614 . . . . 0.0 111.738 167.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.52 -70.14 0.02 OUTLIER Glycine 0 N--CA 1.473 1.125 0 C-N-CA 124.863 1.22 . . . . 0.0 113.313 -177.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -114.5 26.6 10.09 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 127.06 2.144 . . . . 0.0 110.659 176.043 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 51.6 67.5 0.95 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.795 2.038 . . . . 0.0 113.043 -173.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.64 -178.47 4.38 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 177.047 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -155.17 164.22 39.13 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.72 2.408 . . . . 0.0 110.118 178.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.472 ' CD2' HG21 ' A' ' 60' ' ' VAL . 5.2 m-30 -107.78 150.23 27.24 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.423 1.489 . . . . 0.0 108.146 161.057 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 19.2 tt -132.87 119.75 38.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.938 1.295 . . . . 0.0 108.356 165.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -121.47 133.55 55.05 Favored 'General case' 0 CA--C 1.513 -0.454 0 C-N-CA 125.947 1.699 . . . . 0.0 110.84 -165.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.443 ' CE ' HG22 ' A' ' 85' ' ' VAL 0.287 1.3 ptm -137.66 159.41 42.06 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 117.188 2.292 . . . . 0.0 117.188 -169.935 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.4 -18.07 64.37 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 127.035 2.134 . . . . 0.0 112.726 -165.458 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.11 143.59 34.4 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-O 123.504 1.621 . . . . 0.0 111.86 178.533 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -66.71 -32.93 74.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 113.492 -1.685 . . . . 0.0 110.762 177.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -72.56 -37.82 68.13 Favored 'General case' 0 N--CA 1.462 0.13 0 C-N-CA 123.763 0.825 . . . . 0.0 113.024 177.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -57.12 -59.25 5.37 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 119.033 0.833 . . . . 0.0 109.62 169.044 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.45 -39.41 87.47 Favored 'General case' 0 C--O 1.224 -0.26 0 N-CA-C 114.752 1.389 . . . . 0.0 114.752 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -56.01 -51.05 69.14 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.475 -0.766 . . . . 0.0 111.047 172.032 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -63.65 -32.3 73.73 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.536 -0.727 . . . . 0.0 111.231 175.032 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.42 ' HG3' ' CG ' ' A' ' 82' ' ' PHE . 5.1 ttp -71.01 -49.05 49.39 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.083 1.353 . . . . 0.0 111.13 -176.681 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -64.97 -40.17 88.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 124.43 1.092 . . . . 0.0 111.23 178.013 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -67.58 -46.3 73.06 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.798 0.839 . . . . 0.0 110.196 177.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -49.37 -41.72 39.94 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.18 1.392 . . . . 0.0 112.279 168.031 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.506 ' HA ' HG12 ' A' ' 117' ' ' VAL . 25.4 m-85 -88.85 -11.46 44.67 Favored 'General case' 0 C--O 1.232 0.166 0 O-C-N 120.405 -1.435 . . . . 0.0 112.996 -176.39 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 70.6 m -81.04 -17.82 48.88 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.095 0.958 . . . . 0.0 110.195 167.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.62 -57.89 2.71 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 129.189 2.995 . . . . 0.0 113.294 176.292 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.506 HG12 ' HA ' ' A' ' 114' ' ' TYR . 5.9 p -79.44 -37.65 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -149.615 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.425 ' HA ' ' HD3' ' A' ' 119' ' ' PRO . 0.2 OUTLIER 12.09 112.71 0.0 OUTLIER Pre-proline 0 N--CA 1.484 1.268 0 C-N-CA 130.095 3.358 . . . . 0.0 116.396 -137.86 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.441 ' HD2' HD12 ' A' ' 126' ' ' ILE . 5.0 Cg_exo -79.38 -20.37 9.7 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.979 3.119 . . . . 0.0 113.684 -168.37 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 6.9 t 64.29 99.98 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 128.742 2.817 . . . . 0.0 112.659 176.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 6.2 tt -70.61 -75.3 0.12 Allowed 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -155.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -92.08 -44.36 8.88 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.908 1.283 . . . . 0.0 109.512 175.027 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -177.35 18.61 0.04 OUTLIER Glycine 0 CA--C 1.538 1.472 0 C-N-CA 126.192 1.853 . . . . 0.0 112.948 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -144.39 156.8 57.06 Favored Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 126.67 1.988 . . . . 0.0 110.766 -170.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -59.58 164.16 11.78 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 122.502 2.135 . . . . 0.0 113.815 -179.158 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.441 HD12 ' HD2' ' A' ' 119' ' ' PRO . 0.4 OUTLIER -127.47 149.24 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.125 1.37 . . . . 0.0 110.018 -178.805 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -130.1 95.73 4.0 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.007 -153.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -108.28 144.64 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 124.134 0.974 . . . . 0.0 112.844 -177.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -145.17 159.01 43.66 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.632 1.973 . . . . 0.0 109.085 154.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -54.6 155.32 4.18 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 121.262 -0.899 . . . . 0.0 111.733 165.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.748 ' HB3' HG13 ' A' ' 60' ' ' VAL . 27.1 t -79.25 148.96 32.0 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 177.622 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -61.08 -31.07 70.74 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.404 1.481 . . . . 0.0 112.945 167.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 57.3 m-70 -89.33 -18.83 26.14 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.767 1.227 . . . . 0.0 113.407 -176.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . 0.28 62.6 pttt 48.94 9.07 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 130.181 3.392 . . . . 0.0 118.205 177.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.598 ' N ' HG12 ' A' ' 60' ' ' VAL . 59.9 tt0 -164.98 124.94 1.89 Allowed 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 128.973 2.909 . . . . 0.0 110.463 172.029 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 22.7 tp -106.86 106.27 16.71 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.682 1.993 . . . . 0.0 110.857 -178.37 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt . . . . . 0 N--CA 1.472 0.653 0 C-N-CA 125.791 1.636 . . . . 0.0 109.269 173.754 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 58.2 m . . . . . 0 N--CA 1.48 1.026 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 25.2 mtp180 -124.19 -11.48 7.49 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 116.432 2.012 . . . . 0.0 116.432 -160.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.703 HG13 ' HB3' ' A' ' 131' ' ' SER 0.293 3.6 p -110.89 137.57 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 119.815 1.188 . . . . 0.0 112.162 172.981 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.0 mt -119.55 142.03 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 127.923 2.489 . . . . 0.0 108.369 175.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -112.51 148.39 34.56 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.937 1.695 . . . . 0.0 111.222 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 mp -133.12 138.98 50.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 126.227 1.811 . . . . 0.0 109.854 -176.139 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.67 176.61 5.11 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 125.6 1.56 . . . . 0.0 111.87 169.025 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.475 ' HG3' ' CD1' ' A' ' 127' ' ' TYR . 21.9 mmmt 73.98 8.64 4.76 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 127.015 2.126 . . . . 0.0 115.003 165.195 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.638 HD22 HG11 ' A' ' 70' ' ' VAL . 0.6 OUTLIER -62.74 159.82 41.16 Favored Pre-proline 0 CA--C 1.546 0.804 0 CA-C-N 119.181 0.9 . . . . 0.0 112.937 -176.925 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -51.72 173.75 0.09 OUTLIER 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 124.385 3.39 . . . . 0.0 115.087 163.188 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 36.4 pt -60.95 -34.55 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 127.065 2.146 . . . . 0.0 113.221 -167.224 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -140.01 -10.59 1.14 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.822 1.649 . . . . 0.0 113.485 166.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.638 HG11 HD22 ' A' ' 66' ' ' LEU 0.298 3.8 p 38.98 -139.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 127.599 2.359 . . . . 0.0 111.87 -169.151 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.449 ' H ' HG22 ' A' ' 70' ' ' VAL . 1.7 t -147.97 139.54 23.74 Favored 'General case' 0 C--O 1.239 0.519 0 O-C-N 120.803 -1.185 . . . . 0.0 109.931 154.022 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -55.93 -32.63 63.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.621 173.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -61.28 -32.53 81.1 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 125.05 1.31 . . . . 0.0 112.871 175.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -67.19 -55.41 14.21 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 118.725 1.263 . . . . 0.0 110.648 167.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.2 t -57.66 -44.83 86.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -175.247 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.3 pp -81.33 -29.16 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 O-C-N 120.313 -1.492 . . . . 0.0 113.871 -179.153 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 18.1 t -63.75 -29.36 70.58 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 119.61 1.096 . . . . 0.0 110.55 168.289 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.0 mt -78.72 -20.69 49.45 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 172.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -101.45 -16.55 24.41 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-N 119.859 1.209 . . . . 0.0 116.116 176.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.9 mt -61.55 -52.57 68.76 Favored Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 117.171 2.286 . . . . 0.0 117.171 -172.277 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -75.2 39.52 0.61 Allowed 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 124.125 3.217 . . . . 0.0 113.974 -178.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -127.84 -36.65 1.99 Allowed 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 126.87 2.068 . . . . 0.0 111.902 177.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -152.76 -108.84 0.38 Allowed Glycine 0 CA--C 1.525 0.717 0 CA-C-O 122.774 1.208 . . . . 0.0 111.989 168.206 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 15.6 tptm -149.23 132.01 16.01 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 131.625 3.97 . . . . 0.0 103.726 173.083 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.58 HG22 ' HE2' ' A' ' 101' ' ' MET 0.313 14.3 t -128.1 92.56 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-N 120.666 1.576 . . . . 0.0 110.773 -163.666 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.5 t -80.82 -32.75 35.09 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 126.727 2.011 . . . . 0.0 112.825 -161.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -130.74 160.53 34.06 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 174.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -147.19 167.83 23.21 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 126.963 2.105 . . . . 0.0 110.102 166.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.52 HD13 ' C ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -149.76 152.09 34.67 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 125.288 1.435 . . . . 0.0 108.969 173.709 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 5.8 mtt -126.93 110.4 12.97 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.406 1.483 . . . . 0.0 110.267 177.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.488 HD22 ' CD1' ' A' ' 89' ' ' LEU . 2.8 mm? -72.1 79.65 0.95 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.62 1.168 . . . . 0.0 110.178 178.357 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -44.69 -47.97 10.63 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 127.549 2.339 . . . . 0.0 114.445 -168.159 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -79.79 -12.16 83.84 Favored Glycine 0 CA--C 1.535 1.317 0 N-CA-C 116.31 1.284 . . . . 0.0 116.31 -174.321 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -126.66 3.04 6.79 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 -173.633 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.0 m120 58.94 36.1 24.39 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.187 1.395 . . . . 0.0 113.918 -178.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -111.2 176.13 5.15 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.519 0.727 . . . . 0.0 111.095 175.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -158.03 167.36 30.11 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.708 1.603 . . . . 0.0 111.928 176.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.451 ' CD2' HG21 ' A' ' 60' ' ' VAL . 4.8 m-30 -118.72 152.62 35.81 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.966 2.106 . . . . 0.0 108.118 163.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 14.4 tt -135.41 127.19 46.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 124.778 1.231 . . . . 0.0 108.669 163.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -130.98 121.1 24.49 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.252 1.421 . . . . 0.0 112.929 -163.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.58 ' HE2' HG22 ' A' ' 85' ' ' VAL . 1.0 OUTLIER -129.22 162.62 27.43 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.12 -1.4 . . . . 0.0 113.696 -159.479 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.35 -12.57 60.09 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -158.261 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -143.18 142.47 31.45 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.177 1.391 . . . . 0.0 110.879 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -61.46 -33.41 73.7 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.742 175.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -75.74 -36.04 60.03 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 123.641 0.776 . . . . 0.0 112.987 178.431 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -56.82 -52.08 66.45 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-N 118.973 0.806 . . . . 0.0 110.642 168.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.94 -39.16 79.73 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -54.93 -48.41 73.16 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 118.754 0.706 . . . . 0.0 111.255 170.143 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -64.77 -32.5 74.22 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 121.242 -0.911 . . . . 0.0 111.46 175.006 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 7.5 ttp -65.86 -57.63 7.47 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.467 1.107 . . . . 0.0 109.686 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -57.97 -41.65 80.72 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.372 0 C-N-CA 124.95 1.3 . . . . 0.0 111.607 177.71 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -65.43 -42.9 91.94 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 118.897 0.771 . . . . 0.0 111.924 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -53.92 -37.43 63.83 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 118.61 0.641 . . . . 0.0 112.037 167.65 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.681 ' HA ' HG12 ' A' ' 117' ' ' VAL . 34.2 m-85 -85.73 -13.88 47.0 Favored 'General case' 0 C--N 1.332 -0.182 0 O-C-N 120.263 -1.523 . . . . 0.0 113.192 -178.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 54.8 m -84.79 -15.62 44.3 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.144 1.377 . . . . 0.0 110.307 169.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.28 -49.04 11.22 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 128.464 2.706 . . . . 0.0 111.26 172.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.681 HG12 ' HA ' ' A' ' 114' ' ' TYR . 0.5 OUTLIER -94.97 178.82 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 127.556 2.342 . . . . 0.0 111.754 -165.726 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.409 ' CA ' HG13 ' A' ' 117' ' ' VAL . 1.1 m -137.91 130.06 16.31 Favored Pre-proline 0 N--CA 1.477 0.876 0 O-C-N 120.985 -1.072 . . . . 0.0 109.212 129.074 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -83.44 -16.85 6.7 Favored 'Trans proline' 0 CA--C 1.547 1.157 0 C-N-CA 122.667 2.245 . . . . 0.0 112.753 -167.212 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 14.3 t 58.36 99.37 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 129.759 3.224 . . . . 0.0 113.498 177.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.6 tt -67.1 -62.6 1.35 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.285 1.034 . . . . 0.0 112.4 -156.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -125.56 4.41 7.57 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 126.722 2.009 . . . . 0.0 114.566 -179.388 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 124.5 9.26 5.51 Favored Glycine 0 CA--C 1.539 1.565 0 C-N-CA 125.119 1.342 . . . . 0.0 114.725 -160.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -139.66 144.33 38.74 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 126.854 2.061 . . . . 0.0 109.658 -176.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.99 166.23 7.29 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 123.576 2.851 . . . . 0.0 112.966 175.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -127.67 145.01 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.165 0.986 . . . . 0.0 111.056 -173.314 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.475 ' CD1' ' HG3' ' A' ' 65' ' ' LYS . 3.6 m-85 -126.26 79.66 1.86 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.105 -1.407 . . . . 0.0 109.441 -153.458 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -91.1 149.81 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 124.514 1.125 . . . . 0.0 112.688 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -145.37 159.42 43.09 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 128.235 2.614 . . . . 0.0 108.159 161.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -55.98 155.49 6.25 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 120.437 -1.415 . . . . 0.0 111.368 154.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.703 ' HB3' HG13 ' A' ' 60' ' ' VAL . 31.0 t -71.03 158.33 36.69 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.473 -0.767 . . . . 0.0 112.167 172.363 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -65.29 -11.76 44.83 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.857 1.263 . . . . 0.0 112.861 163.314 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 40.5 m-70 -116.05 -179.15 3.58 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 127.675 2.39 . . . . 0.0 110.726 -175.594 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -125.4 4.26 7.69 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 125.525 1.53 . . . . 0.0 114.4 -172.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -176.36 164.79 2.68 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 128.3 2.64 . . . . 0.0 109.111 -170.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 23.9 tp -137.15 91.87 2.66 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.035 1.734 . . . . 0.0 111.482 -174.076 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.472 0.644 0 C-N-CA 124.436 1.095 . . . . 0.0 110.493 172.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 44.3 t . . . . . 0 N--CA 1.476 0.865 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.44 -2.14 18.37 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.585 1.154 . . . . 0.0 113.596 167.146 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.693 HG13 ' HB3' ' A' ' 131' ' ' SER 0.312 7.4 p -85.11 131.11 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 119.396 0.998 . . . . 0.0 111.628 163.796 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.0 mt -110.72 144.99 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 127.785 2.434 . . . . 0.0 107.769 169.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -108.21 150.49 27.19 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.993 1.317 . . . . 0.0 110.529 172.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 7.5 mt -127.56 142.27 44.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 125.888 1.675 . . . . 0.0 109.093 -173.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.26 170.06 11.14 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 128.579 2.752 . . . . 0.0 109.223 164.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.57 20.29 12.1 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.617 1.167 . . . . 0.0 113.989 176.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 37.5 mt -64.01 167.7 7.36 Favored Pre-proline 0 CA--C 1.542 0.673 0 C-N-CA 123.474 0.71 . . . . 0.0 110.908 162.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -54.41 172.29 0.33 Allowed 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.934 2.423 . . . . 0.0 113.981 156.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 21.7 pt -80.98 -18.6 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 127.614 2.366 . . . . 0.0 113.332 -179.131 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -144.97 12.17 1.41 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 127.347 2.259 . . . . 0.0 113.281 -164.531 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -55.22 151.37 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.328 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.8 t -101.27 148.54 25.0 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 122.398 1.094 . . . . 0.0 113.281 -173.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -50.45 -44.24 55.5 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.217 1.407 . . . . 0.0 111.432 174.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -58.36 -35.1 77.39 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 123.852 0.739 . . . . 0.0 113.349 -179.07 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -74.7 -44.04 52.07 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.456 1.103 . . . . 0.0 112.167 175.077 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 95.1 t -60.68 -51.61 71.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 123.168 0.587 . . . . 0.0 111.084 177.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.1 pp -69.12 -30.45 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 O-C-N 120.73 -1.231 . . . . 0.0 113.099 178.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 49.2 m -73.73 -16.66 61.18 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 119.288 0.949 . . . . 0.0 112.306 174.011 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 22.7 mt -86.44 -15.25 40.83 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.121 0.968 . . . . 0.0 113.291 165.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.439 ' HA2' ' SD ' ' A' ' 110' ' ' MET . . . -75.88 -33.09 51.81 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 124.311 0.958 . . . . 0.0 113.241 168.043 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 16.5 mt -80.22 -16.83 0.24 Allowed Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 119.923 3.305 . . . . 0.0 119.923 -159.099 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -61.07 -4.61 3.96 Favored 'Trans proline' 0 C--N 1.347 0.493 0 CA-C-N 122.919 2.078 . . . . 0.0 116.474 169.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.514 ' CD2' ' HG3' ' A' ' 110' ' ' MET . 34.2 m-85 -120.6 -43.66 2.48 Favored 'General case' 0 C--N 1.34 0.195 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 -166.731 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -142.38 -118.36 1.37 Allowed Glycine 0 CA--C 1.525 0.706 0 CA-C-O 122.648 1.138 . . . . 0.0 112.555 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.41 ' HB3' ' CG ' ' A' ' 102' ' ' ASN . 15.2 tptm -148.03 122.24 9.57 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 130.45 3.5 . . . . 0.0 104.363 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.431 HG22 ' HE2' ' A' ' 101' ' ' MET 0.28 19.6 t -130.36 82.49 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 CA-C-O 122.778 1.275 . . . . 0.0 109.213 -159.515 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 41.5 p -79.86 -16.4 55.47 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 127.433 2.293 . . . . 0.0 112.725 -163.008 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -142.17 158.3 43.9 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 173.022 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.24 170.23 16.69 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.693 2.397 . . . . 0.0 110.34 167.695 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.496 HD23 ' C ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -148.49 155.12 40.75 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.184 0.994 . . . . 0.0 109.805 174.18 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 4.0 mtp -132.55 94.15 3.36 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.353 0.661 . . . . 0.0 111.355 -168.102 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.07 66.74 1.66 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.57 1.148 . . . . 0.0 110.505 170.044 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 53.9 tttm -55.79 -34.38 65.24 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.538 1.535 . . . . 0.0 113.579 -169.11 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -64.18 -16.86 60.67 Favored Glycine 0 CA--C 1.54 1.603 0 C-N-CA 125.538 1.542 . . . . 0.0 116.075 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 18.9 mtmt -124.53 7.26 8.27 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.123 1.369 . . . . 0.0 114.216 -176.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.5 m120 58.92 34.03 23.39 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.786 1.235 . . . . 0.0 112.095 -168.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -117.87 164.47 15.0 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.723 0.809 . . . . 0.0 111.985 -175.02 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -158.06 168.98 25.6 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.684 1.593 . . . . 0.0 111.662 -179.161 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.456 ' CD2' HG21 ' A' ' 60' ' ' VAL . 5.5 m-30 -114.8 157.76 22.8 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.105 1.762 . . . . 0.0 108.42 160.332 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 19.8 tt -140.45 122.06 14.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 125.084 1.354 . . . . 0.0 109.129 163.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -119.3 125.73 49.79 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 127.242 2.217 . . . . 0.0 111.253 -169.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.431 ' HE2' HG22 ' A' ' 85' ' ' VAL . 0.3 OUTLIER -128.87 160.06 33.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 113.276 -1.784 . . . . 0.0 114.129 -167.519 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.475 ' CG ' HG23 ' A' ' 103' ' ' THR . 3.0 p-10 -71.81 -20.44 61.84 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 -163.343 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.475 HG23 ' CG ' ' A' ' 102' ' ' ASN . 8.3 p -138.45 137.73 37.47 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.128 1.371 . . . . 0.0 110.988 -174.401 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -59.25 -34.67 72.5 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.199 175.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -73.27 -40.05 64.91 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.99 -52.52 63.9 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-N 119.491 1.041 . . . . 0.0 109.552 168.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.71 -37.1 79.25 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 -175.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -56.12 -52.23 65.06 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.779 0.718 . . . . 0.0 110.684 169.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -61.33 -32.18 72.06 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 118.931 -0.557 . . . . 0.0 111.324 174.222 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.514 ' HG3' ' CD2' ' A' ' 82' ' ' PHE . 13.4 ttp -73.48 -50.16 22.98 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-N 119.486 1.039 . . . . 0.0 111.918 -175.47 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -63.14 -35.34 71.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.168 0.987 . . . . 0.0 111.107 178.329 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -75.65 -41.58 53.73 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.381 1.072 . . . . 0.0 112.091 176.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -48.28 -52.95 19.0 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.509 1.124 . . . . 0.0 109.989 165.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -79.88 16.12 1.25 Allowed 'General case' 0 C--N 1.326 -0.423 0 O-C-N 118.932 -2.355 . . . . 0.0 113.044 178.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . 0.289 0.5 OUTLIER -118.63 -10.32 10.06 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 164.584 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.478 ' CB ' HG23 ' A' ' 117' ' ' VAL . 0.4 OUTLIER -85.01 -43.05 14.31 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.273 1.829 . . . . 0.0 111.413 161.25 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.478 HG23 ' CB ' ' A' ' 116' ' ' SER . 89.6 t -115.12 -57.9 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.386 1.074 . . . . 0.0 111.856 -144.157 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.0 m 70.89 135.04 0.04 OUTLIER Pre-proline 0 N--CA 1.485 1.315 0 C-N-CA 128.027 2.531 . . . . 0.0 112.234 -173.075 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -76.26 -22.49 12.64 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.256 1.971 . . . . 0.0 114.966 -176.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.9 t 36.37 89.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 129.802 3.241 . . . . 0.0 113.305 175.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.537 ' H ' HD11 ' A' ' 126' ' ' ILE . 2.4 tt -100.05 -66.09 0.93 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 113.783 -1.553 . . . . 0.0 109.597 -134.515 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -84.53 -9.6 58.19 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 159.497 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 110.34 55.42 0.53 Allowed Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.347 1.451 . . . . 0.0 113.22 -166.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -145.06 162.49 37.54 Favored Pre-proline 0 CA--C 1.541 0.631 0 CA-C-N 119.075 1.438 . . . . 0.0 112.931 156.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.34 100.22 0.15 Allowed 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 123.293 2.662 . . . . 0.0 111.973 168.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.537 HD11 ' H ' ' A' ' 121' ' ' LEU . 3.0 mm -77.75 138.24 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.303 1.041 . . . . 0.0 108.69 177.593 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 11.7 m-30 -109.3 128.6 55.22 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 120.674 -1.266 . . . . 0.0 110.667 -173.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.25 151.07 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.902 1.281 . . . . 0.0 111.888 178.624 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -158.27 160.8 37.47 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.158 1.783 . . . . 0.0 110.172 157.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -54.65 144.2 22.58 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.261 -0.899 . . . . 0.0 112.398 170.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.693 ' HB3' HG13 ' A' ' 60' ' ' VAL . 21.4 t -73.78 147.13 43.74 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.986 -0.447 . . . . 0.0 111.371 173.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 12.7 p30 -80.62 -9.24 59.8 Favored 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 113.977 1.102 . . . . 0.0 113.977 175.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -83.63 179.82 7.51 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.381 1.072 . . . . 0.0 112.608 174.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -113.06 97.25 6.4 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.794 2.038 . . . . 0.0 109.837 173.063 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 61.28 -174.97 0.13 Allowed 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.696 1.998 . . . . 0.0 112.558 -176.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 34.7 tp -135.14 99.36 4.24 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 126.413 1.885 . . . . 0.0 110.962 -170.286 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 50.8 tttp . . . . . 0 N--CA 1.468 0.439 0 C-N-CA 125.719 1.608 . . . . 0.0 110.062 176.172 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.7 t . . . . . 0 N--CA 1.477 0.906 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.2 mtp180 -54.44 -13.51 0.95 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 131.536 3.935 . . . . 0.0 118.804 -173.152 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.43 HG21 ' CD2' ' A' ' 98' ' ' PHE 0.269 0.1 OUTLIER -81.94 122.45 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-N 120.885 1.675 . . . . 0.0 110.106 162.534 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.42 HD13 ' CE ' ' A' ' 110' ' ' MET . 2.0 mp -87.18 135.38 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 156.232 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -102.61 144.37 31.1 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.888 1.275 . . . . 0.0 110.566 174.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.2 mt -129.94 140.71 48.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 126.158 1.783 . . . . 0.0 109.862 -176.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 5.4 ptt-85 -123.74 179.15 4.91 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 126.835 2.054 . . . . 0.0 112.281 173.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 58.64 17.94 5.46 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 127.083 2.153 . . . . 0.0 114.607 178.23 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.6 mp -50.29 156.83 1.32 Allowed Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 125.273 1.429 . . . . 0.0 113.15 178.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -45.3 -62.55 0.43 Allowed 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 125.075 3.85 . . . . 0.0 114.776 -179.04 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.5 pt -163.64 -52.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 131.324 3.85 . . . . 0.0 107.723 176.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -146.3 -11.31 0.48 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.567 1.547 . . . . 0.0 114.143 -176.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.301 2.9 p 42.4 -145.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 127.268 2.227 . . . . 0.0 112.148 -174.425 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.0 t -141.97 137.44 31.21 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 120.553 -1.342 . . . . 0.0 110.772 164.041 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -55.54 -39.35 70.45 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.367 1.067 . . . . 0.0 111.883 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.25 -38.28 56.51 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 125.111 1.339 . . . . 0.0 113.937 172.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -72.51 -48.12 43.09 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 121.449 -1.03 . . . . 0.0 112.405 174.32 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.3 t -58.63 -49.37 82.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-N 117.979 0.354 . . . . 0.0 111.701 -176.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.95 -31.43 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 O-C-N 120.86 -1.15 . . . . 0.0 114.001 177.523 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 48.7 m -71.42 -18.12 62.35 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 120.664 1.575 . . . . 0.0 111.433 176.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 29.6 mt -84.37 -24.17 29.8 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 167.009 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -86.36 -18.92 58.11 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-N 118.72 0.691 . . . . 0.0 114.168 175.481 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 13.0 mt -73.29 -18.1 0.34 Allowed Pre-proline 0 CA--C 1.548 0.872 0 N-CA-C 119.416 3.117 . . . . 0.0 119.416 -171.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -59.16 -2.42 1.24 Allowed 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.411 2.74 . . . . 0.0 118.083 174.001 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -120.83 -35.91 3.26 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 -169.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -151.73 -109.69 0.44 Allowed Glycine 0 C--N 1.337 0.638 0 CA-C-O 122.253 0.918 . . . . 0.0 112.51 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -152.89 129.08 10.46 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 129.408 3.083 . . . . 0.0 104.893 -176.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.411 ' CG2' ' CE ' ' A' ' 101' ' ' MET 0.304 11.9 t -135.24 81.92 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 120.161 1.346 . . . . 0.0 109.678 -165.562 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 58.9 p -79.64 -22.31 43.72 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 126.829 2.051 . . . . 0.0 112.436 -164.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 65.5 m-80 -136.03 156.0 49.38 Favored 'General case' 0 C--N 1.343 0.323 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 177.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -146.91 170.33 17.29 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.824 2.05 . . . . 0.0 110.044 162.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.534 HD23 ' C ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -141.01 153.93 45.77 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.837 1.655 . . . . 0.0 109.748 175.784 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 40.0 mtt -131.22 117.29 18.8 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.062 0.945 . . . . 0.0 110.908 178.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -76.2 69.67 2.76 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.754 1.222 . . . . 0.0 110.325 175.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -56.21 105.98 0.24 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.626 1.97 . . . . 0.0 111.327 -177.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 124.03 -15.97 7.77 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 126.077 1.798 . . . . 0.0 115.052 -176.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 10.6 mtmt -118.22 -2.21 11.21 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 119.142 1.471 . . . . 0.0 114.644 178.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.3 m120 60.05 46.9 10.26 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.0 1.72 . . . . 0.0 112.398 -173.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -131.8 165.76 23.08 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.44 0.696 . . . . 0.0 112.418 -179.035 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -157.82 163.26 38.19 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.131 1.372 . . . . 0.0 113.001 -178.438 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.43 ' CD2' HG21 ' A' ' 60' ' ' VAL . 4.5 m-30 -115.91 148.2 40.27 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 128.61 2.764 . . . . 0.0 106.287 166.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 6.4 tp -134.5 106.79 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 125.854 1.662 . . . . 0.0 108.874 170.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -102.93 109.38 20.91 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 128.602 2.761 . . . . 0.0 111.552 -167.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.411 ' CE ' ' CG2' ' A' ' 85' ' ' VAL . 16.1 ttm -107.02 158.5 17.0 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 114.095 -1.411 . . . . 0.0 112.695 -174.348 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.422 ' CG ' HG23 ' A' ' 103' ' ' THR . 2.6 p-10 -73.96 -21.23 60.1 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -163.098 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.422 HG23 ' CG ' ' A' ' 102' ' ' ASN . 1.9 p -138.15 147.43 43.89 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.805 0.842 . . . . 0.0 111.74 -175.363 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -64.92 -36.65 85.07 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.432 0.693 . . . . 0.0 112.15 179.525 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -72.35 -42.56 65.17 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 118.763 0.71 . . . . 0.0 112.817 179.095 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -57.73 -48.25 80.13 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 118.567 0.622 . . . . 0.0 110.071 172.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.16 -37.4 78.21 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -55.62 -51.89 65.64 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 121.339 -0.85 . . . . 0.0 110.876 169.323 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -64.81 -24.76 67.65 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-O 117.77 -1.109 . . . . 0.0 111.665 173.564 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.42 ' CE ' HD13 ' A' ' 61' ' ' ILE . 10.3 ttp -73.13 -48.51 34.92 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 120.514 1.506 . . . . 0.0 110.227 -178.434 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -65.56 -37.78 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 O-C-N 121.532 -0.73 . . . . 0.0 111.441 177.471 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -68.05 -46.48 71.0 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.869 0.868 . . . . 0.0 110.958 174.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -48.43 -42.27 31.82 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.026 1.73 . . . . 0.0 112.01 167.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.586 ' HA ' HG12 ' A' ' 117' ' ' VAL . 14.7 m-85 -84.01 -17.7 39.58 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 120.843 -1.16 . . . . 0.0 112.563 -176.566 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 84.1 m -80.97 -14.63 57.78 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.514 1.126 . . . . 0.0 110.469 170.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.55 -58.18 2.36 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 129.766 3.226 . . . . 0.0 112.879 176.549 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.586 HG12 ' HA ' ' A' ' 114' ' ' TYR . 6.0 p -74.19 -35.66 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 126.683 1.993 . . . . 0.0 113.056 -158.484 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.512 ' CG2' ' H ' ' A' ' 126' ' ' ILE . 0.8 OUTLIER 4.09 114.57 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.047 0 C-N-CA 130.351 3.46 . . . . 0.0 115.953 -134.711 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 118' ' ' THR . 5.7 Cg_exo -77.76 -3.84 13.94 Favored 'Trans proline' 0 CA--C 1.55 1.303 0 C-N-CA 123.711 2.941 . . . . 0.0 113.99 -159.243 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.4 t 62.07 112.47 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 131.62 3.968 . . . . 0.0 115.799 174.224 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.8 tt -72.82 75.69 1.14 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 127.909 2.483 . . . . 0.0 109.583 173.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . 0.262 0.0 OUTLIER 48.39 -15.68 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.507 1 C-N-CA 132.713 4.405 . . . . 0.0 119.004 -170.56 . . . . . . . . 4 3 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -179.51 2.95 0.02 OUTLIER Glycine 0 CA--C 1.54 1.624 0 C-N-CA 125.869 1.699 . . . . 0.0 115.265 -172.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -139.62 148.0 54.19 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 126.995 2.118 . . . . 0.0 109.46 -177.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -57.6 167.0 4.24 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.35 2.7 . . . . 0.0 114.35 175.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.512 ' H ' ' CG2' ' A' ' 118' ' ' THR . 0.5 OUTLIER -120.86 148.79 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.911 1.684 . . . . 0.0 109.299 179.697 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -122.35 101.05 7.27 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.494 1.118 . . . . 0.0 110.951 -154.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.45 152.74 28.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -167.117 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -150.87 171.44 17.22 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 129.46 3.104 . . . . 0.0 109.418 165.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -65.38 166.01 10.87 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 120.311 -1.493 . . . . 0.0 111.394 153.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.405 ' CB ' HG13 ' A' ' 60' ' ' VAL . 83.3 p -60.26 154.11 20.76 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 120.933 -1.104 . . . . 0.0 112.546 163.443 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 14.3 p30 -85.69 -19.42 30.91 Favored 'General case' 0 CA--C 1.548 0.897 0 O-C-N 121.363 -0.836 . . . . 0.0 112.28 158.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 67.5 m-70 -75.21 -171.1 1.31 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.772 1.629 . . . . 0.0 111.985 164.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -141.7 121.21 13.27 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 127.123 2.169 . . . . 0.0 110.181 174.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 66.04 99.4 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 126.026 1.73 . . . . 0.0 114.939 171.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 61.8 tp -61.78 125.71 24.79 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.273 1.429 . . . . 0.0 112.171 172.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 86.8 tttt . . . . . 0 N--CA 1.476 0.845 0 C-N-CA 125.023 1.329 . . . . 0.0 113.763 179.505 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 73.8 m . . . . . 0 N--CA 1.474 0.773 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 41.0 mtp180 59.92 -28.78 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 131.342 3.857 . . . . 0.0 118.017 172.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.556 HG13 ' HB3' ' A' ' 131' ' ' SER . 1.7 p -98.09 134.72 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 120.254 1.388 . . . . 0.0 112.122 167.66 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.443 ' HA ' ' HA ' ' A' ' 130' ' ' PHE . 44.8 mt -110.07 124.32 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 C-N-CA 127.585 2.354 . . . . 0.0 108.263 168.519 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -83.44 149.02 26.92 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.898 0.856 . . . . 0.0 111.208 169.166 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 8.7 mt -124.47 140.83 46.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 126.539 1.936 . . . . 0.0 108.99 179.388 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.51 167.91 13.27 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 127.432 2.293 . . . . 0.0 110.464 165.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.439 ' HG2' ' CD2' ' A' ' 127' ' ' TYR . 19.8 mmtt 53.64 41.57 32.05 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.768 1.627 . . . . 0.0 113.04 -176.694 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.62 176.99 0.63 Allowed Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 126.493 1.917 . . . . 0.0 109.737 159.408 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -59.52 -175.37 0.09 OUTLIER 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 124.53 3.487 . . . . 0.0 114.543 147.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 28.7 pt -81.24 -31.99 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 126.038 1.735 . . . . 0.0 113.479 -177.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -156.37 37.44 0.33 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.557 1.943 . . . . 0.0 110.725 -168.124 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -51.75 156.49 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.869 0.867 . . . . 0.0 112.669 177.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.82 144.28 26.68 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 122.448 1.118 . . . . 0.0 112.188 -176.235 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -58.04 -42.67 85.91 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.127 171.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.62 -39.8 61.55 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.927 1.251 . . . . 0.0 112.938 178.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -68.37 -49.41 60.36 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.688 1.195 . . . . 0.0 112.098 173.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 95.6 t -61.61 -44.89 99.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 122.965 0.506 . . . . 0.0 112.005 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.8 pp -74.68 -30.04 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 O-C-N 120.597 -1.314 . . . . 0.0 112.488 176.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.7 t -61.92 -31.74 72.08 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 119.839 1.2 . . . . 0.0 110.482 170.054 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 10.3 mt -78.23 -21.83 49.34 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 175.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -98.66 -16.14 32.28 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-N 119.116 0.871 . . . . 0.0 115.186 175.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.4 mt -57.69 -54.59 53.65 Favored Pre-proline 0 CA--C 1.543 0.675 0 N-CA-C 116.823 2.157 . . . . 0.0 116.823 -168.181 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -77.72 41.88 1.07 Allowed 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 124.0 3.133 . . . . 0.0 114.081 -175.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -129.3 -42.48 1.34 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.901 1.68 . . . . 0.0 112.589 179.297 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -155.79 -99.44 0.16 Allowed Glycine 0 C--N 1.336 0.564 0 C-N-CA 124.484 1.04 . . . . 0.0 110.653 167.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 38.9 tptt -136.08 -12.84 1.9 Allowed 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 116.132 1.901 . . . . 0.0 116.132 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.521 ' HA ' ' HA ' ' A' ' 101' ' ' MET 0.25 0.1 OUTLIER 30.44 82.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 128.643 2.777 . . . . 0.0 113.247 -174.184 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.6 t -68.5 -31.03 70.0 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.092 0.957 . . . . 0.0 112.554 -170.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -147.85 174.07 12.21 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 123.296 1.522 . . . . 0.0 114.586 175.272 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -143.24 174.64 10.53 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 127.324 2.249 . . . . 0.0 111.371 157.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.54 HD13 ' C ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -143.15 154.08 43.53 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.964 2.105 . . . . 0.0 108.148 169.383 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 5.0 mtp -129.71 106.51 8.76 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.641 1.176 . . . . 0.0 110.597 -176.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -74.18 76.15 1.79 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.025 0.93 . . . . 0.0 110.519 173.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt -64.54 98.62 0.26 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.986 1.314 . . . . 0.0 110.269 173.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 168.76 -52.94 0.21 Allowed Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.909 1.719 . . . . 0.0 112.689 -166.406 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt -133.1 12.61 4.26 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.12 1.368 . . . . 0.0 114.559 -166.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 59.83 53.38 4.84 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.014 1.726 . . . . 0.0 112.161 -172.609 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -130.28 166.0 21.27 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.396 1.078 . . . . 0.0 111.855 -179.257 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -166.05 169.97 14.01 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.513 1.925 . . . . 0.0 110.628 -177.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.545 ' CD2' HD13 ' A' ' 136' ' ' LEU . 4.5 m-30 -118.22 141.07 48.88 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.783 2.433 . . . . 0.0 105.46 166.253 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 15.6 tt -122.2 113.26 37.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 125.336 1.454 . . . . 0.0 107.446 166.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -109.71 117.01 32.77 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 127.27 2.228 . . . . 0.0 110.333 -166.199 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.521 ' HA ' ' HA ' ' A' ' 85' ' ' VAL 0.296 0.9 OUTLIER -121.46 146.5 46.85 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -169.067 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.416 ' CG ' HG23 ' A' ' 103' ' ' THR . 3.7 p-10 -63.13 -18.08 63.04 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 113.673 -1.603 . . . . 0.0 114.653 -160.579 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.416 HG23 ' CG ' ' A' ' 102' ' ' ASN . 4.1 p -139.68 146.57 39.81 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.934 0.873 . . . . 0.0 111.125 -176.455 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -59.34 -41.25 88.75 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.096 178.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -77.37 -35.64 54.33 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -177.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.02 -51.38 69.93 Favored 'General case' 0 C--O 1.222 -0.387 0 CA-C-N 119.992 1.269 . . . . 0.0 110.253 169.184 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.83 -36.53 78.3 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 178.658 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -57.9 -47.16 83.61 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.693 1.133 . . . . 0.0 111.262 170.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -64.77 -33.96 77.21 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-O 117.915 -1.041 . . . . 0.0 110.9 173.279 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 11.1 ttp -66.66 -47.89 71.11 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 120.019 1.281 . . . . 0.0 111.225 -178.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -68.34 -38.55 79.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 124.604 1.161 . . . . 0.0 112.055 178.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -70.18 -43.39 70.88 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.442 0.697 . . . . 0.0 110.597 176.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -49.62 -37.7 29.03 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.803 1.241 . . . . 0.0 112.075 166.001 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -90.77 -12.95 34.97 Favored 'General case' 0 CA--C 1.518 -0.252 0 O-C-N 120.162 -1.586 . . . . 0.0 113.657 -177.049 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -83.93 -15.78 46.68 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.75 0.786 . . . . 0.0 110.932 167.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.89 -59.79 2.64 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 128.567 2.747 . . . . 0.0 111.742 166.566 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -93.84 -49.57 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -153.646 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.5 m 54.88 129.36 0.01 OUTLIER Pre-proline 0 N--CA 1.481 1.101 0 C-N-CA 129.535 3.134 . . . . 0.0 113.069 -157.078 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -75.76 -22.25 13.7 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 121.991 1.794 . . . . 0.0 114.752 -173.532 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.5 t 38.87 89.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 129.223 3.009 . . . . 0.0 113.179 174.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.46 ' H ' HD11 ' A' ' 126' ' ' ILE . 2.8 tt -101.45 -50.56 3.71 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 113.444 -1.707 . . . . 0.0 110.376 -132.469 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.96 1.94 29.24 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 126.266 1.827 . . . . 0.0 113.64 165.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 125.46 12.37 3.81 Favored Glycine 0 CA--C 1.537 1.411 0 N-CA-C 117.108 1.603 . . . . 0.0 117.108 175.131 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -147.13 163.97 25.64 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 120.251 2.025 . . . . 0.0 112.837 174.057 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -56.74 143.57 89.73 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.522 2.815 . . . . 0.0 115.621 -168.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.46 HD11 ' H ' ' A' ' 121' ' ' LEU . 3.9 mm -118.81 147.28 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 127.292 2.237 . . . . 0.0 108.122 -178.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.439 ' CD2' ' HG2' ' A' ' 65' ' ' LYS . 19.5 m-30 -117.82 127.9 54.33 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.193 -0.942 . . . . 0.0 111.099 -169.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -124.65 147.13 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.764 1.225 . . . . 0.0 113.326 -178.631 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -158.37 159.43 35.8 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.308 1.843 . . . . 0.0 110.001 159.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.443 ' HA ' ' HA ' ' A' ' 61' ' ' ILE . 32.1 m-85 -56.43 162.48 2.12 Favored 'General case' 0 CA--C 1.556 1.177 0 O-C-N 120.473 -1.392 . . . . 0.0 113.057 166.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.556 ' HB3' HG13 ' A' ' 60' ' ' VAL . 5.3 p -72.25 174.72 6.86 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 116.135 1.902 . . . . 0.0 116.135 -174.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -95.37 2.58 54.67 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 127.246 2.218 . . . . 0.0 114.068 166.167 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -121.99 -26.72 4.72 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 117.19 2.293 . . . . 0.0 117.19 -162.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp 58.82 109.51 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 126.108 1.763 . . . . 0.0 112.963 -164.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 60.28 110.26 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 128.06 2.544 . . . . 0.0 115.406 176.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.545 HD13 ' CD2' ' A' ' 98' ' ' PHE . 32.1 tp -71.32 140.87 50.43 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.054 1.341 . . . . 0.0 111.479 174.078 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.014 0 C-N-CA 126.157 1.783 . . . . 0.0 110.82 168.098 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 66.5 p . . . . . 0 N--CA 1.476 0.825 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 -124.73 -10.46 7.28 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 -161.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.512 HG13 ' HB3' ' A' ' 131' ' ' SER 0.337 3.8 p -112.03 135.95 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-N 119.842 1.201 . . . . 0.0 112.154 168.654 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.6 mt -114.93 150.56 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 127.629 2.372 . . . . 0.0 107.859 173.044 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -118.08 130.2 56.0 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.758 1.223 . . . . 0.0 110.73 178.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.5 mt -117.01 125.77 74.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 127.494 2.318 . . . . 0.0 108.414 -173.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -112.43 175.91 5.24 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 125.931 1.692 . . . . 0.0 113.024 -178.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 11.6 mmmt 59.34 27.81 16.99 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 127.392 2.277 . . . . 0.0 114.671 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.3 mp -55.01 155.63 8.17 Favored Pre-proline 0 CA--C 1.554 1.126 0 C-N-CA 124.858 1.263 . . . . 0.0 112.321 176.419 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.497 ' HD3' HD11 ' A' ' 121' ' ' LEU . 62.2 Cg_exo -45.8 -67.25 0.12 Allowed 'Trans proline' 0 C--N 1.351 0.706 1 C-N-CA 125.87 4.38 . . . . 0.0 115.151 -177.946 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.7 pt -153.05 -50.36 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 130.933 3.693 . . . . 0.0 107.615 175.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -151.52 -5.99 0.25 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.309 1.444 . . . . 0.0 114.174 178.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.291 2.8 p 43.8 -146.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 C-N-CA 127.237 2.215 . . . . 0.0 112.084 -174.535 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.2 t -140.02 136.02 33.27 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 120.723 -1.236 . . . . 0.0 110.522 161.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -56.76 -34.91 68.04 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.598 0.759 . . . . 0.0 113.03 179.081 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -55.28 -40.17 74.72 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.892 1.234 . . . . 0.0 113.434 172.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -67.12 -50.9 59.87 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.776 -0.837 . . . . 0.0 111.292 171.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 87.7 t -55.89 -49.89 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.578 0.751 . . . . 0.0 112.725 -176.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -82.01 -26.07 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 O-C-N 120.264 -1.522 . . . . 0.0 114.409 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.3 t -61.56 -32.4 72.48 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 119.76 1.164 . . . . 0.0 110.377 168.147 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.9 mt -76.3 -26.18 55.6 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 171.497 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -85.51 -19.86 57.63 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-N 119.549 1.068 . . . . 0.0 114.836 175.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 11.5 mt -69.95 -31.17 2.28 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 117.982 2.586 . . . . 0.0 117.982 -168.071 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -58.62 -4.63 1.96 Allowed 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 123.517 2.811 . . . . 0.0 116.821 169.424 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -108.41 -40.61 5.09 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -166.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -150.88 -109.78 0.47 Allowed Glycine 0 CA--C 1.525 0.665 0 CA-C-O 122.348 0.971 . . . . 0.0 111.974 176.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 17.1 tptm -147.7 138.16 23.12 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 128.895 2.878 . . . . 0.0 103.997 164.02 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.497 HG22 ' HE2' ' A' ' 101' ' ' MET 0.307 12.4 t -130.15 82.97 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 CA-C-N 120.717 1.599 . . . . 0.0 109.567 -163.047 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.5 t -77.08 -21.83 53.77 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 126.669 1.988 . . . . 0.0 113.149 -159.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -141.51 165.65 26.91 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-O 122.615 1.197 . . . . 0.0 113.619 165.586 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -137.55 179.07 6.63 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.253 1.421 . . . . 0.0 109.924 157.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.499 HD23 ' C ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -150.47 159.12 44.71 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.395 1.478 . . . . 0.0 109.69 172.798 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 6.9 mtt -133.65 100.58 4.83 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.074 0.95 . . . . 0.0 112.529 -174.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -73.92 92.34 2.08 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.087 1.355 . . . . 0.0 111.15 171.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 48.8 mttp -62.41 -20.94 64.99 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 175.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.89 -53.98 41.06 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 125.768 1.651 . . . . 0.0 115.138 -174.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.5 mtmt -123.33 20.05 9.71 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 126.04 1.736 . . . . 0.0 112.01 179.072 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 23.2 m120 53.67 66.64 1.17 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 126.841 2.056 . . . . 0.0 112.575 -173.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . 0.257 0.0 OUTLIER -125.53 179.43 5.14 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.51 0.671 . . . . 0.0 112.471 170.087 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -154.07 162.77 40.96 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 126.542 1.937 . . . . 0.0 109.904 -176.166 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.48 ' CD2' HG21 ' A' ' 60' ' ' VAL . 5.6 m-30 -108.11 150.91 26.58 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.546 1.539 . . . . 0.0 107.333 159.519 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.2 tt -132.9 124.04 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 124.624 1.169 . . . . 0.0 108.405 163.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.44 ' HG3' ' H ' ' A' ' 136' ' ' LEU . 3.6 tm-20 -130.74 126.6 36.86 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 122.588 1.185 . . . . 0.0 112.946 -162.278 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.497 ' HE2' HG22 ' A' ' 85' ' ' VAL . 0.5 OUTLIER -134.04 161.37 35.02 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.111 -1.404 . . . . 0.0 113.933 -159.903 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -79.32 -12.64 59.93 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.391 1.877 . . . . 0.0 113.26 -161.667 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.34 138.38 33.05 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.845 1.258 . . . . 0.0 111.32 -178.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -62.44 -34.79 77.5 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.312 176.369 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -75.69 -36.53 60.01 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.763 0.825 . . . . 0.0 112.963 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -56.22 -53.68 54.23 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 118.823 0.738 . . . . 0.0 109.693 168.137 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.31 -36.22 79.0 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -177.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -55.19 -50.28 69.75 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.109 0.868 . . . . 0.0 110.955 168.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -65.27 -30.75 71.65 Favored 'General case' 0 C--O 1.225 -0.222 0 O-C-N 121.441 -0.787 . . . . 0.0 111.603 174.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 5.6 ttp -73.39 -46.33 49.48 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 119.908 1.231 . . . . 0.0 111.591 -177.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -65.21 -40.12 87.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 124.145 0.978 . . . . 0.0 110.958 177.676 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -68.5 -46.1 70.55 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.597 0.759 . . . . 0.0 110.647 176.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -48.34 -42.88 32.67 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.111 1.364 . . . . 0.0 111.937 168.228 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.569 ' HA ' HG12 ' A' ' 117' ' ' VAL . 17.3 m-85 -84.96 -14.21 48.28 Favored 'General case' 0 C--N 1.334 -0.105 0 O-C-N 120.764 -1.21 . . . . 0.0 112.485 -176.144 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 92.9 m -83.18 -14.06 54.2 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.422 1.089 . . . . 0.0 110.618 169.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.21 -56.83 2.5 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 129.228 3.011 . . . . 0.0 113.257 178.173 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.569 HG12 ' HA ' ' A' ' 114' ' ' TYR . 9.8 p -72.65 -33.55 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 127.187 2.195 . . . . 0.0 113.777 -157.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.428 ' CG2' ' H ' ' A' ' 126' ' ' ILE . 0.3 OUTLIER -2.25 114.36 0.01 OUTLIER Pre-proline 0 N--CA 1.484 1.256 0 C-N-CA 129.206 3.002 . . . . 0.0 116.449 -131.544 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -77.26 -7.76 17.19 Favored 'Trans proline' 0 CA--C 1.546 1.117 0 C-N-CA 123.675 2.916 . . . . 0.0 114.336 -161.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.5 t 61.05 107.95 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 130.71 3.604 . . . . 0.0 114.509 176.269 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.497 HD11 ' HD3' ' A' ' 67' ' ' PRO . 14.2 tp -73.17 -55.86 5.89 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.766 0.826 . . . . 0.0 112.335 -168.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -125.52 -4.95 7.14 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 127.584 2.354 . . . . 0.0 113.492 -161.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 99.63 13.87 36.56 Favored Glycine 0 CA--C 1.539 1.556 0 C-N-CA 124.282 0.944 . . . . 0.0 112.432 -148.059 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -138.9 144.7 42.49 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 128.402 2.681 . . . . 0.0 109.259 -178.005 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -57.35 168.96 2.46 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 124.0 3.133 . . . . 0.0 114.077 176.535 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.428 ' H ' ' CG2' ' A' ' 118' ' ' THR . 0.3 OUTLIER -125.27 149.45 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.092 1.357 . . . . 0.0 109.896 -177.661 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -120.88 101.35 7.64 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.419 -153.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.85 150.51 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.53 1.132 . . . . 0.0 112.739 -177.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -152.37 163.6 39.16 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 126.832 2.053 . . . . 0.0 109.074 154.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -53.02 151.81 4.49 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.362 -0.836 . . . . 0.0 112.076 164.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.512 ' HB3' HG13 ' A' ' 60' ' ' VAL . 31.6 t -71.6 156.22 39.65 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.665 0.745 . . . . 0.0 112.051 176.133 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -68.99 -7.71 37.88 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.137 1.375 . . . . 0.0 113.196 164.304 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 36.8 m-70 -119.47 177.89 4.75 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 127.361 2.264 . . . . 0.0 110.916 -176.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -119.55 5.9 11.07 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 -167.316 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 162.41 167.45 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 131.077 3.751 . . . . 0.0 111.22 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.44 ' H ' ' HG3' ' A' ' 100' ' ' GLU . 3.6 mm? -74.54 147.55 41.69 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.669 0.788 . . . . 0.0 109.475 158.276 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 16.4 tttp . . . . . 0 N--CA 1.469 0.521 0 CA-C-O 122.558 1.171 . . . . 0.0 110.506 173.173 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 31.5 t . . . . . 0 CA--C 1.546 0.795 0 N-CA-C 115.354 1.613 . . . . 0.0 115.354 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 21.9 mtp180 -139.54 -9.19 1.25 Allowed 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 117.01 2.226 . . . . 0.0 117.01 -154.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.539 HG13 ' HB3' ' A' ' 131' ' ' SER 0.272 3.9 p -106.82 131.15 57.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 CA-C-N 120.615 1.552 . . . . 0.0 112.13 169.46 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.2 mt -109.97 155.8 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 127.672 2.389 . . . . 0.0 108.231 170.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -124.02 138.72 54.41 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.349 1.46 . . . . 0.0 110.689 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.2 mt -122.38 132.18 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 126.95 2.1 . . . . 0.0 109.807 -171.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.96 173.89 6.12 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 125.803 1.641 . . . . 0.0 113.246 178.587 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 13.8 mmmt 64.9 15.98 10.24 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 128.903 2.881 . . . . 0.0 116.416 173.201 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 30.8 mt -61.99 141.89 95.45 Favored Pre-proline 0 CA--C 1.555 1.158 0 CA-C-O 118.444 -0.788 . . . . 0.0 110.517 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -37.54 -62.92 0.26 Allowed 'Trans proline' 0 CA--C 1.539 0.766 1 C-N-CA 125.589 4.193 . . . . 0.0 116.043 -177.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.1 pt -153.74 -42.44 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 129.964 3.306 . . . . 0.0 109.323 174.188 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -153.3 -7.49 0.17 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.412 1.485 . . . . 0.0 113.187 -170.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.415 HG22 ' H ' ' A' ' 71' ' ' THR 0.298 12.0 p 34.27 -122.21 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 127.09 2.156 . . . . 0.0 111.496 -165.474 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.415 ' H ' HG22 ' A' ' 70' ' ' VAL . 0.9 OUTLIER -148.75 135.55 19.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 122.368 1.08 . . . . 0.0 109.045 152.775 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -55.17 -31.13 61.12 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.057 0.943 . . . . 0.0 112.768 178.227 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -60.42 -37.94 93.98 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 124.832 1.206 . . . . 0.0 114.121 172.085 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -69.86 -44.86 68.98 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.422 -1.046 . . . . 0.0 110.579 172.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 85.5 t -57.76 -51.76 66.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 123.808 0.843 . . . . 0.0 112.182 -176.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -78.92 -26.06 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 O-C-N 120.341 -1.474 . . . . 0.0 114.381 177.291 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 38.7 t -62.15 -28.53 69.72 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 119.846 1.203 . . . . 0.0 110.553 169.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 22.8 mt -82.55 -23.48 34.48 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.923 1.082 . . . . 0.0 113.923 170.433 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -89.06 -11.02 65.6 Favored Glycine 0 CA--C 1.534 1.229 0 CA-C-N 119.406 1.003 . . . . 0.0 114.67 176.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.2 mt -77.55 -17.12 0.26 Allowed Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 118.859 2.911 . . . . 0.0 118.859 -174.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -59.6 -2.51 1.51 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.868 2.379 . . . . 0.0 117.363 169.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -119.56 -44.77 2.54 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -166.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -150.88 -108.52 0.42 Allowed Glycine 0 C--N 1.337 0.591 0 C-N-CA 123.796 0.712 . . . . 0.0 111.581 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 21.7 tptp -142.84 -15.73 0.71 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 115.524 1.675 . . . . 0.0 115.524 -171.108 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.563 HG13 ' HB2' ' A' ' 101' ' ' MET 0.256 0.2 OUTLIER 34.6 81.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 128.159 2.584 . . . . 0.0 113.493 175.088 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 54.3 p -68.06 -36.18 79.43 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.352 1.061 . . . . 0.0 112.205 -169.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -145.0 165.71 27.39 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 123.611 1.672 . . . . 0.0 114.838 -177.448 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -150.31 169.14 22.1 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 126.489 1.916 . . . . 0.0 112.377 162.083 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.527 HD23 ' C ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -145.67 150.97 37.28 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 127.305 2.242 . . . . 0.0 108.536 -174.724 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 5.5 mtp -133.45 94.97 3.4 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.786 0.834 . . . . 0.0 111.811 -169.499 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.406 ' CD1' HD21 ' A' ' 89' ' ' LEU . 0.8 OUTLIER -72.34 84.35 1.07 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.102 1.361 . . . . 0.0 111.443 175.244 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.01 -11.28 12.82 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 115.265 1.579 . . . . 0.0 115.265 170.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -60.62 -56.45 24.26 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 126.403 1.954 . . . . 0.0 114.494 177.558 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 31.6 mtmt -125.49 22.51 7.66 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 126.16 1.784 . . . . 0.0 112.144 -176.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 57.51 56.18 5.16 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.559 2.344 . . . . 0.0 113.92 -178.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . 0.264 0.0 OUTLIER -129.63 -179.39 5.15 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 173.964 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -158.25 164.78 36.14 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.72 2.008 . . . . 0.0 110.44 -177.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.5 ' CD2' HG21 ' A' ' 60' ' ' VAL . 4.8 m-30 -111.14 151.77 27.78 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.488 1.915 . . . . 0.0 107.896 163.636 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.9 tt -133.79 104.21 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 C-N-CA 125.544 1.538 . . . . 0.0 108.018 167.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -97.77 127.69 43.9 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 128.387 2.675 . . . . 0.0 110.762 -174.566 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.563 ' HB2' HG13 ' A' ' 85' ' ' VAL 0.305 20.8 ttm -126.86 157.52 39.12 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 -173.921 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.429 ' ND2' HG23 ' A' ' 103' ' ' THR . 19.9 p-10 -54.54 -37.07 64.98 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 127.037 2.135 . . . . 0.0 114.299 -172.185 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.429 HG23 ' ND2' ' A' ' 102' ' ' ASN . 69.2 p -141.39 137.78 32.53 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.976 0.91 . . . . 0.0 110.589 -162.262 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -59.81 -38.62 82.48 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.658 0.783 . . . . 0.0 112.041 -177.453 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -74.18 -37.94 63.79 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -178.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -57.64 -48.85 78.31 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 119.185 0.902 . . . . 0.0 110.408 169.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.74 -37.29 70.58 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.338 0.972 . . . . 0.0 113.585 -178.252 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -55.21 -50.86 68.3 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 120.96 -1.088 . . . . 0.0 111.085 169.167 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -64.33 -27.84 69.3 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-O 117.961 -1.019 . . . . 0.0 111.466 173.048 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 16.7 ttp -71.64 -47.78 52.18 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-N 120.444 1.474 . . . . 0.0 110.335 -177.158 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.51 -40.61 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 123.636 0.775 . . . . 0.0 111.207 176.5 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -67.43 -47.28 70.67 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.586 0.754 . . . . 0.0 110.829 177.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -48.26 -41.84 28.89 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.93 1.692 . . . . 0.0 112.561 167.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.601 ' HA ' HG12 ' A' ' 117' ' ' VAL . 16.8 m-85 -85.36 -17.62 36.21 Favored 'General case' 0 C--O 1.232 0.166 0 O-C-N 120.551 -1.343 . . . . 0.0 112.613 -177.217 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 67.5 m -78.18 -16.58 57.76 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.071 0.948 . . . . 0.0 110.193 169.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.47 -57.43 2.77 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 129.126 2.97 . . . . 0.0 112.808 177.009 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.601 HG12 ' HA ' ' A' ' 114' ' ' TYR . 8.8 p -76.68 -40.82 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.504 1.521 . . . . 0.0 113.66 -154.022 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 11.52 113.67 0.0 OUTLIER Pre-proline 0 N--CA 1.482 1.14 0 C-N-CA 129.011 2.924 . . . . 0.0 116.175 -133.427 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.444 ' HD2' HD12 ' A' ' 126' ' ' ILE . 3.9 Cg_exo -75.77 -19.33 16.39 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.463 2.775 . . . . 0.0 112.969 -165.314 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 6.4 t 61.08 110.19 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 130.514 3.526 . . . . 0.0 113.065 -178.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.0 tt -75.0 80.01 2.19 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.732 1.613 . . . . 0.0 109.6 -176.39 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . 0.29 2.9 ppt_? 46.61 -13.19 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.249 1 C-N-CA 132.733 4.413 . . . . 0.0 118.906 -168.944 . . . . . . . . 3 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -174.04 3.37 0.03 OUTLIER Glycine 0 CA--C 1.538 1.512 0 N-CA-C 116.493 1.357 . . . . 0.0 116.493 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 5.3 tp60 -139.37 140.72 26.63 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 126.019 1.728 . . . . 0.0 109.489 -177.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.94 164.68 7.73 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 123.628 2.885 . . . . 0.0 113.329 174.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.444 HD12 ' HD2' ' A' ' 119' ' ' PRO . 0.7 OUTLIER -127.76 147.6 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.462 1.105 . . . . 0.0 110.762 -174.737 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -127.19 102.07 6.78 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.637 1.175 . . . . 0.0 109.923 -153.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.8 150.19 23.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -173.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -153.04 161.98 41.87 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 126.485 1.914 . . . . 0.0 109.264 154.39 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -53.33 151.39 5.43 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-O 121.756 0.788 . . . . 0.0 112.24 164.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.539 ' HB3' HG13 ' A' ' 60' ' ' VAL . 32.6 t -68.09 154.21 42.14 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.901 0.88 . . . . 0.0 112.283 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -64.22 -16.72 62.59 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.35 1.06 . . . . 0.0 112.85 165.117 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 54.9 m-70 -110.57 -176.95 3.11 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 127.523 2.329 . . . . 0.0 112.075 -176.294 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -134.47 153.58 51.86 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.607 1.563 . . . . 0.0 110.975 159.478 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 45.93 93.71 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 128.313 2.645 . . . . 0.0 115.262 -178.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 25.2 tp -56.09 100.34 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 127.463 2.305 . . . . 0.0 112.38 173.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.47 0.537 0 C-N-CA 126.832 2.053 . . . . 0.0 109.478 172.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.0 t . . . . . 0 N--CA 1.474 0.74 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.4 mtp180 -46.61 -20.44 0.13 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 130.436 3.494 . . . . 0.0 119.167 -166.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.682 HG13 ' HB3' ' A' ' 131' ' ' SER 0.311 7.4 p -93.9 130.8 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 CA-C-N 121.585 1.993 . . . . 0.0 112.946 173.759 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 21.6 mt -105.21 156.97 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 127.19 2.196 . . . . 0.0 108.338 167.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -121.62 140.64 51.99 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.706 1.602 . . . . 0.0 110.374 177.314 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.0 mt -120.37 141.11 42.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 127.667 2.387 . . . . 0.0 108.777 -176.208 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.12 -171.79 2.05 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 125.667 1.587 . . . . 0.0 111.244 176.696 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 52.71 11.62 0.21 Allowed 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 127.664 2.386 . . . . 0.0 117.363 169.496 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 22.4 mt -62.75 155.94 67.73 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 124.785 1.234 . . . . 0.0 113.241 -176.238 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -51.95 173.06 0.12 Allowed 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 123.58 2.853 . . . . 0.0 114.669 161.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 32.5 pt -69.54 -30.78 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 126.568 1.947 . . . . 0.0 112.951 -172.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -156.36 34.86 0.32 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.78 2.032 . . . . 0.0 110.702 -170.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -53.09 147.75 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 O-C-N 121.095 -1.003 . . . . 0.0 111.051 174.482 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.41 HG23 ' H ' ' A' ' 74' ' ' GLU . 5.5 t -88.91 136.83 32.8 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 123.05 1.405 . . . . 0.0 112.187 -173.19 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -55.49 -34.45 64.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.588 -1.187 . . . . 0.0 112.984 171.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -54.83 -40.3 71.48 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.856 1.217 . . . . 0.0 113.277 171.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.41 ' H ' HG23 ' A' ' 71' ' ' THR . 12.0 mt-10 -66.94 -51.2 58.15 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.052 0.941 . . . . 0.0 110.868 172.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 86.2 t -58.61 -48.7 84.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 123.652 0.781 . . . . 0.0 112.788 -175.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -80.7 -24.64 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 O-C-N 120.191 -1.568 . . . . 0.0 114.432 177.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 75.5 m -64.16 -27.1 68.84 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 120.407 1.458 . . . . 0.0 110.856 168.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.7 mt -77.68 -28.38 51.06 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 118.16 -0.924 . . . . 0.0 113.237 170.005 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -89.44 -13.78 61.02 Favored Glycine 0 CA--C 1.536 1.404 0 CA-C-N 119.979 1.263 . . . . 0.0 115.425 175.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.3 mt -68.13 -38.06 12.74 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 117.429 2.381 . . . . 0.0 117.429 -169.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -57.51 -3.52 0.94 Allowed 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.89 3.06 . . . . 0.0 117.277 173.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -106.34 -27.12 11.18 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -164.429 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -172.14 -95.45 0.1 OUTLIER Glycine 0 C--N 1.336 0.542 0 C-N-CA 124.631 1.11 . . . . 0.0 110.634 169.133 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.7 tppt? -149.24 155.65 40.91 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 127.021 2.129 . . . . 0.0 105.503 160.021 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.623 HG22 ' CE ' ' A' ' 101' ' ' MET . 3.1 t -131.4 102.0 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 120.341 1.428 . . . . 0.0 110.05 -171.765 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 30.5 m -67.23 -46.88 72.47 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 128.872 2.869 . . . . 0.0 112.22 -162.081 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 53.3 m-20 -144.92 162.06 37.8 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 122.236 1.017 . . . . 0.0 112.491 177.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -135.61 171.78 13.95 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.378 1.071 . . . . 0.0 110.936 157.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.529 HD23 ' C ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -145.56 152.36 39.59 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.563 1.545 . . . . 0.0 109.11 -179.42 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 8.2 mtt -131.61 104.13 6.77 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.139 0.976 . . . . 0.0 112.408 -175.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -78.03 74.03 4.58 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.019 1.328 . . . . 0.0 109.878 170.447 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -58.27 -28.78 65.26 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -172.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -79.15 -6.49 88.84 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 125.279 1.419 . . . . 0.0 115.491 175.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.4 mtmt -120.8 4.47 10.53 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.252 1.821 . . . . 0.0 114.139 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 15.5 m120 54.42 38.5 29.7 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.317 1.447 . . . . 0.0 112.507 -170.186 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -137.09 160.0 40.24 Favored 'General case' 0 CA--C 1.554 1.129 0 O-C-N 121.258 -0.901 . . . . 0.0 111.032 -159.117 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -154.78 167.82 28.93 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 120.127 -1.608 . . . . 0.0 112.644 -177.606 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.442 ' CD2' HG21 ' A' ' 60' ' ' VAL . 5.4 m-30 -116.05 155.52 27.98 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.63 1.972 . . . . 0.0 108.818 165.598 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 16.6 tt -139.68 99.41 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 125.373 1.469 . . . . 0.0 109.249 168.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.0 tp10 -88.97 122.67 32.57 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 128.617 2.767 . . . . 0.0 110.628 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.623 ' CE ' HG22 ' A' ' 85' ' ' VAL 0.332 0.9 OUTLIER -119.17 161.18 20.78 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 -176.942 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -70.0 -15.81 63.08 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.376 1.47 . . . . 0.0 113.336 -164.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.28 144.77 33.44 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 122.153 0.978 . . . . 0.0 111.069 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -60.98 -43.42 98.84 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.78 177.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -73.55 -35.42 65.5 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -178.083 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -57.13 -54.61 44.81 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 168.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.58 -39.17 91.33 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 120.986 -1.071 . . . . 0.0 113.458 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -49.3 -55.07 13.98 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 120.226 1.375 . . . . 0.0 113.211 168.001 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -62.49 -34.62 77.21 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 118.708 -0.663 . . . . 0.0 111.012 175.327 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 4.6 ttp -63.34 -56.05 19.52 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.009 1.324 . . . . 0.0 110.189 179.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -61.4 -37.57 78.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 125.877 1.671 . . . . 0.0 112.006 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -69.96 -46.42 65.3 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.706 0.802 . . . . 0.0 111.301 177.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -49.35 -38.48 28.33 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.434 0.694 . . . . 0.0 111.821 166.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.671 ' HA ' HG12 ' A' ' 117' ' ' VAL . 14.4 m-85 -83.98 -20.69 32.41 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 120.723 -1.236 . . . . 0.0 113.075 -174.579 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -82.56 -13.69 56.15 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.993 0.901 . . . . 0.0 111.222 171.271 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.77 -53.17 5.3 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 127.721 2.408 . . . . 0.0 112.37 174.438 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.671 HG12 ' HA ' ' A' ' 114' ' ' TYR . 10.0 p -75.8 -42.66 40.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 125.695 1.598 . . . . 0.0 114.868 -157.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.438 ' CA ' HG13 ' A' ' 117' ' ' VAL . 0.2 OUTLIER 1.53 113.35 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.462 0 C-N-CA 127.349 2.26 . . . . 0.0 116.437 -124.836 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.425 ' HD2' HD12 ' A' ' 126' ' ' ILE . 5.4 Cg_exo -76.66 -18.85 14.99 Favored 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 123.604 2.869 . . . . 0.0 113.216 -164.124 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.6 t 62.46 105.05 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 129.938 3.295 . . . . 0.0 112.947 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.8 tt -70.87 -64.35 0.92 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.233 0.613 . . . . 0.0 111.563 -162.292 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -142.02 71.69 1.36 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.492 1.517 . . . . 0.0 109.879 172.446 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 77.85 8.82 87.24 Favored Glycine 0 CA--C 1.538 1.476 0 N-CA-C 115.641 1.016 . . . . 0.0 115.641 -179.296 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -138.29 139.34 25.0 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 126.142 1.777 . . . . 0.0 110.417 177.218 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -58.79 162.07 13.87 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 123.35 2.7 . . . . 0.0 111.872 171.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.425 HD12 ' HD2' ' A' ' 119' ' ' PRO . 3.0 mt -106.39 -45.07 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -156.529 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 77.25 110.07 0.07 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.992 2.117 . . . . 0.0 112.103 170.522 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.47 153.84 35.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 125.723 1.609 . . . . 0.0 111.206 178.459 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -151.33 164.2 37.21 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.919 1.688 . . . . 0.0 109.005 151.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -51.89 146.16 8.75 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.278 -0.889 . . . . 0.0 111.673 164.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.682 ' HB3' HG13 ' A' ' 60' ' ' VAL . 29.0 t -68.73 154.37 42.07 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.919 -0.488 . . . . 0.0 111.576 178.527 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -63.54 -20.42 65.62 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.177 0.991 . . . . 0.0 112.525 165.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 37.4 m-70 -101.08 177.43 4.95 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.955 2.102 . . . . 0.0 110.665 178.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -128.7 7.66 5.72 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.94 1.296 . . . . 0.0 113.87 -168.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -173.16 155.58 3.0 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 127.821 2.449 . . . . 0.0 109.643 -167.062 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 47.6 tp -134.61 74.46 1.53 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.528 1.931 . . . . 0.0 110.034 170.507 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 23.7 tptm . . . . . 0 N--CA 1.47 0.561 0 C-N-CA 124.709 1.204 . . . . 0.0 109.651 176.605 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.642 0 N-CA-C 112.229 -0.349 . . . . 0.0 112.229 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -94.2 -1.7 53.69 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.145 1.778 . . . . 0.0 114.951 -175.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.5 m -61.62 -5.47 1.89 Allowed 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 127.29 2.236 . . . . 0.0 116.896 -169.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 23.1 mmt180 -56.65 -48.98 76.38 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.937 1.295 . . . . 0.0 111.904 173.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.8 m -75.94 136.05 40.07 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.741 1.216 . . . . 0.0 111.831 177.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.49 ' HB1' ' HB3' ' A' ' 57' ' ' PRO . . . -66.62 166.96 11.83 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.103 0.961 . . . . 0.0 113.551 172.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -153.47 -36.96 0.03 OUTLIER Glycine 0 CA--C 1.536 1.391 0 C-N-CA 125.723 1.63 . . . . 0.0 113.096 170.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.3 p -143.97 71.72 16.74 Favored Pre-proline 0 N--CA 1.479 1.01 0 C-N-CA 126.577 1.951 . . . . 0.0 109.734 164.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.49 ' HB3' ' HB1' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -93.2 -173.25 0.37 Allowed 'Trans proline' 0 CA--C 1.548 1.208 1 C-N-CA 125.436 4.091 . . . . 0.0 112.276 -163.636 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.2 t -138.34 -178.59 5.35 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.265 1.026 . . . . 0.0 113.448 176.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 -51.87 -7.49 0.05 Allowed 'General case' 0 N--CA 1.474 0.775 1 C-N-CA 132.408 4.283 . . . . 0.0 120.412 -155.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.678 HG13 ' HB3' ' A' ' 131' ' ' SER 0.294 5.7 p -99.31 129.63 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-N 121.991 2.178 . . . . 0.0 112.099 170.241 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 16.1 mt -105.84 157.87 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 128.157 2.583 . . . . 0.0 108.149 170.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -128.17 142.87 51.05 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.206 1.802 . . . . 0.0 110.455 179.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.0 mt -123.76 140.01 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 126.953 2.101 . . . . 0.0 109.957 -174.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.69 174.3 6.03 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 125.958 1.703 . . . . 0.0 112.056 172.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.494 ' HE3' ' CE2' ' A' ' 127' ' ' TYR . 2.5 mmtp 71.39 -2.92 2.25 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 128.341 2.656 . . . . 0.0 116.571 172.029 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -35.34 145.72 0.2 Allowed Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 129.977 3.311 . . . . 0.0 115.933 -164.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.26 165.23 1.01 Allowed 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.36 2.707 . . . . 0.0 115.126 176.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 37.7 pt -56.66 -31.59 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 128.197 2.599 . . . . 0.0 113.984 -169.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -161.45 41.71 0.15 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.455 1.902 . . . . 0.0 110.365 -177.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -57.63 157.93 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 O-C-N 121.544 -0.722 . . . . 0.0 110.898 174.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 14.4 t -123.71 154.7 39.06 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 122.559 1.171 . . . . 0.0 113.216 -175.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -54.78 -42.6 71.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.74 175.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.62 -36.96 55.59 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.088 0.852 . . . . 0.0 113.463 178.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -71.44 -52.34 18.99 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.911 1.284 . . . . 0.0 112.16 173.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 57.6 t -59.71 -46.25 93.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -177.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.9 pp -69.75 -34.24 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 O-C-N 120.553 -1.342 . . . . 0.0 112.422 175.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 74.8 m -67.8 -19.31 65.07 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 119.895 1.225 . . . . 0.0 111.742 175.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 62.5 mt -89.62 -15.53 32.54 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 172.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -101.3 -13.23 33.79 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-N 119.168 0.894 . . . . 0.0 114.977 172.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.3 mt -63.34 -44.98 84.31 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 116.563 2.06 . . . . 0.0 116.563 -175.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.1 -5.22 1.28 Allowed 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 124.441 3.428 . . . . 0.0 117.972 176.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -103.96 -39.93 6.4 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -164.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -154.77 -82.77 0.04 OUTLIER Glycine 0 CA--C 1.518 0.257 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 172.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 22.5 tptp -152.05 -8.98 0.2 Allowed 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 116.972 2.212 . . . . 0.0 116.972 174.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.413 ' H ' ' HE1' ' A' ' 101' ' ' MET . 0.4 OUTLIER 27.18 109.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.173 0 C-N-CA 127.635 2.374 . . . . 0.0 115.449 -147.208 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.2 m -59.3 -36.62 75.94 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 119.678 -1.889 . . . . 0.0 112.226 170.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -162.56 178.23 8.75 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 115.903 1.816 . . . . 0.0 115.903 175.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -136.88 172.76 12.53 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.31 1.844 . . . . 0.0 112.601 155.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.51 HD23 ' C ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -142.43 156.27 45.17 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.923 1.689 . . . . 0.0 109.538 169.984 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 3.5 mtt -128.98 107.76 9.87 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.92 0.888 . . . . 0.0 111.81 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -78.34 54.4 1.4 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.226 1.01 . . . . 0.0 109.488 164.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 66.4 tttt -64.78 -27.37 68.84 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -159.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -65.62 -14.39 60.25 Favored Glycine 0 CA--C 1.541 1.718 0 C-N-CA 125.152 1.358 . . . . 0.0 115.707 171.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.01 2.89 17.09 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.887 1.675 . . . . 0.0 113.054 169.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 7.9 m120 50.66 54.27 11.48 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.656 1.582 . . . . 0.0 112.164 -167.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -132.12 168.52 17.85 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.166 0.986 . . . . 0.0 110.76 173.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -154.6 166.47 33.24 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.918 1.287 . . . . 0.0 112.102 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.473 ' CD2' HG21 ' A' ' 60' ' ' VAL . 5.2 m-30 -111.5 156.08 22.26 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.119 1.768 . . . . 0.0 108.359 161.086 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 15.2 tt -139.69 106.69 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.979 1.312 . . . . 0.0 109.045 166.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -96.97 137.6 35.81 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 129.291 3.036 . . . . 0.0 111.135 -174.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.481 ' HE2' ' HB2' ' A' ' 101' ' ' MET 0.316 19.9 tpp -133.04 150.55 52.11 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 115.842 1.793 . . . . 0.0 115.842 -167.282 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.92 -15.28 62.09 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 114.166 1.172 . . . . 0.0 114.166 -166.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.53 143.83 31.03 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.41 1.084 . . . . 0.0 110.234 -177.001 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -64.2 -37.74 88.55 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.637 0.775 . . . . 0.0 111.424 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -73.26 -39.73 65.19 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.764 0.826 . . . . 0.0 113.007 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -54.62 -51.52 65.1 Favored 'General case' 0 C--O 1.217 -0.62 0 C-N-CA 123.494 0.718 . . . . 0.0 110.618 169.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.62 -37.6 76.9 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -55.54 -49.62 72.17 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.995 0.816 . . . . 0.0 110.552 169.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -66.63 -29.49 69.54 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-O 118.067 -0.968 . . . . 0.0 111.691 174.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 11.6 ttp -71.73 -45.25 62.36 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 120.329 1.422 . . . . 0.0 110.154 -177.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -68.74 -40.4 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 O-C-N 121.334 -0.854 . . . . 0.0 112.068 175.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -68.43 -43.1 77.85 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.737 -0.602 . . . . 0.0 110.402 178.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -48.57 -44.91 37.15 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 125.428 1.491 . . . . 0.0 111.833 165.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.579 ' HA ' HG12 ' A' ' 117' ' ' VAL . 14.2 m-85 -80.24 -14.87 58.08 Favored 'General case' 0 C--N 1.332 -0.194 0 O-C-N 121.032 -1.043 . . . . 0.0 112.837 -177.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 97.8 m -85.22 -13.55 49.57 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.763 1.225 . . . . 0.0 110.635 171.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.89 -56.04 2.62 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 129.02 2.928 . . . . 0.0 112.892 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.579 HG12 ' HA ' ' A' ' 114' ' ' TYR . 9.9 p -70.86 -32.49 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 127.948 2.499 . . . . 0.0 113.436 -162.233 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.491 ' CG2' ' H ' ' A' ' 126' ' ' ILE . 1.3 m -6.26 113.86 0.03 OUTLIER Pre-proline 0 N--CA 1.483 1.178 0 C-N-CA 128.857 2.863 . . . . 0.0 115.864 -129.133 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 118' ' ' THR . 5.5 Cg_exo -75.61 -0.72 10.49 Favored 'Trans proline' 0 CA--C 1.553 1.441 0 C-N-CA 124.154 3.236 . . . . 0.0 114.384 -159.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.2 t 59.89 108.96 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.787 1 C-N-CA 131.903 4.081 . . . . 0.0 115.645 176.038 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.9 tt -76.02 80.47 2.88 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.852 2.061 . . . . 0.0 109.271 174.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . 0.332 0.1 OUTLIER 45.3 -13.91 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 1 C-N-CA 133.707 4.803 . . . . 0.0 119.301 -173.146 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 178.46 12.09 0.02 OUTLIER Glycine 0 CA--C 1.537 1.436 0 C-N-CA 126.431 1.967 . . . . 0.0 115.029 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -142.53 156.13 63.59 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 126.53 1.932 . . . . 0.0 109.325 177.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_exo -53.32 166.74 1.0 Allowed 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 123.35 2.7 . . . . 0.0 114.339 167.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.491 ' H ' ' CG2' ' A' ' 118' ' ' THR . 0.7 OUTLIER -119.21 142.86 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.528 1.531 . . . . 0.0 108.858 178.196 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.494 ' CE2' ' HE3' ' A' ' 65' ' ' LYS . 3.0 m-85 -114.16 98.68 7.1 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.633 -156.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.18 147.56 25.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 124.014 0.926 . . . . 0.0 113.449 -174.22 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -150.96 160.51 43.87 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.495 1.918 . . . . 0.0 109.924 161.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -54.12 152.01 6.46 Favored 'General case' 0 CA--C 1.553 1.059 0 O-C-N 120.976 -1.077 . . . . 0.0 112.213 160.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.678 ' HB3' HG13 ' A' ' 60' ' ' VAL . 28.5 t -75.04 159.64 31.49 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.513 1.125 . . . . 0.0 113.594 -172.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -67.99 -12.3 60.51 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 126.41 1.884 . . . . 0.0 112.389 166.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 55.8 m-70 -118.24 -176.49 3.08 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.884 2.074 . . . . 0.0 113.057 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -129.73 147.08 51.47 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 126.855 2.062 . . . . 0.0 109.456 164.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 51.87 92.07 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 127.348 2.259 . . . . 0.0 115.554 176.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 42.4 tp -64.72 139.8 58.8 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.337 1.455 . . . . 0.0 112.546 174.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.0 146.51 52.12 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.496 1.918 . . . . 0.0 111.361 167.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 48.2 p -132.65 15.47 4.4 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.678 1.191 . . . . 0.0 113.902 -164.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -61.14 156.08 19.09 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.044 1.338 . . . . 0.0 113.876 -178.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 65.7 m -69.99 166.31 19.93 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.448 1.899 . . . . 0.0 114.344 -176.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 99.3 p -71.0 160.87 81.1 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 125.099 1.36 . . . . 0.0 113.646 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_exo -57.88 -25.24 68.53 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 123.934 3.089 . . . . 0.0 115.263 173.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -60.67 -43.69 97.37 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.91 0.884 . . . . 0.0 112.385 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -55.44 -36.8 66.91 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.637 1.175 . . . . 0.0 113.108 -178.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.4 -13.41 62.35 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.337 1.455 . . . . 0.0 114.582 177.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 . . . . . 0 N--CA 1.473 0.719 0 C-N-CA 126.312 1.845 . . . . 0.0 114.655 -165.008 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 147' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.506 0 N19-C1'-C2' 116.97 2.231 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 148' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.453 0 O4'-C1'-N19 111.83 3.63 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 149' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.622 2.897 1 O5'-C5'-C4' 117.594 5.281 OUTLIER-EPSILON 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 150' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.687 3 P-O3'-C3' 127.133 6.194 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 151' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.545 2.713 0 O4'-C1'-N19 110.646 2.446 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 152' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.444 0 O4'-C1'-N19 111.184 2.984 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.555 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -72.38 94.21 1.6 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.929 1.291 . . . . 0.0 111.557 176.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.5 m -57.72 -16.95 12.61 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 116.16 1.911 . . . . 0.0 116.16 -169.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -63.93 -26.6 68.66 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.228 1.411 . . . . 0.0 113.144 169.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.5 m -68.15 158.36 33.33 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.725 1.21 . . . . 0.0 113.65 -175.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.79 176.6 6.17 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 124.549 1.14 . . . . 0.0 112.086 165.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -86.4 -62.02 1.59 Allowed Glycine 0 N--CA 1.471 1.017 0 O-C-N 121.045 -1.035 . . . . 0.0 112.349 -168.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 17.1 t -134.88 75.3 61.89 Favored Pre-proline 0 N--CA 1.476 0.828 0 C-N-CA 124.738 1.215 . . . . 0.0 110.387 169.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -99.68 163.29 0.54 Allowed 'Trans proline' 0 CA--C 1.546 1.116 0 C-N-CA 125.124 3.882 . . . . 0.0 112.645 -169.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 65.1 m -141.29 -86.64 0.17 Allowed 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -177.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 72.5 mtm-85 -117.58 -17.48 9.96 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 -166.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.668 HG13 ' HB3' ' A' ' 131' ' ' SER 0.364 10.8 p -98.17 136.85 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 121.077 1.762 . . . . 0.0 113.575 170.117 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.8 mt -113.2 156.93 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 128.947 2.899 . . . . 0.0 107.937 170.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -124.99 132.38 53.27 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.672 1.589 . . . . 0.0 109.906 177.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.0 mt -111.97 131.16 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 127.747 2.419 . . . . 0.0 108.484 -175.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -87.55 178.67 6.72 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 119.898 1.226 . . . . 0.0 110.65 170.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 23.6 mtpp 33.49 53.95 0.46 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 129.03 2.932 . . . . 0.0 115.081 156.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.7 mt -68.88 152.11 96.93 Favored Pre-proline 0 C--N 1.309 -1.17 0 CA-C-N 113.628 -1.624 . . . . 0.0 109.206 167.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -51.12 160.98 1.76 Allowed 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 125.022 3.815 . . . . 0.0 115.339 174.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 29.7 pt -65.38 -24.13 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 128.533 2.733 . . . . 0.0 113.914 -176.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -139.97 19.63 2.47 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.624 1.969 . . . . 0.0 111.891 -171.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -57.87 166.48 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 123.956 0.902 . . . . 0.0 112.881 175.002 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.1 t -132.29 156.64 46.19 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-O 122.523 1.154 . . . . 0.0 112.42 171.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.5 -34.98 67.5 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.907 174.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -59.65 -31.32 70.85 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 125.303 1.43 . . . . 0.0 113.782 175.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -75.28 -44.88 43.31 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.718 1.207 . . . . 0.0 111.538 173.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 66.3 t -64.24 -45.43 96.26 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.427 HG23 HD13 ' A' ' 88' ' ' LEU . 2.4 pp -71.37 -29.49 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 O-C-N 120.216 -1.553 . . . . 0.0 113.317 174.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 35.1 t -63.24 -28.73 70.23 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 119.264 0.938 . . . . 0.0 110.649 171.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.9 mt -82.67 -17.11 45.72 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 173.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -94.44 -19.8 31.55 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-N 119.198 0.908 . . . . 0.0 115.188 172.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 13.9 mt -68.49 -33.13 4.28 Favored Pre-proline 0 CA--C 1.54 0.558 0 N-CA-C 117.547 2.425 . . . . 0.0 117.547 -169.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -59.0 -5.14 2.51 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.199 2.599 . . . . 0.0 117.16 169.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -109.47 -36.89 5.86 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -163.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -161.3 -98.83 0.14 Allowed Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 167.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.422 ' HB3' ' CG ' ' A' ' 102' ' ' ASN . 21.2 tptp -136.24 -10.83 1.95 Allowed 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 115.819 1.785 . . . . 0.0 115.819 -178.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.523 HG13 ' HB2' ' A' ' 101' ' ' MET . 0.1 OUTLIER 28.87 89.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 129.423 3.089 . . . . 0.0 113.389 -174.511 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.24 -42.03 94.41 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.793 2.037 . . . . 0.0 111.916 -173.389 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -152.0 168.73 24.27 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.427 HD13 HG23 ' A' ' 76' ' ' ILE . 1.9 pt? -144.21 170.65 15.57 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.003 1.721 . . . . 0.0 112.165 159.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.482 HD23 ' C ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -143.7 156.96 44.7 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.867 1.667 . . . . 0.0 109.328 -177.925 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 8.3 mtt -130.21 107.22 9.13 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.581 0.753 . . . . 0.0 112.234 -177.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -77.15 68.29 3.26 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.552 1.141 . . . . 0.0 109.378 167.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -56.08 -39.22 71.77 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.414 1.085 . . . . 0.0 113.481 -166.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -64.57 -20.97 66.47 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 124.673 1.13 . . . . 0.0 115.779 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -109.31 1.32 20.03 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.611 1.565 . . . . 0.0 112.737 174.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.0 m120 56.97 46.2 19.89 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.252 1.821 . . . . 0.0 113.417 -169.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -126.01 173.12 9.4 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 120.937 -1.102 . . . . 0.0 112.131 -177.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -152.22 160.92 43.28 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.53 1.132 . . . . 0.0 112.234 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.42 ' CD2' HG21 ' A' ' 60' ' ' VAL . 5.6 m-30 -99.56 154.09 18.53 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 155.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 17.1 tt -134.4 106.41 7.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 124.781 1.232 . . . . 0.0 107.979 165.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -105.44 122.18 45.45 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.714 1.605 . . . . 0.0 110.863 -172.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.523 ' HB2' HG13 ' A' ' 85' ' ' VAL . 0.9 OUTLIER -124.79 148.77 47.97 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 115.74 1.755 . . . . 0.0 115.74 -166.572 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.422 ' CG ' ' HB3' ' A' ' 84' ' ' LYS . 3.6 p-10 -63.77 -17.88 63.51 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 115.558 1.688 . . . . 0.0 115.558 -158.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.9 p -139.78 146.76 39.88 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.378 0.609 . . . . 0.0 110.468 -178.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -62.05 -34.56 76.48 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.019 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -77.24 -38.09 51.87 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 114.225 1.195 . . . . 0.0 114.225 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.66 -49.53 77.2 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-N 119.486 1.039 . . . . 0.0 110.431 170.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.54 -36.82 76.72 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 177.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -58.3 -46.47 86.06 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 119.727 1.149 . . . . 0.0 111.23 170.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -64.82 -33.91 77.12 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 121.032 -1.042 . . . . 0.0 111.127 173.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 9.8 ttp -65.43 -51.5 59.82 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.539 1.136 . . . . 0.0 110.414 -179.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -65.98 -36.7 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 C-N-CA 125.215 1.406 . . . . 0.0 112.593 177.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -72.19 -40.84 67.6 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.129 0.877 . . . . 0.0 111.165 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -52.76 -40.29 62.99 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.924 0.89 . . . . 0.0 111.693 162.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -88.5 12.86 13.29 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 119.667 -1.896 . . . . 0.0 112.291 177.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 52.0 m -112.52 -12.09 13.52 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.897 1.679 . . . . 0.0 110.175 169.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.52 -41.06 63.52 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.007 1.723 . . . . 0.0 111.544 153.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -142.38 160.8 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 124.897 1.279 . . . . 0.0 112.182 -150.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 18.7 m -125.01 135.63 27.04 Favored Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 125.657 1.583 . . . . 0.0 107.728 164.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -75.28 -17.09 19.23 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 121.895 1.73 . . . . 0.0 114.166 -171.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 4.0 t 39.85 73.88 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 128.39 2.676 . . . . 0.0 111.76 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.636 ' H ' HD11 ' A' ' 126' ' ' ILE . 5.5 tt -92.24 -32.8 14.92 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 112.397 -2.183 . . . . 0.0 110.609 -121.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -136.99 39.35 2.55 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.701 1.201 . . . . 0.0 111.539 151.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 126.66 2.68 6.72 Favored Glycine 0 CA--C 1.535 1.298 0 N-CA-C 119.328 2.491 . . . . 0.0 119.328 160.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.64 168.39 11.16 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 121.991 2.896 . . . . 0.0 113.604 173.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -60.33 147.12 94.98 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.912 2.408 . . . . 0.0 114.387 -172.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.636 HD11 ' H ' ' A' ' 121' ' ' LEU . 26.0 mm -120.3 -55.93 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 125.294 1.438 . . . . 0.0 113.245 -163.505 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 65.36 150.46 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.841 2.456 . . . . 0.0 115.743 -173.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.66 150.67 22.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 C-N-CA 126.958 2.103 . . . . 0.0 110.601 172.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -139.34 159.93 41.01 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.287 1.035 . . . . 0.0 108.623 149.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -51.81 150.73 3.86 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.348 -0.845 . . . . 0.0 110.931 159.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.668 ' HB3' HG13 ' A' ' 60' ' ' VAL . 44.0 t -72.14 154.06 41.29 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.59 -0.694 . . . . 0.0 111.623 174.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -77.46 -18.7 56.92 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.061 0.544 . . . . 0.0 112.398 165.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 38.0 m-70 -80.36 176.04 10.13 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.216 1.406 . . . . 0.0 110.144 160.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -119.2 -9.67 9.92 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -173.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -175.91 175.36 1.98 Allowed 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 129.129 2.971 . . . . 0.0 109.889 -172.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 23.8 tp -138.2 122.52 18.24 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.735 1.614 . . . . 0.0 113.033 -164.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -113.07 96.04 5.72 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.549 1.94 . . . . 0.0 110.506 170.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 10.7 p -75.71 -9.8 58.9 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.463 1.505 . . . . 0.0 114.194 174.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -70.39 88.62 0.66 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.882 1.673 . . . . 0.0 112.131 175.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 61.2 p -149.26 80.26 1.41 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.795 2.038 . . . . 0.0 112.266 176.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 47.6 m -62.37 152.35 79.9 Favored Pre-proline 0 N--CA 1.475 0.801 0 C-N-CA 125.122 1.369 . . . . 0.0 112.969 179.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -68.89 -23.53 34.86 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 122.844 2.363 . . . . 0.0 114.03 -177.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -66.47 -32.38 73.72 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.272 1.029 . . . . 0.0 113.249 175.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -122.16 82.8 2.01 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.489 1.516 . . . . 0.0 110.303 177.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.35 -25.11 66.93 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.497 1.919 . . . . 0.0 115.338 -174.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 63.3 ttp85 . . . . . 0 N--CA 1.476 0.848 0 C-N-CA 125.944 1.698 . . . . 99.989999999999995 111.209 -177.581 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 147' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.32 0 O4'-C1'-N19 111.328 3.128 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 148' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.729 0 O4'-C4'-C3' 110.036 3.24 . 0.01 4p . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 149' ' ' ' C' . . . . . 0.407 ' N3 ' ' HA ' ' A' ' 131' ' ' SER . . . . . . . . 0 O4'--C4' 1.424 -2.43 0 N19-C1'-C2' 107.903 -3.436 . 0.074 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 150' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.946 1 O4'-C1'-N19 112.721 4.521 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 151' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.537 2.068 1 O4'-C1'-N19 112.868 4.668 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 152' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.541 2.42 0 O4'-C1'-N19 111.643 3.443 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.707 0 N-CA-C 111.886 -0.485 . . . . 0.0 111.886 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -59.85 -16.86 32.04 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 -172.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 58.6 m -60.28 -30.25 69.34 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 121.164 -0.96 . . . . 0.0 112.978 170.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 39.8 mmt180 -68.22 -28.37 67.18 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.318 1.047 . . . . 0.0 112.771 175.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 17.4 m -74.31 -5.83 44.49 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.677 1.591 . . . . 0.0 114.197 176.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -132.26 -10.55 3.29 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 125.732 1.613 . . . . 0.0 113.926 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.12 41.89 7.32 Favored Glycine 0 CA--C 1.534 1.266 0 O-C-N 120.892 -1.13 . . . . 0.0 114.11 178.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.7 t 49.84 74.01 0.89 Allowed Pre-proline 0 N--CA 1.479 0.98 0 C-N-CA 127.715 2.406 . . . . 0.0 109.907 -171.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -90.92 -179.32 1.49 Allowed 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.867 3.044 . . . . 0.0 113.757 -149.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 29.0 t -131.99 -177.97 4.68 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.37 1.868 . . . . 0.0 110.949 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.445 ' H ' ' HD3' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -63.1 -3.89 2.01 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 116.246 1.943 . . . . 0.0 116.246 -172.44 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.688 HG13 ' HB3' ' A' ' 131' ' ' SER 0.322 8.7 p -81.34 128.61 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-N 121.17 1.804 . . . . 0.0 112.634 166.918 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 15.8 mt -113.67 153.73 15.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 128.867 2.867 . . . . 0.0 107.456 174.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.444 ' CD2' ' C6 ' ' B' ' 149' ' ' ' C' . 1.8 t-80 -123.96 142.35 51.23 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.434 1.494 . . . . 0.0 110.772 178.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.8 mt -119.53 138.25 50.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 127.828 2.451 . . . . 0.0 109.837 -172.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 17.0 mtt85 -96.87 176.38 6.0 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 119.488 1.04 . . . . 0.0 110.521 171.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp 44.23 42.67 5.29 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 126.958 2.103 . . . . 0.0 116.291 158.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.2 mp -55.98 161.29 3.71 Favored Pre-proline 0 CA--C 1.558 1.279 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.473 160.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.45 ' HD3' HD22 ' A' ' 121' ' ' LEU . 9.9 Cg_endo -60.06 -68.42 0.05 OUTLIER 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.734 2.956 . . . . 0.0 113.996 -173.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.1 pt -164.23 -39.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 130.848 3.659 . . . . 0.0 108.812 -171.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -151.69 -29.5 0.17 Allowed 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 -177.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.48 HG22 ' H ' ' A' ' 71' ' ' THR 0.29 2.0 p 40.02 -150.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 127.141 2.176 . . . . 0.0 112.192 -166.236 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.48 ' H ' HG22 ' A' ' 70' ' ' VAL . 2.9 t -141.75 141.91 33.25 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 120.482 -1.386 . . . . 0.0 109.681 156.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -57.1 -32.58 66.45 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 176.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.92 -41.08 58.6 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 125.088 1.328 . . . . 0.0 113.353 170.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -69.21 -48.94 60.66 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.451 -1.029 . . . . 0.0 111.107 172.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.5 t -58.81 -50.38 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 123.146 0.579 . . . . 0.0 112.497 -176.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -76.37 -27.98 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 O-C-N 120.103 -1.623 . . . . 0.0 113.877 177.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 33.0 t -62.77 -26.79 68.89 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 120.022 1.283 . . . . 0.0 110.826 169.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 33.8 mt -83.71 -18.26 38.54 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 114.306 1.225 . . . . 0.0 114.306 170.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -87.87 -18.64 55.86 Favored Glycine 0 CA--C 1.536 1.383 0 CA-C-N 119.376 0.989 . . . . 0.0 113.832 170.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 80' ' ' LEU . 17.8 mt -73.96 -16.8 0.28 Allowed Pre-proline 0 CA--C 1.542 0.67 0 N-CA-C 119.035 2.976 . . . . 0.0 119.035 -174.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -59.55 -5.07 2.95 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.593 2.195 . . . . 0.0 116.773 168.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.419 ' CD2' ' HG3' ' A' ' 110' ' ' MET . 24.8 m-85 -120.66 -36.09 3.25 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -166.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -162.95 -101.59 0.16 Allowed Glycine 0 CA--C 1.523 0.548 0 C-N-CA 123.724 0.678 . . . . 0.0 111.782 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 32.2 tptt -147.73 -9.99 0.41 Allowed 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 117.348 2.351 . . . . 0.0 117.348 -174.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.434 HG13 ' HB2' ' A' ' 101' ' ' MET . 0.0 OUTLIER 32.21 89.03 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 C-N-CA 128.927 2.891 . . . . 0.0 113.651 -175.693 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 38.1 m -55.87 -40.65 73.26 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 127.142 2.177 . . . . 0.0 112.264 -175.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -153.18 168.81 24.72 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -141.89 173.53 11.42 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.685 1.594 . . . . 0.0 112.303 158.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.468 HD23 ' C ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -149.9 154.97 39.21 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.85 1.66 . . . . 0.0 109.678 -179.835 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 14.8 mtt -129.66 110.57 11.9 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.934 0.894 . . . . 0.0 112.219 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -75.17 76.92 2.32 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 122.518 1.151 . . . . 0.0 109.761 169.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.17 -13.75 8.33 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.894 1.678 . . . . 0.0 115.309 -176.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -58.15 -40.9 94.35 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.685 1.612 . . . . 0.0 114.694 170.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -136.85 10.54 3.1 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 -162.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 52.65 49.37 20.5 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.022 1.329 . . . . 0.0 112.981 -167.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -113.52 167.09 10.89 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.516 0.726 . . . . 0.0 110.191 170.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -155.55 163.12 40.41 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 120.734 -1.229 . . . . 0.0 111.318 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.453 ' CD2' HG21 ' A' ' 60' ' ' VAL . 6.0 m-30 -108.32 155.88 20.02 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.444 1.497 . . . . 0.0 108.871 162.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.5 tt -141.68 106.69 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 125.872 1.669 . . . . 0.0 108.276 168.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -102.78 127.75 49.81 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 129.588 3.155 . . . . 0.0 110.776 -171.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.434 ' HB2' HG13 ' A' ' 85' ' ' VAL 0.362 1.9 tpp -124.58 158.7 32.4 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 118.201 2.667 . . . . 0.0 118.201 -171.144 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -71.27 -21.48 62.09 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.515 1.526 . . . . 0.0 114.07 -166.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.98 146.81 39.58 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.458 0.647 . . . . 0.0 110.988 -178.063 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -63.36 -37.9 89.07 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.726 0.81 . . . . 0.0 111.451 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -76.14 -38.03 57.27 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 178.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.35 -48.48 81.48 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-N 118.74 0.7 . . . . 0.0 110.565 171.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.18 -38.49 75.38 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 178.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -57.7 -46.99 83.61 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.996 0.816 . . . . 0.0 111.186 170.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -65.71 -29.6 70.16 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-O 117.799 -1.096 . . . . 0.0 111.525 171.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.419 ' HG3' ' CD2' ' A' ' 82' ' ' PHE . 18.8 ttp -69.24 -49.58 55.03 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 120.54 1.518 . . . . 0.0 109.839 -176.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -63.59 -40.01 87.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 124.116 0.966 . . . . 0.0 111.753 175.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -70.51 -43.65 69.24 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 121.663 -0.648 . . . . 0.0 111.076 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -48.93 -39.98 28.34 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 126.332 1.853 . . . . 0.0 111.667 166.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.61 ' HA ' HG12 ' A' ' 117' ' ' VAL . 11.3 m-85 -85.28 -22.06 28.74 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 120.602 -1.311 . . . . 0.0 113.197 -178.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 99.0 m -76.51 -19.19 58.23 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.877 0.871 . . . . 0.0 110.174 172.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.9 -60.62 2.27 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 129.507 3.123 . . . . 0.0 111.252 170.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.61 HG12 ' HA ' ' A' ' 114' ' ' TYR . 2.3 p -79.42 -48.43 21.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 124.412 1.085 . . . . 0.0 112.478 -158.051 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 4.9 m 33.92 126.14 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 129.013 2.925 . . . . 0.0 114.248 -139.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -76.15 -10.59 19.42 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 121.366 1.377 . . . . 0.0 115.018 -170.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.4 t 30.02 89.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 130.04 3.336 . . . . 0.0 113.102 175.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.569 ' H ' HD11 ' A' ' 126' ' ' ILE . 1.5 tt -104.76 -68.48 0.85 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 112.301 -2.227 . . . . 0.0 108.159 -138.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -66.76 -44.67 80.83 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.118 0.967 . . . . 0.0 110.476 167.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 159.82 12.51 0.04 OUTLIER Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.315 1.436 . . . . 0.0 115.527 178.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -147.28 168.68 10.78 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 119.491 1.646 . . . . 0.0 112.007 -179.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -54.87 142.87 74.05 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.984 2.456 . . . . 0.0 114.235 -175.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.569 HD11 ' H ' ' A' ' 121' ' ' LEU . 20.2 mm -106.87 -43.05 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.729 1.211 . . . . 0.0 112.423 -167.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 61.11 141.38 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 128.192 2.597 . . . . 0.0 115.101 -173.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.46 155.56 31.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 126.264 1.825 . . . . 0.0 111.323 171.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -151.47 162.25 41.28 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.344 1.858 . . . . 0.0 109.252 158.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -52.29 143.37 14.93 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 121.201 -0.937 . . . . 0.0 111.147 160.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.688 ' HB3' HG13 ' A' ' 60' ' ' VAL . 30.2 t -66.93 153.39 43.68 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.24 1.016 . . . . 0.0 112.179 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -64.76 -25.88 68.12 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.628 1.171 . . . . 0.0 112.349 168.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 57.5 m-70 -92.74 169.82 10.19 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.553 1.541 . . . . 0.0 111.259 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.66 111.75 14.66 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 125.096 1.358 . . . . 0.0 108.915 175.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 74.71 145.88 0.08 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 128.411 2.684 . . . . 0.0 113.592 -170.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 26.2 tp -113.32 111.62 22.32 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.802 2.041 . . . . 0.0 110.994 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.98 83.39 1.93 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 128.002 2.521 . . . . 0.0 110.552 -177.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 16.4 p -69.97 -14.02 62.51 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.67 1.588 . . . . 0.0 114.068 178.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -69.16 -10.24 56.72 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.539 1.535 . . . . 0.0 114.335 175.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 26.4 m 55.62 40.18 30.98 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.179 1.792 . . . . 0.0 114.53 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 55.4 p -62.3 148.17 90.07 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 124.179 0.991 . . . . 0.0 112.373 173.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -78.68 -25.61 6.37 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 123.07 2.513 . . . . 0.0 114.088 -173.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -154.33 -54.9 0.1 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.411 1.484 . . . . 0.0 111.867 -177.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -145.75 175.0 10.73 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.617 1.567 . . . . 0.0 112.074 -176.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.67 -25.36 67.34 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.395 1.478 . . . . 0.0 114.985 -174.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 . . . . . 0 N--CA 1.475 0.785 0 C-N-CA 126.133 1.773 . . . . 99.989999999999995 110.311 172.282 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 147' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.19 0 C5'-C4'-C3' 111.402 -2.732 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 148' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.883 1 C5'-C4'-C3' 108.171 -4.886 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 149' ' ' ' C' . . . . . 0.444 ' C6 ' ' CD2' ' A' ' 62' ' ' HIS . . . . . . . . 0 O4'--C4' 1.418 -2.93 0 N19-C1'-C2' 107.972 -3.392 . 0.01 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 150' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.657 1 O4'-C1'-N19 112.833 4.633 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 151' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.543 2.549 0 O5'-C5'-C4' 113.257 2.183 . 0.07 1[ . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 152' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.536 2.023 1 O4'-C1'-N19 112.962 4.762 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.711 0 N-CA-C 110.644 -0.983 . . . . 0.0 110.644 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -77.16 49.17 0.66 Allowed 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 125.036 1.335 . . . . 0.0 111.757 170.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.3 m -75.37 8.05 3.07 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 128.304 2.642 . . . . 0.0 115.464 -164.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.4 -8.64 1.24 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 128.256 2.623 . . . . 0.0 116.625 179.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 69.5 m -131.37 96.53 4.02 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.702 2.001 . . . . 0.0 109.889 -177.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.451 ' HB3' ' HB3' ' A' ' 57' ' ' PRO . . . -143.98 179.29 7.28 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 129.712 3.205 . . . . 0.0 112.056 -0.053 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -85.36 -61.47 1.72 Allowed Glycine 0 N--CA 1.473 1.106 0 C-N-CA 124.657 1.122 . . . . 0.0 112.357 -167.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.2 t -134.9 74.19 64.47 Favored Pre-proline 0 N--CA 1.479 1.019 0 C-N-CA 124.659 1.183 . . . . 0.0 110.347 168.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.451 ' HB3' ' HB3' ' A' ' 54' ' ' ALA . 0.8 OUTLIER -97.66 178.48 0.43 Allowed 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 125.12 3.88 . . . . 0.0 113.607 -168.543 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.5 t -151.74 -175.12 5.08 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.737 2.015 . . . . 0.0 110.787 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.15 -7.33 40.81 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.689 HG13 ' HB3' ' A' ' 131' ' ' SER 0.306 7.5 p -79.91 126.4 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 120.173 1.351 . . . . 0.0 112.021 164.065 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 21.7 mt -107.2 154.53 8.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 128.08 2.552 . . . . 0.0 108.249 169.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.42 ' CD2' ' C6 ' ' B' ' 149' ' ' ' C' . 2.2 t-80 -122.47 145.66 48.09 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.785 1.634 . . . . 0.0 110.87 176.024 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.5 mt -125.55 143.94 37.36 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 127.438 2.295 . . . . 0.0 110.097 -171.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.5 mtm-85 -108.12 170.18 8.16 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 125.847 1.659 . . . . 0.0 111.072 169.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp 56.22 32.32 20.07 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 155.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.5 171.74 2.58 Favored Pre-proline 0 C--N 1.321 -0.669 0 C-N-CA 124.728 1.211 . . . . 0.0 110.731 165.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -52.02 174.21 0.09 OUTLIER 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 124.185 3.257 . . . . 0.0 114.262 156.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 31.2 pt -64.6 -35.95 76.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 126.517 1.927 . . . . 0.0 113.027 -170.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -142.9 -10.99 0.77 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.848 1.659 . . . . 0.0 113.48 171.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.538 HG22 ' H ' ' A' ' 71' ' ' THR 0.287 4.3 p 42.34 -151.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 128.249 2.619 . . . . 0.0 112.065 -172.623 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.538 ' H ' HG22 ' A' ' 70' ' ' VAL . 1.1 p -129.36 145.19 51.43 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 120.601 -1.312 . . . . 0.0 109.88 153.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.98 -38.63 83.13 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 122.042 -0.411 . . . . 0.0 110.621 173.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -54.01 -41.29 68.15 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 125.658 1.599 . . . . 0.0 112.711 174.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -63.14 -53.61 50.65 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.106 0.962 . . . . 0.0 111.68 172.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.9 t -59.59 -48.0 88.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.344 0.657 . . . . 0.0 112.522 -178.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.0 pp -73.93 -33.0 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 O-C-N 120.488 -1.383 . . . . 0.0 112.801 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.5 t -63.55 -30.73 71.81 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.494 1.043 . . . . 0.0 110.771 171.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 14.0 mt -76.1 -20.43 57.68 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 173.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -96.66 -17.32 33.66 Favored Glycine 0 CA--C 1.536 1.37 0 N-CA-C 115.374 0.91 . . . . 0.0 115.374 172.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.6 mt -60.81 -52.8 69.84 Favored Pre-proline 0 CA--C 1.54 0.588 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 -170.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -76.21 42.44 1.0 Allowed 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 123.957 3.105 . . . . 0.0 113.5 -179.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -129.54 -41.89 1.34 Allowed 'General case' 0 C--O 1.233 0.218 0 C-N-CA 126.74 2.016 . . . . 0.0 111.196 178.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -158.11 -101.22 0.17 Allowed Glycine 0 C--N 1.34 0.784 0 CA-C-O 122.059 0.81 . . . . 0.0 112.053 163.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 13.8 tptm -143.48 139.04 29.66 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 130.084 3.354 . . . . 0.0 104.326 166.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.699 HG22 ' HE2' ' A' ' 101' ' ' MET . 3.6 t -123.35 99.41 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 120.203 1.365 . . . . 0.0 109.333 -169.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 16.0 m -65.21 -38.23 89.77 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 128.73 2.812 . . . . 0.0 112.283 -161.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.58 161.5 42.45 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 177.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -133.69 175.06 9.78 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.109 0.964 . . . . 0.0 111.033 156.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.468 HD23 ' C ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -150.32 154.21 37.46 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.932 1.693 . . . . 0.0 109.29 178.739 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 5.7 mtt -129.93 111.27 12.39 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.357 1.063 . . . . 0.0 111.273 -178.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -74.15 86.11 1.88 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.752 0.821 . . . . 0.0 110.156 174.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.6 tpmt? -63.65 89.01 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.943 1.697 . . . . 0.0 110.476 174.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 179.76 -61.97 0.08 OUTLIER Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.359 1.457 . . . . 0.0 112.748 -166.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.94 20.71 3.81 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 125.77 1.628 . . . . 0.0 114.161 -169.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 14.1 m-20 56.3 42.61 27.63 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.87 1.668 . . . . 0.0 113.496 -173.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -106.47 165.22 11.43 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.862 -0.524 . . . . 0.0 111.603 175.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -153.8 165.61 35.49 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.672 1.189 . . . . 0.0 111.371 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.466 ' CD2' HG21 ' A' ' 60' ' ' VAL . 6.0 m-30 -112.71 156.65 22.43 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.671 1.588 . . . . 0.0 108.689 163.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.8 tt -141.92 108.75 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 125.283 1.433 . . . . 0.0 109.606 166.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -100.46 122.01 42.49 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 129.09 2.956 . . . . 0.0 111.275 -175.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.699 ' HE2' HG22 ' A' ' 85' ' ' VAL 0.298 3.1 ttm -121.75 160.66 24.11 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 -173.766 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -75.95 -13.95 60.25 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.288 1.035 . . . . 0.0 113.616 -162.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.35 144.73 38.35 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.675 1.19 . . . . 0.0 111.194 177.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -63.38 -35.73 81.36 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.56 1.144 . . . . 0.0 111.846 176.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -75.99 -39.97 54.76 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -56.35 -50.66 70.87 Favored 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 122.809 0.444 . . . . 0.0 110.293 170.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.09 -37.19 72.43 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 121.026 -1.046 . . . . 0.0 113.334 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -56.18 -47.2 78.78 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.118 0.872 . . . . 0.0 111.408 169.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -65.21 -34.34 78.14 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 118.08 -0.962 . . . . 0.0 110.88 174.013 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 3.2 ttp -64.12 -52.18 60.4 Favored 'General case' 0 C--N 1.343 0.298 0 CA-C-N 119.664 1.12 . . . . 0.0 110.633 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.91 -37.84 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 C-N-CA 125.259 1.424 . . . . 0.0 112.133 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -72.01 -44.07 64.02 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.486 0.714 . . . . 0.0 111.702 177.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -49.4 -36.87 23.33 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.17 0.988 . . . . 0.0 112.071 165.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.583 ' HA ' HG12 ' A' ' 117' ' ' VAL . 13.2 m-85 -87.23 -18.73 29.61 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 120.468 -1.395 . . . . 0.0 113.222 -177.277 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.22 -12.57 58.01 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.638 0.732 . . . . 0.0 110.912 170.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.91 -60.9 2.01 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 129.481 3.112 . . . . 0.0 111.874 168.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.583 HG12 ' HA ' ' A' ' 114' ' ' TYR . 4.2 p -78.08 -44.43 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.517 1.127 . . . . 0.0 113.622 -154.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.3 m 27.56 119.29 0.0 OUTLIER Pre-proline 0 N--CA 1.479 0.988 0 C-N-CA 129.855 3.262 . . . . 0.0 115.854 -139.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -76.53 -13.82 18.16 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 121.933 1.755 . . . . 0.0 116.073 -167.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.8 t 29.85 90.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 129.907 3.283 . . . . 0.0 114.067 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.48 ' H ' HD11 ' A' ' 126' ' ' ILE 0.265 1.1 tt -113.15 76.44 0.98 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 112.545 -2.116 . . . . 0.0 105.919 -134.592 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . 0.349 2.1 ppt_? 46.84 14.17 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 129.922 3.289 . . . . 0.0 116.73 -152.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -126.41 -113.52 1.87 Allowed Glycine 0 N--CA 1.472 1.065 0 C-N-CA 125.005 1.288 . . . . 0.0 116.254 -174.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.413 ' O ' HD13 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -148.88 173.74 3.98 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 128.229 2.612 . . . . 0.0 108.062 -174.242 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -44.73 105.25 0.06 OUTLIER 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 123.691 2.927 . . . . 0.0 116.386 -163.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.48 HD11 ' H ' ' A' ' 121' ' ' LEU . 3.9 mm -68.18 162.09 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 125.24 1.416 . . . . 0.0 108.426 172.268 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -134.63 147.65 50.22 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 121.789 -0.57 . . . . 0.0 111.177 174.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.83 146.13 32.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.95 1.3 . . . . 0.0 110.896 173.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -147.3 158.79 44.09 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.478 1.911 . . . . 0.0 108.865 160.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -53.77 146.88 12.74 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.236 -0.915 . . . . 0.0 111.549 163.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.689 ' HB3' HG13 ' A' ' 60' ' ' VAL . 30.0 t -69.72 156.11 39.49 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.977 0.911 . . . . 0.0 112.706 -179.041 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -66.95 -20.95 65.98 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.781 1.232 . . . . 0.0 112.888 167.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 40.4 m-70 -105.1 177.65 4.79 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.869 1.667 . . . . 0.0 112.188 -173.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 4.6 mptt -136.76 117.92 14.45 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 126.255 1.822 . . . . 0.0 109.679 -175.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 69.27 84.35 0.15 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.362 1.465 . . . . 0.0 113.328 176.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 31.4 tp -57.54 127.55 32.6 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.518 1.527 . . . . 0.0 112.586 177.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -128.04 109.34 11.45 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 126.479 1.912 . . . . 0.0 110.581 173.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 56.6 p -103.09 -4.12 24.95 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.286 1.434 . . . . 0.0 113.469 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -60.86 -38.5 85.76 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.652 1.981 . . . . 0.0 114.654 -167.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.3 t -79.08 96.92 5.94 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.018 1.327 . . . . 0.0 111.693 -178.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 42.1 m -62.13 138.8 96.03 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 124.526 1.13 . . . . 0.0 112.825 -176.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -54.62 -25.01 39.39 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 124.364 3.376 . . . . 0.0 116.735 -178.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -70.53 -1.5 11.17 Favored 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 115.362 1.615 . . . . 0.0 115.362 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -67.54 86.34 0.19 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.381 1.073 . . . . 0.0 112.197 176.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -57.96 -34.86 70.37 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.389 1.875 . . . . 0.0 114.289 -176.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 . . . . . 0 N--CA 1.479 0.999 0 C-N-CA 126.327 1.851 . . . . 99.989999999999995 115.373 -177.811 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 147' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.145 0 C5'-C4'-C3' 110.698 -3.201 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 148' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.284 0 C1'-O4'-C4' 107.129 -2.745 . 0.419 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 149' ' ' ' C' . . . . . 0.42 ' C6 ' ' CD2' ' A' ' 62' ' ' HIS . . . . . . . . 0 O4'--C4' 1.426 -2.226 1 O4'-C1'-N19 112.341 4.141 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 150' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.063 2 O4'-C1'-N19 113.695 5.495 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 151' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.151 0 N19-C1'-C2' 117.514 2.571 OUTLIER-DELTA 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 152' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.618 2.499 1 O4'-C1'-N19 113.97 5.77 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.557 ' N ' ' HG1' ' A' ' 115' ' ' THR . . . . . . . . 0 N--CA 1.477 1.385 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -139.81 -60.02 0.55 Allowed 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.001 1.32 . . . . 0.0 112.539 -173.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.6 m 57.48 14.18 2.16 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 116.445 2.017 . . . . 0.0 116.445 178.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.4 ttm180 -68.04 -28.92 67.81 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.589 1.955 . . . . 0.0 113.924 -175.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 68.3 m -133.8 130.48 38.02 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.843 1.657 . . . . 0.0 111.356 -173.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.831 ' HB3' ' HB3' ' A' ' 57' ' ' PRO . . . -130.68 -12.72 3.8 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.328 1.451 . . . . 0.0 114.718 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 135.88 -77.4 0.36 Allowed Glycine 0 C--N 1.338 0.656 0 C-N-CA 126.056 1.789 . . . . 0.0 108.737 -179.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 19.9 t -147.74 74.08 11.35 Favored Pre-proline 0 N--CA 1.48 1.065 0 C-N-CA 125.218 1.407 . . . . 0.0 108.352 165.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.831 ' HB3' ' HB3' ' A' ' 54' ' ' ALA . 20.1 Cg_endo -90.81 159.17 4.12 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.227 2.618 . . . . 0.0 113.759 -162.08 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 57.4 m -142.75 -173.66 3.94 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.298 1.439 . . . . 0.0 112.753 -163.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 31.0 mtp180 -50.84 -17.44 0.56 Allowed 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 128.902 2.881 . . . . 0.0 118.063 -177.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.645 HG13 ' HB3' ' A' ' 131' ' ' SER 0.265 3.4 p -96.98 137.17 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-N 120.261 1.391 . . . . 0.0 112.966 172.488 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.2 mt -118.88 130.78 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 127.93 2.492 . . . . 0.0 108.787 175.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.444 ' CD2' ' C6 ' ' B' ' 149' ' ' ' C' . 1.8 t-80 -96.69 141.23 30.18 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.33 1.052 . . . . 0.0 110.719 176.545 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.3 mt -116.51 135.5 56.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 126.79 2.036 . . . . 0.0 108.291 -178.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.0 ptt-85 -119.53 171.48 8.32 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 127.387 2.275 . . . . 0.0 111.376 165.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.6 mmmt 61.29 23.34 13.58 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.579 1.552 . . . . 0.0 113.27 178.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.551 ' CD2' HD13 ' A' ' 121' ' ' LEU . 14.7 mt -69.31 173.97 3.35 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 126.313 1.845 . . . . 0.0 111.502 166.257 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -48.79 176.43 0.02 OUTLIER 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 123.042 2.495 . . . . 0.0 114.295 152.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 26.5 pt -64.81 -41.24 91.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.863 1.665 . . . . 0.0 112.961 -171.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -141.89 -11.85 0.87 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.016 1.726 . . . . 0.0 114.539 174.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.584 HG22 ' H ' ' A' ' 71' ' ' THR 0.309 2.9 p 43.0 -154.48 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 128.124 2.57 . . . . 0.0 113.412 -175.719 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.584 ' H ' HG22 ' A' ' 70' ' ' VAL . 10.8 t -142.32 148.53 38.14 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 120.065 -1.647 . . . . 0.0 111.665 171.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -55.6 -46.25 77.33 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.328 1.051 . . . . 0.0 111.961 -177.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -51.37 -43.18 51.51 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.526 1.06 . . . . 0.0 113.116 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -64.85 -56.03 15.91 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.778 0.831 . . . . 0.0 112.264 172.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 80.1 t -56.06 -53.81 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-O 121.657 0.741 . . . . 0.0 111.811 -176.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.9 pp -67.29 -39.54 83.08 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 CA-C-O 117.89 -1.052 . . . . 0.0 112.437 -178.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.8 t -68.52 -19.97 64.55 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 119.945 1.248 . . . . 0.0 111.384 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 26.6 mt -87.45 -21.78 25.35 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 172.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -99.36 -21.98 13.83 Favored Glycine 0 C--O 1.215 -1.077 0 CA-C-N 119.376 0.989 . . . . 0.0 113.705 177.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.8 mt -60.1 -35.51 28.69 Favored Pre-proline 0 CA--C 1.549 0.936 0 N-CA-C 118.785 2.883 . . . . 0.0 118.785 -173.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -55.36 7.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.949 1 C-N-CA 125.739 4.293 . . . . 0.0 120.728 -171.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -125.33 -19.42 5.08 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 -171.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -163.96 -100.06 0.14 Allowed Glycine 0 CA--C 1.524 0.62 0 CA-C-N 118.622 0.647 . . . . 0.0 112.444 -177.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 31.5 tptt -153.06 156.46 38.79 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 125.03 1.332 . . . . 0.0 107.891 165.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -131.22 106.04 11.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 119.812 1.187 . . . . 0.0 109.177 -174.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 33.9 p -104.66 -25.77 12.58 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.399 -1.273 . . . . 0.0 112.393 -162.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -138.03 152.49 48.91 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.101 0.864 . . . . 0.0 113.095 170.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -137.61 169.86 17.05 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.419 1.088 . . . . 0.0 111.267 159.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.513 HD23 ' C ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -147.63 153.22 39.1 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.091 1.356 . . . . 0.0 109.589 178.191 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 5.2 mtp -135.59 98.98 4.07 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.91 0.884 . . . . 0.0 110.326 -169.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -74.56 89.12 2.18 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.961 0.904 . . . . 0.0 110.693 177.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.9 pttt -122.01 60.24 0.98 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.227 1.811 . . . . 0.0 113.829 -178.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 84.1 -118.41 4.69 Favored Glycine 0 N--CA 1.47 0.96 0 C-N-CA 130.286 3.803 . . . . 0.0 113.769 4.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.5 mtmm -135.05 -95.39 0.27 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.69 1.596 . . . . 0.0 110.464 -167.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -155.88 32.32 0.35 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 129.737 3.215 . . . . 0.0 110.15 -176.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -122.8 163.52 20.07 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -173.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -154.51 166.16 34.17 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 126.364 1.866 . . . . 0.0 110.348 177.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.532 ' CD2' HG21 ' A' ' 60' ' ' VAL . 5.7 m-30 -112.5 149.44 32.64 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.867 1.667 . . . . 0.0 107.329 162.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.8 tt -128.83 121.03 53.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 C-N-CA 124.186 0.994 . . . . 0.0 108.883 159.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.499 ' HG3' ' H ' ' A' ' 136' ' ' LEU . 2.0 tm-20 -110.95 108.89 18.8 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 126.018 1.727 . . . . 0.0 110.159 -174.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -102.18 149.66 24.07 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 112.921 -1.945 . . . . 0.0 111.403 -176.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.43 -13.34 60.7 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.577 1.551 . . . . 0.0 114.065 -161.019 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.03 144.02 48.44 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.502 0.721 . . . . 0.0 110.789 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -63.46 -41.06 98.63 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.021 0.928 . . . . 0.0 111.575 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -74.78 -36.75 62.52 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 178.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.95 -46.34 89.74 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 118.708 0.685 . . . . 0.0 110.305 171.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.57 -37.79 80.18 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 175.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -56.38 -50.78 70.59 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 120.946 -1.096 . . . . 0.0 111.372 169.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -64.63 -26.08 68.24 Favored 'General case' 0 C--O 1.219 -0.548 0 O-C-N 120.597 -1.315 . . . . 0.0 111.374 173.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 18.8 ttp -69.35 -48.51 61.12 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-N 120.168 1.349 . . . . 0.0 110.38 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -64.27 -38.2 81.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 O-C-N 121.046 -1.034 . . . . 0.0 111.66 176.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -67.57 -47.33 70.09 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.358 1.063 . . . . 0.0 111.137 173.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -49.91 -34.19 19.68 Favored 'General case' 0 C--O 1.223 -0.329 0 C-N-CA 126.151 1.781 . . . . 0.0 112.236 169.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.528 ' HA ' HG12 ' A' ' 117' ' ' VAL . 17.0 m-85 -90.76 -18.91 24.15 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 120.437 -1.415 . . . . 0.0 113.312 -177.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.557 ' HG1' ' N ' ' A' ' 49' ' ' GLY . 0.7 OUTLIER -81.59 -10.62 59.39 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 121.581 0.705 . . . . 0.0 111.196 168.693 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.36 -63.96 1.24 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 130.226 3.41 . . . . 0.0 111.743 168.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.528 HG12 ' HA ' ' A' ' 114' ' ' TYR . 2.2 p -78.76 -46.5 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 124.626 1.17 . . . . 0.0 112.213 -156.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.4 m 37.33 123.85 0.0 OUTLIER Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 130.17 3.388 . . . . 0.0 115.023 -145.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -75.01 -20.96 16.32 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 121.88 1.72 . . . . 0.0 115.723 -168.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 5.6 t 42.4 99.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 129.595 3.158 . . . . 0.0 114.579 176.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.551 HD13 ' CD2' ' A' ' 66' ' ' LEU . 4.5 tt -135.3 -59.5 0.78 Allowed 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 113.591 -1.641 . . . . 0.0 109.844 -137.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.07 -3.04 14.67 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 156.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 98.76 17.06 29.3 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 125.392 1.472 . . . . 0.0 115.945 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -153.61 170.59 8.07 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 127.634 2.373 . . . . 0.0 109.794 171.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -47.02 142.13 11.49 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 124.009 3.139 . . . . 0.0 115.644 -179.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.428 HD11 ' H ' ' A' ' 121' ' ' LEU . 4.9 mm -117.08 143.81 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 127.347 2.259 . . . . 0.0 107.823 -177.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 9.1 m-30 -116.82 125.34 51.43 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 121.249 -0.907 . . . . 0.0 110.523 -166.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.1 149.95 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -178.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -149.26 160.1 43.69 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 127.525 2.33 . . . . 0.0 109.326 163.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -53.2 149.77 6.75 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 120.803 -1.186 . . . . 0.0 112.09 160.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.645 ' HB3' HG13 ' A' ' 60' ' ' VAL . 27.5 t -72.0 154.78 40.95 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.36 0.664 . . . . 0.0 112.207 177.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -66.61 -12.09 56.45 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.664 1.586 . . . . 0.0 113.261 168.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 65.2 m-70 -114.94 171.49 7.63 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.631 1.572 . . . . 0.0 112.837 -169.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -123.9 103.13 8.16 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 126.412 1.885 . . . . 0.0 110.961 -176.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 62.02 115.67 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 126.773 2.029 . . . . 0.0 113.364 -170.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.499 ' H ' ' HG3' ' A' ' 100' ' ' GLU . 24.0 tp -64.03 101.04 0.35 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.063 1.745 . . . . 0.0 111.86 168.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -92.63 106.65 18.6 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.42 1.488 . . . . 0.0 109.139 170.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 11.0 t -145.51 159.61 42.85 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.147 1.379 . . . . 0.0 112.278 -175.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -77.19 -14.9 59.7 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.132 1.373 . . . . 0.0 112.729 167.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.8 t -75.14 79.42 2.28 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.184 1.793 . . . . 0.0 113.35 -177.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 93.3 p -143.16 161.13 49.61 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 125.307 1.443 . . . . 0.0 112.503 172.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -60.42 161.54 20.11 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.755 2.97 . . . . 0.0 115.197 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -132.35 -29.6 1.57 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.191 1.796 . . . . 0.0 113.965 177.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -58.33 -22.9 54.93 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -172.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -73.15 -19.89 61.03 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 176.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 . . . . . 0 N--CA 1.481 1.097 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -167.131 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 147' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.207 0 O5'-C5'-C4' 113.81 2.579 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 148' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.26 0 O4'-C1'-N19 111.742 3.542 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 149' ' ' ' C' . . . . . 0.444 ' C6 ' ' CD2' ' A' ' 62' ' ' HIS . . . . . . . . 0 O4'--C4' 1.421 -2.68 0 N19-C1'-C2' 107.995 -3.378 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 150' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 1 O4'--C4' 1.404 -4.08 0 O4'-C1'-N19 111.895 3.695 . 0.01 0a . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 151' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.543 2.568 1 O4'-C1'-N19 112.386 4.186 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 152' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.226 0 N19-C1'-C2' 118.046 2.904 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.566 0 N-CA-C 111.061 -0.815 . . . . 0.0 111.061 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -68.56 -39.63 80.98 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.733 0.813 . . . . 0.0 112.363 175.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 79.0 p -78.06 179.72 6.64 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.911 2.084 . . . . 0.0 113.31 171.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 84.6 mmt-85 -129.3 175.55 8.65 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.514 1.926 . . . . 0.0 110.622 173.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 57.6 p -54.14 156.2 3.21 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.253 1.021 . . . . 0.0 112.38 171.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 54.78 6.65 0.13 Allowed 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 126.074 1.75 . . . . 0.0 115.571 -169.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.85 30.89 55.28 Favored Glycine 0 CA--C 1.535 1.297 0 O-C-N 120.75 -1.219 . . . . 0.0 113.623 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 51.0 t 58.82 80.45 0.28 Allowed Pre-proline 0 N--CA 1.476 0.843 0 C-N-CA 127.967 2.507 . . . . 0.0 109.95 -171.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -95.27 169.57 1.44 Allowed 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.03 2.487 . . . . 0.0 114.474 -148.452 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 45.3 m -147.49 -166.15 2.44 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.022 1.329 . . . . 0.0 112.908 -165.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 46.5 mtp180 -55.13 -16.85 3.4 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 119.521 3.156 . . . . 0.0 119.521 -161.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.607 HG13 ' HB3' ' A' ' 131' ' ' SER 0.31 6.9 p -98.2 128.91 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 CA-C-N 121.366 1.894 . . . . 0.0 112.879 169.605 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 39.7 mt -100.4 155.01 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.84 1.656 . . . . 0.0 108.378 165.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -119.08 148.76 42.69 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.58 1.552 . . . . 0.0 110.957 173.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.4 mt -127.98 141.4 46.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 126.501 1.92 . . . . 0.0 109.639 -172.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.45 165.83 17.73 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 127.95 2.5 . . . . 0.0 109.885 167.245 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 67.31 23.59 9.26 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 125.148 1.379 . . . . 0.0 113.887 177.249 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.99 165.62 0.76 Allowed Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 127.7 2.4 . . . . 0.0 111.292 165.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -58.68 175.61 0.55 Allowed 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 123.007 2.471 . . . . 0.0 113.993 154.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 28.1 pt -73.81 -32.36 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 126.645 1.978 . . . . 0.0 113.47 -175.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -154.91 32.34 0.4 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.871 1.668 . . . . 0.0 111.357 -168.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -51.49 147.61 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.574 0.75 . . . . 0.0 112.267 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.401 HG23 ' H ' ' A' ' 74' ' ' GLU . 8.4 t -88.91 140.97 28.89 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 122.584 1.183 . . . . 0.0 112.092 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -57.84 -36.03 71.72 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.429 175.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -57.4 -36.0 74.63 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 123.643 0.639 . . . . 0.0 112.865 177.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.401 ' H ' HG23 ' A' ' 71' ' ' THR . 6.0 mm-40 -70.34 -51.33 30.83 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.955 1.302 . . . . 0.0 112.045 172.325 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 88.6 t -63.13 -41.49 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -176.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.0 pp -72.73 -34.8 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 O-C-N 120.285 -1.509 . . . . 0.0 112.413 174.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 73.1 m -66.54 -22.49 66.16 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 119.809 1.186 . . . . 0.0 111.886 174.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.6 mt -76.39 -30.86 57.68 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.016 0.927 . . . . 0.0 113.046 170.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -94.27 -11.89 56.81 Favored Glycine 0 CA--C 1.534 1.272 0 CA-C-N 119.818 1.19 . . . . 0.0 115.693 178.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.7 mt -64.71 -36.07 15.94 Favored Pre-proline 0 CA--C 1.545 0.764 0 N-CA-C 117.379 2.363 . . . . 0.0 117.379 -172.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.74 -5.18 1.69 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.575 2.85 . . . . 0.0 117.583 173.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -107.48 -33.76 7.25 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -163.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -164.92 -98.26 0.12 Allowed Glycine 0 CA--C 1.522 0.527 0 C-N-CA 124.201 0.905 . . . . 0.0 111.344 172.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 33.6 tptt -149.15 145.04 26.99 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 105.423 -2.065 . . . . 0.0 105.423 161.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.709 HG22 ' HE2' ' A' ' 101' ' ' MET . 3.5 t -128.48 89.13 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-N 120.331 1.423 . . . . 0.0 108.76 -171.13 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 31.3 p -77.58 -19.04 56.28 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 126.817 2.047 . . . . 0.0 113.016 -161.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -148.27 160.97 42.43 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 172.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.8 pp -140.32 172.23 13.03 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.775 1.23 . . . . 0.0 111.493 155.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.52 HD23 ' C ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -142.2 152.77 43.45 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 125.93 1.692 . . . . 0.0 108.747 175.709 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 5.4 mtt -132.19 102.64 5.87 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.159 0.984 . . . . 0.0 111.84 -174.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -72.43 100.17 2.63 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.587 1.155 . . . . 0.0 110.215 177.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -57.8 -23.0 50.33 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.82 1.648 . . . . 0.0 114.933 -176.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -63.97 -44.87 95.34 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.659 1.599 . . . . 0.0 115.956 -174.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -136.92 8.97 3.03 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 115.394 1.628 . . . . 0.0 115.394 -151.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 55.15 60.69 3.29 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.7 1.2 . . . . 0.0 110.745 -165.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -130.66 163.92 26.13 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.647 0.779 . . . . 0.0 112.255 177.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -155.36 167.19 31.2 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.917 1.287 . . . . 0.0 111.941 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.452 ' CD2' HG21 ' A' ' 60' ' ' VAL . 4.8 m-30 -110.19 152.17 26.4 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.594 1.958 . . . . 0.0 107.24 160.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 19.8 tt -134.09 105.4 6.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 125.252 1.421 . . . . 0.0 108.717 167.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 21.4 tp10 -96.95 124.1 40.84 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 127.377 2.271 . . . . 0.0 110.753 -175.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.709 ' HE2' HG22 ' A' ' 85' ' ' VAL 0.305 1.6 ttm -125.23 157.27 36.95 Favored 'General case' 0 C--O 1.223 -0.301 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 -177.213 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -69.97 -18.99 63.37 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.731 2.012 . . . . 0.0 113.318 -165.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.09 140.72 42.16 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 122.62 1.2 . . . . 0.0 111.875 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -61.84 -40.9 96.93 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.577 1.151 . . . . 0.0 111.137 177.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -74.54 -35.24 63.11 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -56.43 -55.4 34.05 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-N 118.755 0.707 . . . . 0.0 109.861 168.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.5 -34.36 76.99 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.444 1.02 . . . . 0.0 113.585 -178.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -56.56 -51.48 68.44 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.149 -0.969 . . . . 0.0 111.633 169.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -63.26 -31.21 72.31 Favored 'General case' 0 C--O 1.224 -0.257 0 O-C-N 121.289 -0.882 . . . . 0.0 110.972 174.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 6.2 ttp -71.0 -46.45 62.24 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.872 1.269 . . . . 0.0 111.886 -178.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -67.81 -37.88 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 O-C-N 120.843 -1.16 . . . . 0.0 111.366 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -71.78 -41.93 67.74 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.441 1.096 . . . . 0.0 111.285 176.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -48.78 -52.29 24.69 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.51 1.124 . . . . 0.0 110.819 165.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -77.9 12.41 1.77 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 118.74 -2.475 . . . . 0.0 113.344 178.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . 0.289 0.5 OUTLIER -116.35 -10.63 11.33 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.814 0.846 . . . . 0.0 113.067 167.494 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.482 ' CB ' HG23 ' A' ' 117' ' ' VAL . 0.4 OUTLIER -84.46 -42.51 15.53 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 126.029 1.732 . . . . 0.0 111.45 159.926 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.482 HG23 ' CB ' ' A' ' 116' ' ' SER . 85.5 t -116.22 -63.33 1.99 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.228 0 C-N-CA 124.937 1.295 . . . . 0.0 111.09 -144.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.0 m 68.96 136.47 0.05 OUTLIER Pre-proline 0 N--CA 1.484 1.255 0 C-N-CA 127.93 2.492 . . . . 0.0 112.588 -175.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -81.41 -9.76 12.4 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 122.605 2.203 . . . . 0.0 115.616 -174.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.5 t 26.57 90.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 130.867 3.667 . . . . 0.0 114.606 173.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.7 tt -118.98 -59.27 1.87 Allowed 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.716 -126.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.72 -1.56 39.06 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 153.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 106.27 32.55 3.69 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 124.999 1.285 . . . . 0.0 115.047 -177.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -139.49 150.51 63.96 Favored Pre-proline 0 CA--C 1.536 0.404 0 C-N-CA 125.342 1.457 . . . . 0.0 110.762 175.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -55.59 109.1 0.37 Allowed 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.354 2.703 . . . . 0.0 112.713 174.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.1 mm -78.19 145.77 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 124.892 1.277 . . . . 0.0 109.109 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 9.8 m-30 -111.02 128.71 55.94 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.82 0.848 . . . . 0.0 109.811 -173.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.3 tt -131.48 146.0 34.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 124.505 1.122 . . . . 0.0 111.667 -178.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -155.21 160.25 40.72 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.179 1.792 . . . . 0.0 108.958 160.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -50.71 148.57 3.89 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.271 -0.893 . . . . 0.0 112.767 167.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.607 ' HB3' HG13 ' A' ' 60' ' ' VAL . 37.5 t -68.24 158.02 34.23 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.509 0.724 . . . . 0.0 112.057 178.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -67.34 -13.36 61.93 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.563 1.145 . . . . 0.0 112.72 164.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 36.5 m-70 -111.81 178.82 4.2 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 127.778 2.431 . . . . 0.0 110.473 -178.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -125.6 -0.55 7.46 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 115.737 1.754 . . . . 0.0 115.737 -171.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -164.48 166.85 20.11 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 130.087 3.355 . . . . 0.0 108.302 -173.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 21.3 tp -134.67 105.51 6.52 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.431 1.492 . . . . 0.0 110.979 175.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 8.1 mmpt? -94.72 99.27 11.4 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.216 1.806 . . . . 0.0 109.829 176.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.6 p -82.28 1.85 34.83 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.864 1.666 . . . . 0.0 113.75 174.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -63.35 -4.21 2.49 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 127.297 2.239 . . . . 0.0 115.178 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 42.8 m 62.35 31.99 17.12 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.947 2.099 . . . . 0.0 115.086 173.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 46.8 m -148.24 149.35 31.9 Favored Pre-proline 0 N--CA 1.474 0.769 0 C-N-CA 126.849 2.06 . . . . 0.0 110.242 162.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -74.44 -22.74 15.8 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 123.184 2.59 . . . . 0.0 113.539 -177.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -145.41 167.66 22.4 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 127.778 2.431 . . . . 0.0 108.858 172.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -69.16 93.57 0.61 Allowed 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.1 -1.0 . . . . 0.0 112.066 178.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -68.55 172.08 6.67 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.894 1.678 . . . . 0.0 112.773 172.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 25.1 tpp180 . . . . . 0 N--CA 1.471 0.602 0 C-N-CA 125.35 1.46 . . . . 0.0 110.864 170.784 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 147' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.2 0 C5'-C4'-C3' 111.736 -2.51 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 148' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.734 0 O5'-C5'-C4' 115.358 3.684 . 0.0 OUTLIER '7D dist 4p' 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 149' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.521 1 N19-C1'-C2' 106.885 -4.072 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 150' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.407 -3.853 0 O4'-C1'-N19 111.537 3.337 . 0.01 4a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 151' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.123 1 O4'-C1'-N19 112.539 4.339 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 152' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.147 1 O4'-C1'-N19 113.69 5.49 . 0.43 2u . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.634 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -53.55 -48.57 68.97 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 126.076 1.75 . . . . 0.0 113.825 -169.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.8 m -66.12 -19.83 65.96 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.738 1.215 . . . . 0.0 114.212 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.2 ttt180 -72.07 -2.32 17.98 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.437 1.495 . . . . 0.0 113.666 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.0 p -60.23 -14.46 17.87 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.088 1.755 . . . . 0.0 114.41 166.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.442 ' HB3' ' HB3' ' A' ' 57' ' ' PRO . . . -135.81 176.05 9.04 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 126.242 1.817 . . . . 0.0 111.179 162.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -83.9 -55.82 2.73 Favored Glycine 0 N--CA 1.473 1.123 0 O-C-N 120.979 -1.076 . . . . 0.0 112.963 -163.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.1 p -140.8 70.73 30.12 Favored Pre-proline 0 N--CA 1.475 0.81 0 C-N-CA 124.643 1.177 . . . . 0.0 110.877 167.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.442 ' HB3' ' HB3' ' A' ' 54' ' ' ALA . 4.1 Cg_endo -96.67 148.13 1.05 Allowed 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 124.62 3.546 . . . . 0.0 113.089 -165.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.7 m -161.97 117.75 2.01 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.495 1.118 . . . . 0.0 113.137 176.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 35.6 mtp180 61.72 -12.68 0.06 Allowed 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 128.789 2.836 . . . . 0.0 118.029 167.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.52 HG21 ' CD2' ' A' ' 98' ' ' PHE 0.298 2.4 p -107.52 139.86 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 124.306 1.042 . . . . 0.0 112.207 164.443 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.2 mt -113.54 152.35 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 128.927 2.891 . . . . 0.0 107.581 170.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.467 ' CD2' ' C6 ' ' B' ' 149' ' ' ' C' . 5.0 t-80 -120.25 150.46 40.64 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.353 1.461 . . . . 0.0 110.741 175.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.5 mt -129.9 141.73 45.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 126.114 1.766 . . . . 0.0 109.479 -175.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.86 173.38 6.91 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 127.348 2.259 . . . . 0.0 111.067 171.051 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 17.2 mmmt 62.67 28.88 16.78 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 126.064 1.745 . . . . 0.0 113.503 175.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.89 164.41 21.7 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 124.7 1.2 . . . . 0.0 110.802 173.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.477 ' HD3' HD13 ' A' ' 121' ' ' LEU . 52.2 Cg_exo -59.19 -175.82 0.09 OUTLIER 'Trans proline' 0 CA--C 1.537 0.64 1 C-N-CA 125.505 4.137 . . . . 0.0 113.965 157.287 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 30.3 pt -82.56 -30.18 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 126.665 1.986 . . . . 0.0 112.893 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -155.23 35.15 0.38 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.737 1.615 . . . . 0.0 111.331 -168.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -51.54 150.4 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.644 0.778 . . . . 0.0 111.398 174.041 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.425 HG23 ' H ' ' A' ' 74' ' ' GLU . 8.9 t -89.89 136.42 33.05 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 123.129 1.442 . . . . 0.0 112.413 -177.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.49 -37.59 65.46 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 114.487 -1.233 . . . . 0.0 111.395 173.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -56.21 -38.55 78.01 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.292 0.949 . . . . 0.0 113.605 175.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.425 ' H ' HG23 ' A' ' 71' ' ' THR . 11.2 mt-10 -65.85 -52.41 50.67 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.222 1.009 . . . . 0.0 111.214 171.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.4 t -60.75 -49.05 86.13 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 122.828 0.451 . . . . 0.0 112.203 -177.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.3 pp -70.51 -30.01 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 O-C-N 120.176 -1.577 . . . . 0.0 113.44 178.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 52.1 m -72.19 -17.84 61.9 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 119.175 0.898 . . . . 0.0 112.017 172.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 35.0 mt -85.52 -17.27 36.85 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 165.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.427 ' HA2' ' SD ' ' A' ' 110' ' ' MET . . . -74.12 -40.74 41.57 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 124.3 0.952 . . . . 0.0 112.901 167.175 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.9 mt -70.17 -34.12 3.91 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 119.097 2.999 . . . . 0.0 119.097 -155.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -59.36 4.16 0.15 Allowed 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 124.029 3.153 . . . . 0.0 117.551 175.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.434 ' CD2' ' HG3' ' A' ' 110' ' ' MET . 56.7 m-85 -120.34 -41.37 2.62 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -167.024 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -147.61 -113.62 0.75 Allowed Glycine 0 C--N 1.341 0.809 0 CA-C-O 122.374 0.986 . . . . 0.0 111.983 176.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.429 ' HB3' ' CG ' ' A' ' 102' ' ' ASN . 33.5 tptt -149.48 117.42 6.3 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 129.821 3.248 . . . . 0.0 104.78 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.437 HG22 ' HE2' ' A' ' 101' ' ' MET 0.29 16.3 t -127.29 82.68 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 CA-C-O 122.9 1.334 . . . . 0.0 109.145 -158.229 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.3 t -74.3 -26.82 60.41 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 127.054 2.142 . . . . 0.0 112.148 -162.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -141.02 166.22 25.4 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 123.268 1.508 . . . . 0.0 114.364 177.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -147.38 174.83 11.3 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 128.047 2.539 . . . . 0.0 109.874 160.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.516 HD23 ' C ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -145.63 155.77 43.23 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.96 1.304 . . . . 0.0 110.137 177.179 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 3.7 mtt -127.55 107.05 9.6 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.096 0.958 . . . . 0.0 111.705 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -76.08 64.66 1.98 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.958 0.903 . . . . 0.0 109.133 165.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 31.8 tttp -53.48 -45.19 69.51 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.706 1.602 . . . . 0.0 113.471 -159.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -70.73 -11.62 69.39 Favored Glycine 0 CA--C 1.539 1.592 0 C-N-CA 124.979 1.276 . . . . 0.0 115.797 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.6 -1.04 25.15 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 118.919 1.36 . . . . 0.0 113.191 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.4 m120 60.24 38.26 20.08 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.441 1.496 . . . . 0.0 112.64 -167.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -128.35 163.25 25.24 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.146 0.979 . . . . 0.0 112.062 -172.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -155.0 166.41 33.68 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.79 1.636 . . . . 0.0 112.035 -178.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.52 ' CD2' HG21 ' A' ' 60' ' ' VAL . 5.1 m-30 -113.66 155.8 24.87 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.769 2.028 . . . . 0.0 108.512 160.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.6 tt -137.02 130.61 45.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 119.632 1.106 . . . . 0.0 109.711 162.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -127.16 120.04 27.88 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.995 2.118 . . . . 0.0 112.241 -160.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.437 ' HE2' HG22 ' A' ' 85' ' ' VAL . 0.2 OUTLIER -134.72 154.34 51.61 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 112.994 -1.912 . . . . 0.0 113.232 -164.479 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.449 ' CG ' HG23 ' A' ' 103' ' ' THR . 4.2 p-10 -72.26 -20.31 61.55 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 115.29 1.589 . . . . 0.0 115.29 -158.253 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.449 HG23 ' CG ' ' A' ' 102' ' ' ASN . 9.4 p -136.66 138.07 40.71 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.702 1.201 . . . . 0.0 111.209 -175.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -58.42 -32.29 68.54 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.96 174.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -73.54 -42.67 61.41 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -54.34 -53.11 58.3 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 119.669 1.122 . . . . 0.0 109.518 169.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.62 -34.33 71.98 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -174.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -58.44 -50.47 73.61 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.109 0.868 . . . . 0.0 110.56 169.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -62.11 -33.1 73.83 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 121.583 -0.698 . . . . 0.0 110.99 175.154 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.434 ' HG3' ' CD2' ' A' ' 82' ' ' PHE . 11.1 ttp -73.46 -48.94 29.58 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 124.085 0.954 . . . . 0.0 112.263 -176.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 1.1 p -63.78 -38.72 83.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 124.341 1.056 . . . . 0.0 110.995 179.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -71.96 -42.59 66.4 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.881 1.272 . . . . 0.0 111.549 177.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -47.68 -55.56 9.19 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.909 1.284 . . . . 0.0 109.984 165.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -78.29 11.58 2.32 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 118.855 -2.403 . . . . 0.0 113.826 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 53.3 m -111.82 -15.48 13.37 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.633 1.173 . . . . 0.0 110.988 171.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.417 ' CB ' HG23 ' A' ' 117' ' ' VAL . 0.4 OUTLIER -89.41 -44.59 10.07 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.733 2.013 . . . . 0.0 111.841 163.763 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.417 HG23 ' CB ' ' A' ' 116' ' ' SER . 96.4 t -112.35 -49.73 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 125.02 1.328 . . . . 0.0 111.951 -143.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.445 ' CG2' ' H ' ' A' ' 126' ' ' ILE . 31.5 m 69.81 141.45 0.08 OUTLIER Pre-proline 0 N--CA 1.485 1.29 0 C-N-CA 128.21 2.604 . . . . 0.0 112.308 -173.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -82.05 -12.88 10.52 Favored 'Trans proline' 0 CA--C 1.549 1.251 0 C-N-CA 123.385 2.723 . . . . 0.0 114.105 -176.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 22.0 t 50.6 101.17 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 131.144 3.778 . . . . 0.0 115.541 175.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.477 HD13 ' HD3' ' A' ' 67' ' ' PRO . 1.2 tt -92.08 101.62 14.16 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 123.763 0.825 . . . . 0.0 109.819 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 45.6 62.47 2.18 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.735 2.014 . . . . 0.0 112.086 178.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 81.2 6.93 89.01 Favored Glycine 0 CA--C 1.537 1.426 0 N-CA-C 116.015 1.166 . . . . 0.0 116.015 173.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 35.1 tp60 -131.72 142.49 45.45 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 125.83 1.652 . . . . 0.0 110.109 -173.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -61.1 166.31 10.94 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 123.119 2.546 . . . . 0.0 114.529 179.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.445 ' H ' ' CG2' ' A' ' 118' ' ' THR . 0.6 OUTLIER -136.79 154.41 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.797 1.639 . . . . 0.0 109.989 178.088 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -120.45 91.05 3.45 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 124.33 1.052 . . . . 0.0 109.056 -155.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -95.95 152.76 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 124.913 1.285 . . . . 0.0 111.994 -179.1 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -147.92 161.48 41.22 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.75 1.62 . . . . 0.0 108.339 152.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.91 153.31 4.86 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.006 -1.059 . . . . 0.0 112.041 158.064 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.498 ' OG ' HG13 ' A' ' 60' ' ' VAL . 54.7 p -65.11 170.17 4.76 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 177.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -87.64 6.75 33.13 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.405 1.482 . . . . 0.0 112.874 164.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -132.84 -176.01 3.97 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.445 1.498 . . . . 0.0 113.243 -161.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 42.0 tttp -140.26 101.35 4.11 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.536 1.935 . . . . 0.0 111.162 -177.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 64.74 108.11 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 127.448 2.299 . . . . 0.0 114.611 -174.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 18.8 tp -63.88 124.7 22.2 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.245 1.818 . . . . 0.0 111.956 169.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -101.89 102.58 13.17 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 127.163 2.185 . . . . 0.0 110.634 167.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 12.9 p -77.24 60.61 1.98 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 126.094 1.758 . . . . 0.0 111.788 174.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -60.55 -44.99 95.53 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.474 1.51 . . . . 0.0 114.877 -168.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 74.6 m -88.74 87.3 7.2 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.109 1.363 . . . . 0.0 113.195 -174.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 49.8 m -65.73 136.12 95.78 Favored Pre-proline 0 N--CA 1.475 0.819 0 C-N-CA 124.368 1.067 . . . . 0.0 112.268 173.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -51.63 138.96 48.78 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 124.025 3.15 . . . . 0.0 114.645 176.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -72.49 84.86 1.13 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.178 1.391 . . . . 0.0 110.877 175.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -123.68 -81.14 0.63 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.41 1.084 . . . . 0.0 113.476 -163.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -74.81 -70.84 0.38 Allowed 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -165.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 56.4 ttm-85 . . . . . 0 N--CA 1.482 1.149 0 C-N-CA 125.947 1.699 . . . . 0.0 113.599 -172.988 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 147' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.665 0 O4'-C4'-C3' 108.79 2.35 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 148' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.749 1 C5'-C4'-C3' 109.277 -4.149 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 149' ' ' ' C' . . . . . 0.467 ' C6 ' ' CD2' ' A' ' 62' ' ' HIS . . . . . . . . 0 O4'--C4' 1.423 -2.539 0 N19-C1'-C2' 107.657 -3.589 . 0.01 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 150' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.676 1 O4'-C1'-N19 113.087 4.887 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 151' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.541 2.378 0 O4'-C1'-N19 110.642 2.442 . 0.01 7p . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 152' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.537 2.077 0 O4'-C1'-N19 111.682 3.482 . 0.341 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.564 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -65.26 155.79 34.01 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.167 0.987 . . . . 0.0 113.509 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 82.8 p -135.1 -5.27 2.37 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.688 1.995 . . . . 0.0 114.077 169.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 72.7 mtp85 -75.93 -28.24 57.9 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.639 1.176 . . . . 0.0 113.664 -174.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.5 t -58.51 161.9 4.2 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.965 0.906 . . . . 0.0 112.543 173.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 53.52 6.29 0.07 Allowed 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 127.235 2.214 . . . . 0.0 115.957 -176.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.56 38.95 26.91 Favored Glycine 0 CA--C 1.536 1.4 0 O-C-N 120.721 -1.237 . . . . 0.0 113.317 -174.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . 0.321 14.1 p 50.31 78.0 0.43 Allowed Pre-proline 0 N--CA 1.485 1.283 0 C-N-CA 127.558 2.343 . . . . 0.0 111.374 -174.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -97.34 -179.73 0.38 Allowed 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 123.344 2.696 . . . . 0.0 113.431 -144.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 30.0 p -144.96 -156.79 0.73 Allowed 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -175.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 32.2 mtp180 -61.02 -6.09 1.72 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 130.541 3.537 . . . . 0.0 118.339 -165.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.617 HG13 ' HB3' ' A' ' 131' ' ' SER 0.254 2.5 p -101.17 131.35 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 120.809 1.64 . . . . 0.0 112.092 166.973 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 16.9 mt -103.24 153.92 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 127.379 2.272 . . . . 0.0 109.478 165.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.427 ' CD2' ' C6 ' ' B' ' 149' ' ' ' C' . 2.1 t-80 -120.39 143.95 48.16 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.772 1.629 . . . . 0.0 110.528 175.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.9 mt -122.58 133.46 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 127.071 2.148 . . . . 0.0 109.776 -173.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 28.9 mtt180 -88.39 166.63 14.12 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.672 1.589 . . . . 0.0 110.543 173.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.9 mtpp 50.51 35.42 11.23 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 155.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.79 162.82 0.71 Allowed Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 126.446 1.898 . . . . 0.0 111.521 162.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -56.14 179.24 0.1 OUTLIER 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 124.326 3.351 . . . . 0.0 114.912 156.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 31.1 pt -77.36 -30.41 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 126.599 1.96 . . . . 0.0 113.168 -176.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -157.75 36.86 0.26 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.993 1.717 . . . . 0.0 110.971 -170.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -50.27 151.05 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.966 0.906 . . . . 0.0 111.627 175.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.7 t -85.19 128.05 34.52 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 123.583 1.659 . . . . 0.0 111.11 174.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -60.9 -22.68 64.57 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 114.823 -1.081 . . . . 0.0 111.773 174.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -62.38 -35.91 92.35 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 125.224 1.392 . . . . 0.0 114.024 167.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -67.88 -46.46 71.61 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.576 -0.955 . . . . 0.0 109.812 171.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 62.0 t -64.85 -44.55 96.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -176.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -75.81 -25.7 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-N 121.973 2.17 . . . . 0.0 114.051 173.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.7 t -62.61 -28.05 69.63 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 119.705 1.139 . . . . 0.0 111.126 166.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 14.8 mt -81.84 -16.02 52.18 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 170.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.43 ' HA2' ' SD ' ' A' ' 110' ' ' MET . . . -91.71 -25.69 22.17 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 115.091 0.796 . . . . 0.0 115.091 171.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 13.4 mt -74.36 -26.72 0.7 Allowed Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 117.974 2.583 . . . . 0.0 117.974 -165.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -59.87 -0.62 0.89 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.174 2.583 . . . . 0.0 116.615 167.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -114.6 -43.92 3.12 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 -168.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -148.42 -112.85 0.68 Allowed Glycine 0 C--N 1.338 0.658 0 CA-C-O 122.587 1.104 . . . . 0.0 112.652 173.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.42 ' HB3' ' CG ' ' A' ' 102' ' ' ASN . 32.7 tptt -146.1 123.02 11.34 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 130.545 3.538 . . . . 0.0 103.894 176.394 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.466 HG22 ' HE2' ' A' ' 101' ' ' MET 0.276 17.8 t -130.48 85.79 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 CA-C-O 122.604 1.192 . . . . 0.0 109.432 -159.564 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 22.2 p -72.49 -36.04 68.32 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 112.74 -2.027 . . . . 0.0 111.741 -162.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -135.01 160.3 38.76 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 122.822 1.296 . . . . 0.0 114.047 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -149.88 171.95 15.95 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 126.454 1.902 . . . . 0.0 110.487 161.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.506 HD23 ' C ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -146.7 155.03 42.11 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.49 1.116 . . . . 0.0 110.101 -175.187 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 3.0 mtt -132.94 102.99 5.84 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.357 1.063 . . . . 0.0 111.476 -174.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.0 69.43 3.29 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 122.341 1.067 . . . . 0.0 109.748 168.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -60.53 -20.6 60.78 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.296 1.438 . . . . 0.0 113.25 -177.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.63 -30.34 62.25 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 125.358 1.456 . . . . 0.0 114.968 169.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.6 mtmt -132.39 -5.67 3.35 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 115.548 1.684 . . . . 0.0 115.548 -170.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.7 m120 72.61 38.71 0.76 Allowed 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 127.614 2.366 . . . . 0.0 113.611 -173.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -112.13 167.17 10.61 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.546 0.738 . . . . 0.0 111.271 171.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -147.39 164.48 33.18 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.499 1.519 . . . . 0.0 111.232 172.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.476 ' CD2' HG21 ' A' ' 60' ' ' VAL . 6.7 m-30 -109.27 157.33 18.94 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.44 1.496 . . . . 0.0 107.99 160.251 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 19.2 tt -137.31 124.33 29.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 124.599 1.16 . . . . 0.0 109.216 162.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -120.91 123.6 42.9 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 127.514 2.326 . . . . 0.0 111.445 -167.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.466 ' HE2' HG22 ' A' ' 85' ' ' VAL . 0.1 OUTLIER -133.99 157.45 46.04 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 112.724 -2.035 . . . . 0.0 113.222 -164.287 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.455 ' CG ' HG23 ' A' ' 103' ' ' THR . 2.5 p-10 -70.78 -23.06 62.32 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.376 1.251 . . . . 0.0 114.376 -161.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.455 HG23 ' CG ' ' A' ' 102' ' ' ASN . 9.8 p -135.58 140.64 44.79 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 122.622 1.201 . . . . 0.0 111.772 -175.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -59.83 -33.01 71.21 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.084 174.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -74.49 -41.61 60.41 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -54.54 -51.67 64.48 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 119.4 1.0 . . . . 0.0 109.803 168.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.28 -36.09 74.15 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -176.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -58.91 -46.98 86.6 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.226 -0.921 . . . . 0.0 111.034 170.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -64.32 -32.7 74.41 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.024 -1.048 . . . . 0.0 111.278 173.012 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.43 ' SD ' ' HA2' ' A' ' 79' ' ' GLY . 12.9 ttp -71.75 -48.76 44.65 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 119.729 1.15 . . . . 0.0 111.238 -176.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.16 -40.44 89.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 124.498 1.119 . . . . 0.0 111.071 177.336 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -68.67 -44.77 73.35 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.512 0.725 . . . . 0.0 110.445 177.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -50.15 -38.05 37.5 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.114 1.366 . . . . 0.0 112.25 168.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.442 ' HA ' HG12 ' A' ' 117' ' ' VAL . 25.8 m-85 -92.92 -11.16 34.09 Favored 'General case' 0 C--O 1.231 0.127 0 O-C-N 120.064 -1.648 . . . . 0.0 113.131 -177.187 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 84.2 m -80.89 -18.22 47.97 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.37 1.068 . . . . 0.0 110.069 166.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.04 -62.2 1.63 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 129.621 3.168 . . . . 0.0 112.3 170.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.442 HG12 ' HA ' ' A' ' 114' ' ' TYR . 1.4 p -83.02 -44.51 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 124.418 1.087 . . . . 0.0 113.018 -151.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.0 m 38.0 121.54 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.068 0 C-N-CA 130.674 3.589 . . . . 0.0 114.636 -147.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -69.84 -33.2 16.74 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 121.204 1.269 . . . . 0.0 114.118 -171.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.2 t 50.89 99.17 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 128.757 2.823 . . . . 0.0 112.313 -176.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.589 ' H ' HD11 ' A' ' 126' ' ' ILE . 1.2 tt -116.33 -73.37 0.65 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 112.201 -2.272 . . . . 0.0 107.472 -146.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.53 -35.01 79.59 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.56 1.144 . . . . 0.0 111.643 172.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 147.41 4.38 0.39 Allowed Glycine 0 CA--C 1.533 1.2 0 C-N-CA 125.083 1.325 . . . . 0.0 116.229 175.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -152.6 167.59 13.02 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 119.15 1.475 . . . . 0.0 111.272 178.594 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -45.3 110.06 0.22 Allowed 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 124.347 3.364 . . . . 0.0 116.447 -171.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.589 HD11 ' H ' ' A' ' 121' ' ' LEU . 2.5 mm -74.14 166.19 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 125.175 1.39 . . . . 0.0 107.707 166.05 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -140.66 156.34 46.26 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.218 -0.926 . . . . 0.0 110.483 168.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.21 153.27 38.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 125.517 1.527 . . . . 0.0 111.098 176.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -150.2 167.99 25.3 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.357 1.463 . . . . 0.0 108.772 154.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -55.12 149.47 12.19 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 120.878 -1.139 . . . . 0.0 111.74 159.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.617 ' HB3' HG13 ' A' ' 60' ' ' VAL . 30.8 t -69.28 153.16 44.08 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.897 0.879 . . . . 0.0 112.669 176.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -61.86 -29.13 69.98 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.047 1.339 . . . . 0.0 112.15 167.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 51.1 m-70 -95.11 175.96 6.42 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.592 1.957 . . . . 0.0 111.548 -174.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -134.64 120.53 19.67 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.272 1.429 . . . . 0.0 111.072 -177.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 58.55 90.39 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 128.201 2.601 . . . . 0.0 114.131 -178.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.471 HD12 ' C4 ' ' B' ' 150' ' ' ' U' . 35.9 tp -59.04 128.73 38.66 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.2 1.4 . . . . 0.0 112.111 176.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -113.76 112.09 22.85 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 126.348 1.859 . . . . 0.0 110.523 170.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 21.2 p -118.67 164.28 15.58 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.351 1.861 . . . . 0.0 110.895 171.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -64.02 158.99 21.1 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.472 0.709 . . . . 0.0 111.704 172.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 41.2 m 49.71 41.44 21.97 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.716 1.606 . . . . 0.0 114.469 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 38.0 m -61.66 140.07 95.21 Favored Pre-proline 0 N--CA 1.474 0.732 0 C-N-CA 123.878 0.871 . . . . 0.0 111.563 174.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -76.26 0.6 9.23 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 123.671 2.914 . . . . 0.0 114.801 -176.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -66.41 -1.27 3.31 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 126.275 1.83 . . . . 0.0 114.981 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 54.63 78.24 0.18 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.821 2.449 . . . . 0.0 113.969 177.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -151.33 168.12 25.77 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.341 1.456 . . . . 0.0 111.275 166.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 . . . . . 0 N--CA 1.476 0.831 0 C-N-CA 126.14 1.776 . . . . 0.0 111.609 178.278 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 147' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.265 0 C5'-C4'-C3' 111.312 -2.792 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 148' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.598 0 O4'-C1'-N19 110.599 2.399 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 149' ' ' ' C' . . . . . 0.427 ' C6 ' ' CD2' ' A' ' 62' ' ' HIS . . . . . . . . 0 O4'--C4' 1.421 -2.695 0 C3'-C2'-C1' 104.027 2.807 . 0.112 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 150' ' ' ' U' . . . . . 0.471 ' C4 ' HD12 ' A' ' 136' ' ' LEU . . . . . . . . 0 O4'--C4' 1.419 -2.817 1 O4'-C1'-N19 113.752 5.552 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 151' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.277 0 O4'-C1'-N19 110.844 2.644 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 152' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.259 0 O4'-C1'-N19 112.084 3.884 . 0.189 5q . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.645 0 N-CA-C 112.104 -0.398 . . . . 0.0 112.104 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -141.89 -50.1 0.39 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 127.948 2.499 . . . . 0.0 112.32 -0.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.6 m -62.28 -18.93 62.62 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.768 1.227 . . . . 0.0 114.255 179.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 49.9 tpt85 -58.07 -26.71 62.87 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 126.279 1.832 . . . . 0.0 114.273 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 48.7 m -60.17 -25.58 65.66 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 114.684 1.364 . . . . 0.0 114.684 -178.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -77.76 -2.13 34.78 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.889 1.676 . . . . 0.0 114.052 172.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 90.38 38.31 6.32 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 125.123 1.344 . . . . 0.0 113.839 -177.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . 0.314 7.7 p 47.78 76.66 0.52 Allowed Pre-proline 0 N--CA 1.485 1.302 0 C-N-CA 127.648 2.379 . . . . 0.0 111.619 -169.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -95.39 178.24 0.73 Allowed 'Trans proline' 0 CA--C 1.546 1.101 0 C-N-CA 123.927 3.085 . . . . 0.0 114.262 -147.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 49.1 m -135.97 177.88 7.49 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.944 1.298 . . . . 0.0 114.396 -167.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 34.4 mtp180 -55.82 -7.43 0.3 Allowed 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 129.909 3.284 . . . . 0.0 119.324 -170.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.658 HG13 ' HB3' ' A' ' 131' ' ' SER . 2.6 p -105.66 134.71 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-N 119.759 1.163 . . . . 0.0 111.878 169.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 10.4 mt -106.0 150.25 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 126.433 1.893 . . . . 0.0 108.561 167.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.406 ' CD2' ' C6 ' ' B' ' 149' ' ' ' C' . 2.6 t-80 -114.03 143.97 43.87 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.082 1.353 . . . . 0.0 110.569 173.088 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 7.2 mt -118.46 144.8 25.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 126.488 1.915 . . . . 0.0 108.395 -175.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.23 167.87 17.75 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 127.739 2.415 . . . . 0.0 109.639 168.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.72 27.91 17.27 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.816 1.246 . . . . 0.0 113.229 178.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 28.2 mt -66.96 177.25 0.9 Allowed Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 125.05 1.34 . . . . 0.0 109.792 163.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -51.88 -171.97 0.01 OUTLIER 'Trans proline' 0 CA--C 1.545 1.062 0 C-N-CA 123.181 2.587 . . . . 0.0 114.507 147.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.418 HG12 ' H ' ' A' ' 68' ' ' ILE . 3.7 mm -60.31 -47.26 93.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 127.427 2.291 . . . . 0.0 111.189 -176.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -155.51 -7.44 0.12 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 129.334 3.054 . . . . 0.0 111.666 -162.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.429 HG22 ' H ' ' A' ' 71' ' ' THR 0.307 7.9 p 26.05 -127.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 128.903 2.881 . . . . 0.0 113.457 -167.956 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.429 ' H ' HG22 ' A' ' 70' ' ' VAL . 9.8 t -154.51 143.8 21.27 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 120.004 1.275 . . . . 0.0 110.421 163.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -58.31 -42.12 86.0 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 123.562 0.745 . . . . 0.0 112.276 -175.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -55.79 -37.94 71.33 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 123.861 0.743 . . . . 0.0 112.516 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -69.12 -53.37 20.53 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.454 1.102 . . . . 0.0 112.125 173.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 97.7 t -58.97 -46.69 91.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 122.941 0.496 . . . . 0.0 112.14 -176.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.0 pp -73.05 -33.74 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 O-C-N 120.674 -1.266 . . . . 0.0 112.531 177.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 64.0 m -69.55 -21.44 63.64 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 120.047 1.294 . . . . 0.0 111.599 175.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.9 mt -77.63 -27.67 51.17 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 170.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -89.98 -21.25 39.84 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-N 119.239 0.927 . . . . 0.0 114.526 176.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.0 mt -64.05 -37.65 28.68 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 117.858 2.54 . . . . 0.0 117.858 -169.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.48 -4.01 1.09 Allowed 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.787 2.991 . . . . 0.0 116.845 171.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -106.97 -35.34 6.93 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 113.496 0.925 . . . . 0.0 113.496 -167.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -154.58 -108.37 0.31 Allowed Glycine 0 C--N 1.338 0.647 0 CA-C-O 122.622 1.123 . . . . 0.0 111.964 172.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.416 ' HB3' ' CG ' ' A' ' 102' ' ' ASN . 32.0 tptt -149.61 122.14 8.54 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 130.415 3.486 . . . . 0.0 104.135 175.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.431 HG22 ' HE2' ' A' ' 101' ' ' MET 0.308 20.8 t -128.74 83.98 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 CA-C-N 120.034 1.288 . . . . 0.0 109.955 -160.409 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.5 t -79.72 -21.22 44.84 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 126.894 2.077 . . . . 0.0 112.765 -163.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -141.51 161.74 37.17 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 175.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -149.37 171.82 15.92 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.577 2.351 . . . . 0.0 110.551 162.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.529 HD13 ' C ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -142.99 154.47 44.05 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.266 1.426 . . . . 0.0 108.772 172.692 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 3.7 mtt -128.28 105.62 8.47 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.748 1.219 . . . . 0.0 110.434 -175.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.415 HD13 HD11 ' A' ' 89' ' ' LEU . 1.6 mm? -74.11 71.52 1.64 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.186 0.994 . . . . 0.0 110.525 173.127 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -49.85 118.87 3.11 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.835 1.654 . . . . 0.0 111.574 -176.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.04 -6.37 82.72 Favored Glycine 0 CA--C 1.539 1.556 0 CA-C-O 118.279 -1.289 . . . . 0.0 116.178 177.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.51 -2.98 50.72 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-N 119.837 1.818 . . . . 0.0 113.154 165.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.9 m120 63.24 27.37 15.5 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.313 1.845 . . . . 0.0 113.283 -167.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -124.58 164.51 19.66 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.513 0.725 . . . . 0.0 112.302 -168.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -164.12 170.71 16.07 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.091 1.756 . . . . 0.0 111.177 -178.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.478 ' CD2' HG21 ' A' ' 60' ' ' VAL . 4.3 m-30 -116.74 156.02 27.9 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.448 1.899 . . . . 0.0 108.088 164.405 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 17.4 tt -138.14 124.41 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 124.722 1.209 . . . . 0.0 109.138 164.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -122.79 122.17 38.04 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 127.034 2.134 . . . . 0.0 111.474 -164.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.431 ' HE2' HG22 ' A' ' 85' ' ' VAL . 0.9 OUTLIER -132.63 157.33 45.07 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 113.389 -1.732 . . . . 0.0 112.97 -166.028 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.416 ' CG ' ' HB3' ' A' ' 84' ' ' LYS . 2.2 p-10 -71.79 -19.34 62.02 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 114.065 -1.425 . . . . 0.0 114.308 -159.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.415 HG23 ' CG ' ' A' ' 102' ' ' ASN . 16.8 p -137.83 142.64 40.77 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 122.956 1.36 . . . . 0.0 111.766 -176.375 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -59.43 -37.42 78.04 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 114.125 -1.398 . . . . 0.0 110.706 176.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -71.64 -40.35 69.79 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 179.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.0 -52.53 62.85 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 119.403 1.001 . . . . 0.0 110.073 169.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.99 -38.16 82.35 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -56.15 -48.24 76.65 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.818 -0.551 . . . . 0.0 111.048 171.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -64.84 -35.01 79.74 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 118.407 -0.806 . . . . 0.0 111.233 173.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 8.2 ttp -67.76 -48.55 66.07 Favored 'General case' 0 C--N 1.343 0.303 0 C-N-CA 124.554 1.142 . . . . 0.0 110.554 -175.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.84 -40.64 88.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 C-N-CA 124.752 1.221 . . . . 0.0 111.761 178.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -67.71 -45.3 75.48 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.377 0.671 . . . . 0.0 110.693 177.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -50.97 -38.31 49.98 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.604 1.562 . . . . 0.0 112.482 167.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.442 ' HA ' HG12 ' A' ' 117' ' ' VAL . 17.8 m-85 -88.73 -16.47 32.15 Favored 'General case' 0 CA--C 1.517 -0.289 0 O-C-N 119.966 -1.709 . . . . 0.0 112.88 -178.167 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 70.0 m -79.06 -18.61 53.13 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.434 1.093 . . . . 0.0 109.865 169.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.42 -60.58 2.22 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 129.384 3.074 . . . . 0.0 111.697 169.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.442 HG12 ' HA ' ' A' ' 114' ' ' TYR . 0.8 OUTLIER -88.47 -48.07 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.048 0.939 . . . . 0.0 112.955 -153.302 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.2 m 43.08 125.28 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.88 0 C-N-CA 129.866 3.266 . . . . 0.0 114.267 -148.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -70.14 -35.35 11.67 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 121.416 1.411 . . . . 0.0 114.012 -171.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.6 t 53.86 102.33 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 128.597 2.759 . . . . 0.0 113.031 -178.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.532 ' H ' HD11 ' A' ' 126' ' ' ILE . 0.8 OUTLIER -123.59 -71.46 0.72 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 112.479 -2.146 . . . . 0.0 108.28 -147.293 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.78 -42.51 99.09 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.521 0.728 . . . . 0.0 111.086 171.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 158.18 -2.47 0.12 Allowed Glycine 0 CA--C 1.533 1.198 0 N-CA-C 116.208 1.243 . . . . 0.0 116.208 173.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -148.13 169.56 9.07 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 119.54 1.67 . . . . 0.0 111.192 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -50.98 116.07 2.41 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.734 2.956 . . . . 0.0 116.535 -166.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.532 HD11 ' H ' ' A' ' 121' ' ' LEU . 4.3 mm -76.27 150.06 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 126.364 1.866 . . . . 0.0 109.166 174.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 10.2 m-30 -114.7 136.7 52.77 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.042 -1.036 . . . . 0.0 110.787 -176.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.5 149.3 32.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 125.1 1.36 . . . . 0.0 112.319 176.335 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -153.46 164.9 37.39 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.763 2.025 . . . . 0.0 109.627 153.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -53.19 152.23 4.53 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 120.873 -1.142 . . . . 0.0 112.593 167.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.658 ' HB3' HG13 ' A' ' 60' ' ' VAL . 27.9 t -76.18 157.87 32.27 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.726 0.81 . . . . 0.0 113.086 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -68.51 -12.03 60.68 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.854 1.662 . . . . 0.0 113.636 168.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 42.6 m-70 -119.6 -178.69 3.68 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.484 1.513 . . . . 0.0 112.895 -170.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -136.88 124.95 22.9 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.981 2.112 . . . . 0.0 110.639 178.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 58.28 93.05 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 127.185 2.194 . . . . 0.0 113.946 -178.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 28.9 tp -64.01 110.96 2.31 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.666 1.587 . . . . 0.0 111.814 178.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -107.48 100.41 9.84 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.204 1.802 . . . . 0.0 110.425 174.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 22.1 p -91.62 -7.09 51.06 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 126.165 1.786 . . . . 0.0 114.044 178.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 20.2 t70 64.61 -6.79 0.28 Allowed 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 128.244 2.618 . . . . 0.0 116.642 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 54.8 m 31.91 73.13 0.06 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 129.051 2.94 . . . . 0.0 115.347 171.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 82.6 p -114.62 158.28 40.65 Favored Pre-proline 0 N--CA 1.476 0.832 0 C-N-CA 124.591 1.156 . . . . 0.0 113.907 -173.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -57.64 -22.64 53.15 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.778 2.985 . . . . 0.0 115.456 175.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -70.72 -23.42 62.45 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.95 1.3 . . . . 0.0 113.832 178.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -76.3 167.97 20.9 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -174.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -120.88 1.1 10.43 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -157.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.998 0 C-N-CA 125.926 1.691 . . . . 0.0 111.022 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 147' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.306 0 C5'-C4'-C3' 111.335 -2.776 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 148' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.377 1 O4'-C1'-N19 113.273 5.073 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 149' ' ' ' C' . . . . . 0.406 ' C6 ' ' CD2' ' A' ' 62' ' ' HIS . . . . . . . . 0 O4'--C4' 1.422 -2.586 0 O4'-C1'-N19 111.908 3.708 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 150' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.28 2 O4'-C1'-N19 114.881 6.681 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 151' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.544 2.618 0 C4'-C3'-C2' 99.8 -2.9 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 152' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.166 0 O4'-C1'-N19 111.177 2.977 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.642 0 N-CA-C 111.823 -0.511 . . . . 0.0 111.823 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -144.77 151.51 38.95 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.534 1.533 . . . . 0.0 111.511 178.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 11.0 m -71.69 29.44 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 127.188 2.195 . . . . 0.0 114.531 178.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 31.9 mtp85 42.03 54.34 4.07 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 127.592 2.357 . . . . 0.0 112.06 -169.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.5 m 57.31 -82.22 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 128.319 2.648 . . . . 0.0 113.952 -169.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 55.55 -67.91 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 128.78 2.832 . . . . 0.0 114.917 -170.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 160.77 -78.21 0.17 Allowed Glycine 0 CA--C 1.53 0.98 0 C-N-CA 126.731 2.11 . . . . 0.0 110.178 174.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.1 t -147.84 76.97 10.43 Favored Pre-proline 0 N--CA 1.479 0.989 0 C-N-CA 126.786 2.034 . . . . 0.0 107.614 169.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -104.97 19.05 0.14 Allowed 'Trans proline' 0 CA--C 1.543 0.974 0 C-N-CA 123.734 2.956 . . . . 0.0 114.222 -152.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.1 t -43.08 118.18 1.23 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.882 1.673 . . . . 0.0 114.785 -159.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 25.8 mtp180 61.5 -8.54 0.09 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 128.836 2.854 . . . . 0.0 117.839 171.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.681 HG13 ' HB3' ' A' ' 131' ' ' SER 0.3 3.9 p -104.81 130.3 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 120.906 1.685 . . . . 0.0 113.409 175.347 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.8 mp -103.21 155.21 5.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 127.617 2.367 . . . . 0.0 108.103 169.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.427 ' CD2' ' C6 ' ' B' ' 149' ' ' ' C' . 3.1 t-80 -126.93 140.96 51.94 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.801 2.04 . . . . 0.0 111.024 177.262 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.6 mt -120.75 136.63 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 128.309 2.644 . . . . 0.0 109.857 -170.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.6 mtt180 -97.19 176.65 5.85 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 120.517 1.508 . . . . 0.0 111.02 172.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp 45.34 35.79 2.01 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 127.739 2.415 . . . . 0.0 117.068 159.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.8 mp -52.03 157.42 2.16 Favored Pre-proline 0 CA--C 1.559 1.303 0 C-N-CA 124.771 1.228 . . . . 0.0 110.912 165.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -42.0 -65.72 0.18 Allowed 'Trans proline' 0 CA--C 1.537 0.648 1 C-N-CA 126.033 4.488 . . . . 0.0 115.385 177.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 pt -160.54 -55.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 130.262 3.425 . . . . 0.0 107.898 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -145.99 -9.47 0.52 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.31 1.444 . . . . 0.0 114.508 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.518 HG22 ' H ' ' A' ' 71' ' ' THR 0.28 1.7 p 45.14 -154.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 127.611 2.364 . . . . 0.0 112.997 -178.616 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.518 ' H ' HG22 ' A' ' 70' ' ' VAL . 4.0 t -137.43 143.0 41.63 Favored 'General case' 0 C--O 1.238 0.499 0 O-C-N 120.396 -1.44 . . . . 0.0 110.466 160.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -58.46 -33.41 69.71 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.763 177.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -56.59 -41.3 89.16 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 123.953 0.787 . . . . 0.0 112.96 175.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -64.53 -55.83 18.0 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.815 0.846 . . . . 0.0 111.11 171.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.7 t -61.05 -44.22 97.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -173.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.9 pp -69.44 -32.65 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 O-C-N 120.301 -1.499 . . . . 0.0 112.652 175.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.6 p -64.28 -21.23 66.52 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 119.738 1.153 . . . . 0.0 112.214 173.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 86.8 mt -91.6 -16.14 27.55 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 173.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -90.02 -22.78 34.52 Favored Glycine 0 CA--C 1.538 1.509 0 CA-C-N 119.144 0.884 . . . . 0.0 113.214 168.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 80' ' ' LEU . 21.0 mt -73.37 -14.98 0.25 Allowed Pre-proline 0 CA--C 1.543 0.677 0 N-CA-C 119.314 3.079 . . . . 0.0 119.314 -175.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -60.5 -1.53 1.49 Allowed 'Trans proline' 0 C--N 1.348 0.525 0 CA-C-N 123.152 2.162 . . . . 0.0 116.62 168.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -122.05 -53.62 1.94 Allowed 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 114.698 1.369 . . . . 0.0 114.698 -168.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -144.06 -106.57 0.54 Allowed Glycine 0 C--N 1.337 0.598 0 C-N-CA 124.149 0.88 . . . . 0.0 111.985 -178.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 13.7 tptm -143.41 -7.52 0.78 Allowed 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 116.805 2.15 . . . . 0.0 116.805 -174.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 101' ' ' MET . 0.1 OUTLIER 30.26 87.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 129.029 2.932 . . . . 0.0 113.37 -176.782 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 24.1 m -55.42 -42.3 73.94 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 127.378 2.271 . . . . 0.0 111.695 -175.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -149.72 169.53 20.83 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.4 pp -139.49 171.95 13.51 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.97 1.708 . . . . 0.0 112.189 155.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.529 HD13 ' C ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -144.18 151.95 40.22 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.176 1.79 . . . . 0.0 108.476 173.867 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 5.1 mtt -128.77 103.52 7.11 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.326 1.05 . . . . 0.0 111.924 -175.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.444 ' CD1' HD11 ' A' ' 89' ' ' LEU . 1.2 mm? -74.43 96.02 2.82 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.927 1.291 . . . . 0.0 110.878 172.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 49.4 mttp -61.17 -19.18 61.26 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 171.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -53.33 -61.07 7.33 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 126.379 1.942 . . . . 0.0 114.968 -177.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.34 27.06 4.79 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.632 1.973 . . . . 0.0 112.239 -175.116 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 59.45 48.5 9.78 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.723 2.009 . . . . 0.0 113.709 -177.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . 0.28 0.0 OUTLIER -117.59 176.14 5.31 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.042 0.937 . . . . 0.0 111.935 176.838 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -166.48 165.81 16.73 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 120.276 -1.515 . . . . 0.0 111.018 -174.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.439 ' CD2' HG21 ' A' ' 60' ' ' VAL . 4.2 m-30 -112.46 157.37 21.17 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.908 1.683 . . . . 0.0 108.484 166.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 8.6 tt -143.62 108.32 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 126.111 1.764 . . . . 0.0 107.618 170.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -115.34 131.91 56.78 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.846 2.058 . . . . 0.0 112.014 -166.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.452 ' HA ' ' HA ' ' A' ' 85' ' ' VAL 0.292 1.2 tpp -130.46 153.5 48.72 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 116.835 2.161 . . . . 0.0 116.835 -161.498 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -69.0 -9.2 51.23 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.182 1.793 . . . . 0.0 114.675 -165.191 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -148.76 143.89 26.68 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.459 1.504 . . . . 0.0 110.111 -177.279 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -66.54 -32.76 74.31 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.221 1.008 . . . . 0.0 111.726 176.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -71.83 -47.44 53.16 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.346 0.658 . . . . 0.0 112.09 177.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.79 -46.47 87.48 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 122.83 0.452 . . . . 0.0 110.619 175.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.22 -40.65 82.0 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -60.77 -46.43 90.48 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.851 -0.531 . . . . 0.0 111.102 171.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -63.3 -29.09 70.48 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 120.421 -1.425 . . . . 0.0 111.198 171.29 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 10.4 ttp -67.06 -52.11 46.27 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 120.13 1.332 . . . . 0.0 110.048 -177.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.74 -40.51 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 124.547 1.139 . . . . 0.0 111.85 176.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -71.29 -44.07 65.91 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.751 0.82 . . . . 0.0 111.824 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -48.42 -38.66 20.22 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.454 1.501 . . . . 0.0 111.629 166.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.64 ' HA ' HG12 ' A' ' 117' ' ' VAL . 11.6 m-85 -85.98 -22.26 27.42 Favored 'General case' 0 N--CA 1.445 -0.715 0 O-C-N 120.649 -1.282 . . . . 0.0 113.248 -175.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.08 -15.89 57.54 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.984 0.897 . . . . 0.0 111.107 171.5 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.7 -59.43 2.79 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 128.932 2.893 . . . . 0.0 111.045 169.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.64 HG12 ' HA ' ' A' ' 114' ' ' TYR . 3.2 p -78.01 -48.92 22.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 124.474 1.11 . . . . 0.0 112.43 -158.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.5 m 28.78 121.91 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.038 0 C-N-CA 129.044 2.938 . . . . 0.0 114.789 -138.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -80.86 -7.65 13.34 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 121.789 1.659 . . . . 0.0 115.002 -167.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 4.1 t 28.88 85.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 C-N-CA 130.239 3.416 . . . . 0.0 114.041 173.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . 0.268 9.7 tt -106.95 -23.6 12.29 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 118.01 -1.476 . . . . 0.0 112.507 -121.126 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.35 -6.68 11.25 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.633 1.173 . . . . 0.0 113.997 148.053 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 139.74 11.51 0.72 Allowed Glycine 0 CA--C 1.536 1.364 0 N-CA-C 118.059 1.984 . . . . 0.0 118.059 -169.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.8 155.75 69.06 Favored Pre-proline 0 C--N 1.346 0.417 0 CA-C-N 120.771 2.286 . . . . 0.0 112.999 172.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.04 152.72 49.68 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.985 2.456 . . . . 0.0 113.674 -177.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 29.8 mm -117.74 -53.88 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 123.646 0.778 . . . . 0.0 112.917 -163.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 62.13 151.14 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.975 2.11 . . . . 0.0 115.255 -170.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.45 157.06 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 125.914 1.686 . . . . 0.0 110.799 174.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -147.75 166.06 28.65 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.384 1.474 . . . . 0.0 109.453 155.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -55.64 146.89 19.58 Favored 'General case' 0 CA--C 1.547 0.858 0 O-C-N 121.353 -0.842 . . . . 0.0 111.303 158.195 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.681 ' HB3' HG13 ' A' ' 60' ' ' VAL . 29.4 t -73.39 161.48 30.4 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.669 1.187 . . . . 0.0 113.673 -175.149 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -73.03 -10.88 60.27 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.139 1.376 . . . . 0.0 113.573 167.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 57.7 m-70 -115.46 172.35 7.16 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.441 1.497 . . . . 0.0 112.403 -172.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -122.02 110.04 15.31 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 126.576 1.95 . . . . 0.0 109.728 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 61.88 167.94 0.11 Allowed 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 126.592 1.957 . . . . 0.0 113.924 -166.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 22.7 tp -132.19 97.87 4.25 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 128.617 2.767 . . . . 0.0 112.521 -172.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -99.33 93.27 5.83 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 127.601 2.361 . . . . 0.0 111.156 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 16.7 p -94.57 -18.72 21.14 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 115.908 1.818 . . . . 0.0 115.908 -171.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -126.64 -59.49 1.28 Allowed 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -163.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 49.3 m 49.26 36.3 9.1 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.309 1.443 . . . . 0.0 114.064 -170.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 25.5 p -67.45 155.63 90.51 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 125.584 1.554 . . . . 0.0 112.733 178.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -58.08 161.59 13.11 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.394 2.73 . . . . 0.0 114.123 173.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -135.75 -38.91 0.72 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.904 1.682 . . . . 0.0 111.573 170.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -68.41 167.08 15.4 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.141 1.776 . . . . 0.0 112.453 165.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -73.05 179.15 3.92 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.875 1.27 . . . . 0.0 112.638 169.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 75.2 ttt-85 . . . . . 0 N--CA 1.48 1.042 0 C-N-CA 125.722 1.609 . . . . 0.0 114.013 177.673 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 147' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.196 0 O4'-C1'-N19 110.849 2.649 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 148' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.422 0 O4'-C1'-N19 111.036 2.836 . 0.324 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 149' ' ' ' C' . . . . . 0.427 ' C6 ' ' CD2' ' A' ' 62' ' ' HIS . . . . . . . . 0 O4'--C4' 1.422 -2.59 0 O4'-C1'-N19 111.659 3.459 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 150' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.291 2 O4'-C1'-N19 113.262 5.062 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 151' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.386 0 C4'-C3'-C2' 98.991 -3.709 . 0.01 1g . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 152' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.122 1 O4'-C1'-N19 112.588 4.388 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.559 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -125.52 4.57 7.59 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.658 1.583 . . . . 0.0 114.319 -171.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 56.0 p -61.75 -29.99 70.49 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.686 1.594 . . . . 0.0 114.688 -175.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -77.93 73.73 4.49 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.668 1.587 . . . . 0.0 110.877 175.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 68.1 m -74.76 -7.3 52.94 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.617 ' HB1' ' HB3' ' A' ' 57' ' ' PRO . . . -114.23 -72.32 0.7 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.765 1.226 . . . . 0.0 112.307 -175.438 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.07 68.08 1.13 Allowed Glycine 0 CA--C 1.531 1.042 0 C-N-CA 124.644 1.116 . . . . 0.0 111.932 175.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 36.8 t 45.49 72.15 1.32 Allowed Pre-proline 0 N--CA 1.481 1.101 0 C-N-CA 127.656 2.382 . . . . 0.0 110.933 -170.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.617 ' HB3' ' HB1' ' A' ' 54' ' ' ALA . 0.5 OUTLIER -93.59 -179.79 0.89 Allowed 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 124.624 3.549 . . . . 0.0 114.185 -156.994 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.3 t -145.77 -157.09 0.76 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.19 1.396 . . . . 0.0 111.65 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 44.4 mtp180 -55.11 -9.21 0.37 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 130.121 3.368 . . . . 0.0 119.474 -158.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.479 HG13 ' HB3' ' A' ' 131' ' ' SER 0.409 7.2 p -101.26 132.27 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 CA-C-N 122.404 2.366 . . . . 0.0 113.495 170.702 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 26.0 mt -111.22 153.71 12.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 128.287 2.635 . . . . 0.0 107.696 172.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -124.14 146.99 48.29 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.874 1.27 . . . . 0.0 111.446 178.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.1 mt -126.27 142.76 41.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 127.367 2.267 . . . . 0.0 109.977 -173.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.09 172.55 8.16 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 126.904 2.082 . . . . 0.0 112.41 170.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 67.13 19.51 10.4 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 126.456 1.902 . . . . 0.0 114.529 175.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.2 mp -54.02 154.95 6.92 Favored Pre-proline 0 CA--C 1.556 1.174 0 C-N-CA 122.791 0.437 . . . . 0.0 111.897 171.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -48.75 -58.4 1.78 Allowed 'Trans proline' 0 CA--C 1.536 0.596 1 C-N-CA 125.454 4.102 . . . . 0.0 114.651 175.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 pt -171.6 -53.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 131.372 3.869 . . . . 0.0 108.428 -178.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -147.27 -10.13 0.43 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 126.096 1.758 . . . . 0.0 113.701 -171.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.412 HG22 ' H ' ' A' ' 71' ' ' THR 0.293 5.0 p 40.47 -136.64 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 127.262 2.225 . . . . 0.0 112.251 -177.833 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.412 ' H ' HG22 ' A' ' 70' ' ' VAL . 1.8 t -143.32 133.99 25.12 Favored 'General case' 0 C--O 1.241 0.618 0 O-C-N 120.846 -1.159 . . . . 0.0 109.175 156.123 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.59 -30.21 68.5 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.335 -178.64 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -60.31 -36.59 91.32 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.938 1.256 . . . . 0.0 113.405 174.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -66.23 -52.25 49.63 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 118.153 0.976 . . . . 0.0 110.814 170.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.0 t -63.58 -42.29 95.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -174.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.423 ' CG2' HD22 ' A' ' 88' ' ' LEU . 2.3 pp -72.92 -32.43 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 O-C-N 120.168 -1.583 . . . . 0.0 113.131 175.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 36.2 t -62.38 -27.31 68.99 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 119.038 0.836 . . . . 0.0 110.852 171.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 31.3 mt -86.53 -15.67 39.27 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 173.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -92.43 -19.59 37.85 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.887 1.232 . . . . 0.0 113.599 172.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.5 mt -65.11 -46.08 73.02 Favored Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 116.808 2.151 . . . . 0.0 116.808 -171.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.61 -4.03 0.74 Allowed 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 124.657 3.571 . . . . 0.0 118.496 178.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -104.92 -33.8 8.25 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -165.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -160.99 -78.34 0.03 OUTLIER Glycine 0 C--N 1.331 0.262 0 C-N-CA 125.785 1.659 . . . . 0.0 109.032 176.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -150.96 -13.79 0.22 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 116.678 2.103 . . . . 0.0 116.678 170.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.485 ' H ' ' HE1' ' A' ' 101' ' ' MET . 2.2 m 29.49 171.73 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.246 0 CA-C-O 123.262 1.506 . . . . 0.0 114.829 -127.579 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.3 t -124.27 -26.81 3.89 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 119.16 -2.212 . . . . 0.0 112.435 163.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -162.22 166.28 25.7 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 172.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.423 HD22 ' CG2' ' A' ' 76' ' ' ILE . 1.4 pt? -140.43 166.85 23.58 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.656 1.582 . . . . 0.0 113.411 159.346 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.516 HD13 ' C ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -143.13 151.44 40.7 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 128.073 2.549 . . . . 0.0 108.662 -177.562 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 6.4 mtt -127.45 111.9 14.36 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.258 1.023 . . . . 0.0 111.132 -179.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.469 HD13 HD11 ' A' ' 89' ' ' LEU . 1.9 mm? -73.31 72.4 1.28 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.689 1.196 . . . . 0.0 111.102 175.247 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -57.79 125.36 22.69 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.467 1.107 . . . . 0.0 110.75 175.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 96.58 -8.72 66.41 Favored Glycine 0 CA--C 1.537 1.458 0 C-N-CA 125.242 1.401 . . . . 0.0 115.56 -173.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.94 -9.14 10.13 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 119.343 1.571 . . . . 0.0 113.693 169.125 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.2 m120 59.76 39.67 20.54 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.305 1.842 . . . . 0.0 112.806 -174.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -121.82 172.64 8.02 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.232 1.013 . . . . 0.0 111.325 -179.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -159.75 165.38 32.6 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.654 1.582 . . . . 0.0 111.336 178.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.432 ' CD2' HG21 ' A' ' 60' ' ' VAL . 4.0 m-30 -115.44 150.39 36.52 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 126.498 1.919 . . . . 0.0 107.638 166.273 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 16.2 tt -134.92 98.93 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 125.046 1.339 . . . . 0.0 108.659 167.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -85.49 131.67 34.33 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 127.495 2.318 . . . . 0.0 110.974 176.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.485 ' HE1' ' H ' ' A' ' 85' ' ' VAL 0.283 11.6 tpp -120.27 155.81 32.5 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 -170.989 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.72 -22.0 64.36 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -170.423 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.91 147.64 37.4 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.168 0.987 . . . . 0.0 110.96 -175.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -66.04 -38.53 88.63 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.047 0.539 . . . . 0.0 111.843 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -71.9 -40.71 68.67 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 178.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -54.67 -50.52 68.0 Favored 'General case' 0 C--O 1.219 -0.545 0 C-N-CA 122.997 0.519 . . . . 0.0 110.607 170.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.59 -37.88 73.95 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -178.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -55.92 -47.87 76.72 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.45 1.023 . . . . 0.0 110.875 169.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -66.39 -32.04 73.18 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-O 118.345 -0.836 . . . . 0.0 111.649 173.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 13.3 ttp -70.41 -45.79 65.22 Favored 'General case' 0 C--N 1.345 0.388 0 C-N-CA 125.069 1.348 . . . . 0.0 110.588 -176.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -67.79 -41.11 84.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 124.183 0.993 . . . . 0.0 111.745 177.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -68.52 -44.92 73.59 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.299 0.64 . . . . 0.0 110.564 178.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -47.14 -45.23 22.4 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.375 1.47 . . . . 0.0 111.98 166.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.597 ' HA ' HG12 ' A' ' 117' ' ' VAL . 12.6 m-85 -82.23 -16.66 48.81 Favored 'General case' 0 N--CA 1.456 -0.128 0 O-C-N 121.054 -1.029 . . . . 0.0 112.64 -176.529 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 92.8 m -80.57 -14.63 58.04 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.364 1.065 . . . . 0.0 110.653 170.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.33 -54.53 3.02 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 128.809 2.843 . . . . 0.0 113.229 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.597 HG12 ' HA ' ' A' ' 114' ' ' TYR . 10.9 p -71.46 -35.82 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 127.171 2.189 . . . . 0.0 114.274 -156.381 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.455 ' HA ' ' HD3' ' A' ' 119' ' ' PRO . 0.2 OUTLIER -2.51 115.91 0.01 OUTLIER Pre-proline 0 N--CA 1.486 1.347 0 C-N-CA 127.754 2.422 . . . . 0.0 116.875 -125.876 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 118' ' ' THR . 6.1 Cg_exo -76.16 -18.88 15.98 Favored 'Trans proline' 0 CA--C 1.547 1.166 0 C-N-CA 123.506 2.804 . . . . 0.0 113.095 -167.406 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 6.4 t 60.9 104.03 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 130.072 3.349 . . . . 0.0 113.057 -178.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.6 tt -65.5 -66.93 0.48 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.583 1.153 . . . . 0.0 111.714 -158.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.07 66.56 1.24 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.248 1.419 . . . . 0.0 110.054 168.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 86.04 12.37 71.2 Favored Glycine 0 CA--C 1.54 1.654 0 C-N-CA 124.628 1.109 . . . . 0.0 114.985 -178.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -136.18 141.47 36.31 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 126.564 1.945 . . . . 0.0 109.399 177.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -56.68 166.44 3.72 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 123.579 2.853 . . . . 0.0 112.65 171.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.45 ' H ' ' CG2' ' A' ' 118' ' ' THR . 0.8 OUTLIER -125.23 146.38 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.388 1.075 . . . . 0.0 110.124 -174.957 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -128.94 95.17 4.01 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.28 -1.327 . . . . 0.0 109.039 -153.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.12 151.49 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 124.682 1.193 . . . . 0.0 112.953 -173.225 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -156.66 170.02 23.37 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.38 1.072 . . . . 0.0 109.976 147.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -52.34 149.28 5.71 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 120.853 -1.154 . . . . 0.0 112.525 170.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.479 ' HB3' HG13 ' A' ' 60' ' ' VAL . 30.3 t -70.64 158.53 36.03 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.182 0.993 . . . . 0.0 112.381 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -63.34 -15.27 56.89 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.826 1.25 . . . . 0.0 112.859 163.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 28.2 m-70 -117.61 -179.83 3.85 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 127.354 2.262 . . . . 0.0 111.206 -175.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -130.81 11.87 5.22 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.73 1.612 . . . . 0.0 113.398 -173.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -167.76 150.95 5.98 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.895 2.078 . . . . 0.0 110.571 -166.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 55.9 tp -140.07 -62.47 0.51 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.019 1.328 . . . . 0.0 113.207 177.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.4 ptmm? 28.37 69.73 0.07 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 128.969 2.907 . . . . 0.0 116.455 178.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 41.7 p -72.38 -5.58 37.44 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -63.15 -16.97 61.8 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.375 1.87 . . . . 0.0 115.795 -172.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 19.7 m -73.72 35.94 0.09 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 127.071 2.148 . . . . 0.0 115.53 -175.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 77.8 p -74.21 162.99 71.43 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 125.936 1.695 . . . . 0.0 113.52 176.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.89 164.15 10.33 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 124.09 3.193 . . . . 0.0 114.968 174.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -95.92 153.29 17.84 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.931 1.292 . . . . 0.0 111.988 173.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -74.26 -55.57 5.89 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.438 1.095 . . . . 0.0 112.654 177.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -77.51 -52.68 8.66 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.034 1.334 . . . . 0.0 112.908 -173.168 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 22.8 tpp85 . . . . . 0 N--CA 1.472 0.643 0 C-N-CA 125.017 1.327 . . . . 0.0 110.925 179.469 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 147' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.244 0 C5'-C4'-C3' 112.154 -2.231 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 148' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.782 0 O4'-C4'-C3' 109.671 2.979 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 149' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.526 0 N19-C1'-C2' 107.683 -3.573 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 150' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.213 2 O4'-C1'-N19 113.799 5.599 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 151' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.537 2.073 1 O4'-C1'-N19 112.655 4.455 . 0.132 &a . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 152' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.201 1 O4'-C1'-N19 113.715 5.515 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.535 0 N-CA-C 111.955 -0.458 . . . . 0.0 111.955 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -133.42 54.81 1.93 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.432 1.493 . . . . 0.0 110.955 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.7 m -61.18 -7.65 2.91 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 127.015 2.126 . . . . 0.0 116.431 -168.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -58.66 -17.62 23.97 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 126.473 1.909 . . . . 0.0 114.661 173.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.0 t -138.81 152.7 48.1 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.93 1.692 . . . . 0.0 111.33 168.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.404 ' HB1' ' HB3' ' A' ' 57' ' ' PRO . . . -80.9 -11.13 59.63 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.752 1.221 . . . . 0.0 113.518 171.59 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.61 43.42 8.44 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.324 0.964 . . . . 0.0 113.55 176.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.4 t 51.75 84.8 0.2 Allowed Pre-proline 0 N--CA 1.478 0.927 0 C-N-CA 127.949 2.5 . . . . 0.0 110.825 -171.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.404 ' HB3' ' HB1' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -106.96 9.28 0.16 Allowed 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 123.481 2.787 . . . . 0.0 116.108 -149.808 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.2 m -4.66 107.49 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 130.443 3.497 . . . . 0.0 117.887 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 40.6 mtm-85 81.5 -6.53 1.52 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 128.361 2.665 . . . . 0.0 117.484 152.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.662 HG13 ' HB3' ' A' ' 131' ' ' SER . 2.5 p -118.22 136.57 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 CA-C-N 120.297 1.408 . . . . 0.0 113.125 163.065 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 10.9 mt -110.86 147.61 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 126.987 2.115 . . . . 0.0 108.795 168.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -110.7 116.59 31.57 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.295 1.438 . . . . 0.0 110.601 175.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 8.9 mt -89.53 134.3 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 126.505 1.922 . . . . 0.0 108.416 175.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -123.38 168.85 11.98 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 126.425 1.89 . . . . 0.0 112.248 171.019 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.5 mmtt 46.38 39.05 5.92 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 127.664 2.386 . . . . 0.0 114.418 -172.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.2 mt -60.55 174.22 0.54 Allowed Pre-proline 0 CA--C 1.556 1.207 0 C-N-CA 125.466 1.506 . . . . 0.0 111.043 158.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.56 -169.88 0.01 OUTLIER 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 124.55 3.5 . . . . 0.0 114.743 151.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 22.4 pt -58.81 -52.5 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.3 1.44 . . . . 0.0 112.644 -175.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -149.07 8.69 0.74 Allowed 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 127.103 2.161 . . . . 0.0 112.889 172.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.309 10.4 p 30.88 -125.46 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 C-N-CA 128.38 2.672 . . . . 0.0 113.294 -169.436 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.8 t -153.8 143.1 21.49 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 120.248 1.385 . . . . 0.0 110.237 167.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -55.86 -43.21 76.88 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.03 0.932 . . . . 0.0 112.329 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.03 -42.79 61.46 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 124.074 0.845 . . . . 0.0 112.907 178.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -64.94 -53.42 46.62 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.726 0.81 . . . . 0.0 111.894 172.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 83.5 t -59.5 -48.81 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 123.506 0.722 . . . . 0.0 112.442 -175.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.7 pp -70.01 -35.34 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 O-C-N 120.654 -1.279 . . . . 0.0 112.403 178.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.0 m -69.52 -20.85 63.69 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 119.714 1.143 . . . . 0.0 111.82 175.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.2 mt -79.48 -24.5 42.29 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 170.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -94.37 -21.6 26.68 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-N 119.061 0.846 . . . . 0.0 115.161 174.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.5 mt -59.95 -43.02 93.56 Favored Pre-proline 0 CA--C 1.538 0.514 0 N-CA-C 117.113 2.264 . . . . 0.0 117.113 -169.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.54 -6.18 1.44 Allowed 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.88 3.053 . . . . 0.0 116.981 174.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -104.03 -36.08 7.86 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 -167.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -153.03 -108.19 0.35 Allowed Glycine 0 C--N 1.336 0.54 0 CA-C-O 122.763 1.202 . . . . 0.0 111.846 172.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.424 ' HB3' ' CG ' ' A' ' 102' ' ' ASN . 7.0 tppt? -149.53 122.22 8.63 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 130.42 3.488 . . . . 0.0 104.533 175.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.42 HG22 ' HE2' ' A' ' 101' ' ' MET 0.288 21.6 t -129.06 84.71 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 CA-C-O 122.954 1.359 . . . . 0.0 109.213 -160.705 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 41.0 p -82.66 -17.21 45.36 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 127.524 2.33 . . . . 0.0 113.008 -162.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -141.51 160.16 40.73 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 174.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -146.21 175.73 10.28 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.575 1.95 . . . . 0.0 110.773 158.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.463 HD23 ' C ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -151.48 153.43 34.61 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 125.728 1.611 . . . . 0.0 109.645 177.654 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 4.9 mtp -134.73 95.67 3.39 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.535 0.734 . . . . 0.0 111.628 -167.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.0 91.3 2.5 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.111 1.364 . . . . 0.0 110.947 173.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -63.85 -17.31 63.02 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -65.18 -51.5 49.53 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 125.394 1.473 . . . . 0.0 115.155 -174.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 29.0 mtmt -126.11 22.92 7.19 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 125.73 1.612 . . . . 0.0 112.852 -172.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 20.9 m120 62.45 49.54 4.04 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.661 1.984 . . . . 0.0 113.621 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . 0.281 0.0 OUTLIER -128.78 172.51 11.21 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 177.157 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -157.54 163.24 38.59 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 127.095 2.158 . . . . 0.0 109.614 -175.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.528 ' CD2' HG21 ' A' ' 60' ' ' VAL . 5.2 m-30 -107.84 154.59 21.33 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.98 1.312 . . . . 0.0 107.887 162.089 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.0 tt -134.51 123.82 43.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 124.404 1.082 . . . . 0.0 108.636 164.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -121.19 122.36 39.81 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.539 1.936 . . . . 0.0 111.769 -165.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.42 ' HE2' HG22 ' A' ' 85' ' ' VAL . 0.6 OUTLIER -137.98 150.29 46.87 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 113.041 -1.891 . . . . 0.0 113.249 -164.721 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.424 ' CG ' ' HB3' ' A' ' 84' ' ' LYS . 2.7 p-10 -68.98 -18.87 64.12 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 113.038 -1.892 . . . . 0.0 114.385 -155.587 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.405 HG23 ' CG ' ' A' ' 102' ' ' ASN . 30.2 p -138.54 141.47 39.3 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 123.32 1.533 . . . . 0.0 112.08 -175.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -57.54 -37.31 72.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 113.769 -1.559 . . . . 0.0 110.75 176.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -72.59 -41.39 65.69 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.05 -52.56 62.79 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 119.231 0.923 . . . . 0.0 110.02 170.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.63 -36.87 79.21 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -178.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -55.77 -50.83 69.36 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 118.83 0.741 . . . . 0.0 110.506 170.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -63.66 -35.33 80.19 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-O 118.19 -0.909 . . . . 0.0 111.178 174.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 8.5 ttp -66.93 -51.14 58.88 Favored 'General case' 0 C--N 1.343 0.291 0 CA-C-N 119.747 1.158 . . . . 0.0 110.802 -176.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.41 -39.58 85.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 124.673 1.189 . . . . 0.0 111.761 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -70.22 -45.15 67.16 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.472 0.709 . . . . 0.0 110.942 177.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -50.62 -33.88 23.94 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.678 1.191 . . . . 0.0 112.556 167.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -92.12 -11.74 34.85 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 119.929 -1.732 . . . . 0.0 113.619 -177.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.2 t -86.13 -14.39 44.32 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.964 0.887 . . . . 0.0 111.629 165.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.29 -58.76 3.1 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 128.448 2.699 . . . . 0.0 111.449 167.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -92.27 -49.33 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 123.709 0.804 . . . . 0.0 112.736 -155.307 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.6 m 45.68 125.9 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.04 0 C-N-CA 130.493 3.517 . . . . 0.0 113.701 -152.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -77.02 -13.88 17.16 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 121.775 1.65 . . . . 0.0 115.76 -171.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.1 t 30.11 92.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 130.032 3.333 . . . . 0.0 114.36 175.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.471 HD23 ' C ' ' A' ' 121' ' ' LEU . 1.4 tt -102.92 -57.31 2.07 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 113.489 -1.687 . . . . 0.0 109.419 -131.501 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.91 6.71 43.48 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.992 1.717 . . . . 0.0 113.61 165.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 103.23 20.54 11.02 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 126.061 1.791 . . . . 0.0 115.127 -178.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.419 ' HA ' ' HD3' ' A' ' 125' ' ' PRO . 10.8 tp60 -146.71 142.06 16.83 Favored Pre-proline 0 CA--C 1.538 0.489 0 CA-C-O 116.706 -1.616 . . . . 0.0 110.245 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 124' ' ' GLN . 78.5 Cg_exo -52.18 147.35 27.94 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 124.636 3.557 . . . . 0.0 116.115 -167.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.423 HD11 ' H ' ' A' ' 121' ' ' LEU . 3.2 mm -117.93 153.01 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 126.653 1.981 . . . . 0.0 108.629 -177.306 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 20.0 m-30 -122.54 142.37 50.67 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.979 0.912 . . . . 0.0 110.209 -175.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -131.88 147.88 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.019 1.327 . . . . 0.0 111.628 172.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -147.52 162.54 38.87 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.836 0.854 . . . . 0.0 109.977 145.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -53.35 147.68 10.06 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.47 0.708 . . . . 0.0 112.171 168.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.662 ' HB3' HG13 ' A' ' 60' ' ' VAL . 29.2 t -74.68 133.89 42.04 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 121.486 -0.758 . . . . 0.0 112.215 178.088 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -67.95 -19.87 65.0 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 176.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -69.59 -52.28 27.53 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -177.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 16.4 mtmm 79.15 152.65 0.13 Allowed 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 128.739 2.816 . . . . 0.0 111.461 -149.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 36.29 95.59 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 129.389 3.076 . . . . 0.0 117.258 164.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 27.6 tp -64.58 110.32 2.29 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.03 1.732 . . . . 0.0 111.596 172.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -97.74 141.7 30.42 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.239 1.416 . . . . 0.0 110.537 172.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 46.2 p -137.11 154.47 50.28 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.457 1.503 . . . . 0.0 111.641 -173.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -75.91 -65.26 0.93 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.171 0.988 . . . . 0.0 113.278 -170.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 37.3 p -74.99 159.92 31.19 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.6 1.56 . . . . 0.0 113.705 -177.051 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 67.9 p -78.67 161.07 70.67 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 124.805 1.242 . . . . 0.0 112.104 169.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -57.1 -47.02 24.74 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 123.472 2.782 . . . . 0.0 113.689 174.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -158.68 145.96 17.67 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.797 1.639 . . . . 0.0 111.197 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -81.0 94.55 6.58 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.27 1.028 . . . . 0.0 110.038 166.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -64.78 165.15 10.97 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -178.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 . . . . . 0 N--CA 1.475 0.788 0 C-N-CA 125.921 1.688 . . . . 0.0 111.974 174.143 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 147' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.338 0 O4'-C1'-N19 110.973 2.773 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 148' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.462 0 O4'-C1'-N19 111.324 3.124 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 149' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.142 0 N19-C1'-C2' 107.688 -3.57 . 0.165 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 150' ' ' ' U' . . . . . 0.402 " C1'" HD11 ' A' ' 89' ' ' LEU . . . . . . . . 0 O4'--C4' 1.415 -3.203 1 O4'-C1'-N19 112.941 4.741 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 151' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.536 2.032 0 C5'-C4'-C3' 109.553 -3.964 . 0.204 1t . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 152' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.534 1.883 1 O4'-C1'-N19 113.361 5.161 . 0.742 2u . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.549 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -69.95 166.92 18.57 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.656 1.182 . . . . 0.0 113.735 175.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.8 m -142.19 155.54 45.29 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.124 1.77 . . . . 0.0 111.17 174.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -138.07 -62.94 0.57 Allowed 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.81 1.244 . . . . 0.0 113.795 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.8 m -65.36 -14.75 61.55 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 116.772 2.138 . . . . 0.0 116.772 -164.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.594 ' HB1' ' HB3' ' A' ' 57' ' ' PRO . . . -134.77 -63.64 0.69 Allowed 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 119.592 1.087 . . . . 0.0 112.791 -171.006 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 93.01 63.16 1.1 Allowed Glycine 0 N--CA 1.472 1.066 0 C-N-CA 124.476 1.036 . . . . 0.0 112.777 174.028 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 42.7 t 46.19 72.19 1.33 Allowed Pre-proline 0 N--CA 1.479 0.996 0 C-N-CA 127.598 2.359 . . . . 0.0 110.632 -170.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.594 ' HB3' ' HB1' ' A' ' 54' ' ' ALA . 2.7 Cg_endo -91.41 170.7 3.08 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 124.763 3.642 . . . . 0.0 113.979 -155.539 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 25.1 m -140.35 -84.83 0.22 Allowed 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -164.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 25.1 mtp180 -125.86 -16.4 5.66 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 118.05 2.611 . . . . 0.0 118.05 -159.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.748 HG13 ' HB3' ' A' ' 131' ' ' SER 0.328 7.1 p -105.59 136.58 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 CA-C-N 121.138 1.79 . . . . 0.0 112.002 166.13 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.4 mt -113.41 155.33 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 128.773 2.829 . . . . 0.0 108.06 171.054 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -122.33 135.44 54.72 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.358 1.463 . . . . 0.0 110.377 177.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.4 mt -120.85 117.15 52.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 126.736 2.014 . . . . 0.0 109.291 -174.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.0 ptt180 -98.26 177.25 5.44 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 126.083 1.753 . . . . 0.0 112.917 177.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 59.63 25.9 14.87 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 127.192 2.197 . . . . 0.0 114.623 175.272 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 26.2 mt -64.45 150.94 92.53 Favored Pre-proline 0 CA--C 1.56 1.329 0 C-N-CA 122.927 0.491 . . . . 0.0 111.244 176.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -45.91 -66.52 0.15 Allowed 'Trans proline' 0 C--N 1.352 0.751 1 C-N-CA 125.313 4.009 . . . . 0.0 115.124 -178.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 12.4 pt -159.73 -41.87 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 130.177 3.391 . . . . 0.0 109.968 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -154.21 -11.48 0.14 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.949 1.3 . . . . 0.0 113.072 -169.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.512 HG22 ' H ' ' A' ' 71' ' ' THR 0.295 14.4 p 31.29 -121.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 127.099 2.16 . . . . 0.0 111.296 -161.225 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.512 ' H ' HG22 ' A' ' 70' ' ' VAL . 1.1 t -151.29 133.94 15.6 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 126.395 1.878 . . . . 0.0 106.439 155.007 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -69.28 -20.99 63.91 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.059 -1.026 . . . . 0.0 113.041 -173.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -58.6 -33.6 72.82 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 125.182 1.372 . . . . 0.0 113.665 164.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -75.58 -40.87 55.98 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 121.232 -1.158 . . . . 0.0 111.798 170.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.1 t -57.11 -46.15 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -84.73 -24.56 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 O-C-N 120.534 -1.354 . . . . 0.0 114.52 175.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.0 t -60.79 -31.97 71.33 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 120.187 1.358 . . . . 0.0 110.764 166.044 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 15.6 mt -74.22 -31.02 62.45 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 171.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -85.72 -19.25 58.45 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-N 119.438 1.017 . . . . 0.0 115.141 178.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.0 mt -70.27 -33.14 3.12 Favored Pre-proline 0 CA--C 1.541 0.605 0 N-CA-C 118.016 2.599 . . . . 0.0 118.016 -165.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -60.25 1.15 0.52 Allowed 'Trans proline' 0 C--N 1.35 0.605 0 C-N-CA 123.646 2.898 . . . . 0.0 116.809 170.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.42 ' CG ' ' HG3' ' A' ' 110' ' ' MET . 33.8 m-85 -116.02 -44.17 2.93 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -167.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -148.14 -108.7 0.51 Allowed Glycine 0 C--N 1.338 0.683 0 C-N-CA 123.873 0.749 . . . . 0.0 111.855 174.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 37.0 tptt -144.49 -12.98 0.59 Allowed 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 178.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.443 HG22 ' CE ' ' A' ' 101' ' ' MET 0.355 1.4 t 45.63 79.71 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 128.577 2.751 . . . . 0.0 114.553 164.914 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.1 m -66.01 -43.34 87.99 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 129.798 3.239 . . . . 0.0 111.811 -168.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -138.32 170.57 15.8 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 122.993 1.378 . . . . 0.0 113.362 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -146.63 173.27 12.49 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.153 2.181 . . . . 0.0 110.827 159.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.464 HD23 ' C ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -150.59 156.51 41.52 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.45 1.9 . . . . 0.0 109.495 176.003 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 8.1 mtt -129.32 110.56 12.03 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.605 1.162 . . . . 0.0 113.2 -178.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -77.29 97.87 4.99 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.407 1.883 . . . . 0.0 112.396 178.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -75.36 64.37 1.53 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.736 1.614 . . . . 0.0 111.738 167.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.52 -70.14 0.02 OUTLIER Glycine 0 N--CA 1.473 1.125 0 C-N-CA 124.863 1.22 . . . . 0.0 113.313 -177.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -114.5 26.6 10.09 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 127.06 2.144 . . . . 0.0 110.659 176.043 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 51.6 67.5 0.95 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.795 2.038 . . . . 0.0 113.043 -173.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.64 -178.47 4.38 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 177.047 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -155.17 164.22 39.13 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.72 2.408 . . . . 0.0 110.118 178.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.472 ' CD2' HG21 ' A' ' 60' ' ' VAL . 5.2 m-30 -107.78 150.23 27.24 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.423 1.489 . . . . 0.0 108.146 161.057 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 19.2 tt -132.87 119.75 38.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.938 1.295 . . . . 0.0 108.356 165.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -121.47 133.55 55.05 Favored 'General case' 0 CA--C 1.513 -0.454 0 C-N-CA 125.947 1.699 . . . . 0.0 110.84 -165.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.443 ' CE ' HG22 ' A' ' 85' ' ' VAL 0.287 1.3 ptm -137.66 159.41 42.06 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 117.188 2.292 . . . . 0.0 117.188 -169.935 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.4 -18.07 64.37 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 127.035 2.134 . . . . 0.0 112.726 -165.458 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.11 143.59 34.4 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-O 123.504 1.621 . . . . 0.0 111.86 178.533 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -66.71 -32.93 74.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 113.492 -1.685 . . . . 0.0 110.762 177.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -72.56 -37.82 68.13 Favored 'General case' 0 N--CA 1.462 0.13 0 C-N-CA 123.763 0.825 . . . . 0.0 113.024 177.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -57.12 -59.25 5.37 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 119.033 0.833 . . . . 0.0 109.62 169.044 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.45 -39.41 87.47 Favored 'General case' 0 C--O 1.224 -0.26 0 N-CA-C 114.752 1.389 . . . . 0.0 114.752 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -56.01 -51.05 69.14 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.475 -0.766 . . . . 0.0 111.047 172.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -63.65 -32.3 73.73 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.536 -0.727 . . . . 0.0 111.231 175.032 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.42 ' HG3' ' CG ' ' A' ' 82' ' ' PHE . 5.1 ttp -71.01 -49.05 49.39 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.083 1.353 . . . . 0.0 111.13 -176.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -64.97 -40.17 88.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 124.43 1.092 . . . . 0.0 111.23 178.013 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -67.58 -46.3 73.06 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.798 0.839 . . . . 0.0 110.196 177.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -49.37 -41.72 39.94 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.18 1.392 . . . . 0.0 112.279 168.031 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.506 ' HA ' HG12 ' A' ' 117' ' ' VAL . 25.4 m-85 -88.85 -11.46 44.67 Favored 'General case' 0 C--O 1.232 0.166 0 O-C-N 120.405 -1.435 . . . . 0.0 112.996 -176.39 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 70.6 m -81.04 -17.82 48.88 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.095 0.958 . . . . 0.0 110.195 167.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.62 -57.89 2.71 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 129.189 2.995 . . . . 0.0 113.294 176.292 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.506 HG12 ' HA ' ' A' ' 114' ' ' TYR . 5.9 p -79.44 -37.65 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -149.615 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.425 ' HA ' ' HD3' ' A' ' 119' ' ' PRO . 0.2 OUTLIER 12.09 112.71 0.0 OUTLIER Pre-proline 0 N--CA 1.484 1.268 0 C-N-CA 130.095 3.358 . . . . 0.0 116.396 -137.86 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.441 ' HD2' HD12 ' A' ' 126' ' ' ILE . 5.0 Cg_exo -79.38 -20.37 9.7 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.979 3.119 . . . . 0.0 113.684 -168.37 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 6.9 t 64.29 99.98 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 128.742 2.817 . . . . 0.0 112.659 176.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 6.2 tt -70.61 -75.3 0.12 Allowed 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -155.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -92.08 -44.36 8.88 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.908 1.283 . . . . 0.0 109.512 175.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -177.35 18.61 0.04 OUTLIER Glycine 0 CA--C 1.538 1.472 0 C-N-CA 126.192 1.853 . . . . 0.0 112.948 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -144.39 156.8 57.06 Favored Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 126.67 1.988 . . . . 0.0 110.766 -170.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -59.58 164.16 11.78 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 122.502 2.135 . . . . 0.0 113.815 -179.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.441 HD12 ' HD2' ' A' ' 119' ' ' PRO . 0.4 OUTLIER -127.47 149.24 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.125 1.37 . . . . 0.0 110.018 -178.805 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -130.1 95.73 4.0 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.007 -153.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -108.28 144.64 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 124.134 0.974 . . . . 0.0 112.844 -177.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -145.17 159.01 43.66 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.632 1.973 . . . . 0.0 109.085 154.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -54.6 155.32 4.18 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 121.262 -0.899 . . . . 0.0 111.733 165.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.748 ' HB3' HG13 ' A' ' 60' ' ' VAL . 27.1 t -79.25 148.96 32.0 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 177.622 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -61.08 -31.07 70.74 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.404 1.481 . . . . 0.0 112.945 167.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 57.3 m-70 -89.33 -18.83 26.14 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.767 1.227 . . . . 0.0 113.407 -176.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . 0.28 62.6 pttt 48.94 9.07 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 130.181 3.392 . . . . 0.0 118.205 177.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.598 ' N ' HG12 ' A' ' 60' ' ' VAL . 59.9 tt0 -164.98 124.94 1.89 Allowed 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 128.973 2.909 . . . . 0.0 110.463 172.029 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 22.7 tp -106.86 106.27 16.71 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.682 1.993 . . . . 0.0 110.857 -178.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt -131.17 84.26 2.17 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.791 1.636 . . . . 0.0 109.269 173.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 23.9 p -54.28 -36.84 64.08 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 126.664 1.986 . . . . 0.0 115.987 -159.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -128.94 5.74 5.43 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.537 1.535 . . . . 0.0 114.215 -173.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.3 t -69.12 154.87 41.34 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -168.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 68.6 m -69.13 168.57 15.06 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 127.726 2.41 . . . . 0.0 113.557 177.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -65.48 -177.2 0.64 Allowed 'Trans proline' 0 CA--C 1.547 1.154 0 C-N-CA 123.094 2.529 . . . . 0.0 111.801 158.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -65.59 74.1 0.06 Allowed 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 126.524 1.929 . . . . 0.0 113.841 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -65.87 166.88 10.43 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.09 1.756 . . . . 0.0 112.79 174.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -141.82 -39.63 0.37 Allowed 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 -173.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? . . . . . 0 N--CA 1.484 1.253 0 C-N-CA 126.217 1.807 . . . . 0.0 113.441 -177.685 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 147' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.263 0 O5'-C5'-C4' 113.62 2.443 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 148' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.492 1 O4'-C1'-N19 112.364 4.164 . 0.014 4p . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 149' ' ' ' C' . . . . . 0.42 ' N3 ' ' HA ' ' A' ' 131' ' ' SER . . . . . . . . 0 C5'--C4' 1.541 2.404 0 N19-C1'-C2' 107.756 -3.527 . 0.087 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 150' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.85 1 O4'-C1'-N19 113.876 5.676 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 151' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.148 1 O4'-C1'-N19 113.362 5.162 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 152' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.543 2.515 1 O4'-C1'-N19 113.89 5.69 . 0.532 4s . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.447 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -62.1 139.61 58.44 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.431 1.092 . . . . 0.0 112.581 176.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 79.2 p -142.41 -8.76 0.86 Allowed 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 -173.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.1 ptp85 -66.72 161.48 23.42 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.599 1.16 . . . . 0.0 113.813 -177.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 98.4 p -160.63 154.66 22.89 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.198 1.799 . . . . 0.0 110.85 159.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.531 ' HB1' ' HB3' ' A' ' 57' ' ' PRO . . . -158.09 -170.51 3.17 Favored 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 128.481 2.713 . . . . 0.0 107.629 167.02 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -137.1 67.08 0.54 Allowed Glycine 0 N--CA 1.471 1.015 0 O-C-N 120.322 -1.486 . . . . 0.0 111.639 -176.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . 0.276 13.6 p 35.15 69.48 1.08 Allowed Pre-proline 0 N--CA 1.484 1.234 0 C-N-CA 127.343 2.257 . . . . 0.0 111.294 -163.102 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.531 ' HB3' ' HB1' ' A' ' 54' ' ' ALA . 7.0 Cg_endo -91.52 164.1 3.53 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 123.318 2.679 . . . . 0.0 113.887 -138.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 58.2 m -134.88 -82.33 0.43 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 -165.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 25.2 mtp180 -124.19 -11.48 7.49 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 116.432 2.012 . . . . 0.0 116.432 -160.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.703 HG13 ' HB3' ' A' ' 131' ' ' SER 0.293 3.6 p -110.89 137.57 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 119.815 1.188 . . . . 0.0 112.162 172.981 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.0 mt -119.55 142.03 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 127.923 2.489 . . . . 0.0 108.369 175.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -112.51 148.39 34.56 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.937 1.695 . . . . 0.0 111.222 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 mp -133.12 138.98 50.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 126.227 1.811 . . . . 0.0 109.854 -176.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.67 176.61 5.11 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 125.6 1.56 . . . . 0.0 111.87 169.025 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.475 ' HG3' ' CD1' ' A' ' 127' ' ' TYR . 21.9 mmmt 73.98 8.64 4.76 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 127.015 2.126 . . . . 0.0 115.003 165.195 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.638 HD22 HG11 ' A' ' 70' ' ' VAL . 0.6 OUTLIER -62.74 159.82 41.16 Favored Pre-proline 0 CA--C 1.546 0.804 0 CA-C-N 119.181 0.9 . . . . 0.0 112.937 -176.925 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -51.72 173.75 0.09 OUTLIER 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 124.385 3.39 . . . . 0.0 115.087 163.188 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 36.4 pt -60.95 -34.55 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 127.065 2.146 . . . . 0.0 113.221 -167.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -140.01 -10.59 1.14 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.822 1.649 . . . . 0.0 113.485 166.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.638 HG11 HD22 ' A' ' 66' ' ' LEU 0.298 3.8 p 38.98 -139.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 127.599 2.359 . . . . 0.0 111.87 -169.151 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.449 ' H ' HG22 ' A' ' 70' ' ' VAL . 1.7 t -147.97 139.54 23.74 Favored 'General case' 0 C--O 1.239 0.519 0 O-C-N 120.803 -1.185 . . . . 0.0 109.931 154.022 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -55.93 -32.63 63.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.621 173.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -61.28 -32.53 81.1 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 125.05 1.31 . . . . 0.0 112.871 175.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -67.19 -55.41 14.21 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 118.725 1.263 . . . . 0.0 110.648 167.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.2 t -57.66 -44.83 86.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -175.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.3 pp -81.33 -29.16 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 O-C-N 120.313 -1.492 . . . . 0.0 113.871 -179.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 18.1 t -63.75 -29.36 70.58 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 119.61 1.096 . . . . 0.0 110.55 168.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.0 mt -78.72 -20.69 49.45 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 172.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -101.45 -16.55 24.41 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-N 119.859 1.209 . . . . 0.0 116.116 176.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.9 mt -61.55 -52.57 68.76 Favored Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 117.171 2.286 . . . . 0.0 117.171 -172.277 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -75.2 39.52 0.61 Allowed 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 124.125 3.217 . . . . 0.0 113.974 -178.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -127.84 -36.65 1.99 Allowed 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 126.87 2.068 . . . . 0.0 111.902 177.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -152.76 -108.84 0.38 Allowed Glycine 0 CA--C 1.525 0.717 0 CA-C-O 122.774 1.208 . . . . 0.0 111.989 168.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 15.6 tptm -149.23 132.01 16.01 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 131.625 3.97 . . . . 0.0 103.726 173.083 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.58 HG22 ' HE2' ' A' ' 101' ' ' MET 0.313 14.3 t -128.1 92.56 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-N 120.666 1.576 . . . . 0.0 110.773 -163.666 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.5 t -80.82 -32.75 35.09 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 126.727 2.011 . . . . 0.0 112.825 -161.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -130.74 160.53 34.06 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 174.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -147.19 167.83 23.21 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 126.963 2.105 . . . . 0.0 110.102 166.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.52 HD13 ' C ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -149.76 152.09 34.67 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 125.288 1.435 . . . . 0.0 108.969 173.709 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 5.8 mtt -126.93 110.4 12.97 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.406 1.483 . . . . 0.0 110.267 177.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.488 HD22 ' CD1' ' A' ' 89' ' ' LEU . 2.8 mm? -72.1 79.65 0.95 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.62 1.168 . . . . 0.0 110.178 178.357 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -44.69 -47.97 10.63 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 127.549 2.339 . . . . 0.0 114.445 -168.159 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -79.79 -12.16 83.84 Favored Glycine 0 CA--C 1.535 1.317 0 N-CA-C 116.31 1.284 . . . . 0.0 116.31 -174.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -126.66 3.04 6.79 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 -173.633 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.0 m120 58.94 36.1 24.39 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.187 1.395 . . . . 0.0 113.918 -178.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -111.2 176.13 5.15 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.519 0.727 . . . . 0.0 111.095 175.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -158.03 167.36 30.11 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.708 1.603 . . . . 0.0 111.928 176.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.451 ' CD2' HG21 ' A' ' 60' ' ' VAL . 4.8 m-30 -118.72 152.62 35.81 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.966 2.106 . . . . 0.0 108.118 163.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 14.4 tt -135.41 127.19 46.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 124.778 1.231 . . . . 0.0 108.669 163.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -130.98 121.1 24.49 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.252 1.421 . . . . 0.0 112.929 -163.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.58 ' HE2' HG22 ' A' ' 85' ' ' VAL . 1.0 OUTLIER -129.22 162.62 27.43 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.12 -1.4 . . . . 0.0 113.696 -159.479 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.35 -12.57 60.09 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -158.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -143.18 142.47 31.45 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.177 1.391 . . . . 0.0 110.879 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -61.46 -33.41 73.7 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.742 175.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -75.74 -36.04 60.03 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 123.641 0.776 . . . . 0.0 112.987 178.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -56.82 -52.08 66.45 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-N 118.973 0.806 . . . . 0.0 110.642 168.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.94 -39.16 79.73 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -54.93 -48.41 73.16 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 118.754 0.706 . . . . 0.0 111.255 170.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -64.77 -32.5 74.22 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 121.242 -0.911 . . . . 0.0 111.46 175.006 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 7.5 ttp -65.86 -57.63 7.47 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.467 1.107 . . . . 0.0 109.686 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -57.97 -41.65 80.72 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.372 0 C-N-CA 124.95 1.3 . . . . 0.0 111.607 177.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -65.43 -42.9 91.94 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 118.897 0.771 . . . . 0.0 111.924 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -53.92 -37.43 63.83 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 118.61 0.641 . . . . 0.0 112.037 167.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.681 ' HA ' HG12 ' A' ' 117' ' ' VAL . 34.2 m-85 -85.73 -13.88 47.0 Favored 'General case' 0 C--N 1.332 -0.182 0 O-C-N 120.263 -1.523 . . . . 0.0 113.192 -178.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 54.8 m -84.79 -15.62 44.3 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.144 1.377 . . . . 0.0 110.307 169.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.28 -49.04 11.22 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 128.464 2.706 . . . . 0.0 111.26 172.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.681 HG12 ' HA ' ' A' ' 114' ' ' TYR . 0.5 OUTLIER -94.97 178.82 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 127.556 2.342 . . . . 0.0 111.754 -165.726 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.409 ' CA ' HG13 ' A' ' 117' ' ' VAL . 1.1 m -137.91 130.06 16.31 Favored Pre-proline 0 N--CA 1.477 0.876 0 O-C-N 120.985 -1.072 . . . . 0.0 109.212 129.074 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -83.44 -16.85 6.7 Favored 'Trans proline' 0 CA--C 1.547 1.157 0 C-N-CA 122.667 2.245 . . . . 0.0 112.753 -167.212 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 14.3 t 58.36 99.37 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 129.759 3.224 . . . . 0.0 113.498 177.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.6 tt -67.1 -62.6 1.35 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.285 1.034 . . . . 0.0 112.4 -156.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -125.56 4.41 7.57 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 126.722 2.009 . . . . 0.0 114.566 -179.388 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 124.5 9.26 5.51 Favored Glycine 0 CA--C 1.539 1.565 0 C-N-CA 125.119 1.342 . . . . 0.0 114.725 -160.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -139.66 144.33 38.74 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 126.854 2.061 . . . . 0.0 109.658 -176.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.99 166.23 7.29 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 123.576 2.851 . . . . 0.0 112.966 175.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -127.67 145.01 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.165 0.986 . . . . 0.0 111.056 -173.314 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.475 ' CD1' ' HG3' ' A' ' 65' ' ' LYS . 3.6 m-85 -126.26 79.66 1.86 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.105 -1.407 . . . . 0.0 109.441 -153.458 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -91.1 149.81 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 124.514 1.125 . . . . 0.0 112.688 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -145.37 159.42 43.09 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 128.235 2.614 . . . . 0.0 108.159 161.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -55.98 155.49 6.25 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 120.437 -1.415 . . . . 0.0 111.368 154.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.703 ' HB3' HG13 ' A' ' 60' ' ' VAL . 31.0 t -71.03 158.33 36.69 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.473 -0.767 . . . . 0.0 112.167 172.363 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -65.29 -11.76 44.83 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.857 1.263 . . . . 0.0 112.861 163.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 40.5 m-70 -116.05 -179.15 3.58 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 127.675 2.39 . . . . 0.0 110.726 -175.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -125.4 4.26 7.69 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 125.525 1.53 . . . . 0.0 114.4 -172.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -176.36 164.79 2.68 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 128.3 2.64 . . . . 0.0 109.111 -170.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 23.9 tp -137.15 91.87 2.66 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.035 1.734 . . . . 0.0 111.482 -174.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.7 91.48 6.54 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.436 1.095 . . . . 0.0 110.493 172.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 10.0 p -75.28 94.05 2.96 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.847 1.259 . . . . 0.0 109.933 173.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -55.12 -37.1 66.47 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 115.208 1.559 . . . . 0.0 115.208 -167.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 98.5 p -157.31 177.16 11.77 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.898 1.679 . . . . 0.0 111.936 176.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 66.9 m -110.93 143.18 27.76 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 124.947 1.299 . . . . 0.0 111.26 175.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -68.02 125.13 12.64 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.356 2.704 . . . . 0.0 112.024 -178.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -137.6 166.77 23.11 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.29 1.836 . . . . 0.0 111.113 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -135.39 166.03 24.11 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 126.019 1.727 . . . . 0.0 112.516 178.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -64.91 -25.64 67.97 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.729 1.612 . . . . 0.0 114.474 -179.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 11.8 ptm85 . . . . . 0 N--CA 1.476 0.835 0 C-N-CA 126.756 2.022 . . . . 0.0 112.127 176.137 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 147' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.406 0 C5'-C4'-C3' 110.635 -3.244 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 148' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.376 1 O4'-C1'-N19 112.277 4.077 . 0.024 2[ . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 149' ' ' ' C' . . . . . 0.422 ' N3 ' ' HA ' ' A' ' 131' ' ' SER . . . . . . . . 0 O4'--C4' 1.423 -2.508 0 N19-C1'-C2' 107.875 -3.453 . 0.056 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 150' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.167 2 O4'-C1'-N19 114.123 5.923 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 151' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.535 1.924 0 O4'-C1'-N19 111.735 3.535 . 0.092 1b . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 152' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.547 2.859 0 O5'-C5'-C4' 114.4 3.0 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.595 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -125.45 -3.43 7.34 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.663 1.585 . . . . 0.0 114.909 -174.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 79.7 p -87.33 177.98 6.98 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.446 1.898 . . . . 0.0 113.531 178.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -137.04 136.37 38.35 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 126.8 2.04 . . . . 0.0 110.725 177.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.7 m -63.13 -65.09 0.73 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.302 1.441 . . . . 0.0 114.68 -167.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.622 ' HB1' ' HB3' ' A' ' 57' ' ' PRO . . . -102.94 86.96 2.82 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.823 1.249 . . . . 0.0 111.621 178.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -82.94 -25.13 50.57 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 123.325 0.488 . . . . 0.0 113.917 170.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.9 p -161.21 72.43 2.62 Favored Pre-proline 0 N--CA 1.479 1.01 0 C-N-CA 126.875 2.07 . . . . 0.0 110.637 178.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.622 ' HB3' ' HB1' ' A' ' 54' ' ' ALA . 0.4 OUTLIER -93.5 -144.56 0.02 OUTLIER 'Trans proline' 0 CA--C 1.547 1.148 0 C-N-CA 124.702 3.602 . . . . 0.0 113.331 -159.57 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 44.3 t -144.45 177.69 8.47 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.564 1.545 . . . . 0.0 112.947 -169.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.44 -2.14 18.37 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.585 1.154 . . . . 0.0 113.596 167.146 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.693 HG13 ' HB3' ' A' ' 131' ' ' SER 0.312 7.4 p -85.11 131.11 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 119.396 0.998 . . . . 0.0 111.628 163.796 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.0 mt -110.72 144.99 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 127.785 2.434 . . . . 0.0 107.769 169.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.438 ' CD2' ' C6 ' ' B' ' 149' ' ' ' C' . 2.1 t-80 -108.21 150.49 27.19 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.993 1.317 . . . . 0.0 110.529 172.624 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 7.5 mt -127.56 142.27 44.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 125.888 1.675 . . . . 0.0 109.093 -173.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.26 170.06 11.14 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 128.579 2.752 . . . . 0.0 109.223 164.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.57 20.29 12.1 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.617 1.167 . . . . 0.0 113.989 176.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 37.5 mt -64.01 167.7 7.36 Favored Pre-proline 0 CA--C 1.542 0.673 0 C-N-CA 123.474 0.71 . . . . 0.0 110.908 162.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -54.41 172.29 0.33 Allowed 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.934 2.423 . . . . 0.0 113.981 156.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 21.7 pt -80.98 -18.6 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 127.614 2.366 . . . . 0.0 113.332 -179.131 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -144.97 12.17 1.41 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 127.347 2.259 . . . . 0.0 113.281 -164.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -55.22 151.37 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.328 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.8 t -101.27 148.54 25.0 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 122.398 1.094 . . . . 0.0 113.281 -173.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -50.45 -44.24 55.5 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.217 1.407 . . . . 0.0 111.432 174.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -58.36 -35.1 77.39 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 123.852 0.739 . . . . 0.0 113.349 -179.07 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -74.7 -44.04 52.07 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.456 1.103 . . . . 0.0 112.167 175.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 95.1 t -60.68 -51.61 71.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 123.168 0.587 . . . . 0.0 111.084 177.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.1 pp -69.12 -30.45 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 O-C-N 120.73 -1.231 . . . . 0.0 113.099 178.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 49.2 m -73.73 -16.66 61.18 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 119.288 0.949 . . . . 0.0 112.306 174.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 22.7 mt -86.44 -15.25 40.83 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.121 0.968 . . . . 0.0 113.291 165.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.439 ' HA2' ' SD ' ' A' ' 110' ' ' MET . . . -75.88 -33.09 51.81 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 124.311 0.958 . . . . 0.0 113.241 168.043 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 16.5 mt -80.22 -16.83 0.24 Allowed Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 119.923 3.305 . . . . 0.0 119.923 -159.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -61.07 -4.61 3.96 Favored 'Trans proline' 0 C--N 1.347 0.493 0 CA-C-N 122.919 2.078 . . . . 0.0 116.474 169.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.514 ' CD2' ' HG3' ' A' ' 110' ' ' MET . 34.2 m-85 -120.6 -43.66 2.48 Favored 'General case' 0 C--N 1.34 0.195 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 -166.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -142.38 -118.36 1.37 Allowed Glycine 0 CA--C 1.525 0.706 0 CA-C-O 122.648 1.138 . . . . 0.0 112.555 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.41 ' HB3' ' CG ' ' A' ' 102' ' ' ASN . 15.2 tptm -148.03 122.24 9.57 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 130.45 3.5 . . . . 0.0 104.363 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.431 HG22 ' HE2' ' A' ' 101' ' ' MET 0.28 19.6 t -130.36 82.49 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 CA-C-O 122.778 1.275 . . . . 0.0 109.213 -159.515 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 41.5 p -79.86 -16.4 55.47 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 127.433 2.293 . . . . 0.0 112.725 -163.008 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -142.17 158.3 43.9 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 173.022 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.24 170.23 16.69 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.693 2.397 . . . . 0.0 110.34 167.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.496 HD23 ' C ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -148.49 155.12 40.75 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.184 0.994 . . . . 0.0 109.805 174.18 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 4.0 mtp -132.55 94.15 3.36 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.353 0.661 . . . . 0.0 111.355 -168.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.07 66.74 1.66 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.57 1.148 . . . . 0.0 110.505 170.044 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 53.9 tttm -55.79 -34.38 65.24 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.538 1.535 . . . . 0.0 113.579 -169.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -64.18 -16.86 60.67 Favored Glycine 0 CA--C 1.54 1.603 0 C-N-CA 125.538 1.542 . . . . 0.0 116.075 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 18.9 mtmt -124.53 7.26 8.27 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.123 1.369 . . . . 0.0 114.216 -176.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.5 m120 58.92 34.03 23.39 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.786 1.235 . . . . 0.0 112.095 -168.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -117.87 164.47 15.0 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.723 0.809 . . . . 0.0 111.985 -175.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -158.06 168.98 25.6 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.684 1.593 . . . . 0.0 111.662 -179.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.456 ' CD2' HG21 ' A' ' 60' ' ' VAL . 5.5 m-30 -114.8 157.76 22.8 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.105 1.762 . . . . 0.0 108.42 160.332 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 19.8 tt -140.45 122.06 14.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 125.084 1.354 . . . . 0.0 109.129 163.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -119.3 125.73 49.79 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 127.242 2.217 . . . . 0.0 111.253 -169.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.431 ' HE2' HG22 ' A' ' 85' ' ' VAL . 0.3 OUTLIER -128.87 160.06 33.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 113.276 -1.784 . . . . 0.0 114.129 -167.519 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.475 ' CG ' HG23 ' A' ' 103' ' ' THR . 3.0 p-10 -71.81 -20.44 61.84 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 -163.343 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.475 HG23 ' CG ' ' A' ' 102' ' ' ASN . 8.3 p -138.45 137.73 37.47 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.128 1.371 . . . . 0.0 110.988 -174.401 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -59.25 -34.67 72.5 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.199 175.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -73.27 -40.05 64.91 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.99 -52.52 63.9 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-N 119.491 1.041 . . . . 0.0 109.552 168.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.71 -37.1 79.25 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 -175.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -56.12 -52.23 65.06 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.779 0.718 . . . . 0.0 110.684 169.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -61.33 -32.18 72.06 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 118.931 -0.557 . . . . 0.0 111.324 174.222 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.514 ' HG3' ' CD2' ' A' ' 82' ' ' PHE . 13.4 ttp -73.48 -50.16 22.98 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-N 119.486 1.039 . . . . 0.0 111.918 -175.47 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -63.14 -35.34 71.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.168 0.987 . . . . 0.0 111.107 178.329 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -75.65 -41.58 53.73 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.381 1.072 . . . . 0.0 112.091 176.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -48.28 -52.95 19.0 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.509 1.124 . . . . 0.0 109.989 165.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -79.88 16.12 1.25 Allowed 'General case' 0 C--N 1.326 -0.423 0 O-C-N 118.932 -2.355 . . . . 0.0 113.044 178.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . 0.289 0.5 OUTLIER -118.63 -10.32 10.06 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 164.584 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.478 ' CB ' HG23 ' A' ' 117' ' ' VAL . 0.4 OUTLIER -85.01 -43.05 14.31 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.273 1.829 . . . . 0.0 111.413 161.25 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.478 HG23 ' CB ' ' A' ' 116' ' ' SER . 89.6 t -115.12 -57.9 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.386 1.074 . . . . 0.0 111.856 -144.157 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.0 m 70.89 135.04 0.04 OUTLIER Pre-proline 0 N--CA 1.485 1.315 0 C-N-CA 128.027 2.531 . . . . 0.0 112.234 -173.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -76.26 -22.49 12.64 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.256 1.971 . . . . 0.0 114.966 -176.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.9 t 36.37 89.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 129.802 3.241 . . . . 0.0 113.305 175.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.537 ' H ' HD11 ' A' ' 126' ' ' ILE . 2.4 tt -100.05 -66.09 0.93 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 113.783 -1.553 . . . . 0.0 109.597 -134.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -84.53 -9.6 58.19 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 159.497 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 110.34 55.42 0.53 Allowed Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.347 1.451 . . . . 0.0 113.22 -166.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -145.06 162.49 37.54 Favored Pre-proline 0 CA--C 1.541 0.631 0 CA-C-N 119.075 1.438 . . . . 0.0 112.931 156.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.34 100.22 0.15 Allowed 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 123.293 2.662 . . . . 0.0 111.973 168.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.537 HD11 ' H ' ' A' ' 121' ' ' LEU . 3.0 mm -77.75 138.24 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.303 1.041 . . . . 0.0 108.69 177.593 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 11.7 m-30 -109.3 128.6 55.22 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 120.674 -1.266 . . . . 0.0 110.667 -173.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.25 151.07 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.902 1.281 . . . . 0.0 111.888 178.624 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -158.27 160.8 37.47 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.158 1.783 . . . . 0.0 110.172 157.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -54.65 144.2 22.58 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.261 -0.899 . . . . 0.0 112.398 170.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.693 ' HB3' HG13 ' A' ' 60' ' ' VAL . 21.4 t -73.78 147.13 43.74 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.986 -0.447 . . . . 0.0 111.371 173.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 12.7 p30 -80.62 -9.24 59.8 Favored 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 113.977 1.102 . . . . 0.0 113.977 175.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -83.63 179.82 7.51 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.381 1.072 . . . . 0.0 112.608 174.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -113.06 97.25 6.4 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.794 2.038 . . . . 0.0 109.837 173.063 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 61.28 -174.97 0.13 Allowed 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.696 1.998 . . . . 0.0 112.558 -176.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 34.7 tp -135.14 99.36 4.24 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 126.413 1.885 . . . . 0.0 110.962 -170.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 50.8 tttp -98.55 111.51 23.85 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.719 1.608 . . . . 0.0 110.062 176.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 40.8 p -110.64 -1.58 16.72 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 126.021 1.729 . . . . 0.0 112.823 176.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -54.73 126.72 25.16 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.281 1.832 . . . . 0.0 112.692 177.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 61.0 m -136.93 170.74 15.6 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.758 2.023 . . . . 0.0 112.475 -175.065 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 32.0 m -59.73 154.32 47.41 Favored Pre-proline 0 N--CA 1.475 0.792 0 C-N-CA 125.097 1.359 . . . . 0.0 112.965 177.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -70.59 174.5 10.14 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 123.389 2.726 . . . . 0.0 112.728 176.312 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 63.99 8.99 4.27 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 126.96 2.104 . . . . 0.0 115.051 -177.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -139.27 164.34 30.08 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.854 2.062 . . . . 0.0 110.525 176.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -127.74 -172.31 2.65 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.719 1.608 . . . . 0.0 112.893 -178.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 23.4 ptt-85 . . . . . 0 N--CA 1.473 0.715 0 C-N-CA 127.374 2.27 . . . . 0.0 114.688 -178.796 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 147' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.168 0 C5'-C4'-C3' 111.247 -2.835 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 148' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.422 0 O4'-C1'-N19 111.895 3.695 . 0.0 OUTLIER alpha 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 149' ' ' ' C' . . . . . 0.438 ' C6 ' ' CD2' ' A' ' 62' ' ' HIS . . . . . . . . 0 O4'--C4' 1.425 -2.341 0 N19-C1'-C2' 107.972 -3.393 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 150' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.412 -3.38 1 O4'-C1'-N19 112.583 4.383 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 151' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.613 2.017 0 O4'-C1'-N19 110.873 2.673 . 0.0 OUTLIER '7D dist 1f' 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 152' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.278 0 O4'-C1'-N19 110.639 2.439 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.537 0 N-CA-C 111.714 -0.555 . . . . 0.0 111.714 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -122.95 65.32 0.97 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.697 1.599 . . . . 0.0 111.049 -177.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 45.5 m -70.45 150.39 46.26 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.059 1.344 . . . . 0.0 112.898 -179.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -130.2 158.97 38.25 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 126.294 1.838 . . . . 0.0 110.879 171.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.7 m -68.86 154.74 41.47 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.887 1.275 . . . . 0.0 113.002 178.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.541 ' HB3' ' HB3' ' A' ' 57' ' ' PRO . . . -73.02 -26.57 61.36 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 114.784 1.402 . . . . 0.0 114.784 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 132.66 -68.35 0.55 Allowed Glycine 0 CA--C 1.528 0.888 0 C-N-CA 125.5 1.524 . . . . 0.0 111.11 172.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.1 p -150.66 69.79 8.69 Favored Pre-proline 0 N--CA 1.477 0.895 0 C-N-CA 125.49 1.516 . . . . 0.0 110.591 169.109 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.541 ' HB3' ' HB3' ' A' ' 54' ' ' ALA . 0.5 OUTLIER -97.02 172.03 0.8 Allowed 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 124.368 3.379 . . . . 0.0 113.863 -158.306 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.7 t -154.64 -159.45 0.95 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.313 1.045 . . . . 0.0 113.249 179.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.2 mtp180 -54.44 -13.51 0.95 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 131.536 3.935 . . . . 0.0 118.804 -173.152 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.43 HG21 ' CD2' ' A' ' 98' ' ' PHE 0.269 0.1 OUTLIER -81.94 122.45 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-N 120.885 1.675 . . . . 0.0 110.106 162.534 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.42 HD13 ' CE ' ' A' ' 110' ' ' MET . 2.0 mp -87.18 135.38 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 156.232 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -102.61 144.37 31.1 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.888 1.275 . . . . 0.0 110.566 174.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.2 mt -129.94 140.71 48.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 126.158 1.783 . . . . 0.0 109.862 -176.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 5.4 ptt-85 -123.74 179.15 4.91 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 126.835 2.054 . . . . 0.0 112.281 173.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 58.64 17.94 5.46 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 127.083 2.153 . . . . 0.0 114.607 178.23 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.6 mp -50.29 156.83 1.32 Allowed Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 125.273 1.429 . . . . 0.0 113.15 178.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -45.3 -62.55 0.43 Allowed 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 125.075 3.85 . . . . 0.0 114.776 -179.04 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.5 pt -163.64 -52.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 131.324 3.85 . . . . 0.0 107.723 176.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -146.3 -11.31 0.48 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.567 1.547 . . . . 0.0 114.143 -176.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.301 2.9 p 42.4 -145.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 127.268 2.227 . . . . 0.0 112.148 -174.425 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.0 t -141.97 137.44 31.21 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 120.553 -1.342 . . . . 0.0 110.772 164.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -55.54 -39.35 70.45 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.367 1.067 . . . . 0.0 111.883 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.25 -38.28 56.51 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 125.111 1.339 . . . . 0.0 113.937 172.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -72.51 -48.12 43.09 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 121.449 -1.03 . . . . 0.0 112.405 174.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.3 t -58.63 -49.37 82.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-N 117.979 0.354 . . . . 0.0 111.701 -176.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.95 -31.43 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 O-C-N 120.86 -1.15 . . . . 0.0 114.001 177.523 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 48.7 m -71.42 -18.12 62.35 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 120.664 1.575 . . . . 0.0 111.433 176.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 29.6 mt -84.37 -24.17 29.8 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 167.009 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -86.36 -18.92 58.11 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-N 118.72 0.691 . . . . 0.0 114.168 175.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 13.0 mt -73.29 -18.1 0.34 Allowed Pre-proline 0 CA--C 1.548 0.872 0 N-CA-C 119.416 3.117 . . . . 0.0 119.416 -171.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -59.16 -2.42 1.24 Allowed 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.411 2.74 . . . . 0.0 118.083 174.001 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -120.83 -35.91 3.26 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 -169.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -151.73 -109.69 0.44 Allowed Glycine 0 C--N 1.337 0.638 0 CA-C-O 122.253 0.918 . . . . 0.0 112.51 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -152.89 129.08 10.46 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 129.408 3.083 . . . . 0.0 104.893 -176.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.411 ' CG2' ' CE ' ' A' ' 101' ' ' MET 0.304 11.9 t -135.24 81.92 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 120.161 1.346 . . . . 0.0 109.678 -165.562 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 58.9 p -79.64 -22.31 43.72 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 126.829 2.051 . . . . 0.0 112.436 -164.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 65.5 m-80 -136.03 156.0 49.38 Favored 'General case' 0 C--N 1.343 0.323 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 177.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -146.91 170.33 17.29 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.824 2.05 . . . . 0.0 110.044 162.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.534 HD23 ' C ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -141.01 153.93 45.77 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.837 1.655 . . . . 0.0 109.748 175.784 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 40.0 mtt -131.22 117.29 18.8 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.062 0.945 . . . . 0.0 110.908 178.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -76.2 69.67 2.76 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.754 1.222 . . . . 0.0 110.325 175.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -56.21 105.98 0.24 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.626 1.97 . . . . 0.0 111.327 -177.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 124.03 -15.97 7.77 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 126.077 1.798 . . . . 0.0 115.052 -176.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 10.6 mtmt -118.22 -2.21 11.21 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 119.142 1.471 . . . . 0.0 114.644 178.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.3 m120 60.05 46.9 10.26 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.0 1.72 . . . . 0.0 112.398 -173.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -131.8 165.76 23.08 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.44 0.696 . . . . 0.0 112.418 -179.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -157.82 163.26 38.19 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.131 1.372 . . . . 0.0 113.001 -178.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.43 ' CD2' HG21 ' A' ' 60' ' ' VAL . 4.5 m-30 -115.91 148.2 40.27 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 128.61 2.764 . . . . 0.0 106.287 166.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 6.4 tp -134.5 106.79 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 125.854 1.662 . . . . 0.0 108.874 170.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -102.93 109.38 20.91 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 128.602 2.761 . . . . 0.0 111.552 -167.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.411 ' CE ' ' CG2' ' A' ' 85' ' ' VAL . 16.1 ttm -107.02 158.5 17.0 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 114.095 -1.411 . . . . 0.0 112.695 -174.348 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.422 ' CG ' HG23 ' A' ' 103' ' ' THR . 2.6 p-10 -73.96 -21.23 60.1 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -163.098 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.422 HG23 ' CG ' ' A' ' 102' ' ' ASN . 1.9 p -138.15 147.43 43.89 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.805 0.842 . . . . 0.0 111.74 -175.363 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -64.92 -36.65 85.07 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.432 0.693 . . . . 0.0 112.15 179.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -72.35 -42.56 65.17 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 118.763 0.71 . . . . 0.0 112.817 179.095 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -57.73 -48.25 80.13 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 118.567 0.622 . . . . 0.0 110.071 172.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.16 -37.4 78.21 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -55.62 -51.89 65.64 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 121.339 -0.85 . . . . 0.0 110.876 169.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -64.81 -24.76 67.65 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-O 117.77 -1.109 . . . . 0.0 111.665 173.564 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.42 ' CE ' HD13 ' A' ' 61' ' ' ILE . 10.3 ttp -73.13 -48.51 34.92 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 120.514 1.506 . . . . 0.0 110.227 -178.434 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -65.56 -37.78 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 O-C-N 121.532 -0.73 . . . . 0.0 111.441 177.471 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -68.05 -46.48 71.0 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.869 0.868 . . . . 0.0 110.958 174.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -48.43 -42.27 31.82 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.026 1.73 . . . . 0.0 112.01 167.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.586 ' HA ' HG12 ' A' ' 117' ' ' VAL . 14.7 m-85 -84.01 -17.7 39.58 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 120.843 -1.16 . . . . 0.0 112.563 -176.566 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 84.1 m -80.97 -14.63 57.78 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.514 1.126 . . . . 0.0 110.469 170.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.55 -58.18 2.36 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 129.766 3.226 . . . . 0.0 112.879 176.549 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.586 HG12 ' HA ' ' A' ' 114' ' ' TYR . 6.0 p -74.19 -35.66 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 126.683 1.993 . . . . 0.0 113.056 -158.484 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.512 ' CG2' ' H ' ' A' ' 126' ' ' ILE . 0.8 OUTLIER 4.09 114.57 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.047 0 C-N-CA 130.351 3.46 . . . . 0.0 115.953 -134.711 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 118' ' ' THR . 5.7 Cg_exo -77.76 -3.84 13.94 Favored 'Trans proline' 0 CA--C 1.55 1.303 0 C-N-CA 123.711 2.941 . . . . 0.0 113.99 -159.243 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.4 t 62.07 112.47 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 131.62 3.968 . . . . 0.0 115.799 174.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.8 tt -72.82 75.69 1.14 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 127.909 2.483 . . . . 0.0 109.583 173.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . 0.262 0.0 OUTLIER 48.39 -15.68 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.507 1 C-N-CA 132.713 4.405 . . . . 0.0 119.004 -170.56 . . . . . . . . 4 3 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -179.51 2.95 0.02 OUTLIER Glycine 0 CA--C 1.54 1.624 0 C-N-CA 125.869 1.699 . . . . 0.0 115.265 -172.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -139.62 148.0 54.19 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 126.995 2.118 . . . . 0.0 109.46 -177.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -57.6 167.0 4.24 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.35 2.7 . . . . 0.0 114.35 175.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.512 ' H ' ' CG2' ' A' ' 118' ' ' THR . 0.5 OUTLIER -120.86 148.79 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.911 1.684 . . . . 0.0 109.299 179.697 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -122.35 101.05 7.27 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.494 1.118 . . . . 0.0 110.951 -154.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.45 152.74 28.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -167.117 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -150.87 171.44 17.22 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 129.46 3.104 . . . . 0.0 109.418 165.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -65.38 166.01 10.87 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 120.311 -1.493 . . . . 0.0 111.394 153.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.405 ' CB ' HG13 ' A' ' 60' ' ' VAL . 83.3 p -60.26 154.11 20.76 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 120.933 -1.104 . . . . 0.0 112.546 163.443 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 14.3 p30 -85.69 -19.42 30.91 Favored 'General case' 0 CA--C 1.548 0.897 0 O-C-N 121.363 -0.836 . . . . 0.0 112.28 158.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 67.5 m-70 -75.21 -171.1 1.31 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.772 1.629 . . . . 0.0 111.985 164.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -141.7 121.21 13.27 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 127.123 2.169 . . . . 0.0 110.181 174.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 66.04 99.4 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 126.026 1.73 . . . . 0.0 114.939 171.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.441 HD11 HG23 ' A' ' 138' ' ' THR . 61.8 tp -61.78 125.71 24.79 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.273 1.429 . . . . 0.0 112.171 172.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -74.64 -58.14 3.48 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.023 1.329 . . . . 0.0 113.763 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.441 HG23 HD11 ' A' ' 136' ' ' LEU . 1.4 p 34.17 81.82 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 128.029 2.532 . . . . 0.0 114.988 -174.478 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -59.28 -26.12 64.68 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.781 0.832 . . . . 0.0 113.129 166.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 12.9 t -145.81 109.87 4.91 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.903 2.081 . . . . 0.0 110.513 168.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 97.5 p -74.9 163.18 69.94 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 125.133 1.373 . . . . 0.0 112.549 177.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -75.29 7.06 3.15 Favored 'Trans proline' 0 CA--C 1.548 1.192 0 C-N-CA 123.814 3.009 . . . . 0.0 114.65 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -50.08 116.54 1.88 Allowed 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 126.318 1.847 . . . . 0.0 112.393 174.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -52.29 -42.64 63.9 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.515 1.526 . . . . 0.0 114.063 -170.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -67.67 -14.71 63.17 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -179.009 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 8.5 ttm180 . . . . . 0 N--CA 1.476 0.835 0 C-N-CA 125.515 1.526 . . . . 0.0 114.612 -168.297 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 147' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.319 0 O5'-C5'-C4' 113.635 2.453 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 148' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.43 1 O5'-C5'-C4' 117.359 5.114 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 149' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.446 0 O4'-C1'-N19 111.728 3.528 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 150' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.414 -3.257 1 O4'-C1'-N19 112.857 4.657 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 151' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.277 1 O4'-C1'-N19 112.519 4.319 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 152' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.429 -2.041 0 N19-C1'-C2' 117.462 2.539 . 0.121 8d . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.608 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -63.21 -21.66 66.36 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -176.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 19.1 m -69.01 -2.51 10.12 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 126.743 2.017 . . . . 0.0 115.237 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.1 ttt85 -57.64 158.51 5.99 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 126.805 2.042 . . . . 0.0 113.149 177.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.4 p 64.0 177.47 0.17 Allowed 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 128.244 2.617 . . . . 0.0 114.893 -174.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.808 ' HB3' ' HB3' ' A' ' 57' ' ' PRO . . . -138.67 -21.59 1.0 Allowed 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 116.694 2.109 . . . . 0.0 116.694 -165.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 146.22 -85.0 0.18 Allowed Glycine 0 N--CA 1.468 0.82 0 N-CA-C 109.979 -1.249 . . . . 0.0 109.979 -172.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 13.7 t -143.69 74.13 16.82 Favored Pre-proline 0 N--CA 1.487 1.425 0 C-N-CA 124.788 1.235 . . . . 0.0 108.501 163.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.808 ' HB3' ' HB3' ' A' ' 54' ' ' ALA . 43.7 Cg_endo -91.26 86.74 0.29 Allowed 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.42 2.08 . . . . 0.0 115.272 -153.411 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 73.8 m -140.96 122.64 15.21 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.208 1.403 . . . . 0.0 112.745 177.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 41.0 mtp180 59.92 -28.78 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 131.342 3.857 . . . . 0.0 118.017 172.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.556 HG13 ' HB3' ' A' ' 131' ' ' SER . 1.7 p -98.09 134.72 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 120.254 1.388 . . . . 0.0 112.122 167.66 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.443 ' HA ' ' HA ' ' A' ' 130' ' ' PHE . 44.8 mt -110.07 124.32 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 C-N-CA 127.585 2.354 . . . . 0.0 108.263 168.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -83.44 149.02 26.92 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.898 0.856 . . . . 0.0 111.208 169.166 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 8.7 mt -124.47 140.83 46.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 126.539 1.936 . . . . 0.0 108.99 179.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.51 167.91 13.27 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 127.432 2.293 . . . . 0.0 110.464 165.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.439 ' HG2' ' CD2' ' A' ' 127' ' ' TYR . 19.8 mmtt 53.64 41.57 32.05 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.768 1.627 . . . . 0.0 113.04 -176.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.62 176.99 0.63 Allowed Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 126.493 1.917 . . . . 0.0 109.737 159.408 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -59.52 -175.37 0.09 OUTLIER 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 124.53 3.487 . . . . 0.0 114.543 147.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 28.7 pt -81.24 -31.99 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 126.038 1.735 . . . . 0.0 113.479 -177.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -156.37 37.44 0.33 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.557 1.943 . . . . 0.0 110.725 -168.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -51.75 156.49 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.869 0.867 . . . . 0.0 112.669 177.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.82 144.28 26.68 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 122.448 1.118 . . . . 0.0 112.188 -176.235 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -58.04 -42.67 85.91 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.127 171.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.62 -39.8 61.55 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.927 1.251 . . . . 0.0 112.938 178.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -68.37 -49.41 60.36 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.688 1.195 . . . . 0.0 112.098 173.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 95.6 t -61.61 -44.89 99.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 122.965 0.506 . . . . 0.0 112.005 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.8 pp -74.68 -30.04 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 O-C-N 120.597 -1.314 . . . . 0.0 112.488 176.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.7 t -61.92 -31.74 72.08 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 119.839 1.2 . . . . 0.0 110.482 170.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 10.3 mt -78.23 -21.83 49.34 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 175.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -98.66 -16.14 32.28 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-N 119.116 0.871 . . . . 0.0 115.186 175.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.4 mt -57.69 -54.59 53.65 Favored Pre-proline 0 CA--C 1.543 0.675 0 N-CA-C 116.823 2.157 . . . . 0.0 116.823 -168.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -77.72 41.88 1.07 Allowed 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 124.0 3.133 . . . . 0.0 114.081 -175.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -129.3 -42.48 1.34 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.901 1.68 . . . . 0.0 112.589 179.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -155.79 -99.44 0.16 Allowed Glycine 0 C--N 1.336 0.564 0 C-N-CA 124.484 1.04 . . . . 0.0 110.653 167.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 38.9 tptt -136.08 -12.84 1.9 Allowed 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 116.132 1.901 . . . . 0.0 116.132 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.521 ' HA ' ' HA ' ' A' ' 101' ' ' MET 0.25 0.1 OUTLIER 30.44 82.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 128.643 2.777 . . . . 0.0 113.247 -174.184 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.6 t -68.5 -31.03 70.0 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.092 0.957 . . . . 0.0 112.554 -170.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -147.85 174.07 12.21 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 123.296 1.522 . . . . 0.0 114.586 175.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -143.24 174.64 10.53 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 127.324 2.249 . . . . 0.0 111.371 157.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.54 HD13 ' C ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -143.15 154.08 43.53 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.964 2.105 . . . . 0.0 108.148 169.383 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 5.0 mtp -129.71 106.51 8.76 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.641 1.176 . . . . 0.0 110.597 -176.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -74.18 76.15 1.79 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.025 0.93 . . . . 0.0 110.519 173.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt -64.54 98.62 0.26 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.986 1.314 . . . . 0.0 110.269 173.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 168.76 -52.94 0.21 Allowed Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.909 1.719 . . . . 0.0 112.689 -166.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt -133.1 12.61 4.26 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.12 1.368 . . . . 0.0 114.559 -166.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 59.83 53.38 4.84 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.014 1.726 . . . . 0.0 112.161 -172.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -130.28 166.0 21.27 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.396 1.078 . . . . 0.0 111.855 -179.257 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -166.05 169.97 14.01 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.513 1.925 . . . . 0.0 110.628 -177.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.545 ' CD2' HD13 ' A' ' 136' ' ' LEU . 4.5 m-30 -118.22 141.07 48.88 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.783 2.433 . . . . 0.0 105.46 166.253 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 15.6 tt -122.2 113.26 37.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 125.336 1.454 . . . . 0.0 107.446 166.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -109.71 117.01 32.77 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 127.27 2.228 . . . . 0.0 110.333 -166.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.521 ' HA ' ' HA ' ' A' ' 85' ' ' VAL 0.296 0.9 OUTLIER -121.46 146.5 46.85 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -169.067 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.416 ' CG ' HG23 ' A' ' 103' ' ' THR . 3.7 p-10 -63.13 -18.08 63.04 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 113.673 -1.603 . . . . 0.0 114.653 -160.579 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.416 HG23 ' CG ' ' A' ' 102' ' ' ASN . 4.1 p -139.68 146.57 39.81 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.934 0.873 . . . . 0.0 111.125 -176.455 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -59.34 -41.25 88.75 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.096 178.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -77.37 -35.64 54.33 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -177.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.02 -51.38 69.93 Favored 'General case' 0 C--O 1.222 -0.387 0 CA-C-N 119.992 1.269 . . . . 0.0 110.253 169.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.83 -36.53 78.3 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 178.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -57.9 -47.16 83.61 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.693 1.133 . . . . 0.0 111.262 170.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -64.77 -33.96 77.21 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-O 117.915 -1.041 . . . . 0.0 110.9 173.279 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 11.1 ttp -66.66 -47.89 71.11 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 120.019 1.281 . . . . 0.0 111.225 -178.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -68.34 -38.55 79.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 124.604 1.161 . . . . 0.0 112.055 178.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -70.18 -43.39 70.88 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.442 0.697 . . . . 0.0 110.597 176.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -49.62 -37.7 29.03 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.803 1.241 . . . . 0.0 112.075 166.001 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -90.77 -12.95 34.97 Favored 'General case' 0 CA--C 1.518 -0.252 0 O-C-N 120.162 -1.586 . . . . 0.0 113.657 -177.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -83.93 -15.78 46.68 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.75 0.786 . . . . 0.0 110.932 167.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.89 -59.79 2.64 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 128.567 2.747 . . . . 0.0 111.742 166.566 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -93.84 -49.57 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -153.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.5 m 54.88 129.36 0.01 OUTLIER Pre-proline 0 N--CA 1.481 1.101 0 C-N-CA 129.535 3.134 . . . . 0.0 113.069 -157.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -75.76 -22.25 13.7 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 121.991 1.794 . . . . 0.0 114.752 -173.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.5 t 38.87 89.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 129.223 3.009 . . . . 0.0 113.179 174.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.46 ' H ' HD11 ' A' ' 126' ' ' ILE . 2.8 tt -101.45 -50.56 3.71 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 113.444 -1.707 . . . . 0.0 110.376 -132.469 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.96 1.94 29.24 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 126.266 1.827 . . . . 0.0 113.64 165.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 125.46 12.37 3.81 Favored Glycine 0 CA--C 1.537 1.411 0 N-CA-C 117.108 1.603 . . . . 0.0 117.108 175.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -147.13 163.97 25.64 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 120.251 2.025 . . . . 0.0 112.837 174.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -56.74 143.57 89.73 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.522 2.815 . . . . 0.0 115.621 -168.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.46 HD11 ' H ' ' A' ' 121' ' ' LEU . 3.9 mm -118.81 147.28 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 127.292 2.237 . . . . 0.0 108.122 -178.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.439 ' CD2' ' HG2' ' A' ' 65' ' ' LYS . 19.5 m-30 -117.82 127.9 54.33 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.193 -0.942 . . . . 0.0 111.099 -169.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -124.65 147.13 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.764 1.225 . . . . 0.0 113.326 -178.631 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -158.37 159.43 35.8 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.308 1.843 . . . . 0.0 110.001 159.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.443 ' HA ' ' HA ' ' A' ' 61' ' ' ILE . 32.1 m-85 -56.43 162.48 2.12 Favored 'General case' 0 CA--C 1.556 1.177 0 O-C-N 120.473 -1.392 . . . . 0.0 113.057 166.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.556 ' HB3' HG13 ' A' ' 60' ' ' VAL . 5.3 p -72.25 174.72 6.86 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 116.135 1.902 . . . . 0.0 116.135 -174.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -95.37 2.58 54.67 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 127.246 2.218 . . . . 0.0 114.068 166.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -121.99 -26.72 4.72 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 117.19 2.293 . . . . 0.0 117.19 -162.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp 58.82 109.51 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 126.108 1.763 . . . . 0.0 112.963 -164.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 60.28 110.26 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 128.06 2.544 . . . . 0.0 115.406 176.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.545 HD13 ' CD2' ' A' ' 98' ' ' PHE . 32.1 tp -71.32 140.87 50.43 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.054 1.341 . . . . 0.0 111.479 174.078 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.72 111.24 8.06 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 126.157 1.783 . . . . 0.0 110.82 168.098 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 21.7 p -98.37 -75.95 0.54 Allowed 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 125.378 1.471 . . . . 0.0 112.222 -175.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -69.67 -23.14 63.42 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.675 1.59 . . . . 0.0 114.033 -174.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 19.3 m -74.88 54.97 0.67 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 127.162 2.185 . . . . 0.0 113.636 -177.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 46.7 m -60.1 143.97 87.63 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 124.877 1.271 . . . . 0.0 112.355 178.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -79.1 66.07 8.8 Favored 'Trans proline' 0 CA--C 1.546 1.093 0 C-N-CA 124.275 3.317 . . . . 0.0 112.218 -178.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -69.46 -20.72 63.75 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -178.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -152.23 -176.85 5.85 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.998 1.719 . . . . 0.0 112.395 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -121.19 -176.29 3.25 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 126.373 1.869 . . . . 0.0 111.189 165.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 77.3 ttt-85 . . . . . 0 N--CA 1.48 1.072 0 C-N-CA 125.868 1.667 . . . . 0.0 113.499 177.714 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 147' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.323 0 O4'-C1'-N19 111.2 3.0 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 148' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.98 1 C5'-C4'-C3' 108.105 -4.93 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 149' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.639 0 N19-C1'-C2' 108.736 -2.915 . 0.01 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 150' ' ' ' U' . . . . . 0.518 ' C4 ' HD12 ' A' ' 136' ' ' LEU . . . . . . . . 0 O4'--C4' 1.426 -2.282 2 O4'-C1'-N19 114.568 6.368 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 151' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.541 2.348 0 O4'-C1'-N19 110.987 2.787 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 152' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.325 0 C5'-C4'-C3' 110.903 -3.065 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.7 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -68.64 -45.35 72.06 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.361 1.065 . . . . 0.0 112.656 178.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 45.7 m -68.51 99.14 0.93 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.834 1.654 . . . . 0.0 112.52 -177.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 24.5 mtm180 -130.82 -49.36 1.04 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.943 1.697 . . . . 0.0 113.184 178.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 87.5 p -148.66 171.47 16.12 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.324 1.45 . . . . 0.0 112.451 177.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.454 ' HB3' ' HB3' ' A' ' 57' ' ' PRO . . . -140.43 -87.69 0.19 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.118 1.367 . . . . 0.0 110.885 177.325 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -148.95 43.83 0.77 Allowed Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.959 1.742 . . . . 0.0 112.09 175.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 62.1 t 53.94 72.07 1.21 Allowed Pre-proline 0 N--CA 1.48 1.042 0 C-N-CA 127.75 2.42 . . . . 0.0 109.568 -162.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.454 ' HB3' ' HB3' ' A' ' 54' ' ' ALA . 0.1 OUTLIER -96.68 164.96 1.09 Allowed 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 124.68 3.587 . . . . 0.0 112.639 -156.438 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 66.5 p -156.27 -75.52 0.1 Allowed 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -175.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 -124.73 -10.46 7.28 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 -161.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.512 HG13 ' HB3' ' A' ' 131' ' ' SER 0.337 3.8 p -112.03 135.95 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-N 119.842 1.201 . . . . 0.0 112.154 168.654 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.6 mt -114.93 150.56 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 127.629 2.372 . . . . 0.0 107.859 173.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -118.08 130.2 56.0 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.758 1.223 . . . . 0.0 110.73 178.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.5 mt -117.01 125.77 74.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 127.494 2.318 . . . . 0.0 108.414 -173.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -112.43 175.91 5.24 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 125.931 1.692 . . . . 0.0 113.024 -178.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 11.6 mmmt 59.34 27.81 16.99 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 127.392 2.277 . . . . 0.0 114.671 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.3 mp -55.01 155.63 8.17 Favored Pre-proline 0 CA--C 1.554 1.126 0 C-N-CA 124.858 1.263 . . . . 0.0 112.321 176.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.497 ' HD3' HD11 ' A' ' 121' ' ' LEU . 62.2 Cg_exo -45.8 -67.25 0.12 Allowed 'Trans proline' 0 C--N 1.351 0.706 1 C-N-CA 125.87 4.38 . . . . 0.0 115.151 -177.946 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.7 pt -153.05 -50.36 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 130.933 3.693 . . . . 0.0 107.615 175.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -151.52 -5.99 0.25 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.309 1.444 . . . . 0.0 114.174 178.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.291 2.8 p 43.8 -146.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 C-N-CA 127.237 2.215 . . . . 0.0 112.084 -174.535 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.2 t -140.02 136.02 33.27 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 120.723 -1.236 . . . . 0.0 110.522 161.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -56.76 -34.91 68.04 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.598 0.759 . . . . 0.0 113.03 179.081 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -55.28 -40.17 74.72 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.892 1.234 . . . . 0.0 113.434 172.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -67.12 -50.9 59.87 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.776 -0.837 . . . . 0.0 111.292 171.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 87.7 t -55.89 -49.89 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.578 0.751 . . . . 0.0 112.725 -176.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -82.01 -26.07 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 O-C-N 120.264 -1.522 . . . . 0.0 114.409 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.3 t -61.56 -32.4 72.48 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 119.76 1.164 . . . . 0.0 110.377 168.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.9 mt -76.3 -26.18 55.6 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 171.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -85.51 -19.86 57.63 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-N 119.549 1.068 . . . . 0.0 114.836 175.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 11.5 mt -69.95 -31.17 2.28 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 117.982 2.586 . . . . 0.0 117.982 -168.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -58.62 -4.63 1.96 Allowed 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 123.517 2.811 . . . . 0.0 116.821 169.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -108.41 -40.61 5.09 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -166.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -150.88 -109.78 0.47 Allowed Glycine 0 CA--C 1.525 0.665 0 CA-C-O 122.348 0.971 . . . . 0.0 111.974 176.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 17.1 tptm -147.7 138.16 23.12 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 128.895 2.878 . . . . 0.0 103.997 164.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.497 HG22 ' HE2' ' A' ' 101' ' ' MET 0.307 12.4 t -130.15 82.97 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 CA-C-N 120.717 1.599 . . . . 0.0 109.567 -163.047 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.5 t -77.08 -21.83 53.77 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 126.669 1.988 . . . . 0.0 113.149 -159.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -141.51 165.65 26.91 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-O 122.615 1.197 . . . . 0.0 113.619 165.586 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -137.55 179.07 6.63 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.253 1.421 . . . . 0.0 109.924 157.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.499 HD23 ' C ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -150.47 159.12 44.71 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.395 1.478 . . . . 0.0 109.69 172.798 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 6.9 mtt -133.65 100.58 4.83 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.074 0.95 . . . . 0.0 112.529 -174.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -73.92 92.34 2.08 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.087 1.355 . . . . 0.0 111.15 171.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 48.8 mttp -62.41 -20.94 64.99 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 175.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.89 -53.98 41.06 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 125.768 1.651 . . . . 0.0 115.138 -174.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.5 mtmt -123.33 20.05 9.71 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 126.04 1.736 . . . . 0.0 112.01 179.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 23.2 m120 53.67 66.64 1.17 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 126.841 2.056 . . . . 0.0 112.575 -173.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . 0.257 0.0 OUTLIER -125.53 179.43 5.14 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.51 0.671 . . . . 0.0 112.471 170.087 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -154.07 162.77 40.96 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 126.542 1.937 . . . . 0.0 109.904 -176.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.48 ' CD2' HG21 ' A' ' 60' ' ' VAL . 5.6 m-30 -108.11 150.91 26.58 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.546 1.539 . . . . 0.0 107.333 159.519 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.2 tt -132.9 124.04 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 124.624 1.169 . . . . 0.0 108.405 163.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.44 ' HG3' ' H ' ' A' ' 136' ' ' LEU . 3.6 tm-20 -130.74 126.6 36.86 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 122.588 1.185 . . . . 0.0 112.946 -162.278 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.497 ' HE2' HG22 ' A' ' 85' ' ' VAL . 0.5 OUTLIER -134.04 161.37 35.02 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.111 -1.404 . . . . 0.0 113.933 -159.903 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -79.32 -12.64 59.93 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.391 1.877 . . . . 0.0 113.26 -161.667 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.34 138.38 33.05 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.845 1.258 . . . . 0.0 111.32 -178.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -62.44 -34.79 77.5 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.312 176.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -75.69 -36.53 60.01 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.763 0.825 . . . . 0.0 112.963 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -56.22 -53.68 54.23 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 118.823 0.738 . . . . 0.0 109.693 168.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.31 -36.22 79.0 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -177.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -55.19 -50.28 69.75 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.109 0.868 . . . . 0.0 110.955 168.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -65.27 -30.75 71.65 Favored 'General case' 0 C--O 1.225 -0.222 0 O-C-N 121.441 -0.787 . . . . 0.0 111.603 174.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 5.6 ttp -73.39 -46.33 49.48 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 119.908 1.231 . . . . 0.0 111.591 -177.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -65.21 -40.12 87.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 124.145 0.978 . . . . 0.0 110.958 177.676 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -68.5 -46.1 70.55 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.597 0.759 . . . . 0.0 110.647 176.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -48.34 -42.88 32.67 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.111 1.364 . . . . 0.0 111.937 168.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.569 ' HA ' HG12 ' A' ' 117' ' ' VAL . 17.3 m-85 -84.96 -14.21 48.28 Favored 'General case' 0 C--N 1.334 -0.105 0 O-C-N 120.764 -1.21 . . . . 0.0 112.485 -176.144 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 92.9 m -83.18 -14.06 54.2 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.422 1.089 . . . . 0.0 110.618 169.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.21 -56.83 2.5 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 129.228 3.011 . . . . 0.0 113.257 178.173 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.569 HG12 ' HA ' ' A' ' 114' ' ' TYR . 9.8 p -72.65 -33.55 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 127.187 2.195 . . . . 0.0 113.777 -157.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.428 ' CG2' ' H ' ' A' ' 126' ' ' ILE . 0.3 OUTLIER -2.25 114.36 0.01 OUTLIER Pre-proline 0 N--CA 1.484 1.256 0 C-N-CA 129.206 3.002 . . . . 0.0 116.449 -131.544 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -77.26 -7.76 17.19 Favored 'Trans proline' 0 CA--C 1.546 1.117 0 C-N-CA 123.675 2.916 . . . . 0.0 114.336 -161.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.5 t 61.05 107.95 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 130.71 3.604 . . . . 0.0 114.509 176.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.497 HD11 ' HD3' ' A' ' 67' ' ' PRO . 14.2 tp -73.17 -55.86 5.89 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.766 0.826 . . . . 0.0 112.335 -168.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -125.52 -4.95 7.14 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 127.584 2.354 . . . . 0.0 113.492 -161.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 99.63 13.87 36.56 Favored Glycine 0 CA--C 1.539 1.556 0 C-N-CA 124.282 0.944 . . . . 0.0 112.432 -148.059 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -138.9 144.7 42.49 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 128.402 2.681 . . . . 0.0 109.259 -178.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -57.35 168.96 2.46 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 124.0 3.133 . . . . 0.0 114.077 176.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.428 ' H ' ' CG2' ' A' ' 118' ' ' THR . 0.3 OUTLIER -125.27 149.45 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.092 1.357 . . . . 0.0 109.896 -177.661 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -120.88 101.35 7.64 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.419 -153.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.85 150.51 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.53 1.132 . . . . 0.0 112.739 -177.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -152.37 163.6 39.16 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 126.832 2.053 . . . . 0.0 109.074 154.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -53.02 151.81 4.49 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.362 -0.836 . . . . 0.0 112.076 164.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.512 ' HB3' HG13 ' A' ' 60' ' ' VAL . 31.6 t -71.6 156.22 39.65 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.665 0.745 . . . . 0.0 112.051 176.133 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -68.99 -7.71 37.88 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.137 1.375 . . . . 0.0 113.196 164.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 36.8 m-70 -119.47 177.89 4.75 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 127.361 2.264 . . . . 0.0 110.916 -176.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -119.55 5.9 11.07 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 -167.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 162.41 167.45 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 131.077 3.751 . . . . 0.0 111.22 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.44 ' H ' ' HG3' ' A' ' 100' ' ' GLU . 3.6 mm? -74.54 147.55 41.69 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.669 0.788 . . . . 0.0 109.475 158.276 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 16.4 tttp -140.39 71.13 1.36 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.558 1.171 . . . . 0.0 110.506 173.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 29.9 p -69.64 -17.43 63.51 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.339 1.856 . . . . 0.0 113.606 178.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -58.15 128.21 36.0 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.175 1.39 . . . . 0.0 111.76 166.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 87.9 p -133.31 23.4 4.09 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.327 1.851 . . . . 0.0 114.013 175.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.8 m -65.03 137.84 97.25 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 125.48 1.512 . . . . 0.0 112.744 -174.287 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -75.27 -9.06 20.25 Favored 'Trans proline' 0 CA--C 1.545 1.049 0 C-N-CA 123.251 2.634 . . . . 0.0 114.018 177.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.03 -22.16 65.89 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.494 1.517 . . . . 0.0 114.342 -172.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -139.55 -19.08 0.95 Allowed 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 -174.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -157.75 -159.42 0.83 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.979 1.712 . . . . 0.0 110.432 -177.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.344 0 C-N-CA 126.168 1.787 . . . . 0.0 113.736 178.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 147' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.536 2.012 0 O4'-C1'-N19 111.034 2.834 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 148' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.173 0 O4'-C1'-N19 112.039 3.839 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 149' ' ' ' C' . . . . . 0.406 ' N3 ' ' HA ' ' A' ' 131' ' ' SER . . . . . . . . 0 O4'--C4' 1.424 -2.424 0 O4'-C1'-N19 112.047 3.847 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 150' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -3.034 2 O4'-C1'-N19 113.204 5.004 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 151' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.192 0 C5'-C4'-C3' 111.282 -2.812 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 152' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.365 1 O4'-C1'-N19 113.467 5.267 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.597 0 N-CA-C 111.559 -0.617 . . . . 0.0 111.559 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -72.42 172.19 10.89 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.23 1.012 . . . . 0.0 113.54 176.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 16.5 m -76.51 -12.56 60.05 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 116.283 1.957 . . . . 0.0 116.283 -170.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 61.9 mtp180 -101.69 151.64 21.79 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 119.96 1.255 . . . . 0.0 113.235 -167.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.2 m -87.79 -10.2 51.64 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.338 1.455 . . . . 0.0 113.711 171.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.554 ' HB1' ' HB3' ' A' ' 57' ' ' PRO . . . -143.64 159.77 41.87 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.777 1.631 . . . . 0.0 112.325 175.011 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -140.02 -42.74 0.07 OUTLIER Glycine 0 CA--C 1.537 1.415 0 C-N-CA 126.135 1.826 . . . . 0.0 113.181 171.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 20.1 t -140.5 75.12 27.42 Favored Pre-proline 0 N--CA 1.485 1.306 0 C-N-CA 126.293 1.837 . . . . 0.0 108.862 168.246 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.554 ' HB3' ' HB1' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -98.6 -0.74 1.11 Allowed 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 125.095 3.863 . . . . 0.0 114.344 -163.427 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 31.5 t 55.98 -87.74 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 128.037 2.535 . . . . 0.0 115.354 175.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 21.9 mtp180 -139.54 -9.19 1.25 Allowed 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 117.01 2.226 . . . . 0.0 117.01 -154.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.539 HG13 ' HB3' ' A' ' 131' ' ' SER 0.272 3.9 p -106.82 131.15 57.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 CA-C-N 120.615 1.552 . . . . 0.0 112.13 169.46 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.2 mt -109.97 155.8 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 127.672 2.389 . . . . 0.0 108.231 170.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -124.02 138.72 54.41 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.349 1.46 . . . . 0.0 110.689 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.2 mt -122.38 132.18 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 126.95 2.1 . . . . 0.0 109.807 -171.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.96 173.89 6.12 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 125.803 1.641 . . . . 0.0 113.246 178.587 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 13.8 mmmt 64.9 15.98 10.24 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 128.903 2.881 . . . . 0.0 116.416 173.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 30.8 mt -61.99 141.89 95.45 Favored Pre-proline 0 CA--C 1.555 1.158 0 CA-C-O 118.444 -0.788 . . . . 0.0 110.517 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -37.54 -62.92 0.26 Allowed 'Trans proline' 0 CA--C 1.539 0.766 1 C-N-CA 125.589 4.193 . . . . 0.0 116.043 -177.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.1 pt -153.74 -42.44 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 129.964 3.306 . . . . 0.0 109.323 174.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -153.3 -7.49 0.17 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.412 1.485 . . . . 0.0 113.187 -170.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.415 HG22 ' H ' ' A' ' 71' ' ' THR 0.298 12.0 p 34.27 -122.21 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 127.09 2.156 . . . . 0.0 111.496 -165.474 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.415 ' H ' HG22 ' A' ' 70' ' ' VAL . 0.9 OUTLIER -148.75 135.55 19.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 122.368 1.08 . . . . 0.0 109.045 152.775 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -55.17 -31.13 61.12 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.057 0.943 . . . . 0.0 112.768 178.227 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -60.42 -37.94 93.98 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 124.832 1.206 . . . . 0.0 114.121 172.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -69.86 -44.86 68.98 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.422 -1.046 . . . . 0.0 110.579 172.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 85.5 t -57.76 -51.76 66.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 123.808 0.843 . . . . 0.0 112.182 -176.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -78.92 -26.06 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 O-C-N 120.341 -1.474 . . . . 0.0 114.381 177.291 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 38.7 t -62.15 -28.53 69.72 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 119.846 1.203 . . . . 0.0 110.553 169.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 22.8 mt -82.55 -23.48 34.48 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.923 1.082 . . . . 0.0 113.923 170.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -89.06 -11.02 65.6 Favored Glycine 0 CA--C 1.534 1.229 0 CA-C-N 119.406 1.003 . . . . 0.0 114.67 176.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.2 mt -77.55 -17.12 0.26 Allowed Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 118.859 2.911 . . . . 0.0 118.859 -174.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -59.6 -2.51 1.51 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.868 2.379 . . . . 0.0 117.363 169.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -119.56 -44.77 2.54 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -166.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -150.88 -108.52 0.42 Allowed Glycine 0 C--N 1.337 0.591 0 C-N-CA 123.796 0.712 . . . . 0.0 111.581 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 21.7 tptp -142.84 -15.73 0.71 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 115.524 1.675 . . . . 0.0 115.524 -171.108 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.563 HG13 ' HB2' ' A' ' 101' ' ' MET 0.256 0.2 OUTLIER 34.6 81.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 128.159 2.584 . . . . 0.0 113.493 175.088 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 54.3 p -68.06 -36.18 79.43 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.352 1.061 . . . . 0.0 112.205 -169.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -145.0 165.71 27.39 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 123.611 1.672 . . . . 0.0 114.838 -177.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -150.31 169.14 22.1 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 126.489 1.916 . . . . 0.0 112.377 162.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.527 HD23 ' C ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -145.67 150.97 37.28 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 127.305 2.242 . . . . 0.0 108.536 -174.724 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 5.5 mtp -133.45 94.97 3.4 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.786 0.834 . . . . 0.0 111.811 -169.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.406 ' CD1' HD21 ' A' ' 89' ' ' LEU . 0.8 OUTLIER -72.34 84.35 1.07 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.102 1.361 . . . . 0.0 111.443 175.244 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.01 -11.28 12.82 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 115.265 1.579 . . . . 0.0 115.265 170.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -60.62 -56.45 24.26 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 126.403 1.954 . . . . 0.0 114.494 177.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 31.6 mtmt -125.49 22.51 7.66 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 126.16 1.784 . . . . 0.0 112.144 -176.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 57.51 56.18 5.16 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.559 2.344 . . . . 0.0 113.92 -178.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . 0.264 0.0 OUTLIER -129.63 -179.39 5.15 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 173.964 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -158.25 164.78 36.14 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.72 2.008 . . . . 0.0 110.44 -177.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.5 ' CD2' HG21 ' A' ' 60' ' ' VAL . 4.8 m-30 -111.14 151.77 27.78 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.488 1.915 . . . . 0.0 107.896 163.636 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.9 tt -133.79 104.21 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 C-N-CA 125.544 1.538 . . . . 0.0 108.018 167.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -97.77 127.69 43.9 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 128.387 2.675 . . . . 0.0 110.762 -174.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.563 ' HB2' HG13 ' A' ' 85' ' ' VAL 0.305 20.8 ttm -126.86 157.52 39.12 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 -173.921 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.429 ' ND2' HG23 ' A' ' 103' ' ' THR . 19.9 p-10 -54.54 -37.07 64.98 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 127.037 2.135 . . . . 0.0 114.299 -172.185 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.429 HG23 ' ND2' ' A' ' 102' ' ' ASN . 69.2 p -141.39 137.78 32.53 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.976 0.91 . . . . 0.0 110.589 -162.262 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -59.81 -38.62 82.48 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.658 0.783 . . . . 0.0 112.041 -177.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -74.18 -37.94 63.79 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -178.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -57.64 -48.85 78.31 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 119.185 0.902 . . . . 0.0 110.408 169.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.74 -37.29 70.58 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.338 0.972 . . . . 0.0 113.585 -178.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -55.21 -50.86 68.3 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 120.96 -1.088 . . . . 0.0 111.085 169.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -64.33 -27.84 69.3 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-O 117.961 -1.019 . . . . 0.0 111.466 173.048 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 16.7 ttp -71.64 -47.78 52.18 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-N 120.444 1.474 . . . . 0.0 110.335 -177.158 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.51 -40.61 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 123.636 0.775 . . . . 0.0 111.207 176.5 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -67.43 -47.28 70.67 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.586 0.754 . . . . 0.0 110.829 177.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -48.26 -41.84 28.89 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.93 1.692 . . . . 0.0 112.561 167.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.601 ' HA ' HG12 ' A' ' 117' ' ' VAL . 16.8 m-85 -85.36 -17.62 36.21 Favored 'General case' 0 C--O 1.232 0.166 0 O-C-N 120.551 -1.343 . . . . 0.0 112.613 -177.217 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 67.5 m -78.18 -16.58 57.76 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.071 0.948 . . . . 0.0 110.193 169.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.47 -57.43 2.77 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 129.126 2.97 . . . . 0.0 112.808 177.009 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.601 HG12 ' HA ' ' A' ' 114' ' ' TYR . 8.8 p -76.68 -40.82 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.504 1.521 . . . . 0.0 113.66 -154.022 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 11.52 113.67 0.0 OUTLIER Pre-proline 0 N--CA 1.482 1.14 0 C-N-CA 129.011 2.924 . . . . 0.0 116.175 -133.427 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.444 ' HD2' HD12 ' A' ' 126' ' ' ILE . 3.9 Cg_exo -75.77 -19.33 16.39 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.463 2.775 . . . . 0.0 112.969 -165.314 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 6.4 t 61.08 110.19 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 130.514 3.526 . . . . 0.0 113.065 -178.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.0 tt -75.0 80.01 2.19 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.732 1.613 . . . . 0.0 109.6 -176.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . 0.29 2.9 ppt_? 46.61 -13.19 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.249 1 C-N-CA 132.733 4.413 . . . . 0.0 118.906 -168.944 . . . . . . . . 3 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -174.04 3.37 0.03 OUTLIER Glycine 0 CA--C 1.538 1.512 0 N-CA-C 116.493 1.357 . . . . 0.0 116.493 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 5.3 tp60 -139.37 140.72 26.63 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 126.019 1.728 . . . . 0.0 109.489 -177.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.94 164.68 7.73 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 123.628 2.885 . . . . 0.0 113.329 174.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.444 HD12 ' HD2' ' A' ' 119' ' ' PRO . 0.7 OUTLIER -127.76 147.6 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.462 1.105 . . . . 0.0 110.762 -174.737 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -127.19 102.07 6.78 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.637 1.175 . . . . 0.0 109.923 -153.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.8 150.19 23.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -173.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -153.04 161.98 41.87 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 126.485 1.914 . . . . 0.0 109.264 154.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -53.33 151.39 5.43 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-O 121.756 0.788 . . . . 0.0 112.24 164.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.539 ' HB3' HG13 ' A' ' 60' ' ' VAL . 32.6 t -68.09 154.21 42.14 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.901 0.88 . . . . 0.0 112.283 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -64.22 -16.72 62.59 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.35 1.06 . . . . 0.0 112.85 165.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 54.9 m-70 -110.57 -176.95 3.11 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 127.523 2.329 . . . . 0.0 112.075 -176.294 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -134.47 153.58 51.86 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.607 1.563 . . . . 0.0 110.975 159.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 45.93 93.71 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 128.313 2.645 . . . . 0.0 115.262 -178.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 25.2 tp -56.09 100.34 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 127.463 2.305 . . . . 0.0 112.38 173.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -81.64 94.85 7.02 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.832 2.053 . . . . 0.0 109.478 172.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 6.7 t -131.25 7.57 4.61 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.277 1.431 . . . . 0.0 113.615 -176.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -77.54 -3.01 38.5 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.942 1.697 . . . . 0.0 115.156 -173.302 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 63.6 m -58.0 151.6 18.18 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.91 1.284 . . . . 0.0 113.216 179.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 19.5 m -55.63 118.25 18.73 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 125.615 1.566 . . . . 0.0 113.5 -172.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.59 -37.94 94.67 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 124.195 3.263 . . . . 0.0 115.142 178.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 23.5 t30 -143.4 110.6 5.73 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.555 1.542 . . . . 0.0 110.928 -174.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -151.58 164.86 35.93 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 128.98 2.912 . . . . 0.0 111.087 -2.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -77.54 169.12 18.85 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.187 0.995 . . . . 0.0 112.545 168.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.484 1.257 0 C-N-CA 127.697 2.399 . . . . 0.0 114.723 171.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 147' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.18 0 O4'-C1'-N19 110.811 2.611 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 148' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.33 1 C5'-C4'-C3' 108.391 -4.739 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 149' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.385 1 N19-C1'-C2' 106.793 -4.129 . 0.139 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 150' ' ' ' U' . . . . . 0.422 " C1'" HD11 ' A' ' 89' ' ' LEU . . . . . . . . 0 O4'--C4' 1.413 -3.311 0 C3'-C2'-C1' 104.893 3.77 . 0.0 OUTLIER '7D dist 4a' 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 151' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.429 -1.998 0 O4'-C1'-N19 111.807 3.607 . 0.01 5q . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 152' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.536 2.022 0 O4'-C1'-N19 111.561 3.361 . 0.0 OUTLIER '7D dist 2o' 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.498 0 N-CA-C 112.257 -0.337 . . . . 0.0 112.257 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -65.51 -27.24 68.33 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.92 1.288 . . . . 0.0 114.104 -178.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 45.2 m -64.97 100.19 0.4 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.173 1.789 . . . . 0.0 112.62 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 82.9 mtt85 -67.08 168.85 9.38 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.138 1.375 . . . . 0.0 112.195 170.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.4 m -123.99 -80.01 0.62 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.146 1.378 . . . . 0.0 110.588 174.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.476 ' HB1' ' HB3' ' A' ' 57' ' ' PRO . . . -98.62 -25.38 14.74 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.212 1.005 . . . . 0.0 113.221 175.324 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.47 51.03 4.5 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.585 1.088 . . . . 0.0 113.113 175.246 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 40.5 t 48.63 74.51 0.8 Allowed Pre-proline 0 N--CA 1.478 0.965 0 C-N-CA 127.727 2.411 . . . . 0.0 110.985 -172.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.476 ' HB3' ' HB1' ' A' ' 54' ' ' ALA . 0.3 OUTLIER -93.92 176.65 1.25 Allowed 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 124.498 3.465 . . . . 0.0 113.595 -155.427 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.0 t -152.48 -157.79 0.83 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.948 1.299 . . . . 0.0 111.887 177.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.4 mtp180 -46.61 -20.44 0.13 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 130.436 3.494 . . . . 0.0 119.167 -166.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.682 HG13 ' HB3' ' A' ' 131' ' ' SER 0.311 7.4 p -93.9 130.8 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 CA-C-N 121.585 1.993 . . . . 0.0 112.946 173.759 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 21.6 mt -105.21 156.97 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 127.19 2.196 . . . . 0.0 108.338 167.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.403 ' CD2' ' C6 ' ' B' ' 149' ' ' ' C' . 1.0 OUTLIER -121.62 140.64 51.99 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.706 1.602 . . . . 0.0 110.374 177.314 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.0 mt -120.37 141.11 42.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 127.667 2.387 . . . . 0.0 108.777 -176.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.12 -171.79 2.05 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 125.667 1.587 . . . . 0.0 111.244 176.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 52.71 11.62 0.21 Allowed 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 127.664 2.386 . . . . 0.0 117.363 169.496 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 22.4 mt -62.75 155.94 67.73 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 124.785 1.234 . . . . 0.0 113.241 -176.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -51.95 173.06 0.12 Allowed 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 123.58 2.853 . . . . 0.0 114.669 161.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 32.5 pt -69.54 -30.78 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 126.568 1.947 . . . . 0.0 112.951 -172.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -156.36 34.86 0.32 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.78 2.032 . . . . 0.0 110.702 -170.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -53.09 147.75 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 O-C-N 121.095 -1.003 . . . . 0.0 111.051 174.482 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.41 HG23 ' H ' ' A' ' 74' ' ' GLU . 5.5 t -88.91 136.83 32.8 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 123.05 1.405 . . . . 0.0 112.187 -173.19 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -55.49 -34.45 64.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.588 -1.187 . . . . 0.0 112.984 171.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -54.83 -40.3 71.48 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.856 1.217 . . . . 0.0 113.277 171.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.41 ' H ' HG23 ' A' ' 71' ' ' THR . 12.0 mt-10 -66.94 -51.2 58.15 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.052 0.941 . . . . 0.0 110.868 172.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 86.2 t -58.61 -48.7 84.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 123.652 0.781 . . . . 0.0 112.788 -175.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -80.7 -24.64 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 O-C-N 120.191 -1.568 . . . . 0.0 114.432 177.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 75.5 m -64.16 -27.1 68.84 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 120.407 1.458 . . . . 0.0 110.856 168.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.7 mt -77.68 -28.38 51.06 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 118.16 -0.924 . . . . 0.0 113.237 170.005 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -89.44 -13.78 61.02 Favored Glycine 0 CA--C 1.536 1.404 0 CA-C-N 119.979 1.263 . . . . 0.0 115.425 175.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.3 mt -68.13 -38.06 12.74 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 117.429 2.381 . . . . 0.0 117.429 -169.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -57.51 -3.52 0.94 Allowed 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.89 3.06 . . . . 0.0 117.277 173.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -106.34 -27.12 11.18 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -164.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -172.14 -95.45 0.1 OUTLIER Glycine 0 C--N 1.336 0.542 0 C-N-CA 124.631 1.11 . . . . 0.0 110.634 169.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.7 tppt? -149.24 155.65 40.91 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 127.021 2.129 . . . . 0.0 105.503 160.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.623 HG22 ' CE ' ' A' ' 101' ' ' MET . 3.1 t -131.4 102.0 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 120.341 1.428 . . . . 0.0 110.05 -171.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 30.5 m -67.23 -46.88 72.47 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 128.872 2.869 . . . . 0.0 112.22 -162.081 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 53.3 m-20 -144.92 162.06 37.8 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 122.236 1.017 . . . . 0.0 112.491 177.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -135.61 171.78 13.95 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.378 1.071 . . . . 0.0 110.936 157.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.529 HD23 ' C ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -145.56 152.36 39.59 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.563 1.545 . . . . 0.0 109.11 -179.42 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 8.2 mtt -131.61 104.13 6.77 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.139 0.976 . . . . 0.0 112.408 -175.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -78.03 74.03 4.58 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.019 1.328 . . . . 0.0 109.878 170.447 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -58.27 -28.78 65.26 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -172.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -79.15 -6.49 88.84 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 125.279 1.419 . . . . 0.0 115.491 175.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.4 mtmt -120.8 4.47 10.53 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.252 1.821 . . . . 0.0 114.139 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 15.5 m120 54.42 38.5 29.7 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.317 1.447 . . . . 0.0 112.507 -170.186 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -137.09 160.0 40.24 Favored 'General case' 0 CA--C 1.554 1.129 0 O-C-N 121.258 -0.901 . . . . 0.0 111.032 -159.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -154.78 167.82 28.93 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 120.127 -1.608 . . . . 0.0 112.644 -177.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.442 ' CD2' HG21 ' A' ' 60' ' ' VAL . 5.4 m-30 -116.05 155.52 27.98 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.63 1.972 . . . . 0.0 108.818 165.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 16.6 tt -139.68 99.41 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 125.373 1.469 . . . . 0.0 109.249 168.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.0 tp10 -88.97 122.67 32.57 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 128.617 2.767 . . . . 0.0 110.628 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.623 ' CE ' HG22 ' A' ' 85' ' ' VAL 0.332 0.9 OUTLIER -119.17 161.18 20.78 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 -176.942 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -70.0 -15.81 63.08 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.376 1.47 . . . . 0.0 113.336 -164.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.28 144.77 33.44 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 122.153 0.978 . . . . 0.0 111.069 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -60.98 -43.42 98.84 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.78 177.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -73.55 -35.42 65.5 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -178.083 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -57.13 -54.61 44.81 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 168.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.58 -39.17 91.33 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 120.986 -1.071 . . . . 0.0 113.458 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -49.3 -55.07 13.98 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 120.226 1.375 . . . . 0.0 113.211 168.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -62.49 -34.62 77.21 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 118.708 -0.663 . . . . 0.0 111.012 175.327 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 4.6 ttp -63.34 -56.05 19.52 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.009 1.324 . . . . 0.0 110.189 179.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -61.4 -37.57 78.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 125.877 1.671 . . . . 0.0 112.006 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -69.96 -46.42 65.3 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.706 0.802 . . . . 0.0 111.301 177.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -49.35 -38.48 28.33 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.434 0.694 . . . . 0.0 111.821 166.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.671 ' HA ' HG12 ' A' ' 117' ' ' VAL . 14.4 m-85 -83.98 -20.69 32.41 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 120.723 -1.236 . . . . 0.0 113.075 -174.579 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -82.56 -13.69 56.15 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.993 0.901 . . . . 0.0 111.222 171.271 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.77 -53.17 5.3 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 127.721 2.408 . . . . 0.0 112.37 174.438 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.671 HG12 ' HA ' ' A' ' 114' ' ' TYR . 10.0 p -75.8 -42.66 40.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 125.695 1.598 . . . . 0.0 114.868 -157.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.438 ' CA ' HG13 ' A' ' 117' ' ' VAL . 0.2 OUTLIER 1.53 113.35 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.462 0 C-N-CA 127.349 2.26 . . . . 0.0 116.437 -124.836 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.425 ' HD2' HD12 ' A' ' 126' ' ' ILE . 5.4 Cg_exo -76.66 -18.85 14.99 Favored 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 123.604 2.869 . . . . 0.0 113.216 -164.124 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.6 t 62.46 105.05 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 129.938 3.295 . . . . 0.0 112.947 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.8 tt -70.87 -64.35 0.92 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.233 0.613 . . . . 0.0 111.563 -162.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -142.02 71.69 1.36 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.492 1.517 . . . . 0.0 109.879 172.446 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 77.85 8.82 87.24 Favored Glycine 0 CA--C 1.538 1.476 0 N-CA-C 115.641 1.016 . . . . 0.0 115.641 -179.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -138.29 139.34 25.0 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 126.142 1.777 . . . . 0.0 110.417 177.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -58.79 162.07 13.87 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 123.35 2.7 . . . . 0.0 111.872 171.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.425 HD12 ' HD2' ' A' ' 119' ' ' PRO . 3.0 mt -106.39 -45.07 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -156.529 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 77.25 110.07 0.07 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.992 2.117 . . . . 0.0 112.103 170.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.47 153.84 35.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 125.723 1.609 . . . . 0.0 111.206 178.459 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -151.33 164.2 37.21 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.919 1.688 . . . . 0.0 109.005 151.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -51.89 146.16 8.75 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.278 -0.889 . . . . 0.0 111.673 164.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.682 ' HB3' HG13 ' A' ' 60' ' ' VAL . 29.0 t -68.73 154.37 42.07 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.919 -0.488 . . . . 0.0 111.576 178.527 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -63.54 -20.42 65.62 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.177 0.991 . . . . 0.0 112.525 165.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 37.4 m-70 -101.08 177.43 4.95 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.955 2.102 . . . . 0.0 110.665 178.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -128.7 7.66 5.72 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.94 1.296 . . . . 0.0 113.87 -168.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -173.16 155.58 3.0 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 127.821 2.449 . . . . 0.0 109.643 -167.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 47.6 tp -134.61 74.46 1.53 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.528 1.931 . . . . 0.0 110.034 170.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -80.76 91.36 5.9 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.709 1.204 . . . . 0.0 109.651 176.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 22.8 p -68.58 -15.83 63.66 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.977 1.711 . . . . 0.0 114.366 -177.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 27.7 t70 46.15 58.29 4.59 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 127.282 2.233 . . . . 0.0 114.287 172.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 22.1 m -61.46 161.31 9.64 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.495 1.518 . . . . 0.0 113.868 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 37.3 m -62.64 157.79 55.39 Favored Pre-proline 0 N--CA 1.476 0.849 0 C-N-CA 125.04 1.336 . . . . 0.0 113.293 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -54.92 153.76 24.12 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.799 2.999 . . . . 0.0 114.219 173.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -106.54 -21.17 13.15 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.633 1.173 . . . . 0.0 114.051 -178.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -69.81 147.07 50.87 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.164 0.985 . . . . 0.0 111.461 178.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -58.48 -43.96 89.19 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.554 1.541 . . . . 0.0 114.239 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 56.9 mmm-85 . . . . . 0 N--CA 1.483 1.187 0 C-N-CA 126.247 1.819 . . . . 0.0 114.804 -176.894 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 147' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.13 0 O4'-C1'-N19 110.492 2.292 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 148' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.43 0 O4'-C4'-C3' 108.78 2.343 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 149' ' ' ' C' . . . . . 0.403 ' C6 ' ' CD2' ' A' ' 62' ' ' HIS . . . . . . . . 0 O4'--C4' 1.422 -2.588 0 N19-C1'-C2' 107.263 -3.836 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 150' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.822 2 O4'-C1'-N19 113.41 5.21 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 151' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.293 1 C5'-C4'-C3' 108.878 -4.415 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 152' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.544 2.598 0 C5'-C4'-C3' 110.034 -3.644 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.2 t . . . . . 0 N--CA 1.478 0.93 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 -51.87 -7.49 0.05 Allowed 'General case' 0 N--CA 1.474 0.775 1 C-N-CA 132.408 4.283 . . . . 0.0 120.412 -155.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.678 HG13 ' HB3' ' A' ' 131' ' ' SER 0.294 5.7 p -99.31 129.63 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-N 121.991 2.178 . . . . 0.0 112.099 170.241 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 16.1 mt -105.84 157.87 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 128.157 2.583 . . . . 0.0 108.149 170.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -128.17 142.87 51.05 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.206 1.802 . . . . 0.0 110.455 179.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.0 mt -123.76 140.01 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 126.953 2.101 . . . . 0.0 109.957 -174.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.69 174.3 6.03 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 125.958 1.703 . . . . 0.0 112.056 172.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.494 ' HE3' ' CE2' ' A' ' 127' ' ' TYR . 2.5 mmtp 71.39 -2.92 2.25 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 128.341 2.656 . . . . 0.0 116.571 172.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -35.34 145.72 0.2 Allowed Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 129.977 3.311 . . . . 0.0 115.933 -164.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.26 165.23 1.01 Allowed 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.36 2.707 . . . . 0.0 115.126 176.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 37.7 pt -56.66 -31.59 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 128.197 2.599 . . . . 0.0 113.984 -169.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -161.45 41.71 0.15 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.455 1.902 . . . . 0.0 110.365 -177.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -57.63 157.93 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 O-C-N 121.544 -0.722 . . . . 0.0 110.898 174.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 14.4 t -123.71 154.7 39.06 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 122.559 1.171 . . . . 0.0 113.216 -175.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -54.78 -42.6 71.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.74 175.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.62 -36.96 55.59 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.088 0.852 . . . . 0.0 113.463 178.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -71.44 -52.34 18.99 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.911 1.284 . . . . 0.0 112.16 173.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 57.6 t -59.71 -46.25 93.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -177.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.9 pp -69.75 -34.24 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 O-C-N 120.553 -1.342 . . . . 0.0 112.422 175.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 74.8 m -67.8 -19.31 65.07 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 119.895 1.225 . . . . 0.0 111.742 175.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 62.5 mt -89.62 -15.53 32.54 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 172.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -101.3 -13.23 33.79 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-N 119.168 0.894 . . . . 0.0 114.977 172.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.3 mt -63.34 -44.98 84.31 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 116.563 2.06 . . . . 0.0 116.563 -175.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.1 -5.22 1.28 Allowed 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 124.441 3.428 . . . . 0.0 117.972 176.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -103.96 -39.93 6.4 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -164.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -154.77 -82.77 0.04 OUTLIER Glycine 0 CA--C 1.518 0.257 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 172.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 22.5 tptp -152.05 -8.98 0.2 Allowed 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 116.972 2.212 . . . . 0.0 116.972 174.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.413 ' H ' ' HE1' ' A' ' 101' ' ' MET . 0.4 OUTLIER 27.18 109.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.173 0 C-N-CA 127.635 2.374 . . . . 0.0 115.449 -147.208 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.2 m -59.3 -36.62 75.94 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 119.678 -1.889 . . . . 0.0 112.226 170.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -162.56 178.23 8.75 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 115.903 1.816 . . . . 0.0 115.903 175.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -136.88 172.76 12.53 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.31 1.844 . . . . 0.0 112.601 155.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.51 ' C ' HD23 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -142.43 156.27 45.17 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.923 1.689 . . . . 0.0 109.538 169.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 3.5 mtt -128.98 107.76 9.87 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.92 0.888 . . . . 0.0 111.81 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -78.34 54.4 1.4 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.226 1.01 . . . . 0.0 109.488 164.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 66.4 tttt -64.78 -27.37 68.84 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -159.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -65.62 -14.39 60.25 Favored Glycine 0 CA--C 1.541 1.718 0 C-N-CA 125.152 1.358 . . . . 0.0 115.707 171.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.01 2.89 17.09 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.887 1.675 . . . . 0.0 113.054 169.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 7.9 m120 50.66 54.27 11.48 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.656 1.582 . . . . 0.0 112.164 -167.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -132.12 168.52 17.85 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.166 0.986 . . . . 0.0 110.76 173.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -154.6 166.47 33.24 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.918 1.287 . . . . 0.0 112.102 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.473 ' CD2' HG21 ' A' ' 60' ' ' VAL . 5.2 m-30 -111.5 156.08 22.26 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.119 1.768 . . . . 0.0 108.359 161.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 15.2 tt -139.69 106.69 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.979 1.312 . . . . 0.0 109.045 166.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -96.97 137.6 35.81 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 129.291 3.036 . . . . 0.0 111.135 -174.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.481 ' HE2' ' HB2' ' A' ' 101' ' ' MET 0.316 19.9 tpp -133.04 150.55 52.11 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 115.842 1.793 . . . . 0.0 115.842 -167.282 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -71.92 -15.28 62.09 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 114.166 1.172 . . . . 0.0 114.166 -166.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.53 143.83 31.03 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.41 1.084 . . . . 0.0 110.234 -177.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -64.2 -37.74 88.55 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.637 0.775 . . . . 0.0 111.424 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -73.26 -39.73 65.19 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.764 0.826 . . . . 0.0 113.007 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -54.62 -51.52 65.1 Favored 'General case' 0 C--O 1.217 -0.62 0 C-N-CA 123.494 0.718 . . . . 0.0 110.618 169.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.62 -37.6 76.9 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -55.54 -49.62 72.17 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.995 0.816 . . . . 0.0 110.552 169.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -66.63 -29.49 69.54 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-O 118.067 -0.968 . . . . 0.0 111.691 174.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 11.6 ttp -71.73 -45.25 62.36 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 120.329 1.422 . . . . 0.0 110.154 -177.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -68.74 -40.4 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 O-C-N 121.334 -0.854 . . . . 0.0 112.068 175.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -68.43 -43.1 77.85 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.737 -0.602 . . . . 0.0 110.402 178.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -48.57 -44.91 37.15 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 125.428 1.491 . . . . 0.0 111.833 165.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.579 ' HA ' HG12 ' A' ' 117' ' ' VAL . 14.2 m-85 -80.24 -14.87 58.08 Favored 'General case' 0 C--N 1.332 -0.194 0 O-C-N 121.032 -1.043 . . . . 0.0 112.837 -177.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 97.8 m -85.22 -13.55 49.57 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.763 1.225 . . . . 0.0 110.635 171.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.89 -56.04 2.62 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 129.02 2.928 . . . . 0.0 112.892 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.579 HG12 ' HA ' ' A' ' 114' ' ' TYR . 9.9 p -70.86 -32.49 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 127.948 2.499 . . . . 0.0 113.436 -162.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.491 ' CG2' ' H ' ' A' ' 126' ' ' ILE . 1.3 m -6.26 113.86 0.03 OUTLIER Pre-proline 0 N--CA 1.483 1.178 0 C-N-CA 128.857 2.863 . . . . 0.0 115.864 -129.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 118' ' ' THR . 5.5 Cg_exo -75.61 -0.72 10.49 Favored 'Trans proline' 0 CA--C 1.553 1.441 0 C-N-CA 124.154 3.236 . . . . 0.0 114.384 -159.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.2 t 59.89 108.96 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.787 1 C-N-CA 131.903 4.081 . . . . 0.0 115.645 176.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.9 tt -76.02 80.47 2.88 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.852 2.061 . . . . 0.0 109.271 174.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . 0.332 0.1 OUTLIER 45.3 -13.91 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 1 C-N-CA 133.707 4.803 . . . . 0.0 119.301 -173.146 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 178.46 12.09 0.02 OUTLIER Glycine 0 CA--C 1.537 1.436 0 C-N-CA 126.431 1.967 . . . . 0.0 115.029 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -142.53 156.13 63.59 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 126.53 1.932 . . . . 0.0 109.325 177.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_exo -53.32 166.74 1.0 Allowed 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 123.35 2.7 . . . . 0.0 114.339 167.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.491 ' H ' ' CG2' ' A' ' 118' ' ' THR . 0.7 OUTLIER -119.21 142.86 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.528 1.531 . . . . 0.0 108.858 178.196 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.494 ' CE2' ' HE3' ' A' ' 65' ' ' LYS . 3.0 m-85 -114.16 98.68 7.1 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.633 -156.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.18 147.56 25.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 124.014 0.926 . . . . 0.0 113.449 -174.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -150.96 160.51 43.87 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.495 1.918 . . . . 0.0 109.924 161.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -54.12 152.01 6.46 Favored 'General case' 0 CA--C 1.553 1.059 0 O-C-N 120.976 -1.077 . . . . 0.0 112.213 160.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.678 ' HB3' HG13 ' A' ' 60' ' ' VAL . 28.5 t -75.04 159.64 31.49 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.513 1.125 . . . . 0.0 113.594 -172.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -67.99 -12.3 60.51 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 126.41 1.884 . . . . 0.0 112.389 166.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 55.8 m-70 -118.24 -176.49 3.08 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.884 2.074 . . . . 0.0 113.057 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -129.73 147.08 51.47 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 126.855 2.062 . . . . 0.0 109.456 164.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 51.87 92.07 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 127.348 2.259 . . . . 0.0 115.554 176.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 42.4 tp -64.72 139.8 58.8 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.337 1.455 . . . . 0.0 112.546 174.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.478 0.961 0 C-N-CA 126.496 1.918 . . . . 0.0 111.361 167.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 65.1 m . . . . . 0 N--CA 1.481 1.082 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 72.5 mtm-85 -117.58 -17.48 9.96 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 -166.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.668 HG13 ' HB3' ' A' ' 131' ' ' SER 0.364 10.8 p -98.17 136.85 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 121.077 1.762 . . . . 0.0 113.575 170.117 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.8 mt -113.2 156.93 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 128.947 2.899 . . . . 0.0 107.937 170.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -124.99 132.38 53.27 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.672 1.589 . . . . 0.0 109.906 177.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.0 mt -111.97 131.16 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 127.747 2.419 . . . . 0.0 108.484 -175.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -87.55 178.67 6.72 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 119.898 1.226 . . . . 0.0 110.65 170.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 23.6 mtpp 33.49 53.95 0.46 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 129.03 2.932 . . . . 0.0 115.081 156.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.7 mt -68.88 152.11 96.93 Favored Pre-proline 0 C--N 1.309 -1.17 0 CA-C-N 113.628 -1.624 . . . . 0.0 109.206 167.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -51.12 160.98 1.76 Allowed 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 125.022 3.815 . . . . 0.0 115.339 174.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 29.7 pt -65.38 -24.13 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 128.533 2.733 . . . . 0.0 113.914 -176.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -139.97 19.63 2.47 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.624 1.969 . . . . 0.0 111.891 -171.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -57.87 166.48 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 123.956 0.902 . . . . 0.0 112.881 175.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.1 t -132.29 156.64 46.19 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-O 122.523 1.154 . . . . 0.0 112.42 171.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.5 -34.98 67.5 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.907 174.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -59.65 -31.32 70.85 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 125.303 1.43 . . . . 0.0 113.782 175.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -75.28 -44.88 43.31 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.718 1.207 . . . . 0.0 111.538 173.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 66.3 t -64.24 -45.43 96.26 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.427 HG23 HD13 ' A' ' 88' ' ' LEU . 2.4 pp -71.37 -29.49 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 O-C-N 120.216 -1.553 . . . . 0.0 113.317 174.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 35.1 t -63.24 -28.73 70.23 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 119.264 0.938 . . . . 0.0 110.649 171.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.9 mt -82.67 -17.11 45.72 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 173.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -94.44 -19.8 31.55 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-N 119.198 0.908 . . . . 0.0 115.188 172.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 13.9 mt -68.49 -33.13 4.28 Favored Pre-proline 0 CA--C 1.54 0.558 0 N-CA-C 117.547 2.425 . . . . 0.0 117.547 -169.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -59.0 -5.14 2.51 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.199 2.599 . . . . 0.0 117.16 169.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -109.47 -36.89 5.86 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -163.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -161.3 -98.83 0.14 Allowed Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 167.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.422 ' HB3' ' CG ' ' A' ' 102' ' ' ASN . 21.2 tptp -136.24 -10.83 1.95 Allowed 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 115.819 1.785 . . . . 0.0 115.819 -178.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.523 HG13 ' HB2' ' A' ' 101' ' ' MET . 0.1 OUTLIER 28.87 89.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 129.423 3.089 . . . . 0.0 113.389 -174.511 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.24 -42.03 94.41 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.793 2.037 . . . . 0.0 111.916 -173.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -152.0 168.73 24.27 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.427 HD13 HG23 ' A' ' 76' ' ' ILE . 1.9 pt? -144.21 170.65 15.57 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.003 1.721 . . . . 0.0 112.165 159.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.482 ' C ' HD23 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -143.7 156.96 44.7 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.867 1.667 . . . . 0.0 109.328 -177.925 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 8.3 mtt -130.21 107.22 9.13 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.581 0.753 . . . . 0.0 112.234 -177.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -77.15 68.29 3.26 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.552 1.141 . . . . 0.0 109.378 167.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -56.08 -39.22 71.77 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.414 1.085 . . . . 0.0 113.481 -166.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -64.57 -20.97 66.47 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 124.673 1.13 . . . . 0.0 115.779 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -109.31 1.32 20.03 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.611 1.565 . . . . 0.0 112.737 174.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.0 m120 56.97 46.2 19.89 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.252 1.821 . . . . 0.0 113.417 -169.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -126.01 173.12 9.4 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 120.937 -1.102 . . . . 0.0 112.131 -177.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -152.22 160.92 43.28 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.53 1.132 . . . . 0.0 112.234 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.42 ' CD2' HG21 ' A' ' 60' ' ' VAL . 5.6 m-30 -99.56 154.09 18.53 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 155.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 17.1 tt -134.4 106.41 7.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 124.781 1.232 . . . . 0.0 107.979 165.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -105.44 122.18 45.45 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.714 1.605 . . . . 0.0 110.863 -172.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.523 ' HB2' HG13 ' A' ' 85' ' ' VAL . 0.9 OUTLIER -124.79 148.77 47.97 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 115.74 1.755 . . . . 0.0 115.74 -166.572 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.422 ' CG ' ' HB3' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -63.77 -17.88 63.51 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 115.558 1.688 . . . . 0.0 115.558 -158.246 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.409 HG23 ' ND2' ' A' ' 102' ' ' ASN . 1.9 p -139.78 146.76 39.88 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.378 0.609 . . . . 0.0 110.468 -178.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -62.05 -34.56 76.48 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.019 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -77.24 -38.09 51.87 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 114.225 1.195 . . . . 0.0 114.225 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.66 -49.53 77.2 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-N 119.486 1.039 . . . . 0.0 110.431 170.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.54 -36.82 76.72 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 177.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -58.3 -46.47 86.06 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 119.727 1.149 . . . . 0.0 111.23 170.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -64.82 -33.91 77.12 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 121.032 -1.042 . . . . 0.0 111.127 173.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 9.8 ttp -65.43 -51.5 59.82 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.539 1.136 . . . . 0.0 110.414 -179.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -65.98 -36.7 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 C-N-CA 125.215 1.406 . . . . 0.0 112.593 177.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -72.19 -40.84 67.6 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.129 0.877 . . . . 0.0 111.165 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -52.76 -40.29 62.99 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.924 0.89 . . . . 0.0 111.693 162.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -88.5 12.86 13.29 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 119.667 -1.896 . . . . 0.0 112.291 177.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 52.0 m -112.52 -12.09 13.52 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.897 1.679 . . . . 0.0 110.175 169.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.52 -41.06 63.52 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.007 1.723 . . . . 0.0 111.544 153.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -142.38 160.8 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 124.897 1.279 . . . . 0.0 112.182 -150.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 18.7 m -125.01 135.63 27.04 Favored Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 125.657 1.583 . . . . 0.0 107.728 164.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -75.28 -17.09 19.23 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 121.895 1.73 . . . . 0.0 114.166 -171.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 4.0 t 39.85 73.88 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 128.39 2.676 . . . . 0.0 111.76 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.636 ' H ' HD11 ' A' ' 126' ' ' ILE . 5.5 tt -92.24 -32.8 14.92 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 112.397 -2.183 . . . . 0.0 110.609 -121.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -136.99 39.35 2.55 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.701 1.201 . . . . 0.0 111.539 151.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 126.66 2.68 6.72 Favored Glycine 0 CA--C 1.535 1.298 0 N-CA-C 119.328 2.491 . . . . 0.0 119.328 160.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.64 168.39 11.16 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 121.991 2.896 . . . . 0.0 113.604 173.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -60.33 147.12 94.98 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.912 2.408 . . . . 0.0 114.387 -172.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.636 HD11 ' H ' ' A' ' 121' ' ' LEU . 26.0 mm -120.3 -55.93 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 125.294 1.438 . . . . 0.0 113.245 -163.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 65.36 150.46 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.841 2.456 . . . . 0.0 115.743 -173.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.66 150.67 22.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 C-N-CA 126.958 2.103 . . . . 0.0 110.601 172.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -139.34 159.93 41.01 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.287 1.035 . . . . 0.0 108.623 149.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -51.81 150.73 3.86 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.348 -0.845 . . . . 0.0 110.931 159.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.668 ' HB3' HG13 ' A' ' 60' ' ' VAL . 44.0 t -72.14 154.06 41.29 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.59 -0.694 . . . . 0.0 111.623 174.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -77.46 -18.7 56.92 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.061 0.544 . . . . 0.0 112.398 165.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 38.0 m-70 -80.36 176.04 10.13 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.216 1.406 . . . . 0.0 110.144 160.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -119.2 -9.67 9.92 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -173.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -175.91 175.36 1.98 Allowed 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 129.129 2.971 . . . . 0.0 109.889 -172.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 23.8 tp -138.2 122.52 18.24 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.735 1.614 . . . . 0.0 113.033 -164.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 63.2 tttm . . . . . 0 N--CA 1.474 0.746 0 C-N-CA 126.549 1.94 . . . . 0.0 110.506 170.779 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 29.0 t . . . . . 0 N--CA 1.473 0.685 0 CA-C-O 120.771 0.32 . . . . 0.0 110.949 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.445 ' H ' ' HD3' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -63.1 -3.89 2.01 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 116.246 1.943 . . . . 0.0 116.246 -172.44 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.688 HG13 ' HB3' ' A' ' 131' ' ' SER 0.322 8.7 p -81.34 128.61 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-N 121.17 1.804 . . . . 0.0 112.634 166.918 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 15.8 mt -113.67 153.73 15.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 128.867 2.867 . . . . 0.0 107.456 174.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -123.96 142.35 51.23 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.434 1.494 . . . . 0.0 110.772 178.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.8 mt -119.53 138.25 50.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 127.828 2.451 . . . . 0.0 109.837 -172.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 17.0 mtt85 -96.87 176.38 6.0 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 119.488 1.04 . . . . 0.0 110.521 171.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp 44.23 42.67 5.29 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 126.958 2.103 . . . . 0.0 116.291 158.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.2 mp -55.98 161.29 3.71 Favored Pre-proline 0 CA--C 1.558 1.279 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.473 160.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.45 ' HD3' HD22 ' A' ' 121' ' ' LEU . 9.9 Cg_endo -60.06 -68.42 0.05 OUTLIER 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.734 2.956 . . . . 0.0 113.996 -173.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.1 pt -164.23 -39.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 130.848 3.659 . . . . 0.0 108.812 -171.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -151.69 -29.5 0.17 Allowed 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 -177.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.48 HG22 ' H ' ' A' ' 71' ' ' THR 0.29 2.0 p 40.02 -150.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 127.141 2.176 . . . . 0.0 112.192 -166.236 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.48 ' H ' HG22 ' A' ' 70' ' ' VAL . 2.9 t -141.75 141.91 33.25 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 120.482 -1.386 . . . . 0.0 109.681 156.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -57.1 -32.58 66.45 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 176.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.92 -41.08 58.6 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 125.088 1.328 . . . . 0.0 113.353 170.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -69.21 -48.94 60.66 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.451 -1.029 . . . . 0.0 111.107 172.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.5 t -58.81 -50.38 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 123.146 0.579 . . . . 0.0 112.497 -176.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -76.37 -27.98 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 O-C-N 120.103 -1.623 . . . . 0.0 113.877 177.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 33.0 t -62.77 -26.79 68.89 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 120.022 1.283 . . . . 0.0 110.826 169.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 33.8 mt -83.71 -18.26 38.54 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 114.306 1.225 . . . . 0.0 114.306 170.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -87.87 -18.64 55.86 Favored Glycine 0 CA--C 1.536 1.383 0 CA-C-N 119.376 0.989 . . . . 0.0 113.832 170.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 80' ' ' LEU . 17.8 mt -73.96 -16.8 0.28 Allowed Pre-proline 0 CA--C 1.542 0.67 0 N-CA-C 119.035 2.976 . . . . 0.0 119.035 -174.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -59.55 -5.07 2.95 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.593 2.195 . . . . 0.0 116.773 168.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.419 ' CD2' ' HG3' ' A' ' 110' ' ' MET . 24.8 m-85 -120.66 -36.09 3.25 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -166.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -162.95 -101.59 0.16 Allowed Glycine 0 CA--C 1.523 0.548 0 C-N-CA 123.724 0.678 . . . . 0.0 111.782 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 32.2 tptt -147.73 -9.99 0.41 Allowed 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 117.348 2.351 . . . . 0.0 117.348 -174.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.434 HG13 ' HB2' ' A' ' 101' ' ' MET . 0.0 OUTLIER 32.21 89.03 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 C-N-CA 128.927 2.891 . . . . 0.0 113.651 -175.693 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 38.1 m -55.87 -40.65 73.26 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 127.142 2.177 . . . . 0.0 112.264 -175.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -153.18 168.81 24.72 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -141.89 173.53 11.42 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.685 1.594 . . . . 0.0 112.303 158.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.468 ' C ' HD23 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -149.9 154.97 39.21 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.85 1.66 . . . . 0.0 109.678 -179.835 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 14.8 mtt -129.66 110.57 11.9 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.934 0.894 . . . . 0.0 112.219 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -75.17 76.92 2.32 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 122.518 1.151 . . . . 0.0 109.761 169.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.17 -13.75 8.33 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.894 1.678 . . . . 0.0 115.309 -176.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -58.15 -40.9 94.35 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.685 1.612 . . . . 0.0 114.694 170.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -136.85 10.54 3.1 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 -162.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 52.65 49.37 20.5 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.022 1.329 . . . . 0.0 112.981 -167.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -113.52 167.09 10.89 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.516 0.726 . . . . 0.0 110.191 170.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -155.55 163.12 40.41 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 120.734 -1.229 . . . . 0.0 111.318 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.453 ' CD2' HG21 ' A' ' 60' ' ' VAL . 6.0 m-30 -108.32 155.88 20.02 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.444 1.497 . . . . 0.0 108.871 162.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.5 tt -141.68 106.69 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 125.872 1.669 . . . . 0.0 108.276 168.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -102.78 127.75 49.81 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 129.588 3.155 . . . . 0.0 110.776 -171.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.434 ' HB2' HG13 ' A' ' 85' ' ' VAL 0.362 1.9 tpp -124.58 158.7 32.4 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 118.201 2.667 . . . . 0.0 118.201 -171.144 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -71.27 -21.48 62.09 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.515 1.526 . . . . 0.0 114.07 -166.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.98 146.81 39.58 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.458 0.647 . . . . 0.0 110.988 -178.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -63.36 -37.9 89.07 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.726 0.81 . . . . 0.0 111.451 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -76.14 -38.03 57.27 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 178.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.35 -48.48 81.48 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-N 118.74 0.7 . . . . 0.0 110.565 171.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.18 -38.49 75.38 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 178.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -57.7 -46.99 83.61 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.996 0.816 . . . . 0.0 111.186 170.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -65.71 -29.6 70.16 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-O 117.799 -1.096 . . . . 0.0 111.525 171.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.419 ' HG3' ' CD2' ' A' ' 82' ' ' PHE . 18.8 ttp -69.24 -49.58 55.03 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 120.54 1.518 . . . . 0.0 109.839 -176.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -63.59 -40.01 87.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 124.116 0.966 . . . . 0.0 111.753 175.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -70.51 -43.65 69.24 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 121.663 -0.648 . . . . 0.0 111.076 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -48.93 -39.98 28.34 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 126.332 1.853 . . . . 0.0 111.667 166.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.61 ' HA ' HG12 ' A' ' 117' ' ' VAL . 11.3 m-85 -85.28 -22.06 28.74 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 120.602 -1.311 . . . . 0.0 113.197 -178.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 99.0 m -76.51 -19.19 58.23 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.877 0.871 . . . . 0.0 110.174 172.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.9 -60.62 2.27 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 129.507 3.123 . . . . 0.0 111.252 170.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.61 HG12 ' HA ' ' A' ' 114' ' ' TYR . 2.3 p -79.42 -48.43 21.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 124.412 1.085 . . . . 0.0 112.478 -158.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 4.9 m 33.92 126.14 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 129.013 2.925 . . . . 0.0 114.248 -139.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -76.15 -10.59 19.42 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 121.366 1.377 . . . . 0.0 115.018 -170.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.4 t 30.02 89.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 130.04 3.336 . . . . 0.0 113.102 175.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.569 ' H ' HD11 ' A' ' 126' ' ' ILE . 1.5 tt -104.76 -68.48 0.85 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 112.301 -2.227 . . . . 0.0 108.159 -138.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -66.76 -44.67 80.83 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.118 0.967 . . . . 0.0 110.476 167.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 159.82 12.51 0.04 OUTLIER Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.315 1.436 . . . . 0.0 115.527 178.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -147.28 168.68 10.78 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 119.491 1.646 . . . . 0.0 112.007 -179.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -54.87 142.87 74.05 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.984 2.456 . . . . 0.0 114.235 -175.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.569 HD11 ' H ' ' A' ' 121' ' ' LEU . 20.2 mm -106.87 -43.05 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.729 1.211 . . . . 0.0 112.423 -167.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 61.11 141.38 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 128.192 2.597 . . . . 0.0 115.101 -173.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.46 155.56 31.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 126.264 1.825 . . . . 0.0 111.323 171.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -151.47 162.25 41.28 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.344 1.858 . . . . 0.0 109.252 158.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -52.29 143.37 14.93 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 121.201 -0.937 . . . . 0.0 111.147 160.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.688 ' HB3' HG13 ' A' ' 60' ' ' VAL . 30.2 t -66.93 153.39 43.68 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.24 1.016 . . . . 0.0 112.179 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -64.76 -25.88 68.12 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.628 1.171 . . . . 0.0 112.349 168.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 57.5 m-70 -92.74 169.82 10.19 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.553 1.541 . . . . 0.0 111.259 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.66 111.75 14.66 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 125.096 1.358 . . . . 0.0 108.915 175.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 74.71 145.88 0.08 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 128.411 2.684 . . . . 0.0 113.592 -170.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 26.2 tp -113.32 111.62 22.32 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.802 2.041 . . . . 0.0 110.994 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.507 0 C-N-CA 128.002 2.521 . . . . 0.0 110.552 -177.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.5 t . . . . . 0 N--CA 1.477 0.887 0 CA-C-O 119.78 -0.152 . . . . 0.0 110.787 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.15 -7.33 40.81 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.689 HG13 ' HB3' ' A' ' 131' ' ' SER 0.306 7.5 p -79.91 126.4 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 120.173 1.351 . . . . 0.0 112.021 164.065 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 21.7 mt -107.2 154.53 8.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 128.08 2.552 . . . . 0.0 108.249 169.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -122.47 145.66 48.09 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.785 1.634 . . . . 0.0 110.87 176.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.5 mt -125.55 143.94 37.36 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 127.438 2.295 . . . . 0.0 110.097 -171.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.5 mtm-85 -108.12 170.18 8.16 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 125.847 1.659 . . . . 0.0 111.072 169.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp 56.22 32.32 20.07 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 155.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.5 171.74 2.58 Favored Pre-proline 0 C--N 1.321 -0.669 0 C-N-CA 124.728 1.211 . . . . 0.0 110.731 165.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -52.02 174.21 0.09 OUTLIER 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 124.185 3.257 . . . . 0.0 114.262 156.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 31.2 pt -64.6 -35.95 76.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 126.517 1.927 . . . . 0.0 113.027 -170.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -142.9 -10.99 0.77 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.848 1.659 . . . . 0.0 113.48 171.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.538 HG22 ' H ' ' A' ' 71' ' ' THR 0.287 4.3 p 42.34 -151.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 128.249 2.619 . . . . 0.0 112.065 -172.623 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.538 ' H ' HG22 ' A' ' 70' ' ' VAL . 1.1 p -129.36 145.19 51.43 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 120.601 -1.312 . . . . 0.0 109.88 153.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.98 -38.63 83.13 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 122.042 -0.411 . . . . 0.0 110.621 173.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -54.01 -41.29 68.15 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 125.658 1.599 . . . . 0.0 112.711 174.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -63.14 -53.61 50.65 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.106 0.962 . . . . 0.0 111.68 172.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.9 t -59.59 -48.0 88.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.344 0.657 . . . . 0.0 112.522 -178.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.0 pp -73.93 -33.0 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 O-C-N 120.488 -1.383 . . . . 0.0 112.801 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.5 t -63.55 -30.73 71.81 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.494 1.043 . . . . 0.0 110.771 171.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 14.0 mt -76.1 -20.43 57.68 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 173.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -96.66 -17.32 33.66 Favored Glycine 0 CA--C 1.536 1.37 0 N-CA-C 115.374 0.91 . . . . 0.0 115.374 172.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.6 mt -60.81 -52.8 69.84 Favored Pre-proline 0 CA--C 1.54 0.588 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 -170.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -76.21 42.44 1.0 Allowed 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 123.957 3.105 . . . . 0.0 113.5 -179.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -129.54 -41.89 1.34 Allowed 'General case' 0 C--O 1.233 0.218 0 C-N-CA 126.74 2.016 . . . . 0.0 111.196 178.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -158.11 -101.22 0.17 Allowed Glycine 0 C--N 1.34 0.784 0 CA-C-O 122.059 0.81 . . . . 0.0 112.053 163.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 13.8 tptm -143.48 139.04 29.66 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 130.084 3.354 . . . . 0.0 104.326 166.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.699 HG22 ' HE2' ' A' ' 101' ' ' MET . 3.6 t -123.35 99.41 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 120.203 1.365 . . . . 0.0 109.333 -169.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 16.0 m -65.21 -38.23 89.77 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 128.73 2.812 . . . . 0.0 112.283 -161.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.58 161.5 42.45 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 177.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -133.69 175.06 9.78 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.109 0.964 . . . . 0.0 111.033 156.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.468 ' C ' HD23 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -150.32 154.21 37.46 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.932 1.693 . . . . 0.0 109.29 178.739 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 5.7 mtt -129.93 111.27 12.39 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.357 1.063 . . . . 0.0 111.273 -178.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -74.15 86.11 1.88 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.752 0.821 . . . . 0.0 110.156 174.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.6 tpmt? -63.65 89.01 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.943 1.697 . . . . 0.0 110.476 174.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 179.76 -61.97 0.08 OUTLIER Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.359 1.457 . . . . 0.0 112.748 -166.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.94 20.71 3.81 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 125.77 1.628 . . . . 0.0 114.161 -169.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 14.1 m-20 56.3 42.61 27.63 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.87 1.668 . . . . 0.0 113.496 -173.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -106.47 165.22 11.43 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.862 -0.524 . . . . 0.0 111.603 175.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -153.8 165.61 35.49 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.672 1.189 . . . . 0.0 111.371 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.466 ' CD2' HG21 ' A' ' 60' ' ' VAL . 6.0 m-30 -112.71 156.65 22.43 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.671 1.588 . . . . 0.0 108.689 163.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.8 tt -141.92 108.75 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 125.283 1.433 . . . . 0.0 109.606 166.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -100.46 122.01 42.49 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 129.09 2.956 . . . . 0.0 111.275 -175.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.699 ' HE2' HG22 ' A' ' 85' ' ' VAL 0.298 3.1 ttm -121.75 160.66 24.11 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 -173.766 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.95 -13.95 60.25 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.288 1.035 . . . . 0.0 113.616 -162.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.35 144.73 38.35 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.675 1.19 . . . . 0.0 111.194 177.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -63.38 -35.73 81.36 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.56 1.144 . . . . 0.0 111.846 176.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -75.99 -39.97 54.76 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -56.35 -50.66 70.87 Favored 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 122.809 0.444 . . . . 0.0 110.293 170.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.09 -37.19 72.43 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 121.026 -1.046 . . . . 0.0 113.334 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -56.18 -47.2 78.78 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.118 0.872 . . . . 0.0 111.408 169.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -65.21 -34.34 78.14 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 118.08 -0.962 . . . . 0.0 110.88 174.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 3.2 ttp -64.12 -52.18 60.4 Favored 'General case' 0 C--N 1.343 0.298 0 CA-C-N 119.664 1.12 . . . . 0.0 110.633 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.91 -37.84 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 C-N-CA 125.259 1.424 . . . . 0.0 112.133 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -72.01 -44.07 64.02 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.486 0.714 . . . . 0.0 111.702 177.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -49.4 -36.87 23.33 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.17 0.988 . . . . 0.0 112.071 165.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.583 ' HA ' HG12 ' A' ' 117' ' ' VAL . 13.2 m-85 -87.23 -18.73 29.61 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 120.468 -1.395 . . . . 0.0 113.222 -177.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.22 -12.57 58.01 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.638 0.732 . . . . 0.0 110.912 170.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.91 -60.9 2.01 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 129.481 3.112 . . . . 0.0 111.874 168.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.583 HG12 ' HA ' ' A' ' 114' ' ' TYR . 4.2 p -78.08 -44.43 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.517 1.127 . . . . 0.0 113.622 -154.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.3 m 27.56 119.29 0.0 OUTLIER Pre-proline 0 N--CA 1.479 0.988 0 C-N-CA 129.855 3.262 . . . . 0.0 115.854 -139.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -76.53 -13.82 18.16 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 121.933 1.755 . . . . 0.0 116.073 -167.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.8 t 29.85 90.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 129.907 3.283 . . . . 0.0 114.067 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.48 ' H ' HD11 ' A' ' 126' ' ' ILE 0.265 1.1 tt -113.15 76.44 0.98 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 112.545 -2.116 . . . . 0.0 105.919 -134.592 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . 0.349 2.1 ppt_? 46.84 14.17 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 129.922 3.289 . . . . 0.0 116.73 -152.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -126.41 -113.52 1.87 Allowed Glycine 0 N--CA 1.472 1.065 0 C-N-CA 125.005 1.288 . . . . 0.0 116.254 -174.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.413 ' O ' HD13 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -148.88 173.74 3.98 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 128.229 2.612 . . . . 0.0 108.062 -174.242 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -44.73 105.25 0.06 OUTLIER 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 123.691 2.927 . . . . 0.0 116.386 -163.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.48 HD11 ' H ' ' A' ' 121' ' ' LEU . 3.9 mm -68.18 162.09 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 125.24 1.416 . . . . 0.0 108.426 172.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -134.63 147.65 50.22 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 121.789 -0.57 . . . . 0.0 111.177 174.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.83 146.13 32.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.95 1.3 . . . . 0.0 110.896 173.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -147.3 158.79 44.09 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.478 1.911 . . . . 0.0 108.865 160.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -53.77 146.88 12.74 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.236 -0.915 . . . . 0.0 111.549 163.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.689 ' HB3' HG13 ' A' ' 60' ' ' VAL . 30.0 t -69.72 156.11 39.49 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.977 0.911 . . . . 0.0 112.706 -179.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -66.95 -20.95 65.98 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.781 1.232 . . . . 0.0 112.888 167.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 40.4 m-70 -105.1 177.65 4.79 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.869 1.667 . . . . 0.0 112.188 -173.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 4.6 mptt -136.76 117.92 14.45 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 126.255 1.822 . . . . 0.0 109.679 -175.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 69.27 84.35 0.15 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.362 1.465 . . . . 0.0 113.328 176.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 31.4 tp -57.54 127.55 32.6 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.518 1.527 . . . . 0.0 112.586 177.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 99.1 mttt . . . . . 0 N--CA 1.473 0.697 0 C-N-CA 126.479 1.912 . . . . 0.0 110.581 173.615 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 57.4 m . . . . . 0 N--CA 1.475 0.799 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 31.0 mtp180 -50.84 -17.44 0.56 Allowed 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 128.902 2.881 . . . . 0.0 118.063 -177.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.645 HG13 ' HB3' ' A' ' 131' ' ' SER 0.265 3.4 p -96.98 137.17 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-N 120.261 1.391 . . . . 0.0 112.966 172.488 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.2 mt -118.88 130.78 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 127.93 2.492 . . . . 0.0 108.787 175.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -96.69 141.23 30.18 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.33 1.052 . . . . 0.0 110.719 176.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.3 mt -116.51 135.5 56.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 126.79 2.036 . . . . 0.0 108.291 -178.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.0 ptt-85 -119.53 171.48 8.32 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 127.387 2.275 . . . . 0.0 111.376 165.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.6 mmmt 61.29 23.34 13.58 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.579 1.552 . . . . 0.0 113.27 178.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.551 ' CD2' HD13 ' A' ' 121' ' ' LEU . 14.7 mt -69.31 173.97 3.35 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 126.313 1.845 . . . . 0.0 111.502 166.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -48.79 176.43 0.02 OUTLIER 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 123.042 2.495 . . . . 0.0 114.295 152.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 26.5 pt -64.81 -41.24 91.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.863 1.665 . . . . 0.0 112.961 -171.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -141.89 -11.85 0.87 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.016 1.726 . . . . 0.0 114.539 174.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.584 HG22 ' H ' ' A' ' 71' ' ' THR 0.309 2.9 p 43.0 -154.48 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 128.124 2.57 . . . . 0.0 113.412 -175.719 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.584 ' H ' HG22 ' A' ' 70' ' ' VAL . 10.8 t -142.32 148.53 38.14 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 120.065 -1.647 . . . . 0.0 111.665 171.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -55.6 -46.25 77.33 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.328 1.051 . . . . 0.0 111.961 -177.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -51.37 -43.18 51.51 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.526 1.06 . . . . 0.0 113.116 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -64.85 -56.03 15.91 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.778 0.831 . . . . 0.0 112.264 172.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 80.1 t -56.06 -53.81 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-O 121.657 0.741 . . . . 0.0 111.811 -176.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.9 pp -67.29 -39.54 83.08 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 CA-C-O 117.89 -1.052 . . . . 0.0 112.437 -178.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.8 t -68.52 -19.97 64.55 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 119.945 1.248 . . . . 0.0 111.384 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 26.6 mt -87.45 -21.78 25.35 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 172.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -99.36 -21.98 13.83 Favored Glycine 0 C--O 1.215 -1.077 0 CA-C-N 119.376 0.989 . . . . 0.0 113.705 177.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.8 mt -60.1 -35.51 28.69 Favored Pre-proline 0 CA--C 1.549 0.936 0 N-CA-C 118.785 2.883 . . . . 0.0 118.785 -173.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -55.36 7.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.949 1 C-N-CA 125.739 4.293 . . . . 0.0 120.728 -171.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -125.33 -19.42 5.08 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 -171.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -163.96 -100.06 0.14 Allowed Glycine 0 CA--C 1.524 0.62 0 CA-C-N 118.622 0.647 . . . . 0.0 112.444 -177.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 31.5 tptt -153.06 156.46 38.79 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 125.03 1.332 . . . . 0.0 107.891 165.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -131.22 106.04 11.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 119.812 1.187 . . . . 0.0 109.177 -174.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 33.9 p -104.66 -25.77 12.58 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.399 -1.273 . . . . 0.0 112.393 -162.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -138.03 152.49 48.91 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.101 0.864 . . . . 0.0 113.095 170.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -137.61 169.86 17.05 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.419 1.088 . . . . 0.0 111.267 159.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.513 ' C ' HD23 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -147.63 153.22 39.1 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.091 1.356 . . . . 0.0 109.589 178.191 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 5.2 mtp -135.59 98.98 4.07 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.91 0.884 . . . . 0.0 110.326 -169.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -74.56 89.12 2.18 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.961 0.904 . . . . 0.0 110.693 177.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.9 pttt -122.01 60.24 0.98 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.227 1.811 . . . . 0.0 113.829 -178.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 84.1 -118.41 4.69 Favored Glycine 0 N--CA 1.47 0.96 0 C-N-CA 130.286 3.803 . . . . 0.0 113.769 4.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.5 mtmm -135.05 -95.39 0.27 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.69 1.596 . . . . 0.0 110.464 -167.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -155.88 32.32 0.35 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 129.737 3.215 . . . . 0.0 110.15 -176.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -122.8 163.52 20.07 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -173.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -154.51 166.16 34.17 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 126.364 1.866 . . . . 0.0 110.348 177.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.532 ' CD2' HG21 ' A' ' 60' ' ' VAL . 5.7 m-30 -112.5 149.44 32.64 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.867 1.667 . . . . 0.0 107.329 162.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.8 tt -128.83 121.03 53.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 C-N-CA 124.186 0.994 . . . . 0.0 108.883 159.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.499 ' HG3' ' H ' ' A' ' 136' ' ' LEU . 2.0 tm-20 -110.95 108.89 18.8 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 126.018 1.727 . . . . 0.0 110.159 -174.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -102.18 149.66 24.07 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 112.921 -1.945 . . . . 0.0 111.403 -176.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.43 -13.34 60.7 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.577 1.551 . . . . 0.0 114.065 -161.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.03 144.02 48.44 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.502 0.721 . . . . 0.0 110.789 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -63.46 -41.06 98.63 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.021 0.928 . . . . 0.0 111.575 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -74.78 -36.75 62.52 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 178.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.95 -46.34 89.74 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 118.708 0.685 . . . . 0.0 110.305 171.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.57 -37.79 80.18 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 175.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -56.38 -50.78 70.59 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 120.946 -1.096 . . . . 0.0 111.372 169.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -64.63 -26.08 68.24 Favored 'General case' 0 C--O 1.219 -0.548 0 O-C-N 120.597 -1.315 . . . . 0.0 111.374 173.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 18.8 ttp -69.35 -48.51 61.12 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-N 120.168 1.349 . . . . 0.0 110.38 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -64.27 -38.2 81.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 O-C-N 121.046 -1.034 . . . . 0.0 111.66 176.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -67.57 -47.33 70.09 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.358 1.063 . . . . 0.0 111.137 173.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -49.91 -34.19 19.68 Favored 'General case' 0 C--O 1.223 -0.329 0 C-N-CA 126.151 1.781 . . . . 0.0 112.236 169.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.528 ' HA ' HG12 ' A' ' 117' ' ' VAL . 17.0 m-85 -90.76 -18.91 24.15 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 120.437 -1.415 . . . . 0.0 113.312 -177.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -81.59 -10.62 59.39 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 121.581 0.705 . . . . 0.0 111.196 168.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.36 -63.96 1.24 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 130.226 3.41 . . . . 0.0 111.743 168.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.528 HG12 ' HA ' ' A' ' 114' ' ' TYR . 2.2 p -78.76 -46.5 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 124.626 1.17 . . . . 0.0 112.213 -156.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.4 m 37.33 123.85 0.0 OUTLIER Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 130.17 3.388 . . . . 0.0 115.023 -145.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -75.01 -20.96 16.32 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 121.88 1.72 . . . . 0.0 115.723 -168.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 5.6 t 42.4 99.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 129.595 3.158 . . . . 0.0 114.579 176.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.551 HD13 ' CD2' ' A' ' 66' ' ' LEU . 4.5 tt -135.3 -59.5 0.78 Allowed 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 113.591 -1.641 . . . . 0.0 109.844 -137.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.07 -3.04 14.67 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 156.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 98.76 17.06 29.3 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 125.392 1.472 . . . . 0.0 115.945 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -153.61 170.59 8.07 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 127.634 2.373 . . . . 0.0 109.794 171.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -47.02 142.13 11.49 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 124.009 3.139 . . . . 0.0 115.644 -179.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.428 HD11 ' H ' ' A' ' 121' ' ' LEU . 4.9 mm -117.08 143.81 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 127.347 2.259 . . . . 0.0 107.823 -177.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 9.1 m-30 -116.82 125.34 51.43 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 121.249 -0.907 . . . . 0.0 110.523 -166.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.1 149.95 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -178.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -149.26 160.1 43.69 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 127.525 2.33 . . . . 0.0 109.326 163.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -53.2 149.77 6.75 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 120.803 -1.186 . . . . 0.0 112.09 160.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.645 ' HB3' HG13 ' A' ' 60' ' ' VAL . 27.5 t -72.0 154.78 40.95 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.36 0.664 . . . . 0.0 112.207 177.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -66.61 -12.09 56.45 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.664 1.586 . . . . 0.0 113.261 168.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 65.2 m-70 -114.94 171.49 7.63 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.631 1.572 . . . . 0.0 112.837 -169.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -123.9 103.13 8.16 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 126.412 1.885 . . . . 0.0 110.961 -176.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 62.02 115.67 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 126.773 2.029 . . . . 0.0 113.364 -170.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.499 ' H ' ' HG3' ' A' ' 100' ' ' GLU . 24.0 tp -64.03 101.04 0.35 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.063 1.745 . . . . 0.0 111.86 168.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 67.4 mttm . . . . . 0 N--CA 1.469 0.513 0 C-N-CA 125.42 1.488 . . . . 0.0 109.139 170.902 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 45.3 m . . . . . 0 CA--C 1.549 0.938 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 46.5 mtp180 -55.13 -16.85 3.4 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 119.521 3.156 . . . . 0.0 119.521 -161.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.607 HG13 ' HB3' ' A' ' 131' ' ' SER 0.31 6.9 p -98.2 128.91 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 CA-C-N 121.366 1.894 . . . . 0.0 112.879 169.605 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 39.7 mt -100.4 155.01 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.84 1.656 . . . . 0.0 108.378 165.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -119.08 148.76 42.69 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.58 1.552 . . . . 0.0 110.957 173.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.4 mt -127.98 141.4 46.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 126.501 1.92 . . . . 0.0 109.639 -172.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.45 165.83 17.73 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 127.95 2.5 . . . . 0.0 109.885 167.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 67.31 23.59 9.26 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 125.148 1.379 . . . . 0.0 113.887 177.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.99 165.62 0.76 Allowed Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 127.7 2.4 . . . . 0.0 111.292 165.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -58.68 175.61 0.55 Allowed 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 123.007 2.471 . . . . 0.0 113.993 154.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 28.1 pt -73.81 -32.36 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 126.645 1.978 . . . . 0.0 113.47 -175.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -154.91 32.34 0.4 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.871 1.668 . . . . 0.0 111.357 -168.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -51.49 147.61 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.574 0.75 . . . . 0.0 112.267 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.401 HG23 ' H ' ' A' ' 74' ' ' GLU . 8.4 t -88.91 140.97 28.89 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 122.584 1.183 . . . . 0.0 112.092 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -57.84 -36.03 71.72 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.429 175.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -57.4 -36.0 74.63 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 123.643 0.639 . . . . 0.0 112.865 177.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.401 ' H ' HG23 ' A' ' 71' ' ' THR . 6.0 mm-40 -70.34 -51.33 30.83 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.955 1.302 . . . . 0.0 112.045 172.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 88.6 t -63.13 -41.49 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -176.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.0 pp -72.73 -34.8 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 O-C-N 120.285 -1.509 . . . . 0.0 112.413 174.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 73.1 m -66.54 -22.49 66.16 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 119.809 1.186 . . . . 0.0 111.886 174.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.6 mt -76.39 -30.86 57.68 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.016 0.927 . . . . 0.0 113.046 170.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -94.27 -11.89 56.81 Favored Glycine 0 CA--C 1.534 1.272 0 CA-C-N 119.818 1.19 . . . . 0.0 115.693 178.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.7 mt -64.71 -36.07 15.94 Favored Pre-proline 0 CA--C 1.545 0.764 0 N-CA-C 117.379 2.363 . . . . 0.0 117.379 -172.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.74 -5.18 1.69 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.575 2.85 . . . . 0.0 117.583 173.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -107.48 -33.76 7.25 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -163.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -164.92 -98.26 0.12 Allowed Glycine 0 CA--C 1.522 0.527 0 C-N-CA 124.201 0.905 . . . . 0.0 111.344 172.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 33.6 tptt -149.15 145.04 26.99 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 105.423 -2.065 . . . . 0.0 105.423 161.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.709 HG22 ' HE2' ' A' ' 101' ' ' MET . 3.5 t -128.48 89.13 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-N 120.331 1.423 . . . . 0.0 108.76 -171.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 31.3 p -77.58 -19.04 56.28 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 126.817 2.047 . . . . 0.0 113.016 -161.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -148.27 160.97 42.43 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 172.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.8 pp -140.32 172.23 13.03 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.775 1.23 . . . . 0.0 111.493 155.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.52 ' C ' HD23 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -142.2 152.77 43.45 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 125.93 1.692 . . . . 0.0 108.747 175.709 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 5.4 mtt -132.19 102.64 5.87 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.159 0.984 . . . . 0.0 111.84 -174.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -72.43 100.17 2.63 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.587 1.155 . . . . 0.0 110.215 177.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -57.8 -23.0 50.33 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.82 1.648 . . . . 0.0 114.933 -176.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -63.97 -44.87 95.34 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.659 1.599 . . . . 0.0 115.956 -174.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -136.92 8.97 3.03 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 115.394 1.628 . . . . 0.0 115.394 -151.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 55.15 60.69 3.29 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.7 1.2 . . . . 0.0 110.745 -165.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -130.66 163.92 26.13 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.647 0.779 . . . . 0.0 112.255 177.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -155.36 167.19 31.2 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.917 1.287 . . . . 0.0 111.941 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.452 ' CD2' HG21 ' A' ' 60' ' ' VAL . 4.8 m-30 -110.19 152.17 26.4 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.594 1.958 . . . . 0.0 107.24 160.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 19.8 tt -134.09 105.4 6.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 125.252 1.421 . . . . 0.0 108.717 167.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 21.4 tp10 -96.95 124.1 40.84 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 127.377 2.271 . . . . 0.0 110.753 -175.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.709 ' HE2' HG22 ' A' ' 85' ' ' VAL 0.305 1.6 ttm -125.23 157.27 36.95 Favored 'General case' 0 C--O 1.223 -0.301 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 -177.213 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -69.97 -18.99 63.37 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.731 2.012 . . . . 0.0 113.318 -165.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.09 140.72 42.16 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 122.62 1.2 . . . . 0.0 111.875 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -61.84 -40.9 96.93 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.577 1.151 . . . . 0.0 111.137 177.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -74.54 -35.24 63.11 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -56.43 -55.4 34.05 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-N 118.755 0.707 . . . . 0.0 109.861 168.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.5 -34.36 76.99 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.444 1.02 . . . . 0.0 113.585 -178.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -56.56 -51.48 68.44 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.149 -0.969 . . . . 0.0 111.633 169.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -63.26 -31.21 72.31 Favored 'General case' 0 C--O 1.224 -0.257 0 O-C-N 121.289 -0.882 . . . . 0.0 110.972 174.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 6.2 ttp -71.0 -46.45 62.24 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.872 1.269 . . . . 0.0 111.886 -178.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -67.81 -37.88 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 O-C-N 120.843 -1.16 . . . . 0.0 111.366 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -71.78 -41.93 67.74 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.441 1.096 . . . . 0.0 111.285 176.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -48.78 -52.29 24.69 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.51 1.124 . . . . 0.0 110.819 165.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -77.9 12.41 1.77 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 118.74 -2.475 . . . . 0.0 113.344 178.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . 0.289 0.5 OUTLIER -116.35 -10.63 11.33 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.814 0.846 . . . . 0.0 113.067 167.494 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.482 ' CB ' HG23 ' A' ' 117' ' ' VAL . 0.4 OUTLIER -84.46 -42.51 15.53 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 126.029 1.732 . . . . 0.0 111.45 159.926 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.482 HG23 ' CB ' ' A' ' 116' ' ' SER . 85.5 t -116.22 -63.33 1.99 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.228 0 C-N-CA 124.937 1.295 . . . . 0.0 111.09 -144.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.0 m 68.96 136.47 0.05 OUTLIER Pre-proline 0 N--CA 1.484 1.255 0 C-N-CA 127.93 2.492 . . . . 0.0 112.588 -175.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -81.41 -9.76 12.4 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 122.605 2.203 . . . . 0.0 115.616 -174.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.5 t 26.57 90.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 130.867 3.667 . . . . 0.0 114.606 173.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.7 tt -118.98 -59.27 1.87 Allowed 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.716 -126.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.72 -1.56 39.06 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 153.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 106.27 32.55 3.69 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 124.999 1.285 . . . . 0.0 115.047 -177.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -139.49 150.51 63.96 Favored Pre-proline 0 CA--C 1.536 0.404 0 C-N-CA 125.342 1.457 . . . . 0.0 110.762 175.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -55.59 109.1 0.37 Allowed 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.354 2.703 . . . . 0.0 112.713 174.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.1 mm -78.19 145.77 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 124.892 1.277 . . . . 0.0 109.109 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 9.8 m-30 -111.02 128.71 55.94 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.82 0.848 . . . . 0.0 109.811 -173.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.3 tt -131.48 146.0 34.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 124.505 1.122 . . . . 0.0 111.667 -178.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -155.21 160.25 40.72 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.179 1.792 . . . . 0.0 108.958 160.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -50.71 148.57 3.89 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.271 -0.893 . . . . 0.0 112.767 167.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.607 ' HB3' HG13 ' A' ' 60' ' ' VAL . 37.5 t -68.24 158.02 34.23 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.509 0.724 . . . . 0.0 112.057 178.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -67.34 -13.36 61.93 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.563 1.145 . . . . 0.0 112.72 164.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 36.5 m-70 -111.81 178.82 4.2 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 127.778 2.431 . . . . 0.0 110.473 -178.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -125.6 -0.55 7.46 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 115.737 1.754 . . . . 0.0 115.737 -171.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -164.48 166.85 20.11 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 130.087 3.355 . . . . 0.0 108.302 -173.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 21.3 tp -134.67 105.51 6.52 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.431 1.492 . . . . 0.0 110.979 175.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 8.1 mmpt? . . . . . 0 CA--C 1.536 0.438 0 C-N-CA 126.216 1.806 . . . . 0.0 109.829 176.358 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.7 m . . . . . 0 N--CA 1.473 0.714 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 35.6 mtp180 61.72 -12.68 0.06 Allowed 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 128.789 2.836 . . . . 0.0 118.029 167.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.52 HG21 ' CD2' ' A' ' 98' ' ' PHE 0.298 2.4 p -107.52 139.86 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 124.306 1.042 . . . . 0.0 112.207 164.443 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.2 mt -113.54 152.35 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 128.927 2.891 . . . . 0.0 107.581 170.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 5.0 t-80 -120.25 150.46 40.64 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.353 1.461 . . . . 0.0 110.741 175.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.5 mt -129.9 141.73 45.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 126.114 1.766 . . . . 0.0 109.479 -175.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.86 173.38 6.91 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 127.348 2.259 . . . . 0.0 111.067 171.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 17.2 mmmt 62.67 28.88 16.78 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 126.064 1.745 . . . . 0.0 113.503 175.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.89 164.41 21.7 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 124.7 1.2 . . . . 0.0 110.802 173.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.477 ' HD3' HD13 ' A' ' 121' ' ' LEU . 52.2 Cg_exo -59.19 -175.82 0.09 OUTLIER 'Trans proline' 0 CA--C 1.537 0.64 1 C-N-CA 125.505 4.137 . . . . 0.0 113.965 157.287 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 30.3 pt -82.56 -30.18 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 126.665 1.986 . . . . 0.0 112.893 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -155.23 35.15 0.38 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.737 1.615 . . . . 0.0 111.331 -168.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -51.54 150.4 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.644 0.778 . . . . 0.0 111.398 174.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.425 HG23 ' H ' ' A' ' 74' ' ' GLU . 8.9 t -89.89 136.42 33.05 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 123.129 1.442 . . . . 0.0 112.413 -177.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.49 -37.59 65.46 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 114.487 -1.233 . . . . 0.0 111.395 173.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -56.21 -38.55 78.01 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.292 0.949 . . . . 0.0 113.605 175.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.425 ' H ' HG23 ' A' ' 71' ' ' THR . 11.2 mt-10 -65.85 -52.41 50.67 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.222 1.009 . . . . 0.0 111.214 171.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.4 t -60.75 -49.05 86.13 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 122.828 0.451 . . . . 0.0 112.203 -177.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.3 pp -70.51 -30.01 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 O-C-N 120.176 -1.577 . . . . 0.0 113.44 178.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 52.1 m -72.19 -17.84 61.9 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 119.175 0.898 . . . . 0.0 112.017 172.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 35.0 mt -85.52 -17.27 36.85 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 165.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.427 ' HA2' ' SD ' ' A' ' 110' ' ' MET . . . -74.12 -40.74 41.57 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 124.3 0.952 . . . . 0.0 112.901 167.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.9 mt -70.17 -34.12 3.91 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 119.097 2.999 . . . . 0.0 119.097 -155.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -59.36 4.16 0.15 Allowed 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 124.029 3.153 . . . . 0.0 117.551 175.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.434 ' CD2' ' HG3' ' A' ' 110' ' ' MET . 56.7 m-85 -120.34 -41.37 2.62 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -167.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -147.61 -113.62 0.75 Allowed Glycine 0 C--N 1.341 0.809 0 CA-C-O 122.374 0.986 . . . . 0.0 111.983 176.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.429 ' HB3' ' CG ' ' A' ' 102' ' ' ASN . 33.5 tptt -149.48 117.42 6.3 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 129.821 3.248 . . . . 0.0 104.78 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.437 HG22 ' HE2' ' A' ' 101' ' ' MET 0.29 16.3 t -127.29 82.68 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 CA-C-O 122.9 1.334 . . . . 0.0 109.145 -158.229 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.3 t -74.3 -26.82 60.41 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 127.054 2.142 . . . . 0.0 112.148 -162.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -141.02 166.22 25.4 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 123.268 1.508 . . . . 0.0 114.364 177.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -147.38 174.83 11.3 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 128.047 2.539 . . . . 0.0 109.874 160.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.516 ' C ' HD23 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -145.63 155.77 43.23 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.96 1.304 . . . . 0.0 110.137 177.179 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 3.7 mtt -127.55 107.05 9.6 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.096 0.958 . . . . 0.0 111.705 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -76.08 64.66 1.98 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.958 0.903 . . . . 0.0 109.133 165.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 31.8 tttp -53.48 -45.19 69.51 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.706 1.602 . . . . 0.0 113.471 -159.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -70.73 -11.62 69.39 Favored Glycine 0 CA--C 1.539 1.592 0 C-N-CA 124.979 1.276 . . . . 0.0 115.797 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.6 -1.04 25.15 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 118.919 1.36 . . . . 0.0 113.191 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.4 m120 60.24 38.26 20.08 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.441 1.496 . . . . 0.0 112.64 -167.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -128.35 163.25 25.24 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.146 0.979 . . . . 0.0 112.062 -172.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -155.0 166.41 33.68 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.79 1.636 . . . . 0.0 112.035 -178.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.52 ' CD2' HG21 ' A' ' 60' ' ' VAL . 5.1 m-30 -113.66 155.8 24.87 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.769 2.028 . . . . 0.0 108.512 160.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.6 tt -137.02 130.61 45.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 119.632 1.106 . . . . 0.0 109.711 162.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -127.16 120.04 27.88 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.995 2.118 . . . . 0.0 112.241 -160.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.437 ' HE2' HG22 ' A' ' 85' ' ' VAL . 0.2 OUTLIER -134.72 154.34 51.61 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 112.994 -1.912 . . . . 0.0 113.232 -164.479 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.449 ' CG ' HG23 ' A' ' 103' ' ' THR . 0.0 OUTLIER -72.26 -20.31 61.55 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 115.29 1.589 . . . . 0.0 115.29 -158.253 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.449 HG23 ' CG ' ' A' ' 102' ' ' ASN . 9.4 p -136.66 138.07 40.71 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.702 1.201 . . . . 0.0 111.209 -175.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -58.42 -32.29 68.54 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.96 174.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -73.54 -42.67 61.41 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -54.34 -53.11 58.3 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 119.669 1.122 . . . . 0.0 109.518 169.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.62 -34.33 71.98 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -174.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -58.44 -50.47 73.61 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.109 0.868 . . . . 0.0 110.56 169.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -62.11 -33.1 73.83 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 121.583 -0.698 . . . . 0.0 110.99 175.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.434 ' HG3' ' CD2' ' A' ' 82' ' ' PHE . 11.1 ttp -73.46 -48.94 29.58 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 124.085 0.954 . . . . 0.0 112.263 -176.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 1.1 p -63.78 -38.72 83.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 124.341 1.056 . . . . 0.0 110.995 179.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -71.96 -42.59 66.4 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.881 1.272 . . . . 0.0 111.549 177.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -47.68 -55.56 9.19 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.909 1.284 . . . . 0.0 109.984 165.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -78.29 11.58 2.32 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 118.855 -2.403 . . . . 0.0 113.826 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 53.3 m -111.82 -15.48 13.37 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.633 1.173 . . . . 0.0 110.988 171.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.417 ' CB ' HG23 ' A' ' 117' ' ' VAL . 0.4 OUTLIER -89.41 -44.59 10.07 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.733 2.013 . . . . 0.0 111.841 163.763 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.417 HG23 ' CB ' ' A' ' 116' ' ' SER . 96.4 t -112.35 -49.73 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 125.02 1.328 . . . . 0.0 111.951 -143.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.445 ' CG2' ' H ' ' A' ' 126' ' ' ILE . 31.5 m 69.81 141.45 0.08 OUTLIER Pre-proline 0 N--CA 1.485 1.29 0 C-N-CA 128.21 2.604 . . . . 0.0 112.308 -173.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -82.05 -12.88 10.52 Favored 'Trans proline' 0 CA--C 1.549 1.251 0 C-N-CA 123.385 2.723 . . . . 0.0 114.105 -176.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 22.0 t 50.6 101.17 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 131.144 3.778 . . . . 0.0 115.541 175.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.477 HD13 ' HD3' ' A' ' 67' ' ' PRO . 1.2 tt -92.08 101.62 14.16 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 123.763 0.825 . . . . 0.0 109.819 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 45.6 62.47 2.18 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.735 2.014 . . . . 0.0 112.086 178.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 81.2 6.93 89.01 Favored Glycine 0 CA--C 1.537 1.426 0 N-CA-C 116.015 1.166 . . . . 0.0 116.015 173.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 35.1 tp60 -131.72 142.49 45.45 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 125.83 1.652 . . . . 0.0 110.109 -173.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -61.1 166.31 10.94 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 123.119 2.546 . . . . 0.0 114.529 179.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.445 ' H ' ' CG2' ' A' ' 118' ' ' THR . 0.6 OUTLIER -136.79 154.41 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.797 1.639 . . . . 0.0 109.989 178.088 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -120.45 91.05 3.45 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 124.33 1.052 . . . . 0.0 109.056 -155.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -95.95 152.76 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 124.913 1.285 . . . . 0.0 111.994 -179.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -147.92 161.48 41.22 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.75 1.62 . . . . 0.0 108.339 152.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.91 153.31 4.86 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.006 -1.059 . . . . 0.0 112.041 158.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.498 ' OG ' HG13 ' A' ' 60' ' ' VAL . 54.7 p -65.11 170.17 4.76 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 177.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -87.64 6.75 33.13 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.405 1.482 . . . . 0.0 112.874 164.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -132.84 -176.01 3.97 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.445 1.498 . . . . 0.0 113.243 -161.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 42.0 tttp -140.26 101.35 4.11 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.536 1.935 . . . . 0.0 111.162 -177.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 64.74 108.11 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 127.448 2.299 . . . . 0.0 114.611 -174.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 18.8 tp -63.88 124.7 22.2 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.245 1.818 . . . . 0.0 111.956 169.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt . . . . . 0 N--CA 1.473 0.715 0 C-N-CA 127.163 2.185 . . . . 0.0 110.634 167.288 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 30.0 p . . . . . 0 CA--C 1.547 0.836 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 32.2 mtp180 -61.02 -6.09 1.72 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 130.541 3.537 . . . . 0.0 118.339 -165.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.617 HG13 ' HB3' ' A' ' 131' ' ' SER 0.254 2.5 p -101.17 131.35 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 120.809 1.64 . . . . 0.0 112.092 166.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 16.9 mt -103.24 153.92 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 127.379 2.272 . . . . 0.0 109.478 165.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -120.39 143.95 48.16 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.772 1.629 . . . . 0.0 110.528 175.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.9 mt -122.58 133.46 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 127.071 2.148 . . . . 0.0 109.776 -173.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 28.9 mtt180 -88.39 166.63 14.12 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.672 1.589 . . . . 0.0 110.543 173.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.9 mtpp 50.51 35.42 11.23 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 155.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.79 162.82 0.71 Allowed Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 126.446 1.898 . . . . 0.0 111.521 162.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -56.14 179.24 0.1 OUTLIER 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 124.326 3.351 . . . . 0.0 114.912 156.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 31.1 pt -77.36 -30.41 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 126.599 1.96 . . . . 0.0 113.168 -176.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -157.75 36.86 0.26 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.993 1.717 . . . . 0.0 110.971 -170.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -50.27 151.05 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.966 0.906 . . . . 0.0 111.627 175.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.7 t -85.19 128.05 34.52 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 123.583 1.659 . . . . 0.0 111.11 174.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -60.9 -22.68 64.57 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 114.823 -1.081 . . . . 0.0 111.773 174.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -62.38 -35.91 92.35 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 125.224 1.392 . . . . 0.0 114.024 167.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -67.88 -46.46 71.61 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.576 -0.955 . . . . 0.0 109.812 171.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 62.0 t -64.85 -44.55 96.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -176.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -75.81 -25.7 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-N 121.973 2.17 . . . . 0.0 114.051 173.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.7 t -62.61 -28.05 69.63 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 119.705 1.139 . . . . 0.0 111.126 166.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 14.8 mt -81.84 -16.02 52.18 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 170.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.43 ' HA2' ' SD ' ' A' ' 110' ' ' MET . . . -91.71 -25.69 22.17 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 115.091 0.796 . . . . 0.0 115.091 171.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 13.4 mt -74.36 -26.72 0.7 Allowed Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 117.974 2.583 . . . . 0.0 117.974 -165.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -59.87 -0.62 0.89 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.174 2.583 . . . . 0.0 116.615 167.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -114.6 -43.92 3.12 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 -168.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -148.42 -112.85 0.68 Allowed Glycine 0 C--N 1.338 0.658 0 CA-C-O 122.587 1.104 . . . . 0.0 112.652 173.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.42 ' HB3' ' CG ' ' A' ' 102' ' ' ASN . 32.7 tptt -146.1 123.02 11.34 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 130.545 3.538 . . . . 0.0 103.894 176.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.466 HG22 ' HE2' ' A' ' 101' ' ' MET 0.276 17.8 t -130.48 85.79 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 CA-C-O 122.604 1.192 . . . . 0.0 109.432 -159.564 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 22.2 p -72.49 -36.04 68.32 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 112.74 -2.027 . . . . 0.0 111.741 -162.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -135.01 160.3 38.76 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 122.822 1.296 . . . . 0.0 114.047 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -149.88 171.95 15.95 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 126.454 1.902 . . . . 0.0 110.487 161.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.506 ' C ' HD23 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -146.7 155.03 42.11 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.49 1.116 . . . . 0.0 110.101 -175.187 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 3.0 mtt -132.94 102.99 5.84 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.357 1.063 . . . . 0.0 111.476 -174.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.0 69.43 3.29 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 122.341 1.067 . . . . 0.0 109.748 168.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -60.53 -20.6 60.78 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.296 1.438 . . . . 0.0 113.25 -177.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.63 -30.34 62.25 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 125.358 1.456 . . . . 0.0 114.968 169.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.6 mtmt -132.39 -5.67 3.35 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 115.548 1.684 . . . . 0.0 115.548 -170.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.7 m120 72.61 38.71 0.76 Allowed 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 127.614 2.366 . . . . 0.0 113.611 -173.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -112.13 167.17 10.61 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.546 0.738 . . . . 0.0 111.271 171.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -147.39 164.48 33.18 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.499 1.519 . . . . 0.0 111.232 172.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.476 ' CD2' HG21 ' A' ' 60' ' ' VAL . 6.7 m-30 -109.27 157.33 18.94 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.44 1.496 . . . . 0.0 107.99 160.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 19.2 tt -137.31 124.33 29.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 124.599 1.16 . . . . 0.0 109.216 162.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -120.91 123.6 42.9 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 127.514 2.326 . . . . 0.0 111.445 -167.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.466 ' HE2' HG22 ' A' ' 85' ' ' VAL . 0.1 OUTLIER -133.99 157.45 46.04 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 112.724 -2.035 . . . . 0.0 113.222 -164.287 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.455 ' CG ' HG23 ' A' ' 103' ' ' THR . 0.0 OUTLIER -70.78 -23.06 62.32 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.376 1.251 . . . . 0.0 114.376 -161.581 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.455 HG23 ' CG ' ' A' ' 102' ' ' ASN . 9.8 p -135.58 140.64 44.79 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 122.622 1.201 . . . . 0.0 111.772 -175.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -59.83 -33.01 71.21 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.084 174.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -74.49 -41.61 60.41 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -54.54 -51.67 64.48 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 119.4 1.0 . . . . 0.0 109.803 168.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.28 -36.09 74.15 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -176.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -58.91 -46.98 86.6 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.226 -0.921 . . . . 0.0 111.034 170.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -64.32 -32.7 74.41 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.024 -1.048 . . . . 0.0 111.278 173.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.43 ' SD ' ' HA2' ' A' ' 79' ' ' GLY . 12.9 ttp -71.75 -48.76 44.65 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 119.729 1.15 . . . . 0.0 111.238 -176.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.16 -40.44 89.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 124.498 1.119 . . . . 0.0 111.071 177.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -68.67 -44.77 73.35 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.512 0.725 . . . . 0.0 110.445 177.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -50.15 -38.05 37.5 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.114 1.366 . . . . 0.0 112.25 168.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.442 ' HA ' HG12 ' A' ' 117' ' ' VAL . 25.8 m-85 -92.92 -11.16 34.09 Favored 'General case' 0 C--O 1.231 0.127 0 O-C-N 120.064 -1.648 . . . . 0.0 113.131 -177.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 84.2 m -80.89 -18.22 47.97 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.37 1.068 . . . . 0.0 110.069 166.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.04 -62.2 1.63 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 129.621 3.168 . . . . 0.0 112.3 170.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.442 HG12 ' HA ' ' A' ' 114' ' ' TYR . 1.4 p -83.02 -44.51 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 124.418 1.087 . . . . 0.0 113.018 -151.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.0 m 38.0 121.54 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.068 0 C-N-CA 130.674 3.589 . . . . 0.0 114.636 -147.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -69.84 -33.2 16.74 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 121.204 1.269 . . . . 0.0 114.118 -171.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.2 t 50.89 99.17 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 128.757 2.823 . . . . 0.0 112.313 -176.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.589 ' H ' HD11 ' A' ' 126' ' ' ILE . 1.2 tt -116.33 -73.37 0.65 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 112.201 -2.272 . . . . 0.0 107.472 -146.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.53 -35.01 79.59 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.56 1.144 . . . . 0.0 111.643 172.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 147.41 4.38 0.39 Allowed Glycine 0 CA--C 1.533 1.2 0 C-N-CA 125.083 1.325 . . . . 0.0 116.229 175.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -152.6 167.59 13.02 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 119.15 1.475 . . . . 0.0 111.272 178.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -45.3 110.06 0.22 Allowed 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 124.347 3.364 . . . . 0.0 116.447 -171.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.589 HD11 ' H ' ' A' ' 121' ' ' LEU . 2.5 mm -74.14 166.19 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 125.175 1.39 . . . . 0.0 107.707 166.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -140.66 156.34 46.26 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.218 -0.926 . . . . 0.0 110.483 168.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.21 153.27 38.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 125.517 1.527 . . . . 0.0 111.098 176.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -150.2 167.99 25.3 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.357 1.463 . . . . 0.0 108.772 154.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -55.12 149.47 12.19 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 120.878 -1.139 . . . . 0.0 111.74 159.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.617 ' HB3' HG13 ' A' ' 60' ' ' VAL . 30.8 t -69.28 153.16 44.08 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.897 0.879 . . . . 0.0 112.669 176.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -61.86 -29.13 69.98 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.047 1.339 . . . . 0.0 112.15 167.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 51.1 m-70 -95.11 175.96 6.42 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.592 1.957 . . . . 0.0 111.548 -174.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -134.64 120.53 19.67 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.272 1.429 . . . . 0.0 111.072 -177.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 58.55 90.39 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 128.201 2.601 . . . . 0.0 114.131 -178.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 35.9 tp -59.04 128.73 38.66 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.2 1.4 . . . . 0.0 112.111 176.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt . . . . . 0 N--CA 1.469 0.483 0 C-N-CA 126.348 1.859 . . . . 0.0 110.523 170.075 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 49.1 m . . . . . 0 N--CA 1.479 1.015 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 34.4 mtp180 -55.82 -7.43 0.3 Allowed 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 129.909 3.284 . . . . 0.0 119.324 -170.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.658 HG13 ' HB3' ' A' ' 131' ' ' SER . 2.6 p -105.66 134.71 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-N 119.759 1.163 . . . . 0.0 111.878 169.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 10.4 mt -106.0 150.25 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 126.433 1.893 . . . . 0.0 108.561 167.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -114.03 143.97 43.87 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.082 1.353 . . . . 0.0 110.569 173.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 7.2 mt -118.46 144.8 25.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 126.488 1.915 . . . . 0.0 108.395 -175.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.23 167.87 17.75 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 127.739 2.415 . . . . 0.0 109.639 168.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.72 27.91 17.27 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.816 1.246 . . . . 0.0 113.229 178.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 28.2 mt -66.96 177.25 0.9 Allowed Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 125.05 1.34 . . . . 0.0 109.792 163.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -51.88 -171.97 0.01 OUTLIER 'Trans proline' 0 CA--C 1.545 1.062 0 C-N-CA 123.181 2.587 . . . . 0.0 114.507 147.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.418 HG12 ' H ' ' A' ' 68' ' ' ILE . 3.7 mm -60.31 -47.26 93.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 127.427 2.291 . . . . 0.0 111.189 -176.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -155.51 -7.44 0.12 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 129.334 3.054 . . . . 0.0 111.666 -162.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.429 HG22 ' H ' ' A' ' 71' ' ' THR 0.307 7.9 p 26.05 -127.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 128.903 2.881 . . . . 0.0 113.457 -167.956 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.429 ' H ' HG22 ' A' ' 70' ' ' VAL . 9.8 t -154.51 143.8 21.27 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 120.004 1.275 . . . . 0.0 110.421 163.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -58.31 -42.12 86.0 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 123.562 0.745 . . . . 0.0 112.276 -175.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -55.79 -37.94 71.33 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 123.861 0.743 . . . . 0.0 112.516 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -69.12 -53.37 20.53 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.454 1.102 . . . . 0.0 112.125 173.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 97.7 t -58.97 -46.69 91.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 122.941 0.496 . . . . 0.0 112.14 -176.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.0 pp -73.05 -33.74 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 O-C-N 120.674 -1.266 . . . . 0.0 112.531 177.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 64.0 m -69.55 -21.44 63.64 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 120.047 1.294 . . . . 0.0 111.599 175.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.9 mt -77.63 -27.67 51.17 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 170.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -89.98 -21.25 39.84 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-N 119.239 0.927 . . . . 0.0 114.526 176.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.0 mt -64.05 -37.65 28.68 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 117.858 2.54 . . . . 0.0 117.858 -169.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.48 -4.01 1.09 Allowed 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.787 2.991 . . . . 0.0 116.845 171.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -106.97 -35.34 6.93 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 113.496 0.925 . . . . 0.0 113.496 -167.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -154.58 -108.37 0.31 Allowed Glycine 0 C--N 1.338 0.647 0 CA-C-O 122.622 1.123 . . . . 0.0 111.964 172.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.416 ' HB3' ' CG ' ' A' ' 102' ' ' ASN . 32.0 tptt -149.61 122.14 8.54 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 130.415 3.486 . . . . 0.0 104.135 175.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.431 HG22 ' HE2' ' A' ' 101' ' ' MET 0.308 20.8 t -128.74 83.98 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 CA-C-N 120.034 1.288 . . . . 0.0 109.955 -160.409 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.5 t -79.72 -21.22 44.84 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 126.894 2.077 . . . . 0.0 112.765 -163.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -141.51 161.74 37.17 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 175.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -149.37 171.82 15.92 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.577 2.351 . . . . 0.0 110.551 162.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.529 ' C ' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -142.99 154.47 44.05 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.266 1.426 . . . . 0.0 108.772 172.692 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 3.7 mtt -128.28 105.62 8.47 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.748 1.219 . . . . 0.0 110.434 -175.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.415 HD13 HD11 ' A' ' 89' ' ' LEU . 1.6 mm? -74.11 71.52 1.64 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.186 0.994 . . . . 0.0 110.525 173.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -49.85 118.87 3.11 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.835 1.654 . . . . 0.0 111.574 -176.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.04 -6.37 82.72 Favored Glycine 0 CA--C 1.539 1.556 0 CA-C-O 118.279 -1.289 . . . . 0.0 116.178 177.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.51 -2.98 50.72 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-N 119.837 1.818 . . . . 0.0 113.154 165.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.9 m120 63.24 27.37 15.5 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.313 1.845 . . . . 0.0 113.283 -167.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -124.58 164.51 19.66 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.513 0.725 . . . . 0.0 112.302 -168.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -164.12 170.71 16.07 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.091 1.756 . . . . 0.0 111.177 -178.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.478 ' CD2' HG21 ' A' ' 60' ' ' VAL . 4.3 m-30 -116.74 156.02 27.9 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.448 1.899 . . . . 0.0 108.088 164.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 17.4 tt -138.14 124.41 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 124.722 1.209 . . . . 0.0 109.138 164.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -122.79 122.17 38.04 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 127.034 2.134 . . . . 0.0 111.474 -164.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.431 ' HE2' HG22 ' A' ' 85' ' ' VAL . 0.9 OUTLIER -132.63 157.33 45.07 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 113.389 -1.732 . . . . 0.0 112.97 -166.028 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.416 ' CG ' ' HB3' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -71.79 -19.34 62.02 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 114.065 -1.425 . . . . 0.0 114.308 -159.508 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.415 HG23 ' CG ' ' A' ' 102' ' ' ASN . 16.8 p -137.83 142.64 40.77 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 122.956 1.36 . . . . 0.0 111.766 -176.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -59.43 -37.42 78.04 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 114.125 -1.398 . . . . 0.0 110.706 176.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -71.64 -40.35 69.79 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 179.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.0 -52.53 62.85 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 119.403 1.001 . . . . 0.0 110.073 169.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.99 -38.16 82.35 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -56.15 -48.24 76.65 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.818 -0.551 . . . . 0.0 111.048 171.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -64.84 -35.01 79.74 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 118.407 -0.806 . . . . 0.0 111.233 173.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 8.2 ttp -67.76 -48.55 66.07 Favored 'General case' 0 C--N 1.343 0.303 0 C-N-CA 124.554 1.142 . . . . 0.0 110.554 -175.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.84 -40.64 88.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 C-N-CA 124.752 1.221 . . . . 0.0 111.761 178.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -67.71 -45.3 75.48 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.377 0.671 . . . . 0.0 110.693 177.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -50.97 -38.31 49.98 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.604 1.562 . . . . 0.0 112.482 167.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.442 ' HA ' HG12 ' A' ' 117' ' ' VAL . 17.8 m-85 -88.73 -16.47 32.15 Favored 'General case' 0 CA--C 1.517 -0.289 0 O-C-N 119.966 -1.709 . . . . 0.0 112.88 -178.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 70.0 m -79.06 -18.61 53.13 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.434 1.093 . . . . 0.0 109.865 169.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.42 -60.58 2.22 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 129.384 3.074 . . . . 0.0 111.697 169.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.442 HG12 ' HA ' ' A' ' 114' ' ' TYR . 0.8 OUTLIER -88.47 -48.07 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.048 0.939 . . . . 0.0 112.955 -153.302 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.2 m 43.08 125.28 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.88 0 C-N-CA 129.866 3.266 . . . . 0.0 114.267 -148.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -70.14 -35.35 11.67 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 121.416 1.411 . . . . 0.0 114.012 -171.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.6 t 53.86 102.33 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 128.597 2.759 . . . . 0.0 113.031 -178.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.532 ' H ' HD11 ' A' ' 126' ' ' ILE . 0.8 OUTLIER -123.59 -71.46 0.72 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 112.479 -2.146 . . . . 0.0 108.28 -147.293 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.78 -42.51 99.09 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.521 0.728 . . . . 0.0 111.086 171.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 158.18 -2.47 0.12 Allowed Glycine 0 CA--C 1.533 1.198 0 N-CA-C 116.208 1.243 . . . . 0.0 116.208 173.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -148.13 169.56 9.07 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 119.54 1.67 . . . . 0.0 111.192 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -50.98 116.07 2.41 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.734 2.956 . . . . 0.0 116.535 -166.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.532 HD11 ' H ' ' A' ' 121' ' ' LEU . 4.3 mm -76.27 150.06 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 126.364 1.866 . . . . 0.0 109.166 174.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 10.2 m-30 -114.7 136.7 52.77 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.042 -1.036 . . . . 0.0 110.787 -176.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.5 149.3 32.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 125.1 1.36 . . . . 0.0 112.319 176.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -153.46 164.9 37.39 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.763 2.025 . . . . 0.0 109.627 153.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -53.19 152.23 4.53 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 120.873 -1.142 . . . . 0.0 112.593 167.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.658 ' HB3' HG13 ' A' ' 60' ' ' VAL . 27.9 t -76.18 157.87 32.27 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.726 0.81 . . . . 0.0 113.086 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -68.51 -12.03 60.68 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.854 1.662 . . . . 0.0 113.636 168.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 42.6 m-70 -119.6 -178.69 3.68 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.484 1.513 . . . . 0.0 112.895 -170.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -136.88 124.95 22.9 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.981 2.112 . . . . 0.0 110.639 178.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 58.28 93.05 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 127.185 2.194 . . . . 0.0 113.946 -178.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 28.9 tp -64.01 110.96 2.31 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.666 1.587 . . . . 0.0 111.814 178.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt . . . . . 0 N--CA 1.473 0.678 0 C-N-CA 126.204 1.802 . . . . 0.0 110.425 174.989 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.1 t . . . . . 0 N--CA 1.473 0.714 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 25.8 mtp180 61.5 -8.54 0.09 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 128.836 2.854 . . . . 0.0 117.839 171.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.681 HG13 ' HB3' ' A' ' 131' ' ' SER 0.3 3.9 p -104.81 130.3 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 120.906 1.685 . . . . 0.0 113.409 175.347 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.8 mp -103.21 155.21 5.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 127.617 2.367 . . . . 0.0 108.103 169.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -126.93 140.96 51.94 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.801 2.04 . . . . 0.0 111.024 177.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.6 mt -120.75 136.63 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 128.309 2.644 . . . . 0.0 109.857 -170.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.6 mtt180 -97.19 176.65 5.85 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 120.517 1.508 . . . . 0.0 111.02 172.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp 45.34 35.79 2.01 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 127.739 2.415 . . . . 0.0 117.068 159.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.8 mp -52.03 157.42 2.16 Favored Pre-proline 0 CA--C 1.559 1.303 0 C-N-CA 124.771 1.228 . . . . 0.0 110.912 165.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -42.0 -65.72 0.18 Allowed 'Trans proline' 0 CA--C 1.537 0.648 1 C-N-CA 126.033 4.488 . . . . 0.0 115.385 177.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 pt -160.54 -55.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 130.262 3.425 . . . . 0.0 107.898 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -145.99 -9.47 0.52 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.31 1.444 . . . . 0.0 114.508 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.518 HG22 ' H ' ' A' ' 71' ' ' THR 0.28 1.7 p 45.14 -154.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 127.611 2.364 . . . . 0.0 112.997 -178.616 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.518 ' H ' HG22 ' A' ' 70' ' ' VAL . 4.0 t -137.43 143.0 41.63 Favored 'General case' 0 C--O 1.238 0.499 0 O-C-N 120.396 -1.44 . . . . 0.0 110.466 160.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -58.46 -33.41 69.71 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.763 177.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -56.59 -41.3 89.16 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 123.953 0.787 . . . . 0.0 112.96 175.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -64.53 -55.83 18.0 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.815 0.846 . . . . 0.0 111.11 171.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.7 t -61.05 -44.22 97.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -173.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.9 pp -69.44 -32.65 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 O-C-N 120.301 -1.499 . . . . 0.0 112.652 175.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.6 p -64.28 -21.23 66.52 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 119.738 1.153 . . . . 0.0 112.214 173.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 86.8 mt -91.6 -16.14 27.55 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 173.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -90.02 -22.78 34.52 Favored Glycine 0 CA--C 1.538 1.509 0 CA-C-N 119.144 0.884 . . . . 0.0 113.214 168.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 80' ' ' LEU . 21.0 mt -73.37 -14.98 0.25 Allowed Pre-proline 0 CA--C 1.543 0.677 0 N-CA-C 119.314 3.079 . . . . 0.0 119.314 -175.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -60.5 -1.53 1.49 Allowed 'Trans proline' 0 C--N 1.348 0.525 0 CA-C-N 123.152 2.162 . . . . 0.0 116.62 168.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -122.05 -53.62 1.94 Allowed 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 114.698 1.369 . . . . 0.0 114.698 -168.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -144.06 -106.57 0.54 Allowed Glycine 0 C--N 1.337 0.598 0 C-N-CA 124.149 0.88 . . . . 0.0 111.985 -178.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 13.7 tptm -143.41 -7.52 0.78 Allowed 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 116.805 2.15 . . . . 0.0 116.805 -174.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 101' ' ' MET . 0.1 OUTLIER 30.26 87.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 129.029 2.932 . . . . 0.0 113.37 -176.782 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 24.1 m -55.42 -42.3 73.94 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 127.378 2.271 . . . . 0.0 111.695 -175.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -149.72 169.53 20.83 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.4 pp -139.49 171.95 13.51 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.97 1.708 . . . . 0.0 112.189 155.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.529 ' C ' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -144.18 151.95 40.22 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.176 1.79 . . . . 0.0 108.476 173.867 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 5.1 mtt -128.77 103.52 7.11 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.326 1.05 . . . . 0.0 111.924 -175.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.444 ' CD1' HD11 ' A' ' 89' ' ' LEU . 1.2 mm? -74.43 96.02 2.82 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.927 1.291 . . . . 0.0 110.878 172.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 49.4 mttp -61.17 -19.18 61.26 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 171.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -53.33 -61.07 7.33 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 126.379 1.942 . . . . 0.0 114.968 -177.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.34 27.06 4.79 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.632 1.973 . . . . 0.0 112.239 -175.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 59.45 48.5 9.78 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.723 2.009 . . . . 0.0 113.709 -177.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . 0.28 0.0 OUTLIER -117.59 176.14 5.31 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.042 0.937 . . . . 0.0 111.935 176.838 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -166.48 165.81 16.73 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 120.276 -1.515 . . . . 0.0 111.018 -174.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.439 ' CD2' HG21 ' A' ' 60' ' ' VAL . 4.2 m-30 -112.46 157.37 21.17 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.908 1.683 . . . . 0.0 108.484 166.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 8.6 tt -143.62 108.32 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 126.111 1.764 . . . . 0.0 107.618 170.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -115.34 131.91 56.78 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.846 2.058 . . . . 0.0 112.014 -166.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.452 ' HA ' ' HA ' ' A' ' 85' ' ' VAL 0.292 1.2 tpp -130.46 153.5 48.72 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 116.835 2.161 . . . . 0.0 116.835 -161.498 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.0 -9.2 51.23 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.182 1.793 . . . . 0.0 114.675 -165.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -148.76 143.89 26.68 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.459 1.504 . . . . 0.0 110.111 -177.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -66.54 -32.76 74.31 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.221 1.008 . . . . 0.0 111.726 176.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -71.83 -47.44 53.16 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.346 0.658 . . . . 0.0 112.09 177.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.79 -46.47 87.48 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 122.83 0.452 . . . . 0.0 110.619 175.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.22 -40.65 82.0 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -60.77 -46.43 90.48 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.851 -0.531 . . . . 0.0 111.102 171.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -63.3 -29.09 70.48 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 120.421 -1.425 . . . . 0.0 111.198 171.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 10.4 ttp -67.06 -52.11 46.27 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 120.13 1.332 . . . . 0.0 110.048 -177.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.74 -40.51 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 124.547 1.139 . . . . 0.0 111.85 176.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -71.29 -44.07 65.91 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.751 0.82 . . . . 0.0 111.824 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -48.42 -38.66 20.22 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.454 1.501 . . . . 0.0 111.629 166.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.64 ' HA ' HG12 ' A' ' 117' ' ' VAL . 11.6 m-85 -85.98 -22.26 27.42 Favored 'General case' 0 N--CA 1.445 -0.715 0 O-C-N 120.649 -1.282 . . . . 0.0 113.248 -175.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.08 -15.89 57.54 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.984 0.897 . . . . 0.0 111.107 171.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.7 -59.43 2.79 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 128.932 2.893 . . . . 0.0 111.045 169.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.64 HG12 ' HA ' ' A' ' 114' ' ' TYR . 3.2 p -78.01 -48.92 22.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 124.474 1.11 . . . . 0.0 112.43 -158.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.5 m 28.78 121.91 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.038 0 C-N-CA 129.044 2.938 . . . . 0.0 114.789 -138.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -80.86 -7.65 13.34 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 121.789 1.659 . . . . 0.0 115.002 -167.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 4.1 t 28.88 85.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 C-N-CA 130.239 3.416 . . . . 0.0 114.041 173.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . 0.268 9.7 tt -106.95 -23.6 12.29 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 118.01 -1.476 . . . . 0.0 112.507 -121.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.35 -6.68 11.25 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.633 1.173 . . . . 0.0 113.997 148.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 139.74 11.51 0.72 Allowed Glycine 0 CA--C 1.536 1.364 0 N-CA-C 118.059 1.984 . . . . 0.0 118.059 -169.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.8 155.75 69.06 Favored Pre-proline 0 C--N 1.346 0.417 0 CA-C-N 120.771 2.286 . . . . 0.0 112.999 172.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.04 152.72 49.68 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.985 2.456 . . . . 0.0 113.674 -177.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 29.8 mm -117.74 -53.88 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 123.646 0.778 . . . . 0.0 112.917 -163.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 62.13 151.14 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.975 2.11 . . . . 0.0 115.255 -170.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.45 157.06 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 125.914 1.686 . . . . 0.0 110.799 174.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -147.75 166.06 28.65 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.384 1.474 . . . . 0.0 109.453 155.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -55.64 146.89 19.58 Favored 'General case' 0 CA--C 1.547 0.858 0 O-C-N 121.353 -0.842 . . . . 0.0 111.303 158.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.681 ' HB3' HG13 ' A' ' 60' ' ' VAL . 29.4 t -73.39 161.48 30.4 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.669 1.187 . . . . 0.0 113.673 -175.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -73.03 -10.88 60.27 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.139 1.376 . . . . 0.0 113.573 167.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 57.7 m-70 -115.46 172.35 7.16 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.441 1.497 . . . . 0.0 112.403 -172.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -122.02 110.04 15.31 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 126.576 1.95 . . . . 0.0 109.728 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 61.88 167.94 0.11 Allowed 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 126.592 1.957 . . . . 0.0 113.924 -166.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 22.7 tp -132.19 97.87 4.25 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 128.617 2.767 . . . . 0.0 112.521 -172.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? . . . . . 0 N--CA 1.474 0.754 0 C-N-CA 127.601 2.361 . . . . 0.0 111.156 179.796 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 CA--C 1.543 0.71 0 CA-C-O 120.995 0.426 . . . . 0.0 111.65 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 44.4 mtp180 -55.11 -9.21 0.37 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 130.121 3.368 . . . . 0.0 119.474 -158.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.479 HG13 ' HB3' ' A' ' 131' ' ' SER 0.409 7.2 p -101.26 132.27 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 CA-C-N 122.404 2.366 . . . . 0.0 113.495 170.702 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 26.0 mt -111.22 153.71 12.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 128.287 2.635 . . . . 0.0 107.696 172.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -124.14 146.99 48.29 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.874 1.27 . . . . 0.0 111.446 178.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.1 mt -126.27 142.76 41.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 127.367 2.267 . . . . 0.0 109.977 -173.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.09 172.55 8.16 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 126.904 2.082 . . . . 0.0 112.41 170.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 67.13 19.51 10.4 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 126.456 1.902 . . . . 0.0 114.529 175.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.2 mp -54.02 154.95 6.92 Favored Pre-proline 0 CA--C 1.556 1.174 0 C-N-CA 122.791 0.437 . . . . 0.0 111.897 171.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -48.75 -58.4 1.78 Allowed 'Trans proline' 0 CA--C 1.536 0.596 1 C-N-CA 125.454 4.102 . . . . 0.0 114.651 175.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 pt -171.6 -53.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 131.372 3.869 . . . . 0.0 108.428 -178.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -147.27 -10.13 0.43 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 126.096 1.758 . . . . 0.0 113.701 -171.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.412 HG22 ' H ' ' A' ' 71' ' ' THR 0.293 5.0 p 40.47 -136.64 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 127.262 2.225 . . . . 0.0 112.251 -177.833 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.412 ' H ' HG22 ' A' ' 70' ' ' VAL . 1.8 t -143.32 133.99 25.12 Favored 'General case' 0 C--O 1.241 0.618 0 O-C-N 120.846 -1.159 . . . . 0.0 109.175 156.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.59 -30.21 68.5 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.335 -178.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -60.31 -36.59 91.32 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.938 1.256 . . . . 0.0 113.405 174.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -66.23 -52.25 49.63 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 118.153 0.976 . . . . 0.0 110.814 170.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.0 t -63.58 -42.29 95.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -174.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.423 ' CG2' HD22 ' A' ' 88' ' ' LEU . 2.3 pp -72.92 -32.43 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 O-C-N 120.168 -1.583 . . . . 0.0 113.131 175.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 36.2 t -62.38 -27.31 68.99 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 119.038 0.836 . . . . 0.0 110.852 171.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 31.3 mt -86.53 -15.67 39.27 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 173.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -92.43 -19.59 37.85 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.887 1.232 . . . . 0.0 113.599 172.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.5 mt -65.11 -46.08 73.02 Favored Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 116.808 2.151 . . . . 0.0 116.808 -171.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.61 -4.03 0.74 Allowed 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 124.657 3.571 . . . . 0.0 118.496 178.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -104.92 -33.8 8.25 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -165.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -160.99 -78.34 0.03 OUTLIER Glycine 0 C--N 1.331 0.262 0 C-N-CA 125.785 1.659 . . . . 0.0 109.032 176.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -150.96 -13.79 0.22 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 116.678 2.103 . . . . 0.0 116.678 170.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.485 ' H ' ' HE1' ' A' ' 101' ' ' MET . 2.2 m 29.49 171.73 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.246 0 CA-C-O 123.262 1.506 . . . . 0.0 114.829 -127.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.3 t -124.27 -26.81 3.89 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 119.16 -2.212 . . . . 0.0 112.435 163.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -162.22 166.28 25.7 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 172.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.423 HD22 ' CG2' ' A' ' 76' ' ' ILE . 1.4 pt? -140.43 166.85 23.58 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.656 1.582 . . . . 0.0 113.411 159.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.516 ' C ' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -143.13 151.44 40.7 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 128.073 2.549 . . . . 0.0 108.662 -177.562 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 6.4 mtt -127.45 111.9 14.36 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.258 1.023 . . . . 0.0 111.132 -179.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.469 HD13 HD11 ' A' ' 89' ' ' LEU . 1.9 mm? -73.31 72.4 1.28 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.689 1.196 . . . . 0.0 111.102 175.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -57.79 125.36 22.69 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.467 1.107 . . . . 0.0 110.75 175.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 96.58 -8.72 66.41 Favored Glycine 0 CA--C 1.537 1.458 0 C-N-CA 125.242 1.401 . . . . 0.0 115.56 -173.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.94 -9.14 10.13 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 119.343 1.571 . . . . 0.0 113.693 169.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.2 m120 59.76 39.67 20.54 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.305 1.842 . . . . 0.0 112.806 -174.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -121.82 172.64 8.02 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.232 1.013 . . . . 0.0 111.325 -179.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -159.75 165.38 32.6 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.654 1.582 . . . . 0.0 111.336 178.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.432 ' CD2' HG21 ' A' ' 60' ' ' VAL . 4.0 m-30 -115.44 150.39 36.52 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 126.498 1.919 . . . . 0.0 107.638 166.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 16.2 tt -134.92 98.93 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 125.046 1.339 . . . . 0.0 108.659 167.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -85.49 131.67 34.33 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 127.495 2.318 . . . . 0.0 110.974 176.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.485 ' HE1' ' H ' ' A' ' 85' ' ' VAL 0.283 11.6 tpp -120.27 155.81 32.5 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 -170.989 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.72 -22.0 64.36 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -170.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.91 147.64 37.4 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.168 0.987 . . . . 0.0 110.96 -175.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -66.04 -38.53 88.63 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.047 0.539 . . . . 0.0 111.843 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -71.9 -40.71 68.67 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 178.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -54.67 -50.52 68.0 Favored 'General case' 0 C--O 1.219 -0.545 0 C-N-CA 122.997 0.519 . . . . 0.0 110.607 170.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.59 -37.88 73.95 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -178.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -55.92 -47.87 76.72 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.45 1.023 . . . . 0.0 110.875 169.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -66.39 -32.04 73.18 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-O 118.345 -0.836 . . . . 0.0 111.649 173.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 13.3 ttp -70.41 -45.79 65.22 Favored 'General case' 0 C--N 1.345 0.388 0 C-N-CA 125.069 1.348 . . . . 0.0 110.588 -176.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -67.79 -41.11 84.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 124.183 0.993 . . . . 0.0 111.745 177.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -68.52 -44.92 73.59 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.299 0.64 . . . . 0.0 110.564 178.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -47.14 -45.23 22.4 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.375 1.47 . . . . 0.0 111.98 166.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.597 ' HA ' HG12 ' A' ' 117' ' ' VAL . 12.6 m-85 -82.23 -16.66 48.81 Favored 'General case' 0 N--CA 1.456 -0.128 0 O-C-N 121.054 -1.029 . . . . 0.0 112.64 -176.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 92.8 m -80.57 -14.63 58.04 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.364 1.065 . . . . 0.0 110.653 170.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.33 -54.53 3.02 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 128.809 2.843 . . . . 0.0 113.229 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.597 HG12 ' HA ' ' A' ' 114' ' ' TYR . 10.9 p -71.46 -35.82 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 127.171 2.189 . . . . 0.0 114.274 -156.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.455 ' HA ' ' HD3' ' A' ' 119' ' ' PRO . 0.2 OUTLIER -2.51 115.91 0.01 OUTLIER Pre-proline 0 N--CA 1.486 1.347 0 C-N-CA 127.754 2.422 . . . . 0.0 116.875 -125.876 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 118' ' ' THR . 6.1 Cg_exo -76.16 -18.88 15.98 Favored 'Trans proline' 0 CA--C 1.547 1.166 0 C-N-CA 123.506 2.804 . . . . 0.0 113.095 -167.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 6.4 t 60.9 104.03 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 130.072 3.349 . . . . 0.0 113.057 -178.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.6 tt -65.5 -66.93 0.48 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.583 1.153 . . . . 0.0 111.714 -158.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.07 66.56 1.24 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.248 1.419 . . . . 0.0 110.054 168.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 86.04 12.37 71.2 Favored Glycine 0 CA--C 1.54 1.654 0 C-N-CA 124.628 1.109 . . . . 0.0 114.985 -178.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -136.18 141.47 36.31 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 126.564 1.945 . . . . 0.0 109.399 177.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -56.68 166.44 3.72 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 123.579 2.853 . . . . 0.0 112.65 171.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.45 ' H ' ' CG2' ' A' ' 118' ' ' THR . 0.8 OUTLIER -125.23 146.38 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.388 1.075 . . . . 0.0 110.124 -174.957 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -128.94 95.17 4.01 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.28 -1.327 . . . . 0.0 109.039 -153.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.12 151.49 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 124.682 1.193 . . . . 0.0 112.953 -173.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -156.66 170.02 23.37 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.38 1.072 . . . . 0.0 109.976 147.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -52.34 149.28 5.71 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 120.853 -1.154 . . . . 0.0 112.525 170.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.479 ' HB3' HG13 ' A' ' 60' ' ' VAL . 30.3 t -70.64 158.53 36.03 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.182 0.993 . . . . 0.0 112.381 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -63.34 -15.27 56.89 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.826 1.25 . . . . 0.0 112.859 163.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 28.2 m-70 -117.61 -179.83 3.85 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 127.354 2.262 . . . . 0.0 111.206 -175.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -130.81 11.87 5.22 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.73 1.612 . . . . 0.0 113.398 -173.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -167.76 150.95 5.98 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.895 2.078 . . . . 0.0 110.571 -166.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 55.9 tp -140.07 -62.47 0.51 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.019 1.328 . . . . 0.0 113.207 177.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.4 ptmm? . . . . . 0 N--CA 1.481 1.099 0 C-N-CA 128.969 2.907 . . . . 0.0 116.455 178.519 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.2 m . . . . . 0 N--CA 1.478 0.969 0 N-CA-C 117.887 2.551 . . . . 0.0 117.887 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 40.6 mtm-85 81.5 -6.53 1.52 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 128.361 2.665 . . . . 0.0 117.484 152.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.662 HG13 ' HB3' ' A' ' 131' ' ' SER . 2.5 p -118.22 136.57 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 CA-C-N 120.297 1.408 . . . . 0.0 113.125 163.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 10.9 mt -110.86 147.61 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 126.987 2.115 . . . . 0.0 108.795 168.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -110.7 116.59 31.57 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.295 1.438 . . . . 0.0 110.601 175.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 8.9 mt -89.53 134.3 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 126.505 1.922 . . . . 0.0 108.416 175.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -123.38 168.85 11.98 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 126.425 1.89 . . . . 0.0 112.248 171.019 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.5 mmtt 46.38 39.05 5.92 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 127.664 2.386 . . . . 0.0 114.418 -172.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.2 mt -60.55 174.22 0.54 Allowed Pre-proline 0 CA--C 1.556 1.207 0 C-N-CA 125.466 1.506 . . . . 0.0 111.043 158.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.56 -169.88 0.01 OUTLIER 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 124.55 3.5 . . . . 0.0 114.743 151.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 22.4 pt -58.81 -52.5 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.3 1.44 . . . . 0.0 112.644 -175.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -149.07 8.69 0.74 Allowed 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 127.103 2.161 . . . . 0.0 112.889 172.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.309 10.4 p 30.88 -125.46 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 C-N-CA 128.38 2.672 . . . . 0.0 113.294 -169.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.8 t -153.8 143.1 21.49 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 120.248 1.385 . . . . 0.0 110.237 167.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -55.86 -43.21 76.88 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.03 0.932 . . . . 0.0 112.329 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.03 -42.79 61.46 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 124.074 0.845 . . . . 0.0 112.907 178.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -64.94 -53.42 46.62 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.726 0.81 . . . . 0.0 111.894 172.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 83.5 t -59.5 -48.81 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 123.506 0.722 . . . . 0.0 112.442 -175.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.7 pp -70.01 -35.34 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 O-C-N 120.654 -1.279 . . . . 0.0 112.403 178.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.0 m -69.52 -20.85 63.69 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 119.714 1.143 . . . . 0.0 111.82 175.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.2 mt -79.48 -24.5 42.29 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 170.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -94.37 -21.6 26.68 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-N 119.061 0.846 . . . . 0.0 115.161 174.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.5 mt -59.95 -43.02 93.56 Favored Pre-proline 0 CA--C 1.538 0.514 0 N-CA-C 117.113 2.264 . . . . 0.0 117.113 -169.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.54 -6.18 1.44 Allowed 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.88 3.053 . . . . 0.0 116.981 174.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -104.03 -36.08 7.86 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 -167.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -153.03 -108.19 0.35 Allowed Glycine 0 C--N 1.336 0.54 0 CA-C-O 122.763 1.202 . . . . 0.0 111.846 172.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.424 ' HB3' ' CG ' ' A' ' 102' ' ' ASN . 7.0 tppt? -149.53 122.22 8.63 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 130.42 3.488 . . . . 0.0 104.533 175.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.42 HG22 ' HE2' ' A' ' 101' ' ' MET 0.288 21.6 t -129.06 84.71 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 CA-C-O 122.954 1.359 . . . . 0.0 109.213 -160.705 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 41.0 p -82.66 -17.21 45.36 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 127.524 2.33 . . . . 0.0 113.008 -162.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -141.51 160.16 40.73 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 174.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -146.21 175.73 10.28 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.575 1.95 . . . . 0.0 110.773 158.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.463 ' C ' HD23 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -151.48 153.43 34.61 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 125.728 1.611 . . . . 0.0 109.645 177.654 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 4.9 mtp -134.73 95.67 3.39 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.535 0.734 . . . . 0.0 111.628 -167.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.0 91.3 2.5 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.111 1.364 . . . . 0.0 110.947 173.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -63.85 -17.31 63.02 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -65.18 -51.5 49.53 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 125.394 1.473 . . . . 0.0 115.155 -174.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 29.0 mtmt -126.11 22.92 7.19 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 125.73 1.612 . . . . 0.0 112.852 -172.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 20.9 m120 62.45 49.54 4.04 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.661 1.984 . . . . 0.0 113.621 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . 0.281 0.0 OUTLIER -128.78 172.51 11.21 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 177.157 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -157.54 163.24 38.59 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 127.095 2.158 . . . . 0.0 109.614 -175.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.528 ' CD2' HG21 ' A' ' 60' ' ' VAL . 5.2 m-30 -107.84 154.59 21.33 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.98 1.312 . . . . 0.0 107.887 162.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.0 tt -134.51 123.82 43.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 124.404 1.082 . . . . 0.0 108.636 164.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -121.19 122.36 39.81 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.539 1.936 . . . . 0.0 111.769 -165.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.42 ' HE2' HG22 ' A' ' 85' ' ' VAL . 0.6 OUTLIER -137.98 150.29 46.87 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 113.041 -1.891 . . . . 0.0 113.249 -164.721 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.424 ' CG ' ' HB3' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -68.98 -18.87 64.12 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 113.038 -1.892 . . . . 0.0 114.385 -155.587 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.405 HG23 ' CG ' ' A' ' 102' ' ' ASN . 30.2 p -138.54 141.47 39.3 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 123.32 1.533 . . . . 0.0 112.08 -175.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -57.54 -37.31 72.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 113.769 -1.559 . . . . 0.0 110.75 176.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -72.59 -41.39 65.69 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.05 -52.56 62.79 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 119.231 0.923 . . . . 0.0 110.02 170.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.63 -36.87 79.21 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -178.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -55.77 -50.83 69.36 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 118.83 0.741 . . . . 0.0 110.506 170.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -63.66 -35.33 80.19 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-O 118.19 -0.909 . . . . 0.0 111.178 174.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 8.5 ttp -66.93 -51.14 58.88 Favored 'General case' 0 C--N 1.343 0.291 0 CA-C-N 119.747 1.158 . . . . 0.0 110.802 -176.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.41 -39.58 85.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 124.673 1.189 . . . . 0.0 111.761 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -70.22 -45.15 67.16 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.472 0.709 . . . . 0.0 110.942 177.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -50.62 -33.88 23.94 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.678 1.191 . . . . 0.0 112.556 167.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -92.12 -11.74 34.85 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 119.929 -1.732 . . . . 0.0 113.619 -177.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.2 t -86.13 -14.39 44.32 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.964 0.887 . . . . 0.0 111.629 165.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.29 -58.76 3.1 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 128.448 2.699 . . . . 0.0 111.449 167.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -92.27 -49.33 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 123.709 0.804 . . . . 0.0 112.736 -155.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.6 m 45.68 125.9 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.04 0 C-N-CA 130.493 3.517 . . . . 0.0 113.701 -152.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -77.02 -13.88 17.16 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 121.775 1.65 . . . . 0.0 115.76 -171.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.1 t 30.11 92.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 130.032 3.333 . . . . 0.0 114.36 175.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.471 ' C ' HD23 ' A' ' 121' ' ' LEU . 1.4 tt -102.92 -57.31 2.07 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 113.489 -1.687 . . . . 0.0 109.419 -131.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.91 6.71 43.48 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.992 1.717 . . . . 0.0 113.61 165.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 103.23 20.54 11.02 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 126.061 1.791 . . . . 0.0 115.127 -178.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.419 ' HA ' ' HD3' ' A' ' 125' ' ' PRO . 10.8 tp60 -146.71 142.06 16.83 Favored Pre-proline 0 CA--C 1.538 0.489 0 CA-C-O 116.706 -1.616 . . . . 0.0 110.245 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 124' ' ' GLN . 78.5 Cg_exo -52.18 147.35 27.94 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 124.636 3.557 . . . . 0.0 116.115 -167.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.423 HD11 ' H ' ' A' ' 121' ' ' LEU . 3.2 mm -117.93 153.01 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 126.653 1.981 . . . . 0.0 108.629 -177.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 20.0 m-30 -122.54 142.37 50.67 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.979 0.912 . . . . 0.0 110.209 -175.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -131.88 147.88 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.019 1.327 . . . . 0.0 111.628 172.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -147.52 162.54 38.87 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.836 0.854 . . . . 0.0 109.977 145.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -53.35 147.68 10.06 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.47 0.708 . . . . 0.0 112.171 168.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.662 ' HB3' HG13 ' A' ' 60' ' ' VAL . 29.2 t -74.68 133.89 42.04 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 121.486 -0.758 . . . . 0.0 112.215 178.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -67.95 -19.87 65.0 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 176.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -69.59 -52.28 27.53 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -177.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 16.4 mtmm 79.15 152.65 0.13 Allowed 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 128.739 2.816 . . . . 0.0 111.461 -149.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 36.29 95.59 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 129.389 3.076 . . . . 0.0 117.258 164.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 27.6 tp -64.58 110.32 2.29 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.03 1.732 . . . . 0.0 111.596 172.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt . . . . . 0 N--CA 1.473 0.697 0 C-N-CA 125.239 1.416 . . . . 0.0 110.537 172.297 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 25.1 m . . . . . 0 N--CA 1.478 0.928 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 25.1 mtp180 -125.86 -16.4 5.66 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 118.05 2.611 . . . . 0.0 118.05 -159.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.748 HG13 ' HB3' ' A' ' 131' ' ' SER 0.328 7.1 p -105.59 136.58 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 CA-C-N 121.138 1.79 . . . . 0.0 112.002 166.13 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.4 mt -113.41 155.33 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 128.773 2.829 . . . . 0.0 108.06 171.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -122.33 135.44 54.72 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.358 1.463 . . . . 0.0 110.377 177.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.4 mt -120.85 117.15 52.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 126.736 2.014 . . . . 0.0 109.291 -174.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.0 ptt180 -98.26 177.25 5.44 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 126.083 1.753 . . . . 0.0 112.917 177.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 59.63 25.9 14.87 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 127.192 2.197 . . . . 0.0 114.623 175.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 26.2 mt -64.45 150.94 92.53 Favored Pre-proline 0 CA--C 1.56 1.329 0 C-N-CA 122.927 0.491 . . . . 0.0 111.244 176.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -45.91 -66.52 0.15 Allowed 'Trans proline' 0 C--N 1.352 0.751 1 C-N-CA 125.313 4.009 . . . . 0.0 115.124 -178.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 12.4 pt -159.73 -41.87 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 130.177 3.391 . . . . 0.0 109.968 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -154.21 -11.48 0.14 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.949 1.3 . . . . 0.0 113.072 -169.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.512 HG22 ' H ' ' A' ' 71' ' ' THR 0.295 14.4 p 31.29 -121.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 127.099 2.16 . . . . 0.0 111.296 -161.225 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.512 ' H ' HG22 ' A' ' 70' ' ' VAL . 1.1 t -151.29 133.94 15.6 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 126.395 1.878 . . . . 0.0 106.439 155.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -69.28 -20.99 63.91 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.059 -1.026 . . . . 0.0 113.041 -173.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -58.6 -33.6 72.82 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 125.182 1.372 . . . . 0.0 113.665 164.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -75.58 -40.87 55.98 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 121.232 -1.158 . . . . 0.0 111.798 170.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.1 t -57.11 -46.15 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -84.73 -24.56 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 O-C-N 120.534 -1.354 . . . . 0.0 114.52 175.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.0 t -60.79 -31.97 71.33 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 120.187 1.358 . . . . 0.0 110.764 166.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 15.6 mt -74.22 -31.02 62.45 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 171.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -85.72 -19.25 58.45 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-N 119.438 1.017 . . . . 0.0 115.141 178.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.0 mt -70.27 -33.14 3.12 Favored Pre-proline 0 CA--C 1.541 0.605 0 N-CA-C 118.016 2.599 . . . . 0.0 118.016 -165.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -60.25 1.15 0.52 Allowed 'Trans proline' 0 C--N 1.35 0.605 0 C-N-CA 123.646 2.898 . . . . 0.0 116.809 170.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.42 ' CG ' ' HG3' ' A' ' 110' ' ' MET . 33.8 m-85 -116.02 -44.17 2.93 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -167.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -148.14 -108.7 0.51 Allowed Glycine 0 C--N 1.338 0.683 0 C-N-CA 123.873 0.749 . . . . 0.0 111.855 174.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 37.0 tptt -144.49 -12.98 0.59 Allowed 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 178.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.443 HG22 ' CE ' ' A' ' 101' ' ' MET 0.355 1.4 t 45.63 79.71 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 128.577 2.751 . . . . 0.0 114.553 164.914 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.1 m -66.01 -43.34 87.99 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 129.798 3.239 . . . . 0.0 111.811 -168.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -138.32 170.57 15.8 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 122.993 1.378 . . . . 0.0 113.362 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -146.63 173.27 12.49 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.153 2.181 . . . . 0.0 110.827 159.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.464 ' C ' HD23 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -150.59 156.51 41.52 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.45 1.9 . . . . 0.0 109.495 176.003 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 8.1 mtt -129.32 110.56 12.03 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.605 1.162 . . . . 0.0 113.2 -178.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -77.29 97.87 4.99 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.407 1.883 . . . . 0.0 112.396 178.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -75.36 64.37 1.53 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.736 1.614 . . . . 0.0 111.738 167.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.52 -70.14 0.02 OUTLIER Glycine 0 N--CA 1.473 1.125 0 C-N-CA 124.863 1.22 . . . . 0.0 113.313 -177.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -114.5 26.6 10.09 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 127.06 2.144 . . . . 0.0 110.659 176.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 51.6 67.5 0.95 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.795 2.038 . . . . 0.0 113.043 -173.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.64 -178.47 4.38 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 177.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -155.17 164.22 39.13 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.72 2.408 . . . . 0.0 110.118 178.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.472 ' CD2' HG21 ' A' ' 60' ' ' VAL . 5.2 m-30 -107.78 150.23 27.24 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.423 1.489 . . . . 0.0 108.146 161.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 19.2 tt -132.87 119.75 38.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.938 1.295 . . . . 0.0 108.356 165.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -121.47 133.55 55.05 Favored 'General case' 0 CA--C 1.513 -0.454 0 C-N-CA 125.947 1.699 . . . . 0.0 110.84 -165.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.443 ' CE ' HG22 ' A' ' 85' ' ' VAL 0.287 1.3 ptm -137.66 159.41 42.06 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 117.188 2.292 . . . . 0.0 117.188 -169.935 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.4 -18.07 64.37 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 127.035 2.134 . . . . 0.0 112.726 -165.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.11 143.59 34.4 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-O 123.504 1.621 . . . . 0.0 111.86 178.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -66.71 -32.93 74.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 113.492 -1.685 . . . . 0.0 110.762 177.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -72.56 -37.82 68.13 Favored 'General case' 0 N--CA 1.462 0.13 0 C-N-CA 123.763 0.825 . . . . 0.0 113.024 177.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -57.12 -59.25 5.37 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 119.033 0.833 . . . . 0.0 109.62 169.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.45 -39.41 87.47 Favored 'General case' 0 C--O 1.224 -0.26 0 N-CA-C 114.752 1.389 . . . . 0.0 114.752 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -56.01 -51.05 69.14 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.475 -0.766 . . . . 0.0 111.047 172.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -63.65 -32.3 73.73 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.536 -0.727 . . . . 0.0 111.231 175.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.42 ' HG3' ' CG ' ' A' ' 82' ' ' PHE . 5.1 ttp -71.01 -49.05 49.39 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.083 1.353 . . . . 0.0 111.13 -176.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -64.97 -40.17 88.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 124.43 1.092 . . . . 0.0 111.23 178.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -67.58 -46.3 73.06 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.798 0.839 . . . . 0.0 110.196 177.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -49.37 -41.72 39.94 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.18 1.392 . . . . 0.0 112.279 168.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.506 ' HA ' HG12 ' A' ' 117' ' ' VAL . 25.4 m-85 -88.85 -11.46 44.67 Favored 'General case' 0 C--O 1.232 0.166 0 O-C-N 120.405 -1.435 . . . . 0.0 112.996 -176.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 70.6 m -81.04 -17.82 48.88 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.095 0.958 . . . . 0.0 110.195 167.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.62 -57.89 2.71 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 129.189 2.995 . . . . 0.0 113.294 176.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.506 HG12 ' HA ' ' A' ' 114' ' ' TYR . 5.9 p -79.44 -37.65 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -149.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.425 ' HA ' ' HD3' ' A' ' 119' ' ' PRO . 0.2 OUTLIER 12.09 112.71 0.0 OUTLIER Pre-proline 0 N--CA 1.484 1.268 0 C-N-CA 130.095 3.358 . . . . 0.0 116.396 -137.86 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.441 ' HD2' HD12 ' A' ' 126' ' ' ILE . 5.0 Cg_exo -79.38 -20.37 9.7 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.979 3.119 . . . . 0.0 113.684 -168.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 6.9 t 64.29 99.98 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 128.742 2.817 . . . . 0.0 112.659 176.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 6.2 tt -70.61 -75.3 0.12 Allowed 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -155.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -92.08 -44.36 8.88 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.908 1.283 . . . . 0.0 109.512 175.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -177.35 18.61 0.04 OUTLIER Glycine 0 CA--C 1.538 1.472 0 C-N-CA 126.192 1.853 . . . . 0.0 112.948 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -144.39 156.8 57.06 Favored Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 126.67 1.988 . . . . 0.0 110.766 -170.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -59.58 164.16 11.78 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 122.502 2.135 . . . . 0.0 113.815 -179.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.441 HD12 ' HD2' ' A' ' 119' ' ' PRO . 0.4 OUTLIER -127.47 149.24 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.125 1.37 . . . . 0.0 110.018 -178.805 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -130.1 95.73 4.0 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.007 -153.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -108.28 144.64 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 124.134 0.974 . . . . 0.0 112.844 -177.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -145.17 159.01 43.66 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.632 1.973 . . . . 0.0 109.085 154.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -54.6 155.32 4.18 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 121.262 -0.899 . . . . 0.0 111.733 165.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.748 ' HB3' HG13 ' A' ' 60' ' ' VAL . 27.1 t -79.25 148.96 32.0 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 177.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -61.08 -31.07 70.74 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.404 1.481 . . . . 0.0 112.945 167.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 57.3 m-70 -89.33 -18.83 26.14 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.767 1.227 . . . . 0.0 113.407 -176.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . 0.28 62.6 pttt 48.94 9.07 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 130.181 3.392 . . . . 0.0 118.205 177.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.598 ' N ' HG12 ' A' ' 60' ' ' VAL . 59.9 tt0 -164.98 124.94 1.89 Allowed 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 128.973 2.909 . . . . 0.0 110.463 172.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 22.7 tp -106.86 106.27 16.71 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.682 1.993 . . . . 0.0 110.857 -178.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt . . . . . 0 N--CA 1.472 0.653 0 C-N-CA 125.791 1.636 . . . . 0.0 109.269 173.754 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 58.2 m . . . . . 0 N--CA 1.48 1.026 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 25.2 mtp180 -124.19 -11.48 7.49 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 116.432 2.012 . . . . 0.0 116.432 -160.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.703 HG13 ' HB3' ' A' ' 131' ' ' SER 0.293 3.6 p -110.89 137.57 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 119.815 1.188 . . . . 0.0 112.162 172.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.0 mt -119.55 142.03 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 127.923 2.489 . . . . 0.0 108.369 175.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -112.51 148.39 34.56 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.937 1.695 . . . . 0.0 111.222 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 mp -133.12 138.98 50.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 126.227 1.811 . . . . 0.0 109.854 -176.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.67 176.61 5.11 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 125.6 1.56 . . . . 0.0 111.87 169.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.475 ' HG3' ' CD1' ' A' ' 127' ' ' TYR . 21.9 mmmt 73.98 8.64 4.76 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 127.015 2.126 . . . . 0.0 115.003 165.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.638 HD22 HG11 ' A' ' 70' ' ' VAL . 0.6 OUTLIER -62.74 159.82 41.16 Favored Pre-proline 0 CA--C 1.546 0.804 0 CA-C-N 119.181 0.9 . . . . 0.0 112.937 -176.925 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -51.72 173.75 0.09 OUTLIER 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 124.385 3.39 . . . . 0.0 115.087 163.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 36.4 pt -60.95 -34.55 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 127.065 2.146 . . . . 0.0 113.221 -167.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -140.01 -10.59 1.14 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.822 1.649 . . . . 0.0 113.485 166.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.638 HG11 HD22 ' A' ' 66' ' ' LEU 0.298 3.8 p 38.98 -139.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 127.599 2.359 . . . . 0.0 111.87 -169.151 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.449 ' H ' HG22 ' A' ' 70' ' ' VAL . 1.7 t -147.97 139.54 23.74 Favored 'General case' 0 C--O 1.239 0.519 0 O-C-N 120.803 -1.185 . . . . 0.0 109.931 154.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -55.93 -32.63 63.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.621 173.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -61.28 -32.53 81.1 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 125.05 1.31 . . . . 0.0 112.871 175.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -67.19 -55.41 14.21 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 118.725 1.263 . . . . 0.0 110.648 167.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.2 t -57.66 -44.83 86.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -175.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.3 pp -81.33 -29.16 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 O-C-N 120.313 -1.492 . . . . 0.0 113.871 -179.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 18.1 t -63.75 -29.36 70.58 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 119.61 1.096 . . . . 0.0 110.55 168.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.0 mt -78.72 -20.69 49.45 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 172.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -101.45 -16.55 24.41 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-N 119.859 1.209 . . . . 0.0 116.116 176.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.9 mt -61.55 -52.57 68.76 Favored Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 117.171 2.286 . . . . 0.0 117.171 -172.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -75.2 39.52 0.61 Allowed 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 124.125 3.217 . . . . 0.0 113.974 -178.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -127.84 -36.65 1.99 Allowed 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 126.87 2.068 . . . . 0.0 111.902 177.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -152.76 -108.84 0.38 Allowed Glycine 0 CA--C 1.525 0.717 0 CA-C-O 122.774 1.208 . . . . 0.0 111.989 168.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 15.6 tptm -149.23 132.01 16.01 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 131.625 3.97 . . . . 0.0 103.726 173.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.58 HG22 ' HE2' ' A' ' 101' ' ' MET 0.313 14.3 t -128.1 92.56 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-N 120.666 1.576 . . . . 0.0 110.773 -163.666 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.5 t -80.82 -32.75 35.09 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 126.727 2.011 . . . . 0.0 112.825 -161.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -130.74 160.53 34.06 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 174.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -147.19 167.83 23.21 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 126.963 2.105 . . . . 0.0 110.102 166.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.52 ' C ' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -149.76 152.09 34.67 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 125.288 1.435 . . . . 0.0 108.969 173.709 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 5.8 mtt -126.93 110.4 12.97 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.406 1.483 . . . . 0.0 110.267 177.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.488 HD22 ' CD1' ' A' ' 89' ' ' LEU . 2.8 mm? -72.1 79.65 0.95 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.62 1.168 . . . . 0.0 110.178 178.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -44.69 -47.97 10.63 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 127.549 2.339 . . . . 0.0 114.445 -168.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -79.79 -12.16 83.84 Favored Glycine 0 CA--C 1.535 1.317 0 N-CA-C 116.31 1.284 . . . . 0.0 116.31 -174.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -126.66 3.04 6.79 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 -173.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.0 m120 58.94 36.1 24.39 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.187 1.395 . . . . 0.0 113.918 -178.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -111.2 176.13 5.15 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.519 0.727 . . . . 0.0 111.095 175.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -158.03 167.36 30.11 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.708 1.603 . . . . 0.0 111.928 176.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.451 ' CD2' HG21 ' A' ' 60' ' ' VAL . 4.8 m-30 -118.72 152.62 35.81 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.966 2.106 . . . . 0.0 108.118 163.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 14.4 tt -135.41 127.19 46.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 124.778 1.231 . . . . 0.0 108.669 163.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -130.98 121.1 24.49 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.252 1.421 . . . . 0.0 112.929 -163.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.58 ' HE2' HG22 ' A' ' 85' ' ' VAL . 1.0 OUTLIER -129.22 162.62 27.43 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.12 -1.4 . . . . 0.0 113.696 -159.479 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.35 -12.57 60.09 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -158.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -143.18 142.47 31.45 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.177 1.391 . . . . 0.0 110.879 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -61.46 -33.41 73.7 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.742 175.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -75.74 -36.04 60.03 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 123.641 0.776 . . . . 0.0 112.987 178.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -56.82 -52.08 66.45 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-N 118.973 0.806 . . . . 0.0 110.642 168.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.94 -39.16 79.73 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -54.93 -48.41 73.16 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 118.754 0.706 . . . . 0.0 111.255 170.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -64.77 -32.5 74.22 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 121.242 -0.911 . . . . 0.0 111.46 175.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 7.5 ttp -65.86 -57.63 7.47 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.467 1.107 . . . . 0.0 109.686 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -57.97 -41.65 80.72 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.372 0 C-N-CA 124.95 1.3 . . . . 0.0 111.607 177.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -65.43 -42.9 91.94 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 118.897 0.771 . . . . 0.0 111.924 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -53.92 -37.43 63.83 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 118.61 0.641 . . . . 0.0 112.037 167.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.681 ' HA ' HG12 ' A' ' 117' ' ' VAL . 34.2 m-85 -85.73 -13.88 47.0 Favored 'General case' 0 C--N 1.332 -0.182 0 O-C-N 120.263 -1.523 . . . . 0.0 113.192 -178.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 54.8 m -84.79 -15.62 44.3 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.144 1.377 . . . . 0.0 110.307 169.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.28 -49.04 11.22 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 128.464 2.706 . . . . 0.0 111.26 172.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.681 HG12 ' HA ' ' A' ' 114' ' ' TYR . 0.5 OUTLIER -94.97 178.82 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 127.556 2.342 . . . . 0.0 111.754 -165.726 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.409 ' CA ' HG13 ' A' ' 117' ' ' VAL . 1.1 m -137.91 130.06 16.31 Favored Pre-proline 0 N--CA 1.477 0.876 0 O-C-N 120.985 -1.072 . . . . 0.0 109.212 129.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -83.44 -16.85 6.7 Favored 'Trans proline' 0 CA--C 1.547 1.157 0 C-N-CA 122.667 2.245 . . . . 0.0 112.753 -167.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 14.3 t 58.36 99.37 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 129.759 3.224 . . . . 0.0 113.498 177.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.6 tt -67.1 -62.6 1.35 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.285 1.034 . . . . 0.0 112.4 -156.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -125.56 4.41 7.57 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 126.722 2.009 . . . . 0.0 114.566 -179.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 124.5 9.26 5.51 Favored Glycine 0 CA--C 1.539 1.565 0 C-N-CA 125.119 1.342 . . . . 0.0 114.725 -160.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -139.66 144.33 38.74 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 126.854 2.061 . . . . 0.0 109.658 -176.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.99 166.23 7.29 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 123.576 2.851 . . . . 0.0 112.966 175.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -127.67 145.01 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.165 0.986 . . . . 0.0 111.056 -173.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.475 ' CD1' ' HG3' ' A' ' 65' ' ' LYS . 3.6 m-85 -126.26 79.66 1.86 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.105 -1.407 . . . . 0.0 109.441 -153.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -91.1 149.81 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 124.514 1.125 . . . . 0.0 112.688 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -145.37 159.42 43.09 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 128.235 2.614 . . . . 0.0 108.159 161.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -55.98 155.49 6.25 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 120.437 -1.415 . . . . 0.0 111.368 154.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.703 ' HB3' HG13 ' A' ' 60' ' ' VAL . 31.0 t -71.03 158.33 36.69 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.473 -0.767 . . . . 0.0 112.167 172.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -65.29 -11.76 44.83 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.857 1.263 . . . . 0.0 112.861 163.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 40.5 m-70 -116.05 -179.15 3.58 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 127.675 2.39 . . . . 0.0 110.726 -175.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -125.4 4.26 7.69 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 125.525 1.53 . . . . 0.0 114.4 -172.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -176.36 164.79 2.68 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 128.3 2.64 . . . . 0.0 109.111 -170.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 23.9 tp -137.15 91.87 2.66 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.035 1.734 . . . . 0.0 111.482 -174.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.472 0.644 0 C-N-CA 124.436 1.095 . . . . 0.0 110.493 172.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 44.3 t . . . . . 0 N--CA 1.476 0.865 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.44 -2.14 18.37 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.585 1.154 . . . . 0.0 113.596 167.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.693 HG13 ' HB3' ' A' ' 131' ' ' SER 0.312 7.4 p -85.11 131.11 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 119.396 0.998 . . . . 0.0 111.628 163.796 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.0 mt -110.72 144.99 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 127.785 2.434 . . . . 0.0 107.769 169.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -108.21 150.49 27.19 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.993 1.317 . . . . 0.0 110.529 172.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 7.5 mt -127.56 142.27 44.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 125.888 1.675 . . . . 0.0 109.093 -173.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.26 170.06 11.14 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 128.579 2.752 . . . . 0.0 109.223 164.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.57 20.29 12.1 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.617 1.167 . . . . 0.0 113.989 176.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 37.5 mt -64.01 167.7 7.36 Favored Pre-proline 0 CA--C 1.542 0.673 0 C-N-CA 123.474 0.71 . . . . 0.0 110.908 162.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -54.41 172.29 0.33 Allowed 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.934 2.423 . . . . 0.0 113.981 156.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 21.7 pt -80.98 -18.6 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 127.614 2.366 . . . . 0.0 113.332 -179.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -144.97 12.17 1.41 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 127.347 2.259 . . . . 0.0 113.281 -164.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -55.22 151.37 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.8 t -101.27 148.54 25.0 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 122.398 1.094 . . . . 0.0 113.281 -173.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -50.45 -44.24 55.5 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.217 1.407 . . . . 0.0 111.432 174.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -58.36 -35.1 77.39 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 123.852 0.739 . . . . 0.0 113.349 -179.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -74.7 -44.04 52.07 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.456 1.103 . . . . 0.0 112.167 175.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 95.1 t -60.68 -51.61 71.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 123.168 0.587 . . . . 0.0 111.084 177.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.1 pp -69.12 -30.45 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 O-C-N 120.73 -1.231 . . . . 0.0 113.099 178.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 49.2 m -73.73 -16.66 61.18 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 119.288 0.949 . . . . 0.0 112.306 174.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 22.7 mt -86.44 -15.25 40.83 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.121 0.968 . . . . 0.0 113.291 165.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.439 ' HA2' ' SD ' ' A' ' 110' ' ' MET . . . -75.88 -33.09 51.81 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 124.311 0.958 . . . . 0.0 113.241 168.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 16.5 mt -80.22 -16.83 0.24 Allowed Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 119.923 3.305 . . . . 0.0 119.923 -159.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -61.07 -4.61 3.96 Favored 'Trans proline' 0 C--N 1.347 0.493 0 CA-C-N 122.919 2.078 . . . . 0.0 116.474 169.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.514 ' CD2' ' HG3' ' A' ' 110' ' ' MET . 34.2 m-85 -120.6 -43.66 2.48 Favored 'General case' 0 C--N 1.34 0.195 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 -166.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -142.38 -118.36 1.37 Allowed Glycine 0 CA--C 1.525 0.706 0 CA-C-O 122.648 1.138 . . . . 0.0 112.555 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.41 ' HB3' ' CG ' ' A' ' 102' ' ' ASN . 15.2 tptm -148.03 122.24 9.57 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 130.45 3.5 . . . . 0.0 104.363 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.431 HG22 ' HE2' ' A' ' 101' ' ' MET 0.28 19.6 t -130.36 82.49 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 CA-C-O 122.778 1.275 . . . . 0.0 109.213 -159.515 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 41.5 p -79.86 -16.4 55.47 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 127.433 2.293 . . . . 0.0 112.725 -163.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -142.17 158.3 43.9 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 173.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.24 170.23 16.69 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.693 2.397 . . . . 0.0 110.34 167.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.496 ' C ' HD23 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -148.49 155.12 40.75 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.184 0.994 . . . . 0.0 109.805 174.18 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 4.0 mtp -132.55 94.15 3.36 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.353 0.661 . . . . 0.0 111.355 -168.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.07 66.74 1.66 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.57 1.148 . . . . 0.0 110.505 170.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 53.9 tttm -55.79 -34.38 65.24 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.538 1.535 . . . . 0.0 113.579 -169.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -64.18 -16.86 60.67 Favored Glycine 0 CA--C 1.54 1.603 0 C-N-CA 125.538 1.542 . . . . 0.0 116.075 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 18.9 mtmt -124.53 7.26 8.27 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.123 1.369 . . . . 0.0 114.216 -176.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.5 m120 58.92 34.03 23.39 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.786 1.235 . . . . 0.0 112.095 -168.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -117.87 164.47 15.0 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.723 0.809 . . . . 0.0 111.985 -175.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -158.06 168.98 25.6 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.684 1.593 . . . . 0.0 111.662 -179.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.456 ' CD2' HG21 ' A' ' 60' ' ' VAL . 5.5 m-30 -114.8 157.76 22.8 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.105 1.762 . . . . 0.0 108.42 160.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 19.8 tt -140.45 122.06 14.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 125.084 1.354 . . . . 0.0 109.129 163.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -119.3 125.73 49.79 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 127.242 2.217 . . . . 0.0 111.253 -169.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.431 ' HE2' HG22 ' A' ' 85' ' ' VAL . 0.3 OUTLIER -128.87 160.06 33.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 113.276 -1.784 . . . . 0.0 114.129 -167.519 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.475 ' CG ' HG23 ' A' ' 103' ' ' THR . 0.0 OUTLIER -71.81 -20.44 61.84 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 -163.343 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.475 HG23 ' CG ' ' A' ' 102' ' ' ASN . 8.3 p -138.45 137.73 37.47 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.128 1.371 . . . . 0.0 110.988 -174.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -59.25 -34.67 72.5 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.199 175.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -73.27 -40.05 64.91 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.99 -52.52 63.9 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-N 119.491 1.041 . . . . 0.0 109.552 168.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.71 -37.1 79.25 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 -175.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -56.12 -52.23 65.06 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.779 0.718 . . . . 0.0 110.684 169.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -61.33 -32.18 72.06 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 118.931 -0.557 . . . . 0.0 111.324 174.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.514 ' HG3' ' CD2' ' A' ' 82' ' ' PHE . 13.4 ttp -73.48 -50.16 22.98 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-N 119.486 1.039 . . . . 0.0 111.918 -175.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -63.14 -35.34 71.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.168 0.987 . . . . 0.0 111.107 178.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -75.65 -41.58 53.73 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.381 1.072 . . . . 0.0 112.091 176.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -48.28 -52.95 19.0 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.509 1.124 . . . . 0.0 109.989 165.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -79.88 16.12 1.25 Allowed 'General case' 0 C--N 1.326 -0.423 0 O-C-N 118.932 -2.355 . . . . 0.0 113.044 178.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . 0.289 0.5 OUTLIER -118.63 -10.32 10.06 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 164.584 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.478 ' CB ' HG23 ' A' ' 117' ' ' VAL . 0.4 OUTLIER -85.01 -43.05 14.31 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.273 1.829 . . . . 0.0 111.413 161.25 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.478 HG23 ' CB ' ' A' ' 116' ' ' SER . 89.6 t -115.12 -57.9 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.386 1.074 . . . . 0.0 111.856 -144.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.0 m 70.89 135.04 0.04 OUTLIER Pre-proline 0 N--CA 1.485 1.315 0 C-N-CA 128.027 2.531 . . . . 0.0 112.234 -173.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -76.26 -22.49 12.64 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.256 1.971 . . . . 0.0 114.966 -176.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.9 t 36.37 89.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 129.802 3.241 . . . . 0.0 113.305 175.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.537 ' H ' HD11 ' A' ' 126' ' ' ILE . 2.4 tt -100.05 -66.09 0.93 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 113.783 -1.553 . . . . 0.0 109.597 -134.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -84.53 -9.6 58.19 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 159.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 110.34 55.42 0.53 Allowed Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.347 1.451 . . . . 0.0 113.22 -166.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -145.06 162.49 37.54 Favored Pre-proline 0 CA--C 1.541 0.631 0 CA-C-N 119.075 1.438 . . . . 0.0 112.931 156.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.34 100.22 0.15 Allowed 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 123.293 2.662 . . . . 0.0 111.973 168.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.537 HD11 ' H ' ' A' ' 121' ' ' LEU . 3.0 mm -77.75 138.24 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.303 1.041 . . . . 0.0 108.69 177.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 11.7 m-30 -109.3 128.6 55.22 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 120.674 -1.266 . . . . 0.0 110.667 -173.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.25 151.07 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.902 1.281 . . . . 0.0 111.888 178.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -158.27 160.8 37.47 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.158 1.783 . . . . 0.0 110.172 157.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -54.65 144.2 22.58 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.261 -0.899 . . . . 0.0 112.398 170.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.693 ' HB3' HG13 ' A' ' 60' ' ' VAL . 21.4 t -73.78 147.13 43.74 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.986 -0.447 . . . . 0.0 111.371 173.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 12.7 p30 -80.62 -9.24 59.8 Favored 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 113.977 1.102 . . . . 0.0 113.977 175.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -83.63 179.82 7.51 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.381 1.072 . . . . 0.0 112.608 174.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -113.06 97.25 6.4 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.794 2.038 . . . . 0.0 109.837 173.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 61.28 -174.97 0.13 Allowed 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.696 1.998 . . . . 0.0 112.558 -176.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 34.7 tp -135.14 99.36 4.24 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 126.413 1.885 . . . . 0.0 110.962 -170.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 50.8 tttp . . . . . 0 N--CA 1.468 0.439 0 C-N-CA 125.719 1.608 . . . . 0.0 110.062 176.172 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.7 t . . . . . 0 N--CA 1.477 0.906 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.2 mtp180 -54.44 -13.51 0.95 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 131.536 3.935 . . . . 0.0 118.804 -173.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.43 HG21 ' CD2' ' A' ' 98' ' ' PHE 0.269 0.1 OUTLIER -81.94 122.45 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-N 120.885 1.675 . . . . 0.0 110.106 162.534 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.42 HD13 ' CE ' ' A' ' 110' ' ' MET . 2.0 mp -87.18 135.38 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 156.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -102.61 144.37 31.1 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.888 1.275 . . . . 0.0 110.566 174.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.2 mt -129.94 140.71 48.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 126.158 1.783 . . . . 0.0 109.862 -176.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 5.4 ptt-85 -123.74 179.15 4.91 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 126.835 2.054 . . . . 0.0 112.281 173.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 58.64 17.94 5.46 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 127.083 2.153 . . . . 0.0 114.607 178.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.6 mp -50.29 156.83 1.32 Allowed Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 125.273 1.429 . . . . 0.0 113.15 178.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -45.3 -62.55 0.43 Allowed 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 125.075 3.85 . . . . 0.0 114.776 -179.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.5 pt -163.64 -52.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 131.324 3.85 . . . . 0.0 107.723 176.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -146.3 -11.31 0.48 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.567 1.547 . . . . 0.0 114.143 -176.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.301 2.9 p 42.4 -145.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 127.268 2.227 . . . . 0.0 112.148 -174.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.0 t -141.97 137.44 31.21 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 120.553 -1.342 . . . . 0.0 110.772 164.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -55.54 -39.35 70.45 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.367 1.067 . . . . 0.0 111.883 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.25 -38.28 56.51 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 125.111 1.339 . . . . 0.0 113.937 172.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -72.51 -48.12 43.09 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 121.449 -1.03 . . . . 0.0 112.405 174.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.3 t -58.63 -49.37 82.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-N 117.979 0.354 . . . . 0.0 111.701 -176.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.95 -31.43 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 O-C-N 120.86 -1.15 . . . . 0.0 114.001 177.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 48.7 m -71.42 -18.12 62.35 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 120.664 1.575 . . . . 0.0 111.433 176.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 29.6 mt -84.37 -24.17 29.8 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 167.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -86.36 -18.92 58.11 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-N 118.72 0.691 . . . . 0.0 114.168 175.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 13.0 mt -73.29 -18.1 0.34 Allowed Pre-proline 0 CA--C 1.548 0.872 0 N-CA-C 119.416 3.117 . . . . 0.0 119.416 -171.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -59.16 -2.42 1.24 Allowed 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.411 2.74 . . . . 0.0 118.083 174.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -120.83 -35.91 3.26 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 -169.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -151.73 -109.69 0.44 Allowed Glycine 0 C--N 1.337 0.638 0 CA-C-O 122.253 0.918 . . . . 0.0 112.51 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -152.89 129.08 10.46 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 129.408 3.083 . . . . 0.0 104.893 -176.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.411 ' CG2' ' CE ' ' A' ' 101' ' ' MET 0.304 11.9 t -135.24 81.92 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 120.161 1.346 . . . . 0.0 109.678 -165.562 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 58.9 p -79.64 -22.31 43.72 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 126.829 2.051 . . . . 0.0 112.436 -164.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 65.5 m-80 -136.03 156.0 49.38 Favored 'General case' 0 C--N 1.343 0.323 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 177.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -146.91 170.33 17.29 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.824 2.05 . . . . 0.0 110.044 162.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.534 ' C ' HD23 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -141.01 153.93 45.77 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.837 1.655 . . . . 0.0 109.748 175.784 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 40.0 mtt -131.22 117.29 18.8 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.062 0.945 . . . . 0.0 110.908 178.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -76.2 69.67 2.76 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.754 1.222 . . . . 0.0 110.325 175.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -56.21 105.98 0.24 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.626 1.97 . . . . 0.0 111.327 -177.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 124.03 -15.97 7.77 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 126.077 1.798 . . . . 0.0 115.052 -176.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 10.6 mtmt -118.22 -2.21 11.21 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 119.142 1.471 . . . . 0.0 114.644 178.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.3 m120 60.05 46.9 10.26 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.0 1.72 . . . . 0.0 112.398 -173.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -131.8 165.76 23.08 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.44 0.696 . . . . 0.0 112.418 -179.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -157.82 163.26 38.19 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.131 1.372 . . . . 0.0 113.001 -178.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.43 ' CD2' HG21 ' A' ' 60' ' ' VAL . 4.5 m-30 -115.91 148.2 40.27 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 128.61 2.764 . . . . 0.0 106.287 166.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 6.4 tp -134.5 106.79 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 125.854 1.662 . . . . 0.0 108.874 170.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -102.93 109.38 20.91 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 128.602 2.761 . . . . 0.0 111.552 -167.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.411 ' CE ' ' CG2' ' A' ' 85' ' ' VAL . 16.1 ttm -107.02 158.5 17.0 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 114.095 -1.411 . . . . 0.0 112.695 -174.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.495 ' ND2' HG23 ' A' ' 103' ' ' THR . 0.0 OUTLIER -73.96 -21.23 60.1 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -163.098 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.495 HG23 ' ND2' ' A' ' 102' ' ' ASN . 1.9 p -138.15 147.43 43.89 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.805 0.842 . . . . 0.0 111.74 -175.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -64.92 -36.65 85.07 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.432 0.693 . . . . 0.0 112.15 179.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -72.35 -42.56 65.17 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 118.763 0.71 . . . . 0.0 112.817 179.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -57.73 -48.25 80.13 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 118.567 0.622 . . . . 0.0 110.071 172.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.16 -37.4 78.21 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -55.62 -51.89 65.64 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 121.339 -0.85 . . . . 0.0 110.876 169.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -64.81 -24.76 67.65 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-O 117.77 -1.109 . . . . 0.0 111.665 173.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.42 ' CE ' HD13 ' A' ' 61' ' ' ILE . 10.3 ttp -73.13 -48.51 34.92 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 120.514 1.506 . . . . 0.0 110.227 -178.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -65.56 -37.78 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 O-C-N 121.532 -0.73 . . . . 0.0 111.441 177.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -68.05 -46.48 71.0 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.869 0.868 . . . . 0.0 110.958 174.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -48.43 -42.27 31.82 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.026 1.73 . . . . 0.0 112.01 167.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.586 ' HA ' HG12 ' A' ' 117' ' ' VAL . 14.7 m-85 -84.01 -17.7 39.58 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 120.843 -1.16 . . . . 0.0 112.563 -176.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 84.1 m -80.97 -14.63 57.78 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.514 1.126 . . . . 0.0 110.469 170.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.55 -58.18 2.36 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 129.766 3.226 . . . . 0.0 112.879 176.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.586 HG12 ' HA ' ' A' ' 114' ' ' TYR . 6.0 p -74.19 -35.66 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 126.683 1.993 . . . . 0.0 113.056 -158.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.512 ' CG2' ' H ' ' A' ' 126' ' ' ILE . 0.8 OUTLIER 4.09 114.57 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.047 0 C-N-CA 130.351 3.46 . . . . 0.0 115.953 -134.711 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 118' ' ' THR . 5.7 Cg_exo -77.76 -3.84 13.94 Favored 'Trans proline' 0 CA--C 1.55 1.303 0 C-N-CA 123.711 2.941 . . . . 0.0 113.99 -159.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.4 t 62.07 112.47 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 131.62 3.968 . . . . 0.0 115.799 174.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.8 tt -72.82 75.69 1.14 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 127.909 2.483 . . . . 0.0 109.583 173.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . 0.262 0.0 OUTLIER 48.39 -15.68 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.507 1 C-N-CA 132.713 4.405 . . . . 0.0 119.004 -170.56 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -179.51 2.95 0.02 OUTLIER Glycine 0 CA--C 1.54 1.624 0 C-N-CA 125.869 1.699 . . . . 0.0 115.265 -172.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -139.62 148.0 54.19 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 126.995 2.118 . . . . 0.0 109.46 -177.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -57.6 167.0 4.24 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.35 2.7 . . . . 0.0 114.35 175.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.512 ' H ' ' CG2' ' A' ' 118' ' ' THR . 0.5 OUTLIER -120.86 148.79 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.911 1.684 . . . . 0.0 109.299 179.697 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -122.35 101.05 7.27 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.494 1.118 . . . . 0.0 110.951 -154.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.45 152.74 28.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -167.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -150.87 171.44 17.22 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 129.46 3.104 . . . . 0.0 109.418 165.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -65.38 166.01 10.87 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 120.311 -1.493 . . . . 0.0 111.394 153.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.405 ' CB ' HG13 ' A' ' 60' ' ' VAL . 83.3 p -60.26 154.11 20.76 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 120.933 -1.104 . . . . 0.0 112.546 163.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 14.3 p30 -85.69 -19.42 30.91 Favored 'General case' 0 CA--C 1.548 0.897 0 O-C-N 121.363 -0.836 . . . . 0.0 112.28 158.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 67.5 m-70 -75.21 -171.1 1.31 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.772 1.629 . . . . 0.0 111.985 164.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -141.7 121.21 13.27 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 127.123 2.169 . . . . 0.0 110.181 174.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 66.04 99.4 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 126.026 1.73 . . . . 0.0 114.939 171.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 61.8 tp -61.78 125.71 24.79 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.273 1.429 . . . . 0.0 112.171 172.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 86.8 tttt . . . . . 0 N--CA 1.476 0.845 0 C-N-CA 125.023 1.329 . . . . 0.0 113.763 179.505 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 73.8 m . . . . . 0 N--CA 1.474 0.773 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 41.0 mtp180 59.92 -28.78 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 131.342 3.857 . . . . 0.0 118.017 172.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.556 HG13 ' HB3' ' A' ' 131' ' ' SER . 1.7 p -98.09 134.72 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 120.254 1.388 . . . . 0.0 112.122 167.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.443 ' HA ' ' HA ' ' A' ' 130' ' ' PHE . 44.8 mt -110.07 124.32 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 C-N-CA 127.585 2.354 . . . . 0.0 108.263 168.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -83.44 149.02 26.92 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.898 0.856 . . . . 0.0 111.208 169.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 8.7 mt -124.47 140.83 46.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 126.539 1.936 . . . . 0.0 108.99 179.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.51 167.91 13.27 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 127.432 2.293 . . . . 0.0 110.464 165.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.439 ' HG2' ' CD2' ' A' ' 127' ' ' TYR . 19.8 mmtt 53.64 41.57 32.05 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.768 1.627 . . . . 0.0 113.04 -176.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.62 176.99 0.63 Allowed Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 126.493 1.917 . . . . 0.0 109.737 159.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -59.52 -175.37 0.09 OUTLIER 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 124.53 3.487 . . . . 0.0 114.543 147.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 28.7 pt -81.24 -31.99 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 126.038 1.735 . . . . 0.0 113.479 -177.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -156.37 37.44 0.33 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.557 1.943 . . . . 0.0 110.725 -168.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -51.75 156.49 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.869 0.867 . . . . 0.0 112.669 177.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.82 144.28 26.68 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 122.448 1.118 . . . . 0.0 112.188 -176.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -58.04 -42.67 85.91 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.127 171.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.62 -39.8 61.55 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.927 1.251 . . . . 0.0 112.938 178.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -68.37 -49.41 60.36 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.688 1.195 . . . . 0.0 112.098 173.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 95.6 t -61.61 -44.89 99.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 122.965 0.506 . . . . 0.0 112.005 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.8 pp -74.68 -30.04 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 O-C-N 120.597 -1.314 . . . . 0.0 112.488 176.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.7 t -61.92 -31.74 72.08 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 119.839 1.2 . . . . 0.0 110.482 170.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 10.3 mt -78.23 -21.83 49.34 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 175.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -98.66 -16.14 32.28 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-N 119.116 0.871 . . . . 0.0 115.186 175.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.4 mt -57.69 -54.59 53.65 Favored Pre-proline 0 CA--C 1.543 0.675 0 N-CA-C 116.823 2.157 . . . . 0.0 116.823 -168.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -77.72 41.88 1.07 Allowed 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 124.0 3.133 . . . . 0.0 114.081 -175.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -129.3 -42.48 1.34 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.901 1.68 . . . . 0.0 112.589 179.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -155.79 -99.44 0.16 Allowed Glycine 0 C--N 1.336 0.564 0 C-N-CA 124.484 1.04 . . . . 0.0 110.653 167.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 38.9 tptt -136.08 -12.84 1.9 Allowed 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 116.132 1.901 . . . . 0.0 116.132 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.521 ' HA ' ' HA ' ' A' ' 101' ' ' MET 0.25 0.1 OUTLIER 30.44 82.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 128.643 2.777 . . . . 0.0 113.247 -174.184 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.6 t -68.5 -31.03 70.0 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.092 0.957 . . . . 0.0 112.554 -170.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -147.85 174.07 12.21 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 123.296 1.522 . . . . 0.0 114.586 175.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -143.24 174.64 10.53 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 127.324 2.249 . . . . 0.0 111.371 157.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.54 ' C ' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -143.15 154.08 43.53 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.964 2.105 . . . . 0.0 108.148 169.383 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 5.0 mtp -129.71 106.51 8.76 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.641 1.176 . . . . 0.0 110.597 -176.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -74.18 76.15 1.79 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.025 0.93 . . . . 0.0 110.519 173.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt -64.54 98.62 0.26 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.986 1.314 . . . . 0.0 110.269 173.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 168.76 -52.94 0.21 Allowed Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.909 1.719 . . . . 0.0 112.689 -166.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt -133.1 12.61 4.26 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.12 1.368 . . . . 0.0 114.559 -166.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 59.83 53.38 4.84 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.014 1.726 . . . . 0.0 112.161 -172.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -130.28 166.0 21.27 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.396 1.078 . . . . 0.0 111.855 -179.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -166.05 169.97 14.01 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.513 1.925 . . . . 0.0 110.628 -177.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.545 ' CD2' HD13 ' A' ' 136' ' ' LEU . 4.5 m-30 -118.22 141.07 48.88 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.783 2.433 . . . . 0.0 105.46 166.253 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 15.6 tt -122.2 113.26 37.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 125.336 1.454 . . . . 0.0 107.446 166.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -109.71 117.01 32.77 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 127.27 2.228 . . . . 0.0 110.333 -166.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.521 ' HA ' ' HA ' ' A' ' 85' ' ' VAL 0.296 0.9 OUTLIER -121.46 146.5 46.85 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -169.067 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.426 ' ND2' HG23 ' A' ' 103' ' ' THR . 0.0 OUTLIER -63.13 -18.08 63.04 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 113.673 -1.603 . . . . 0.0 114.653 -160.579 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.426 HG23 ' ND2' ' A' ' 102' ' ' ASN . 4.1 p -139.68 146.57 39.81 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.934 0.873 . . . . 0.0 111.125 -176.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -59.34 -41.25 88.75 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.096 178.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -77.37 -35.64 54.33 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -177.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.02 -51.38 69.93 Favored 'General case' 0 C--O 1.222 -0.387 0 CA-C-N 119.992 1.269 . . . . 0.0 110.253 169.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.83 -36.53 78.3 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 178.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -57.9 -47.16 83.61 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.693 1.133 . . . . 0.0 111.262 170.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -64.77 -33.96 77.21 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-O 117.915 -1.041 . . . . 0.0 110.9 173.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 11.1 ttp -66.66 -47.89 71.11 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 120.019 1.281 . . . . 0.0 111.225 -178.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -68.34 -38.55 79.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 124.604 1.161 . . . . 0.0 112.055 178.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -70.18 -43.39 70.88 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.442 0.697 . . . . 0.0 110.597 176.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -49.62 -37.7 29.03 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.803 1.241 . . . . 0.0 112.075 166.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -90.77 -12.95 34.97 Favored 'General case' 0 CA--C 1.518 -0.252 0 O-C-N 120.162 -1.586 . . . . 0.0 113.657 -177.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -83.93 -15.78 46.68 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.75 0.786 . . . . 0.0 110.932 167.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.89 -59.79 2.64 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 128.567 2.747 . . . . 0.0 111.742 166.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -93.84 -49.57 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -153.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.5 m 54.88 129.36 0.01 OUTLIER Pre-proline 0 N--CA 1.481 1.101 0 C-N-CA 129.535 3.134 . . . . 0.0 113.069 -157.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -75.76 -22.25 13.7 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 121.991 1.794 . . . . 0.0 114.752 -173.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.5 t 38.87 89.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 129.223 3.009 . . . . 0.0 113.179 174.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.46 ' H ' HD11 ' A' ' 126' ' ' ILE . 2.8 tt -101.45 -50.56 3.71 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 113.444 -1.707 . . . . 0.0 110.376 -132.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.96 1.94 29.24 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 126.266 1.827 . . . . 0.0 113.64 165.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 125.46 12.37 3.81 Favored Glycine 0 CA--C 1.537 1.411 0 N-CA-C 117.108 1.603 . . . . 0.0 117.108 175.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -147.13 163.97 25.64 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 120.251 2.025 . . . . 0.0 112.837 174.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -56.74 143.57 89.73 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.522 2.815 . . . . 0.0 115.621 -168.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.46 HD11 ' H ' ' A' ' 121' ' ' LEU . 3.9 mm -118.81 147.28 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 127.292 2.237 . . . . 0.0 108.122 -178.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.439 ' CD2' ' HG2' ' A' ' 65' ' ' LYS . 19.5 m-30 -117.82 127.9 54.33 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.193 -0.942 . . . . 0.0 111.099 -169.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -124.65 147.13 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.764 1.225 . . . . 0.0 113.326 -178.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -158.37 159.43 35.8 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.308 1.843 . . . . 0.0 110.001 159.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.443 ' HA ' ' HA ' ' A' ' 61' ' ' ILE . 32.1 m-85 -56.43 162.48 2.12 Favored 'General case' 0 CA--C 1.556 1.177 0 O-C-N 120.473 -1.392 . . . . 0.0 113.057 166.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.556 ' HB3' HG13 ' A' ' 60' ' ' VAL . 5.3 p -72.25 174.72 6.86 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 116.135 1.902 . . . . 0.0 116.135 -174.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -95.37 2.58 54.67 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 127.246 2.218 . . . . 0.0 114.068 166.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -121.99 -26.72 4.72 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 117.19 2.293 . . . . 0.0 117.19 -162.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp 58.82 109.51 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 126.108 1.763 . . . . 0.0 112.963 -164.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 60.28 110.26 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 128.06 2.544 . . . . 0.0 115.406 176.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.545 HD13 ' CD2' ' A' ' 98' ' ' PHE . 32.1 tp -71.32 140.87 50.43 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.054 1.341 . . . . 0.0 111.479 174.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.014 0 C-N-CA 126.157 1.783 . . . . 0.0 110.82 168.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 66.5 p . . . . . 0 N--CA 1.476 0.825 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 -124.73 -10.46 7.28 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 -161.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.512 HG13 ' HB3' ' A' ' 131' ' ' SER 0.337 3.8 p -112.03 135.95 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-N 119.842 1.201 . . . . 0.0 112.154 168.654 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.6 mt -114.93 150.56 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 127.629 2.372 . . . . 0.0 107.859 173.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -118.08 130.2 56.0 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.758 1.223 . . . . 0.0 110.73 178.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.5 mt -117.01 125.77 74.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 127.494 2.318 . . . . 0.0 108.414 -173.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -112.43 175.91 5.24 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 125.931 1.692 . . . . 0.0 113.024 -178.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 11.6 mmmt 59.34 27.81 16.99 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 127.392 2.277 . . . . 0.0 114.671 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.3 mp -55.01 155.63 8.17 Favored Pre-proline 0 CA--C 1.554 1.126 0 C-N-CA 124.858 1.263 . . . . 0.0 112.321 176.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.497 ' HD3' HD11 ' A' ' 121' ' ' LEU . 62.2 Cg_exo -45.8 -67.25 0.12 Allowed 'Trans proline' 0 C--N 1.351 0.706 1 C-N-CA 125.87 4.38 . . . . 0.0 115.151 -177.946 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.7 pt -153.05 -50.36 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 130.933 3.693 . . . . 0.0 107.615 175.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -151.52 -5.99 0.25 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.309 1.444 . . . . 0.0 114.174 178.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.291 2.8 p 43.8 -146.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 C-N-CA 127.237 2.215 . . . . 0.0 112.084 -174.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.2 t -140.02 136.02 33.27 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 120.723 -1.236 . . . . 0.0 110.522 161.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -56.76 -34.91 68.04 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.598 0.759 . . . . 0.0 113.03 179.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -55.28 -40.17 74.72 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.892 1.234 . . . . 0.0 113.434 172.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -67.12 -50.9 59.87 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.776 -0.837 . . . . 0.0 111.292 171.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 87.7 t -55.89 -49.89 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.578 0.751 . . . . 0.0 112.725 -176.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -82.01 -26.07 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 O-C-N 120.264 -1.522 . . . . 0.0 114.409 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.3 t -61.56 -32.4 72.48 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 119.76 1.164 . . . . 0.0 110.377 168.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.9 mt -76.3 -26.18 55.6 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 171.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -85.51 -19.86 57.63 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-N 119.549 1.068 . . . . 0.0 114.836 175.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 11.5 mt -69.95 -31.17 2.28 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 117.982 2.586 . . . . 0.0 117.982 -168.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -58.62 -4.63 1.96 Allowed 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 123.517 2.811 . . . . 0.0 116.821 169.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -108.41 -40.61 5.09 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -166.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -150.88 -109.78 0.47 Allowed Glycine 0 CA--C 1.525 0.665 0 CA-C-O 122.348 0.971 . . . . 0.0 111.974 176.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 17.1 tptm -147.7 138.16 23.12 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 128.895 2.878 . . . . 0.0 103.997 164.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.497 HG22 ' HE2' ' A' ' 101' ' ' MET 0.307 12.4 t -130.15 82.97 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 CA-C-N 120.717 1.599 . . . . 0.0 109.567 -163.047 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.5 t -77.08 -21.83 53.77 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 126.669 1.988 . . . . 0.0 113.149 -159.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -141.51 165.65 26.91 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-O 122.615 1.197 . . . . 0.0 113.619 165.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -137.55 179.07 6.63 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.253 1.421 . . . . 0.0 109.924 157.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.499 ' C ' HD23 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -150.47 159.12 44.71 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.395 1.478 . . . . 0.0 109.69 172.798 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 6.9 mtt -133.65 100.58 4.83 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.074 0.95 . . . . 0.0 112.529 -174.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -73.92 92.34 2.08 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.087 1.355 . . . . 0.0 111.15 171.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 48.8 mttp -62.41 -20.94 64.99 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 175.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.89 -53.98 41.06 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 125.768 1.651 . . . . 0.0 115.138 -174.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.5 mtmt -123.33 20.05 9.71 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 126.04 1.736 . . . . 0.0 112.01 179.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 23.2 m120 53.67 66.64 1.17 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 126.841 2.056 . . . . 0.0 112.575 -173.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . 0.257 0.0 OUTLIER -125.53 179.43 5.14 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.51 0.671 . . . . 0.0 112.471 170.087 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -154.07 162.77 40.96 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 126.542 1.937 . . . . 0.0 109.904 -176.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.48 ' CD2' HG21 ' A' ' 60' ' ' VAL . 5.6 m-30 -108.11 150.91 26.58 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.546 1.539 . . . . 0.0 107.333 159.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.2 tt -132.9 124.04 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 124.624 1.169 . . . . 0.0 108.405 163.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.44 ' HG3' ' H ' ' A' ' 136' ' ' LEU . 3.6 tm-20 -130.74 126.6 36.86 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 122.588 1.185 . . . . 0.0 112.946 -162.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.497 ' HE2' HG22 ' A' ' 85' ' ' VAL . 0.5 OUTLIER -134.04 161.37 35.02 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.111 -1.404 . . . . 0.0 113.933 -159.903 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -79.32 -12.64 59.93 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.391 1.877 . . . . 0.0 113.26 -161.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.34 138.38 33.05 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.845 1.258 . . . . 0.0 111.32 -178.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -62.44 -34.79 77.5 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.312 176.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -75.69 -36.53 60.01 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.763 0.825 . . . . 0.0 112.963 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -56.22 -53.68 54.23 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 118.823 0.738 . . . . 0.0 109.693 168.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.31 -36.22 79.0 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -177.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -55.19 -50.28 69.75 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.109 0.868 . . . . 0.0 110.955 168.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -65.27 -30.75 71.65 Favored 'General case' 0 C--O 1.225 -0.222 0 O-C-N 121.441 -0.787 . . . . 0.0 111.603 174.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 5.6 ttp -73.39 -46.33 49.48 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 119.908 1.231 . . . . 0.0 111.591 -177.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -65.21 -40.12 87.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 124.145 0.978 . . . . 0.0 110.958 177.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -68.5 -46.1 70.55 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.597 0.759 . . . . 0.0 110.647 176.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -48.34 -42.88 32.67 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.111 1.364 . . . . 0.0 111.937 168.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.569 ' HA ' HG12 ' A' ' 117' ' ' VAL . 17.3 m-85 -84.96 -14.21 48.28 Favored 'General case' 0 C--N 1.334 -0.105 0 O-C-N 120.764 -1.21 . . . . 0.0 112.485 -176.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 92.9 m -83.18 -14.06 54.2 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.422 1.089 . . . . 0.0 110.618 169.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.21 -56.83 2.5 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 129.228 3.011 . . . . 0.0 113.257 178.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.569 HG12 ' HA ' ' A' ' 114' ' ' TYR . 9.8 p -72.65 -33.55 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 127.187 2.195 . . . . 0.0 113.777 -157.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.428 ' CG2' ' H ' ' A' ' 126' ' ' ILE . 0.3 OUTLIER -2.25 114.36 0.01 OUTLIER Pre-proline 0 N--CA 1.484 1.256 0 C-N-CA 129.206 3.002 . . . . 0.0 116.449 -131.544 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -77.26 -7.76 17.19 Favored 'Trans proline' 0 CA--C 1.546 1.117 0 C-N-CA 123.675 2.916 . . . . 0.0 114.336 -161.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.5 t 61.05 107.95 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 130.71 3.604 . . . . 0.0 114.509 176.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.497 HD11 ' HD3' ' A' ' 67' ' ' PRO . 14.2 tp -73.17 -55.86 5.89 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.766 0.826 . . . . 0.0 112.335 -168.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -125.52 -4.95 7.14 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 127.584 2.354 . . . . 0.0 113.492 -161.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 99.63 13.87 36.56 Favored Glycine 0 CA--C 1.539 1.556 0 C-N-CA 124.282 0.944 . . . . 0.0 112.432 -148.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -138.9 144.7 42.49 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 128.402 2.681 . . . . 0.0 109.259 -178.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -57.35 168.96 2.46 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 124.0 3.133 . . . . 0.0 114.077 176.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.428 ' H ' ' CG2' ' A' ' 118' ' ' THR . 0.3 OUTLIER -125.27 149.45 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.092 1.357 . . . . 0.0 109.896 -177.661 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -120.88 101.35 7.64 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.419 -153.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.85 150.51 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.53 1.132 . . . . 0.0 112.739 -177.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -152.37 163.6 39.16 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 126.832 2.053 . . . . 0.0 109.074 154.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -53.02 151.81 4.49 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.362 -0.836 . . . . 0.0 112.076 164.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.512 ' HB3' HG13 ' A' ' 60' ' ' VAL . 31.6 t -71.6 156.22 39.65 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.665 0.745 . . . . 0.0 112.051 176.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -68.99 -7.71 37.88 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.137 1.375 . . . . 0.0 113.196 164.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 36.8 m-70 -119.47 177.89 4.75 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 127.361 2.264 . . . . 0.0 110.916 -176.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -119.55 5.9 11.07 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 -167.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 162.41 167.45 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 131.077 3.751 . . . . 0.0 111.22 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.44 ' H ' ' HG3' ' A' ' 100' ' ' GLU . 3.6 mm? -74.54 147.55 41.69 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.669 0.788 . . . . 0.0 109.475 158.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 16.4 tttp . . . . . 0 N--CA 1.469 0.521 0 CA-C-O 122.558 1.171 . . . . 0.0 110.506 173.173 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 31.5 t . . . . . 0 CA--C 1.546 0.795 0 N-CA-C 115.354 1.613 . . . . 0.0 115.354 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 21.9 mtp180 -139.54 -9.19 1.25 Allowed 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 117.01 2.226 . . . . 0.0 117.01 -154.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.539 HG13 ' HB3' ' A' ' 131' ' ' SER 0.272 3.9 p -106.82 131.15 57.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 CA-C-N 120.615 1.552 . . . . 0.0 112.13 169.46 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.2 mt -109.97 155.8 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 127.672 2.389 . . . . 0.0 108.231 170.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -124.02 138.72 54.41 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.349 1.46 . . . . 0.0 110.689 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.2 mt -122.38 132.18 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 126.95 2.1 . . . . 0.0 109.807 -171.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.96 173.89 6.12 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 125.803 1.641 . . . . 0.0 113.246 178.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 13.8 mmmt 64.9 15.98 10.24 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 128.903 2.881 . . . . 0.0 116.416 173.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 30.8 mt -61.99 141.89 95.45 Favored Pre-proline 0 CA--C 1.555 1.158 0 CA-C-O 118.444 -0.788 . . . . 0.0 110.517 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -37.54 -62.92 0.26 Allowed 'Trans proline' 0 CA--C 1.539 0.766 1 C-N-CA 125.589 4.193 . . . . 0.0 116.043 -177.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.1 pt -153.74 -42.44 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 129.964 3.306 . . . . 0.0 109.323 174.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -153.3 -7.49 0.17 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.412 1.485 . . . . 0.0 113.187 -170.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.415 HG22 ' H ' ' A' ' 71' ' ' THR 0.298 12.0 p 34.27 -122.21 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 127.09 2.156 . . . . 0.0 111.496 -165.474 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.415 ' H ' HG22 ' A' ' 70' ' ' VAL . 0.9 OUTLIER -148.75 135.55 19.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 122.368 1.08 . . . . 0.0 109.045 152.775 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -55.17 -31.13 61.12 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.057 0.943 . . . . 0.0 112.768 178.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -60.42 -37.94 93.98 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 124.832 1.206 . . . . 0.0 114.121 172.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -69.86 -44.86 68.98 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.422 -1.046 . . . . 0.0 110.579 172.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 85.5 t -57.76 -51.76 66.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 123.808 0.843 . . . . 0.0 112.182 -176.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -78.92 -26.06 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 O-C-N 120.341 -1.474 . . . . 0.0 114.381 177.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 38.7 t -62.15 -28.53 69.72 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 119.846 1.203 . . . . 0.0 110.553 169.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 22.8 mt -82.55 -23.48 34.48 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.923 1.082 . . . . 0.0 113.923 170.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -89.06 -11.02 65.6 Favored Glycine 0 CA--C 1.534 1.229 0 CA-C-N 119.406 1.003 . . . . 0.0 114.67 176.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.2 mt -77.55 -17.12 0.26 Allowed Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 118.859 2.911 . . . . 0.0 118.859 -174.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -59.6 -2.51 1.51 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.868 2.379 . . . . 0.0 117.363 169.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -119.56 -44.77 2.54 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -166.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -150.88 -108.52 0.42 Allowed Glycine 0 C--N 1.337 0.591 0 C-N-CA 123.796 0.712 . . . . 0.0 111.581 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 21.7 tptp -142.84 -15.73 0.71 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 115.524 1.675 . . . . 0.0 115.524 -171.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.563 HG13 ' HB2' ' A' ' 101' ' ' MET 0.256 0.2 OUTLIER 34.6 81.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 128.159 2.584 . . . . 0.0 113.493 175.088 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 54.3 p -68.06 -36.18 79.43 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.352 1.061 . . . . 0.0 112.205 -169.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -145.0 165.71 27.39 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 123.611 1.672 . . . . 0.0 114.838 -177.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -150.31 169.14 22.1 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 126.489 1.916 . . . . 0.0 112.377 162.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.527 ' C ' HD23 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -145.67 150.97 37.28 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 127.305 2.242 . . . . 0.0 108.536 -174.724 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 5.5 mtp -133.45 94.97 3.4 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.786 0.834 . . . . 0.0 111.811 -169.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.406 ' CD1' HD21 ' A' ' 89' ' ' LEU . 0.8 OUTLIER -72.34 84.35 1.07 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.102 1.361 . . . . 0.0 111.443 175.244 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.01 -11.28 12.82 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 115.265 1.579 . . . . 0.0 115.265 170.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -60.62 -56.45 24.26 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 126.403 1.954 . . . . 0.0 114.494 177.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 31.6 mtmt -125.49 22.51 7.66 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 126.16 1.784 . . . . 0.0 112.144 -176.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 57.51 56.18 5.16 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.559 2.344 . . . . 0.0 113.92 -178.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . 0.264 0.0 OUTLIER -129.63 -179.39 5.15 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 173.964 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -158.25 164.78 36.14 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.72 2.008 . . . . 0.0 110.44 -177.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.5 ' CD2' HG21 ' A' ' 60' ' ' VAL . 4.8 m-30 -111.14 151.77 27.78 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.488 1.915 . . . . 0.0 107.896 163.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.9 tt -133.79 104.21 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 C-N-CA 125.544 1.538 . . . . 0.0 108.018 167.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -97.77 127.69 43.9 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 128.387 2.675 . . . . 0.0 110.762 -174.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.563 ' HB2' HG13 ' A' ' 85' ' ' VAL 0.305 20.8 ttm -126.86 157.52 39.12 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 -173.921 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.429 ' ND2' HG23 ' A' ' 103' ' ' THR . 19.9 p-10 -54.54 -37.07 64.98 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 127.037 2.135 . . . . 0.0 114.299 -172.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.429 HG23 ' ND2' ' A' ' 102' ' ' ASN . 69.2 p -141.39 137.78 32.53 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.976 0.91 . . . . 0.0 110.589 -162.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -59.81 -38.62 82.48 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.658 0.783 . . . . 0.0 112.041 -177.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -74.18 -37.94 63.79 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -178.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -57.64 -48.85 78.31 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 119.185 0.902 . . . . 0.0 110.408 169.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.74 -37.29 70.58 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.338 0.972 . . . . 0.0 113.585 -178.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -55.21 -50.86 68.3 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 120.96 -1.088 . . . . 0.0 111.085 169.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -64.33 -27.84 69.3 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-O 117.961 -1.019 . . . . 0.0 111.466 173.048 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 16.7 ttp -71.64 -47.78 52.18 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-N 120.444 1.474 . . . . 0.0 110.335 -177.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.51 -40.61 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 123.636 0.775 . . . . 0.0 111.207 176.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -67.43 -47.28 70.67 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.586 0.754 . . . . 0.0 110.829 177.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -48.26 -41.84 28.89 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.93 1.692 . . . . 0.0 112.561 167.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.601 ' HA ' HG12 ' A' ' 117' ' ' VAL . 16.8 m-85 -85.36 -17.62 36.21 Favored 'General case' 0 C--O 1.232 0.166 0 O-C-N 120.551 -1.343 . . . . 0.0 112.613 -177.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 67.5 m -78.18 -16.58 57.76 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.071 0.948 . . . . 0.0 110.193 169.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.47 -57.43 2.77 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 129.126 2.97 . . . . 0.0 112.808 177.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.601 HG12 ' HA ' ' A' ' 114' ' ' TYR . 8.8 p -76.68 -40.82 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.504 1.521 . . . . 0.0 113.66 -154.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 11.52 113.67 0.0 OUTLIER Pre-proline 0 N--CA 1.482 1.14 0 C-N-CA 129.011 2.924 . . . . 0.0 116.175 -133.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.444 ' HD2' HD12 ' A' ' 126' ' ' ILE . 3.9 Cg_exo -75.77 -19.33 16.39 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.463 2.775 . . . . 0.0 112.969 -165.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 6.4 t 61.08 110.19 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 130.514 3.526 . . . . 0.0 113.065 -178.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.0 tt -75.0 80.01 2.19 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.732 1.613 . . . . 0.0 109.6 -176.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . 0.29 2.9 ppt_? 46.61 -13.19 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.249 1 C-N-CA 132.733 4.413 . . . . 0.0 118.906 -168.944 . . . . . . . . 3 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -174.04 3.37 0.03 OUTLIER Glycine 0 CA--C 1.538 1.512 0 N-CA-C 116.493 1.357 . . . . 0.0 116.493 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 5.3 tp60 -139.37 140.72 26.63 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 126.019 1.728 . . . . 0.0 109.489 -177.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.94 164.68 7.73 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 123.628 2.885 . . . . 0.0 113.329 174.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.444 HD12 ' HD2' ' A' ' 119' ' ' PRO . 0.7 OUTLIER -127.76 147.6 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.462 1.105 . . . . 0.0 110.762 -174.737 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -127.19 102.07 6.78 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.637 1.175 . . . . 0.0 109.923 -153.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.8 150.19 23.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -173.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -153.04 161.98 41.87 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 126.485 1.914 . . . . 0.0 109.264 154.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -53.33 151.39 5.43 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-O 121.756 0.788 . . . . 0.0 112.24 164.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.539 ' HB3' HG13 ' A' ' 60' ' ' VAL . 32.6 t -68.09 154.21 42.14 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.901 0.88 . . . . 0.0 112.283 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -64.22 -16.72 62.59 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.35 1.06 . . . . 0.0 112.85 165.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 54.9 m-70 -110.57 -176.95 3.11 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 127.523 2.329 . . . . 0.0 112.075 -176.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -134.47 153.58 51.86 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.607 1.563 . . . . 0.0 110.975 159.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 45.93 93.71 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 128.313 2.645 . . . . 0.0 115.262 -178.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 25.2 tp -56.09 100.34 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 127.463 2.305 . . . . 0.0 112.38 173.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.47 0.537 0 C-N-CA 126.832 2.053 . . . . 0.0 109.478 172.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.0 t . . . . . 0 N--CA 1.474 0.74 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.4 mtp180 -46.61 -20.44 0.13 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 130.436 3.494 . . . . 0.0 119.167 -166.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.682 HG13 ' HB3' ' A' ' 131' ' ' SER 0.311 7.4 p -93.9 130.8 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 CA-C-N 121.585 1.993 . . . . 0.0 112.946 173.759 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 21.6 mt -105.21 156.97 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 127.19 2.196 . . . . 0.0 108.338 167.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -121.62 140.64 51.99 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.706 1.602 . . . . 0.0 110.374 177.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.0 mt -120.37 141.11 42.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 127.667 2.387 . . . . 0.0 108.777 -176.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.12 -171.79 2.05 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 125.667 1.587 . . . . 0.0 111.244 176.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 52.71 11.62 0.21 Allowed 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 127.664 2.386 . . . . 0.0 117.363 169.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 22.4 mt -62.75 155.94 67.73 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 124.785 1.234 . . . . 0.0 113.241 -176.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -51.95 173.06 0.12 Allowed 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 123.58 2.853 . . . . 0.0 114.669 161.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 32.5 pt -69.54 -30.78 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 126.568 1.947 . . . . 0.0 112.951 -172.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -156.36 34.86 0.32 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.78 2.032 . . . . 0.0 110.702 -170.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -53.09 147.75 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 O-C-N 121.095 -1.003 . . . . 0.0 111.051 174.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.41 HG23 ' H ' ' A' ' 74' ' ' GLU . 5.5 t -88.91 136.83 32.8 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 123.05 1.405 . . . . 0.0 112.187 -173.19 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -55.49 -34.45 64.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.588 -1.187 . . . . 0.0 112.984 171.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -54.83 -40.3 71.48 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.856 1.217 . . . . 0.0 113.277 171.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.41 ' H ' HG23 ' A' ' 71' ' ' THR . 12.0 mt-10 -66.94 -51.2 58.15 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.052 0.941 . . . . 0.0 110.868 172.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 86.2 t -58.61 -48.7 84.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 123.652 0.781 . . . . 0.0 112.788 -175.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -80.7 -24.64 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 O-C-N 120.191 -1.568 . . . . 0.0 114.432 177.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 75.5 m -64.16 -27.1 68.84 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 120.407 1.458 . . . . 0.0 110.856 168.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.7 mt -77.68 -28.38 51.06 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 118.16 -0.924 . . . . 0.0 113.237 170.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -89.44 -13.78 61.02 Favored Glycine 0 CA--C 1.536 1.404 0 CA-C-N 119.979 1.263 . . . . 0.0 115.425 175.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.3 mt -68.13 -38.06 12.74 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 117.429 2.381 . . . . 0.0 117.429 -169.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -57.51 -3.52 0.94 Allowed 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.89 3.06 . . . . 0.0 117.277 173.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -106.34 -27.12 11.18 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -164.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -172.14 -95.45 0.1 OUTLIER Glycine 0 C--N 1.336 0.542 0 C-N-CA 124.631 1.11 . . . . 0.0 110.634 169.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.7 tppt? -149.24 155.65 40.91 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 127.021 2.129 . . . . 0.0 105.503 160.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.623 HG22 ' CE ' ' A' ' 101' ' ' MET . 3.1 t -131.4 102.0 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 120.341 1.428 . . . . 0.0 110.05 -171.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 30.5 m -67.23 -46.88 72.47 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 128.872 2.869 . . . . 0.0 112.22 -162.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 53.3 m-20 -144.92 162.06 37.8 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 122.236 1.017 . . . . 0.0 112.491 177.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -135.61 171.78 13.95 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.378 1.071 . . . . 0.0 110.936 157.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.529 ' C ' HD23 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -145.56 152.36 39.59 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.563 1.545 . . . . 0.0 109.11 -179.42 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 8.2 mtt -131.61 104.13 6.77 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.139 0.976 . . . . 0.0 112.408 -175.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -78.03 74.03 4.58 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.019 1.328 . . . . 0.0 109.878 170.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -58.27 -28.78 65.26 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -172.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -79.15 -6.49 88.84 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 125.279 1.419 . . . . 0.0 115.491 175.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.4 mtmt -120.8 4.47 10.53 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.252 1.821 . . . . 0.0 114.139 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 15.5 m120 54.42 38.5 29.7 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.317 1.447 . . . . 0.0 112.507 -170.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -137.09 160.0 40.24 Favored 'General case' 0 CA--C 1.554 1.129 0 O-C-N 121.258 -0.901 . . . . 0.0 111.032 -159.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -154.78 167.82 28.93 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 120.127 -1.608 . . . . 0.0 112.644 -177.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.442 ' CD2' HG21 ' A' ' 60' ' ' VAL . 5.4 m-30 -116.05 155.52 27.98 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.63 1.972 . . . . 0.0 108.818 165.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 16.6 tt -139.68 99.41 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 125.373 1.469 . . . . 0.0 109.249 168.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.0 tp10 -88.97 122.67 32.57 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 128.617 2.767 . . . . 0.0 110.628 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.623 ' CE ' HG22 ' A' ' 85' ' ' VAL 0.332 0.9 OUTLIER -119.17 161.18 20.78 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 -176.942 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.0 -15.81 63.08 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.376 1.47 . . . . 0.0 113.336 -164.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.28 144.77 33.44 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 122.153 0.978 . . . . 0.0 111.069 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -60.98 -43.42 98.84 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.78 177.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -73.55 -35.42 65.5 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -178.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -57.13 -54.61 44.81 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 168.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.58 -39.17 91.33 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 120.986 -1.071 . . . . 0.0 113.458 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -49.3 -55.07 13.98 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 120.226 1.375 . . . . 0.0 113.211 168.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -62.49 -34.62 77.21 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 118.708 -0.663 . . . . 0.0 111.012 175.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 4.6 ttp -63.34 -56.05 19.52 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.009 1.324 . . . . 0.0 110.189 179.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -61.4 -37.57 78.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 125.877 1.671 . . . . 0.0 112.006 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -69.96 -46.42 65.3 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.706 0.802 . . . . 0.0 111.301 177.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -49.35 -38.48 28.33 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.434 0.694 . . . . 0.0 111.821 166.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.671 ' HA ' HG12 ' A' ' 117' ' ' VAL . 14.4 m-85 -83.98 -20.69 32.41 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 120.723 -1.236 . . . . 0.0 113.075 -174.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -82.56 -13.69 56.15 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.993 0.901 . . . . 0.0 111.222 171.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.77 -53.17 5.3 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 127.721 2.408 . . . . 0.0 112.37 174.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.671 HG12 ' HA ' ' A' ' 114' ' ' TYR . 10.0 p -75.8 -42.66 40.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 125.695 1.598 . . . . 0.0 114.868 -157.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.438 ' CA ' HG13 ' A' ' 117' ' ' VAL . 0.2 OUTLIER 1.53 113.35 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.462 0 C-N-CA 127.349 2.26 . . . . 0.0 116.437 -124.836 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.425 ' HD2' HD12 ' A' ' 126' ' ' ILE . 5.4 Cg_exo -76.66 -18.85 14.99 Favored 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 123.604 2.869 . . . . 0.0 113.216 -164.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.6 t 62.46 105.05 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 129.938 3.295 . . . . 0.0 112.947 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.8 tt -70.87 -64.35 0.92 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.233 0.613 . . . . 0.0 111.563 -162.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -142.02 71.69 1.36 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.492 1.517 . . . . 0.0 109.879 172.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 77.85 8.82 87.24 Favored Glycine 0 CA--C 1.538 1.476 0 N-CA-C 115.641 1.016 . . . . 0.0 115.641 -179.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -138.29 139.34 25.0 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 126.142 1.777 . . . . 0.0 110.417 177.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -58.79 162.07 13.87 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 123.35 2.7 . . . . 0.0 111.872 171.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.425 HD12 ' HD2' ' A' ' 119' ' ' PRO . 3.0 mt -106.39 -45.07 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -156.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 77.25 110.07 0.07 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.992 2.117 . . . . 0.0 112.103 170.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.47 153.84 35.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 125.723 1.609 . . . . 0.0 111.206 178.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -151.33 164.2 37.21 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.919 1.688 . . . . 0.0 109.005 151.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -51.89 146.16 8.75 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.278 -0.889 . . . . 0.0 111.673 164.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.682 ' HB3' HG13 ' A' ' 60' ' ' VAL . 29.0 t -68.73 154.37 42.07 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.919 -0.488 . . . . 0.0 111.576 178.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -63.54 -20.42 65.62 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.177 0.991 . . . . 0.0 112.525 165.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 37.4 m-70 -101.08 177.43 4.95 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.955 2.102 . . . . 0.0 110.665 178.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -128.7 7.66 5.72 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.94 1.296 . . . . 0.0 113.87 -168.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -173.16 155.58 3.0 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 127.821 2.449 . . . . 0.0 109.643 -167.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 47.6 tp -134.61 74.46 1.53 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.528 1.931 . . . . 0.0 110.034 170.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 23.7 tptm . . . . . 0 N--CA 1.47 0.561 0 C-N-CA 124.709 1.204 . . . . 0.0 109.651 176.605 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.642 0 N-CA-C 112.229 -0.349 . . . . 0.0 112.229 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -94.2 -1.7 53.69 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.145 1.778 . . . . 0.0 114.951 -175.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.5 m -61.62 -5.47 1.89 Allowed 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 127.29 2.236 . . . . 0.0 116.896 -169.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 23.1 mmt180 -56.65 -48.98 76.38 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.937 1.295 . . . . 0.0 111.904 173.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.8 m -75.94 136.05 40.07 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.741 1.216 . . . . 0.0 111.831 177.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.49 ' HB1' ' HB3' ' A' ' 57' ' ' PRO . . . -66.62 166.96 11.83 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.103 0.961 . . . . 0.0 113.551 172.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -153.47 -36.96 0.03 OUTLIER Glycine 0 CA--C 1.536 1.391 0 C-N-CA 125.723 1.63 . . . . 0.0 113.096 170.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.3 p -143.97 71.72 16.74 Favored Pre-proline 0 N--CA 1.479 1.01 0 C-N-CA 126.577 1.951 . . . . 0.0 109.734 164.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.49 ' HB3' ' HB1' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -93.2 -173.25 0.37 Allowed 'Trans proline' 0 CA--C 1.548 1.208 1 C-N-CA 125.436 4.091 . . . . 0.0 112.276 -163.636 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.2 t -138.34 -178.59 5.35 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.265 1.026 . . . . 0.0 113.448 176.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 -51.87 -7.49 0.05 Allowed 'General case' 0 N--CA 1.474 0.775 1 C-N-CA 132.408 4.283 . . . . 0.0 120.412 -155.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.678 HG13 ' HB3' ' A' ' 131' ' ' SER 0.294 5.7 p -99.31 129.63 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-N 121.991 2.178 . . . . 0.0 112.099 170.241 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 16.1 mt -105.84 157.87 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 128.157 2.583 . . . . 0.0 108.149 170.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -128.17 142.87 51.05 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.206 1.802 . . . . 0.0 110.455 179.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.0 mt -123.76 140.01 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 126.953 2.101 . . . . 0.0 109.957 -174.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.69 174.3 6.03 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 125.958 1.703 . . . . 0.0 112.056 172.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.494 ' HE3' ' CE2' ' A' ' 127' ' ' TYR . 2.5 mmtp 71.39 -2.92 2.25 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 128.341 2.656 . . . . 0.0 116.571 172.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -35.34 145.72 0.2 Allowed Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 129.977 3.311 . . . . 0.0 115.933 -164.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.26 165.23 1.01 Allowed 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.36 2.707 . . . . 0.0 115.126 176.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 37.7 pt -56.66 -31.59 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 128.197 2.599 . . . . 0.0 113.984 -169.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -161.45 41.71 0.15 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.455 1.902 . . . . 0.0 110.365 -177.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -57.63 157.93 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 O-C-N 121.544 -0.722 . . . . 0.0 110.898 174.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 14.4 t -123.71 154.7 39.06 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 122.559 1.171 . . . . 0.0 113.216 -175.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -54.78 -42.6 71.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.74 175.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.62 -36.96 55.59 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.088 0.852 . . . . 0.0 113.463 178.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -71.44 -52.34 18.99 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.911 1.284 . . . . 0.0 112.16 173.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 57.6 t -59.71 -46.25 93.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -177.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.9 pp -69.75 -34.24 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 O-C-N 120.553 -1.342 . . . . 0.0 112.422 175.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 74.8 m -67.8 -19.31 65.07 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 119.895 1.225 . . . . 0.0 111.742 175.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 62.5 mt -89.62 -15.53 32.54 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 172.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -101.3 -13.23 33.79 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-N 119.168 0.894 . . . . 0.0 114.977 172.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.3 mt -63.34 -44.98 84.31 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 116.563 2.06 . . . . 0.0 116.563 -175.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.1 -5.22 1.28 Allowed 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 124.441 3.428 . . . . 0.0 117.972 176.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -103.96 -39.93 6.4 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -164.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -154.77 -82.77 0.04 OUTLIER Glycine 0 CA--C 1.518 0.257 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 172.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 22.5 tptp -152.05 -8.98 0.2 Allowed 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 116.972 2.212 . . . . 0.0 116.972 174.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.413 ' H ' ' HE1' ' A' ' 101' ' ' MET . 0.4 OUTLIER 27.18 109.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.173 0 C-N-CA 127.635 2.374 . . . . 0.0 115.449 -147.208 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.2 m -59.3 -36.62 75.94 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 119.678 -1.889 . . . . 0.0 112.226 170.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -162.56 178.23 8.75 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 115.903 1.816 . . . . 0.0 115.903 175.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -136.88 172.76 12.53 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.31 1.844 . . . . 0.0 112.601 155.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.51 ' C ' HD23 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -142.43 156.27 45.17 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.923 1.689 . . . . 0.0 109.538 169.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 3.5 mtt -128.98 107.76 9.87 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.92 0.888 . . . . 0.0 111.81 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -78.34 54.4 1.4 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.226 1.01 . . . . 0.0 109.488 164.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 66.4 tttt -64.78 -27.37 68.84 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -159.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -65.62 -14.39 60.25 Favored Glycine 0 CA--C 1.541 1.718 0 C-N-CA 125.152 1.358 . . . . 0.0 115.707 171.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.01 2.89 17.09 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.887 1.675 . . . . 0.0 113.054 169.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 7.9 m120 50.66 54.27 11.48 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.656 1.582 . . . . 0.0 112.164 -167.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -132.12 168.52 17.85 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.166 0.986 . . . . 0.0 110.76 173.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -154.6 166.47 33.24 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.918 1.287 . . . . 0.0 112.102 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.473 ' CD2' HG21 ' A' ' 60' ' ' VAL . 5.2 m-30 -111.5 156.08 22.26 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.119 1.768 . . . . 0.0 108.359 161.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 15.2 tt -139.69 106.69 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.979 1.312 . . . . 0.0 109.045 166.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -96.97 137.6 35.81 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 129.291 3.036 . . . . 0.0 111.135 -174.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.481 ' HE2' ' HB2' ' A' ' 101' ' ' MET 0.316 19.9 tpp -133.04 150.55 52.11 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 115.842 1.793 . . . . 0.0 115.842 -167.282 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -71.92 -15.28 62.09 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 114.166 1.172 . . . . 0.0 114.166 -166.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.53 143.83 31.03 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.41 1.084 . . . . 0.0 110.234 -177.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -64.2 -37.74 88.55 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.637 0.775 . . . . 0.0 111.424 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -73.26 -39.73 65.19 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.764 0.826 . . . . 0.0 113.007 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -54.62 -51.52 65.1 Favored 'General case' 0 C--O 1.217 -0.62 0 C-N-CA 123.494 0.718 . . . . 0.0 110.618 169.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.62 -37.6 76.9 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -55.54 -49.62 72.17 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.995 0.816 . . . . 0.0 110.552 169.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -66.63 -29.49 69.54 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-O 118.067 -0.968 . . . . 0.0 111.691 174.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 11.6 ttp -71.73 -45.25 62.36 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 120.329 1.422 . . . . 0.0 110.154 -177.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -68.74 -40.4 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 O-C-N 121.334 -0.854 . . . . 0.0 112.068 175.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -68.43 -43.1 77.85 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.737 -0.602 . . . . 0.0 110.402 178.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -48.57 -44.91 37.15 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 125.428 1.491 . . . . 0.0 111.833 165.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.579 ' HA ' HG12 ' A' ' 117' ' ' VAL . 14.2 m-85 -80.24 -14.87 58.08 Favored 'General case' 0 C--N 1.332 -0.194 0 O-C-N 121.032 -1.043 . . . . 0.0 112.837 -177.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 97.8 m -85.22 -13.55 49.57 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.763 1.225 . . . . 0.0 110.635 171.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.89 -56.04 2.62 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 129.02 2.928 . . . . 0.0 112.892 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.579 HG12 ' HA ' ' A' ' 114' ' ' TYR . 9.9 p -70.86 -32.49 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 127.948 2.499 . . . . 0.0 113.436 -162.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.491 ' CG2' ' H ' ' A' ' 126' ' ' ILE . 1.3 m -6.26 113.86 0.03 OUTLIER Pre-proline 0 N--CA 1.483 1.178 0 C-N-CA 128.857 2.863 . . . . 0.0 115.864 -129.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 118' ' ' THR . 5.5 Cg_exo -75.61 -0.72 10.49 Favored 'Trans proline' 0 CA--C 1.553 1.441 0 C-N-CA 124.154 3.236 . . . . 0.0 114.384 -159.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.2 t 59.89 108.96 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.787 1 C-N-CA 131.903 4.081 . . . . 0.0 115.645 176.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.9 tt -76.02 80.47 2.88 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.852 2.061 . . . . 0.0 109.271 174.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . 0.332 0.1 OUTLIER 45.3 -13.91 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 1 C-N-CA 133.707 4.803 . . . . 0.0 119.301 -173.146 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 178.46 12.09 0.02 OUTLIER Glycine 0 CA--C 1.537 1.436 0 C-N-CA 126.431 1.967 . . . . 0.0 115.029 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -142.53 156.13 63.59 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 126.53 1.932 . . . . 0.0 109.325 177.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_exo -53.32 166.74 1.0 Allowed 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 123.35 2.7 . . . . 0.0 114.339 167.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.491 ' H ' ' CG2' ' A' ' 118' ' ' THR . 0.7 OUTLIER -119.21 142.86 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.528 1.531 . . . . 0.0 108.858 178.196 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.494 ' CE2' ' HE3' ' A' ' 65' ' ' LYS . 3.0 m-85 -114.16 98.68 7.1 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.633 -156.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.18 147.56 25.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 124.014 0.926 . . . . 0.0 113.449 -174.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -150.96 160.51 43.87 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.495 1.918 . . . . 0.0 109.924 161.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -54.12 152.01 6.46 Favored 'General case' 0 CA--C 1.553 1.059 0 O-C-N 120.976 -1.077 . . . . 0.0 112.213 160.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.678 ' HB3' HG13 ' A' ' 60' ' ' VAL . 28.5 t -75.04 159.64 31.49 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.513 1.125 . . . . 0.0 113.594 -172.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -67.99 -12.3 60.51 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 126.41 1.884 . . . . 0.0 112.389 166.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 55.8 m-70 -118.24 -176.49 3.08 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.884 2.074 . . . . 0.0 113.057 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -129.73 147.08 51.47 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 126.855 2.062 . . . . 0.0 109.456 164.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 51.87 92.07 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 127.348 2.259 . . . . 0.0 115.554 176.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 42.4 tp -64.72 139.8 58.8 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.337 1.455 . . . . 0.0 112.546 174.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.0 146.51 52.12 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.496 1.918 . . . . 0.0 111.361 167.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 48.2 p -132.65 15.47 4.4 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.678 1.191 . . . . 0.0 113.902 -164.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -61.14 156.08 19.09 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.044 1.338 . . . . 0.0 113.876 -178.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 65.7 m -69.99 166.31 19.93 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.448 1.899 . . . . 0.0 114.344 -176.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 99.3 p -71.0 160.87 81.1 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 125.099 1.36 . . . . 0.0 113.646 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_exo -57.88 -25.24 68.53 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 123.934 3.089 . . . . 0.0 115.263 173.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -60.67 -43.69 97.37 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.91 0.884 . . . . 0.0 112.385 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -55.44 -36.8 66.91 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.637 1.175 . . . . 0.0 113.108 -178.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.4 -13.41 62.35 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.337 1.455 . . . . 0.0 114.582 177.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 . . . . . 0 N--CA 1.473 0.719 0 C-N-CA 126.312 1.845 . . . . 0.0 114.655 -165.008 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 147' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.506 0 N19-C1'-C2' 116.97 2.231 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 148' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.453 0 O4'-C1'-N19 111.83 3.63 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 149' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.622 2.897 1 O5'-C5'-C4' 117.594 5.281 OUTLIER-EPSILON 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 150' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.687 3 P-O3'-C3' 127.133 6.194 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 151' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.545 2.713 0 O4'-C1'-N19 110.646 2.446 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 152' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.444 0 O4'-C1'-N19 111.184 2.984 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.555 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -72.38 94.21 1.6 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.929 1.291 . . . . 0.0 111.557 176.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.5 m -57.72 -16.95 12.61 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 116.16 1.911 . . . . 0.0 116.16 -169.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -63.93 -26.6 68.66 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.228 1.411 . . . . 0.0 113.144 169.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.5 m -68.15 158.36 33.33 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.725 1.21 . . . . 0.0 113.65 -175.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.79 176.6 6.17 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 124.549 1.14 . . . . 0.0 112.086 165.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -86.4 -62.02 1.59 Allowed Glycine 0 N--CA 1.471 1.017 0 O-C-N 121.045 -1.035 . . . . 0.0 112.349 -168.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 17.1 t -134.88 75.3 61.89 Favored Pre-proline 0 N--CA 1.476 0.828 0 C-N-CA 124.738 1.215 . . . . 0.0 110.387 169.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -99.68 163.29 0.54 Allowed 'Trans proline' 0 CA--C 1.546 1.116 0 C-N-CA 125.124 3.882 . . . . 0.0 112.645 -169.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 65.1 m -141.29 -86.64 0.17 Allowed 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 -177.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 72.5 mtm-85 -117.58 -17.48 9.96 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 -166.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.668 HG13 ' HB3' ' A' ' 131' ' ' SER 0.364 10.8 p -98.17 136.85 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 121.077 1.762 . . . . 0.0 113.575 170.117 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 27.8 mt -113.2 156.93 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 128.947 2.899 . . . . 0.0 107.937 170.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -124.99 132.38 53.27 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.672 1.589 . . . . 0.0 109.906 177.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.0 mt -111.97 131.16 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 127.747 2.419 . . . . 0.0 108.484 -175.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -87.55 178.67 6.72 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 119.898 1.226 . . . . 0.0 110.65 170.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 23.6 mtpp 33.49 53.95 0.46 Allowed 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 129.03 2.932 . . . . 0.0 115.081 156.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.7 mt -68.88 152.11 96.93 Favored Pre-proline 0 C--N 1.309 -1.17 0 CA-C-N 113.628 -1.624 . . . . 0.0 109.206 167.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -51.12 160.98 1.76 Allowed 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 125.022 3.815 . . . . 0.0 115.339 174.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 29.7 pt -65.38 -24.13 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 128.533 2.733 . . . . 0.0 113.914 -176.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -139.97 19.63 2.47 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.624 1.969 . . . . 0.0 111.891 -171.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -57.87 166.48 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 123.956 0.902 . . . . 0.0 112.881 175.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.1 t -132.29 156.64 46.19 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-O 122.523 1.154 . . . . 0.0 112.42 171.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.5 -34.98 67.5 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.907 174.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -59.65 -31.32 70.85 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 125.303 1.43 . . . . 0.0 113.782 175.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -75.28 -44.88 43.31 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.718 1.207 . . . . 0.0 111.538 173.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 66.3 t -64.24 -45.43 96.26 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.427 HG23 HD13 ' A' ' 88' ' ' LEU . 2.4 pp -71.37 -29.49 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 O-C-N 120.216 -1.553 . . . . 0.0 113.317 174.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 35.1 t -63.24 -28.73 70.23 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 119.264 0.938 . . . . 0.0 110.649 171.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.9 mt -82.67 -17.11 45.72 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 114.686 1.365 . . . . 0.0 114.686 173.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -94.44 -19.8 31.55 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-N 119.198 0.908 . . . . 0.0 115.188 172.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 13.9 mt -68.49 -33.13 4.28 Favored Pre-proline 0 CA--C 1.54 0.558 0 N-CA-C 117.547 2.425 . . . . 0.0 117.547 -169.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -59.0 -5.14 2.51 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.199 2.599 . . . . 0.0 117.16 169.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -109.47 -36.89 5.86 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -163.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -161.3 -98.83 0.14 Allowed Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 167.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.422 ' HB3' ' CG ' ' A' ' 102' ' ' ASN . 21.2 tptp -136.24 -10.83 1.95 Allowed 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 115.819 1.785 . . . . 0.0 115.819 -178.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.523 HG13 ' HB2' ' A' ' 101' ' ' MET . 0.1 OUTLIER 28.87 89.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 129.423 3.089 . . . . 0.0 113.389 -174.511 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.24 -42.03 94.41 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.793 2.037 . . . . 0.0 111.916 -173.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -152.0 168.73 24.27 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.427 HD13 HG23 ' A' ' 76' ' ' ILE . 1.9 pt? -144.21 170.65 15.57 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.003 1.721 . . . . 0.0 112.165 159.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.482 ' C ' HD23 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -143.7 156.96 44.7 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.867 1.667 . . . . 0.0 109.328 -177.925 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 8.3 mtt -130.21 107.22 9.13 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.581 0.753 . . . . 0.0 112.234 -177.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -77.15 68.29 3.26 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.552 1.141 . . . . 0.0 109.378 167.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -56.08 -39.22 71.77 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.414 1.085 . . . . 0.0 113.481 -166.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -64.57 -20.97 66.47 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 124.673 1.13 . . . . 0.0 115.779 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.1 mppt? -109.31 1.32 20.03 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.611 1.565 . . . . 0.0 112.737 174.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.0 m120 56.97 46.2 19.89 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.252 1.821 . . . . 0.0 113.417 -169.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -126.01 173.12 9.4 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 120.937 -1.102 . . . . 0.0 112.131 -177.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -152.22 160.92 43.28 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.53 1.132 . . . . 0.0 112.234 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.42 ' CD2' HG21 ' A' ' 60' ' ' VAL . 5.6 m-30 -99.56 154.09 18.53 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 155.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 17.1 tt -134.4 106.41 7.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 124.781 1.232 . . . . 0.0 107.979 165.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -105.44 122.18 45.45 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.714 1.605 . . . . 0.0 110.863 -172.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.523 ' HB2' HG13 ' A' ' 85' ' ' VAL . 0.9 OUTLIER -124.79 148.77 47.97 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 115.74 1.755 . . . . 0.0 115.74 -166.572 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.422 ' CG ' ' HB3' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -63.77 -17.88 63.51 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 115.558 1.688 . . . . 0.0 115.558 -158.246 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.409 HG23 ' ND2' ' A' ' 102' ' ' ASN . 1.9 p -139.78 146.76 39.88 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.378 0.609 . . . . 0.0 110.468 -178.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -62.05 -34.56 76.48 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.019 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -77.24 -38.09 51.87 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 114.225 1.195 . . . . 0.0 114.225 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.66 -49.53 77.2 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-N 119.486 1.039 . . . . 0.0 110.431 170.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.54 -36.82 76.72 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 177.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -58.3 -46.47 86.06 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 119.727 1.149 . . . . 0.0 111.23 170.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -64.82 -33.91 77.12 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 121.032 -1.042 . . . . 0.0 111.127 173.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 9.8 ttp -65.43 -51.5 59.82 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.539 1.136 . . . . 0.0 110.414 -179.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -65.98 -36.7 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 C-N-CA 125.215 1.406 . . . . 0.0 112.593 177.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -72.19 -40.84 67.6 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.129 0.877 . . . . 0.0 111.165 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -52.76 -40.29 62.99 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.924 0.89 . . . . 0.0 111.693 162.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -88.5 12.86 13.29 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 119.667 -1.896 . . . . 0.0 112.291 177.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 52.0 m -112.52 -12.09 13.52 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.897 1.679 . . . . 0.0 110.175 169.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.52 -41.06 63.52 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.007 1.723 . . . . 0.0 111.544 153.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -142.38 160.8 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 124.897 1.279 . . . . 0.0 112.182 -150.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 18.7 m -125.01 135.63 27.04 Favored Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 125.657 1.583 . . . . 0.0 107.728 164.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -75.28 -17.09 19.23 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 121.895 1.73 . . . . 0.0 114.166 -171.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 4.0 t 39.85 73.88 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 128.39 2.676 . . . . 0.0 111.76 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.636 ' H ' HD11 ' A' ' 126' ' ' ILE . 5.5 tt -92.24 -32.8 14.92 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 112.397 -2.183 . . . . 0.0 110.609 -121.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -136.99 39.35 2.55 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.701 1.201 . . . . 0.0 111.539 151.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 126.66 2.68 6.72 Favored Glycine 0 CA--C 1.535 1.298 0 N-CA-C 119.328 2.491 . . . . 0.0 119.328 160.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.64 168.39 11.16 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 121.991 2.896 . . . . 0.0 113.604 173.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -60.33 147.12 94.98 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.912 2.408 . . . . 0.0 114.387 -172.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.636 HD11 ' H ' ' A' ' 121' ' ' LEU . 26.0 mm -120.3 -55.93 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 125.294 1.438 . . . . 0.0 113.245 -163.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 65.36 150.46 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.841 2.456 . . . . 0.0 115.743 -173.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.66 150.67 22.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 C-N-CA 126.958 2.103 . . . . 0.0 110.601 172.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -139.34 159.93 41.01 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.287 1.035 . . . . 0.0 108.623 149.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -51.81 150.73 3.86 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.348 -0.845 . . . . 0.0 110.931 159.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.668 ' HB3' HG13 ' A' ' 60' ' ' VAL . 44.0 t -72.14 154.06 41.29 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.59 -0.694 . . . . 0.0 111.623 174.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -77.46 -18.7 56.92 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.061 0.544 . . . . 0.0 112.398 165.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 38.0 m-70 -80.36 176.04 10.13 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.216 1.406 . . . . 0.0 110.144 160.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -119.2 -9.67 9.92 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 114.477 1.288 . . . . 0.0 114.477 -173.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -175.91 175.36 1.98 Allowed 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 129.129 2.971 . . . . 0.0 109.889 -172.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 23.8 tp -138.2 122.52 18.24 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.735 1.614 . . . . 0.0 113.033 -164.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -113.07 96.04 5.72 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.549 1.94 . . . . 0.0 110.506 170.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 10.7 p -75.71 -9.8 58.9 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.463 1.505 . . . . 0.0 114.194 174.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -70.39 88.62 0.66 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.882 1.673 . . . . 0.0 112.131 175.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 61.2 p -149.26 80.26 1.41 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.795 2.038 . . . . 0.0 112.266 176.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 47.6 m -62.37 152.35 79.9 Favored Pre-proline 0 N--CA 1.475 0.801 0 C-N-CA 125.122 1.369 . . . . 0.0 112.969 179.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -68.89 -23.53 34.86 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 122.844 2.363 . . . . 0.0 114.03 -177.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -66.47 -32.38 73.72 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.272 1.029 . . . . 0.0 113.249 175.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -122.16 82.8 2.01 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.489 1.516 . . . . 0.0 110.303 177.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.35 -25.11 66.93 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.497 1.919 . . . . 0.0 115.338 -174.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 63.3 ttp85 . . . . . 0 N--CA 1.476 0.848 0 C-N-CA 125.944 1.698 . . . . 99.99 111.209 -177.581 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 147' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.32 0 O4'-C1'-N19 111.328 3.128 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 148' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.729 0 O4'-C4'-C3' 110.036 3.24 . 0.01 4p . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 149' ' ' ' C' . . . . . 0.407 ' N3 ' ' HA ' ' A' ' 131' ' ' SER . . . . . . . . 0 O4'--C4' 1.424 -2.43 0 N19-C1'-C2' 107.903 -3.436 . 0.074 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 150' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.946 1 O4'-C1'-N19 112.721 4.521 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 151' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.537 2.068 1 O4'-C1'-N19 112.868 4.668 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 152' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.541 2.42 0 O4'-C1'-N19 111.643 3.443 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.707 0 N-CA-C 111.886 -0.485 . . . . 0.0 111.886 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -59.85 -16.86 32.04 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 -172.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 58.6 m -60.28 -30.25 69.34 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 121.164 -0.96 . . . . 0.0 112.978 170.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 39.8 mmt180 -68.22 -28.37 67.18 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.318 1.047 . . . . 0.0 112.771 175.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 17.4 m -74.31 -5.83 44.49 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.677 1.591 . . . . 0.0 114.197 176.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -132.26 -10.55 3.29 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 125.732 1.613 . . . . 0.0 113.926 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.12 41.89 7.32 Favored Glycine 0 CA--C 1.534 1.266 0 O-C-N 120.892 -1.13 . . . . 0.0 114.11 178.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.7 t 49.84 74.01 0.89 Allowed Pre-proline 0 N--CA 1.479 0.98 0 C-N-CA 127.715 2.406 . . . . 0.0 109.907 -171.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -90.92 -179.32 1.49 Allowed 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.867 3.044 . . . . 0.0 113.757 -149.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 29.0 t -131.99 -177.97 4.68 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.37 1.868 . . . . 0.0 110.949 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.445 ' H ' ' HD3' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -63.1 -3.89 2.01 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 116.246 1.943 . . . . 0.0 116.246 -172.44 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.688 HG13 ' HB3' ' A' ' 131' ' ' SER 0.322 8.7 p -81.34 128.61 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-N 121.17 1.804 . . . . 0.0 112.634 166.918 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 15.8 mt -113.67 153.73 15.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 128.867 2.867 . . . . 0.0 107.456 174.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.444 ' CD2' ' C6 ' ' B' ' 149' ' ' ' C' . 1.8 t-80 -123.96 142.35 51.23 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.434 1.494 . . . . 0.0 110.772 178.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.8 mt -119.53 138.25 50.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 127.828 2.451 . . . . 0.0 109.837 -172.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 17.0 mtt85 -96.87 176.38 6.0 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 119.488 1.04 . . . . 0.0 110.521 171.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp 44.23 42.67 5.29 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 126.958 2.103 . . . . 0.0 116.291 158.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.2 mp -55.98 161.29 3.71 Favored Pre-proline 0 CA--C 1.558 1.279 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.473 160.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.45 ' HD3' HD22 ' A' ' 121' ' ' LEU . 9.9 Cg_endo -60.06 -68.42 0.05 OUTLIER 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.734 2.956 . . . . 0.0 113.996 -173.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.1 pt -164.23 -39.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 130.848 3.659 . . . . 0.0 108.812 -171.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -151.69 -29.5 0.17 Allowed 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 -177.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.48 HG22 ' H ' ' A' ' 71' ' ' THR 0.29 2.0 p 40.02 -150.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 127.141 2.176 . . . . 0.0 112.192 -166.236 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.48 ' H ' HG22 ' A' ' 70' ' ' VAL . 2.9 t -141.75 141.91 33.25 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 120.482 -1.386 . . . . 0.0 109.681 156.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -57.1 -32.58 66.45 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 176.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -52.92 -41.08 58.6 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 125.088 1.328 . . . . 0.0 113.353 170.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -69.21 -48.94 60.66 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.451 -1.029 . . . . 0.0 111.107 172.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.5 t -58.81 -50.38 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 123.146 0.579 . . . . 0.0 112.497 -176.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -76.37 -27.98 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 O-C-N 120.103 -1.623 . . . . 0.0 113.877 177.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 33.0 t -62.77 -26.79 68.89 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 120.022 1.283 . . . . 0.0 110.826 169.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 33.8 mt -83.71 -18.26 38.54 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 114.306 1.225 . . . . 0.0 114.306 170.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -87.87 -18.64 55.86 Favored Glycine 0 CA--C 1.536 1.383 0 CA-C-N 119.376 0.989 . . . . 0.0 113.832 170.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 80' ' ' LEU . 17.8 mt -73.96 -16.8 0.28 Allowed Pre-proline 0 CA--C 1.542 0.67 0 N-CA-C 119.035 2.976 . . . . 0.0 119.035 -174.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -59.55 -5.07 2.95 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.593 2.195 . . . . 0.0 116.773 168.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.419 ' CD2' ' HG3' ' A' ' 110' ' ' MET . 24.8 m-85 -120.66 -36.09 3.25 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -166.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -162.95 -101.59 0.16 Allowed Glycine 0 CA--C 1.523 0.548 0 C-N-CA 123.724 0.678 . . . . 0.0 111.782 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 32.2 tptt -147.73 -9.99 0.41 Allowed 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 117.348 2.351 . . . . 0.0 117.348 -174.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.434 HG13 ' HB2' ' A' ' 101' ' ' MET . 0.0 OUTLIER 32.21 89.03 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 C-N-CA 128.927 2.891 . . . . 0.0 113.651 -175.693 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 38.1 m -55.87 -40.65 73.26 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 127.142 2.177 . . . . 0.0 112.264 -175.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -153.18 168.81 24.72 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -141.89 173.53 11.42 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.685 1.594 . . . . 0.0 112.303 158.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.468 ' C ' HD23 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -149.9 154.97 39.21 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.85 1.66 . . . . 0.0 109.678 -179.835 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 14.8 mtt -129.66 110.57 11.9 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.934 0.894 . . . . 0.0 112.219 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -75.17 76.92 2.32 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 122.518 1.151 . . . . 0.0 109.761 169.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.17 -13.75 8.33 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.894 1.678 . . . . 0.0 115.309 -176.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -58.15 -40.9 94.35 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.685 1.612 . . . . 0.0 114.694 170.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -136.85 10.54 3.1 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 -162.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 52.65 49.37 20.5 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.022 1.329 . . . . 0.0 112.981 -167.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -113.52 167.09 10.89 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.516 0.726 . . . . 0.0 110.191 170.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -155.55 163.12 40.41 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 120.734 -1.229 . . . . 0.0 111.318 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.453 ' CD2' HG21 ' A' ' 60' ' ' VAL . 6.0 m-30 -108.32 155.88 20.02 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.444 1.497 . . . . 0.0 108.871 162.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.5 tt -141.68 106.69 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 125.872 1.669 . . . . 0.0 108.276 168.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -102.78 127.75 49.81 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 129.588 3.155 . . . . 0.0 110.776 -171.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.434 ' HB2' HG13 ' A' ' 85' ' ' VAL 0.362 1.9 tpp -124.58 158.7 32.4 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 118.201 2.667 . . . . 0.0 118.201 -171.144 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -71.27 -21.48 62.09 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.515 1.526 . . . . 0.0 114.07 -166.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.98 146.81 39.58 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.458 0.647 . . . . 0.0 110.988 -178.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -63.36 -37.9 89.07 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.726 0.81 . . . . 0.0 111.451 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -76.14 -38.03 57.27 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 178.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.35 -48.48 81.48 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-N 118.74 0.7 . . . . 0.0 110.565 171.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.18 -38.49 75.38 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 178.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -57.7 -46.99 83.61 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.996 0.816 . . . . 0.0 111.186 170.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -65.71 -29.6 70.16 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-O 117.799 -1.096 . . . . 0.0 111.525 171.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.419 ' HG3' ' CD2' ' A' ' 82' ' ' PHE . 18.8 ttp -69.24 -49.58 55.03 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 120.54 1.518 . . . . 0.0 109.839 -176.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -63.59 -40.01 87.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 124.116 0.966 . . . . 0.0 111.753 175.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -70.51 -43.65 69.24 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 121.663 -0.648 . . . . 0.0 111.076 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -48.93 -39.98 28.34 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 126.332 1.853 . . . . 0.0 111.667 166.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.61 ' HA ' HG12 ' A' ' 117' ' ' VAL . 11.3 m-85 -85.28 -22.06 28.74 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 120.602 -1.311 . . . . 0.0 113.197 -178.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 99.0 m -76.51 -19.19 58.23 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.877 0.871 . . . . 0.0 110.174 172.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.9 -60.62 2.27 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 129.507 3.123 . . . . 0.0 111.252 170.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.61 HG12 ' HA ' ' A' ' 114' ' ' TYR . 2.3 p -79.42 -48.43 21.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 124.412 1.085 . . . . 0.0 112.478 -158.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 4.9 m 33.92 126.14 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 129.013 2.925 . . . . 0.0 114.248 -139.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -76.15 -10.59 19.42 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 121.366 1.377 . . . . 0.0 115.018 -170.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.4 t 30.02 89.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 130.04 3.336 . . . . 0.0 113.102 175.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.569 ' H ' HD11 ' A' ' 126' ' ' ILE . 1.5 tt -104.76 -68.48 0.85 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 112.301 -2.227 . . . . 0.0 108.159 -138.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -66.76 -44.67 80.83 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.118 0.967 . . . . 0.0 110.476 167.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 159.82 12.51 0.04 OUTLIER Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.315 1.436 . . . . 0.0 115.527 178.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -147.28 168.68 10.78 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 119.491 1.646 . . . . 0.0 112.007 -179.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -54.87 142.87 74.05 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.984 2.456 . . . . 0.0 114.235 -175.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.569 HD11 ' H ' ' A' ' 121' ' ' LEU . 20.2 mm -106.87 -43.05 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.729 1.211 . . . . 0.0 112.423 -167.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 61.11 141.38 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 128.192 2.597 . . . . 0.0 115.101 -173.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.46 155.56 31.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 126.264 1.825 . . . . 0.0 111.323 171.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -151.47 162.25 41.28 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.344 1.858 . . . . 0.0 109.252 158.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -52.29 143.37 14.93 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 121.201 -0.937 . . . . 0.0 111.147 160.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.688 ' HB3' HG13 ' A' ' 60' ' ' VAL . 30.2 t -66.93 153.39 43.68 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.24 1.016 . . . . 0.0 112.179 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -64.76 -25.88 68.12 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.628 1.171 . . . . 0.0 112.349 168.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 57.5 m-70 -92.74 169.82 10.19 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.553 1.541 . . . . 0.0 111.259 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.66 111.75 14.66 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 125.096 1.358 . . . . 0.0 108.915 175.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 74.71 145.88 0.08 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 128.411 2.684 . . . . 0.0 113.592 -170.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 26.2 tp -113.32 111.62 22.32 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.802 2.041 . . . . 0.0 110.994 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.98 83.39 1.93 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 128.002 2.521 . . . . 0.0 110.552 -177.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 16.4 p -69.97 -14.02 62.51 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.67 1.588 . . . . 0.0 114.068 178.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -69.16 -10.24 56.72 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.539 1.535 . . . . 0.0 114.335 175.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 26.4 m 55.62 40.18 30.98 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.179 1.792 . . . . 0.0 114.53 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 55.4 p -62.3 148.17 90.07 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 124.179 0.991 . . . . 0.0 112.373 173.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -78.68 -25.61 6.37 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 123.07 2.513 . . . . 0.0 114.088 -173.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -154.33 -54.9 0.1 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.411 1.484 . . . . 0.0 111.867 -177.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -145.75 175.0 10.73 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.617 1.567 . . . . 0.0 112.074 -176.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.67 -25.36 67.34 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.395 1.478 . . . . 0.0 114.985 -174.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 . . . . . 0 N--CA 1.475 0.785 0 C-N-CA 126.133 1.773 . . . . 99.99 110.311 172.282 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 147' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.19 0 C5'-C4'-C3' 111.402 -2.732 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 148' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.883 1 C5'-C4'-C3' 108.171 -4.886 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 149' ' ' ' C' . . . . . 0.444 ' C6 ' ' CD2' ' A' ' 62' ' ' HIS . . . . . . . . 0 O4'--C4' 1.418 -2.93 0 N19-C1'-C2' 107.972 -3.392 . 0.01 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 150' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.657 1 O4'-C1'-N19 112.833 4.633 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 151' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.543 2.549 0 O5'-C5'-C4' 113.257 2.183 . 0.07 1[ . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 152' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.536 2.023 1 O4'-C1'-N19 112.962 4.762 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.711 0 N-CA-C 110.644 -0.983 . . . . 0.0 110.644 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -77.16 49.17 0.66 Allowed 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 125.036 1.335 . . . . 0.0 111.757 170.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.3 m -75.37 8.05 3.07 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 128.304 2.642 . . . . 0.0 115.464 -164.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.4 -8.64 1.24 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 128.256 2.623 . . . . 0.0 116.625 179.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 69.5 m -131.37 96.53 4.02 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.702 2.001 . . . . 0.0 109.889 -177.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.451 ' HB3' ' HB3' ' A' ' 57' ' ' PRO . . . -143.98 179.29 7.28 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 129.712 3.205 . . . . 0.0 112.056 -0.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -85.36 -61.47 1.72 Allowed Glycine 0 N--CA 1.473 1.106 0 C-N-CA 124.657 1.122 . . . . 0.0 112.357 -167.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.2 t -134.9 74.19 64.47 Favored Pre-proline 0 N--CA 1.479 1.019 0 C-N-CA 124.659 1.183 . . . . 0.0 110.347 168.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.451 ' HB3' ' HB3' ' A' ' 54' ' ' ALA . 0.8 OUTLIER -97.66 178.48 0.43 Allowed 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 125.12 3.88 . . . . 0.0 113.607 -168.543 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.5 t -151.74 -175.12 5.08 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.737 2.015 . . . . 0.0 110.787 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.15 -7.33 40.81 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.689 HG13 ' HB3' ' A' ' 131' ' ' SER 0.306 7.5 p -79.91 126.4 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 120.173 1.351 . . . . 0.0 112.021 164.065 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 21.7 mt -107.2 154.53 8.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 128.08 2.552 . . . . 0.0 108.249 169.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.42 ' CD2' ' C6 ' ' B' ' 149' ' ' ' C' . 2.2 t-80 -122.47 145.66 48.09 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.785 1.634 . . . . 0.0 110.87 176.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.5 mt -125.55 143.94 37.36 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 127.438 2.295 . . . . 0.0 110.097 -171.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.5 mtm-85 -108.12 170.18 8.16 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 125.847 1.659 . . . . 0.0 111.072 169.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp 56.22 32.32 20.07 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 155.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.5 171.74 2.58 Favored Pre-proline 0 C--N 1.321 -0.669 0 C-N-CA 124.728 1.211 . . . . 0.0 110.731 165.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -52.02 174.21 0.09 OUTLIER 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 124.185 3.257 . . . . 0.0 114.262 156.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 31.2 pt -64.6 -35.95 76.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 126.517 1.927 . . . . 0.0 113.027 -170.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -142.9 -10.99 0.77 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.848 1.659 . . . . 0.0 113.48 171.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.538 HG22 ' H ' ' A' ' 71' ' ' THR 0.287 4.3 p 42.34 -151.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 128.249 2.619 . . . . 0.0 112.065 -172.623 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.538 ' H ' HG22 ' A' ' 70' ' ' VAL . 1.1 p -129.36 145.19 51.43 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 120.601 -1.312 . . . . 0.0 109.88 153.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.98 -38.63 83.13 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 122.042 -0.411 . . . . 0.0 110.621 173.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -54.01 -41.29 68.15 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 125.658 1.599 . . . . 0.0 112.711 174.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -63.14 -53.61 50.65 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.106 0.962 . . . . 0.0 111.68 172.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.9 t -59.59 -48.0 88.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.344 0.657 . . . . 0.0 112.522 -178.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.0 pp -73.93 -33.0 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 O-C-N 120.488 -1.383 . . . . 0.0 112.801 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.5 t -63.55 -30.73 71.81 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.494 1.043 . . . . 0.0 110.771 171.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 14.0 mt -76.1 -20.43 57.68 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 173.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -96.66 -17.32 33.66 Favored Glycine 0 CA--C 1.536 1.37 0 N-CA-C 115.374 0.91 . . . . 0.0 115.374 172.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.6 mt -60.81 -52.8 69.84 Favored Pre-proline 0 CA--C 1.54 0.588 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 -170.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -76.21 42.44 1.0 Allowed 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 123.957 3.105 . . . . 0.0 113.5 -179.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -129.54 -41.89 1.34 Allowed 'General case' 0 C--O 1.233 0.218 0 C-N-CA 126.74 2.016 . . . . 0.0 111.196 178.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -158.11 -101.22 0.17 Allowed Glycine 0 C--N 1.34 0.784 0 CA-C-O 122.059 0.81 . . . . 0.0 112.053 163.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 13.8 tptm -143.48 139.04 29.66 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 130.084 3.354 . . . . 0.0 104.326 166.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.699 HG22 ' HE2' ' A' ' 101' ' ' MET . 3.6 t -123.35 99.41 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 120.203 1.365 . . . . 0.0 109.333 -169.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 16.0 m -65.21 -38.23 89.77 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 128.73 2.812 . . . . 0.0 112.283 -161.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.58 161.5 42.45 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 177.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -133.69 175.06 9.78 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.109 0.964 . . . . 0.0 111.033 156.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.468 ' C ' HD23 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -150.32 154.21 37.46 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.932 1.693 . . . . 0.0 109.29 178.739 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 5.7 mtt -129.93 111.27 12.39 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.357 1.063 . . . . 0.0 111.273 -178.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -74.15 86.11 1.88 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.752 0.821 . . . . 0.0 110.156 174.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.6 tpmt? -63.65 89.01 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.943 1.697 . . . . 0.0 110.476 174.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 179.76 -61.97 0.08 OUTLIER Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.359 1.457 . . . . 0.0 112.748 -166.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.94 20.71 3.81 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 125.77 1.628 . . . . 0.0 114.161 -169.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 14.1 m-20 56.3 42.61 27.63 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.87 1.668 . . . . 0.0 113.496 -173.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -106.47 165.22 11.43 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.862 -0.524 . . . . 0.0 111.603 175.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -153.8 165.61 35.49 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.672 1.189 . . . . 0.0 111.371 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.466 ' CD2' HG21 ' A' ' 60' ' ' VAL . 6.0 m-30 -112.71 156.65 22.43 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.671 1.588 . . . . 0.0 108.689 163.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.8 tt -141.92 108.75 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 125.283 1.433 . . . . 0.0 109.606 166.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -100.46 122.01 42.49 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 129.09 2.956 . . . . 0.0 111.275 -175.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.699 ' HE2' HG22 ' A' ' 85' ' ' VAL 0.298 3.1 ttm -121.75 160.66 24.11 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 -173.766 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -75.95 -13.95 60.25 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.288 1.035 . . . . 0.0 113.616 -162.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.35 144.73 38.35 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.675 1.19 . . . . 0.0 111.194 177.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -63.38 -35.73 81.36 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.56 1.144 . . . . 0.0 111.846 176.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -75.99 -39.97 54.76 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -56.35 -50.66 70.87 Favored 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 122.809 0.444 . . . . 0.0 110.293 170.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.09 -37.19 72.43 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 121.026 -1.046 . . . . 0.0 113.334 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -56.18 -47.2 78.78 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.118 0.872 . . . . 0.0 111.408 169.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -65.21 -34.34 78.14 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 118.08 -0.962 . . . . 0.0 110.88 174.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 3.2 ttp -64.12 -52.18 60.4 Favored 'General case' 0 C--N 1.343 0.298 0 CA-C-N 119.664 1.12 . . . . 0.0 110.633 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.91 -37.84 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 C-N-CA 125.259 1.424 . . . . 0.0 112.133 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -72.01 -44.07 64.02 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.486 0.714 . . . . 0.0 111.702 177.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -49.4 -36.87 23.33 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.17 0.988 . . . . 0.0 112.071 165.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.583 ' HA ' HG12 ' A' ' 117' ' ' VAL . 13.2 m-85 -87.23 -18.73 29.61 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 120.468 -1.395 . . . . 0.0 113.222 -177.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.22 -12.57 58.01 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.638 0.732 . . . . 0.0 110.912 170.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.91 -60.9 2.01 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 129.481 3.112 . . . . 0.0 111.874 168.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.583 HG12 ' HA ' ' A' ' 114' ' ' TYR . 4.2 p -78.08 -44.43 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.517 1.127 . . . . 0.0 113.622 -154.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.3 m 27.56 119.29 0.0 OUTLIER Pre-proline 0 N--CA 1.479 0.988 0 C-N-CA 129.855 3.262 . . . . 0.0 115.854 -139.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -76.53 -13.82 18.16 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 121.933 1.755 . . . . 0.0 116.073 -167.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.8 t 29.85 90.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 129.907 3.283 . . . . 0.0 114.067 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.48 ' H ' HD11 ' A' ' 126' ' ' ILE 0.265 1.1 tt -113.15 76.44 0.98 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 112.545 -2.116 . . . . 0.0 105.919 -134.592 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . 0.349 2.1 ppt_? 46.84 14.17 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 129.922 3.289 . . . . 0.0 116.73 -152.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -126.41 -113.52 1.87 Allowed Glycine 0 N--CA 1.472 1.065 0 C-N-CA 125.005 1.288 . . . . 0.0 116.254 -174.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.413 ' O ' HD13 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -148.88 173.74 3.98 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 128.229 2.612 . . . . 0.0 108.062 -174.242 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -44.73 105.25 0.06 OUTLIER 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 123.691 2.927 . . . . 0.0 116.386 -163.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.48 HD11 ' H ' ' A' ' 121' ' ' LEU . 3.9 mm -68.18 162.09 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 125.24 1.416 . . . . 0.0 108.426 172.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -134.63 147.65 50.22 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 121.789 -0.57 . . . . 0.0 111.177 174.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.83 146.13 32.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 124.95 1.3 . . . . 0.0 110.896 173.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -147.3 158.79 44.09 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.478 1.911 . . . . 0.0 108.865 160.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -53.77 146.88 12.74 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.236 -0.915 . . . . 0.0 111.549 163.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.689 ' HB3' HG13 ' A' ' 60' ' ' VAL . 30.0 t -69.72 156.11 39.49 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.977 0.911 . . . . 0.0 112.706 -179.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -66.95 -20.95 65.98 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.781 1.232 . . . . 0.0 112.888 167.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 40.4 m-70 -105.1 177.65 4.79 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.869 1.667 . . . . 0.0 112.188 -173.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 4.6 mptt -136.76 117.92 14.45 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 126.255 1.822 . . . . 0.0 109.679 -175.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 69.27 84.35 0.15 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.362 1.465 . . . . 0.0 113.328 176.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 31.4 tp -57.54 127.55 32.6 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.518 1.527 . . . . 0.0 112.586 177.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -128.04 109.34 11.45 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 126.479 1.912 . . . . 0.0 110.581 173.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 56.6 p -103.09 -4.12 24.95 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.286 1.434 . . . . 0.0 113.469 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -60.86 -38.5 85.76 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.652 1.981 . . . . 0.0 114.654 -167.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.3 t -79.08 96.92 5.94 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.018 1.327 . . . . 0.0 111.693 -178.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 42.1 m -62.13 138.8 96.03 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 124.526 1.13 . . . . 0.0 112.825 -176.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -54.62 -25.01 39.39 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 124.364 3.376 . . . . 0.0 116.735 -178.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -70.53 -1.5 11.17 Favored 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 115.362 1.615 . . . . 0.0 115.362 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -67.54 86.34 0.19 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.381 1.073 . . . . 0.0 112.197 176.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -57.96 -34.86 70.37 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.389 1.875 . . . . 0.0 114.289 -176.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 . . . . . 0 N--CA 1.479 0.999 0 C-N-CA 126.327 1.851 . . . . 99.99 115.373 -177.811 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 147' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.145 0 C5'-C4'-C3' 110.698 -3.201 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 148' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.284 0 C1'-O4'-C4' 107.129 -2.745 . 0.419 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 149' ' ' ' C' . . . . . 0.42 ' C6 ' ' CD2' ' A' ' 62' ' ' HIS . . . . . . . . 0 O4'--C4' 1.426 -2.226 1 O4'-C1'-N19 112.341 4.141 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 150' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.063 2 O4'-C1'-N19 113.695 5.495 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 151' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.151 0 N19-C1'-C2' 117.514 2.571 OUTLIER-DELTA 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 152' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.618 2.499 1 O4'-C1'-N19 113.97 5.77 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.557 ' N ' ' HG1' ' A' ' 115' ' ' THR . . . . . . . . 0 N--CA 1.477 1.385 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -139.81 -60.02 0.55 Allowed 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.001 1.32 . . . . 0.0 112.539 -173.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.6 m 57.48 14.18 2.16 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 116.445 2.017 . . . . 0.0 116.445 178.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.4 ttm180 -68.04 -28.92 67.81 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.589 1.955 . . . . 0.0 113.924 -175.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 68.3 m -133.8 130.48 38.02 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.843 1.657 . . . . 0.0 111.356 -173.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.831 ' HB3' ' HB3' ' A' ' 57' ' ' PRO . . . -130.68 -12.72 3.8 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.328 1.451 . . . . 0.0 114.718 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 135.88 -77.4 0.36 Allowed Glycine 0 C--N 1.338 0.656 0 C-N-CA 126.056 1.789 . . . . 0.0 108.737 -179.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 19.9 t -147.74 74.08 11.35 Favored Pre-proline 0 N--CA 1.48 1.065 0 C-N-CA 125.218 1.407 . . . . 0.0 108.352 165.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.831 ' HB3' ' HB3' ' A' ' 54' ' ' ALA . 20.1 Cg_endo -90.81 159.17 4.12 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.227 2.618 . . . . 0.0 113.759 -162.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 57.4 m -142.75 -173.66 3.94 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.298 1.439 . . . . 0.0 112.753 -163.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 31.0 mtp180 -50.84 -17.44 0.56 Allowed 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 128.902 2.881 . . . . 0.0 118.063 -177.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.645 HG13 ' HB3' ' A' ' 131' ' ' SER 0.265 3.4 p -96.98 137.17 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-N 120.261 1.391 . . . . 0.0 112.966 172.488 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.2 mt -118.88 130.78 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 127.93 2.492 . . . . 0.0 108.787 175.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.444 ' CD2' ' C6 ' ' B' ' 149' ' ' ' C' . 1.8 t-80 -96.69 141.23 30.18 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.33 1.052 . . . . 0.0 110.719 176.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.3 mt -116.51 135.5 56.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 126.79 2.036 . . . . 0.0 108.291 -178.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.0 ptt-85 -119.53 171.48 8.32 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 127.387 2.275 . . . . 0.0 111.376 165.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.6 mmmt 61.29 23.34 13.58 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.579 1.552 . . . . 0.0 113.27 178.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.551 ' CD2' HD13 ' A' ' 121' ' ' LEU . 14.7 mt -69.31 173.97 3.35 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 126.313 1.845 . . . . 0.0 111.502 166.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -48.79 176.43 0.02 OUTLIER 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 123.042 2.495 . . . . 0.0 114.295 152.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 26.5 pt -64.81 -41.24 91.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.863 1.665 . . . . 0.0 112.961 -171.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -141.89 -11.85 0.87 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 126.016 1.726 . . . . 0.0 114.539 174.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.584 HG22 ' H ' ' A' ' 71' ' ' THR 0.309 2.9 p 43.0 -154.48 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 128.124 2.57 . . . . 0.0 113.412 -175.719 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.584 ' H ' HG22 ' A' ' 70' ' ' VAL . 10.8 t -142.32 148.53 38.14 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 120.065 -1.647 . . . . 0.0 111.665 171.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -55.6 -46.25 77.33 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.328 1.051 . . . . 0.0 111.961 -177.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -51.37 -43.18 51.51 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 124.526 1.06 . . . . 0.0 113.116 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -64.85 -56.03 15.91 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.778 0.831 . . . . 0.0 112.264 172.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 80.1 t -56.06 -53.81 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-O 121.657 0.741 . . . . 0.0 111.811 -176.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.9 pp -67.29 -39.54 83.08 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 CA-C-O 117.89 -1.052 . . . . 0.0 112.437 -178.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.8 t -68.52 -19.97 64.55 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 119.945 1.248 . . . . 0.0 111.384 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 26.6 mt -87.45 -21.78 25.35 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 172.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -99.36 -21.98 13.83 Favored Glycine 0 C--O 1.215 -1.077 0 CA-C-N 119.376 0.989 . . . . 0.0 113.705 177.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.8 mt -60.1 -35.51 28.69 Favored Pre-proline 0 CA--C 1.549 0.936 0 N-CA-C 118.785 2.883 . . . . 0.0 118.785 -173.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -55.36 7.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.949 1 C-N-CA 125.739 4.293 . . . . 0.0 120.728 -171.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -125.33 -19.42 5.08 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 -171.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -163.96 -100.06 0.14 Allowed Glycine 0 CA--C 1.524 0.62 0 CA-C-N 118.622 0.647 . . . . 0.0 112.444 -177.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 31.5 tptt -153.06 156.46 38.79 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 125.03 1.332 . . . . 0.0 107.891 165.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -131.22 106.04 11.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 119.812 1.187 . . . . 0.0 109.177 -174.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 33.9 p -104.66 -25.77 12.58 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.399 -1.273 . . . . 0.0 112.393 -162.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -138.03 152.49 48.91 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.101 0.864 . . . . 0.0 113.095 170.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -137.61 169.86 17.05 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.419 1.088 . . . . 0.0 111.267 159.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.513 ' C ' HD23 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -147.63 153.22 39.1 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.091 1.356 . . . . 0.0 109.589 178.191 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 5.2 mtp -135.59 98.98 4.07 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.91 0.884 . . . . 0.0 110.326 -169.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -74.56 89.12 2.18 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.961 0.904 . . . . 0.0 110.693 177.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.9 pttt -122.01 60.24 0.98 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.227 1.811 . . . . 0.0 113.829 -178.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 84.1 -118.41 4.69 Favored Glycine 0 N--CA 1.47 0.96 0 C-N-CA 130.286 3.803 . . . . 0.0 113.769 4.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 21.5 mtmm -135.05 -95.39 0.27 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.69 1.596 . . . . 0.0 110.464 -167.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -155.88 32.32 0.35 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 129.737 3.215 . . . . 0.0 110.15 -176.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -122.8 163.52 20.07 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -173.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -154.51 166.16 34.17 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 126.364 1.866 . . . . 0.0 110.348 177.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.532 ' CD2' HG21 ' A' ' 60' ' ' VAL . 5.7 m-30 -112.5 149.44 32.64 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.867 1.667 . . . . 0.0 107.329 162.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.8 tt -128.83 121.03 53.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 C-N-CA 124.186 0.994 . . . . 0.0 108.883 159.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.499 ' HG3' ' H ' ' A' ' 136' ' ' LEU . 2.0 tm-20 -110.95 108.89 18.8 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 126.018 1.727 . . . . 0.0 110.159 -174.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -102.18 149.66 24.07 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 112.921 -1.945 . . . . 0.0 111.403 -176.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.43 -13.34 60.7 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.577 1.551 . . . . 0.0 114.065 -161.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.03 144.02 48.44 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.502 0.721 . . . . 0.0 110.789 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -63.46 -41.06 98.63 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.021 0.928 . . . . 0.0 111.575 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -74.78 -36.75 62.52 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 178.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.95 -46.34 89.74 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 118.708 0.685 . . . . 0.0 110.305 171.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.57 -37.79 80.18 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 175.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -56.38 -50.78 70.59 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 120.946 -1.096 . . . . 0.0 111.372 169.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -64.63 -26.08 68.24 Favored 'General case' 0 C--O 1.219 -0.548 0 O-C-N 120.597 -1.315 . . . . 0.0 111.374 173.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 18.8 ttp -69.35 -48.51 61.12 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-N 120.168 1.349 . . . . 0.0 110.38 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -64.27 -38.2 81.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 O-C-N 121.046 -1.034 . . . . 0.0 111.66 176.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -67.57 -47.33 70.09 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.358 1.063 . . . . 0.0 111.137 173.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -49.91 -34.19 19.68 Favored 'General case' 0 C--O 1.223 -0.329 0 C-N-CA 126.151 1.781 . . . . 0.0 112.236 169.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.528 ' HA ' HG12 ' A' ' 117' ' ' VAL . 17.0 m-85 -90.76 -18.91 24.15 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 120.437 -1.415 . . . . 0.0 113.312 -177.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.557 ' HG1' ' N ' ' A' ' 49' ' ' GLY . 0.7 OUTLIER -81.59 -10.62 59.39 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 121.581 0.705 . . . . 0.0 111.196 168.693 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.36 -63.96 1.24 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 130.226 3.41 . . . . 0.0 111.743 168.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.528 HG12 ' HA ' ' A' ' 114' ' ' TYR . 2.2 p -78.76 -46.5 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 124.626 1.17 . . . . 0.0 112.213 -156.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.4 m 37.33 123.85 0.0 OUTLIER Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 130.17 3.388 . . . . 0.0 115.023 -145.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -75.01 -20.96 16.32 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 121.88 1.72 . . . . 0.0 115.723 -168.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 5.6 t 42.4 99.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 129.595 3.158 . . . . 0.0 114.579 176.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.551 HD13 ' CD2' ' A' ' 66' ' ' LEU . 4.5 tt -135.3 -59.5 0.78 Allowed 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 113.591 -1.641 . . . . 0.0 109.844 -137.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.07 -3.04 14.67 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 156.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 98.76 17.06 29.3 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 125.392 1.472 . . . . 0.0 115.945 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -153.61 170.59 8.07 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 127.634 2.373 . . . . 0.0 109.794 171.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -47.02 142.13 11.49 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 124.009 3.139 . . . . 0.0 115.644 -179.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.428 HD11 ' H ' ' A' ' 121' ' ' LEU . 4.9 mm -117.08 143.81 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 127.347 2.259 . . . . 0.0 107.823 -177.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 9.1 m-30 -116.82 125.34 51.43 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 121.249 -0.907 . . . . 0.0 110.523 -166.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.1 149.95 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -178.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -149.26 160.1 43.69 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 127.525 2.33 . . . . 0.0 109.326 163.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -53.2 149.77 6.75 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 120.803 -1.186 . . . . 0.0 112.09 160.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.645 ' HB3' HG13 ' A' ' 60' ' ' VAL . 27.5 t -72.0 154.78 40.95 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.36 0.664 . . . . 0.0 112.207 177.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -66.61 -12.09 56.45 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.664 1.586 . . . . 0.0 113.261 168.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 65.2 m-70 -114.94 171.49 7.63 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.631 1.572 . . . . 0.0 112.837 -169.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -123.9 103.13 8.16 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 126.412 1.885 . . . . 0.0 110.961 -176.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 62.02 115.67 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 126.773 2.029 . . . . 0.0 113.364 -170.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.499 ' H ' ' HG3' ' A' ' 100' ' ' GLU . 24.0 tp -64.03 101.04 0.35 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.063 1.745 . . . . 0.0 111.86 168.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -92.63 106.65 18.6 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.42 1.488 . . . . 0.0 109.139 170.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 11.0 t -145.51 159.61 42.85 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.147 1.379 . . . . 0.0 112.278 -175.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -77.19 -14.9 59.7 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.132 1.373 . . . . 0.0 112.729 167.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.8 t -75.14 79.42 2.28 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 126.184 1.793 . . . . 0.0 113.35 -177.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 93.3 p -143.16 161.13 49.61 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 125.307 1.443 . . . . 0.0 112.503 172.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -60.42 161.54 20.11 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.755 2.97 . . . . 0.0 115.197 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -132.35 -29.6 1.57 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.191 1.796 . . . . 0.0 113.965 177.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -58.33 -22.9 54.93 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -172.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -73.15 -19.89 61.03 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 176.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 . . . . . 0 N--CA 1.481 1.097 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -167.131 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 147' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.207 0 O5'-C5'-C4' 113.81 2.579 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 148' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.26 0 O4'-C1'-N19 111.742 3.542 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 149' ' ' ' C' . . . . . 0.444 ' C6 ' ' CD2' ' A' ' 62' ' ' HIS . . . . . . . . 0 O4'--C4' 1.421 -2.68 0 N19-C1'-C2' 107.995 -3.378 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 150' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 1 O4'--C4' 1.404 -4.08 0 O4'-C1'-N19 111.895 3.695 . 0.01 0a . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 151' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.543 2.568 1 O4'-C1'-N19 112.386 4.186 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 152' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.226 0 N19-C1'-C2' 118.046 2.904 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.566 0 N-CA-C 111.061 -0.815 . . . . 0.0 111.061 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -68.56 -39.63 80.98 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.733 0.813 . . . . 0.0 112.363 175.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 79.0 p -78.06 179.72 6.64 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.911 2.084 . . . . 0.0 113.31 171.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 84.6 mmt-85 -129.3 175.55 8.65 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.514 1.926 . . . . 0.0 110.622 173.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 57.6 p -54.14 156.2 3.21 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.253 1.021 . . . . 0.0 112.38 171.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 54.78 6.65 0.13 Allowed 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 126.074 1.75 . . . . 0.0 115.571 -169.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.85 30.89 55.28 Favored Glycine 0 CA--C 1.535 1.297 0 O-C-N 120.75 -1.219 . . . . 0.0 113.623 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 51.0 t 58.82 80.45 0.28 Allowed Pre-proline 0 N--CA 1.476 0.843 0 C-N-CA 127.967 2.507 . . . . 0.0 109.95 -171.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -95.27 169.57 1.44 Allowed 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.03 2.487 . . . . 0.0 114.474 -148.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 45.3 m -147.49 -166.15 2.44 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.022 1.329 . . . . 0.0 112.908 -165.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 46.5 mtp180 -55.13 -16.85 3.4 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 119.521 3.156 . . . . 0.0 119.521 -161.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.607 HG13 ' HB3' ' A' ' 131' ' ' SER 0.31 6.9 p -98.2 128.91 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 CA-C-N 121.366 1.894 . . . . 0.0 112.879 169.605 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 39.7 mt -100.4 155.01 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.84 1.656 . . . . 0.0 108.378 165.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -119.08 148.76 42.69 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.58 1.552 . . . . 0.0 110.957 173.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.4 mt -127.98 141.4 46.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 126.501 1.92 . . . . 0.0 109.639 -172.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.45 165.83 17.73 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 127.95 2.5 . . . . 0.0 109.885 167.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 67.31 23.59 9.26 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 125.148 1.379 . . . . 0.0 113.887 177.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.99 165.62 0.76 Allowed Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 127.7 2.4 . . . . 0.0 111.292 165.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -58.68 175.61 0.55 Allowed 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 123.007 2.471 . . . . 0.0 113.993 154.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 28.1 pt -73.81 -32.36 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 126.645 1.978 . . . . 0.0 113.47 -175.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -154.91 32.34 0.4 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.871 1.668 . . . . 0.0 111.357 -168.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -51.49 147.61 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.574 0.75 . . . . 0.0 112.267 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.401 HG23 ' H ' ' A' ' 74' ' ' GLU . 8.4 t -88.91 140.97 28.89 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 122.584 1.183 . . . . 0.0 112.092 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -57.84 -36.03 71.72 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.429 175.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -57.4 -36.0 74.63 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 123.643 0.639 . . . . 0.0 112.865 177.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.401 ' H ' HG23 ' A' ' 71' ' ' THR . 6.0 mm-40 -70.34 -51.33 30.83 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.955 1.302 . . . . 0.0 112.045 172.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 88.6 t -63.13 -41.49 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -176.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.0 pp -72.73 -34.8 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 O-C-N 120.285 -1.509 . . . . 0.0 112.413 174.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 73.1 m -66.54 -22.49 66.16 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 119.809 1.186 . . . . 0.0 111.886 174.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.6 mt -76.39 -30.86 57.68 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.016 0.927 . . . . 0.0 113.046 170.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -94.27 -11.89 56.81 Favored Glycine 0 CA--C 1.534 1.272 0 CA-C-N 119.818 1.19 . . . . 0.0 115.693 178.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.7 mt -64.71 -36.07 15.94 Favored Pre-proline 0 CA--C 1.545 0.764 0 N-CA-C 117.379 2.363 . . . . 0.0 117.379 -172.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.74 -5.18 1.69 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.575 2.85 . . . . 0.0 117.583 173.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -107.48 -33.76 7.25 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -163.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -164.92 -98.26 0.12 Allowed Glycine 0 CA--C 1.522 0.527 0 C-N-CA 124.201 0.905 . . . . 0.0 111.344 172.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 33.6 tptt -149.15 145.04 26.99 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 105.423 -2.065 . . . . 0.0 105.423 161.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.709 HG22 ' HE2' ' A' ' 101' ' ' MET . 3.5 t -128.48 89.13 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-N 120.331 1.423 . . . . 0.0 108.76 -171.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 31.3 p -77.58 -19.04 56.28 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 126.817 2.047 . . . . 0.0 113.016 -161.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -148.27 160.97 42.43 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 172.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.8 pp -140.32 172.23 13.03 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.775 1.23 . . . . 0.0 111.493 155.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.52 ' C ' HD23 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -142.2 152.77 43.45 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 125.93 1.692 . . . . 0.0 108.747 175.709 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 5.4 mtt -132.19 102.64 5.87 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.159 0.984 . . . . 0.0 111.84 -174.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -72.43 100.17 2.63 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.587 1.155 . . . . 0.0 110.215 177.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -57.8 -23.0 50.33 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.82 1.648 . . . . 0.0 114.933 -176.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -63.97 -44.87 95.34 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.659 1.599 . . . . 0.0 115.956 -174.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -136.92 8.97 3.03 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 115.394 1.628 . . . . 0.0 115.394 -151.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 55.15 60.69 3.29 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.7 1.2 . . . . 0.0 110.745 -165.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -130.66 163.92 26.13 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.647 0.779 . . . . 0.0 112.255 177.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -155.36 167.19 31.2 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.917 1.287 . . . . 0.0 111.941 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.452 ' CD2' HG21 ' A' ' 60' ' ' VAL . 4.8 m-30 -110.19 152.17 26.4 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.594 1.958 . . . . 0.0 107.24 160.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 19.8 tt -134.09 105.4 6.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 125.252 1.421 . . . . 0.0 108.717 167.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 21.4 tp10 -96.95 124.1 40.84 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 127.377 2.271 . . . . 0.0 110.753 -175.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.709 ' HE2' HG22 ' A' ' 85' ' ' VAL 0.305 1.6 ttm -125.23 157.27 36.95 Favored 'General case' 0 C--O 1.223 -0.301 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 -177.213 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -69.97 -18.99 63.37 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.731 2.012 . . . . 0.0 113.318 -165.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.09 140.72 42.16 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 122.62 1.2 . . . . 0.0 111.875 -179.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -61.84 -40.9 96.93 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.577 1.151 . . . . 0.0 111.137 177.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -74.54 -35.24 63.11 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -56.43 -55.4 34.05 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-N 118.755 0.707 . . . . 0.0 109.861 168.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.5 -34.36 76.99 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.444 1.02 . . . . 0.0 113.585 -178.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -56.56 -51.48 68.44 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.149 -0.969 . . . . 0.0 111.633 169.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -63.26 -31.21 72.31 Favored 'General case' 0 C--O 1.224 -0.257 0 O-C-N 121.289 -0.882 . . . . 0.0 110.972 174.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 6.2 ttp -71.0 -46.45 62.24 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.872 1.269 . . . . 0.0 111.886 -178.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -67.81 -37.88 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 O-C-N 120.843 -1.16 . . . . 0.0 111.366 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -71.78 -41.93 67.74 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.441 1.096 . . . . 0.0 111.285 176.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -48.78 -52.29 24.69 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.51 1.124 . . . . 0.0 110.819 165.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -77.9 12.41 1.77 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 118.74 -2.475 . . . . 0.0 113.344 178.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . 0.289 0.5 OUTLIER -116.35 -10.63 11.33 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.814 0.846 . . . . 0.0 113.067 167.494 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.482 ' CB ' HG23 ' A' ' 117' ' ' VAL . 0.4 OUTLIER -84.46 -42.51 15.53 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 126.029 1.732 . . . . 0.0 111.45 159.926 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.482 HG23 ' CB ' ' A' ' 116' ' ' SER . 85.5 t -116.22 -63.33 1.99 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.228 0 C-N-CA 124.937 1.295 . . . . 0.0 111.09 -144.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.0 m 68.96 136.47 0.05 OUTLIER Pre-proline 0 N--CA 1.484 1.255 0 C-N-CA 127.93 2.492 . . . . 0.0 112.588 -175.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -81.41 -9.76 12.4 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 122.605 2.203 . . . . 0.0 115.616 -174.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.5 t 26.57 90.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 130.867 3.667 . . . . 0.0 114.606 173.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.7 tt -118.98 -59.27 1.87 Allowed 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.716 -126.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.72 -1.56 39.06 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 153.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 106.27 32.55 3.69 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 124.999 1.285 . . . . 0.0 115.047 -177.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -139.49 150.51 63.96 Favored Pre-proline 0 CA--C 1.536 0.404 0 C-N-CA 125.342 1.457 . . . . 0.0 110.762 175.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -55.59 109.1 0.37 Allowed 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.354 2.703 . . . . 0.0 112.713 174.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.1 mm -78.19 145.77 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 124.892 1.277 . . . . 0.0 109.109 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 9.8 m-30 -111.02 128.71 55.94 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.82 0.848 . . . . 0.0 109.811 -173.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.3 tt -131.48 146.0 34.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 124.505 1.122 . . . . 0.0 111.667 -178.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -155.21 160.25 40.72 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.179 1.792 . . . . 0.0 108.958 160.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -50.71 148.57 3.89 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.271 -0.893 . . . . 0.0 112.767 167.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.607 ' HB3' HG13 ' A' ' 60' ' ' VAL . 37.5 t -68.24 158.02 34.23 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.509 0.724 . . . . 0.0 112.057 178.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -67.34 -13.36 61.93 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.563 1.145 . . . . 0.0 112.72 164.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 36.5 m-70 -111.81 178.82 4.2 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 127.778 2.431 . . . . 0.0 110.473 -178.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -125.6 -0.55 7.46 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 115.737 1.754 . . . . 0.0 115.737 -171.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -164.48 166.85 20.11 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 130.087 3.355 . . . . 0.0 108.302 -173.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 21.3 tp -134.67 105.51 6.52 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.431 1.492 . . . . 0.0 110.979 175.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 8.1 mmpt? -94.72 99.27 11.4 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.216 1.806 . . . . 0.0 109.829 176.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 27.6 p -82.28 1.85 34.83 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.864 1.666 . . . . 0.0 113.75 174.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -63.35 -4.21 2.49 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 127.297 2.239 . . . . 0.0 115.178 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 42.8 m 62.35 31.99 17.12 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.947 2.099 . . . . 0.0 115.086 173.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 46.8 m -148.24 149.35 31.9 Favored Pre-proline 0 N--CA 1.474 0.769 0 C-N-CA 126.849 2.06 . . . . 0.0 110.242 162.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -74.44 -22.74 15.8 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 123.184 2.59 . . . . 0.0 113.539 -177.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -145.41 167.66 22.4 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 127.778 2.431 . . . . 0.0 108.858 172.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -69.16 93.57 0.61 Allowed 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.1 -1.0 . . . . 0.0 112.066 178.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -68.55 172.08 6.67 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.894 1.678 . . . . 0.0 112.773 172.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 25.1 tpp180 . . . . . 0 N--CA 1.471 0.602 0 C-N-CA 125.35 1.46 . . . . 0.0 110.864 170.784 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 147' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.2 0 C5'-C4'-C3' 111.736 -2.51 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 148' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.734 0 O5'-C5'-C4' 115.358 3.684 . 0.0 OUTLIER '7D dist 4p' 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 149' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.521 1 N19-C1'-C2' 106.885 -4.072 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 150' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.407 -3.853 0 O4'-C1'-N19 111.537 3.337 . 0.01 4a . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 151' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.123 1 O4'-C1'-N19 112.539 4.339 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 152' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.147 1 O4'-C1'-N19 113.69 5.49 . 0.43 2u . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.634 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -53.55 -48.57 68.97 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 126.076 1.75 . . . . 0.0 113.825 -169.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.8 m -66.12 -19.83 65.96 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.738 1.215 . . . . 0.0 114.212 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.2 ttt180 -72.07 -2.32 17.98 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.437 1.495 . . . . 0.0 113.666 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.0 p -60.23 -14.46 17.87 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.088 1.755 . . . . 0.0 114.41 166.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.442 ' HB3' ' HB3' ' A' ' 57' ' ' PRO . . . -135.81 176.05 9.04 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 126.242 1.817 . . . . 0.0 111.179 162.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -83.9 -55.82 2.73 Favored Glycine 0 N--CA 1.473 1.123 0 O-C-N 120.979 -1.076 . . . . 0.0 112.963 -163.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.1 p -140.8 70.73 30.12 Favored Pre-proline 0 N--CA 1.475 0.81 0 C-N-CA 124.643 1.177 . . . . 0.0 110.877 167.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.442 ' HB3' ' HB3' ' A' ' 54' ' ' ALA . 4.1 Cg_endo -96.67 148.13 1.05 Allowed 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 124.62 3.546 . . . . 0.0 113.089 -165.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.7 m -161.97 117.75 2.01 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.495 1.118 . . . . 0.0 113.137 176.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 35.6 mtp180 61.72 -12.68 0.06 Allowed 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 128.789 2.836 . . . . 0.0 118.029 167.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.52 HG21 ' CD2' ' A' ' 98' ' ' PHE 0.298 2.4 p -107.52 139.86 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 124.306 1.042 . . . . 0.0 112.207 164.443 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.2 mt -113.54 152.35 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 128.927 2.891 . . . . 0.0 107.581 170.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.467 ' CD2' ' C6 ' ' B' ' 149' ' ' ' C' . 5.0 t-80 -120.25 150.46 40.64 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.353 1.461 . . . . 0.0 110.741 175.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.5 mt -129.9 141.73 45.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 126.114 1.766 . . . . 0.0 109.479 -175.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.86 173.38 6.91 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 127.348 2.259 . . . . 0.0 111.067 171.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 17.2 mmmt 62.67 28.88 16.78 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 126.064 1.745 . . . . 0.0 113.503 175.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.89 164.41 21.7 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 124.7 1.2 . . . . 0.0 110.802 173.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.477 ' HD3' HD13 ' A' ' 121' ' ' LEU . 52.2 Cg_exo -59.19 -175.82 0.09 OUTLIER 'Trans proline' 0 CA--C 1.537 0.64 1 C-N-CA 125.505 4.137 . . . . 0.0 113.965 157.287 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 30.3 pt -82.56 -30.18 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 126.665 1.986 . . . . 0.0 112.893 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -155.23 35.15 0.38 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.737 1.615 . . . . 0.0 111.331 -168.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -51.54 150.4 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.644 0.778 . . . . 0.0 111.398 174.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.425 HG23 ' H ' ' A' ' 74' ' ' GLU . 8.9 t -89.89 136.42 33.05 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 123.129 1.442 . . . . 0.0 112.413 -177.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.49 -37.59 65.46 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 114.487 -1.233 . . . . 0.0 111.395 173.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -56.21 -38.55 78.01 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 124.292 0.949 . . . . 0.0 113.605 175.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.425 ' H ' HG23 ' A' ' 71' ' ' THR . 11.2 mt-10 -65.85 -52.41 50.67 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.222 1.009 . . . . 0.0 111.214 171.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.4 t -60.75 -49.05 86.13 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 122.828 0.451 . . . . 0.0 112.203 -177.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.3 pp -70.51 -30.01 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 O-C-N 120.176 -1.577 . . . . 0.0 113.44 178.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 52.1 m -72.19 -17.84 61.9 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 119.175 0.898 . . . . 0.0 112.017 172.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 35.0 mt -85.52 -17.27 36.85 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 165.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.427 ' HA2' ' SD ' ' A' ' 110' ' ' MET . . . -74.12 -40.74 41.57 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 124.3 0.952 . . . . 0.0 112.901 167.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.9 mt -70.17 -34.12 3.91 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 119.097 2.999 . . . . 0.0 119.097 -155.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -59.36 4.16 0.15 Allowed 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 124.029 3.153 . . . . 0.0 117.551 175.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.434 ' CD2' ' HG3' ' A' ' 110' ' ' MET . 56.7 m-85 -120.34 -41.37 2.62 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 114.141 1.163 . . . . 0.0 114.141 -167.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -147.61 -113.62 0.75 Allowed Glycine 0 C--N 1.341 0.809 0 CA-C-O 122.374 0.986 . . . . 0.0 111.983 176.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.429 ' HB3' ' CG ' ' A' ' 102' ' ' ASN . 33.5 tptt -149.48 117.42 6.3 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 129.821 3.248 . . . . 0.0 104.78 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.437 HG22 ' HE2' ' A' ' 101' ' ' MET 0.29 16.3 t -127.29 82.68 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 CA-C-O 122.9 1.334 . . . . 0.0 109.145 -158.229 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.3 t -74.3 -26.82 60.41 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 127.054 2.142 . . . . 0.0 112.148 -162.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -141.02 166.22 25.4 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 123.268 1.508 . . . . 0.0 114.364 177.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -147.38 174.83 11.3 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 128.047 2.539 . . . . 0.0 109.874 160.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.516 ' C ' HD23 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -145.63 155.77 43.23 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.96 1.304 . . . . 0.0 110.137 177.179 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 3.7 mtt -127.55 107.05 9.6 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.096 0.958 . . . . 0.0 111.705 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -76.08 64.66 1.98 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.958 0.903 . . . . 0.0 109.133 165.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 31.8 tttp -53.48 -45.19 69.51 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.706 1.602 . . . . 0.0 113.471 -159.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -70.73 -11.62 69.39 Favored Glycine 0 CA--C 1.539 1.592 0 C-N-CA 124.979 1.276 . . . . 0.0 115.797 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.6 -1.04 25.15 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 118.919 1.36 . . . . 0.0 113.191 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.4 m120 60.24 38.26 20.08 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.441 1.496 . . . . 0.0 112.64 -167.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -128.35 163.25 25.24 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.146 0.979 . . . . 0.0 112.062 -172.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -155.0 166.41 33.68 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.79 1.636 . . . . 0.0 112.035 -178.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.52 ' CD2' HG21 ' A' ' 60' ' ' VAL . 5.1 m-30 -113.66 155.8 24.87 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.769 2.028 . . . . 0.0 108.512 160.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.6 tt -137.02 130.61 45.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 119.632 1.106 . . . . 0.0 109.711 162.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -127.16 120.04 27.88 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.995 2.118 . . . . 0.0 112.241 -160.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.437 ' HE2' HG22 ' A' ' 85' ' ' VAL . 0.2 OUTLIER -134.72 154.34 51.61 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 112.994 -1.912 . . . . 0.0 113.232 -164.479 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.449 ' CG ' HG23 ' A' ' 103' ' ' THR . 0.0 OUTLIER -72.26 -20.31 61.55 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 115.29 1.589 . . . . 0.0 115.29 -158.253 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.449 HG23 ' CG ' ' A' ' 102' ' ' ASN . 9.4 p -136.66 138.07 40.71 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.702 1.201 . . . . 0.0 111.209 -175.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -58.42 -32.29 68.54 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.96 174.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -73.54 -42.67 61.41 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -54.34 -53.11 58.3 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 119.669 1.122 . . . . 0.0 109.518 169.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.62 -34.33 71.98 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -174.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -58.44 -50.47 73.61 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.109 0.868 . . . . 0.0 110.56 169.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -62.11 -33.1 73.83 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 121.583 -0.698 . . . . 0.0 110.99 175.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.434 ' HG3' ' CD2' ' A' ' 82' ' ' PHE . 11.1 ttp -73.46 -48.94 29.58 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 124.085 0.954 . . . . 0.0 112.263 -176.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 1.1 p -63.78 -38.72 83.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 124.341 1.056 . . . . 0.0 110.995 179.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -71.96 -42.59 66.4 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.881 1.272 . . . . 0.0 111.549 177.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -47.68 -55.56 9.19 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.909 1.284 . . . . 0.0 109.984 165.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -78.29 11.58 2.32 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 118.855 -2.403 . . . . 0.0 113.826 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 53.3 m -111.82 -15.48 13.37 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.633 1.173 . . . . 0.0 110.988 171.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.417 ' CB ' HG23 ' A' ' 117' ' ' VAL . 0.4 OUTLIER -89.41 -44.59 10.07 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.733 2.013 . . . . 0.0 111.841 163.763 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.417 HG23 ' CB ' ' A' ' 116' ' ' SER . 96.4 t -112.35 -49.73 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 125.02 1.328 . . . . 0.0 111.951 -143.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.445 ' CG2' ' H ' ' A' ' 126' ' ' ILE . 31.5 m 69.81 141.45 0.08 OUTLIER Pre-proline 0 N--CA 1.485 1.29 0 C-N-CA 128.21 2.604 . . . . 0.0 112.308 -173.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -82.05 -12.88 10.52 Favored 'Trans proline' 0 CA--C 1.549 1.251 0 C-N-CA 123.385 2.723 . . . . 0.0 114.105 -176.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 22.0 t 50.6 101.17 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 131.144 3.778 . . . . 0.0 115.541 175.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.477 HD13 ' HD3' ' A' ' 67' ' ' PRO . 1.2 tt -92.08 101.62 14.16 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 123.763 0.825 . . . . 0.0 109.819 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 45.6 62.47 2.18 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.735 2.014 . . . . 0.0 112.086 178.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 81.2 6.93 89.01 Favored Glycine 0 CA--C 1.537 1.426 0 N-CA-C 116.015 1.166 . . . . 0.0 116.015 173.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 35.1 tp60 -131.72 142.49 45.45 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 125.83 1.652 . . . . 0.0 110.109 -173.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -61.1 166.31 10.94 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 123.119 2.546 . . . . 0.0 114.529 179.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.445 ' H ' ' CG2' ' A' ' 118' ' ' THR . 0.6 OUTLIER -136.79 154.41 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.797 1.639 . . . . 0.0 109.989 178.088 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -120.45 91.05 3.45 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 124.33 1.052 . . . . 0.0 109.056 -155.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -95.95 152.76 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 124.913 1.285 . . . . 0.0 111.994 -179.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -147.92 161.48 41.22 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.75 1.62 . . . . 0.0 108.339 152.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.91 153.31 4.86 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.006 -1.059 . . . . 0.0 112.041 158.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.498 ' OG ' HG13 ' A' ' 60' ' ' VAL . 54.7 p -65.11 170.17 4.76 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 177.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -87.64 6.75 33.13 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.405 1.482 . . . . 0.0 112.874 164.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -132.84 -176.01 3.97 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.445 1.498 . . . . 0.0 113.243 -161.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 42.0 tttp -140.26 101.35 4.11 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.536 1.935 . . . . 0.0 111.162 -177.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 64.74 108.11 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 127.448 2.299 . . . . 0.0 114.611 -174.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 18.8 tp -63.88 124.7 22.2 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.245 1.818 . . . . 0.0 111.956 169.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -101.89 102.58 13.17 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 127.163 2.185 . . . . 0.0 110.634 167.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 12.9 p -77.24 60.61 1.98 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 126.094 1.758 . . . . 0.0 111.788 174.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -60.55 -44.99 95.53 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.474 1.51 . . . . 0.0 114.877 -168.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 74.6 m -88.74 87.3 7.2 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.109 1.363 . . . . 0.0 113.195 -174.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 49.8 m -65.73 136.12 95.78 Favored Pre-proline 0 N--CA 1.475 0.819 0 C-N-CA 124.368 1.067 . . . . 0.0 112.268 173.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -51.63 138.96 48.78 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 124.025 3.15 . . . . 0.0 114.645 176.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -72.49 84.86 1.13 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.178 1.391 . . . . 0.0 110.877 175.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -123.68 -81.14 0.63 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.41 1.084 . . . . 0.0 113.476 -163.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -74.81 -70.84 0.38 Allowed 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -165.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 56.4 ttm-85 . . . . . 0 N--CA 1.482 1.149 0 C-N-CA 125.947 1.699 . . . . 0.0 113.599 -172.988 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 147' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.665 0 O4'-C4'-C3' 108.79 2.35 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 148' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.749 1 C5'-C4'-C3' 109.277 -4.149 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 149' ' ' ' C' . . . . . 0.467 ' C6 ' ' CD2' ' A' ' 62' ' ' HIS . . . . . . . . 0 O4'--C4' 1.423 -2.539 0 N19-C1'-C2' 107.657 -3.589 . 0.01 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 150' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.676 1 O4'-C1'-N19 113.087 4.887 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 151' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.541 2.378 0 O4'-C1'-N19 110.642 2.442 . 0.01 7p . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 152' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.537 2.077 0 O4'-C1'-N19 111.682 3.482 . 0.341 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.564 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -65.26 155.79 34.01 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.167 0.987 . . . . 0.0 113.509 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 82.8 p -135.1 -5.27 2.37 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.688 1.995 . . . . 0.0 114.077 169.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 72.7 mtp85 -75.93 -28.24 57.9 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.639 1.176 . . . . 0.0 113.664 -174.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.5 t -58.51 161.9 4.2 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.965 0.906 . . . . 0.0 112.543 173.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 53.52 6.29 0.07 Allowed 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 127.235 2.214 . . . . 0.0 115.957 -176.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.56 38.95 26.91 Favored Glycine 0 CA--C 1.536 1.4 0 O-C-N 120.721 -1.237 . . . . 0.0 113.317 -174.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . 0.321 14.1 p 50.31 78.0 0.43 Allowed Pre-proline 0 N--CA 1.485 1.283 0 C-N-CA 127.558 2.343 . . . . 0.0 111.374 -174.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -97.34 -179.73 0.38 Allowed 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 123.344 2.696 . . . . 0.0 113.431 -144.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 30.0 p -144.96 -156.79 0.73 Allowed 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -175.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 32.2 mtp180 -61.02 -6.09 1.72 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 130.541 3.537 . . . . 0.0 118.339 -165.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.617 HG13 ' HB3' ' A' ' 131' ' ' SER 0.254 2.5 p -101.17 131.35 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 120.809 1.64 . . . . 0.0 112.092 166.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 16.9 mt -103.24 153.92 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 127.379 2.272 . . . . 0.0 109.478 165.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.427 ' CD2' ' C6 ' ' B' ' 149' ' ' ' C' . 2.1 t-80 -120.39 143.95 48.16 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.772 1.629 . . . . 0.0 110.528 175.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.9 mt -122.58 133.46 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 127.071 2.148 . . . . 0.0 109.776 -173.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 28.9 mtt180 -88.39 166.63 14.12 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.672 1.589 . . . . 0.0 110.543 173.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.9 mtpp 50.51 35.42 11.23 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 155.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.79 162.82 0.71 Allowed Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 126.446 1.898 . . . . 0.0 111.521 162.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -56.14 179.24 0.1 OUTLIER 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 124.326 3.351 . . . . 0.0 114.912 156.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 31.1 pt -77.36 -30.41 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 126.599 1.96 . . . . 0.0 113.168 -176.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -157.75 36.86 0.26 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.993 1.717 . . . . 0.0 110.971 -170.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -50.27 151.05 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.966 0.906 . . . . 0.0 111.627 175.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.7 t -85.19 128.05 34.52 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 123.583 1.659 . . . . 0.0 111.11 174.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -60.9 -22.68 64.57 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 114.823 -1.081 . . . . 0.0 111.773 174.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -62.38 -35.91 92.35 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 125.224 1.392 . . . . 0.0 114.024 167.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -67.88 -46.46 71.61 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.576 -0.955 . . . . 0.0 109.812 171.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 62.0 t -64.85 -44.55 96.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -176.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -75.81 -25.7 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-N 121.973 2.17 . . . . 0.0 114.051 173.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.7 t -62.61 -28.05 69.63 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 119.705 1.139 . . . . 0.0 111.126 166.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 14.8 mt -81.84 -16.02 52.18 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 170.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.43 ' HA2' ' SD ' ' A' ' 110' ' ' MET . . . -91.71 -25.69 22.17 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 115.091 0.796 . . . . 0.0 115.091 171.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 13.4 mt -74.36 -26.72 0.7 Allowed Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 117.974 2.583 . . . . 0.0 117.974 -165.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -59.87 -0.62 0.89 Allowed 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.174 2.583 . . . . 0.0 116.615 167.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -114.6 -43.92 3.12 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 -168.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -148.42 -112.85 0.68 Allowed Glycine 0 C--N 1.338 0.658 0 CA-C-O 122.587 1.104 . . . . 0.0 112.652 173.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.42 ' HB3' ' CG ' ' A' ' 102' ' ' ASN . 32.7 tptt -146.1 123.02 11.34 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 130.545 3.538 . . . . 0.0 103.894 176.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.466 HG22 ' HE2' ' A' ' 101' ' ' MET 0.276 17.8 t -130.48 85.79 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 CA-C-O 122.604 1.192 . . . . 0.0 109.432 -159.564 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 22.2 p -72.49 -36.04 68.32 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 112.74 -2.027 . . . . 0.0 111.741 -162.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -135.01 160.3 38.76 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 122.822 1.296 . . . . 0.0 114.047 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -149.88 171.95 15.95 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 126.454 1.902 . . . . 0.0 110.487 161.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.506 ' C ' HD23 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -146.7 155.03 42.11 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.49 1.116 . . . . 0.0 110.101 -175.187 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 3.0 mtt -132.94 102.99 5.84 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.357 1.063 . . . . 0.0 111.476 -174.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.0 69.43 3.29 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 122.341 1.067 . . . . 0.0 109.748 168.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -60.53 -20.6 60.78 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.296 1.438 . . . . 0.0 113.25 -177.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.63 -30.34 62.25 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 125.358 1.456 . . . . 0.0 114.968 169.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.6 mtmt -132.39 -5.67 3.35 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 115.548 1.684 . . . . 0.0 115.548 -170.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.7 m120 72.61 38.71 0.76 Allowed 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 127.614 2.366 . . . . 0.0 113.611 -173.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -112.13 167.17 10.61 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.546 0.738 . . . . 0.0 111.271 171.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -147.39 164.48 33.18 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.499 1.519 . . . . 0.0 111.232 172.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.476 ' CD2' HG21 ' A' ' 60' ' ' VAL . 6.7 m-30 -109.27 157.33 18.94 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.44 1.496 . . . . 0.0 107.99 160.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 19.2 tt -137.31 124.33 29.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 124.599 1.16 . . . . 0.0 109.216 162.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -120.91 123.6 42.9 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 127.514 2.326 . . . . 0.0 111.445 -167.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.466 ' HE2' HG22 ' A' ' 85' ' ' VAL . 0.1 OUTLIER -133.99 157.45 46.04 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 112.724 -2.035 . . . . 0.0 113.222 -164.287 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.455 ' CG ' HG23 ' A' ' 103' ' ' THR . 0.0 OUTLIER -70.78 -23.06 62.32 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.376 1.251 . . . . 0.0 114.376 -161.581 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.455 HG23 ' CG ' ' A' ' 102' ' ' ASN . 9.8 p -135.58 140.64 44.79 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 122.622 1.201 . . . . 0.0 111.772 -175.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -59.83 -33.01 71.21 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.084 174.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -74.49 -41.61 60.41 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -54.54 -51.67 64.48 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 119.4 1.0 . . . . 0.0 109.803 168.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.28 -36.09 74.15 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -176.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -58.91 -46.98 86.6 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.226 -0.921 . . . . 0.0 111.034 170.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -64.32 -32.7 74.41 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.024 -1.048 . . . . 0.0 111.278 173.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.43 ' SD ' ' HA2' ' A' ' 79' ' ' GLY . 12.9 ttp -71.75 -48.76 44.65 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 119.729 1.15 . . . . 0.0 111.238 -176.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.16 -40.44 89.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 124.498 1.119 . . . . 0.0 111.071 177.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -68.67 -44.77 73.35 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.512 0.725 . . . . 0.0 110.445 177.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -50.15 -38.05 37.5 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.114 1.366 . . . . 0.0 112.25 168.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.442 ' HA ' HG12 ' A' ' 117' ' ' VAL . 25.8 m-85 -92.92 -11.16 34.09 Favored 'General case' 0 C--O 1.231 0.127 0 O-C-N 120.064 -1.648 . . . . 0.0 113.131 -177.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 84.2 m -80.89 -18.22 47.97 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.37 1.068 . . . . 0.0 110.069 166.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.04 -62.2 1.63 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 129.621 3.168 . . . . 0.0 112.3 170.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.442 HG12 ' HA ' ' A' ' 114' ' ' TYR . 1.4 p -83.02 -44.51 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 124.418 1.087 . . . . 0.0 113.018 -151.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.0 m 38.0 121.54 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.068 0 C-N-CA 130.674 3.589 . . . . 0.0 114.636 -147.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -69.84 -33.2 16.74 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 121.204 1.269 . . . . 0.0 114.118 -171.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.2 t 50.89 99.17 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 128.757 2.823 . . . . 0.0 112.313 -176.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.589 ' H ' HD11 ' A' ' 126' ' ' ILE . 1.2 tt -116.33 -73.37 0.65 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 112.201 -2.272 . . . . 0.0 107.472 -146.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.53 -35.01 79.59 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.56 1.144 . . . . 0.0 111.643 172.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 147.41 4.38 0.39 Allowed Glycine 0 CA--C 1.533 1.2 0 C-N-CA 125.083 1.325 . . . . 0.0 116.229 175.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -152.6 167.59 13.02 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 119.15 1.475 . . . . 0.0 111.272 178.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -45.3 110.06 0.22 Allowed 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 124.347 3.364 . . . . 0.0 116.447 -171.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.589 HD11 ' H ' ' A' ' 121' ' ' LEU . 2.5 mm -74.14 166.19 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 125.175 1.39 . . . . 0.0 107.707 166.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -140.66 156.34 46.26 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 121.218 -0.926 . . . . 0.0 110.483 168.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.21 153.27 38.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 125.517 1.527 . . . . 0.0 111.098 176.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -150.2 167.99 25.3 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.357 1.463 . . . . 0.0 108.772 154.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -55.12 149.47 12.19 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 120.878 -1.139 . . . . 0.0 111.74 159.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.617 ' HB3' HG13 ' A' ' 60' ' ' VAL . 30.8 t -69.28 153.16 44.08 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.897 0.879 . . . . 0.0 112.669 176.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -61.86 -29.13 69.98 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.047 1.339 . . . . 0.0 112.15 167.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 51.1 m-70 -95.11 175.96 6.42 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.592 1.957 . . . . 0.0 111.548 -174.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -134.64 120.53 19.67 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.272 1.429 . . . . 0.0 111.072 -177.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 58.55 90.39 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 128.201 2.601 . . . . 0.0 114.131 -178.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.471 HD12 ' C4 ' ' B' ' 150' ' ' ' U' . 35.9 tp -59.04 128.73 38.66 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.2 1.4 . . . . 0.0 112.111 176.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -113.76 112.09 22.85 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 126.348 1.859 . . . . 0.0 110.523 170.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 21.2 p -118.67 164.28 15.58 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.351 1.861 . . . . 0.0 110.895 171.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -64.02 158.99 21.1 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.472 0.709 . . . . 0.0 111.704 172.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 41.2 m 49.71 41.44 21.97 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.716 1.606 . . . . 0.0 114.469 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 38.0 m -61.66 140.07 95.21 Favored Pre-proline 0 N--CA 1.474 0.732 0 C-N-CA 123.878 0.871 . . . . 0.0 111.563 174.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -76.26 0.6 9.23 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 123.671 2.914 . . . . 0.0 114.801 -176.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -66.41 -1.27 3.31 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 126.275 1.83 . . . . 0.0 114.981 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 54.63 78.24 0.18 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.821 2.449 . . . . 0.0 113.969 177.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -151.33 168.12 25.77 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.341 1.456 . . . . 0.0 111.275 166.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 . . . . . 0 N--CA 1.476 0.831 0 C-N-CA 126.14 1.776 . . . . 0.0 111.609 178.278 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 147' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.265 0 C5'-C4'-C3' 111.312 -2.792 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 148' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.598 0 O4'-C1'-N19 110.599 2.399 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 149' ' ' ' C' . . . . . 0.427 ' C6 ' ' CD2' ' A' ' 62' ' ' HIS . . . . . . . . 0 O4'--C4' 1.421 -2.695 0 C3'-C2'-C1' 104.027 2.807 . 0.112 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 150' ' ' ' U' . . . . . 0.471 ' C4 ' HD12 ' A' ' 136' ' ' LEU . . . . . . . . 0 O4'--C4' 1.419 -2.817 1 O4'-C1'-N19 113.752 5.552 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 151' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.277 0 O4'-C1'-N19 110.844 2.644 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 152' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.259 0 O4'-C1'-N19 112.084 3.884 . 0.189 5q . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.645 0 N-CA-C 112.104 -0.398 . . . . 0.0 112.104 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -141.89 -50.1 0.39 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 127.948 2.499 . . . . 0.0 112.32 -0.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.6 m -62.28 -18.93 62.62 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.768 1.227 . . . . 0.0 114.255 179.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 49.9 tpt85 -58.07 -26.71 62.87 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 126.279 1.832 . . . . 0.0 114.273 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 48.7 m -60.17 -25.58 65.66 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 114.684 1.364 . . . . 0.0 114.684 -178.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -77.76 -2.13 34.78 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.889 1.676 . . . . 0.0 114.052 172.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 90.38 38.31 6.32 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 125.123 1.344 . . . . 0.0 113.839 -177.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . 0.314 7.7 p 47.78 76.66 0.52 Allowed Pre-proline 0 N--CA 1.485 1.302 0 C-N-CA 127.648 2.379 . . . . 0.0 111.619 -169.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -95.39 178.24 0.73 Allowed 'Trans proline' 0 CA--C 1.546 1.101 0 C-N-CA 123.927 3.085 . . . . 0.0 114.262 -147.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 49.1 m -135.97 177.88 7.49 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.944 1.298 . . . . 0.0 114.396 -167.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 34.4 mtp180 -55.82 -7.43 0.3 Allowed 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 129.909 3.284 . . . . 0.0 119.324 -170.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.658 HG13 ' HB3' ' A' ' 131' ' ' SER . 2.6 p -105.66 134.71 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-N 119.759 1.163 . . . . 0.0 111.878 169.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 10.4 mt -106.0 150.25 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 126.433 1.893 . . . . 0.0 108.561 167.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.406 ' CD2' ' C6 ' ' B' ' 149' ' ' ' C' . 2.6 t-80 -114.03 143.97 43.87 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.082 1.353 . . . . 0.0 110.569 173.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 7.2 mt -118.46 144.8 25.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 126.488 1.915 . . . . 0.0 108.395 -175.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.23 167.87 17.75 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 127.739 2.415 . . . . 0.0 109.639 168.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.72 27.91 17.27 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.816 1.246 . . . . 0.0 113.229 178.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 28.2 mt -66.96 177.25 0.9 Allowed Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 125.05 1.34 . . . . 0.0 109.792 163.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -51.88 -171.97 0.01 OUTLIER 'Trans proline' 0 CA--C 1.545 1.062 0 C-N-CA 123.181 2.587 . . . . 0.0 114.507 147.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.418 HG12 ' H ' ' A' ' 68' ' ' ILE . 3.7 mm -60.31 -47.26 93.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 127.427 2.291 . . . . 0.0 111.189 -176.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -155.51 -7.44 0.12 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 129.334 3.054 . . . . 0.0 111.666 -162.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.429 HG22 ' H ' ' A' ' 71' ' ' THR 0.307 7.9 p 26.05 -127.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 128.903 2.881 . . . . 0.0 113.457 -167.956 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.429 ' H ' HG22 ' A' ' 70' ' ' VAL . 9.8 t -154.51 143.8 21.27 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 120.004 1.275 . . . . 0.0 110.421 163.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -58.31 -42.12 86.0 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 123.562 0.745 . . . . 0.0 112.276 -175.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -55.79 -37.94 71.33 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 123.861 0.743 . . . . 0.0 112.516 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -69.12 -53.37 20.53 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.454 1.102 . . . . 0.0 112.125 173.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 97.7 t -58.97 -46.69 91.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 122.941 0.496 . . . . 0.0 112.14 -176.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.0 pp -73.05 -33.74 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 O-C-N 120.674 -1.266 . . . . 0.0 112.531 177.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 64.0 m -69.55 -21.44 63.64 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 120.047 1.294 . . . . 0.0 111.599 175.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.9 mt -77.63 -27.67 51.17 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 170.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -89.98 -21.25 39.84 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-N 119.239 0.927 . . . . 0.0 114.526 176.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.0 mt -64.05 -37.65 28.68 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 117.858 2.54 . . . . 0.0 117.858 -169.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.48 -4.01 1.09 Allowed 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.787 2.991 . . . . 0.0 116.845 171.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -106.97 -35.34 6.93 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 113.496 0.925 . . . . 0.0 113.496 -167.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -154.58 -108.37 0.31 Allowed Glycine 0 C--N 1.338 0.647 0 CA-C-O 122.622 1.123 . . . . 0.0 111.964 172.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.416 ' HB3' ' CG ' ' A' ' 102' ' ' ASN . 32.0 tptt -149.61 122.14 8.54 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 130.415 3.486 . . . . 0.0 104.135 175.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.431 HG22 ' HE2' ' A' ' 101' ' ' MET 0.308 20.8 t -128.74 83.98 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 CA-C-N 120.034 1.288 . . . . 0.0 109.955 -160.409 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.5 t -79.72 -21.22 44.84 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 126.894 2.077 . . . . 0.0 112.765 -163.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -141.51 161.74 37.17 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 175.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -149.37 171.82 15.92 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.577 2.351 . . . . 0.0 110.551 162.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.529 ' C ' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -142.99 154.47 44.05 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.266 1.426 . . . . 0.0 108.772 172.692 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 3.7 mtt -128.28 105.62 8.47 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.748 1.219 . . . . 0.0 110.434 -175.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.415 HD13 HD11 ' A' ' 89' ' ' LEU . 1.6 mm? -74.11 71.52 1.64 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.186 0.994 . . . . 0.0 110.525 173.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -49.85 118.87 3.11 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.835 1.654 . . . . 0.0 111.574 -176.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.04 -6.37 82.72 Favored Glycine 0 CA--C 1.539 1.556 0 CA-C-O 118.279 -1.289 . . . . 0.0 116.178 177.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.51 -2.98 50.72 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-N 119.837 1.818 . . . . 0.0 113.154 165.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.9 m120 63.24 27.37 15.5 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.313 1.845 . . . . 0.0 113.283 -167.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -124.58 164.51 19.66 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.513 0.725 . . . . 0.0 112.302 -168.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -164.12 170.71 16.07 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.091 1.756 . . . . 0.0 111.177 -178.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.478 ' CD2' HG21 ' A' ' 60' ' ' VAL . 4.3 m-30 -116.74 156.02 27.9 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.448 1.899 . . . . 0.0 108.088 164.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 17.4 tt -138.14 124.41 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 124.722 1.209 . . . . 0.0 109.138 164.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -122.79 122.17 38.04 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 127.034 2.134 . . . . 0.0 111.474 -164.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.431 ' HE2' HG22 ' A' ' 85' ' ' VAL . 0.9 OUTLIER -132.63 157.33 45.07 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 113.389 -1.732 . . . . 0.0 112.97 -166.028 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.416 ' CG ' ' HB3' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -71.79 -19.34 62.02 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 114.065 -1.425 . . . . 0.0 114.308 -159.508 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.415 HG23 ' CG ' ' A' ' 102' ' ' ASN . 16.8 p -137.83 142.64 40.77 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 122.956 1.36 . . . . 0.0 111.766 -176.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -59.43 -37.42 78.04 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 114.125 -1.398 . . . . 0.0 110.706 176.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -71.64 -40.35 69.79 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 179.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.0 -52.53 62.85 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 119.403 1.001 . . . . 0.0 110.073 169.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.99 -38.16 82.35 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -56.15 -48.24 76.65 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.818 -0.551 . . . . 0.0 111.048 171.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -64.84 -35.01 79.74 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 118.407 -0.806 . . . . 0.0 111.233 173.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 8.2 ttp -67.76 -48.55 66.07 Favored 'General case' 0 C--N 1.343 0.303 0 C-N-CA 124.554 1.142 . . . . 0.0 110.554 -175.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.84 -40.64 88.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 C-N-CA 124.752 1.221 . . . . 0.0 111.761 178.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -67.71 -45.3 75.48 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.377 0.671 . . . . 0.0 110.693 177.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -50.97 -38.31 49.98 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.604 1.562 . . . . 0.0 112.482 167.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.442 ' HA ' HG12 ' A' ' 117' ' ' VAL . 17.8 m-85 -88.73 -16.47 32.15 Favored 'General case' 0 CA--C 1.517 -0.289 0 O-C-N 119.966 -1.709 . . . . 0.0 112.88 -178.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 70.0 m -79.06 -18.61 53.13 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.434 1.093 . . . . 0.0 109.865 169.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.42 -60.58 2.22 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 129.384 3.074 . . . . 0.0 111.697 169.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.442 HG12 ' HA ' ' A' ' 114' ' ' TYR . 0.8 OUTLIER -88.47 -48.07 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.048 0.939 . . . . 0.0 112.955 -153.302 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.2 m 43.08 125.28 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.88 0 C-N-CA 129.866 3.266 . . . . 0.0 114.267 -148.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -70.14 -35.35 11.67 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 121.416 1.411 . . . . 0.0 114.012 -171.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.6 t 53.86 102.33 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 128.597 2.759 . . . . 0.0 113.031 -178.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.532 ' H ' HD11 ' A' ' 126' ' ' ILE . 0.8 OUTLIER -123.59 -71.46 0.72 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 112.479 -2.146 . . . . 0.0 108.28 -147.293 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.78 -42.51 99.09 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.521 0.728 . . . . 0.0 111.086 171.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 158.18 -2.47 0.12 Allowed Glycine 0 CA--C 1.533 1.198 0 N-CA-C 116.208 1.243 . . . . 0.0 116.208 173.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -148.13 169.56 9.07 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 119.54 1.67 . . . . 0.0 111.192 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_exo -50.98 116.07 2.41 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.734 2.956 . . . . 0.0 116.535 -166.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.532 HD11 ' H ' ' A' ' 121' ' ' LEU . 4.3 mm -76.27 150.06 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 126.364 1.866 . . . . 0.0 109.166 174.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 10.2 m-30 -114.7 136.7 52.77 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.042 -1.036 . . . . 0.0 110.787 -176.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.5 149.3 32.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 125.1 1.36 . . . . 0.0 112.319 176.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -153.46 164.9 37.39 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.763 2.025 . . . . 0.0 109.627 153.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -53.19 152.23 4.53 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 120.873 -1.142 . . . . 0.0 112.593 167.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.658 ' HB3' HG13 ' A' ' 60' ' ' VAL . 27.9 t -76.18 157.87 32.27 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.726 0.81 . . . . 0.0 113.086 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -68.51 -12.03 60.68 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.854 1.662 . . . . 0.0 113.636 168.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 42.6 m-70 -119.6 -178.69 3.68 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.484 1.513 . . . . 0.0 112.895 -170.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -136.88 124.95 22.9 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.981 2.112 . . . . 0.0 110.639 178.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 58.28 93.05 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 127.185 2.194 . . . . 0.0 113.946 -178.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 28.9 tp -64.01 110.96 2.31 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.666 1.587 . . . . 0.0 111.814 178.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -107.48 100.41 9.84 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.204 1.802 . . . . 0.0 110.425 174.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 22.1 p -91.62 -7.09 51.06 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 126.165 1.786 . . . . 0.0 114.044 178.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 20.2 t70 64.61 -6.79 0.28 Allowed 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 128.244 2.618 . . . . 0.0 116.642 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 54.8 m 31.91 73.13 0.06 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 129.051 2.94 . . . . 0.0 115.347 171.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 82.6 p -114.62 158.28 40.65 Favored Pre-proline 0 N--CA 1.476 0.832 0 C-N-CA 124.591 1.156 . . . . 0.0 113.907 -173.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -57.64 -22.64 53.15 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.778 2.985 . . . . 0.0 115.456 175.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -70.72 -23.42 62.45 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.95 1.3 . . . . 0.0 113.832 178.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -76.3 167.97 20.9 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -174.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -120.88 1.1 10.43 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -157.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.998 0 C-N-CA 125.926 1.691 . . . . 0.0 111.022 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 147' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.306 0 C5'-C4'-C3' 111.335 -2.776 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 148' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.377 1 O4'-C1'-N19 113.273 5.073 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 149' ' ' ' C' . . . . . 0.406 ' C6 ' ' CD2' ' A' ' 62' ' ' HIS . . . . . . . . 0 O4'--C4' 1.422 -2.586 0 O4'-C1'-N19 111.908 3.708 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 150' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.28 2 O4'-C1'-N19 114.881 6.681 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 151' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.544 2.618 0 C4'-C3'-C2' 99.8 -2.9 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 152' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.166 0 O4'-C1'-N19 111.177 2.977 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.642 0 N-CA-C 111.823 -0.511 . . . . 0.0 111.823 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -144.77 151.51 38.95 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.534 1.533 . . . . 0.0 111.511 178.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 11.0 m -71.69 29.44 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 127.188 2.195 . . . . 0.0 114.531 178.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 31.9 mtp85 42.03 54.34 4.07 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 127.592 2.357 . . . . 0.0 112.06 -169.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.5 m 57.31 -82.22 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 128.319 2.648 . . . . 0.0 113.952 -169.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 55.55 -67.91 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 128.78 2.832 . . . . 0.0 114.917 -170.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 160.77 -78.21 0.17 Allowed Glycine 0 CA--C 1.53 0.98 0 C-N-CA 126.731 2.11 . . . . 0.0 110.178 174.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.1 t -147.84 76.97 10.43 Favored Pre-proline 0 N--CA 1.479 0.989 0 C-N-CA 126.786 2.034 . . . . 0.0 107.614 169.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -104.97 19.05 0.14 Allowed 'Trans proline' 0 CA--C 1.543 0.974 0 C-N-CA 123.734 2.956 . . . . 0.0 114.222 -152.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.1 t -43.08 118.18 1.23 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.882 1.673 . . . . 0.0 114.785 -159.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 25.8 mtp180 61.5 -8.54 0.09 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 128.836 2.854 . . . . 0.0 117.839 171.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.681 HG13 ' HB3' ' A' ' 131' ' ' SER 0.3 3.9 p -104.81 130.3 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 120.906 1.685 . . . . 0.0 113.409 175.347 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.8 mp -103.21 155.21 5.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 127.617 2.367 . . . . 0.0 108.103 169.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.427 ' CD2' ' C6 ' ' B' ' 149' ' ' ' C' . 3.1 t-80 -126.93 140.96 51.94 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.801 2.04 . . . . 0.0 111.024 177.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.6 mt -120.75 136.63 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 128.309 2.644 . . . . 0.0 109.857 -170.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.6 mtt180 -97.19 176.65 5.85 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 120.517 1.508 . . . . 0.0 111.02 172.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp 45.34 35.79 2.01 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 127.739 2.415 . . . . 0.0 117.068 159.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.8 mp -52.03 157.42 2.16 Favored Pre-proline 0 CA--C 1.559 1.303 0 C-N-CA 124.771 1.228 . . . . 0.0 110.912 165.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -42.0 -65.72 0.18 Allowed 'Trans proline' 0 CA--C 1.537 0.648 1 C-N-CA 126.033 4.488 . . . . 0.0 115.385 177.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 pt -160.54 -55.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 130.262 3.425 . . . . 0.0 107.898 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -145.99 -9.47 0.52 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.31 1.444 . . . . 0.0 114.508 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.518 HG22 ' H ' ' A' ' 71' ' ' THR 0.28 1.7 p 45.14 -154.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 127.611 2.364 . . . . 0.0 112.997 -178.616 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.518 ' H ' HG22 ' A' ' 70' ' ' VAL . 4.0 t -137.43 143.0 41.63 Favored 'General case' 0 C--O 1.238 0.499 0 O-C-N 120.396 -1.44 . . . . 0.0 110.466 160.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -58.46 -33.41 69.71 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.763 177.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -56.59 -41.3 89.16 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 123.953 0.787 . . . . 0.0 112.96 175.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -64.53 -55.83 18.0 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.815 0.846 . . . . 0.0 111.11 171.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.7 t -61.05 -44.22 97.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -173.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.9 pp -69.44 -32.65 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 O-C-N 120.301 -1.499 . . . . 0.0 112.652 175.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.6 p -64.28 -21.23 66.52 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 119.738 1.153 . . . . 0.0 112.214 173.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 86.8 mt -91.6 -16.14 27.55 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 173.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -90.02 -22.78 34.52 Favored Glycine 0 CA--C 1.538 1.509 0 CA-C-N 119.144 0.884 . . . . 0.0 113.214 168.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 80' ' ' LEU . 21.0 mt -73.37 -14.98 0.25 Allowed Pre-proline 0 CA--C 1.543 0.677 0 N-CA-C 119.314 3.079 . . . . 0.0 119.314 -175.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -60.5 -1.53 1.49 Allowed 'Trans proline' 0 C--N 1.348 0.525 0 CA-C-N 123.152 2.162 . . . . 0.0 116.62 168.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -122.05 -53.62 1.94 Allowed 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 114.698 1.369 . . . . 0.0 114.698 -168.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -144.06 -106.57 0.54 Allowed Glycine 0 C--N 1.337 0.598 0 C-N-CA 124.149 0.88 . . . . 0.0 111.985 -178.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 13.7 tptm -143.41 -7.52 0.78 Allowed 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 116.805 2.15 . . . . 0.0 116.805 -174.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 101' ' ' MET . 0.1 OUTLIER 30.26 87.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 129.029 2.932 . . . . 0.0 113.37 -176.782 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 24.1 m -55.42 -42.3 73.94 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 127.378 2.271 . . . . 0.0 111.695 -175.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -149.72 169.53 20.83 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.4 pp -139.49 171.95 13.51 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.97 1.708 . . . . 0.0 112.189 155.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.529 ' C ' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -144.18 151.95 40.22 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.176 1.79 . . . . 0.0 108.476 173.867 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 5.1 mtt -128.77 103.52 7.11 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.326 1.05 . . . . 0.0 111.924 -175.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.444 ' CD1' HD11 ' A' ' 89' ' ' LEU . 1.2 mm? -74.43 96.02 2.82 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.927 1.291 . . . . 0.0 110.878 172.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 49.4 mttp -61.17 -19.18 61.26 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 171.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -53.33 -61.07 7.33 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 126.379 1.942 . . . . 0.0 114.968 -177.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.34 27.06 4.79 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.632 1.973 . . . . 0.0 112.239 -175.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 59.45 48.5 9.78 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.723 2.009 . . . . 0.0 113.709 -177.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . 0.28 0.0 OUTLIER -117.59 176.14 5.31 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.042 0.937 . . . . 0.0 111.935 176.838 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -166.48 165.81 16.73 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 120.276 -1.515 . . . . 0.0 111.018 -174.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.439 ' CD2' HG21 ' A' ' 60' ' ' VAL . 4.2 m-30 -112.46 157.37 21.17 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.908 1.683 . . . . 0.0 108.484 166.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 8.6 tt -143.62 108.32 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 126.111 1.764 . . . . 0.0 107.618 170.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -115.34 131.91 56.78 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.846 2.058 . . . . 0.0 112.014 -166.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.452 ' HA ' ' HA ' ' A' ' 85' ' ' VAL 0.292 1.2 tpp -130.46 153.5 48.72 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 116.835 2.161 . . . . 0.0 116.835 -161.498 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.0 -9.2 51.23 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.182 1.793 . . . . 0.0 114.675 -165.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -148.76 143.89 26.68 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.459 1.504 . . . . 0.0 110.111 -177.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -66.54 -32.76 74.31 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.221 1.008 . . . . 0.0 111.726 176.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -71.83 -47.44 53.16 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.346 0.658 . . . . 0.0 112.09 177.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.79 -46.47 87.48 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 122.83 0.452 . . . . 0.0 110.619 175.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.22 -40.65 82.0 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -60.77 -46.43 90.48 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.851 -0.531 . . . . 0.0 111.102 171.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -63.3 -29.09 70.48 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 120.421 -1.425 . . . . 0.0 111.198 171.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 10.4 ttp -67.06 -52.11 46.27 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 120.13 1.332 . . . . 0.0 110.048 -177.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.74 -40.51 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 124.547 1.139 . . . . 0.0 111.85 176.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -71.29 -44.07 65.91 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.751 0.82 . . . . 0.0 111.824 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -48.42 -38.66 20.22 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.454 1.501 . . . . 0.0 111.629 166.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.64 ' HA ' HG12 ' A' ' 117' ' ' VAL . 11.6 m-85 -85.98 -22.26 27.42 Favored 'General case' 0 N--CA 1.445 -0.715 0 O-C-N 120.649 -1.282 . . . . 0.0 113.248 -175.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.08 -15.89 57.54 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.984 0.897 . . . . 0.0 111.107 171.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.7 -59.43 2.79 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 128.932 2.893 . . . . 0.0 111.045 169.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.64 HG12 ' HA ' ' A' ' 114' ' ' TYR . 3.2 p -78.01 -48.92 22.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 124.474 1.11 . . . . 0.0 112.43 -158.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.5 m 28.78 121.91 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.038 0 C-N-CA 129.044 2.938 . . . . 0.0 114.789 -138.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -80.86 -7.65 13.34 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 121.789 1.659 . . . . 0.0 115.002 -167.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 4.1 t 28.88 85.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 C-N-CA 130.239 3.416 . . . . 0.0 114.041 173.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . 0.268 9.7 tt -106.95 -23.6 12.29 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 118.01 -1.476 . . . . 0.0 112.507 -121.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.35 -6.68 11.25 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.633 1.173 . . . . 0.0 113.997 148.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 139.74 11.51 0.72 Allowed Glycine 0 CA--C 1.536 1.364 0 N-CA-C 118.059 1.984 . . . . 0.0 118.059 -169.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.8 155.75 69.06 Favored Pre-proline 0 C--N 1.346 0.417 0 CA-C-N 120.771 2.286 . . . . 0.0 112.999 172.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.04 152.72 49.68 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.985 2.456 . . . . 0.0 113.674 -177.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 29.8 mm -117.74 -53.88 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 123.646 0.778 . . . . 0.0 112.917 -163.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 62.13 151.14 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.975 2.11 . . . . 0.0 115.255 -170.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.45 157.06 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 125.914 1.686 . . . . 0.0 110.799 174.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -147.75 166.06 28.65 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.384 1.474 . . . . 0.0 109.453 155.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -55.64 146.89 19.58 Favored 'General case' 0 CA--C 1.547 0.858 0 O-C-N 121.353 -0.842 . . . . 0.0 111.303 158.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.681 ' HB3' HG13 ' A' ' 60' ' ' VAL . 29.4 t -73.39 161.48 30.4 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.669 1.187 . . . . 0.0 113.673 -175.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -73.03 -10.88 60.27 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.139 1.376 . . . . 0.0 113.573 167.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 57.7 m-70 -115.46 172.35 7.16 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.441 1.497 . . . . 0.0 112.403 -172.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -122.02 110.04 15.31 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 126.576 1.95 . . . . 0.0 109.728 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 61.88 167.94 0.11 Allowed 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 126.592 1.957 . . . . 0.0 113.924 -166.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 22.7 tp -132.19 97.87 4.25 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 128.617 2.767 . . . . 0.0 112.521 -172.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -99.33 93.27 5.83 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 127.601 2.361 . . . . 0.0 111.156 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 16.7 p -94.57 -18.72 21.14 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 115.908 1.818 . . . . 0.0 115.908 -171.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -126.64 -59.49 1.28 Allowed 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -163.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 49.3 m 49.26 36.3 9.1 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.309 1.443 . . . . 0.0 114.064 -170.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 25.5 p -67.45 155.63 90.51 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 125.584 1.554 . . . . 0.0 112.733 178.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -58.08 161.59 13.11 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.394 2.73 . . . . 0.0 114.123 173.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -135.75 -38.91 0.72 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.904 1.682 . . . . 0.0 111.573 170.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -68.41 167.08 15.4 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.141 1.776 . . . . 0.0 112.453 165.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -73.05 179.15 3.92 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.875 1.27 . . . . 0.0 112.638 169.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 75.2 ttt-85 . . . . . 0 N--CA 1.48 1.042 0 C-N-CA 125.722 1.609 . . . . 0.0 114.013 177.673 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 147' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.196 0 O4'-C1'-N19 110.849 2.649 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 148' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.422 0 O4'-C1'-N19 111.036 2.836 . 0.324 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 149' ' ' ' C' . . . . . 0.427 ' C6 ' ' CD2' ' A' ' 62' ' ' HIS . . . . . . . . 0 O4'--C4' 1.422 -2.59 0 O4'-C1'-N19 111.659 3.459 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 150' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.291 2 O4'-C1'-N19 113.262 5.062 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 151' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.386 0 C4'-C3'-C2' 98.991 -3.709 . 0.01 1g . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 152' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.122 1 O4'-C1'-N19 112.588 4.388 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.559 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -125.52 4.57 7.59 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.658 1.583 . . . . 0.0 114.319 -171.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 56.0 p -61.75 -29.99 70.49 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.686 1.594 . . . . 0.0 114.688 -175.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -77.93 73.73 4.49 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.668 1.587 . . . . 0.0 110.877 175.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 68.1 m -74.76 -7.3 52.94 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.617 ' HB1' ' HB3' ' A' ' 57' ' ' PRO . . . -114.23 -72.32 0.7 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.765 1.226 . . . . 0.0 112.307 -175.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.07 68.08 1.13 Allowed Glycine 0 CA--C 1.531 1.042 0 C-N-CA 124.644 1.116 . . . . 0.0 111.932 175.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 36.8 t 45.49 72.15 1.32 Allowed Pre-proline 0 N--CA 1.481 1.101 0 C-N-CA 127.656 2.382 . . . . 0.0 110.933 -170.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.617 ' HB3' ' HB1' ' A' ' 54' ' ' ALA . 0.5 OUTLIER -93.59 -179.79 0.89 Allowed 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 124.624 3.549 . . . . 0.0 114.185 -156.994 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.3 t -145.77 -157.09 0.76 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.19 1.396 . . . . 0.0 111.65 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 44.4 mtp180 -55.11 -9.21 0.37 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 130.121 3.368 . . . . 0.0 119.474 -158.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.479 HG13 ' HB3' ' A' ' 131' ' ' SER 0.409 7.2 p -101.26 132.27 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 CA-C-N 122.404 2.366 . . . . 0.0 113.495 170.702 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 26.0 mt -111.22 153.71 12.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 128.287 2.635 . . . . 0.0 107.696 172.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -124.14 146.99 48.29 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.874 1.27 . . . . 0.0 111.446 178.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.1 mt -126.27 142.76 41.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 127.367 2.267 . . . . 0.0 109.977 -173.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.09 172.55 8.16 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 126.904 2.082 . . . . 0.0 112.41 170.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 67.13 19.51 10.4 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 126.456 1.902 . . . . 0.0 114.529 175.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.2 mp -54.02 154.95 6.92 Favored Pre-proline 0 CA--C 1.556 1.174 0 C-N-CA 122.791 0.437 . . . . 0.0 111.897 171.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -48.75 -58.4 1.78 Allowed 'Trans proline' 0 CA--C 1.536 0.596 1 C-N-CA 125.454 4.102 . . . . 0.0 114.651 175.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 pt -171.6 -53.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 131.372 3.869 . . . . 0.0 108.428 -178.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -147.27 -10.13 0.43 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 126.096 1.758 . . . . 0.0 113.701 -171.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.412 HG22 ' H ' ' A' ' 71' ' ' THR 0.293 5.0 p 40.47 -136.64 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 127.262 2.225 . . . . 0.0 112.251 -177.833 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.412 ' H ' HG22 ' A' ' 70' ' ' VAL . 1.8 t -143.32 133.99 25.12 Favored 'General case' 0 C--O 1.241 0.618 0 O-C-N 120.846 -1.159 . . . . 0.0 109.175 156.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.59 -30.21 68.5 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.335 -178.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -60.31 -36.59 91.32 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.938 1.256 . . . . 0.0 113.405 174.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -66.23 -52.25 49.63 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 118.153 0.976 . . . . 0.0 110.814 170.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.0 t -63.58 -42.29 95.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -174.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.423 ' CG2' HD22 ' A' ' 88' ' ' LEU . 2.3 pp -72.92 -32.43 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 O-C-N 120.168 -1.583 . . . . 0.0 113.131 175.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 36.2 t -62.38 -27.31 68.99 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 119.038 0.836 . . . . 0.0 110.852 171.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 31.3 mt -86.53 -15.67 39.27 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 173.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -92.43 -19.59 37.85 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.887 1.232 . . . . 0.0 113.599 172.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.5 mt -65.11 -46.08 73.02 Favored Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 116.808 2.151 . . . . 0.0 116.808 -171.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.61 -4.03 0.74 Allowed 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 124.657 3.571 . . . . 0.0 118.496 178.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -104.92 -33.8 8.25 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -165.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -160.99 -78.34 0.03 OUTLIER Glycine 0 C--N 1.331 0.262 0 C-N-CA 125.785 1.659 . . . . 0.0 109.032 176.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -150.96 -13.79 0.22 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 116.678 2.103 . . . . 0.0 116.678 170.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.485 ' H ' ' HE1' ' A' ' 101' ' ' MET . 2.2 m 29.49 171.73 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.246 0 CA-C-O 123.262 1.506 . . . . 0.0 114.829 -127.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.3 t -124.27 -26.81 3.89 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 119.16 -2.212 . . . . 0.0 112.435 163.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -162.22 166.28 25.7 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 172.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.423 HD22 ' CG2' ' A' ' 76' ' ' ILE . 1.4 pt? -140.43 166.85 23.58 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.656 1.582 . . . . 0.0 113.411 159.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.516 ' C ' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -143.13 151.44 40.7 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 128.073 2.549 . . . . 0.0 108.662 -177.562 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 6.4 mtt -127.45 111.9 14.36 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.258 1.023 . . . . 0.0 111.132 -179.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.469 HD13 HD11 ' A' ' 89' ' ' LEU . 1.9 mm? -73.31 72.4 1.28 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.689 1.196 . . . . 0.0 111.102 175.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -57.79 125.36 22.69 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.467 1.107 . . . . 0.0 110.75 175.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 96.58 -8.72 66.41 Favored Glycine 0 CA--C 1.537 1.458 0 C-N-CA 125.242 1.401 . . . . 0.0 115.56 -173.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.94 -9.14 10.13 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 119.343 1.571 . . . . 0.0 113.693 169.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.2 m120 59.76 39.67 20.54 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.305 1.842 . . . . 0.0 112.806 -174.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -121.82 172.64 8.02 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.232 1.013 . . . . 0.0 111.325 -179.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -159.75 165.38 32.6 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.654 1.582 . . . . 0.0 111.336 178.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.432 ' CD2' HG21 ' A' ' 60' ' ' VAL . 4.0 m-30 -115.44 150.39 36.52 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 126.498 1.919 . . . . 0.0 107.638 166.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 16.2 tt -134.92 98.93 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 125.046 1.339 . . . . 0.0 108.659 167.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -85.49 131.67 34.33 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 127.495 2.318 . . . . 0.0 110.974 176.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.485 ' HE1' ' H ' ' A' ' 85' ' ' VAL 0.283 11.6 tpp -120.27 155.81 32.5 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 -170.989 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.72 -22.0 64.36 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -170.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.91 147.64 37.4 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.168 0.987 . . . . 0.0 110.96 -175.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -66.04 -38.53 88.63 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.047 0.539 . . . . 0.0 111.843 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -71.9 -40.71 68.67 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 178.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -54.67 -50.52 68.0 Favored 'General case' 0 C--O 1.219 -0.545 0 C-N-CA 122.997 0.519 . . . . 0.0 110.607 170.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -70.59 -37.88 73.95 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 -178.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -55.92 -47.87 76.72 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 119.45 1.023 . . . . 0.0 110.875 169.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -66.39 -32.04 73.18 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-O 118.345 -0.836 . . . . 0.0 111.649 173.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 13.3 ttp -70.41 -45.79 65.22 Favored 'General case' 0 C--N 1.345 0.388 0 C-N-CA 125.069 1.348 . . . . 0.0 110.588 -176.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -67.79 -41.11 84.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 124.183 0.993 . . . . 0.0 111.745 177.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -68.52 -44.92 73.59 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.299 0.64 . . . . 0.0 110.564 178.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -47.14 -45.23 22.4 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.375 1.47 . . . . 0.0 111.98 166.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.597 ' HA ' HG12 ' A' ' 117' ' ' VAL . 12.6 m-85 -82.23 -16.66 48.81 Favored 'General case' 0 N--CA 1.456 -0.128 0 O-C-N 121.054 -1.029 . . . . 0.0 112.64 -176.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 92.8 m -80.57 -14.63 58.04 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.364 1.065 . . . . 0.0 110.653 170.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.33 -54.53 3.02 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 128.809 2.843 . . . . 0.0 113.229 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.597 HG12 ' HA ' ' A' ' 114' ' ' TYR . 10.9 p -71.46 -35.82 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 127.171 2.189 . . . . 0.0 114.274 -156.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.455 ' HA ' ' HD3' ' A' ' 119' ' ' PRO . 0.2 OUTLIER -2.51 115.91 0.01 OUTLIER Pre-proline 0 N--CA 1.486 1.347 0 C-N-CA 127.754 2.422 . . . . 0.0 116.875 -125.876 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 118' ' ' THR . 6.1 Cg_exo -76.16 -18.88 15.98 Favored 'Trans proline' 0 CA--C 1.547 1.166 0 C-N-CA 123.506 2.804 . . . . 0.0 113.095 -167.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 6.4 t 60.9 104.03 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 130.072 3.349 . . . . 0.0 113.057 -178.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.6 tt -65.5 -66.93 0.48 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.583 1.153 . . . . 0.0 111.714 -158.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.07 66.56 1.24 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.248 1.419 . . . . 0.0 110.054 168.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 86.04 12.37 71.2 Favored Glycine 0 CA--C 1.54 1.654 0 C-N-CA 124.628 1.109 . . . . 0.0 114.985 -178.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -136.18 141.47 36.31 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 126.564 1.945 . . . . 0.0 109.399 177.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -56.68 166.44 3.72 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 123.579 2.853 . . . . 0.0 112.65 171.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.45 ' H ' ' CG2' ' A' ' 118' ' ' THR . 0.8 OUTLIER -125.23 146.38 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.388 1.075 . . . . 0.0 110.124 -174.957 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -128.94 95.17 4.01 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.28 -1.327 . . . . 0.0 109.039 -153.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.12 151.49 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 124.682 1.193 . . . . 0.0 112.953 -173.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -156.66 170.02 23.37 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.38 1.072 . . . . 0.0 109.976 147.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -52.34 149.28 5.71 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 120.853 -1.154 . . . . 0.0 112.525 170.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.479 ' HB3' HG13 ' A' ' 60' ' ' VAL . 30.3 t -70.64 158.53 36.03 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.182 0.993 . . . . 0.0 112.381 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -63.34 -15.27 56.89 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.826 1.25 . . . . 0.0 112.859 163.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 28.2 m-70 -117.61 -179.83 3.85 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 127.354 2.262 . . . . 0.0 111.206 -175.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -130.81 11.87 5.22 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.73 1.612 . . . . 0.0 113.398 -173.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -167.76 150.95 5.98 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.895 2.078 . . . . 0.0 110.571 -166.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 55.9 tp -140.07 -62.47 0.51 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.019 1.328 . . . . 0.0 113.207 177.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.4 ptmm? 28.37 69.73 0.07 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 128.969 2.907 . . . . 0.0 116.455 178.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 41.7 p -72.38 -5.58 37.44 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -63.15 -16.97 61.8 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.375 1.87 . . . . 0.0 115.795 -172.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 19.7 m -73.72 35.94 0.09 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 127.071 2.148 . . . . 0.0 115.53 -175.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 77.8 p -74.21 162.99 71.43 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 125.936 1.695 . . . . 0.0 113.52 176.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.89 164.15 10.33 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 124.09 3.193 . . . . 0.0 114.968 174.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -95.92 153.29 17.84 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.931 1.292 . . . . 0.0 111.988 173.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -74.26 -55.57 5.89 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.438 1.095 . . . . 0.0 112.654 177.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -77.51 -52.68 8.66 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.034 1.334 . . . . 0.0 112.908 -173.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 22.8 tpp85 . . . . . 0 N--CA 1.472 0.643 0 C-N-CA 125.017 1.327 . . . . 0.0 110.925 179.469 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 147' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.244 0 C5'-C4'-C3' 112.154 -2.231 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 148' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.782 0 O4'-C4'-C3' 109.671 2.979 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 149' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.526 0 N19-C1'-C2' 107.683 -3.573 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 150' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.213 2 O4'-C1'-N19 113.799 5.599 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 151' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.537 2.073 1 O4'-C1'-N19 112.655 4.455 . 0.132 &a . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 152' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.539 2.201 1 O4'-C1'-N19 113.715 5.515 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.535 0 N-CA-C 111.955 -0.458 . . . . 0.0 111.955 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -133.42 54.81 1.93 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.432 1.493 . . . . 0.0 110.955 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.7 m -61.18 -7.65 2.91 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 127.015 2.126 . . . . 0.0 116.431 -168.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -58.66 -17.62 23.97 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 126.473 1.909 . . . . 0.0 114.661 173.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.0 t -138.81 152.7 48.1 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.93 1.692 . . . . 0.0 111.33 168.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.404 ' HB1' ' HB3' ' A' ' 57' ' ' PRO . . . -80.9 -11.13 59.63 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.752 1.221 . . . . 0.0 113.518 171.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.61 43.42 8.44 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.324 0.964 . . . . 0.0 113.55 176.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 57.4 t 51.75 84.8 0.2 Allowed Pre-proline 0 N--CA 1.478 0.927 0 C-N-CA 127.949 2.5 . . . . 0.0 110.825 -171.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.404 ' HB3' ' HB1' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -106.96 9.28 0.16 Allowed 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 123.481 2.787 . . . . 0.0 116.108 -149.808 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.2 m -4.66 107.49 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 130.443 3.497 . . . . 0.0 117.887 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 40.6 mtm-85 81.5 -6.53 1.52 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 128.361 2.665 . . . . 0.0 117.484 152.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.662 HG13 ' HB3' ' A' ' 131' ' ' SER . 2.5 p -118.22 136.57 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 CA-C-N 120.297 1.408 . . . . 0.0 113.125 163.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 10.9 mt -110.86 147.61 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 126.987 2.115 . . . . 0.0 108.795 168.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -110.7 116.59 31.57 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.295 1.438 . . . . 0.0 110.601 175.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 8.9 mt -89.53 134.3 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 126.505 1.922 . . . . 0.0 108.416 175.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -123.38 168.85 11.98 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 126.425 1.89 . . . . 0.0 112.248 171.019 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.5 mmtt 46.38 39.05 5.92 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 127.664 2.386 . . . . 0.0 114.418 -172.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 25.2 mt -60.55 174.22 0.54 Allowed Pre-proline 0 CA--C 1.556 1.207 0 C-N-CA 125.466 1.506 . . . . 0.0 111.043 158.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.56 -169.88 0.01 OUTLIER 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 124.55 3.5 . . . . 0.0 114.743 151.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 22.4 pt -58.81 -52.5 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.3 1.44 . . . . 0.0 112.644 -175.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -149.07 8.69 0.74 Allowed 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 127.103 2.161 . . . . 0.0 112.889 172.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.309 10.4 p 30.88 -125.46 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 C-N-CA 128.38 2.672 . . . . 0.0 113.294 -169.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.8 t -153.8 143.1 21.49 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 120.248 1.385 . . . . 0.0 110.237 167.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -55.86 -43.21 76.88 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.03 0.932 . . . . 0.0 112.329 -179.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.03 -42.79 61.46 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 124.074 0.845 . . . . 0.0 112.907 178.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -64.94 -53.42 46.62 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.726 0.81 . . . . 0.0 111.894 172.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 83.5 t -59.5 -48.81 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 123.506 0.722 . . . . 0.0 112.442 -175.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.7 pp -70.01 -35.34 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 O-C-N 120.654 -1.279 . . . . 0.0 112.403 178.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.0 m -69.52 -20.85 63.69 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 119.714 1.143 . . . . 0.0 111.82 175.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.2 mt -79.48 -24.5 42.29 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 170.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -94.37 -21.6 26.68 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-N 119.061 0.846 . . . . 0.0 115.161 174.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.5 mt -59.95 -43.02 93.56 Favored Pre-proline 0 CA--C 1.538 0.514 0 N-CA-C 117.113 2.264 . . . . 0.0 117.113 -169.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.54 -6.18 1.44 Allowed 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.88 3.053 . . . . 0.0 116.981 174.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -104.03 -36.08 7.86 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 -167.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -153.03 -108.19 0.35 Allowed Glycine 0 C--N 1.336 0.54 0 CA-C-O 122.763 1.202 . . . . 0.0 111.846 172.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.424 ' HB3' ' CG ' ' A' ' 102' ' ' ASN . 7.0 tppt? -149.53 122.22 8.63 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 130.42 3.488 . . . . 0.0 104.533 175.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.42 HG22 ' HE2' ' A' ' 101' ' ' MET 0.288 21.6 t -129.06 84.71 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 CA-C-O 122.954 1.359 . . . . 0.0 109.213 -160.705 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 41.0 p -82.66 -17.21 45.36 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 127.524 2.33 . . . . 0.0 113.008 -162.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -141.51 160.16 40.73 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 174.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -146.21 175.73 10.28 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.575 1.95 . . . . 0.0 110.773 158.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.463 ' C ' HD23 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -151.48 153.43 34.61 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 125.728 1.611 . . . . 0.0 109.645 177.654 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 4.9 mtp -134.73 95.67 3.39 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.535 0.734 . . . . 0.0 111.628 -167.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.0 91.3 2.5 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.111 1.364 . . . . 0.0 110.947 173.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -63.85 -17.31 63.02 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -65.18 -51.5 49.53 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 125.394 1.473 . . . . 0.0 115.155 -174.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 29.0 mtmt -126.11 22.92 7.19 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 125.73 1.612 . . . . 0.0 112.852 -172.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 20.9 m120 62.45 49.54 4.04 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.661 1.984 . . . . 0.0 113.621 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . 0.281 0.0 OUTLIER -128.78 172.51 11.21 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 177.157 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -157.54 163.24 38.59 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 127.095 2.158 . . . . 0.0 109.614 -175.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.528 ' CD2' HG21 ' A' ' 60' ' ' VAL . 5.2 m-30 -107.84 154.59 21.33 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.98 1.312 . . . . 0.0 107.887 162.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.0 tt -134.51 123.82 43.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 124.404 1.082 . . . . 0.0 108.636 164.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -121.19 122.36 39.81 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.539 1.936 . . . . 0.0 111.769 -165.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.42 ' HE2' HG22 ' A' ' 85' ' ' VAL . 0.6 OUTLIER -137.98 150.29 46.87 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 113.041 -1.891 . . . . 0.0 113.249 -164.721 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.424 ' CG ' ' HB3' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -68.98 -18.87 64.12 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 113.038 -1.892 . . . . 0.0 114.385 -155.587 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.405 HG23 ' CG ' ' A' ' 102' ' ' ASN . 30.2 p -138.54 141.47 39.3 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 123.32 1.533 . . . . 0.0 112.08 -175.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -57.54 -37.31 72.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 113.769 -1.559 . . . . 0.0 110.75 176.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -72.59 -41.39 65.69 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.05 -52.56 62.79 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 119.231 0.923 . . . . 0.0 110.02 170.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.63 -36.87 79.21 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -178.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -55.77 -50.83 69.36 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 118.83 0.741 . . . . 0.0 110.506 170.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -63.66 -35.33 80.19 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-O 118.19 -0.909 . . . . 0.0 111.178 174.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 8.5 ttp -66.93 -51.14 58.88 Favored 'General case' 0 C--N 1.343 0.291 0 CA-C-N 119.747 1.158 . . . . 0.0 110.802 -176.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.41 -39.58 85.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 124.673 1.189 . . . . 0.0 111.761 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -70.22 -45.15 67.16 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.472 0.709 . . . . 0.0 110.942 177.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -50.62 -33.88 23.94 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.678 1.191 . . . . 0.0 112.556 167.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -92.12 -11.74 34.85 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 119.929 -1.732 . . . . 0.0 113.619 -177.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.2 t -86.13 -14.39 44.32 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.964 0.887 . . . . 0.0 111.629 165.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.29 -58.76 3.1 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 128.448 2.699 . . . . 0.0 111.449 167.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -92.27 -49.33 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 123.709 0.804 . . . . 0.0 112.736 -155.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.6 m 45.68 125.9 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.04 0 C-N-CA 130.493 3.517 . . . . 0.0 113.701 -152.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -77.02 -13.88 17.16 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 121.775 1.65 . . . . 0.0 115.76 -171.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.1 t 30.11 92.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 130.032 3.333 . . . . 0.0 114.36 175.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.471 ' C ' HD23 ' A' ' 121' ' ' LEU . 1.4 tt -102.92 -57.31 2.07 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 113.489 -1.687 . . . . 0.0 109.419 -131.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.91 6.71 43.48 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.992 1.717 . . . . 0.0 113.61 165.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 103.23 20.54 11.02 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 126.061 1.791 . . . . 0.0 115.127 -178.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.419 ' HA ' ' HD3' ' A' ' 125' ' ' PRO . 10.8 tp60 -146.71 142.06 16.83 Favored Pre-proline 0 CA--C 1.538 0.489 0 CA-C-O 116.706 -1.616 . . . . 0.0 110.245 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 124' ' ' GLN . 78.5 Cg_exo -52.18 147.35 27.94 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 124.636 3.557 . . . . 0.0 116.115 -167.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.423 HD11 ' H ' ' A' ' 121' ' ' LEU . 3.2 mm -117.93 153.01 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 126.653 1.981 . . . . 0.0 108.629 -177.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 20.0 m-30 -122.54 142.37 50.67 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.979 0.912 . . . . 0.0 110.209 -175.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -131.88 147.88 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.019 1.327 . . . . 0.0 111.628 172.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -147.52 162.54 38.87 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.836 0.854 . . . . 0.0 109.977 145.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -53.35 147.68 10.06 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.47 0.708 . . . . 0.0 112.171 168.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.662 ' HB3' HG13 ' A' ' 60' ' ' VAL . 29.2 t -74.68 133.89 42.04 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 121.486 -0.758 . . . . 0.0 112.215 178.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -67.95 -19.87 65.0 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 176.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -69.59 -52.28 27.53 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -177.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 16.4 mtmm 79.15 152.65 0.13 Allowed 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 128.739 2.816 . . . . 0.0 111.461 -149.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 36.29 95.59 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 129.389 3.076 . . . . 0.0 117.258 164.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 27.6 tp -64.58 110.32 2.29 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.03 1.732 . . . . 0.0 111.596 172.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -97.74 141.7 30.42 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.239 1.416 . . . . 0.0 110.537 172.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 46.2 p -137.11 154.47 50.28 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.457 1.503 . . . . 0.0 111.641 -173.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -75.91 -65.26 0.93 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.171 0.988 . . . . 0.0 113.278 -170.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 37.3 p -74.99 159.92 31.19 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.6 1.56 . . . . 0.0 113.705 -177.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 67.9 p -78.67 161.07 70.67 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 124.805 1.242 . . . . 0.0 112.104 169.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -57.1 -47.02 24.74 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 123.472 2.782 . . . . 0.0 113.689 174.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -158.68 145.96 17.67 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.797 1.639 . . . . 0.0 111.197 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -81.0 94.55 6.58 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.27 1.028 . . . . 0.0 110.038 166.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -64.78 165.15 10.97 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -178.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 . . . . . 0 N--CA 1.475 0.788 0 C-N-CA 125.921 1.688 . . . . 0.0 111.974 174.143 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 147' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.338 0 O4'-C1'-N19 110.973 2.773 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 148' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.462 0 O4'-C1'-N19 111.324 3.124 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 149' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.142 0 N19-C1'-C2' 107.688 -3.57 . 0.165 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 150' ' ' ' U' . . . . . 0.402 " C1'" HD11 ' A' ' 89' ' ' LEU . . . . . . . . 0 O4'--C4' 1.415 -3.203 1 O4'-C1'-N19 112.941 4.741 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 151' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.536 2.032 0 C5'-C4'-C3' 109.553 -3.964 . 0.204 1t . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 152' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.534 1.883 1 O4'-C1'-N19 113.361 5.161 . 0.742 2u . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.549 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -69.95 166.92 18.57 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.656 1.182 . . . . 0.0 113.735 175.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.8 m -142.19 155.54 45.29 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.124 1.77 . . . . 0.0 111.17 174.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -138.07 -62.94 0.57 Allowed 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.81 1.244 . . . . 0.0 113.795 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.8 m -65.36 -14.75 61.55 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 116.772 2.138 . . . . 0.0 116.772 -164.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.594 ' HB1' ' HB3' ' A' ' 57' ' ' PRO . . . -134.77 -63.64 0.69 Allowed 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 119.592 1.087 . . . . 0.0 112.791 -171.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 93.01 63.16 1.1 Allowed Glycine 0 N--CA 1.472 1.066 0 C-N-CA 124.476 1.036 . . . . 0.0 112.777 174.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 42.7 t 46.19 72.19 1.33 Allowed Pre-proline 0 N--CA 1.479 0.996 0 C-N-CA 127.598 2.359 . . . . 0.0 110.632 -170.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.594 ' HB3' ' HB1' ' A' ' 54' ' ' ALA . 2.7 Cg_endo -91.41 170.7 3.08 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 124.763 3.642 . . . . 0.0 113.979 -155.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 25.1 m -140.35 -84.83 0.22 Allowed 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -164.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 25.1 mtp180 -125.86 -16.4 5.66 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 118.05 2.611 . . . . 0.0 118.05 -159.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.748 HG13 ' HB3' ' A' ' 131' ' ' SER 0.328 7.1 p -105.59 136.58 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 CA-C-N 121.138 1.79 . . . . 0.0 112.002 166.13 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.4 mt -113.41 155.33 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 128.773 2.829 . . . . 0.0 108.06 171.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -122.33 135.44 54.72 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.358 1.463 . . . . 0.0 110.377 177.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.4 mt -120.85 117.15 52.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 126.736 2.014 . . . . 0.0 109.291 -174.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.0 ptt180 -98.26 177.25 5.44 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 126.083 1.753 . . . . 0.0 112.917 177.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 59.63 25.9 14.87 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 127.192 2.197 . . . . 0.0 114.623 175.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 26.2 mt -64.45 150.94 92.53 Favored Pre-proline 0 CA--C 1.56 1.329 0 C-N-CA 122.927 0.491 . . . . 0.0 111.244 176.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -45.91 -66.52 0.15 Allowed 'Trans proline' 0 C--N 1.352 0.751 1 C-N-CA 125.313 4.009 . . . . 0.0 115.124 -178.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 12.4 pt -159.73 -41.87 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 130.177 3.391 . . . . 0.0 109.968 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -154.21 -11.48 0.14 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.949 1.3 . . . . 0.0 113.072 -169.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.512 HG22 ' H ' ' A' ' 71' ' ' THR 0.295 14.4 p 31.29 -121.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 127.099 2.16 . . . . 0.0 111.296 -161.225 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.512 ' H ' HG22 ' A' ' 70' ' ' VAL . 1.1 t -151.29 133.94 15.6 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 126.395 1.878 . . . . 0.0 106.439 155.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -69.28 -20.99 63.91 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.059 -1.026 . . . . 0.0 113.041 -173.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -58.6 -33.6 72.82 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 125.182 1.372 . . . . 0.0 113.665 164.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -75.58 -40.87 55.98 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 121.232 -1.158 . . . . 0.0 111.798 170.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.1 t -57.11 -46.15 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -84.73 -24.56 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 O-C-N 120.534 -1.354 . . . . 0.0 114.52 175.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.0 t -60.79 -31.97 71.33 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 120.187 1.358 . . . . 0.0 110.764 166.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 15.6 mt -74.22 -31.02 62.45 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 171.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -85.72 -19.25 58.45 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-N 119.438 1.017 . . . . 0.0 115.141 178.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.0 mt -70.27 -33.14 3.12 Favored Pre-proline 0 CA--C 1.541 0.605 0 N-CA-C 118.016 2.599 . . . . 0.0 118.016 -165.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -60.25 1.15 0.52 Allowed 'Trans proline' 0 C--N 1.35 0.605 0 C-N-CA 123.646 2.898 . . . . 0.0 116.809 170.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.42 ' CG ' ' HG3' ' A' ' 110' ' ' MET . 33.8 m-85 -116.02 -44.17 2.93 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -167.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -148.14 -108.7 0.51 Allowed Glycine 0 C--N 1.338 0.683 0 C-N-CA 123.873 0.749 . . . . 0.0 111.855 174.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 37.0 tptt -144.49 -12.98 0.59 Allowed 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 178.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.443 HG22 ' CE ' ' A' ' 101' ' ' MET 0.355 1.4 t 45.63 79.71 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 128.577 2.751 . . . . 0.0 114.553 164.914 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.1 m -66.01 -43.34 87.99 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 129.798 3.239 . . . . 0.0 111.811 -168.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -138.32 170.57 15.8 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 122.993 1.378 . . . . 0.0 113.362 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -146.63 173.27 12.49 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.153 2.181 . . . . 0.0 110.827 159.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.464 ' C ' HD23 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -150.59 156.51 41.52 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.45 1.9 . . . . 0.0 109.495 176.003 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 8.1 mtt -129.32 110.56 12.03 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.605 1.162 . . . . 0.0 113.2 -178.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -77.29 97.87 4.99 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.407 1.883 . . . . 0.0 112.396 178.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -75.36 64.37 1.53 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.736 1.614 . . . . 0.0 111.738 167.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -143.52 -70.14 0.02 OUTLIER Glycine 0 N--CA 1.473 1.125 0 C-N-CA 124.863 1.22 . . . . 0.0 113.313 -177.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -114.5 26.6 10.09 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 127.06 2.144 . . . . 0.0 110.659 176.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 51.6 67.5 0.95 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.795 2.038 . . . . 0.0 113.043 -173.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.64 -178.47 4.38 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 177.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -155.17 164.22 39.13 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.72 2.408 . . . . 0.0 110.118 178.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.472 ' CD2' HG21 ' A' ' 60' ' ' VAL . 5.2 m-30 -107.78 150.23 27.24 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.423 1.489 . . . . 0.0 108.146 161.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 19.2 tt -132.87 119.75 38.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.938 1.295 . . . . 0.0 108.356 165.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -121.47 133.55 55.05 Favored 'General case' 0 CA--C 1.513 -0.454 0 C-N-CA 125.947 1.699 . . . . 0.0 110.84 -165.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.443 ' CE ' HG22 ' A' ' 85' ' ' VAL 0.287 1.3 ptm -137.66 159.41 42.06 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 117.188 2.292 . . . . 0.0 117.188 -169.935 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.4 -18.07 64.37 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 127.035 2.134 . . . . 0.0 112.726 -165.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.11 143.59 34.4 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-O 123.504 1.621 . . . . 0.0 111.86 178.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -66.71 -32.93 74.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 113.492 -1.685 . . . . 0.0 110.762 177.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -72.56 -37.82 68.13 Favored 'General case' 0 N--CA 1.462 0.13 0 C-N-CA 123.763 0.825 . . . . 0.0 113.024 177.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -57.12 -59.25 5.37 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 119.033 0.833 . . . . 0.0 109.62 169.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.45 -39.41 87.47 Favored 'General case' 0 C--O 1.224 -0.26 0 N-CA-C 114.752 1.389 . . . . 0.0 114.752 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -56.01 -51.05 69.14 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.475 -0.766 . . . . 0.0 111.047 172.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -63.65 -32.3 73.73 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.536 -0.727 . . . . 0.0 111.231 175.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.42 ' HG3' ' CG ' ' A' ' 82' ' ' PHE . 5.1 ttp -71.01 -49.05 49.39 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.083 1.353 . . . . 0.0 111.13 -176.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -64.97 -40.17 88.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 124.43 1.092 . . . . 0.0 111.23 178.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -67.58 -46.3 73.06 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.798 0.839 . . . . 0.0 110.196 177.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -49.37 -41.72 39.94 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.18 1.392 . . . . 0.0 112.279 168.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.506 ' HA ' HG12 ' A' ' 117' ' ' VAL . 25.4 m-85 -88.85 -11.46 44.67 Favored 'General case' 0 C--O 1.232 0.166 0 O-C-N 120.405 -1.435 . . . . 0.0 112.996 -176.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 70.6 m -81.04 -17.82 48.88 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.095 0.958 . . . . 0.0 110.195 167.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.62 -57.89 2.71 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 129.189 2.995 . . . . 0.0 113.294 176.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.506 HG12 ' HA ' ' A' ' 114' ' ' TYR . 5.9 p -79.44 -37.65 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -149.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.425 ' HA ' ' HD3' ' A' ' 119' ' ' PRO . 0.2 OUTLIER 12.09 112.71 0.0 OUTLIER Pre-proline 0 N--CA 1.484 1.268 0 C-N-CA 130.095 3.358 . . . . 0.0 116.396 -137.86 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.441 ' HD2' HD12 ' A' ' 126' ' ' ILE . 5.0 Cg_exo -79.38 -20.37 9.7 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.979 3.119 . . . . 0.0 113.684 -168.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 6.9 t 64.29 99.98 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 128.742 2.817 . . . . 0.0 112.659 176.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 6.2 tt -70.61 -75.3 0.12 Allowed 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -155.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -92.08 -44.36 8.88 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.908 1.283 . . . . 0.0 109.512 175.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -177.35 18.61 0.04 OUTLIER Glycine 0 CA--C 1.538 1.472 0 C-N-CA 126.192 1.853 . . . . 0.0 112.948 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -144.39 156.8 57.06 Favored Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 126.67 1.988 . . . . 0.0 110.766 -170.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -59.58 164.16 11.78 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 122.502 2.135 . . . . 0.0 113.815 -179.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.441 HD12 ' HD2' ' A' ' 119' ' ' PRO . 0.4 OUTLIER -127.47 149.24 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.125 1.37 . . . . 0.0 110.018 -178.805 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -130.1 95.73 4.0 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.007 -153.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -108.28 144.64 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 124.134 0.974 . . . . 0.0 112.844 -177.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -145.17 159.01 43.66 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.632 1.973 . . . . 0.0 109.085 154.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -54.6 155.32 4.18 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 121.262 -0.899 . . . . 0.0 111.733 165.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.748 ' HB3' HG13 ' A' ' 60' ' ' VAL . 27.1 t -79.25 148.96 32.0 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 177.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -61.08 -31.07 70.74 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.404 1.481 . . . . 0.0 112.945 167.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 57.3 m-70 -89.33 -18.83 26.14 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.767 1.227 . . . . 0.0 113.407 -176.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . 0.28 62.6 pttt 48.94 9.07 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 130.181 3.392 . . . . 0.0 118.205 177.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.598 ' N ' HG12 ' A' ' 60' ' ' VAL . 59.9 tt0 -164.98 124.94 1.89 Allowed 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 128.973 2.909 . . . . 0.0 110.463 172.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 22.7 tp -106.86 106.27 16.71 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.682 1.993 . . . . 0.0 110.857 -178.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt -131.17 84.26 2.17 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.791 1.636 . . . . 0.0 109.269 173.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 23.9 p -54.28 -36.84 64.08 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 126.664 1.986 . . . . 0.0 115.987 -159.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -128.94 5.74 5.43 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.537 1.535 . . . . 0.0 114.215 -173.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.3 t -69.12 154.87 41.34 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -168.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 68.6 m -69.13 168.57 15.06 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 127.726 2.41 . . . . 0.0 113.557 177.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -65.48 -177.2 0.64 Allowed 'Trans proline' 0 CA--C 1.547 1.154 0 C-N-CA 123.094 2.529 . . . . 0.0 111.801 158.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -65.59 74.1 0.06 Allowed 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 126.524 1.929 . . . . 0.0 113.841 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -65.87 166.88 10.43 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.09 1.756 . . . . 0.0 112.79 174.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -141.82 -39.63 0.37 Allowed 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 -173.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? . . . . . 0 N--CA 1.484 1.253 0 C-N-CA 126.217 1.807 . . . . 0.0 113.441 -177.685 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 147' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.263 0 O5'-C5'-C4' 113.62 2.443 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 148' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.492 1 O4'-C1'-N19 112.364 4.164 . 0.014 4p . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 149' ' ' ' C' . . . . . 0.42 ' N3 ' ' HA ' ' A' ' 131' ' ' SER . . . . . . . . 0 C5'--C4' 1.541 2.404 0 N19-C1'-C2' 107.756 -3.527 . 0.087 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 150' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.85 1 O4'-C1'-N19 113.876 5.676 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 151' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.148 1 O4'-C1'-N19 113.362 5.162 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 152' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.543 2.515 1 O4'-C1'-N19 113.89 5.69 . 0.532 4s . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.447 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -62.1 139.61 58.44 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.431 1.092 . . . . 0.0 112.581 176.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 79.2 p -142.41 -8.76 0.86 Allowed 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 -173.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.1 ptp85 -66.72 161.48 23.42 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.599 1.16 . . . . 0.0 113.813 -177.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 98.4 p -160.63 154.66 22.89 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.198 1.799 . . . . 0.0 110.85 159.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.531 ' HB1' ' HB3' ' A' ' 57' ' ' PRO . . . -158.09 -170.51 3.17 Favored 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 128.481 2.713 . . . . 0.0 107.629 167.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -137.1 67.08 0.54 Allowed Glycine 0 N--CA 1.471 1.015 0 O-C-N 120.322 -1.486 . . . . 0.0 111.639 -176.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . 0.276 13.6 p 35.15 69.48 1.08 Allowed Pre-proline 0 N--CA 1.484 1.234 0 C-N-CA 127.343 2.257 . . . . 0.0 111.294 -163.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.531 ' HB3' ' HB1' ' A' ' 54' ' ' ALA . 7.0 Cg_endo -91.52 164.1 3.53 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 123.318 2.679 . . . . 0.0 113.887 -138.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 58.2 m -134.88 -82.33 0.43 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 -165.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 25.2 mtp180 -124.19 -11.48 7.49 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 116.432 2.012 . . . . 0.0 116.432 -160.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.703 HG13 ' HB3' ' A' ' 131' ' ' SER 0.293 3.6 p -110.89 137.57 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 119.815 1.188 . . . . 0.0 112.162 172.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.0 mt -119.55 142.03 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 127.923 2.489 . . . . 0.0 108.369 175.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -112.51 148.39 34.56 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.937 1.695 . . . . 0.0 111.222 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 mp -133.12 138.98 50.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 126.227 1.811 . . . . 0.0 109.854 -176.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.67 176.61 5.11 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 125.6 1.56 . . . . 0.0 111.87 169.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.475 ' HG3' ' CD1' ' A' ' 127' ' ' TYR . 21.9 mmmt 73.98 8.64 4.76 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 127.015 2.126 . . . . 0.0 115.003 165.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.638 HD22 HG11 ' A' ' 70' ' ' VAL . 0.6 OUTLIER -62.74 159.82 41.16 Favored Pre-proline 0 CA--C 1.546 0.804 0 CA-C-N 119.181 0.9 . . . . 0.0 112.937 -176.925 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -51.72 173.75 0.09 OUTLIER 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 124.385 3.39 . . . . 0.0 115.087 163.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 36.4 pt -60.95 -34.55 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 127.065 2.146 . . . . 0.0 113.221 -167.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -140.01 -10.59 1.14 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.822 1.649 . . . . 0.0 113.485 166.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.638 HG11 HD22 ' A' ' 66' ' ' LEU 0.298 3.8 p 38.98 -139.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 127.599 2.359 . . . . 0.0 111.87 -169.151 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.449 ' H ' HG22 ' A' ' 70' ' ' VAL . 1.7 t -147.97 139.54 23.74 Favored 'General case' 0 C--O 1.239 0.519 0 O-C-N 120.803 -1.185 . . . . 0.0 109.931 154.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -55.93 -32.63 63.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.621 173.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -61.28 -32.53 81.1 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 125.05 1.31 . . . . 0.0 112.871 175.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -67.19 -55.41 14.21 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 118.725 1.263 . . . . 0.0 110.648 167.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 19.2 t -57.66 -44.83 86.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -175.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.3 pp -81.33 -29.16 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 O-C-N 120.313 -1.492 . . . . 0.0 113.871 -179.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 18.1 t -63.75 -29.36 70.58 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 119.61 1.096 . . . . 0.0 110.55 168.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.0 mt -78.72 -20.69 49.45 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 114.182 1.178 . . . . 0.0 114.182 172.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -101.45 -16.55 24.41 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-N 119.859 1.209 . . . . 0.0 116.116 176.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.9 mt -61.55 -52.57 68.76 Favored Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 117.171 2.286 . . . . 0.0 117.171 -172.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -75.2 39.52 0.61 Allowed 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 124.125 3.217 . . . . 0.0 113.974 -178.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -127.84 -36.65 1.99 Allowed 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 126.87 2.068 . . . . 0.0 111.902 177.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -152.76 -108.84 0.38 Allowed Glycine 0 CA--C 1.525 0.717 0 CA-C-O 122.774 1.208 . . . . 0.0 111.989 168.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 15.6 tptm -149.23 132.01 16.01 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 131.625 3.97 . . . . 0.0 103.726 173.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.58 HG22 ' HE2' ' A' ' 101' ' ' MET 0.313 14.3 t -128.1 92.56 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-N 120.666 1.576 . . . . 0.0 110.773 -163.666 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.5 t -80.82 -32.75 35.09 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 126.727 2.011 . . . . 0.0 112.825 -161.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -130.74 160.53 34.06 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 174.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -147.19 167.83 23.21 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 126.963 2.105 . . . . 0.0 110.102 166.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.52 ' C ' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -149.76 152.09 34.67 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 125.288 1.435 . . . . 0.0 108.969 173.709 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 5.8 mtt -126.93 110.4 12.97 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.406 1.483 . . . . 0.0 110.267 177.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.488 HD22 ' CD1' ' A' ' 89' ' ' LEU . 2.8 mm? -72.1 79.65 0.95 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.62 1.168 . . . . 0.0 110.178 178.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -44.69 -47.97 10.63 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 127.549 2.339 . . . . 0.0 114.445 -168.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -79.79 -12.16 83.84 Favored Glycine 0 CA--C 1.535 1.317 0 N-CA-C 116.31 1.284 . . . . 0.0 116.31 -174.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -126.66 3.04 6.79 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 -173.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.0 m120 58.94 36.1 24.39 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.187 1.395 . . . . 0.0 113.918 -178.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -111.2 176.13 5.15 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.519 0.727 . . . . 0.0 111.095 175.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -158.03 167.36 30.11 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.708 1.603 . . . . 0.0 111.928 176.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.451 ' CD2' HG21 ' A' ' 60' ' ' VAL . 4.8 m-30 -118.72 152.62 35.81 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.966 2.106 . . . . 0.0 108.118 163.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 14.4 tt -135.41 127.19 46.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 124.778 1.231 . . . . 0.0 108.669 163.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -130.98 121.1 24.49 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.252 1.421 . . . . 0.0 112.929 -163.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.58 ' HE2' HG22 ' A' ' 85' ' ' VAL . 1.0 OUTLIER -129.22 162.62 27.43 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.12 -1.4 . . . . 0.0 113.696 -159.479 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.35 -12.57 60.09 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -158.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -143.18 142.47 31.45 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.177 1.391 . . . . 0.0 110.879 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -61.46 -33.41 73.7 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.742 175.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -75.74 -36.04 60.03 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 123.641 0.776 . . . . 0.0 112.987 178.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -56.82 -52.08 66.45 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-N 118.973 0.806 . . . . 0.0 110.642 168.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.94 -39.16 79.73 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -54.93 -48.41 73.16 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 118.754 0.706 . . . . 0.0 111.255 170.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -64.77 -32.5 74.22 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 121.242 -0.911 . . . . 0.0 111.46 175.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 7.5 ttp -65.86 -57.63 7.47 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.467 1.107 . . . . 0.0 109.686 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -57.97 -41.65 80.72 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.372 0 C-N-CA 124.95 1.3 . . . . 0.0 111.607 177.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -65.43 -42.9 91.94 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 118.897 0.771 . . . . 0.0 111.924 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -53.92 -37.43 63.83 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 118.61 0.641 . . . . 0.0 112.037 167.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.681 ' HA ' HG12 ' A' ' 117' ' ' VAL . 34.2 m-85 -85.73 -13.88 47.0 Favored 'General case' 0 C--N 1.332 -0.182 0 O-C-N 120.263 -1.523 . . . . 0.0 113.192 -178.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 54.8 m -84.79 -15.62 44.3 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.144 1.377 . . . . 0.0 110.307 169.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.28 -49.04 11.22 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 128.464 2.706 . . . . 0.0 111.26 172.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.681 HG12 ' HA ' ' A' ' 114' ' ' TYR . 0.5 OUTLIER -94.97 178.82 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 127.556 2.342 . . . . 0.0 111.754 -165.726 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.409 ' CA ' HG13 ' A' ' 117' ' ' VAL . 1.1 m -137.91 130.06 16.31 Favored Pre-proline 0 N--CA 1.477 0.876 0 O-C-N 120.985 -1.072 . . . . 0.0 109.212 129.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -83.44 -16.85 6.7 Favored 'Trans proline' 0 CA--C 1.547 1.157 0 C-N-CA 122.667 2.245 . . . . 0.0 112.753 -167.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 14.3 t 58.36 99.37 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 129.759 3.224 . . . . 0.0 113.498 177.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.6 tt -67.1 -62.6 1.35 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.285 1.034 . . . . 0.0 112.4 -156.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -125.56 4.41 7.57 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 126.722 2.009 . . . . 0.0 114.566 -179.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 124.5 9.26 5.51 Favored Glycine 0 CA--C 1.539 1.565 0 C-N-CA 125.119 1.342 . . . . 0.0 114.725 -160.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -139.66 144.33 38.74 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 126.854 2.061 . . . . 0.0 109.658 -176.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.99 166.23 7.29 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 123.576 2.851 . . . . 0.0 112.966 175.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -127.67 145.01 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.165 0.986 . . . . 0.0 111.056 -173.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.475 ' CD1' ' HG3' ' A' ' 65' ' ' LYS . 3.6 m-85 -126.26 79.66 1.86 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.105 -1.407 . . . . 0.0 109.441 -153.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -91.1 149.81 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 124.514 1.125 . . . . 0.0 112.688 178.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -145.37 159.42 43.09 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 128.235 2.614 . . . . 0.0 108.159 161.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -55.98 155.49 6.25 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 120.437 -1.415 . . . . 0.0 111.368 154.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.703 ' HB3' HG13 ' A' ' 60' ' ' VAL . 31.0 t -71.03 158.33 36.69 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.473 -0.767 . . . . 0.0 112.167 172.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -65.29 -11.76 44.83 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.857 1.263 . . . . 0.0 112.861 163.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 40.5 m-70 -116.05 -179.15 3.58 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 127.675 2.39 . . . . 0.0 110.726 -175.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -125.4 4.26 7.69 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 125.525 1.53 . . . . 0.0 114.4 -172.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -176.36 164.79 2.68 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 128.3 2.64 . . . . 0.0 109.111 -170.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 23.9 tp -137.15 91.87 2.66 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.035 1.734 . . . . 0.0 111.482 -174.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.7 91.48 6.54 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.436 1.095 . . . . 0.0 110.493 172.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 10.0 p -75.28 94.05 2.96 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.847 1.259 . . . . 0.0 109.933 173.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -55.12 -37.1 66.47 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 115.208 1.559 . . . . 0.0 115.208 -167.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 98.5 p -157.31 177.16 11.77 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.898 1.679 . . . . 0.0 111.936 176.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 66.9 m -110.93 143.18 27.76 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 124.947 1.299 . . . . 0.0 111.26 175.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -68.02 125.13 12.64 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 123.356 2.704 . . . . 0.0 112.024 -178.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -137.6 166.77 23.11 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.29 1.836 . . . . 0.0 111.113 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -135.39 166.03 24.11 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 126.019 1.727 . . . . 0.0 112.516 178.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -64.91 -25.64 67.97 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.729 1.612 . . . . 0.0 114.474 -179.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 11.8 ptm85 . . . . . 0 N--CA 1.476 0.835 0 C-N-CA 126.756 2.022 . . . . 0.0 112.127 176.137 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 147' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.406 0 C5'-C4'-C3' 110.635 -3.244 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 148' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.376 1 O4'-C1'-N19 112.277 4.077 . 0.024 2[ . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 149' ' ' ' C' . . . . . 0.422 ' N3 ' ' HA ' ' A' ' 131' ' ' SER . . . . . . . . 0 O4'--C4' 1.423 -2.508 0 N19-C1'-C2' 107.875 -3.453 . 0.056 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 150' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.167 2 O4'-C1'-N19 114.123 5.923 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 151' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.535 1.924 0 O4'-C1'-N19 111.735 3.535 . 0.092 1b . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 152' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.547 2.859 0 O5'-C5'-C4' 114.4 3.0 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.595 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -125.45 -3.43 7.34 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.663 1.585 . . . . 0.0 114.909 -174.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 79.7 p -87.33 177.98 6.98 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.446 1.898 . . . . 0.0 113.531 178.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -137.04 136.37 38.35 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 126.8 2.04 . . . . 0.0 110.725 177.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.7 m -63.13 -65.09 0.73 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.302 1.441 . . . . 0.0 114.68 -167.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.622 ' HB1' ' HB3' ' A' ' 57' ' ' PRO . . . -102.94 86.96 2.82 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.823 1.249 . . . . 0.0 111.621 178.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -82.94 -25.13 50.57 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 123.325 0.488 . . . . 0.0 113.917 170.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.9 p -161.21 72.43 2.62 Favored Pre-proline 0 N--CA 1.479 1.01 0 C-N-CA 126.875 2.07 . . . . 0.0 110.637 178.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.622 ' HB3' ' HB1' ' A' ' 54' ' ' ALA . 0.4 OUTLIER -93.5 -144.56 0.02 OUTLIER 'Trans proline' 0 CA--C 1.547 1.148 0 C-N-CA 124.702 3.602 . . . . 0.0 113.331 -159.57 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 44.3 t -144.45 177.69 8.47 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.564 1.545 . . . . 0.0 112.947 -169.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.44 -2.14 18.37 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.585 1.154 . . . . 0.0 113.596 167.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.693 HG13 ' HB3' ' A' ' 131' ' ' SER 0.312 7.4 p -85.11 131.11 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 119.396 0.998 . . . . 0.0 111.628 163.796 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.0 mt -110.72 144.99 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 127.785 2.434 . . . . 0.0 107.769 169.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.438 ' CD2' ' C6 ' ' B' ' 149' ' ' ' C' . 2.1 t-80 -108.21 150.49 27.19 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.993 1.317 . . . . 0.0 110.529 172.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 7.5 mt -127.56 142.27 44.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 125.888 1.675 . . . . 0.0 109.093 -173.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.26 170.06 11.14 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 128.579 2.752 . . . . 0.0 109.223 164.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.57 20.29 12.1 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.617 1.167 . . . . 0.0 113.989 176.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 37.5 mt -64.01 167.7 7.36 Favored Pre-proline 0 CA--C 1.542 0.673 0 C-N-CA 123.474 0.71 . . . . 0.0 110.908 162.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -54.41 172.29 0.33 Allowed 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.934 2.423 . . . . 0.0 113.981 156.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 21.7 pt -80.98 -18.6 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 127.614 2.366 . . . . 0.0 113.332 -179.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -144.97 12.17 1.41 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 127.347 2.259 . . . . 0.0 113.281 -164.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -55.22 151.37 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.8 t -101.27 148.54 25.0 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 122.398 1.094 . . . . 0.0 113.281 -173.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -50.45 -44.24 55.5 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.217 1.407 . . . . 0.0 111.432 174.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -58.36 -35.1 77.39 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 123.852 0.739 . . . . 0.0 113.349 -179.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -74.7 -44.04 52.07 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.456 1.103 . . . . 0.0 112.167 175.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 95.1 t -60.68 -51.61 71.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 123.168 0.587 . . . . 0.0 111.084 177.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.1 pp -69.12 -30.45 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 O-C-N 120.73 -1.231 . . . . 0.0 113.099 178.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 49.2 m -73.73 -16.66 61.18 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 119.288 0.949 . . . . 0.0 112.306 174.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 22.7 mt -86.44 -15.25 40.83 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.121 0.968 . . . . 0.0 113.291 165.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.439 ' HA2' ' SD ' ' A' ' 110' ' ' MET . . . -75.88 -33.09 51.81 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 124.311 0.958 . . . . 0.0 113.241 168.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 16.5 mt -80.22 -16.83 0.24 Allowed Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 119.923 3.305 . . . . 0.0 119.923 -159.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -61.07 -4.61 3.96 Favored 'Trans proline' 0 C--N 1.347 0.493 0 CA-C-N 122.919 2.078 . . . . 0.0 116.474 169.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.514 ' CD2' ' HG3' ' A' ' 110' ' ' MET . 34.2 m-85 -120.6 -43.66 2.48 Favored 'General case' 0 C--N 1.34 0.195 0 N-CA-C 115.123 1.527 . . . . 0.0 115.123 -166.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -142.38 -118.36 1.37 Allowed Glycine 0 CA--C 1.525 0.706 0 CA-C-O 122.648 1.138 . . . . 0.0 112.555 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.41 ' HB3' ' CG ' ' A' ' 102' ' ' ASN . 15.2 tptm -148.03 122.24 9.57 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 130.45 3.5 . . . . 0.0 104.363 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.431 HG22 ' HE2' ' A' ' 101' ' ' MET 0.28 19.6 t -130.36 82.49 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 CA-C-O 122.778 1.275 . . . . 0.0 109.213 -159.515 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 41.5 p -79.86 -16.4 55.47 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 127.433 2.293 . . . . 0.0 112.725 -163.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -142.17 158.3 43.9 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 173.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.24 170.23 16.69 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.693 2.397 . . . . 0.0 110.34 167.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.496 ' C ' HD23 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -148.49 155.12 40.75 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.184 0.994 . . . . 0.0 109.805 174.18 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 4.0 mtp -132.55 94.15 3.36 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.353 0.661 . . . . 0.0 111.355 -168.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.07 66.74 1.66 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.57 1.148 . . . . 0.0 110.505 170.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 53.9 tttm -55.79 -34.38 65.24 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.538 1.535 . . . . 0.0 113.579 -169.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -64.18 -16.86 60.67 Favored Glycine 0 CA--C 1.54 1.603 0 C-N-CA 125.538 1.542 . . . . 0.0 116.075 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 18.9 mtmt -124.53 7.26 8.27 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.123 1.369 . . . . 0.0 114.216 -176.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.5 m120 58.92 34.03 23.39 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.786 1.235 . . . . 0.0 112.095 -168.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -117.87 164.47 15.0 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.723 0.809 . . . . 0.0 111.985 -175.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -158.06 168.98 25.6 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.684 1.593 . . . . 0.0 111.662 -179.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.456 ' CD2' HG21 ' A' ' 60' ' ' VAL . 5.5 m-30 -114.8 157.76 22.8 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.105 1.762 . . . . 0.0 108.42 160.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 19.8 tt -140.45 122.06 14.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 125.084 1.354 . . . . 0.0 109.129 163.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -119.3 125.73 49.79 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 127.242 2.217 . . . . 0.0 111.253 -169.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.431 ' HE2' HG22 ' A' ' 85' ' ' VAL . 0.3 OUTLIER -128.87 160.06 33.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 113.276 -1.784 . . . . 0.0 114.129 -167.519 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.475 ' CG ' HG23 ' A' ' 103' ' ' THR . 0.0 OUTLIER -71.81 -20.44 61.84 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 -163.343 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.475 HG23 ' CG ' ' A' ' 102' ' ' ASN . 8.3 p -138.45 137.73 37.47 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.128 1.371 . . . . 0.0 110.988 -174.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -59.25 -34.67 72.5 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.199 175.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -73.27 -40.05 64.91 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.99 -52.52 63.9 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-N 119.491 1.041 . . . . 0.0 109.552 168.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.71 -37.1 79.25 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 -175.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -56.12 -52.23 65.06 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.779 0.718 . . . . 0.0 110.684 169.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -61.33 -32.18 72.06 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 118.931 -0.557 . . . . 0.0 111.324 174.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.514 ' HG3' ' CD2' ' A' ' 82' ' ' PHE . 13.4 ttp -73.48 -50.16 22.98 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-N 119.486 1.039 . . . . 0.0 111.918 -175.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -63.14 -35.34 71.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.168 0.987 . . . . 0.0 111.107 178.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -75.65 -41.58 53.73 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.381 1.072 . . . . 0.0 112.091 176.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -48.28 -52.95 19.0 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.509 1.124 . . . . 0.0 109.989 165.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -79.88 16.12 1.25 Allowed 'General case' 0 C--N 1.326 -0.423 0 O-C-N 118.932 -2.355 . . . . 0.0 113.044 178.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . 0.289 0.5 OUTLIER -118.63 -10.32 10.06 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 164.584 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.478 ' CB ' HG23 ' A' ' 117' ' ' VAL . 0.4 OUTLIER -85.01 -43.05 14.31 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.273 1.829 . . . . 0.0 111.413 161.25 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.478 HG23 ' CB ' ' A' ' 116' ' ' SER . 89.6 t -115.12 -57.9 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.386 1.074 . . . . 0.0 111.856 -144.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.0 m 70.89 135.04 0.04 OUTLIER Pre-proline 0 N--CA 1.485 1.315 0 C-N-CA 128.027 2.531 . . . . 0.0 112.234 -173.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -76.26 -22.49 12.64 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.256 1.971 . . . . 0.0 114.966 -176.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.9 t 36.37 89.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 C-N-CA 129.802 3.241 . . . . 0.0 113.305 175.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.537 ' H ' HD11 ' A' ' 126' ' ' ILE . 2.4 tt -100.05 -66.09 0.93 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 113.783 -1.553 . . . . 0.0 109.597 -134.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -84.53 -9.6 58.19 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 159.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 110.34 55.42 0.53 Allowed Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.347 1.451 . . . . 0.0 113.22 -166.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -145.06 162.49 37.54 Favored Pre-proline 0 CA--C 1.541 0.631 0 CA-C-N 119.075 1.438 . . . . 0.0 112.931 156.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.34 100.22 0.15 Allowed 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 123.293 2.662 . . . . 0.0 111.973 168.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.537 HD11 ' H ' ' A' ' 121' ' ' LEU . 3.0 mm -77.75 138.24 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.303 1.041 . . . . 0.0 108.69 177.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 11.7 m-30 -109.3 128.6 55.22 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 120.674 -1.266 . . . . 0.0 110.667 -173.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.25 151.07 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.902 1.281 . . . . 0.0 111.888 178.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -158.27 160.8 37.47 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.158 1.783 . . . . 0.0 110.172 157.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -54.65 144.2 22.58 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.261 -0.899 . . . . 0.0 112.398 170.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.693 ' HB3' HG13 ' A' ' 60' ' ' VAL . 21.4 t -73.78 147.13 43.74 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.986 -0.447 . . . . 0.0 111.371 173.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 12.7 p30 -80.62 -9.24 59.8 Favored 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 113.977 1.102 . . . . 0.0 113.977 175.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -83.63 179.82 7.51 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.381 1.072 . . . . 0.0 112.608 174.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -113.06 97.25 6.4 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.794 2.038 . . . . 0.0 109.837 173.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 61.28 -174.97 0.13 Allowed 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.696 1.998 . . . . 0.0 112.558 -176.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 34.7 tp -135.14 99.36 4.24 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 126.413 1.885 . . . . 0.0 110.962 -170.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 50.8 tttp -98.55 111.51 23.85 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.719 1.608 . . . . 0.0 110.062 176.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 40.8 p -110.64 -1.58 16.72 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 126.021 1.729 . . . . 0.0 112.823 176.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -54.73 126.72 25.16 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.281 1.832 . . . . 0.0 112.692 177.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 61.0 m -136.93 170.74 15.6 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.758 2.023 . . . . 0.0 112.475 -175.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 32.0 m -59.73 154.32 47.41 Favored Pre-proline 0 N--CA 1.475 0.792 0 C-N-CA 125.097 1.359 . . . . 0.0 112.965 177.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -70.59 174.5 10.14 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 123.389 2.726 . . . . 0.0 112.728 176.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 63.99 8.99 4.27 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 126.96 2.104 . . . . 0.0 115.051 -177.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -139.27 164.34 30.08 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.854 2.062 . . . . 0.0 110.525 176.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -127.74 -172.31 2.65 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.719 1.608 . . . . 0.0 112.893 -178.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 23.4 ptt-85 . . . . . 0 N--CA 1.473 0.715 0 C-N-CA 127.374 2.27 . . . . 0.0 114.688 -178.796 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 147' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.168 0 C5'-C4'-C3' 111.247 -2.835 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 148' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.422 0 O4'-C1'-N19 111.895 3.695 . 0.0 OUTLIER alpha 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 149' ' ' ' C' . . . . . 0.438 ' C6 ' ' CD2' ' A' ' 62' ' ' HIS . . . . . . . . 0 O4'--C4' 1.425 -2.341 0 N19-C1'-C2' 107.972 -3.393 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 150' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.412 -3.38 1 O4'-C1'-N19 112.583 4.383 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 151' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 P--O5' 1.613 2.017 0 O4'-C1'-N19 110.873 2.673 . 0.0 OUTLIER '7D dist 1f' 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 152' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.278 0 O4'-C1'-N19 110.639 2.439 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.537 0 N-CA-C 111.714 -0.555 . . . . 0.0 111.714 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -122.95 65.32 0.97 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.697 1.599 . . . . 0.0 111.049 -177.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 45.5 m -70.45 150.39 46.26 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.059 1.344 . . . . 0.0 112.898 -179.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -130.2 158.97 38.25 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 126.294 1.838 . . . . 0.0 110.879 171.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.7 m -68.86 154.74 41.47 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.887 1.275 . . . . 0.0 113.002 178.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.541 ' HB3' ' HB3' ' A' ' 57' ' ' PRO . . . -73.02 -26.57 61.36 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 114.784 1.402 . . . . 0.0 114.784 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 132.66 -68.35 0.55 Allowed Glycine 0 CA--C 1.528 0.888 0 C-N-CA 125.5 1.524 . . . . 0.0 111.11 172.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.1 p -150.66 69.79 8.69 Favored Pre-proline 0 N--CA 1.477 0.895 0 C-N-CA 125.49 1.516 . . . . 0.0 110.591 169.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.541 ' HB3' ' HB3' ' A' ' 54' ' ' ALA . 0.5 OUTLIER -97.02 172.03 0.8 Allowed 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 124.368 3.379 . . . . 0.0 113.863 -158.306 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.7 t -154.64 -159.45 0.95 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.313 1.045 . . . . 0.0 113.249 179.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.2 mtp180 -54.44 -13.51 0.95 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 131.536 3.935 . . . . 0.0 118.804 -173.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.43 HG21 ' CD2' ' A' ' 98' ' ' PHE 0.269 0.1 OUTLIER -81.94 122.45 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 CA-C-N 120.885 1.675 . . . . 0.0 110.106 162.534 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.42 HD13 ' CE ' ' A' ' 110' ' ' MET . 2.0 mp -87.18 135.38 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 156.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -102.61 144.37 31.1 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.888 1.275 . . . . 0.0 110.566 174.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.2 mt -129.94 140.71 48.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 126.158 1.783 . . . . 0.0 109.862 -176.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 5.4 ptt-85 -123.74 179.15 4.91 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 126.835 2.054 . . . . 0.0 112.281 173.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 58.64 17.94 5.46 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 127.083 2.153 . . . . 0.0 114.607 178.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.6 mp -50.29 156.83 1.32 Allowed Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 125.273 1.429 . . . . 0.0 113.15 178.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -45.3 -62.55 0.43 Allowed 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 125.075 3.85 . . . . 0.0 114.776 -179.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.5 pt -163.64 -52.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 131.324 3.85 . . . . 0.0 107.723 176.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -146.3 -11.31 0.48 Allowed 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.567 1.547 . . . . 0.0 114.143 -176.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.301 2.9 p 42.4 -145.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 127.268 2.227 . . . . 0.0 112.148 -174.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.0 t -141.97 137.44 31.21 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 120.553 -1.342 . . . . 0.0 110.772 164.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -55.54 -39.35 70.45 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.367 1.067 . . . . 0.0 111.883 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.25 -38.28 56.51 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 125.111 1.339 . . . . 0.0 113.937 172.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -72.51 -48.12 43.09 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 121.449 -1.03 . . . . 0.0 112.405 174.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 26.3 t -58.63 -49.37 82.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-N 117.979 0.354 . . . . 0.0 111.701 -176.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.95 -31.43 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 O-C-N 120.86 -1.15 . . . . 0.0 114.001 177.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 48.7 m -71.42 -18.12 62.35 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 120.664 1.575 . . . . 0.0 111.433 176.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 29.6 mt -84.37 -24.17 29.8 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 167.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -86.36 -18.92 58.11 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-N 118.72 0.691 . . . . 0.0 114.168 175.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 13.0 mt -73.29 -18.1 0.34 Allowed Pre-proline 0 CA--C 1.548 0.872 0 N-CA-C 119.416 3.117 . . . . 0.0 119.416 -171.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -59.16 -2.42 1.24 Allowed 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.411 2.74 . . . . 0.0 118.083 174.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -120.83 -35.91 3.26 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 -169.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -151.73 -109.69 0.44 Allowed Glycine 0 C--N 1.337 0.638 0 CA-C-O 122.253 0.918 . . . . 0.0 112.51 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -152.89 129.08 10.46 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 129.408 3.083 . . . . 0.0 104.893 -176.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.411 ' CG2' ' CE ' ' A' ' 101' ' ' MET 0.304 11.9 t -135.24 81.92 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 120.161 1.346 . . . . 0.0 109.678 -165.562 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 58.9 p -79.64 -22.31 43.72 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 126.829 2.051 . . . . 0.0 112.436 -164.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 65.5 m-80 -136.03 156.0 49.38 Favored 'General case' 0 C--N 1.343 0.323 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 177.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -146.91 170.33 17.29 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.824 2.05 . . . . 0.0 110.044 162.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.534 ' C ' HD23 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -141.01 153.93 45.77 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.837 1.655 . . . . 0.0 109.748 175.784 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 40.0 mtt -131.22 117.29 18.8 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.062 0.945 . . . . 0.0 110.908 178.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -76.2 69.67 2.76 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.754 1.222 . . . . 0.0 110.325 175.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -56.21 105.98 0.24 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.626 1.97 . . . . 0.0 111.327 -177.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 124.03 -15.97 7.77 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 126.077 1.798 . . . . 0.0 115.052 -176.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 10.6 mtmt -118.22 -2.21 11.21 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 119.142 1.471 . . . . 0.0 114.644 178.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.3 m120 60.05 46.9 10.26 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.0 1.72 . . . . 0.0 112.398 -173.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -131.8 165.76 23.08 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.44 0.696 . . . . 0.0 112.418 -179.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -157.82 163.26 38.19 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.131 1.372 . . . . 0.0 113.001 -178.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.43 ' CD2' HG21 ' A' ' 60' ' ' VAL . 4.5 m-30 -115.91 148.2 40.27 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 128.61 2.764 . . . . 0.0 106.287 166.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 6.4 tp -134.5 106.79 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 125.854 1.662 . . . . 0.0 108.874 170.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 24.4 tp10 -102.93 109.38 20.91 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 128.602 2.761 . . . . 0.0 111.552 -167.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.411 ' CE ' ' CG2' ' A' ' 85' ' ' VAL . 16.1 ttm -107.02 158.5 17.0 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 114.095 -1.411 . . . . 0.0 112.695 -174.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.495 ' ND2' HG23 ' A' ' 103' ' ' THR . 0.0 OUTLIER -73.96 -21.23 60.1 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -163.098 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.495 HG23 ' ND2' ' A' ' 102' ' ' ASN . 1.9 p -138.15 147.43 43.89 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.805 0.842 . . . . 0.0 111.74 -175.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -64.92 -36.65 85.07 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.432 0.693 . . . . 0.0 112.15 179.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -72.35 -42.56 65.17 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 118.763 0.71 . . . . 0.0 112.817 179.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -57.73 -48.25 80.13 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 118.567 0.622 . . . . 0.0 110.071 172.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.16 -37.4 78.21 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -55.62 -51.89 65.64 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 121.339 -0.85 . . . . 0.0 110.876 169.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -64.81 -24.76 67.65 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-O 117.77 -1.109 . . . . 0.0 111.665 173.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.42 ' CE ' HD13 ' A' ' 61' ' ' ILE . 10.3 ttp -73.13 -48.51 34.92 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 120.514 1.506 . . . . 0.0 110.227 -178.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -65.56 -37.78 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 O-C-N 121.532 -0.73 . . . . 0.0 111.441 177.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -68.05 -46.48 71.0 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.869 0.868 . . . . 0.0 110.958 174.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -48.43 -42.27 31.82 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.026 1.73 . . . . 0.0 112.01 167.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.586 ' HA ' HG12 ' A' ' 117' ' ' VAL . 14.7 m-85 -84.01 -17.7 39.58 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 120.843 -1.16 . . . . 0.0 112.563 -176.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 84.1 m -80.97 -14.63 57.78 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.514 1.126 . . . . 0.0 110.469 170.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.55 -58.18 2.36 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 129.766 3.226 . . . . 0.0 112.879 176.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.586 HG12 ' HA ' ' A' ' 114' ' ' TYR . 6.0 p -74.19 -35.66 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 126.683 1.993 . . . . 0.0 113.056 -158.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.512 ' CG2' ' H ' ' A' ' 126' ' ' ILE . 0.8 OUTLIER 4.09 114.57 0.0 OUTLIER Pre-proline 0 N--CA 1.48 1.047 0 C-N-CA 130.351 3.46 . . . . 0.0 115.953 -134.711 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 118' ' ' THR . 5.7 Cg_exo -77.76 -3.84 13.94 Favored 'Trans proline' 0 CA--C 1.55 1.303 0 C-N-CA 123.711 2.941 . . . . 0.0 113.99 -159.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.4 t 62.07 112.47 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 131.62 3.968 . . . . 0.0 115.799 174.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.8 tt -72.82 75.69 1.14 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 127.909 2.483 . . . . 0.0 109.583 173.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . 0.262 0.0 OUTLIER 48.39 -15.68 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.507 1 C-N-CA 132.713 4.405 . . . . 0.0 119.004 -170.56 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -179.51 2.95 0.02 OUTLIER Glycine 0 CA--C 1.54 1.624 0 C-N-CA 125.869 1.699 . . . . 0.0 115.265 -172.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -139.62 148.0 54.19 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 126.995 2.118 . . . . 0.0 109.46 -177.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -57.6 167.0 4.24 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.35 2.7 . . . . 0.0 114.35 175.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.512 ' H ' ' CG2' ' A' ' 118' ' ' THR . 0.5 OUTLIER -120.86 148.79 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.911 1.684 . . . . 0.0 109.299 179.697 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -122.35 101.05 7.27 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.494 1.118 . . . . 0.0 110.951 -154.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.45 152.74 28.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -167.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -150.87 171.44 17.22 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 129.46 3.104 . . . . 0.0 109.418 165.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -65.38 166.01 10.87 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 120.311 -1.493 . . . . 0.0 111.394 153.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.405 ' CB ' HG13 ' A' ' 60' ' ' VAL . 83.3 p -60.26 154.11 20.76 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 120.933 -1.104 . . . . 0.0 112.546 163.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 14.3 p30 -85.69 -19.42 30.91 Favored 'General case' 0 CA--C 1.548 0.897 0 O-C-N 121.363 -0.836 . . . . 0.0 112.28 158.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 67.5 m-70 -75.21 -171.1 1.31 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.772 1.629 . . . . 0.0 111.985 164.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -141.7 121.21 13.27 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 127.123 2.169 . . . . 0.0 110.181 174.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 66.04 99.4 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 126.026 1.73 . . . . 0.0 114.939 171.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.441 HD11 HG23 ' A' ' 138' ' ' THR . 61.8 tp -61.78 125.71 24.79 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.273 1.429 . . . . 0.0 112.171 172.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -74.64 -58.14 3.48 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.023 1.329 . . . . 0.0 113.763 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.441 HG23 HD11 ' A' ' 136' ' ' LEU . 1.4 p 34.17 81.82 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 128.029 2.532 . . . . 0.0 114.988 -174.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -59.28 -26.12 64.68 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.781 0.832 . . . . 0.0 113.129 166.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 12.9 t -145.81 109.87 4.91 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.903 2.081 . . . . 0.0 110.513 168.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 97.5 p -74.9 163.18 69.94 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 125.133 1.373 . . . . 0.0 112.549 177.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -75.29 7.06 3.15 Favored 'Trans proline' 0 CA--C 1.548 1.192 0 C-N-CA 123.814 3.009 . . . . 0.0 114.65 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -50.08 116.54 1.88 Allowed 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 126.318 1.847 . . . . 0.0 112.393 174.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -52.29 -42.64 63.9 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.515 1.526 . . . . 0.0 114.063 -170.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -67.67 -14.71 63.17 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -179.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 8.5 ttm180 . . . . . 0 N--CA 1.476 0.835 0 C-N-CA 125.515 1.526 . . . . 0.0 114.612 -168.297 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 147' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.319 0 O5'-C5'-C4' 113.635 2.453 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 148' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.43 1 O5'-C5'-C4' 117.359 5.114 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 149' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.446 0 O4'-C1'-N19 111.728 3.528 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 150' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.414 -3.257 1 O4'-C1'-N19 112.857 4.657 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 151' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.277 1 O4'-C1'-N19 112.519 4.319 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 152' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.429 -2.041 0 N19-C1'-C2' 117.462 2.539 . 0.121 8d . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.608 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -63.21 -21.66 66.36 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -176.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 19.1 m -69.01 -2.51 10.12 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 126.743 2.017 . . . . 0.0 115.237 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.1 ttt85 -57.64 158.51 5.99 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 126.805 2.042 . . . . 0.0 113.149 177.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.4 p 64.0 177.47 0.17 Allowed 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 128.244 2.617 . . . . 0.0 114.893 -174.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.808 ' HB3' ' HB3' ' A' ' 57' ' ' PRO . . . -138.67 -21.59 1.0 Allowed 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 116.694 2.109 . . . . 0.0 116.694 -165.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 146.22 -85.0 0.18 Allowed Glycine 0 N--CA 1.468 0.82 0 N-CA-C 109.979 -1.249 . . . . 0.0 109.979 -172.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 13.7 t -143.69 74.13 16.82 Favored Pre-proline 0 N--CA 1.487 1.425 0 C-N-CA 124.788 1.235 . . . . 0.0 108.501 163.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.808 ' HB3' ' HB3' ' A' ' 54' ' ' ALA . 43.7 Cg_endo -91.26 86.74 0.29 Allowed 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.42 2.08 . . . . 0.0 115.272 -153.411 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 73.8 m -140.96 122.64 15.21 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.208 1.403 . . . . 0.0 112.745 177.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 41.0 mtp180 59.92 -28.78 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 131.342 3.857 . . . . 0.0 118.017 172.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.556 HG13 ' HB3' ' A' ' 131' ' ' SER . 1.7 p -98.09 134.72 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 120.254 1.388 . . . . 0.0 112.122 167.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.443 ' HA ' ' HA ' ' A' ' 130' ' ' PHE . 44.8 mt -110.07 124.32 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 C-N-CA 127.585 2.354 . . . . 0.0 108.263 168.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -83.44 149.02 26.92 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.898 0.856 . . . . 0.0 111.208 169.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 8.7 mt -124.47 140.83 46.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 126.539 1.936 . . . . 0.0 108.99 179.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.51 167.91 13.27 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 127.432 2.293 . . . . 0.0 110.464 165.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.439 ' HG2' ' CD2' ' A' ' 127' ' ' TYR . 19.8 mmtt 53.64 41.57 32.05 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.768 1.627 . . . . 0.0 113.04 -176.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.62 176.99 0.63 Allowed Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 126.493 1.917 . . . . 0.0 109.737 159.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -59.52 -175.37 0.09 OUTLIER 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 124.53 3.487 . . . . 0.0 114.543 147.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 28.7 pt -81.24 -31.99 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 126.038 1.735 . . . . 0.0 113.479 -177.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -156.37 37.44 0.33 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.557 1.943 . . . . 0.0 110.725 -168.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -51.75 156.49 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.869 0.867 . . . . 0.0 112.669 177.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.82 144.28 26.68 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 122.448 1.118 . . . . 0.0 112.188 -176.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -58.04 -42.67 85.91 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.127 171.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -53.62 -39.8 61.55 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.927 1.251 . . . . 0.0 112.938 178.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -68.37 -49.41 60.36 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.688 1.195 . . . . 0.0 112.098 173.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 95.6 t -61.61 -44.89 99.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 122.965 0.506 . . . . 0.0 112.005 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.8 pp -74.68 -30.04 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 O-C-N 120.597 -1.314 . . . . 0.0 112.488 176.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.7 t -61.92 -31.74 72.08 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 119.839 1.2 . . . . 0.0 110.482 170.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 10.3 mt -78.23 -21.83 49.34 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 175.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -98.66 -16.14 32.28 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-N 119.116 0.871 . . . . 0.0 115.186 175.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.4 mt -57.69 -54.59 53.65 Favored Pre-proline 0 CA--C 1.543 0.675 0 N-CA-C 116.823 2.157 . . . . 0.0 116.823 -168.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -77.72 41.88 1.07 Allowed 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 124.0 3.133 . . . . 0.0 114.081 -175.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -129.3 -42.48 1.34 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.901 1.68 . . . . 0.0 112.589 179.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -155.79 -99.44 0.16 Allowed Glycine 0 C--N 1.336 0.564 0 C-N-CA 124.484 1.04 . . . . 0.0 110.653 167.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 38.9 tptt -136.08 -12.84 1.9 Allowed 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 116.132 1.901 . . . . 0.0 116.132 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.521 ' HA ' ' HA ' ' A' ' 101' ' ' MET 0.25 0.1 OUTLIER 30.44 82.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 128.643 2.777 . . . . 0.0 113.247 -174.184 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.6 t -68.5 -31.03 70.0 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.092 0.957 . . . . 0.0 112.554 -170.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -147.85 174.07 12.21 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 123.296 1.522 . . . . 0.0 114.586 175.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -143.24 174.64 10.53 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 127.324 2.249 . . . . 0.0 111.371 157.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.54 ' C ' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -143.15 154.08 43.53 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.964 2.105 . . . . 0.0 108.148 169.383 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 5.0 mtp -129.71 106.51 8.76 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.641 1.176 . . . . 0.0 110.597 -176.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -74.18 76.15 1.79 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.025 0.93 . . . . 0.0 110.519 173.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt -64.54 98.62 0.26 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.986 1.314 . . . . 0.0 110.269 173.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 168.76 -52.94 0.21 Allowed Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.909 1.719 . . . . 0.0 112.689 -166.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt -133.1 12.61 4.26 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.12 1.368 . . . . 0.0 114.559 -166.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 59.83 53.38 4.84 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.014 1.726 . . . . 0.0 112.161 -172.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -130.28 166.0 21.27 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.396 1.078 . . . . 0.0 111.855 -179.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -166.05 169.97 14.01 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.513 1.925 . . . . 0.0 110.628 -177.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.545 ' CD2' HD13 ' A' ' 136' ' ' LEU . 4.5 m-30 -118.22 141.07 48.88 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.783 2.433 . . . . 0.0 105.46 166.253 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 15.6 tt -122.2 113.26 37.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 125.336 1.454 . . . . 0.0 107.446 166.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -109.71 117.01 32.77 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 127.27 2.228 . . . . 0.0 110.333 -166.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.521 ' HA ' ' HA ' ' A' ' 85' ' ' VAL 0.296 0.9 OUTLIER -121.46 146.5 46.85 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -169.067 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.426 ' ND2' HG23 ' A' ' 103' ' ' THR . 0.0 OUTLIER -63.13 -18.08 63.04 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 113.673 -1.603 . . . . 0.0 114.653 -160.579 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.426 HG23 ' ND2' ' A' ' 102' ' ' ASN . 4.1 p -139.68 146.57 39.81 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.934 0.873 . . . . 0.0 111.125 -176.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -59.34 -41.25 88.75 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.096 178.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -77.37 -35.64 54.33 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -177.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.02 -51.38 69.93 Favored 'General case' 0 C--O 1.222 -0.387 0 CA-C-N 119.992 1.269 . . . . 0.0 110.253 169.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.83 -36.53 78.3 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 178.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -57.9 -47.16 83.61 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 119.693 1.133 . . . . 0.0 111.262 170.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -64.77 -33.96 77.21 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-O 117.915 -1.041 . . . . 0.0 110.9 173.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 11.1 ttp -66.66 -47.89 71.11 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 120.019 1.281 . . . . 0.0 111.225 -178.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -68.34 -38.55 79.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 124.604 1.161 . . . . 0.0 112.055 178.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -70.18 -43.39 70.88 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.442 0.697 . . . . 0.0 110.597 176.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -49.62 -37.7 29.03 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.803 1.241 . . . . 0.0 112.075 166.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -90.77 -12.95 34.97 Favored 'General case' 0 CA--C 1.518 -0.252 0 O-C-N 120.162 -1.586 . . . . 0.0 113.657 -177.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -83.93 -15.78 46.68 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.75 0.786 . . . . 0.0 110.932 167.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.89 -59.79 2.64 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 128.567 2.747 . . . . 0.0 111.742 166.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -93.84 -49.57 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -153.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.5 m 54.88 129.36 0.01 OUTLIER Pre-proline 0 N--CA 1.481 1.101 0 C-N-CA 129.535 3.134 . . . . 0.0 113.069 -157.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -75.76 -22.25 13.7 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 121.991 1.794 . . . . 0.0 114.752 -173.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.5 t 38.87 89.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 129.223 3.009 . . . . 0.0 113.179 174.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.46 ' H ' HD11 ' A' ' 126' ' ' ILE . 2.8 tt -101.45 -50.56 3.71 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 113.444 -1.707 . . . . 0.0 110.376 -132.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.96 1.94 29.24 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 126.266 1.827 . . . . 0.0 113.64 165.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 125.46 12.37 3.81 Favored Glycine 0 CA--C 1.537 1.411 0 N-CA-C 117.108 1.603 . . . . 0.0 117.108 175.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -147.13 163.97 25.64 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 120.251 2.025 . . . . 0.0 112.837 174.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -56.74 143.57 89.73 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.522 2.815 . . . . 0.0 115.621 -168.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.46 HD11 ' H ' ' A' ' 121' ' ' LEU . 3.9 mm -118.81 147.28 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 127.292 2.237 . . . . 0.0 108.122 -178.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.439 ' CD2' ' HG2' ' A' ' 65' ' ' LYS . 19.5 m-30 -117.82 127.9 54.33 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.193 -0.942 . . . . 0.0 111.099 -169.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -124.65 147.13 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.764 1.225 . . . . 0.0 113.326 -178.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -158.37 159.43 35.8 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.308 1.843 . . . . 0.0 110.001 159.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.443 ' HA ' ' HA ' ' A' ' 61' ' ' ILE . 32.1 m-85 -56.43 162.48 2.12 Favored 'General case' 0 CA--C 1.556 1.177 0 O-C-N 120.473 -1.392 . . . . 0.0 113.057 166.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.556 ' HB3' HG13 ' A' ' 60' ' ' VAL . 5.3 p -72.25 174.72 6.86 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 116.135 1.902 . . . . 0.0 116.135 -174.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -95.37 2.58 54.67 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 127.246 2.218 . . . . 0.0 114.068 166.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -121.99 -26.72 4.72 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 117.19 2.293 . . . . 0.0 117.19 -162.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp 58.82 109.51 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 126.108 1.763 . . . . 0.0 112.963 -164.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 60.28 110.26 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 128.06 2.544 . . . . 0.0 115.406 176.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.545 HD13 ' CD2' ' A' ' 98' ' ' PHE . 32.1 tp -71.32 140.87 50.43 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.054 1.341 . . . . 0.0 111.479 174.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.72 111.24 8.06 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 126.157 1.783 . . . . 0.0 110.82 168.098 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 21.7 p -98.37 -75.95 0.54 Allowed 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 125.378 1.471 . . . . 0.0 112.222 -175.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -69.67 -23.14 63.42 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.675 1.59 . . . . 0.0 114.033 -174.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 19.3 m -74.88 54.97 0.67 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 127.162 2.185 . . . . 0.0 113.636 -177.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 46.7 m -60.1 143.97 87.63 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 124.877 1.271 . . . . 0.0 112.355 178.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -79.1 66.07 8.8 Favored 'Trans proline' 0 CA--C 1.546 1.093 0 C-N-CA 124.275 3.317 . . . . 0.0 112.218 -178.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -69.46 -20.72 63.75 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -178.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -152.23 -176.85 5.85 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.998 1.719 . . . . 0.0 112.395 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -121.19 -176.29 3.25 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 126.373 1.869 . . . . 0.0 111.189 165.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 77.3 ttt-85 . . . . . 0 N--CA 1.48 1.072 0 C-N-CA 125.868 1.667 . . . . 0.0 113.499 177.714 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 147' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.323 0 O4'-C1'-N19 111.2 3.0 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 148' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.98 1 C5'-C4'-C3' 108.105 -4.93 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 149' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.639 0 N19-C1'-C2' 108.736 -2.915 . 0.01 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 150' ' ' ' U' . . . . . 0.518 ' C4 ' HD12 ' A' ' 136' ' ' LEU . . . . . . . . 0 O4'--C4' 1.426 -2.282 2 O4'-C1'-N19 114.568 6.368 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 151' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.541 2.348 0 O4'-C1'-N19 110.987 2.787 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 152' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.325 0 C5'-C4'-C3' 110.903 -3.065 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.7 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -68.64 -45.35 72.06 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.361 1.065 . . . . 0.0 112.656 178.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 45.7 m -68.51 99.14 0.93 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.834 1.654 . . . . 0.0 112.52 -177.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 24.5 mtm180 -130.82 -49.36 1.04 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.943 1.697 . . . . 0.0 113.184 178.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 87.5 p -148.66 171.47 16.12 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.324 1.45 . . . . 0.0 112.451 177.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.454 ' HB3' ' HB3' ' A' ' 57' ' ' PRO . . . -140.43 -87.69 0.19 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.118 1.367 . . . . 0.0 110.885 177.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -148.95 43.83 0.77 Allowed Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.959 1.742 . . . . 0.0 112.09 175.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 62.1 t 53.94 72.07 1.21 Allowed Pre-proline 0 N--CA 1.48 1.042 0 C-N-CA 127.75 2.42 . . . . 0.0 109.568 -162.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.454 ' HB3' ' HB3' ' A' ' 54' ' ' ALA . 0.1 OUTLIER -96.68 164.96 1.09 Allowed 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 124.68 3.587 . . . . 0.0 112.639 -156.438 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 66.5 p -156.27 -75.52 0.1 Allowed 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -175.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 -124.73 -10.46 7.28 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 -161.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.512 HG13 ' HB3' ' A' ' 131' ' ' SER 0.337 3.8 p -112.03 135.95 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-N 119.842 1.201 . . . . 0.0 112.154 168.654 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.6 mt -114.93 150.56 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 127.629 2.372 . . . . 0.0 107.859 173.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -118.08 130.2 56.0 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.758 1.223 . . . . 0.0 110.73 178.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.5 mt -117.01 125.77 74.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 127.494 2.318 . . . . 0.0 108.414 -173.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -112.43 175.91 5.24 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 125.931 1.692 . . . . 0.0 113.024 -178.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 11.6 mmmt 59.34 27.81 16.99 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 127.392 2.277 . . . . 0.0 114.671 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.3 mp -55.01 155.63 8.17 Favored Pre-proline 0 CA--C 1.554 1.126 0 C-N-CA 124.858 1.263 . . . . 0.0 112.321 176.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.497 ' HD3' HD11 ' A' ' 121' ' ' LEU . 62.2 Cg_exo -45.8 -67.25 0.12 Allowed 'Trans proline' 0 C--N 1.351 0.706 1 C-N-CA 125.87 4.38 . . . . 0.0 115.151 -177.946 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 8.7 pt -153.05 -50.36 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 130.933 3.693 . . . . 0.0 107.615 175.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -151.52 -5.99 0.25 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.309 1.444 . . . . 0.0 114.174 178.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.291 2.8 p 43.8 -146.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 C-N-CA 127.237 2.215 . . . . 0.0 112.084 -174.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.2 t -140.02 136.02 33.27 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 120.723 -1.236 . . . . 0.0 110.522 161.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -56.76 -34.91 68.04 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.598 0.759 . . . . 0.0 113.03 179.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -55.28 -40.17 74.72 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.892 1.234 . . . . 0.0 113.434 172.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -67.12 -50.9 59.87 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.776 -0.837 . . . . 0.0 111.292 171.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 87.7 t -55.89 -49.89 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.578 0.751 . . . . 0.0 112.725 -176.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -82.01 -26.07 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 O-C-N 120.264 -1.522 . . . . 0.0 114.409 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.3 t -61.56 -32.4 72.48 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 119.76 1.164 . . . . 0.0 110.377 168.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.9 mt -76.3 -26.18 55.6 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 171.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -85.51 -19.86 57.63 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-N 119.549 1.068 . . . . 0.0 114.836 175.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 11.5 mt -69.95 -31.17 2.28 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 117.982 2.586 . . . . 0.0 117.982 -168.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -58.62 -4.63 1.96 Allowed 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 123.517 2.811 . . . . 0.0 116.821 169.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -108.41 -40.61 5.09 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -166.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -150.88 -109.78 0.47 Allowed Glycine 0 CA--C 1.525 0.665 0 CA-C-O 122.348 0.971 . . . . 0.0 111.974 176.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 17.1 tptm -147.7 138.16 23.12 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 128.895 2.878 . . . . 0.0 103.997 164.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.497 HG22 ' HE2' ' A' ' 101' ' ' MET 0.307 12.4 t -130.15 82.97 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 CA-C-N 120.717 1.599 . . . . 0.0 109.567 -163.047 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.5 t -77.08 -21.83 53.77 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 126.669 1.988 . . . . 0.0 113.149 -159.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -141.51 165.65 26.91 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-O 122.615 1.197 . . . . 0.0 113.619 165.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -137.55 179.07 6.63 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.253 1.421 . . . . 0.0 109.924 157.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.499 ' C ' HD23 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -150.47 159.12 44.71 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.395 1.478 . . . . 0.0 109.69 172.798 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 6.9 mtt -133.65 100.58 4.83 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.074 0.95 . . . . 0.0 112.529 -174.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -73.92 92.34 2.08 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.087 1.355 . . . . 0.0 111.15 171.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 48.8 mttp -62.41 -20.94 64.99 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 175.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -57.89 -53.98 41.06 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 125.768 1.651 . . . . 0.0 115.138 -174.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.5 mtmt -123.33 20.05 9.71 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 126.04 1.736 . . . . 0.0 112.01 179.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 23.2 m120 53.67 66.64 1.17 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 126.841 2.056 . . . . 0.0 112.575 -173.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . 0.257 0.0 OUTLIER -125.53 179.43 5.14 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.51 0.671 . . . . 0.0 112.471 170.087 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -154.07 162.77 40.96 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 126.542 1.937 . . . . 0.0 109.904 -176.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.48 ' CD2' HG21 ' A' ' 60' ' ' VAL . 5.6 m-30 -108.11 150.91 26.58 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.546 1.539 . . . . 0.0 107.333 159.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 18.2 tt -132.9 124.04 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 124.624 1.169 . . . . 0.0 108.405 163.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.44 ' HG3' ' H ' ' A' ' 136' ' ' LEU . 3.6 tm-20 -130.74 126.6 36.86 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 122.588 1.185 . . . . 0.0 112.946 -162.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.497 ' HE2' HG22 ' A' ' 85' ' ' VAL . 0.5 OUTLIER -134.04 161.37 35.02 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.111 -1.404 . . . . 0.0 113.933 -159.903 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -79.32 -12.64 59.93 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.391 1.877 . . . . 0.0 113.26 -161.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.34 138.38 33.05 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.845 1.258 . . . . 0.0 111.32 -178.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -62.44 -34.79 77.5 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.312 176.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -75.69 -36.53 60.01 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.763 0.825 . . . . 0.0 112.963 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -56.22 -53.68 54.23 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 118.823 0.738 . . . . 0.0 109.693 168.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.31 -36.22 79.0 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -177.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -55.19 -50.28 69.75 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.109 0.868 . . . . 0.0 110.955 168.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -65.27 -30.75 71.65 Favored 'General case' 0 C--O 1.225 -0.222 0 O-C-N 121.441 -0.787 . . . . 0.0 111.603 174.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 5.6 ttp -73.39 -46.33 49.48 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 119.908 1.231 . . . . 0.0 111.591 -177.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -65.21 -40.12 87.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 124.145 0.978 . . . . 0.0 110.958 177.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -68.5 -46.1 70.55 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.597 0.759 . . . . 0.0 110.647 176.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -48.34 -42.88 32.67 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.111 1.364 . . . . 0.0 111.937 168.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.569 ' HA ' HG12 ' A' ' 117' ' ' VAL . 17.3 m-85 -84.96 -14.21 48.28 Favored 'General case' 0 C--N 1.334 -0.105 0 O-C-N 120.764 -1.21 . . . . 0.0 112.485 -176.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 92.9 m -83.18 -14.06 54.2 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.422 1.089 . . . . 0.0 110.618 169.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.21 -56.83 2.5 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 129.228 3.011 . . . . 0.0 113.257 178.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.569 HG12 ' HA ' ' A' ' 114' ' ' TYR . 9.8 p -72.65 -33.55 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 127.187 2.195 . . . . 0.0 113.777 -157.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.428 ' CG2' ' H ' ' A' ' 126' ' ' ILE . 0.3 OUTLIER -2.25 114.36 0.01 OUTLIER Pre-proline 0 N--CA 1.484 1.256 0 C-N-CA 129.206 3.002 . . . . 0.0 116.449 -131.544 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -77.26 -7.76 17.19 Favored 'Trans proline' 0 CA--C 1.546 1.117 0 C-N-CA 123.675 2.916 . . . . 0.0 114.336 -161.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.5 t 61.05 107.95 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 130.71 3.604 . . . . 0.0 114.509 176.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.497 HD11 ' HD3' ' A' ' 67' ' ' PRO . 14.2 tp -73.17 -55.86 5.89 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.766 0.826 . . . . 0.0 112.335 -168.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -125.52 -4.95 7.14 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 127.584 2.354 . . . . 0.0 113.492 -161.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 99.63 13.87 36.56 Favored Glycine 0 CA--C 1.539 1.556 0 C-N-CA 124.282 0.944 . . . . 0.0 112.432 -148.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -138.9 144.7 42.49 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 128.402 2.681 . . . . 0.0 109.259 -178.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -57.35 168.96 2.46 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 124.0 3.133 . . . . 0.0 114.077 176.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.428 ' H ' ' CG2' ' A' ' 118' ' ' THR . 0.3 OUTLIER -125.27 149.45 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.092 1.357 . . . . 0.0 109.896 -177.661 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -120.88 101.35 7.64 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.419 -153.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.85 150.51 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.53 1.132 . . . . 0.0 112.739 -177.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -152.37 163.6 39.16 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 126.832 2.053 . . . . 0.0 109.074 154.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -53.02 151.81 4.49 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.362 -0.836 . . . . 0.0 112.076 164.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.512 ' HB3' HG13 ' A' ' 60' ' ' VAL . 31.6 t -71.6 156.22 39.65 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.665 0.745 . . . . 0.0 112.051 176.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -68.99 -7.71 37.88 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.137 1.375 . . . . 0.0 113.196 164.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 36.8 m-70 -119.47 177.89 4.75 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 127.361 2.264 . . . . 0.0 110.916 -176.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -119.55 5.9 11.07 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 -167.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 162.41 167.45 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 131.077 3.751 . . . . 0.0 111.22 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.44 ' H ' ' HG3' ' A' ' 100' ' ' GLU . 3.6 mm? -74.54 147.55 41.69 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.669 0.788 . . . . 0.0 109.475 158.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 16.4 tttp -140.39 71.13 1.36 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.558 1.171 . . . . 0.0 110.506 173.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 29.9 p -69.64 -17.43 63.51 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.339 1.856 . . . . 0.0 113.606 178.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -58.15 128.21 36.0 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.175 1.39 . . . . 0.0 111.76 166.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 87.9 p -133.31 23.4 4.09 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.327 1.851 . . . . 0.0 114.013 175.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.8 m -65.03 137.84 97.25 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 125.48 1.512 . . . . 0.0 112.744 -174.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -75.27 -9.06 20.25 Favored 'Trans proline' 0 CA--C 1.545 1.049 0 C-N-CA 123.251 2.634 . . . . 0.0 114.018 177.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.03 -22.16 65.89 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.494 1.517 . . . . 0.0 114.342 -172.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -139.55 -19.08 0.95 Allowed 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 115.647 1.721 . . . . 0.0 115.647 -174.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -157.75 -159.42 0.83 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.979 1.712 . . . . 0.0 110.432 -177.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.344 0 C-N-CA 126.168 1.787 . . . . 0.0 113.736 178.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 147' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.536 2.012 0 O4'-C1'-N19 111.034 2.834 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 148' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.173 0 O4'-C1'-N19 112.039 3.839 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 149' ' ' ' C' . . . . . 0.406 ' N3 ' ' HA ' ' A' ' 131' ' ' SER . . . . . . . . 0 O4'--C4' 1.424 -2.424 0 O4'-C1'-N19 112.047 3.847 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 150' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -3.034 2 O4'-C1'-N19 113.204 5.004 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 151' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.192 0 C5'-C4'-C3' 111.282 -2.812 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 152' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.365 1 O4'-C1'-N19 113.467 5.267 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.597 0 N-CA-C 111.559 -0.617 . . . . 0.0 111.559 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -72.42 172.19 10.89 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.23 1.012 . . . . 0.0 113.54 176.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 16.5 m -76.51 -12.56 60.05 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 116.283 1.957 . . . . 0.0 116.283 -170.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 61.9 mtp180 -101.69 151.64 21.79 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 119.96 1.255 . . . . 0.0 113.235 -167.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.2 m -87.79 -10.2 51.64 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.338 1.455 . . . . 0.0 113.711 171.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.554 ' HB1' ' HB3' ' A' ' 57' ' ' PRO . . . -143.64 159.77 41.87 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.777 1.631 . . . . 0.0 112.325 175.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -140.02 -42.74 0.07 OUTLIER Glycine 0 CA--C 1.537 1.415 0 C-N-CA 126.135 1.826 . . . . 0.0 113.181 171.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 20.1 t -140.5 75.12 27.42 Favored Pre-proline 0 N--CA 1.485 1.306 0 C-N-CA 126.293 1.837 . . . . 0.0 108.862 168.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.554 ' HB3' ' HB1' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -98.6 -0.74 1.11 Allowed 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 125.095 3.863 . . . . 0.0 114.344 -163.427 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 31.5 t 55.98 -87.74 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 128.037 2.535 . . . . 0.0 115.354 175.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 21.9 mtp180 -139.54 -9.19 1.25 Allowed 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 117.01 2.226 . . . . 0.0 117.01 -154.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.539 HG13 ' HB3' ' A' ' 131' ' ' SER 0.272 3.9 p -106.82 131.15 57.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 CA-C-N 120.615 1.552 . . . . 0.0 112.13 169.46 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.2 mt -109.97 155.8 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 127.672 2.389 . . . . 0.0 108.231 170.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -124.02 138.72 54.41 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.349 1.46 . . . . 0.0 110.689 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.2 mt -122.38 132.18 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 126.95 2.1 . . . . 0.0 109.807 -171.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.96 173.89 6.12 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 125.803 1.641 . . . . 0.0 113.246 178.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 13.8 mmmt 64.9 15.98 10.24 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 128.903 2.881 . . . . 0.0 116.416 173.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 30.8 mt -61.99 141.89 95.45 Favored Pre-proline 0 CA--C 1.555 1.158 0 CA-C-O 118.444 -0.788 . . . . 0.0 110.517 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -37.54 -62.92 0.26 Allowed 'Trans proline' 0 CA--C 1.539 0.766 1 C-N-CA 125.589 4.193 . . . . 0.0 116.043 -177.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 11.1 pt -153.74 -42.44 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 129.964 3.306 . . . . 0.0 109.323 174.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -153.3 -7.49 0.17 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.412 1.485 . . . . 0.0 113.187 -170.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.415 HG22 ' H ' ' A' ' 71' ' ' THR 0.298 12.0 p 34.27 -122.21 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 127.09 2.156 . . . . 0.0 111.496 -165.474 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.415 ' H ' HG22 ' A' ' 70' ' ' VAL . 0.9 OUTLIER -148.75 135.55 19.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 122.368 1.08 . . . . 0.0 109.045 152.775 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -55.17 -31.13 61.12 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.057 0.943 . . . . 0.0 112.768 178.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -60.42 -37.94 93.98 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 124.832 1.206 . . . . 0.0 114.121 172.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -69.86 -44.86 68.98 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.422 -1.046 . . . . 0.0 110.579 172.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 85.5 t -57.76 -51.76 66.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 123.808 0.843 . . . . 0.0 112.182 -176.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -78.92 -26.06 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 O-C-N 120.341 -1.474 . . . . 0.0 114.381 177.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 38.7 t -62.15 -28.53 69.72 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 119.846 1.203 . . . . 0.0 110.553 169.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 22.8 mt -82.55 -23.48 34.48 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.923 1.082 . . . . 0.0 113.923 170.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -89.06 -11.02 65.6 Favored Glycine 0 CA--C 1.534 1.229 0 CA-C-N 119.406 1.003 . . . . 0.0 114.67 176.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.2 mt -77.55 -17.12 0.26 Allowed Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 118.859 2.911 . . . . 0.0 118.859 -174.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -59.6 -2.51 1.51 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.868 2.379 . . . . 0.0 117.363 169.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -119.56 -44.77 2.54 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -166.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -150.88 -108.52 0.42 Allowed Glycine 0 C--N 1.337 0.591 0 C-N-CA 123.796 0.712 . . . . 0.0 111.581 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 21.7 tptp -142.84 -15.73 0.71 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 115.524 1.675 . . . . 0.0 115.524 -171.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.563 HG13 ' HB2' ' A' ' 101' ' ' MET 0.256 0.2 OUTLIER 34.6 81.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 128.159 2.584 . . . . 0.0 113.493 175.088 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 54.3 p -68.06 -36.18 79.43 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.352 1.061 . . . . 0.0 112.205 -169.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -145.0 165.71 27.39 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 123.611 1.672 . . . . 0.0 114.838 -177.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -150.31 169.14 22.1 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 126.489 1.916 . . . . 0.0 112.377 162.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.527 ' C ' HD23 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -145.67 150.97 37.28 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 127.305 2.242 . . . . 0.0 108.536 -174.724 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 5.5 mtp -133.45 94.97 3.4 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.786 0.834 . . . . 0.0 111.811 -169.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.406 ' CD1' HD21 ' A' ' 89' ' ' LEU . 0.8 OUTLIER -72.34 84.35 1.07 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.102 1.361 . . . . 0.0 111.443 175.244 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.01 -11.28 12.82 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 115.265 1.579 . . . . 0.0 115.265 170.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -60.62 -56.45 24.26 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 126.403 1.954 . . . . 0.0 114.494 177.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 31.6 mtmt -125.49 22.51 7.66 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 126.16 1.784 . . . . 0.0 112.144 -176.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 57.51 56.18 5.16 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.559 2.344 . . . . 0.0 113.92 -178.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . 0.264 0.0 OUTLIER -129.63 -179.39 5.15 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 173.964 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -158.25 164.78 36.14 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.72 2.008 . . . . 0.0 110.44 -177.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.5 ' CD2' HG21 ' A' ' 60' ' ' VAL . 4.8 m-30 -111.14 151.77 27.78 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.488 1.915 . . . . 0.0 107.896 163.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.9 tt -133.79 104.21 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 C-N-CA 125.544 1.538 . . . . 0.0 108.018 167.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -97.77 127.69 43.9 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 128.387 2.675 . . . . 0.0 110.762 -174.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.563 ' HB2' HG13 ' A' ' 85' ' ' VAL 0.305 20.8 ttm -126.86 157.52 39.12 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 -173.921 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.429 ' ND2' HG23 ' A' ' 103' ' ' THR . 19.9 p-10 -54.54 -37.07 64.98 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 127.037 2.135 . . . . 0.0 114.299 -172.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.429 HG23 ' ND2' ' A' ' 102' ' ' ASN . 69.2 p -141.39 137.78 32.53 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.976 0.91 . . . . 0.0 110.589 -162.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -59.81 -38.62 82.48 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.658 0.783 . . . . 0.0 112.041 -177.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -74.18 -37.94 63.79 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -178.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -57.64 -48.85 78.31 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 119.185 0.902 . . . . 0.0 110.408 169.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.74 -37.29 70.58 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.338 0.972 . . . . 0.0 113.585 -178.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -55.21 -50.86 68.3 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 120.96 -1.088 . . . . 0.0 111.085 169.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -64.33 -27.84 69.3 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-O 117.961 -1.019 . . . . 0.0 111.466 173.048 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 16.7 ttp -71.64 -47.78 52.18 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-N 120.444 1.474 . . . . 0.0 110.335 -177.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.51 -40.61 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 123.636 0.775 . . . . 0.0 111.207 176.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -67.43 -47.28 70.67 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.586 0.754 . . . . 0.0 110.829 177.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -48.26 -41.84 28.89 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.93 1.692 . . . . 0.0 112.561 167.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.601 ' HA ' HG12 ' A' ' 117' ' ' VAL . 16.8 m-85 -85.36 -17.62 36.21 Favored 'General case' 0 C--O 1.232 0.166 0 O-C-N 120.551 -1.343 . . . . 0.0 112.613 -177.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 67.5 m -78.18 -16.58 57.76 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.071 0.948 . . . . 0.0 110.193 169.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.47 -57.43 2.77 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 129.126 2.97 . . . . 0.0 112.808 177.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.601 HG12 ' HA ' ' A' ' 114' ' ' TYR . 8.8 p -76.68 -40.82 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.504 1.521 . . . . 0.0 113.66 -154.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 11.52 113.67 0.0 OUTLIER Pre-proline 0 N--CA 1.482 1.14 0 C-N-CA 129.011 2.924 . . . . 0.0 116.175 -133.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.444 ' HD2' HD12 ' A' ' 126' ' ' ILE . 3.9 Cg_exo -75.77 -19.33 16.39 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.463 2.775 . . . . 0.0 112.969 -165.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 6.4 t 61.08 110.19 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 130.514 3.526 . . . . 0.0 113.065 -178.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.0 tt -75.0 80.01 2.19 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.732 1.613 . . . . 0.0 109.6 -176.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . 0.29 2.9 ppt_? 46.61 -13.19 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.249 1 C-N-CA 132.733 4.413 . . . . 0.0 118.906 -168.944 . . . . . . . . 3 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -174.04 3.37 0.03 OUTLIER Glycine 0 CA--C 1.538 1.512 0 N-CA-C 116.493 1.357 . . . . 0.0 116.493 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 5.3 tp60 -139.37 140.72 26.63 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 126.019 1.728 . . . . 0.0 109.489 -177.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.94 164.68 7.73 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 123.628 2.885 . . . . 0.0 113.329 174.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.444 HD12 ' HD2' ' A' ' 119' ' ' PRO . 0.7 OUTLIER -127.76 147.6 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.462 1.105 . . . . 0.0 110.762 -174.737 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -127.19 102.07 6.78 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.637 1.175 . . . . 0.0 109.923 -153.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.8 150.19 23.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -173.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -153.04 161.98 41.87 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 126.485 1.914 . . . . 0.0 109.264 154.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -53.33 151.39 5.43 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-O 121.756 0.788 . . . . 0.0 112.24 164.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.539 ' HB3' HG13 ' A' ' 60' ' ' VAL . 32.6 t -68.09 154.21 42.14 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.901 0.88 . . . . 0.0 112.283 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -64.22 -16.72 62.59 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.35 1.06 . . . . 0.0 112.85 165.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 54.9 m-70 -110.57 -176.95 3.11 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 127.523 2.329 . . . . 0.0 112.075 -176.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -134.47 153.58 51.86 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.607 1.563 . . . . 0.0 110.975 159.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 45.93 93.71 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 128.313 2.645 . . . . 0.0 115.262 -178.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 25.2 tp -56.09 100.34 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 127.463 2.305 . . . . 0.0 112.38 173.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -81.64 94.85 7.02 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.832 2.053 . . . . 0.0 109.478 172.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 6.7 t -131.25 7.57 4.61 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.277 1.431 . . . . 0.0 113.615 -176.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -77.54 -3.01 38.5 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.942 1.697 . . . . 0.0 115.156 -173.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 63.6 m -58.0 151.6 18.18 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.91 1.284 . . . . 0.0 113.216 179.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 19.5 m -55.63 118.25 18.73 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 125.615 1.566 . . . . 0.0 113.5 -172.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.59 -37.94 94.67 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 124.195 3.263 . . . . 0.0 115.142 178.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 23.5 t30 -143.4 110.6 5.73 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.555 1.542 . . . . 0.0 110.928 -174.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -151.58 164.86 35.93 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 128.98 2.912 . . . . 0.0 111.087 -2.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -77.54 169.12 18.85 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.187 0.995 . . . . 0.0 112.545 168.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.484 1.257 0 C-N-CA 127.697 2.399 . . . . 0.0 114.723 171.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 147' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.427 -2.18 0 O4'-C1'-N19 110.811 2.611 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 148' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.425 -2.33 1 C5'-C4'-C3' 108.391 -4.739 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 149' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.385 1 N19-C1'-C2' 106.793 -4.129 . 0.139 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 150' ' ' ' U' . . . . . 0.422 " C1'" HD11 ' A' ' 89' ' ' LEU . . . . . . . . 0 O4'--C4' 1.413 -3.311 0 C3'-C2'-C1' 104.893 3.77 . 0.0 OUTLIER '7D dist 4a' 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 151' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.429 -1.998 0 O4'-C1'-N19 111.807 3.607 . 0.01 5q . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 152' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.536 2.022 0 O4'-C1'-N19 111.561 3.361 . 0.0 OUTLIER '7D dist 2o' 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.498 0 N-CA-C 112.257 -0.337 . . . . 0.0 112.257 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -65.51 -27.24 68.33 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.92 1.288 . . . . 0.0 114.104 -178.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 45.2 m -64.97 100.19 0.4 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.173 1.789 . . . . 0.0 112.62 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 82.9 mtt85 -67.08 168.85 9.38 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.138 1.375 . . . . 0.0 112.195 170.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.4 m -123.99 -80.01 0.62 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.146 1.378 . . . . 0.0 110.588 174.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.476 ' HB1' ' HB3' ' A' ' 57' ' ' PRO . . . -98.62 -25.38 14.74 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.212 1.005 . . . . 0.0 113.221 175.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.47 51.03 4.5 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.585 1.088 . . . . 0.0 113.113 175.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 40.5 t 48.63 74.51 0.8 Allowed Pre-proline 0 N--CA 1.478 0.965 0 C-N-CA 127.727 2.411 . . . . 0.0 110.985 -172.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.476 ' HB3' ' HB1' ' A' ' 54' ' ' ALA . 0.3 OUTLIER -93.92 176.65 1.25 Allowed 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 124.498 3.465 . . . . 0.0 113.595 -155.427 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.0 t -152.48 -157.79 0.83 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.948 1.299 . . . . 0.0 111.887 177.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.4 mtp180 -46.61 -20.44 0.13 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 130.436 3.494 . . . . 0.0 119.167 -166.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.682 HG13 ' HB3' ' A' ' 131' ' ' SER 0.311 7.4 p -93.9 130.8 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 CA-C-N 121.585 1.993 . . . . 0.0 112.946 173.759 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 21.6 mt -105.21 156.97 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 127.19 2.196 . . . . 0.0 108.338 167.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.403 ' CD2' ' C6 ' ' B' ' 149' ' ' ' C' . 1.0 OUTLIER -121.62 140.64 51.99 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.706 1.602 . . . . 0.0 110.374 177.314 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.0 mt -120.37 141.11 42.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 127.667 2.387 . . . . 0.0 108.777 -176.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.12 -171.79 2.05 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 125.667 1.587 . . . . 0.0 111.244 176.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 52.71 11.62 0.21 Allowed 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 127.664 2.386 . . . . 0.0 117.363 169.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 22.4 mt -62.75 155.94 67.73 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 124.785 1.234 . . . . 0.0 113.241 -176.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -51.95 173.06 0.12 Allowed 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 123.58 2.853 . . . . 0.0 114.669 161.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 32.5 pt -69.54 -30.78 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 126.568 1.947 . . . . 0.0 112.951 -172.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -156.36 34.86 0.32 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.78 2.032 . . . . 0.0 110.702 -170.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -53.09 147.75 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 O-C-N 121.095 -1.003 . . . . 0.0 111.051 174.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.41 HG23 ' H ' ' A' ' 74' ' ' GLU . 5.5 t -88.91 136.83 32.8 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 123.05 1.405 . . . . 0.0 112.187 -173.19 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -55.49 -34.45 64.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.588 -1.187 . . . . 0.0 112.984 171.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -54.83 -40.3 71.48 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 124.856 1.217 . . . . 0.0 113.277 171.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.41 ' H ' HG23 ' A' ' 71' ' ' THR . 12.0 mt-10 -66.94 -51.2 58.15 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.052 0.941 . . . . 0.0 110.868 172.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 86.2 t -58.61 -48.7 84.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 123.652 0.781 . . . . 0.0 112.788 -175.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -80.7 -24.64 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 O-C-N 120.191 -1.568 . . . . 0.0 114.432 177.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 75.5 m -64.16 -27.1 68.84 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 120.407 1.458 . . . . 0.0 110.856 168.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.7 mt -77.68 -28.38 51.06 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 118.16 -0.924 . . . . 0.0 113.237 170.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -89.44 -13.78 61.02 Favored Glycine 0 CA--C 1.536 1.404 0 CA-C-N 119.979 1.263 . . . . 0.0 115.425 175.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.3 mt -68.13 -38.06 12.74 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 117.429 2.381 . . . . 0.0 117.429 -169.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -57.51 -3.52 0.94 Allowed 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.89 3.06 . . . . 0.0 117.277 173.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -106.34 -27.12 11.18 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -164.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -172.14 -95.45 0.1 OUTLIER Glycine 0 C--N 1.336 0.542 0 C-N-CA 124.631 1.11 . . . . 0.0 110.634 169.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.7 tppt? -149.24 155.65 40.91 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 127.021 2.129 . . . . 0.0 105.503 160.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.623 HG22 ' CE ' ' A' ' 101' ' ' MET . 3.1 t -131.4 102.0 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 120.341 1.428 . . . . 0.0 110.05 -171.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 30.5 m -67.23 -46.88 72.47 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 128.872 2.869 . . . . 0.0 112.22 -162.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 53.3 m-20 -144.92 162.06 37.8 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 122.236 1.017 . . . . 0.0 112.491 177.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -135.61 171.78 13.95 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.378 1.071 . . . . 0.0 110.936 157.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.529 ' C ' HD23 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -145.56 152.36 39.59 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.563 1.545 . . . . 0.0 109.11 -179.42 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 8.2 mtt -131.61 104.13 6.77 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.139 0.976 . . . . 0.0 112.408 -175.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -78.03 74.03 4.58 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.019 1.328 . . . . 0.0 109.878 170.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -58.27 -28.78 65.26 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -172.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -79.15 -6.49 88.84 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 125.279 1.419 . . . . 0.0 115.491 175.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.4 mtmt -120.8 4.47 10.53 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.252 1.821 . . . . 0.0 114.139 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 15.5 m120 54.42 38.5 29.7 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.317 1.447 . . . . 0.0 112.507 -170.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -137.09 160.0 40.24 Favored 'General case' 0 CA--C 1.554 1.129 0 O-C-N 121.258 -0.901 . . . . 0.0 111.032 -159.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -154.78 167.82 28.93 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 120.127 -1.608 . . . . 0.0 112.644 -177.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.442 ' CD2' HG21 ' A' ' 60' ' ' VAL . 5.4 m-30 -116.05 155.52 27.98 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.63 1.972 . . . . 0.0 108.818 165.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 16.6 tt -139.68 99.41 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 125.373 1.469 . . . . 0.0 109.249 168.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.0 tp10 -88.97 122.67 32.57 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 128.617 2.767 . . . . 0.0 110.628 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.623 ' CE ' HG22 ' A' ' 85' ' ' VAL 0.332 0.9 OUTLIER -119.17 161.18 20.78 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 -176.942 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.0 -15.81 63.08 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.376 1.47 . . . . 0.0 113.336 -164.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.28 144.77 33.44 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 122.153 0.978 . . . . 0.0 111.069 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -60.98 -43.42 98.84 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.78 177.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -73.55 -35.42 65.5 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -178.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -57.13 -54.61 44.81 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 168.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.58 -39.17 91.33 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 120.986 -1.071 . . . . 0.0 113.458 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -49.3 -55.07 13.98 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 120.226 1.375 . . . . 0.0 113.211 168.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -62.49 -34.62 77.21 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 118.708 -0.663 . . . . 0.0 111.012 175.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 4.6 ttp -63.34 -56.05 19.52 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.009 1.324 . . . . 0.0 110.189 179.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -61.4 -37.57 78.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 125.877 1.671 . . . . 0.0 112.006 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -69.96 -46.42 65.3 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.706 0.802 . . . . 0.0 111.301 177.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -49.35 -38.48 28.33 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.434 0.694 . . . . 0.0 111.821 166.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.671 ' HA ' HG12 ' A' ' 117' ' ' VAL . 14.4 m-85 -83.98 -20.69 32.41 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 120.723 -1.236 . . . . 0.0 113.075 -174.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -82.56 -13.69 56.15 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.993 0.901 . . . . 0.0 111.222 171.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.77 -53.17 5.3 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 127.721 2.408 . . . . 0.0 112.37 174.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.671 HG12 ' HA ' ' A' ' 114' ' ' TYR . 10.0 p -75.8 -42.66 40.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 125.695 1.598 . . . . 0.0 114.868 -157.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.438 ' CA ' HG13 ' A' ' 117' ' ' VAL . 0.2 OUTLIER 1.53 113.35 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.462 0 C-N-CA 127.349 2.26 . . . . 0.0 116.437 -124.836 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.425 ' HD2' HD12 ' A' ' 126' ' ' ILE . 5.4 Cg_exo -76.66 -18.85 14.99 Favored 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 123.604 2.869 . . . . 0.0 113.216 -164.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.6 t 62.46 105.05 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 129.938 3.295 . . . . 0.0 112.947 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.8 tt -70.87 -64.35 0.92 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.233 0.613 . . . . 0.0 111.563 -162.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -142.02 71.69 1.36 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.492 1.517 . . . . 0.0 109.879 172.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 77.85 8.82 87.24 Favored Glycine 0 CA--C 1.538 1.476 0 N-CA-C 115.641 1.016 . . . . 0.0 115.641 -179.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -138.29 139.34 25.0 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 126.142 1.777 . . . . 0.0 110.417 177.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -58.79 162.07 13.87 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 123.35 2.7 . . . . 0.0 111.872 171.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.425 HD12 ' HD2' ' A' ' 119' ' ' PRO . 3.0 mt -106.39 -45.07 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -156.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 77.25 110.07 0.07 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.992 2.117 . . . . 0.0 112.103 170.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.47 153.84 35.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 125.723 1.609 . . . . 0.0 111.206 178.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -151.33 164.2 37.21 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.919 1.688 . . . . 0.0 109.005 151.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -51.89 146.16 8.75 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.278 -0.889 . . . . 0.0 111.673 164.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.682 ' HB3' HG13 ' A' ' 60' ' ' VAL . 29.0 t -68.73 154.37 42.07 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.919 -0.488 . . . . 0.0 111.576 178.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -63.54 -20.42 65.62 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.177 0.991 . . . . 0.0 112.525 165.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 37.4 m-70 -101.08 177.43 4.95 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.955 2.102 . . . . 0.0 110.665 178.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -128.7 7.66 5.72 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.94 1.296 . . . . 0.0 113.87 -168.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -173.16 155.58 3.0 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 127.821 2.449 . . . . 0.0 109.643 -167.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 47.6 tp -134.61 74.46 1.53 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.528 1.931 . . . . 0.0 110.034 170.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -80.76 91.36 5.9 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.709 1.204 . . . . 0.0 109.651 176.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 22.8 p -68.58 -15.83 63.66 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.977 1.711 . . . . 0.0 114.366 -177.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 27.7 t70 46.15 58.29 4.59 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 127.282 2.233 . . . . 0.0 114.287 172.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 22.1 m -61.46 161.31 9.64 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.495 1.518 . . . . 0.0 113.868 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 37.3 m -62.64 157.79 55.39 Favored Pre-proline 0 N--CA 1.476 0.849 0 C-N-CA 125.04 1.336 . . . . 0.0 113.293 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -54.92 153.76 24.12 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.799 2.999 . . . . 0.0 114.219 173.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -106.54 -21.17 13.15 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.633 1.173 . . . . 0.0 114.051 -178.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -69.81 147.07 50.87 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.164 0.985 . . . . 0.0 111.461 178.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -58.48 -43.96 89.19 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.554 1.541 . . . . 0.0 114.239 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 56.9 mmm-85 . . . . . 0 N--CA 1.483 1.187 0 C-N-CA 126.247 1.819 . . . . 0.0 114.804 -176.894 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 147' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.538 2.13 0 O4'-C1'-N19 110.492 2.292 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 148' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.43 0 O4'-C4'-C3' 108.78 2.343 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 149' ' ' ' C' . . . . . 0.403 ' C6 ' ' CD2' ' A' ' 62' ' ' HIS . . . . . . . . 0 O4'--C4' 1.422 -2.588 0 N19-C1'-C2' 107.263 -3.836 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 150' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.822 2 O4'-C1'-N19 113.41 5.21 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 151' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.54 2.293 1 C5'-C4'-C3' 108.878 -4.415 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 152' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 C5'--C4' 1.544 2.598 0 C5'-C4'-C3' 110.034 -3.644 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 stop_ save_